Clustering O 0 1.07765890788869e-05
of O 0 9.461795684728713e-07
missense O 0 9.716707154439064e-07
mutations O 0 1.895589640810158e-08
in O 0 1.5676491216254362e-08
the O 0 1.3271310308482498e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 5.264096216706093e-07
in O 0 8.958777719669797e-09
a O 0 5.47950484985904e-09
sporadic B-Disease 0 0.0001917782356031239
T I-Disease 1 0.9999998807907104
- I-Disease 1 0.502140998840332
cell I-Disease 0 0.04811267927289009
leukaemia I-Disease 1 0.9999911785125732
. O 0 2.1437649877498188e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0009815243538469076
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.61312443589668e-09
is O 0 4.484904461699024e-11
a O 0 1.0813389073049962e-10
recessive B-Disease 0 5.21900780370288e-08
multi I-Disease 1 0.9302815198898315
- I-Disease 1 0.9999709129333496
system I-Disease 1 0.9999942779541016
disorder I-Disease 1 0.9999998807907104
caused O 0 7.078873665022911e-08
by O 0 1.4988126018078418e-10
mutations O 0 3.265033798882655e-10
in O 0 2.9072344531755334e-10
the O 0 5.219509824350155e-10
ATM O 0 1.8778857338475063e-05
gene O 0 1.1445301595358615e-08
at O 0 9.228418207385403e-08
11q22 O 0 1.979757598746801e-06
- O 0 6.137564696473419e-07
q23 O 0 1.1422433772168006e-06
( O 0 2.6983504319844087e-09
ref O 0 2.5032127268787008e-06
. O 0 2.4132833509327156e-09
3 O 0 2.4589400737795586e-08
) O 0 4.301722589250545e-10
. O 0 2.202900750702952e-09

The O 0 6.891414727761003e-07
risk O 0 1.6564408156227728e-07
of O 0 1.1590864232857712e-06
cancer B-Disease 0 0.003504282794892788
, O 0 1.8315048366801534e-09
especially O 0 1.872733612628963e-08
lymphoid B-Disease 0 0.0626319870352745
neoplasias I-Disease 1 0.8578938841819763
, O 0 6.696850185505809e-09
is O 0 2.012561367559229e-10
substantially O 0 3.564942563372142e-09
elevated O 0 1.3800846545564127e-06
in O 0 4.894730665228053e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.92440165089647e-07
and O 0 2.140948085482819e-09
has O 0 8.836259501876498e-11
long O 0 1.1244102871010853e-10
been O 0 3.9012602176535793e-11
associated O 0 7.94472709841898e-10
with O 0 1.474885102936696e-08
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.0433117267893977e-06

By O 0 5.450477758017769e-08
analysing O 0 1.103932208934566e-05
tumour B-Disease 1 1.0
DNA O 0 4.902644377580145e-06
from O 0 1.7491190718033067e-08
patients O 0 1.036306374047058e-09
with O 0 1.5884393800291718e-10
sporadic B-Disease 0 0.00012339411478023976
T I-Disease 1 0.9999998807907104
- I-Disease 0 0.00860804133117199
cell I-Disease 0 4.356267163529992e-05
prolymphocytic I-Disease 1 0.9984819293022156
leukaemia I-Disease 1 0.9999958276748657
( O 0 1.741994850590345e-07
T B-Disease 1 0.9999977350234985
- I-Disease 0 0.0011751154670491815
PLL I-Disease 1 0.9999946355819702
) O 0 1.4366328127124461e-09
, O 0 8.54737530753269e-11
a O 0 1.1570223945600588e-10
rare O 0 1.0870889077807533e-08
clonal B-Disease 0 2.8888507586088963e-05
malignancy I-Disease 0 0.003978035878390074
with O 0 2.4719741809065e-09
similarities O 0 3.5632565786869463e-09
to O 0 4.244321838431375e-10
a O 0 4.3146668460281035e-09
mature B-Disease 0 6.683887363578833e-07
T I-Disease 1 0.9995135068893433
- I-Disease 0 6.054281766409986e-05
cell I-Disease 0 4.250290658092126e-06
leukaemia I-Disease 0 0.0358627513051033
seen O 0 1.2198876575553186e-08
in O 0 2.0587176408071173e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
, O 0 2.380577512894888e-09
we O 0 2.383964900487534e-11
demonstrate O 0 7.243113053778671e-11
a O 0 2.7326661766746696e-11
high O 0 1.3336725057655485e-09
frequency O 0 6.658230078393501e-10
of O 0 1.862832332832909e-09
ATM O 0 3.4151457839470822e-06
mutations O 0 2.459193382264857e-08
in O 0 6.418729014967539e-08
T B-Disease 1 0.9999456405639648
- I-Disease 0 0.0010613524354994297
PLL I-Disease 1 0.9889717698097229
. O 0 1.8647837407570478e-07

In O 0 1.8547363822563057e-07
marked O 0 3.671904025281947e-08
contrast O 0 1.981704356168734e-09
to O 0 1.5541667952589933e-10
the O 0 7.022600279071867e-10
ATM O 0 5.353097549232189e-06
mutation O 0 2.1845238951101464e-09
pattern O 0 1.4803836378973756e-08
in O 0 3.725880048932595e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
, O 0 1.7210286529234509e-09
the O 0 2.959297806803818e-10
most O 0 5.275855707170818e-12
frequent O 0 2.4496675521401556e-11
nucleotide O 0 2.4385643504487575e-10
changes O 0 4.0854687688440805e-11
in O 0 9.746005391608747e-11
this O 0 6.662431717430195e-11
leukaemia B-Disease 0 1.5699397408752702e-05
were O 0 7.61128315929227e-09
missense O 0 1.1729496236512205e-06
mutations O 0 2.0269409617412748e-07
. O 0 9.122870636701919e-08

These O 0 4.240199302785186e-08
clustered O 0 3.155867034365656e-07
in O 0 3.1157743052290243e-09
the O 0 1.457595710796511e-09
region O 0 9.320750837815694e-10
corresponding O 0 2.5545651705094485e-10
to O 0 1.9070107992735785e-10
the O 0 8.629464920417718e-10
kinase O 0 2.846657798372121e-09
domain O 0 1.0216868462364914e-09
, O 0 3.815687696362424e-11
which O 0 1.665145625551201e-11
is O 0 3.750744506647585e-12
highly O 0 1.8758060382761954e-10
conserved O 0 1.1182682557731027e-09
in O 0 3.0201291467690794e-10
ATM O 0 6.748835517100815e-07
- O 0 2.794860520793918e-08
related O 0 6.49331122204444e-09
proteins O 0 1.1514745407170679e-10
in O 0 1.5973968814364525e-09
mouse O 0 1.6489693166477082e-08
, O 0 5.019400450834155e-10
yeast O 0 9.48369383024783e-09
and O 0 6.210300274034353e-09
Drosophila O 0 4.620355014139932e-07
. O 0 1.7253384498872038e-08

The O 0 7.035745284156292e-07
resulting O 0 1.3609329130304104e-07
amino O 0 5.5064539594695816e-08
- O 0 1.0974476793990107e-07
acid O 0 5.565751415304021e-09
substitutions O 0 2.934093501494317e-08
are O 0 1.259484044835446e-10
predicted O 0 1.7382228989504256e-09
to O 0 1.4790922653329375e-10
interfere O 0 1.0104797887322547e-08
with O 0 1.4349540444769104e-09
ATP O 1 0.999995231628418
binding O 0 4.030990652381661e-08
or O 0 7.555538417136631e-09
substrate O 0 9.07817394590893e-08
recognition O 0 5.094590349585815e-08
. O 0 4.154127708488886e-08

Two O 0 1.6737654107146227e-07
of O 0 5.816850716655608e-07
seventeen O 0 2.1256030322547304e-06
mutated O 0 3.135538236165303e-06
T B-Disease 0 0.19770176708698273
- I-Disease 0 9.636766662879381e-06
PLL I-Disease 0 0.0007072559674270451
samples O 0 2.46500722056453e-08
had O 0 4.933491948300173e-10
a O 0 1.9660079120242813e-10
previously O 0 4.3448924458289184e-09
reported O 0 1.9675967521948223e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
allele O 0 5.743711426475784e-07
. O 0 6.930564921958648e-08

In O 0 1.1180197390103785e-07
contrast O 0 1.090715251450547e-08
, O 0 9.234837339278101e-10
no O 0 1.7230115945121582e-10
mutations O 0 2.8936528173595377e-10
were O 0 7.184872696797129e-10
detected O 0 4.5985135699311286e-09
in O 0 1.5003485953624107e-10
the O 0 3.560503003541271e-10
p53 O 0 7.030842574806684e-10
gene O 0 8.466511380866848e-10
, O 0 8.631781400758598e-11
suggesting O 0 2.0690303637049823e-10
that O 0 5.840797897421757e-12
this O 0 8.889271263523568e-11
tumour B-Disease 1 1.0
suppressor O 0 1.520651835562603e-06
is O 0 3.276531268525673e-10
not O 0 1.4548584559292976e-11
frequently O 0 1.2002845939385054e-10
altered O 0 3.7629175331233e-09
in O 0 1.3316948654917837e-09
this O 0 2.929026132747481e-09
leukaemia B-Disease 0 0.008186345919966698
. O 0 8.208363766470939e-08

Occasional O 0 4.330567207944114e-06
missense O 0 1.4032302715349942e-06
mutations O 0 1.0390778015789692e-08
in O 0 8.152689190410456e-09
ATM O 0 1.0582130926195532e-05
were O 0 1.4469320852583678e-08
also O 0 1.7537205021511681e-10
found O 0 1.6194193208640684e-10
in O 0 6.91744439507147e-10
tumour B-Disease 1 0.9999998807907104
DNA O 0 1.3726959195992094e-06
from O 0 4.9919250955099415e-09
patients O 0 4.5850237495592694e-10
with O 0 9.807079592860646e-10
B B-Disease 0 0.05386103689670563
- I-Disease 0 1.5927040522001334e-06
cell I-Disease 0 3.1658447596782935e-07
non I-Disease 0 0.009623067453503609
- I-Disease 1 0.9998675584793091
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9998923540115356
( O 0 1.4625087807473847e-08
B B-Disease 0 2.7809111998067237e-05
- I-Disease 0 1.349451252963263e-07
NHL I-Disease 0 4.817912486032583e-05
) O 0 9.757239460839173e-11
and O 0 1.0771313702084839e-10
a O 0 1.1170403491078673e-09
B B-Disease 0 1.0142751307284925e-05
- I-Disease 0 3.202380867151078e-07
NHL I-Disease 0 0.000766198558267206
cell O 0 1.2837136864618515e-06
line O 0 4.875146260019392e-07
. O 0 2.0456763394349764e-08

The O 0 1.0130391103757574e-07
evidence O 0 6.25853289193401e-08
of O 0 2.0303490444462113e-08
a O 0 2.2415289069321886e-10
significant O 0 1.6924271706297844e-10
proportion O 0 6.742165159501212e-10
of O 0 1.4929309344324793e-08
loss O 0 1.8486157671304682e-07
- O 0 1.8694863967994024e-07
of O 0 2.5010243120959785e-07
- O 0 1.2707545238299645e-07
function O 0 2.7268465263574626e-10
mutations O 0 1.865281262780627e-10
and O 0 1.30712815571421e-10
a O 0 1.1408587269334802e-10
complete O 0 6.710672018073183e-09
absence O 0 2.417034572488319e-08
of O 0 2.512752672600982e-08
the O 0 2.673973487077319e-09
normal O 0 1.371289082285898e-09
copy O 0 4.303784439940728e-09
of O 0 2.4605388837528608e-09
ATM O 0 7.039174079181976e-07
in O 0 9.222146379883611e-10
the O 0 2.6246496642734485e-10
majority O 0 1.807298581624206e-11
of O 0 5.933510127675845e-09
mutated O 0 4.274646130397741e-07
tumours B-Disease 1 0.9999996423721313
establishes O 0 1.736054286993749e-07
somatic O 0 7.16463944172574e-07
inactivation O 0 2.765162435025559e-06
of O 0 7.726738715518877e-08
this O 0 6.155269349772396e-11
gene O 0 1.820126827034585e-10
in O 0 2.256086567564708e-10
the O 0 9.327615346776952e-10
pathogenesis O 0 6.94323944117059e-07
of O 0 1.4113025770257082e-07
sporadic B-Disease 0 4.3496667785802856e-05
T I-Disease 1 0.9999523162841797
- I-Disease 0 2.595020123408176e-05
PLL I-Disease 1 0.721687912940979
and O 0 5.502167610416109e-09
suggests O 0 6.204105007512339e-10
that O 0 1.706214336483214e-11
ATM O 0 1.3878930076316465e-06
acts O 0 7.484143083047456e-08
as O 0 1.0606778566568664e-08
a O 0 5.6859526864627696e-08
tumour B-Disease 1 1.0
suppressor O 0 0.00011641460878308862
. O 0 4.860615376856003e-07

As O 0 4.272934006621654e-08
constitutional O 0 6.447933031950015e-08
DNA O 0 5.64777622003021e-07
was O 0 5.731048080548362e-09
not O 0 6.826031927198439e-12
available O 0 3.56886430130654e-11
, O 0 3.862625150286014e-11
a O 0 2.443112934180647e-10
putative O 0 3.5477700066621765e-07
hereditary O 1 0.9999853372573853
predisposition O 0 0.0012787909945473075
to O 0 4.2274996303603984e-06
T B-Disease 1 1.0
- I-Disease 1 0.9989064931869507
PLL I-Disease 1 0.9999604225158691
will O 0 1.205497923706389e-09
require O 0 1.5046157375575575e-10
further O 0 5.768222011148794e-10
investigation O 0 7.841635785155177e-09
. O 0 1.0296469232784489e-09
. O 0 2.444013658120525e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.3804032050757087e-06
kinase O 0 4.836944640373986e-07
is O 0 1.242906000342714e-09
involved O 0 7.553992431574841e-10
in O 0 1.9804904938247603e-10
the O 0 2.4472590620661094e-10
modulation O 0 9.166677417127289e-10
of O 0 1.5799224151180624e-09
the O 0 1.782088782098512e-10
Ca2 O 0 4.4835729573478034e-10
+ O 0 4.971249634166952e-09
homeostasis O 0 2.0575103576447873e-07
in O 0 2.9334946916037552e-08
skeletal O 0 0.000714329129550606
muscle O 0 5.978703484288417e-06
cells O 0 2.967576619994361e-07
. O 0 5.2092911317913604e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9839381575584412
DM B-Disease 1 1.0
) O 0 1.4424493599562993e-07
, O 0 9.300133441136893e-10
the O 0 3.4181907304642323e-10
most O 0 4.0173855908598455e-10
prevalent O 0 0.013374551199376583
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999994039535522
in O 0 2.4047230340329406e-07
adults O 0 9.335843209612449e-09
, O 0 7.187189177138009e-10
is O 0 1.748326761141783e-10
caused O 0 1.0459099364368285e-08
by O 0 3.4090639200456962e-09
( O 0 1.2523969417088665e-08
CTG O 0 0.0009461408481001854
) O 0 6.710937361376068e-10
n O 0 1.711985886387879e-09
- O 0 1.979267860718892e-09
repeat O 0 1.053145903817665e-09
expansion O 0 1.0480462053763517e-09
in O 0 3.343690949120237e-11
a O 0 1.4831766023681858e-11
gene O 0 9.192475773633912e-12
encoding O 0 2.0520900950726784e-11
a O 0 1.9613075052937745e-10
protein O 0 2.601647508537752e-10
kinase O 0 1.850089681454392e-08
( O 0 4.6383208385236685e-09
DM B-Disease 1 0.9999998807907104
protein O 0 1.0471993938665491e-08
kinase O 0 2.4760003825008425e-08
; O 0 1.2754640676959639e-09
DMPK O 1 0.812699019908905
) O 0 1.2579114139210645e-10
and O 0 3.259189793047845e-11
involves O 0 7.714961308691315e-11
changes O 0 9.255499838767278e-11
in O 0 1.1617685702347558e-09
cytoarchitecture O 0 9.173504622594919e-07
and O 0 8.73473826601412e-09
ion O 0 1.1756699223042233e-06
homeostasis O 0 0.00015651766443625093
. O 0 4.723819699847809e-07

To O 0 1.672918870099238e-08
obtain O 0 7.434981963427845e-09
clues O 0 2.1114264114885373e-08
to O 0 1.4428354344619976e-10
the O 0 3.463414277593557e-10
normal O 0 9.328238181893767e-10
biological O 0 1.2811775640386713e-08
role O 0 1.4366026146461763e-09
of O 0 1.1369215791035003e-08
DMPK O 0 0.2967129349708557
in O 0 6.753391623703919e-09
cellular O 0 7.626835696328271e-08
ion O 0 1.0195540767199418e-07
homeostasis O 0 2.3502573185396614e-06
, O 0 5.361543209403408e-09
we O 0 1.3936324316787818e-10
have O 0 7.299110968417288e-12
compared O 0 1.0266048428020369e-10
the O 0 5.773527211871965e-10
resting O 0 1.89191666777333e-07
[ O 0 4.1676808670843e-09
Ca2 O 0 5.022982030311596e-10
+ O 0 5.804789982022385e-09
] O 0 1.0481106649251615e-08
i O 0 1.0690840435145788e-09
, O 0 3.259370204289347e-11
the O 0 3.7513044753856306e-11
amplitude O 0 4.799769470764659e-10
and O 0 1.4832141070897364e-10
shape O 0 3.529934344825847e-09
of O 0 5.769104749475673e-09
depolarization O 0 4.430207312111634e-09
- O 0 3.3621265771444087e-08
induced O 0 4.596183700300571e-08
Ca2 O 0 4.860295499398148e-10
+ O 0 1.099953017558164e-09
transients O 0 1.1818844569688736e-08
, O 0 7.089834969109532e-11
and O 0 2.014426646324008e-11
the O 0 1.252675185803298e-10
content O 0 9.932447919691612e-11
of O 0 2.169236124061058e-09
ATP O 0 0.0006623813533224165
- O 0 7.479091834738938e-08
driven O 0 6.469599522773706e-09
ion O 0 8.16168199690992e-09
pumps O 0 3.7229195726240505e-08
in O 0 5.362760457927607e-09
cultured O 0 1.7571585431142012e-07
skeletal O 0 1.0943287634290755e-05
muscle O 0 1.6103292921343382e-07
cells O 0 1.1946945654983665e-08
of O 0 1.7141785235708085e-07
wild O 0 7.240795412144507e-07
- O 0 1.544158294564113e-07
type O 0 1.0725059240712653e-07
and O 0 3.269230930413869e-08
DMPK O 1 0.9999991655349731
[ O 0 3.6536775382955966e-07
- O 0 2.0619272618205287e-06
/ O 0 1.17258389309427e-06
- O 0 1.6291029396597878e-06
] O 0 6.701899337713257e-07
knockout O 1 0.9349811673164368
mice O 0 1.3104016716170008e-06
. O 0 3.369181555967771e-08

In O 0 3.7458337942553044e-07
vitro O 0 8.60817351622245e-07
- O 0 2.135445129169966e-06
differentiated O 0 2.808471208481933e-06
DMPK O 1 0.9921607375144958
[ O 0 8.16898818811751e-07
- O 0 3.1263236905942904e-06
/ O 0 4.864613174504484e-07
- O 0 2.4434609713352984e-07
] O 0 1.4453543251136125e-08
myotubes O 0 3.5550755228541675e-07
exhibit O 0 1.5718047308155292e-08
a O 0 9.310036630516549e-10
higher O 0 7.73663089148613e-09
resting O 0 2.902600613197137e-07
[ O 0 7.94327714714882e-09
Ca2 O 0 7.558850212419088e-10
+ O 0 1.1872934635448473e-08
] O 0 1.9343854518183434e-08
i O 0 1.190077036916648e-09
than O 0 9.776725262700126e-11
do O 0 1.6371684563587507e-10
wild O 0 1.7934590701429443e-08
- O 0 2.297516488170004e-08
type O 0 4.0161641123859226e-08
myotubes O 0 2.149801730411127e-06
because O 0 1.6951764991723905e-10
of O 0 1.2733567533729229e-09
an O 0 7.323319901886283e-12
altered O 0 5.161574501144628e-10
open O 0 1.1916716502469171e-09
probability O 0 9.612859119823014e-11
of O 0 6.054529655408203e-10
voltage O 0 1.3096348894237053e-08
- O 0 2.5789042013002472e-08
dependent O 0 2.980496294213708e-09
l O 0 1.6750030251699854e-09
- O 0 4.865566172185254e-09
type O 0 1.998413212689343e-09
Ca2 O 0 1.69105909830769e-10
+ O 0 5.52124623798278e-10
and O 0 9.574656623101419e-10
Na O 0 1.5715745860234165e-07
+ O 0 2.701584511655142e-09
channels O 0 2.3419006733860215e-09
. O 0 2.7055964135769273e-09

The O 0 1.889118038889137e-06
mutant O 0 2.078796569549013e-06
myotubes O 0 7.551783255621558e-06
exhibit O 0 1.0928334148729846e-07
smaller O 0 4.074927950625806e-09
and O 0 1.8144673541442558e-09
slower O 0 1.3561413325646754e-08
Ca2 O 0 5.542485359555371e-10
+ O 0 6.811264330330857e-10
responses O 0 3.327869091407365e-10
upon O 0 3.4517959601743087e-09
triggering O 0 3.4048156294375076e-08
by O 0 4.038004652873184e-10
acetylcholine O 0 2.981817104341644e-08
or O 0 2.5400441749923175e-09
high O 0 4.52019932595249e-08
external O 0 6.95327244670807e-08
K O 0 1.3730336831940804e-06
+ O 0 1.2867836574059766e-07
. O 0 1.7128785501085986e-08

In O 0 6.455488232859352e-08
addition O 0 1.29886341682095e-08
, O 0 3.5409916665507524e-10
we O 0 1.7956606687685728e-11
observed O 0 1.2099315993552295e-10
that O 0 1.4794745289981037e-12
these O 0 7.745596698749413e-12
Ca2 O 0 5.701737415542141e-10
+ O 0 5.567132088657445e-09
transients O 0 3.995092257014221e-08
partially O 0 1.391453263721587e-08
result O 0 2.002758237029667e-10
from O 0 1.2641675206648273e-10
an O 0 3.986201559808e-12
influx O 0 3.5277367832486917e-11
of O 0 5.351027954070275e-10
extracellular O 0 3.8270309143939585e-10
Ca2 O 0 2.6624805138375507e-10
+ O 0 7.302891624760832e-10
through O 0 1.449792508267933e-10
the O 0 3.261087788697381e-10
l O 0 1.037813612825289e-09
- O 0 5.370365929735499e-09
type O 0 2.2374933017488274e-09
Ca2 O 0 2.1654991133601698e-09
+ O 0 1.2846399499721883e-08
channel O 0 1.684230177545487e-08
. O 0 4.801658182174151e-09

Neither O 0 8.192048994715151e-07
the O 0 1.5965905930670488e-08
content O 0 6.318836565100128e-10
nor O 0 8.080358049333825e-10
the O 0 2.070759397287958e-10
activity O 0 1.569080421148783e-10
of O 0 1.2789257430867451e-09
Na O 0 4.687630905664264e-08
+ O 0 3.002452064748695e-09
/ O 0 7.252769940180315e-09
K O 0 1.653362602382913e-08
+ O 0 8.521042205167362e-10
ATPase O 0 6.547959507940959e-09
and O 0 2.8429301135446394e-09
sarcoplasmic O 0 2.6699137833929854e-07
reticulum O 0 1.9286016339492562e-08
Ca2 O 0 1.9486638969112846e-09
+ O 0 3.694220485073174e-09
- O 0 1.0276324680091875e-08
ATPase O 0 5.956903859072327e-09
are O 0 2.809672286496756e-11
affected O 0 7.020778403088457e-10
by O 0 2.167201307301525e-09
DMPK O 1 0.9999613761901855
absence O 0 5.85056523050298e-06
. O 0 1.2386662717744912e-07

In O 0 2.160716832122489e-07
conclusion O 0 5.7050833390803746e-08
, O 0 6.273825903235775e-10
our O 0 2.948058741569781e-10
data O 0 5.379312550957138e-10
suggest O 0 1.4583236007670308e-10
that O 0 6.797244711531647e-11
DMPK O 0 0.07264608889818192
is O 0 1.158882087515245e-10
involved O 0 4.2402520383788556e-10
in O 0 5.508339895321512e-10
modulating O 0 2.1142069428492505e-08
the O 0 1.425675688615513e-09
initial O 0 7.794837553198875e-10
events O 0 2.620377803630447e-10
of O 0 1.6346668463285141e-09
excitation O 0 3.9235633408907233e-08
- O 0 2.743471156918531e-07
contraction O 0 3.537572723644189e-08
coupling O 0 3.488458588662979e-08
in O 0 4.8734726476595824e-08
skeletal O 0 0.026822291314601898
muscle O 0 4.641399755200837e-06
. O 0 3.350399069290688e-08
. O 0 3.8197715213073025e-08

Constitutional O 0 3.115063009317964e-05
RB1 O 1 0.9989272952079773
- O 0 1.1607896340137813e-05
gene O 0 2.0835662084550677e-08
mutations O 0 1.571027641311673e-09
in O 0 2.033421653280243e-09
patients O 0 2.5299002892609224e-09
with O 0 8.840208565175089e-10
isolated O 0 2.29136276175268e-06
unilateral B-Disease 0 8.631071250420064e-05
retinoblastoma I-Disease 1 0.9999502897262573
. O 0 2.584326239229995e-06

In O 0 9.416932300609915e-08
most O 0 1.9785961757889936e-09
patients O 0 2.675570209831335e-09
with O 0 3.4108052493486696e-10
isolated O 0 7.772397481176085e-08
unilateral B-Disease 0 3.939663656638004e-06
retinoblastoma I-Disease 1 0.9971920847892761
, O 0 9.789222588096891e-08
tumor B-Disease 0 1.0292928891431075e-05
development O 0 3.8656526868408037e-08
is O 0 9.49436224084721e-11
initiated O 0 9.569325332137169e-10
by O 0 3.580844301631636e-11
somatic O 0 3.7562429611170955e-08
inactivation O 0 4.0103546439240745e-07
of O 0 9.133835909835852e-09
both O 0 1.115519551730948e-10
alleles O 0 7.732595119769314e-11
of O 0 2.452849257039702e-09
the O 0 4.6312777612911304e-08
RB1 O 1 0.8702111840248108
gene O 0 3.1858280635788105e-07
. O 0 5.8952714709903375e-08

However O 0 1.068298089990094e-07
, O 0 1.0493463875604903e-09
some O 0 1.0654939604226588e-11
of O 0 7.027128878789313e-10
these O 0 1.2971612672885158e-10
patients O 0 1.576301311700945e-09
can O 0 3.688867267204188e-10
transmit O 0 4.558808541332837e-06
retinoblastoma B-Disease 0 0.011953926645219326
predisposition O 0 3.512954890538822e-06
to O 0 7.422810810453484e-09
their O 0 7.690657355396979e-08
offspring O 0 2.729425716552214e-07
. O 0 4.638340911355954e-08

To O 0 9.913229348512687e-09
determine O 0 4.5633981038406546e-09
the O 0 5.29750021627251e-10
frequency O 0 1.407784777640586e-09
and O 0 9.965162722780363e-11
nature O 0 1.1017630141552104e-09
of O 0 1.1660220566866997e-09
constitutional O 0 9.18999987220559e-09
RB1 O 0 0.04651152342557907
- O 0 1.7594321377600863e-07
gene O 0 1.6241810119055344e-09
mutations O 0 4.863299762902784e-10
in O 0 2.1710315489809062e-10
patients O 0 2.408325205927042e-10
with O 0 1.1403887556493686e-10
isolated O 0 1.087711609670805e-07
unilateral B-Disease 0 1.5536398905169335e-06
retinoblastoma I-Disease 0 0.44735637307167053
, O 0 6.662743246010905e-09
we O 0 1.2658636638906984e-10
analyzed O 0 4.359618888116756e-09
DNA O 0 1.1053127479954128e-07
from O 0 4.6825885391399424e-09
peripheral O 0 3.630812443589093e-06
blood O 0 2.0962588109796343e-07
and O 0 9.730579897393454e-09
from O 0 1.1666348598282639e-07
tumor B-Disease 0 0.0021149911917746067
tissue O 0 0.0004334725672379136
. O 0 1.1427783874751185e-06

The O 0 1.0595843491501e-07
analysis O 0 1.1719960113509842e-08
of O 0 2.071751907806174e-07
tumors B-Disease 1 0.9999996423721313
from O 0 3.6319296015108193e-08
54 O 0 2.9995689487805066e-08
( O 0 1.7434416410555542e-10
71 O 0 8.27387580670802e-09
% O 0 1.5101812161910644e-11
) O 0 8.291066617982512e-12
of O 0 2.9355196051739085e-09
76 O 0 1.0138876405108022e-07
informative O 0 2.9644418475527345e-08
patients O 0 1.3185049496655665e-08
showed O 0 2.1429020335972382e-08
loss O 0 3.68461712696444e-07
of O 0 2.7655002554638486e-07
constitutional O 0 5.177988100513176e-07
heterozygosity O 0 0.006507785990834236
( O 0 6.367806122398179e-07
LOH O 1 1.0
) O 0 2.068827065215828e-08
at O 0 3.017219398770976e-07
intragenic O 0 4.93229235871695e-05
loci O 0 7.443192657774489e-07
. O 0 8.030845322082314e-08

Three O 0 8.531594630767358e-07
of O 0 1.4440365703194402e-06
13 O 0 1.550578872411279e-06
uninformative O 0 0.010283835232257843
patients O 0 1.6304521466281585e-07
had O 0 1.0715241138825604e-08
constitutional O 0 2.24428248429831e-07
deletions O 0 2.4106661840050947e-06
. O 0 4.6464077740893117e-07

For O 0 1.8714344207637623e-07
39 O 0 1.3221645644989621e-07
randomly O 0 8.285262254048575e-09
selected O 0 2.543013124522986e-07
tumors B-Disease 1 1.0
, O 0 1.3915757790528005e-07
SSCP O 1 0.9999998807907104
, O 0 4.894852168035868e-08
hetero O 0 3.6601402371161385e-06
- O 0 8.524074246452074e-08
duplex O 0 6.028032117910698e-08
analysis O 0 3.697968875560065e-10
, O 0 3.500070025475033e-11
sequencing O 0 2.9263624856668002e-09
, O 0 1.160700494051703e-10
and O 0 2.1254938087356123e-10
Southern O 0 1.0817422513298425e-08
blot O 0 2.2398778298793331e-07
analysis O 0 2.776834040485454e-10
were O 0 8.974811172013375e-11
used O 0 1.8570099624692915e-10
to O 0 2.75926337334198e-10
identify O 0 2.100773066615602e-08
mutations O 0 1.1320985748852763e-07
. O 0 1.2447790709302353e-07

Mutations O 0 8.308368251164211e-07
were O 0 5.221895094109641e-08
detected O 0 1.1748388573096236e-07
in O 0 3.827719474713831e-09
21 O 0 3.311750873535857e-08
( O 0 2.5917915036366423e-10
91 O 0 1.1870534777358444e-08
% O 0 4.012612464521226e-11
) O 0 1.7944760261068282e-11
of O 0 2.1570329522546672e-08
23 O 0 1.3548426068155095e-05
tumors B-Disease 1 1.0
with O 0 1.0782695426314604e-05
LOH O 1 1.0
. O 0 1.3801372915622778e-06

In O 0 4.1882989876285137e-07
6 O 0 4.0063483197627647e-07
( O 0 1.373867797305195e-09
38 O 0 6.169321498106228e-09
% O 0 3.087776215271454e-11
) O 0 2.1833345895116985e-11
of O 0 9.31261734393729e-09
16 O 0 3.419581389607629e-06
tumors B-Disease 1 1.0
without O 0 5.699144480786345e-07
LOH O 1 1.0
, O 0 6.722150391880177e-09
one O 0 2.1426790897116632e-10
mutation O 0 1.7273420194197087e-10
was O 0 1.3352403627209242e-09
detected O 0 4.748994975045662e-09
, O 0 6.99647284552185e-11
and O 0 1.785777220542073e-10
in O 0 5.63561086686093e-10
9 O 0 1.9139655194067018e-08
( O 0 1.3850756652722396e-10
56 O 0 1.9204773327174962e-09
% O 0 9.29257105292125e-12
) O 0 5.460882614161111e-12
of O 0 2.4917137242397303e-09
the O 0 2.472174003287364e-07
tumors B-Disease 1 1.0
without O 0 2.5959084268833976e-06
LOH O 1 1.0
, O 0 3.242829116345547e-09
both O 0 2.1178696296697552e-10
mutations O 0 1.4514424107048285e-09
were O 0 4.51578507920658e-09
found O 0 1.1126393140159507e-08
. O 0 4.530185293560862e-08

Thus O 0 2.397297294010059e-07
, O 0 2.005813737326889e-09
a O 0 1.053456835653499e-10
total O 0 5.0110086219357086e-11
of O 0 7.322754069782889e-10
45 O 0 7.003579383102476e-10
mutations O 0 2.598775916684559e-10
were O 0 6.519989548259275e-10
identified O 0 1.7964093546041227e-09
in O 0 2.350233962999937e-08
tumors B-Disease 1 1.0
of O 0 2.3376513127004728e-05
36 O 0 3.1825106816540938e-06
patients O 0 2.9952585123282915e-07
. O 0 1.1999566140730167e-07

Thirty O 0 2.245050563942641e-05
- O 0 1.0826565812749323e-06
nine O 0 5.332297092763838e-08
of O 0 8.467032408532305e-09
the O 0 1.1560480350780722e-09
mutations O 0 1.7390354711821487e-09
- O 0 2.2815381583995986e-08
including O 0 4.834280975529737e-09
34 O 0 1.4835438655325106e-08
small O 0 9.584266713602574e-10
mutations O 0 2.3238486690502214e-09
, O 0 1.1815547429350204e-09
2 O 0 6.4411698197375244e-09
large O 0 1.5849568324455277e-09
structural O 0 5.793830268885358e-07
alterations O 0 4.014700152765727e-06
, O 0 5.324488849822728e-09
and O 0 5.2855728682743575e-09
hypermethylation O 0 3.545504659996368e-05
in O 0 3.016493721474944e-08
3 O 0 1.3193058521210332e-06
tumors O 1 1.0
- O 0 4.66047112013257e-07
were O 0 2.4538882037461462e-09
not O 0 2.088253875376367e-11
detected O 0 1.9243602267238202e-09
in O 0 3.7838284588920246e-11
the O 0 2.3697580009418573e-10
corresponding O 0 4.757970906155151e-09
peripheral O 0 1.0020915397035424e-05
blood O 0 1.915837628985173e-06
DNA O 0 1.3638731616083533e-05
. O 0 6.25639628992758e-08

In O 0 8.909991606742551e-07
6 O 0 6.042687346052844e-07
( O 0 1.075325606336719e-09
17 O 0 4.702502831577249e-09
% O 0 1.6720838255657178e-11
) O 0 3.91776021346768e-12
of O 0 4.4142717259276765e-10
the O 0 6.776588179491227e-10
36 O 0 1.3246530095045728e-08
patients O 0 1.1317846659864017e-09
, O 0 1.4896157918276032e-10
a O 0 3.2252042703184713e-10
mutation O 0 8.332405321276326e-10
was O 0 8.319148925295394e-09
detected O 0 3.6537659564572778e-09
in O 0 4.998398916988833e-11
constitutional O 0 1.1102835317799986e-09
DNA O 0 8.412048657646665e-08
, O 0 1.0854634552304177e-10
and O 0 7.067477159061752e-11
1 O 0 5.191788110536777e-10
of O 0 1.0738349098815547e-10
these O 0 5.706975690633609e-12
mutations O 0 1.2151120387660086e-10
is O 0 1.3730281668566935e-11
known O 0 1.7831393306355636e-10
to O 0 1.3452751065901047e-11
be O 0 6.712597838687273e-11
associated O 0 3.082389010700126e-09
with O 0 1.444587449661583e-09
reduced O 0 1.704171950223099e-07
expressivity O 0 4.568581061903387e-05
. O 0 2.2158901913371665e-07

The O 0 1.4873835141315794e-07
presence O 0 7.336542040548011e-09
of O 0 9.896717223512042e-09
a O 0 3.2782565551059406e-10
constitutional O 0 3.871192255644473e-09
mutation O 0 4.539721654150952e-10
was O 0 9.226597819100846e-10
not O 0 3.912562548252785e-12
associated O 0 8.137905627148001e-11
with O 0 2.162925220872136e-11
an O 0 1.9013186858263253e-11
early O 0 1.699555163270361e-08
age O 0 2.5327488994975056e-09
at O 0 1.257116455377627e-08
treatment O 0 6.637972660428204e-08
. O 0 1.710759534034878e-08

In O 0 4.313072849981836e-07
1 O 0 1.5067688252656808e-07
patient O 0 1.0607652711769333e-07
, O 0 2.094263207297331e-09
somatic O 0 4.693124992627418e-06
mosaicism O 0 0.0007923337398096919
was O 0 1.2774324886777322e-07
demonstrated O 0 2.236247409470593e-09
by O 0 2.0478828702263918e-11
molecular O 0 8.077368773840021e-10
analysis O 0 1.5504539319088906e-10
of O 0 1.4475607379438316e-09
DNA O 0 6.35742978261078e-08
and O 0 1.105840974346961e-09
RNA O 0 8.912525828463913e-08
from O 0 2.677925081684407e-08
peripheral O 0 2.4203058273997158e-05
blood O 0 1.65320557243831e-06
. O 0 5.977358341624495e-08

In O 0 1.244155214408238e-06
2 O 0 4.27943490421967e-07
patients O 0 2.8059743417685468e-09
without O 0 3.205414267348772e-10
a O 0 3.7953007403501715e-10
detectable O 0 1.8828664849479537e-07
mutation O 0 9.76428160548437e-10
in O 0 1.0497747116033906e-09
peripheral O 0 3.568030479073059e-06
blood O 0 1.2027377351842006e-06
, O 0 7.0294516874014334e-09
mosaicism O 0 0.00017208945064339787
was O 0 7.091603748676789e-08
suggested O 0 2.4702631051809476e-09
because O 0 1.952904643554021e-10
1 O 0 2.1430113239517823e-09
of O 0 4.2294221458405445e-09
the O 0 1.0443823583727863e-09
patients O 0 8.548590280099688e-09
showed O 0 2.1847007758424297e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 5.939072522664901e-08
the O 0 3.0886877055991135e-08
other O 0 9.76413283559907e-10
later O 0 4.295659650210837e-08
developed O 0 6.24137896920729e-08
bilateral B-Disease 0 4.721982350019971e-06
retinoblastoma I-Disease 0 0.02112562209367752
. O 0 5.164480398889282e-07

In O 0 2.0240202047716593e-07
conclusion O 0 4.3279058559164696e-08
, O 0 7.555015502092033e-10
our O 0 7.905154864040753e-10
results O 0 1.528573156939217e-09
emphasize O 0 2.4112867258452297e-09
that O 0 1.1106805579419454e-11
the O 0 1.7707077470952015e-10
manifestation O 0 1.3731329318034113e-07
and O 0 4.2753778295434586e-09
transmissibility O 0 1.1160494750583894e-06
of O 0 1.1058251203621694e-07
retinoblastoma B-Disease 0 3.748170627204672e-07
depend O 0 9.719723914614065e-10
on O 0 3.928578795608928e-09
the O 0 1.048334086206637e-09
nature O 0 3.1436513392435472e-09
of O 0 3.069200671390604e-09
the O 0 8.743301638247658e-10
first O 0 2.7042035277702325e-09
mutation O 0 1.9758270020098223e-10
, O 0 2.166455383145749e-11
its O 0 2.0540910986022176e-11
time O 0 3.005290807878147e-11
in O 0 5.555140375479439e-11
development O 0 3.2139665928632155e-10
, O 0 4.218171298364659e-11
and O 0 3.471666704113474e-11
the O 0 8.478627522290338e-11
number O 0 1.751847451825217e-11
and O 0 3.3527080417483646e-11
types O 0 1.7076876579480427e-09
of O 0 9.602240780282045e-09
cells O 0 8.672812468191182e-10
that O 0 3.418325691950663e-11
are O 0 2.564875395405508e-11
affected O 0 1.396925131125215e-09
. O 0 2.0900770003606794e-09
. O 0 1.3471310289503435e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999431371688843
the I-Disease 0 5.6347274949075654e-05
fifth I-Disease 0 0.0006761740078218281
component I-Disease 0 3.853249666008196e-07
of I-Disease 0 2.84417438933815e-07
complement I-Disease 0 8.915773008766337e-08
in O 0 3.613205024066701e-08
man O 0 7.140600928323693e-07
. O 0 6.541520036762449e-08

I O 0 0.03907378390431404
. O 0 7.157596428442048e-06

Clinical O 0 0.0029328258242458105
, O 0 1.0263303096280652e-07
immunochemical O 0 0.000221710026380606
, O 0 4.987128487954351e-09
and O 0 4.052666646714442e-09
family O 0 2.6156203869476258e-09
studies O 0 3.377997259690346e-08
. O 0 1.1982820069533773e-08

The O 0 3.2803495741973165e-07
first O 0 2.112594543746127e-08
recognized O 0 1.6947998560112865e-08
human O 0 1.8037471960496987e-08
kindred O 0 9.12517643882893e-05
with O 0 1.6152542059444386e-07
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999958276748657
the I-Disease 0 9.202125511365011e-05
fifth I-Disease 0 0.25252166390419006
component I-Disease 0 8.622346285847016e-07
of I-Disease 0 1.8607206584420055e-06
complement I-Disease 0 2.024507921305485e-06
( O 0 3.987685488482384e-07
C5 O 1 1.0
) O 0 8.694712505530333e-09
is O 0 4.089033556198274e-10
described O 0 1.394418269740072e-08
. O 0 2.2744513827888113e-08

The O 0 3.1343572572950507e-06
proband O 0 0.00018359821115154773
, O 0 1.889352141404288e-08
a O 0 3.818094285179541e-09
20 O 0 9.452326032999281e-09
- O 0 2.1914905445896693e-08
year O 0 2.7917261835597174e-09
- O 0 1.4606082743284787e-07
old O 0 1.5387983864911803e-07
black O 0 7.782749555929058e-09
female O 0 1.3695613532149764e-09
with O 0 1.2208909438982118e-08
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.8045773506164551
age O 0 1.3740672102358076e-06
11 O 0 3.789583047364431e-08
, O 0 5.538606795418843e-10
lacked O 0 1.789623951253816e-07
serum O 0 4.682725830207346e-06
hemolytic O 1 0.9999997615814209
complement O 0 5.548963599721901e-07
activity O 0 3.665348060621909e-07
, O 0 1.8425946324285292e-09
even O 0 4.367106676284038e-10
during O 0 2.119690378776795e-08
remission O 0 1.1062223848057329e-06
. O 0 7.768570675636965e-09

C5 O 1 0.9996987581253052
was O 0 9.29068755795015e-06
undetectable O 0 1.6469282854814082e-05
in O 0 7.263609713703545e-09
her O 0 1.4759593547353234e-09
serum O 0 6.719496958851323e-09
by O 0 2.4537699649940237e-10
both O 0 2.315817759779293e-09
immunodiffusion O 0 8.152258669724688e-05
and O 0 2.7031433091906365e-07
hemolytic O 1 1.0
assays O 0 0.00011010562593583018
. O 0 1.1041490779462038e-06

Other O 0 3.37280816609109e-08
complement O 0 1.2349342171091848e-07
components O 0 6.674561632280529e-07
were O 0 2.0882929163690278e-08
normal O 0 5.179328077531409e-09
during O 0 2.0609294271167755e-09
remission O 0 5.009133730027315e-08
of O 0 4.3735632004882063e-08
lupus O 0 0.4994126558303833
, O 0 1.1981974523678218e-08
but O 0 2.967189383085156e-09
C1 O 0 0.0023187901824712753
, O 0 2.4275129462125733e-08
C4 O 1 0.9999978542327881
, O 0 6.539911368008688e-08
C2 O 0 0.00028578782803379
, O 0 7.617339647936205e-09
and O 0 3.0700160635888096e-08
C3 O 1 0.9999998807907104
levels O 0 3.9087399272830226e-06
fell O 0 1.51332606037613e-05
during O 0 1.524347084114197e-07
exacerbations O 0 0.0001372289698338136
. O 0 8.166839648993118e-08

A O 0 4.71067542093806e-05
younger O 0 1.024101123903165e-07
half O 0 1.7928194040450762e-08
- O 0 1.2958611250724061e-07
sister O 0 8.503013759764144e-08
, O 0 5.187877905044047e-10
who O 0 4.6324039049139287e-10
had O 0 1.1496755769613287e-09
no O 0 8.211507918076677e-09
underlying O 1 0.981724739074707
disease O 1 0.9966496825218201
, O 0 6.924136819463911e-10
was O 0 2.1037806163803907e-08
also O 0 2.0641700848589295e-10
found O 0 2.4854943103669314e-10
to O 0 1.2802582327609002e-09
lack O 0 7.947862172841269e-07
immunochemically O 1 0.997170627117157
detectable O 1 0.9913994073867798
C5 O 1 0.999944806098938
. O 0 9.416067427991948e-07

By O 0 8.085150966508081e-07
hemolytic O 1 0.999996542930603
assay O 0 4.946593890053919e-06
, O 0 7.117268552292444e-08
she O 0 2.6396265173644906e-09
exhibited O 0 3.009786908592105e-08
1 O 0 1.568950303010297e-08
- O 0 1.1787282261366272e-08
2 O 0 1.8299928239429164e-09
% O 0 6.105910048403995e-12
of O 0 8.116544936154213e-11
the O 0 7.514456418222792e-11
normal O 0 3.1120204191381617e-09
serum O 0 8.586882671579588e-08
C5 O 0 0.0017114344518631697
level O 0 2.0980701620487707e-08
and O 0 1.2068131216569356e-10
normal O 0 1.4252427016359093e-10
concentrations O 0 3.0613006574142787e-10
of O 0 4.347874560384213e-10
other O 0 4.871271788720044e-11
complement O 0 1.5636237193916713e-08
components O 0 9.811856216401793e-07
. O 0 9.413970047944531e-08

C5 O 1 0.6511573791503906
levels O 0 4.656766350308317e-07
of O 0 8.294040299006156e-08
other O 0 5.636245359319503e-10
family O 0 2.4065160975084154e-10
members O 0 6.269193497665526e-11
were O 0 2.588017300464429e-10
either O 0 7.728780393456702e-10
normal O 0 4.556978794312272e-09
or O 0 4.3200829025202836e-10
approximately O 0 7.263758483588845e-10
half O 0 1.1850643799604654e-09
- O 0 1.6964428084520478e-08
normal O 0 3.4376630431154354e-09
, O 0 8.747633867267623e-11
consistent O 0 5.795729229873814e-09
with O 0 2.886877958907519e-10
autosomal O 0 1.6805311986445304e-07
codominant O 0 4.114862804271979e-06
inheritance O 0 8.122995609483041e-09
of O 0 3.166152140465783e-08
the O 0 2.3469414855981086e-08
gene O 0 4.1644736370471946e-07
determining O 0 0.0009886311599984765
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.937646402438986e-06

Normal O 0 0.0010007779346778989
hemolytic O 1 1.0
titers O 0 0.0007402756018564105
were O 0 8.391040751121182e-08
restored O 0 2.8562402576426393e-07
to O 0 1.872682675596593e-09
both O 0 3.0908078318958587e-09
homozygous O 0 7.772976459818892e-06
C5 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
( O 0 2.0823840714001562e-06
C5D B-Disease 1 1.0
) O 0 6.882177938649647e-09
sera O 0 2.662671647613024e-07
by O 0 9.703806508332136e-11
addition O 0 5.134738745304901e-10
of O 0 8.109991789240212e-09
highly O 0 3.5255160923952644e-07
purified O 0 9.305113962909672e-06
human O 0 2.310378249603673e-06
C5 O 1 0.9999871253967285
. O 0 5.100054636386631e-07

In O 0 2.6760929472402495e-07
specific O 0 2.1451947418427153e-07
C5 O 1 0.9411712884902954
titrations O 0 2.0520445104921237e-05
, O 0 4.2483008222404806e-09
however O 0 3.1040159331752193e-10
, O 0 5.190627094808775e-11
it O 0 2.0013176879607464e-11
was O 0 1.1774333730230069e-09
noted O 0 7.81898643054113e-11
that O 0 2.584551930112644e-12
when O 0 3.888927721518165e-11
limited O 0 3.8317619910355205e-11
amounts O 0 1.6486437215412764e-10
of O 0 3.7991362944467255e-08
C5 O 0 0.000228408447583206
were O 0 6.638476879317068e-09
assayed O 0 1.3301242773877675e-08
in O 0 2.1487731038938307e-10
the O 0 1.2559647766252624e-10
presence O 0 1.184528169995147e-10
of O 0 1.0758446356007312e-09
low O 0 8.084478864134326e-09
dilutions O 0 3.6045460660716344e-07
of O 0 2.4014337185462864e-08
either O 0 8.963652220472795e-08
C5D B-Disease 1 1.0
serum O 0 2.3080506252881605e-06
, O 0 4.076809112518731e-09
curving O 0 4.540522979823436e-08
rather O 0 3.5557121136342573e-10
than O 0 7.956608462367232e-12
linear O 0 2.3148007122220093e-10
dose O 0 8.457574196540918e-09
- O 0 6.079968084549137e-09
response O 0 1.013402903260463e-10
plots O 0 2.7392754731181412e-09
were O 0 6.782200356880708e-10
consistently O 0 6.521395090608451e-10
obtained O 0 3.8796316159661615e-10
, O 0 9.88959331094108e-11
suggesting O 0 2.1729910926193696e-10
some O 0 2.7073180502990013e-11
inhibitory O 0 1.4827207017731325e-08
effect O 0 3.700548134588644e-08
. O 0 2.5584053986449362e-08

Further O 0 9.618007368317194e-08
studies O 0 1.0629339186607467e-08
suggested O 0 5.320719420609521e-10
that O 0 2.2244360867174073e-11
low O 0 1.3397027487371815e-08
dilutions O 0 2.7852288440044504e-06
of O 0 1.047606929205358e-06
C5D B-Disease 1 1.0
serum O 0 3.2010251516112476e-07
contain O 0 4.774962647502434e-09
a O 0 2.7333973973142633e-10
factor O 0 2.411138233515686e-10
( O 0 3.7667192281931605e-11
or O 0 8.563073167211499e-11
factors O 0 3.685505511885623e-10
) O 0 7.28191326682115e-11
interfering O 0 3.755818767103847e-09
at O 0 6.155475240632313e-09
some O 0 3.613833884918982e-11
step O 0 5.694966720426464e-10
in O 0 1.1255153059552825e-10
the O 0 3.161793715733552e-09
hemolytic O 1 0.9877474308013916
assay O 0 1.288763883167121e-06
of O 0 8.424551197094843e-05
C5 O 1 0.9999998807907104
, O 0 7.194956186395984e-09
rather O 0 9.889070673452238e-10
than O 0 7.092324644242254e-11
a O 0 1.179060404865595e-09
true O 0 8.029879694504416e-08
C5 O 0 0.41573023796081543
inhibitor O 0 3.2830163831931714e-07
or O 0 8.28656183671228e-08
inactivator O 0 7.011633715592325e-05
. O 0 2.477342491147283e-07

Of O 0 8.267242264992092e-06
clinical O 0 7.72194289311301e-06
interest O 0 6.981082822932194e-09
are O 0 1.3128498288494939e-10
( O 0 2.2361269780279969e-10
a O 0 1.1010523048859966e-10
) O 0 1.0202544538373548e-11
the O 0 4.539355349941765e-11
documentation O 0 1.4244180057687572e-08
of O 0 2.573077608758467e-07
membranous O 1 0.9999990463256836
glomerulonephritis B-Disease 1 1.0
, O 0 6.651939474977553e-05
vasculitis B-Disease 1 1.0
, O 0 2.9472963433363475e-05
and O 1 0.833204984664917
arthritis B-Disease 1 1.0
in O 0 5.423188440545346e-07
an O 0 6.298765398149442e-10
individual O 0 4.366425887525338e-09
lacking O 0 0.00016115732432808727
C5 O 1 1.0
( O 0 6.833324572852462e-09
and O 0 5.358473664784924e-10
its O 0 2.192370313069958e-10
biologic O 0 1.2330066567756148e-07
functions O 0 9.220669228149347e-10
) O 0 5.0614196861475946e-11
, O 0 2.493417972093681e-11
and O 0 7.287109804465786e-11
( O 0 1.571083818596719e-10
b O 0 1.4794380831517628e-08
) O 0 1.1707229803648023e-11
a O 0 3.7366935934368684e-11
remarkable O 0 1.5137875397641665e-09
propensity O 0 1.2764120072006335e-07
to O 0 3.072593912634147e-08
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.1369868097309563e-09
the O 0 3.6146163839845258e-09
proband O 0 1.5376132068922743e-05
, O 0 3.1626301577603044e-10
even O 0 4.041670470522618e-11
during O 0 5.962584315177821e-10
periods O 0 4.0443581816873575e-09
of O 0 2.5794242297649816e-09
low O 0 2.145458211089135e-08
- O 0 6.456311485436572e-09
dose O 0 3.6273448689172483e-09
or O 0 1.479851380326025e-10
alternate O 0 7.493839326855323e-09
- O 0 1.1229823115854742e-07
day O 0 5.194338825731393e-08
corticosteroid O 0 0.0001470113347750157
therapy O 0 1.834130125644151e-05
. O 0 9.717804516640172e-08

Other O 0 2.979332691666059e-08
observations O 0 2.750717555954907e-07
indicate O 0 9.66386437539768e-09
that O 0 1.5109713480399023e-10
the O 0 7.978929517094002e-09
C5D B-Disease 1 1.0
state O 0 3.6133962488804627e-09
is O 0 7.211917174565485e-11
compatible O 0 3.2220210943734173e-09
with O 0 4.731720917861004e-11
normal O 0 2.1942538896979613e-09
coagulation O 0 3.376451118697332e-08
function O 0 2.3880253330332835e-10
and O 0 1.6351899001509906e-10
the O 0 2.974849533377011e-10
capacity O 0 6.402387509041318e-10
to O 0 6.076707470548115e-10
mount O 0 1.873764267656952e-05
a O 0 7.938933066498066e-08
neutrophilic O 1 0.9748533368110657
leukocytosis O 0 0.005575426854193211
during O 0 2.6956649890053086e-05
pyogenic B-Disease 1 0.9997829794883728
infection I-Disease 0 1.224429524881998e-05
. O 0 5.873852959581427e-09
. O 0 1.4804880876795323e-08

Susceptibility O 0 0.001353539410047233
to O 0 3.112155900453217e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 1.126804909290513e-05
twins O 0 4.816492946702056e-06
: O 0 7.140295577023892e-10
the O 0 2.9523408717757604e-10
role O 0 6.650868744628724e-10
of O 0 6.06195094121631e-09
genes O 0 3.1466970695781527e-10
, O 0 8.384328786803508e-10
HLA O 0 4.936951427225722e-06
, O 0 7.791804979007111e-10
and O 0 1.1029678281815336e-09
the O 0 6.98559832201795e-09
environment O 0 1.92262291420775e-07
. O 0 8.026970732544214e-08

OBJECTIVE O 0 8.535999768355396e-06
To O 0 2.012247701799197e-09
determine O 0 5.59053858761871e-10
the O 0 2.0146237456053484e-10
relative O 0 5.043767070667116e-10
effects O 0 3.1998158789292575e-08
of O 0 8.634556181164044e-09
genetic O 0 3.154667194138483e-09
and O 0 2.0691130753203169e-10
environmental O 0 1.2384665515341453e-09
factors O 0 1.2388677583796692e-10
in O 0 1.901765689371615e-10
susceptibility O 0 1.9197170786355855e-07
to O 0 3.505741688059061e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.0340054359403439e-05
AS B-Disease 1 1.0
) O 0 7.71835395596554e-09
. O 0 5.26868371153455e-09

METHODS O 0 0.00010311185178579763
Twins O 0 2.1733681933255866e-05
with O 0 6.078182845925539e-09
AS B-Disease 1 0.9999706745147705
were O 0 2.2246886555166157e-09
identified O 0 1.185414266746676e-10
from O 0 9.600472500315149e-11
the O 0 1.9904805581560936e-10
Royal O 0 1.3168685200071195e-06
National O 0 2.4365632270928472e-05
Hospital O 1 0.9999945163726807
for O 0 6.988758741499623e-06
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 1.7091571180571918e-06
. O 0 1.796914546048356e-07

Clinical O 0 0.00012336163490545005
and O 0 2.237844398678135e-08
radiographic O 0 1.5983348930603825e-05
examinations O 0 9.911783536153962e-07
were O 0 9.303899872747934e-09
performed O 0 6.982430988955457e-08
to O 0 1.1904874308577007e-10
establish O 0 1.5166870426241985e-08
diagnoses O 0 0.00013405291247181594
, O 0 1.128510795922466e-08
and O 0 1.0953758646792267e-06
disease O 1 0.9999345541000366
severity O 0 0.00011508668831083924
was O 0 3.2726497067869786e-08
assessed O 0 4.877943382552985e-09
using O 0 5.819475457080614e-10
a O 0 3.9252812111811863e-10
combination O 0 2.527107856309385e-09
of O 0 6.1014833185879525e-09
validated O 0 1.648168108658865e-07
scoring O 0 1.9830898168038402e-07
systems O 0 1.1563655789359473e-05
. O 0 1.3431522916107497e-07

HLA O 0 0.00013220867549534887
typing O 0 7.824821750546107e-07
for O 0 1.1757351536800797e-08
HLA O 0 9.205876267515123e-06
- O 0 8.00102895937016e-07
B27 O 0 2.2820072445028927e-06
, O 0 7.593389916848992e-09
HLA O 0 1.5008374703029403e-06
- O 0 1.4805466719280957e-07
B60 O 0 5.418272053248074e-07
, O 0 6.114435069370927e-10
and O 0 1.070906474609501e-09
HLA O 0 1.93403957382543e-05
- O 0 4.573256319417851e-06
DR1 O 1 0.9795430898666382
was O 0 6.060842849819892e-08
performed O 0 2.496886253311459e-08
by O 0 7.938755208769521e-11
polymerase O 0 2.1802209815291462e-08
chain O 0 1.2628649237456102e-08
reaction O 0 3.556084871014775e-10
with O 0 1.0456216448240241e-10
sequence O 0 1.7847964772776947e-10
- O 0 8.417064267796093e-10
specific O 0 3.335448237051786e-11
primers O 0 1.9808021889389238e-08
, O 0 3.709292595299729e-10
and O 0 5.515551904089477e-10
zygosity O 0 3.70874181498948e-06
was O 0 8.382893490477272e-09
assessed O 0 1.1942184130475653e-08
using O 0 2.70462630069801e-09
microsatellite O 0 5.943707037658896e-07
markers O 0 1.09955715288379e-06
. O 0 6.150888509637298e-08

Genetic O 0 4.008223186247051e-06
and O 0 9.679581580712693e-09
environmental O 0 9.881155449420476e-09
variance O 0 5.078092946142476e-10
components O 0 1.168415941776857e-08
were O 0 3.798596159843015e-10
assessed O 0 3.940240134170381e-09
with O 0 8.39919453432536e-11
the O 0 1.0571791220215232e-09
program O 0 1.3220601280394817e-09
Mx O 0 2.8740802804350096e-07
, O 0 1.3598715903340164e-11
using O 0 3.01712062451831e-12
data O 0 2.336116369794361e-11
from O 0 1.3884924460194625e-11
this O 0 8.926589935981388e-13
and O 0 3.667354614433904e-12
previous O 0 7.850697175681987e-11
studies O 0 1.3368858797768723e-10
of O 0 1.5963947941344259e-09
twins O 0 7.177250438417104e-08
with O 0 1.6688006532206145e-09
AS B-Disease 1 1.0
. O 0 3.1469048167309666e-07

RESULTS O 0 2.596133890619967e-05
Six O 0 2.1308831321675825e-07
of O 0 2.1895147028772044e-07
8 O 0 6.739946911693551e-07
monozygotic O 0 1.5041550796013325e-05
( O 0 7.377815336440108e-08
MZ O 1 0.9999997615814209
) O 0 1.1391072973765404e-08
twin O 0 1.1788640676968498e-06
pairs O 0 8.319529953837446e-09
were O 0 1.042777100224157e-07
disease O 0 4.5866040636610705e-06
concordant O 0 4.477279276215995e-07
, O 0 1.0392199323305817e-09
compared O 0 3.9703240695132536e-10
with O 0 1.3042143753860813e-10
4 O 0 2.111386088188283e-08
of O 0 6.894110526900477e-08
15 O 0 2.347523242463012e-08
B27 O 0 6.998170078986732e-07
- O 0 1.1335701088910355e-07
positive O 0 2.5751327736855956e-09
dizygotic O 0 2.694122713364777e-06
( O 0 1.2274848693039075e-08
DZ O 1 0.9994010925292969
) O 0 3.6021590155144168e-09
twin O 0 3.2501816349395085e-07
pairs O 0 1.4753288590796387e-09
( O 0 4.382025575733195e-10
27 O 0 1.808177074735795e-08
% O 0 2.422033407167845e-11
) O 0 5.667426163785683e-12
and O 0 9.407764151037057e-11
4 O 0 7.020326986406644e-09
of O 0 4.558667754395174e-08
32 O 0 3.486922537376813e-07
DZ O 1 0.9999603033065796
twin O 0 8.936217454902362e-06
pairs O 0 1.7431109000654033e-08
overall O 0 2.1519994675145426e-07
( O 0 2.240871488368157e-09
12 O 0 1.0798107297205206e-08
. O 0 8.221232028482461e-11
5 O 0 1.0476444156637399e-09
% O 0 3.6790282625931425e-11
) O 0 1.3589389336043922e-10
. O 0 5.5042357338663805e-09

Nonsignificant O 0 0.0002817438216879964
increases O 0 1.646203706684446e-08
in O 0 1.737599841789006e-09
similarity O 0 7.245383182308274e-10
with O 0 6.597760532356389e-11
regard O 0 5.442368777863749e-10
to O 0 1.5730507174627206e-10
age O 0 6.117401252225818e-09
at O 0 8.510880320500291e-07
disease O 0 5.2518778829835355e-05
onset O 0 1.80926999746589e-05
and O 0 3.022422589982199e-10
all O 0 1.109772690410793e-10
of O 0 1.0018515794740779e-08
the O 0 1.5705975897617463e-07
disease O 0 0.0013557670172303915
severity O 0 4.1668729977573093e-07
scores O 0 1.9007957874350723e-08
assessed O 0 1.8921072708621978e-08
were O 0 3.2108067316016786e-09
noted O 0 1.0614159551280977e-09
in O 0 4.407863407607238e-09
disease O 0 5.278007847664412e-06
- O 0 9.397014082423993e-07
concordant O 0 7.3355229687877e-05
MZ O 1 0.9999979734420776
twins O 0 3.5169466627849033e-06
compared O 0 7.0480723479704466e-09
with O 0 7.98672594726213e-09
concordant O 0 0.0008541637216694653
DZ O 1 1.0
twins O 0 0.021830493584275246
. O 0 1.872955181170255e-06

HLA O 0 0.0013059709453955293
- O 0 1.8559159798314795e-05
B27 O 0 6.226614914339734e-06
and O 0 5.522796886481274e-09
B60 O 0 5.93686934280413e-07
were O 0 2.441730595492686e-09
associated O 0 2.6991278101462512e-09
with O 0 2.988954361793361e-10
the O 0 5.564650251699277e-08
disease O 0 1.15302227641223e-05
in O 0 2.703692825178905e-09
probands O 0 8.184053876902908e-05
, O 0 4.0939968082298606e-10
and O 0 2.79390344193331e-10
the O 0 7.066294216429014e-10
rate O 0 1.5255672281000443e-09
of O 0 3.958856709118663e-08
disease O 0 8.202102321774873e-07
concordance O 0 6.072657754430111e-08
was O 0 4.552982435512831e-09
significantly O 0 1.269885308019525e-10
increased O 0 2.498651285876008e-10
among O 0 2.5357940192094475e-09
DZ O 1 0.9160410165786743
twin O 0 9.988408464778331e-07
pairs O 0 1.0417284812547223e-09
in O 0 5.629143817742488e-10
which O 0 1.7291483522807738e-10
the O 0 6.257265372511256e-09
co O 0 1.1933671828501247e-07
- O 0 2.5444879270253296e-07
twin O 0 1.1571514733077493e-06
was O 0 3.2133751659557674e-08
positive O 0 1.6771441180285507e-10
for O 0 1.2229313395284436e-10
both O 0 1.5502772399145215e-09
B27 O 0 4.038528004457476e-06
and O 0 4.229545709222293e-07
DR1 O 1 0.9968792200088501
. O 0 7.538166642007127e-07

Additive O 0 7.367324315055157e-07
genetic O 0 9.948938384241046e-08
effects O 0 1.634367521319291e-07
were O 0 6.347222747393744e-10
estimated O 0 4.518864796243527e-11
to O 0 1.9962890715485848e-11
contribute O 0 1.5247753060165792e-10
97 O 0 1.4559764949240162e-08
% O 0 7.1188437089642065e-12
of O 0 1.1397103399923836e-10
the O 0 9.967690561829556e-11
population O 0 1.869853013744538e-12
variance O 0 8.94299856391001e-10
. O 0 4.309066437002684e-09

CONCLUSION O 0 1.8044729586108588e-05
Susceptibility O 0 1.2995072893318138e-06
to O 0 6.5261147597084346e-09
AS B-Disease 1 0.9999948740005493
is O 0 7.468816537459233e-11
largely O 0 4.110694284964467e-10
genetically O 0 1.5783170326244544e-09
determined O 0 2.627165152091493e-09
, O 0 2.9334470963426895e-10
and O 0 4.73938277512076e-10
the O 0 1.4874956821842034e-09
environmental O 0 9.069849227216764e-08
trigger O 0 3.7982740508368806e-08
for O 0 5.565833904874751e-10
the O 0 5.330121055635573e-08
disease O 0 7.270927744684741e-05
is O 0 1.2443381047777535e-10
probably O 0 6.515343820012731e-09
ubiquitous O 0 4.315582771141635e-07
. O 0 3.950114901840607e-08

HLA O 0 0.0014122467255219817
- O 0 8.814060493023135e-06
B27 O 0 5.914677103646682e-07
accounts O 0 9.47683598262472e-10
for O 0 6.018660569928613e-11
a O 0 1.0783709342154779e-10
minority O 0 9.712172038822686e-12
of O 0 3.2095803792486777e-10
the O 0 3.4749741972817105e-10
overall O 0 4.87099827140014e-09
genetic O 0 9.24402421276227e-09
susceptibility O 0 1.8893773656714075e-08
to O 0 3.858358521569016e-09
AS B-Disease 1 0.9999998807907104
. O 0 1.4128377756605914e-07

Cell O 0 1.2646611139643937e-05
cycle O 0 1.3599589010482305e-06
- O 0 3.1574504077980237e-07
dependent O 0 4.3959598627907326e-08
colocalization O 0 1.0363530236645602e-05
of O 0 8.355694376405154e-07
BARD1 O 1 0.99991774559021
and O 0 1.702270679970752e-08
BRCA1 O 0 2.551709421538817e-08
proteins O 0 5.025128646529708e-10
in O 0 8.365033110635522e-10
discrete O 0 2.4327041714400366e-08
nuclear O 0 2.905363771787961e-06
domains O 0 1.5426745392232988e-07
. O 0 7.147114899908047e-08

Germ O 1 0.9987382292747498
- O 0 4.0092741983244196e-05
line O 0 7.897293130554317e-07
mutations O 0 4.203069003949622e-09
of O 0 2.414214783641455e-08
the O 0 3.4685609051621213e-08
BRCA1 O 0 2.536084139137529e-06
gene O 0 3.12888346343243e-08
predispose O 0 1.967247875711564e-08
women O 0 1.6907300559587668e-10
to O 0 1.054325238225573e-10
early O 0 1.0198958761975518e-06
- O 0 4.783604163094424e-05
onset O 1 1.0
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999842643737793
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 2.858889791568231e-09
compromising O 0 3.9208035218507575e-07
the O 0 7.0600738588666445e-09
genes O 0 2.1875929956394202e-09
presumptive O 0 1.4412174209610384e-07
function O 0 6.036713906532043e-10
as O 0 7.153627135103591e-10
a O 0 3.009837046263897e-09
tumor B-Disease 0 2.3912289179861546e-06
suppressor O 0 8.065480869845487e-06
. O 0 1.0176655962368386e-07

Although O 0 5.633263100435215e-08
the O 0 6.949172792758418e-09
biochemical O 0 1.624374590392108e-07
properties O 0 5.585172857536236e-08
of O 0 2.6773793138090696e-07
BRCA1 O 0 1.9506215664932824e-07
polypeptides O 0 1.3895781414419162e-08
are O 0 4.4221321049420226e-11
not O 0 4.971472192250026e-11
understood O 0 8.774191373461804e-10
, O 0 8.044600402490332e-11
their O 0 5.136400679783826e-11
expression O 0 4.282917076547932e-10
pattern O 0 2.3087303180346908e-09
and O 0 1.4645730461726458e-10
subcellular O 0 1.0271293149344274e-07
localization O 0 6.821580456062293e-08
suggest O 0 2.563101397790035e-10
a O 0 1.3287053401978e-10
role O 0 5.270550107461247e-10
in O 0 8.220750191689774e-10
cell O 0 1.2929194781463593e-07
- O 0 6.949704811631818e-07
cycle O 0 1.6223742704823962e-07
regulation O 0 3.9877616586636577e-07
. O 0 1.8983394411975496e-08

When O 0 3.6524164670481696e-07
resting O 0 9.984037205867935e-06
cells O 0 1.308581243364415e-08
are O 0 2.4302207468629433e-10
induced O 0 8.240145632498752e-08
to O 0 6.421809195522599e-10
proliferate O 0 8.502656356768057e-08
, O 0 3.81697118356783e-10
the O 0 3.132827608443023e-10
steady O 0 5.119231705208449e-09
- O 0 7.153463377207459e-10
state O 0 5.284791354531748e-11
levels O 0 2.5481661225512653e-10
of O 0 6.234936456017692e-10
BRCA1 O 0 8.549744245911484e-10
increase O 0 6.471144800568318e-12
in O 0 1.0049874127338043e-10
late O 0 5.385200552154856e-08
G1 O 0 1.218299303218373e-06
and O 0 1.801053750583037e-10
reach O 0 8.842143683907011e-11
a O 0 2.139582434834697e-11
maximum O 0 1.8574598803500209e-10
during O 0 2.2761742712873456e-08
S O 0 5.972121925879037e-06
phase O 0 9.888906333799241e-07
. O 0 3.264364423216648e-08

Moreover O 0 3.950484881443117e-07
, O 0 6.093202831181088e-09
in O 0 3.6626901511738197e-09
S O 0 1.3673795820068335e-06
phase O 0 2.148742908048007e-07
cells O 0 6.129957430545119e-09
, O 0 9.643569276462927e-10
BRCA1 O 0 2.6669356500974573e-08
polypeptides O 0 1.3311876045918325e-08
are O 0 2.3316970576559015e-10
hyperphosphorylated O 0 3.1521852861260413e-07
and O 0 1.0913597803252628e-09
accumulate O 0 1.1090268259295044e-08
into O 0 4.239728568222745e-09
discrete O 0 3.83255702729457e-08
subnuclear O 0 1.5003871340013575e-05
foci O 0 1.2456365766411182e-05
termed O 0 1.0697396646719426e-05
" O 0 1.444411168449733e-06
BRCA1 O 0 1.2350711585895624e-05
nuclear O 0 0.00027237372705712914
dots O 0 2.127911830029916e-05
. O 0 2.7104280775347434e-07

" O 0 2.0492361727519892e-05
BRCA1 O 0 1.4203576029103715e-05
associates O 0 1.5377612498923554e-06
in O 0 1.460067355907313e-08
vivo O 0 1.51756879063214e-07
with O 0 3.8999675711082205e-10
a O 0 4.853905277713011e-09
structurally O 0 1.783367679308867e-06
related O 0 7.519083169427176e-07
protein O 0 3.3517676456540357e-07
termed O 0 6.26648252364248e-05
BARD1 O 1 0.9999997615814209
. O 0 8.952167718234705e-07

Here O 0 4.809924689652689e-07
we O 0 9.468199557716162e-10
show O 0 4.232470762755014e-10
that O 0 3.4129689092249338e-12
the O 0 8.18935197433035e-11
steady O 0 4.599232994451086e-09
- O 0 1.1337313310377795e-09
state O 0 4.606234144111099e-11
levels O 0 4.918186968794203e-10
of O 0 3.0508682247187835e-09
BARD1 O 1 0.9949518442153931
, O 0 2.8344118718770517e-10
unlike O 0 3.5843722434591996e-10
those O 0 4.62575325266279e-11
of O 0 1.3790510067224204e-08
BRCA1 O 0 8.618616931244105e-08
, O 0 1.0487839485762152e-09
remain O 0 7.041646155059311e-10
relatively O 0 1.4198514586283295e-10
constant O 0 5.62582702645642e-10
during O 0 8.221679337339083e-09
cell O 0 1.0418605000950265e-07
cycle O 0 5.729028984546858e-08
progression O 0 1.9063186584844516e-07
. O 0 1.589828269032978e-09

However O 0 5.510419782694953e-07
, O 0 2.503777629669912e-08
immunostaining O 0 1.3575820048572496e-05
revealed O 0 2.3997355924620933e-07
that O 0 2.3439561402938125e-09
BARD1 O 1 0.9998156428337097
resides O 0 8.349521749551059e-07
within O 0 3.859751274148948e-08
BRCA1 O 0 2.6164030941799865e-07
nuclear O 0 6.734987891832134e-06
dots O 0 2.3545327110241487e-07
during O 0 6.841530364454229e-08
S O 0 7.10798872205487e-07
phase O 0 4.5814267934929376e-08
of O 0 5.2247517423609224e-09
the O 0 8.049608202220782e-10
cell O 0 4.95061236449601e-09
cycle O 0 1.1153626910953562e-09
, O 0 1.4818927335236154e-11
but O 0 1.4069719781600876e-12
not O 0 1.7498096071058566e-12
during O 0 6.899233961910056e-10
the O 0 1.3965522072112435e-09
G1 O 0 1.011302083497867e-05
phase O 0 4.787093530467246e-07
. O 0 8.661079853311549e-09

Nevertheless O 0 1.4473439478024375e-05
, O 0 2.8749795433213876e-07
BARD1 O 0 0.004859510343521833
polypeptides O 0 1.0091742552731375e-07
are O 0 3.654851421508454e-10
found O 0 2.536228171923227e-10
exclusively O 0 9.603206008179654e-10
in O 0 1.556961642945609e-10
the O 0 1.3235201823391662e-10
nuclear O 0 8.799536210801762e-09
fractions O 0 2.8296813781025776e-09
of O 0 2.767212459175994e-09
both O 0 1.7929134565886073e-10
G1 O 0 1.8136710195904016e-06
- O 0 4.682385323917515e-08
and O 0 3.2766329649547288e-09
S O 0 4.126758540223818e-06
- O 0 1.4340469078888418e-07
phase O 0 5.177272441869718e-07
cells O 0 4.150991372853241e-08
. O 0 7.69143149170759e-09

Therefore O 0 3.994872201928956e-07
, O 0 1.14081419866352e-08
progression O 0 1.9674953222192926e-08
to O 0 2.6420732268661595e-10
S O 0 5.195201424612605e-07
phase O 0 1.1606689298560013e-07
is O 0 2.3600498291753702e-11
accompanied O 0 5.916171441633367e-10
by O 0 4.0614300117480795e-11
the O 0 1.3385087482831182e-10
aggregation O 0 1.9525592254154844e-09
of O 0 5.628524313294747e-09
nuclear O 0 5.079026777821127e-06
BARD1 O 1 0.9977649450302124
polypeptides O 0 4.5641533574780624e-07
into O 0 9.245913901168024e-08
BRCA1 O 0 4.000452008767752e-06
nuclear O 0 5.922170021221973e-05
dots O 0 1.575079295434989e-05
. O 0 1.4796221137203247e-07

This O 0 2.208539484627181e-08
cell O 0 1.3439978374663042e-07
cycle O 0 4.122083296920209e-08
- O 0 5.098274513670731e-08
dependent O 0 5.725738105866185e-09
colocalization O 0 4.251377049513394e-06
of O 0 3.154269450078573e-07
BARD1 O 1 0.9999978542327881
and O 0 7.415341940486542e-08
BRCA1 O 0 8.916623528421042e-08
indicates O 0 1.0388394589000427e-09
a O 0 2.1772766922723008e-10
role O 0 4.780309481589029e-10
for O 0 3.861448660824607e-10
BARD1 O 1 0.9999237060546875
in O 0 4.6787878460463617e-08
BRCA1 O 0 2.5871001980704023e-06
- O 0 5.167607014300302e-06
mediated O 0 2.5086041205213405e-05
tumor B-Disease 0 0.008210998959839344
suppression O 0 0.0016525405226275325
. O 0 2.1192381893797574e-07

Ethnic O 0 5.062933894350863e-08
differences O 0 1.8769496179515954e-08
in O 0 2.546209465492666e-09
the O 0 1.795029902496026e-08
HFE O 0 0.0037326617166399956
codon O 0 1.4782442576688481e-06
282 O 0 1.6254853107966483e-06
( O 0 3.275697224580654e-08
Cys O 1 0.9999452829360962
/ O 0 5.1367700507398695e-05
Tyr O 0 0.0025763357989490032
) O 0 2.9462235318078456e-08
polymorphism O 0 5.191694754103082e-07
. O 0 4.609308135172796e-08

Recent O 0 1.3144703814305103e-07
studies O 0 8.582359711795107e-09
have O 0 6.400210916801541e-11
shown O 0 9.284537028086959e-10
that O 0 3.1565692282242708e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 4.863666163146263e-06
HH B-Disease 1 1.0
) O 0 6.492320014928055e-09
is O 0 1.06374818675814e-10
likely O 0 5.267030561695307e-11
to O 0 8.435784015770054e-11
be O 0 1.9868202916217825e-10
caused O 0 1.91998381637859e-08
by O 0 9.530382039102392e-10
homozygosity O 0 2.8122394724050537e-06
for O 0 9.697336267322498e-10
a O 0 1.5122869623240831e-09
Cys282Tyr O 0 2.335043291168404e-06
mutation O 0 6.822056253241726e-10
in O 0 2.746247396157031e-10
the O 0 4.634819195104001e-09
HFE O 0 0.0019008548697456717
gene O 0 1.0357697988183645e-07
located O 0 4.4196517023920023e-07
4 O 0 5.831069529449451e-07
. O 0 9.376159226803793e-08

5 O 0 9.405779564986005e-06
Mb O 0 5.542107828659937e-05
telomeric O 0 6.79462609696202e-05
to O 0 2.2924045595118514e-07
HLA O 0 0.0005614413530565798
- O 0 1.1453016668383498e-05
A O 0 2.951473788925796e-06
. O 0 7.388405265373876e-08

Population O 0 5.471741948426256e-10
studies O 0 1.1844203395838804e-09
of O 0 9.169370263073517e-10
this O 0 1.1963184783081449e-11
polymorphism O 0 1.0925761406710421e-09
are O 0 5.932697475646842e-12
facilitated O 0 3.5971176037818964e-10
by O 0 6.845070343874937e-11
the O 0 5.483746789991528e-10
fact O 0 4.1327597594120746e-11
that O 0 3.2461843543080127e-12
the O 0 4.0793274314054884e-10
Cys282Tyr O 0 2.9276086934260093e-05
mutation O 0 2.241294705385144e-09
creates O 0 8.29487589726341e-09
a O 0 5.1458100003287655e-09
Rsal O 0 7.095856744854245e-06
restriction O 0 3.075349397363425e-08
site O 0 3.79038596065584e-07
. O 0 3.250354652095666e-08

We O 0 3.316080565696211e-08
have O 0 1.922558084954673e-10
studied O 0 1.929804938072266e-08
the O 0 1.556748618902759e-09
codon O 0 7.974521309961347e-08
282 O 0 1.7201934099375649e-07
( O 0 1.0151702589666911e-08
Cys O 1 0.9998573064804077
/ O 0 1.2585682270582765e-05
Tyr O 0 0.00011913893831660971
) O 0 3.4180278052353685e-10
polymorphism O 0 3.994981567778666e-10
in O 0 4.2811917205787253e-11
different O 0 1.3020860431534054e-11
ethnic O 0 4.154081939544696e-11
groups O 0 1.581172692777244e-10
. O 0 9.029076153410642e-09

In O 0 1.335915413847033e-07
agreement O 0 1.888602874089429e-08
with O 0 3.4628461209607053e-10
previous O 0 6.680978437145768e-09
observations O 0 3.742619369972999e-08
the O 0 8.705864473768088e-09
Tyr O 0 0.00030480383429676294
allele O 0 7.001792479144342e-09
appeared O 0 2.9495617059893675e-09
to O 0 5.861715973720649e-11
be O 0 4.357103913776861e-11
rare O 0 2.2609207839252576e-09
or O 0 1.0020383411912803e-09
absent O 0 1.539352467716526e-08
in O 0 1.5561459898449925e-09
Asiatic O 0 4.3892492840313935e-07
( O 0 3.958271488357923e-10
Indian O 0 2.8058779744100093e-09
, O 0 1.0824779961282616e-10
Chinese O 0 2.525044617840422e-10
) O 0 1.1076981693003418e-10
populations O 0 2.8277108432561704e-10
. O 0 2.170142510138362e-09

The O 0 1.2858490094913577e-07
highest O 0 1.1016589240853136e-07
allele O 0 5.487429954875722e-10
frequency O 0 1.0539316086521922e-09
( O 0 7.644009730745083e-11
7 O 0 1.5571050004936637e-09
. O 0 1.883067833607921e-11
5 O 0 1.8333423668082105e-10
% O 0 4.604018555287581e-12
) O 0 3.7719727515039825e-12
was O 0 2.46419162852618e-10
found O 0 1.2170046914672383e-10
in O 0 8.546043317458896e-10
Swedes O 0 8.884773023964954e-07
. O 0 9.194931038791765e-08

Saamis O 0 0.0009270899463444948
( O 0 6.76605509397632e-08
2 O 0 4.09410993995607e-08
% O 0 1.1023929685771705e-10
) O 0 2.7952560405219984e-11
and O 0 2.0207542583694504e-10
Mordvinians O 0 5.529700047191e-06
( O 0 6.736201041412926e-10
1 O 0 3.257676572943069e-09
. O 0 3.678501947490531e-11
8 O 0 9.934972844405365e-10
% O 0 8.77286004258293e-12
) O 0 2.1506570396095936e-12
had O 0 1.946470415403745e-11
significantly O 0 1.408127781044044e-10
lower O 0 3.6474436804212473e-09
frequencies O 0 4.127021835387268e-09
of O 0 5.075432518708567e-09
the O 0 1.1220698148406427e-08
Tyr O 0 0.00018044871103484184
allele O 0 5.4167021090734124e-08
. O 0 1.6381196843440193e-08

Comparisons O 0 4.37811621623041e-07
with O 0 2.636723062110491e-09
allele O 0 1.1898909635377208e-09
frequencies O 0 5.2689448359899416e-09
based O 0 2.78389911123611e-09
on O 0 3.7558405274751294e-09
prevalence O 0 4.7332417985046504e-09
estimates O 0 2.53857046494943e-10
of O 0 4.056301516897065e-09
HH B-Disease 1 0.9999960660934448
showed O 0 6.475577407627497e-08
some O 0 1.7689051612368445e-10
disagreements O 0 8.50004155950046e-09
with O 0 1.7867071711030746e-10
the O 0 2.22263163429659e-09
RFLP O 0 5.866930678166682e-06
data O 0 1.2450041886324925e-08
, O 0 3.567062756282269e-10
particularly O 0 1.7034976762531073e-09
in O 0 2.7748339181954407e-09
Finns O 0 1.0956108553727972e-06
. O 0 6.477974068275216e-08

The O 0 1.028767883326509e-06
newly O 0 3.3569097013241844e-06
described O 0 5.659281896441826e-07
HFE O 1 0.9965092539787292
marker O 0 3.8615931430285855e-07
provides O 0 5.157903548713705e-10
a O 0 1.7668988494534688e-10
new O 0 2.126118309186964e-10
approach O 0 3.7853747913985103e-10
to O 0 1.592479099976618e-11
the O 0 6.643308125831027e-11
screening O 0 1.3314612745674026e-09
of O 0 3.1337554773358534e-09
HH B-Disease 1 0.999427080154419
as O 0 2.896288320286544e-09
well O 0 1.57416135682098e-10
as O 0 2.5738092213067887e-11
studies O 0 1.2000488103236506e-10
of O 0 2.7807348090824746e-10
the O 0 2.423541090035286e-10
relationship O 0 5.4084452194569366e-11
between O 0 2.5332841380176774e-10
the O 0 3.3618814399005714e-09
HFE O 1 0.9991886019706726
Tyr O 0 0.0007197356317192316
allele O 0 5.206298503424023e-09
and O 0 9.068958917168857e-10
different O 0 3.905926959646422e-08
disorders O 1 1.0
including O 0 0.18511441349983215
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.9999982118606567
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999414682388306
associated O 0 1.523870309938502e-07
with O 0 1.3578927982038635e-09
a O 0 6.1356657532485315e-09
missense O 0 1.6225259003022074e-07
mutation O 0 3.90905530167629e-09
encoding O 0 8.801332107566395e-09
Gly23 O 0 5.6193111959146336e-05
- O 0 8.45817612571409e-06
- O 0 2.2047868242225377e-06
> O 0 1.9608125967351953e-07
Val O 0 8.596110092184972e-06
in O 0 2.5063529918156746e-08
neurophysin O 0 0.002942415187135339
II O 1 1.0
. O 0 1.3262630318422453e-06

Autosomal B-Disease 1 0.9999983310699463
dominant I-Disease 1 0.9999988079071045
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 0 1.6135918485815637e-05
ADNDI B-Disease 1 1.0
) O 0 3.642092494260396e-08
is O 0 5.009033188230205e-10
an O 0 9.095623809685094e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.00029222300508990884
by O 0 1.516027658965413e-08
progressive O 1 0.9960961937904358
degeneration O 1 1.0
of O 0 0.00011850998998852447
the O 0 9.961306659533875e-07
magnocellular O 1 0.5556990504264832
neurons O 0 5.476476871990599e-07
of O 0 3.6773612919205334e-06
the O 0 3.018942834387417e-06
hypothalamus O 0 4.858337706536986e-05
leading O 0 1.9557417090254603e-06
to O 0 2.745782934354679e-09
decreased O 0 8.258094652546788e-09
ability O 0 2.10237438569294e-10
to O 0 1.3958324773799546e-10
produce O 0 3.0060505196161103e-09
the O 0 2.4504098306010746e-08
hormone O 0 1.206040565193689e-07
arginine O 0 7.125512979655468e-07
vasopressin O 0 1.1002808832927258e-06
( O 0 3.075068022440064e-08
AVP O 1 0.970319926738739
) O 0 1.1641559716224492e-08
. O 0 1.6917963918672285e-08

Affected O 0 5.149799449100101e-07
individuals O 0 4.5587761343668376e-10
are O 0 6.343249536744366e-11
not O 0 1.1649899100962813e-10
symptomatic O 0 5.53686390958319e-07
at O 0 2.3600451015681756e-07
birth O 0 2.134682546284239e-07
, O 0 2.1961538143600023e-10
but O 0 4.488524829593388e-11
usually O 0 2.840464086162342e-09
develop O 0 0.00012416802928783
diabetes B-Disease 1 0.9999998807907104
insipidus I-Disease 0 0.007306688465178013
at O 0 4.709183940576622e-06
1 O 0 2.0141729351053073e-07
- O 0 5.272647740639513e-07
6 O 0 5.069640565125155e-07
yr O 0 1.1287386769254226e-05
of O 0 8.53228812047746e-08
age O 0 3.104540269305289e-08
. O 0 7.579802563384419e-09

The O 0 3.4761251299642026e-07
genetic O 0 1.4831285000127536e-07
locus O 0 3.389782321505663e-08
of O 0 3.765302736269405e-08
the O 0 6.383846340440869e-08
disease O 0 6.349496288748924e-06
is O 0 6.202765384655251e-11
the O 0 4.560900546124458e-09
AVP O 1 0.9999988079071045
- O 0 6.097767254686914e-06
neurophysin O 0 0.0009018238633871078
II O 1 1.0
( O 0 4.738013714700173e-08
NPII O 1 0.999995231628418
) O 0 1.0789702464819584e-09
gene O 0 7.647630306806263e-10
, O 0 5.5857183461904825e-11
and O 0 2.671968202250241e-10
mutations O 0 1.7512279404385822e-09
that O 0 1.231559437764318e-10
cause O 0 4.5348969024416874e-07
ADNDI B-Disease 1 1.0
have O 0 2.778025864902389e-10
been O 0 5.744952430442041e-11
found O 0 2.623306953608573e-11
in O 0 9.61267090232587e-12
both O 0 1.1673070496320825e-11
the O 0 5.134170311116293e-10
signal O 0 5.783648227009053e-09
peptide O 0 4.0596295214356815e-09
of O 0 6.493546145236451e-09
the O 0 1.1420442369569628e-08
prepro O 0 0.00011821697989944369
- O 0 3.083699630224146e-05
AVP O 1 0.9999964237213135
- O 0 1.838032949308399e-05
NPII O 1 0.9998112320899963
precursor O 0 1.682917286416341e-06
and O 0 1.406647420765239e-08
within O 0 8.375322124720697e-08
NPII O 1 0.9999750852584839
itself O 0 3.9348881841760885e-07
. O 0 5.993146601213084e-08

An O 0 5.158844018637865e-08
affected O 0 2.048050760095066e-07
girl O 0 7.889659627835499e-07
who O 0 1.151958417544563e-09
presented O 0 3.311327745336712e-08
at O 0 1.2696690987468173e-07
9 O 0 2.6890678128665968e-08
months O 0 2.1365331726030945e-10
of O 0 1.0036584896511158e-09
age O 0 1.3189771497224e-09
and O 0 1.5198303726648987e-10
her O 0 1.6812531922205665e-10
similarly O 0 1.0850335074863438e-09
affected O 0 6.1848259846897236e-09
younger O 0 2.551928446337115e-08
brother O 0 2.472768301231554e-07
and O 0 6.709942379501399e-09
father O 0 5.96334075453342e-08
were O 0 4.56314541708025e-09
all O 0 3.102494927631483e-10
found O 0 7.280038377688314e-11
to O 0 1.573163994905702e-11
have O 0 1.5167166134144594e-11
a O 0 2.3066383525449652e-10
novel O 0 3.0290900898677364e-09
missense O 0 7.352515041247898e-08
mutation O 0 1.8317389827160468e-09
( O 0 9.078269802564876e-10
G1758 O 0 8.14797260773048e-07
- O 0 6.188965357978304e-07
- O 0 4.822284154215595e-07
> O 0 5.058454632944631e-08
T O 0 2.266216597490711e-06
) O 0 1.870531680936427e-11
encoding O 0 2.595109370451265e-11
the O 0 1.1517776316027906e-10
amino O 0 3.805136761236838e-10
acid O 0 5.743234776645068e-10
substitution O 0 7.66755636760763e-09
Gly23 O 0 5.597304607363185e-06
- O 0 8.522820280632004e-07
- O 0 3.9297430021179025e-07
> O 0 2.286535476514473e-07
Val O 0 2.232089900644496e-05
within O 0 3.4852234875870636e-07
NPII O 1 0.9999254941940308
. O 0 1.3790226205401268e-07

The O 0 1.0742661515905638e-06
mutation O 0 7.164216242472321e-08
was O 0 5.230347710494243e-08
confirmed O 0 9.61499102558605e-10
by O 0 2.55716246788662e-11
restriction O 0 6.063983204462886e-10
endonuclease O 0 5.743044440009726e-08
analysis O 0 1.1291998447404694e-08
. O 0 2.15463185071485e-08

A O 0 6.333179044304416e-05
T1 O 0 0.0030115817207843065
- O 0 4.358000182946853e-07
weighted O 0 9.873300399476648e-09
magnetic O 0 3.420548466692708e-08
resonance O 0 1.5128126307217826e-08
imaging O 0 4.844113732360711e-07
of O 0 4.7470141595340465e-08
the O 0 7.466605467243426e-08
fathers O 0 3.1594998290529475e-05
pituitary O 1 0.9870977997779846
gland O 0 0.0003805590677075088
demonstrates O 0 3.0961197694523435e-07
an O 0 8.408949092597595e-09
attenuated O 0 0.0001277866103919223
posterior O 0 9.389449405716732e-05
pituitary O 1 0.999592125415802
bright O 0 0.015204604715108871
spot O 0 0.00024311390006914735
. O 0 5.182038762541197e-07

This O 0 7.279698177597993e-09
mutation O 0 2.974238189068501e-09
may O 0 3.4976557761190463e-10
be O 0 3.507875934172233e-11
valuable O 0 1.8117699562836265e-09
for O 0 1.1734486993209003e-10
developing O 0 6.99271363036047e-10
models O 0 2.671944443477514e-09
of O 0 7.212697283875968e-08
dominantly B-Disease 1 0.9991330504417419
inherited I-Disease 1 0.9999877214431763
neurodegeneration I-Disease 1 1.0
, O 0 2.5605778830595227e-08
as O 0 5.969355010293498e-10
the O 0 3.7391695295596605e-10
early O 0 1.0637588587769642e-09
age O 0 1.2662597359547334e-10
of O 0 6.806290531180537e-10
onset O 0 0.0002279676409671083
of O 0 2.2909280232852325e-05
symptoms O 1 0.997338593006134
suggests O 0 1.1239026376230754e-09
that O 0 8.986214550255056e-12
this O 0 2.1031154248674078e-11
mutation O 0 2.6883625880991247e-10
may O 0 2.648470887045562e-10
be O 0 1.990024950382363e-10
particularly O 0 2.6192996660512335e-09
deleterious O 0 3.414108817878514e-08
to O 0 2.7264317470354626e-09
the O 0 2.33305179619947e-08
magnocellular O 0 4.681695645558648e-05
neuron O 0 1.9820736270048656e-06
. O 0 1.6975370442651183e-08
. O 0 6.120905027273693e-08

Frequent O 0 2.93353673441743e-06
inactivation O 0 0.00013550682342611253
of O 0 9.188385593006387e-05
PTEN O 1 0.9999998807907104
/ O 0 0.055959075689315796
MMAC1 O 1 0.9999998807907104
in O 0 3.987122738635662e-07
primary O 1 0.9992150068283081
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.060475251004391e-07

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.10476051418118e-07
the O 0 2.0548583279378363e-08
most O 0 8.910444049270438e-10
common O 0 1.641535263274818e-08
male B-Disease 0 3.073643028983497e-08
cancer I-Disease 0 4.457799462898038e-08
in O 0 3.950676175090706e-10
the O 0 2.27093921445487e-09
Western O 0 1.4676707849048398e-07
world O 0 5.574785433282159e-08
, O 0 2.7858099160837924e-10
yet O 0 1.7037501964800583e-10
many O 0 2.2260361956516483e-11
of O 0 1.6091119547922972e-09
the O 0 9.357035146706494e-10
major O 0 9.409927059778056e-09
genetic O 0 1.823300177505871e-09
events O 0 5.712013084746559e-10
involved O 0 2.5696264560615134e-10
in O 0 1.0313504911207971e-10
the O 0 3.6542030512620727e-10
progression O 0 9.202067552394055e-09
of O 0 8.364267056748531e-10
this O 0 2.0710270304258316e-11
often O 0 1.087806555943871e-08
fatal O 1 0.9999997615814209
cancer B-Disease 0 0.0024233965668827295
remain O 0 6.886734738031919e-09
to O 0 5.049831663939131e-10
be O 0 1.4723912089564806e-09
elucidated O 0 1.4796216419199482e-05
. O 0 9.713968296409803e-08

Numerous O 0 8.78231912793126e-06
cytogenetic O 0 0.0011953855864703655
and O 0 3.460585560333129e-07
allelotype O 0 0.00013218773528933525
studies O 0 2.8598510226629514e-08
have O 0 5.7906620470893344e-11
reported O 0 1.0066588673751653e-09
frequent O 0 6.994397949711129e-09
loss O 0 2.7837577931677515e-07
of O 0 5.996880645398051e-07
heterozygosity O 0 0.001174887758679688
on O 0 1.0900094821408857e-05
chromosomal O 1 0.7761943340301514
arm O 1 0.9622231125831604
10q O 0 0.00015676442126277834
in O 0 4.260397759026091e-07
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.842145872567926e-07

Deletion O 0 2.416323695797473e-06
mapping O 0 1.0916480874811896e-07
studies O 0 6.223248583125951e-09
have O 0 1.7971648474945923e-11
unambiguously O 0 1.142920247332313e-08
identified O 0 2.6962398980145963e-10
a O 0 2.3211939315093133e-10
region O 0 3.553062954964048e-09
of O 0 2.0810767864531954e-07
chromosome O 0 5.378128165034468e-08
10q23 O 0 2.3509159063905827e-07
to O 0 1.9177492927013873e-10
be O 0 1.5802138764176021e-10
the O 0 1.0552431151111819e-09
minimal O 0 1.658172443796957e-08
area O 0 3.9700100984418896e-08
of O 0 7.309127880716915e-08
loss O 0 3.1676070193498163e-06
. O 0 1.1734503857496748e-07

A O 0 2.144166955986293e-06
new O 0 2.4322634573081814e-08
tumor B-Disease 0 4.6104645434752456e-07
suppressor O 0 9.263279707738548e-07
gene O 0 2.2152178758005903e-08
, O 0 1.1300013369464068e-08
PTEN O 1 0.9997642636299133
/ O 0 8.674281707499176e-05
MMAC1 O 1 0.9999998807907104
, O 0 1.3927675901470593e-08
was O 0 2.6972454492124598e-08
isolated O 0 1.0013167184297345e-08
recently O 0 2.1028807584144715e-09
at O 0 2.6139894693244514e-09
this O 0 5.560957944128475e-12
region O 0 3.085281197190426e-10
of O 0 1.1236309660489496e-08
chromosome O 0 5.519110946039518e-09
10q23 O 0 1.8351221342527424e-07
and O 0 4.17772261229743e-10
found O 0 1.1146773087888917e-10
to O 0 1.7358125353750253e-11
be O 0 1.9426760547447408e-11
inactivated O 0 4.493139726946538e-08
by O 0 2.5065881661956446e-11
mutation O 0 1.5976581169141468e-10
in O 0 5.12906161986848e-10
three O 0 2.745701408457535e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.563514110282995e-05
lines O 0 4.467614189707092e-07
. O 0 3.874599485698127e-08

We O 0 4.31661192124011e-07
screened O 0 8.009221346583217e-06
80 O 0 1.2855947716161609e-05
prostate B-Disease 1 0.9999922513961792
tumors I-Disease 1 0.9999997615814209
by O 0 5.950328674231287e-09
microsatellite O 0 1.3381276176005485e-07
analysis O 0 5.9019624742973065e-09
and O 0 1.417992945285107e-09
found O 0 2.48481302200787e-09
chromosome O 0 7.99099275639037e-09
10q23 O 0 7.959173586868928e-08
to O 0 1.5833756528138565e-10
be O 0 1.8756450559376248e-10
deleted O 0 1.1043050029968526e-08
in O 0 7.757757214399419e-10
23 O 0 2.5438854578396786e-08
cases O 0 1.387998715962624e-09
. O 0 5.420161652835986e-09

We O 0 3.3816071720593754e-08
then O 0 3.0505191705998413e-09
proceeded O 0 5.183666829111644e-09
with O 0 1.581244336856802e-11
sequence O 0 3.3018119488525954e-11
analysis O 0 3.9071280932834185e-11
of O 0 1.2460724674312473e-09
the O 0 1.1910672448323112e-09
entire O 0 2.443256050810305e-07
PTEN O 1 0.9999516010284424
/ O 0 7.571795140393078e-05
MMAC1 O 1 0.9999914169311523
coding O 0 1.1717595072013864e-07
region O 0 9.905800624210315e-09
and O 0 3.8067266006081013e-10
tested O 0 1.871429455846396e-09
for O 0 4.0282024243998293e-11
homozygous O 0 1.3323045999769079e-09
deletion O 0 1.6551697790134767e-09
with O 0 2.1092025348501409e-10
new O 0 9.589721017277952e-09
intragenic O 0 1.0318481145077385e-05
markers O 0 9.265015421533462e-08
in O 0 5.441289641083813e-10
these O 0 2.7744409547558746e-10
23 O 0 1.0777140069251345e-08
cases O 0 1.4402207204611273e-10
with O 0 3.1132121880439456e-10
10q23 O 0 2.617386599013116e-06
loss O 0 3.0779133339819964e-06
of O 0 4.699368219007738e-06
heterozygosity O 0 0.026990359649062157
. O 0 2.141681989087374e-06

The O 0 7.882412234039293e-08
identification O 0 6.681160158450439e-08
of O 0 6.190612111822702e-08
the O 0 1.3167582579853843e-08
second O 0 4.892089577879233e-08
mutational O 0 4.714867998245609e-07
event O 0 3.231272671655461e-08
in O 0 1.7441210697910492e-09
10 O 0 3.873326548387013e-09
( O 0 1.536441113225706e-10
43 O 0 9.113962029516642e-09
% O 0 3.2448443931798465e-10
) O 0 8.946824614497473e-09
tumors B-Disease 1 1.0
establishes O 0 0.00016793064423836768
PTEN O 1 1.0
/ O 0 0.0171218141913414
MMAC1 O 1 0.9999957084655762
as O 0 1.0816040507677371e-08
a O 0 1.5465442260165219e-09
main O 0 4.809522557991386e-09
inactivation O 0 1.9440992105046462e-07
target O 0 3.77680908769662e-09
of O 0 1.2132119309171685e-08
10q O 0 1.2379356348901638e-06
loss O 0 7.722045438640635e-07
in O 0 5.719508777701776e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8102337406844526e-08
. O 0 2.040781588164009e-08

Risk O 0 1.0786825441755354e-06
reversals O 0 5.163687433196174e-07
in O 0 3.275239635058824e-09
predictive O 0 2.5102186995695774e-08
testing O 0 1.996856440200645e-07
for O 0 2.534181362534582e-07
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.0780899490091542e-07

The O 0 1.4602684927922382e-07
first O 0 3.9920431404993906e-09
predictive O 0 5.765375732380562e-09
testing O 0 3.426288230912178e-08
for O 0 1.6073304465180627e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.953632227686853e-09
HD B-Disease 0 0.001022291835397482
) O 0 8.090640657432147e-11
was O 0 4.399554054401733e-10
based O 0 1.1272791727856557e-10
on O 0 2.3244725588789095e-10
analysis O 0 6.598024904214128e-11
of O 0 8.294128162056325e-10
linked O 0 8.047985389225687e-09
polymorphic O 0 1.6817264025803524e-08
DNA O 0 1.3719862579364417e-07
markers O 0 5.761187527042466e-09
to O 0 4.588153468265688e-11
estimate O 0 2.1875751210487238e-10
the O 0 9.25475807100895e-11
likelihood O 0 1.9768446601897693e-10
of O 0 1.886902190051387e-09
inheriting O 0 1.9232752279663146e-08
the O 0 1.2464789200805626e-09
mutation O 0 9.929290722965334e-10
for O 0 1.142950178945057e-09
HD B-Disease 0 0.0006316900253295898
. O 0 9.090753394502826e-08

Limits O 0 6.875830393937576e-08
to O 0 5.446990081203751e-10
accuracy O 0 1.2084752754049077e-08
included O 0 3.5222469385587374e-09
recombination O 0 1.572874497313137e-09
between O 0 1.8004767121659881e-10
the O 0 3.1017433066438116e-10
DNA O 0 3.6937009895154915e-08
markers O 0 7.750647235127417e-09
and O 0 1.0071346534523684e-10
the O 0 2.792545084062681e-10
mutation O 0 3.004461124334057e-10
, O 0 1.0003496642152498e-10
pedigree O 0 9.399146350119736e-09
structure O 0 1.6907607758298582e-08
, O 0 1.828798640302054e-10
and O 0 7.640059418445588e-11
whether O 0 2.552801026123319e-11
DNA O 0 3.032633699717735e-09
samples O 0 2.890900296925736e-10
were O 0 4.7354137971966637e-11
available O 0 5.97573102112392e-11
from O 0 1.179611519575019e-09
family O 0 6.603542712646515e-10
members O 0 1.9019554819976747e-09
. O 0 1.8303358828575256e-08

With O 0 9.790544375221089e-09
direct O 0 2.3211508271003822e-09
tests O 0 8.78194761355644e-09
for O 0 1.893784434825463e-10
the O 0 1.9992556499204284e-09
HD B-Disease 0 0.0004103643004782498
mutation O 0 1.3623236982951425e-09
, O 0 5.929612356680991e-11
we O 0 8.718180691258404e-12
have O 0 2.2959917387460616e-12
assessed O 0 1.080708522671614e-09
the O 0 2.3493978984490127e-10
accuracy O 0 6.360241222580498e-09
of O 0 1.9251387151086874e-09
results O 0 5.341391773328041e-10
obtained O 0 2.33291608253694e-10
by O 0 1.3379522489920248e-10
linkage O 0 5.8537437119809965e-09
approaches O 0 6.178247247135005e-09
when O 0 2.416856714759774e-10
requested O 0 1.6260584545513268e-10
to O 0 1.0861303523235222e-10
do O 0 6.361011717359588e-11
so O 0 1.0335575277575781e-11
by O 0 2.0331826500186168e-11
the O 0 4.5098177969826736e-10
test O 0 1.0305689635004e-08
individuals O 0 7.202610730061565e-11
. O 0 6.226905657769066e-09

For O 0 2.1815939277303187e-08
six O 0 3.3587408410085118e-09
such O 0 3.108536483775737e-10
individuals O 0 2.0158449562379666e-11
, O 0 3.231041267870438e-10
there O 0 1.9009098461975071e-10
was O 0 4.1253138682861845e-09
significant O 0 5.140823877702871e-10
disparity O 0 4.989773483288218e-09
between O 0 2.7323338036566724e-10
the O 0 9.896770070128014e-10
tests O 0 9.148969581929123e-09
. O 0 3.0120481664397403e-09

Three O 0 4.3453425746520224e-07
went O 0 1.4275545368036546e-07
from O 0 2.8538611474004938e-09
a O 0 7.040759641974148e-10
decreased O 0 3.118592273310128e-09
risk O 0 1.6143525405354353e-10
to O 0 1.490572942852708e-11
an O 0 1.2090705173162242e-11
increased O 0 9.891593100164187e-11
risk O 0 1.0030632990876143e-09
, O 0 7.512063193715335e-11
while O 0 3.065664042067873e-11
in O 0 1.5182912219136036e-11
another O 0 2.7074313277419826e-11
three O 0 3.298803244455861e-11
the O 0 4.33979657765704e-10
risk O 0 9.835314784822913e-09
was O 0 7.547590996637155e-08
decreased O 0 1.3745950866450585e-07
. O 0 1.823673123624303e-08

Knowledge O 0 1.745914687489858e-06
of O 0 4.552767904897337e-07
the O 0 4.94676122286819e-09
potential O 0 7.028215232018908e-10
reasons O 0 2.441417346066288e-10
for O 0 9.098299370846608e-12
these O 0 7.623519003574497e-12
changes O 0 1.7076534630788842e-11
in O 0 7.412333941081428e-11
results O 0 2.1356774682068647e-10
and O 0 1.3511027019408317e-10
impact O 0 4.046433854654197e-09
of O 0 1.593398413213265e-09
these O 0 1.9381246607608205e-10
risk O 0 2.166093970856764e-09
reversals O 0 2.1478287592913148e-08
on O 0 1.4089996724919729e-08
both O 0 3.623705779887132e-10
patients O 0 4.0818956548172025e-10
and O 0 1.9818620355938066e-10
the O 0 2.2477761874029056e-09
counseling O 0 1.3986054092640643e-08
team O 0 3.3011229305657253e-09
can O 0 8.900311911086423e-12
assist O 0 1.3942872412187057e-09
in O 0 3.484757205018951e-10
the O 0 5.93765092649079e-10
development O 0 4.718330726127817e-10
of O 0 2.6512823048108203e-09
strategies O 0 9.781057075386457e-10
for O 0 6.999555796083357e-11
the O 0 9.875159578953685e-10
prevention O 0 4.6228760197664087e-07
and O 0 3.25801025047312e-10
, O 0 5.462302138381503e-11
where O 0 4.952109208811173e-11
necessary O 0 4.2712025583035995e-10
, O 0 1.6000306635177708e-10
management O 0 9.219091268164448e-09
of O 0 9.831600422671727e-09
a O 0 8.398894357775077e-10
risk O 0 8.717990218620741e-10
reversal O 0 1.471251342977098e-09
in O 0 1.0935971572756387e-10
any O 0 5.217675597135596e-11
predictive O 0 9.045619808745187e-10
testing O 0 1.8247796162995655e-08
program O 0 1.4232196532404373e-09
. O 0 1.6068261998736233e-10
. O 0 1.9430226316785593e-09

A O 0 6.046011549187824e-06
novel O 0 1.1485369810770862e-07
common O 0 1.4925666036447183e-08
missense O 0 6.273209010032588e-07
mutation O 0 1.4423251037953833e-08
G301C O 0 3.815141269569722e-07
in O 0 7.639032517658961e-09
the O 0 7.508475619033561e-09
N O 0 5.248026013759954e-07
- O 0 2.889707673148223e-07
acetylgalactosamine O 0 6.663560270681046e-06
- O 0 3.6468478015194705e-07
6 O 0 1.0363665836621294e-07
- O 0 5.6709303919433296e-08
sulfate O 0 4.248294516173701e-08
sulfatase O 0 8.661380888952408e-06
gene O 0 2.0349860463397818e-08
in O 0 1.7241543304180595e-08
mucopolysaccharidosis B-Disease 0 0.41814762353897095
IVA I-Disease 1 1.0
. O 0 1.4210781955625862e-06

Mucopolysaccharidosis B-Disease 1 0.9999823570251465
IVA I-Disease 1 1.0
( O 0 0.00011841543891932815
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 7.078630659407281e-08
is O 0 2.872695414879445e-10
an O 0 2.8999572188048717e-10
autosomal B-Disease 1 0.9999269247055054
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.7513666749000549
by O 0 5.693788196481364e-08
a O 0 1.635680291656172e-06
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999998807907104
in O 0 1.8201778573256888e-07
N O 0 6.396524895535549e-06
- O 0 1.0775864893730613e-06
acetylgalactosamine O 0 4.496913970797323e-05
- O 0 1.6297291267619585e-06
6 O 0 1.3159344689483987e-06
- O 0 1.1015134759873035e-06
sulfate O 0 6.419182341232954e-07
sulfatase O 0 0.00026092302869074047
( O 0 1.1796237942007792e-07
GALNS O 1 0.9999996423721313
) O 0 2.9216346675298155e-08
. O 0 4.4441229363201273e-08

In O 0 7.992702677483976e-08
previous O 0 6.581041844810898e-08
studies O 0 5.263480762351946e-09
, O 0 2.525844255973908e-10
we O 0 1.2683427225157473e-11
have O 0 1.2727647711804901e-12
found O 0 4.495136467913552e-12
two O 0 3.1306500360844813e-12
common O 0 6.249244177691793e-11
mutations O 0 1.7266041374419672e-10
in O 0 5.75322345319762e-10
Caucasians O 0 2.3883741206986997e-08
and O 0 1.5282466403476747e-09
Japanese O 0 2.1793537143821595e-06
, O 0 6.725485057756941e-09
respectively O 0 2.9470328399838763e-08
. O 0 1.986920672436554e-08

To O 0 1.1688844381296803e-07
characterize O 0 1.1688481436067377e-06
the O 0 3.8009190461707476e-08
mutational O 0 4.370708666101564e-06
spectrum O 0 5.0577217081126946e-08
in O 0 2.5060684083477724e-10
various O 0 2.0058701921676914e-10
ethnic O 0 8.311412322270506e-12
groups O 0 3.5289527376691776e-12
, O 0 1.0344017309371623e-11
mutations O 0 4.95526501775867e-11
in O 0 2.0544056733573512e-10
the O 0 2.2605544103271313e-09
GALNS O 1 0.9874277114868164
gene O 0 1.3548873134539008e-08
in O 0 6.9543837355467986e-09
Colombian O 0 6.015048256813316e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.446471848496003e-07
were O 0 5.4107514024792636e-09
investigated O 0 7.678580260517265e-08
, O 0 5.461700536280034e-10
and O 0 5.608599140671799e-10
genetic O 0 1.8392379841358775e-09
backgrounds O 0 3.398784587105297e-10
were O 0 2.1696447416452713e-10
extensively O 0 5.660302226928593e-10
analyzed O 0 2.433472312546314e-10
to O 0 1.7369088806118427e-11
identify O 0 2.125591092028145e-10
racial O 0 1.8578637239752283e-10
origin O 0 2.020984421480243e-11
, O 0 4.352151451725295e-12
based O 0 3.268415399437785e-11
on O 0 3.784754176727745e-10
mitochondrial O 0 9.61961399426059e-10
DNA O 0 2.711073499028771e-08
( O 0 3.1052005411424943e-10
mtDNA O 0 4.269852471594504e-09
) O 0 4.863281444222878e-10
lineages O 0 7.899220832996434e-09
. O 0 4.974768597065804e-09

Three O 0 3.6885407439513074e-07
novel O 0 1.6332191421497555e-07
missense O 0 1.0580490652500885e-06
mutations O 0 2.951082755942025e-08
never O 0 2.8756971914845053e-08
identified O 0 1.8250918554230111e-09
previously O 0 5.48537082423195e-09
in O 0 8.342149193651949e-11
other O 0 2.5705663292407976e-11
populations O 0 2.5575527806687148e-11
and O 0 4.0171921344978045e-11
found O 0 3.994644545701753e-11
in O 0 1.2380881042606262e-10
16 O 0 1.464646404158998e-09
out O 0 2.6736202141108834e-10
of O 0 5.885729681409657e-09
19 O 0 1.1492677742808155e-07
Colombian O 0 4.378673111204989e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 1.8709754385781707e-06
alleles O 0 5.871744201968454e-10
account O 0 6.162132470954873e-10
for O 0 3.3133165100451833e-09
84 O 0 1.0185973451370955e-06
. O 0 1.8014391400811292e-07

2 O 0 4.6979198486951645e-07
% O 0 2.7064001040244534e-10
of O 0 3.2222408075099906e-10
the O 0 7.985514333119781e-11
alleles O 0 1.3692386634234222e-11
in O 0 3.601681453080374e-11
this O 0 5.844007135852314e-12
study O 0 1.53454704499012e-09
. O 0 3.1676183898099453e-09

The O 0 2.0858662992395693e-06
G301C O 0 1.7454902263125405e-05
and O 0 2.0965860159094518e-08
S162F O 0 1.2733132734865649e-06
mutations O 0 2.157715117689918e-09
account O 0 9.989660210152351e-10
for O 0 5.6106457257953934e-09
68 O 0 2.224765466962708e-06
. O 0 8.417521257797489e-08

4 O 0 4.287435785954585e-06
% O 0 3.239985169045667e-09
and O 0 2.144806554582601e-09
10 O 0 2.0620747775978998e-08
. O 0 1.2229186552303872e-08

5 O 0 4.057844193994242e-07
% O 0 7.241970356730576e-10
of O 0 4.307743051157331e-09
mutations O 0 8.140798035682906e-10
, O 0 5.459471763558099e-10
respectively O 0 3.8718050987540664e-09
, O 0 1.6237029776267065e-10
whereas O 0 5.18893705780954e-10
the O 0 1.6731063201547158e-09
remaining O 0 6.092496107612533e-08
F69V O 1 0.9999945163726807
is O 0 2.5592178376498964e-10
limited O 0 1.4358840505490633e-10
to O 0 7.855775058240866e-11
a O 0 6.354853865353505e-10
single O 0 1.035127539239511e-08
allele O 0 6.429202503710485e-09
. O 0 1.203534161220432e-08

The O 0 2.1936696725788352e-07
skewed O 0 8.198819756444209e-08
prevalence O 0 7.595624396117273e-08
of O 0 5.750472542587204e-09
G301C O 0 1.4412174209610384e-07
in O 0 3.894184419372948e-10
only O 0 1.1904760510716983e-10
Colombian O 0 2.406022936440877e-08
patients O 0 8.915204130488519e-10
and O 0 4.449691448638049e-10
haplotype O 0 1.4169789785967168e-09
analysis O 0 8.874549706217039e-11
by O 0 1.0791419841060801e-11
restriction O 0 2.101736978898927e-10
fragment O 0 3.4505385215766182e-09
length O 0 4.132312547699968e-10
polymorphisms O 0 2.7889799358860046e-09
in O 0 5.534298574971785e-10
the O 0 7.120443346053662e-09
GALNS O 1 0.9999444484710693
gene O 0 2.8820266173568143e-09
suggest O 0 1.869648047492234e-10
that O 0 2.7124866588956742e-11
G301C O 0 6.423921661280474e-08
originated O 0 3.5838680911837173e-09
from O 0 2.788659303476493e-10
a O 0 2.58001342512415e-10
common O 0 1.5183447832356478e-09
ancestor O 0 9.632749708998745e-08
. O 0 3.050532271231532e-08

Investigation O 0 1.3004098491364857e-06
of O 0 2.458678238781431e-07
the O 0 7.99448329757979e-09
genetic O 0 3.43880435238475e-09
background O 0 4.2944670042288635e-10
by O 0 1.457772270951896e-11
means O 0 7.988241318424016e-11
of O 0 7.79217690372036e-10
mtDNA O 0 1.1980025860225396e-09
lineages O 0 1.240821057013619e-10
indicate O 0 3.896248254586787e-11
that O 0 3.2579201923038648e-12
all O 0 2.2969447177612068e-10
our O 0 1.8064215678847972e-09
patients O 0 4.971114631047158e-10
are O 0 2.028526652209095e-11
probably O 0 1.9949513152539566e-09
of O 0 1.4198121789377183e-08
native O 0 2.052762582138712e-08
American O 0 2.465985744493082e-07
descent O 0 1.641696940168913e-06

Low O 0 6.963969667594938e-07
frequency O 0 3.283403771092708e-08
of O 0 6.068628266575615e-08
BRCA1 O 0 1.7273379171456327e-07
germline O 0 1.2811339900054008e-07
mutations O 0 3.1874851647017977e-09
in O 0 8.936927864411359e-10
45 O 0 3.47142012913082e-08
German O 1 0.9999997615814209
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.0998358607471346e-08
. O 0 4.7868834229802815e-08

In O 0 4.2983884895875235e-08
this O 0 6.158076132356527e-11
study O 0 1.6478701736488688e-10
we O 0 1.1756750087354995e-11
investigated O 0 1.6645091971412285e-09
45 O 0 1.2024535145371829e-08
German O 1 0.9999816417694092
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.9438754345644256e-11
for O 0 2.96704077973331e-10
germline O 0 5.969656768911591e-08
mutations O 0 1.4908074774666602e-09
in O 0 1.0507643644075415e-09
the O 0 1.5333979419551724e-08
BRCA1 O 0 1.2256107311259257e-06
gene O 0 1.4310973028841545e-07
. O 0 7.574833915668933e-08

We O 0 3.488571564957965e-08
identified O 0 5.668927105517696e-09
four O 0 1.8170613902412924e-09
germline O 0 1.2633316259780258e-07
mutations O 0 3.1333668992772346e-09
in O 0 5.5000062282317685e-09
three O 0 8.581480415159604e-08
breast B-Disease 1 0.9999915361404419
cancer I-Disease 0 0.00037684422568418086
families O 0 5.2459758759226816e-11
and O 0 8.180582877770348e-10
in O 0 5.017354975933586e-09
one O 0 1.2152243016316788e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.180843511860985e-08
. O 0 8.18301260085974e-11
among O 0 2.5597681960198848e-11
these O 0 1.4149600761903525e-11
were O 0 3.725110497843076e-10
one O 0 2.929041453825221e-10
frameshift O 0 1.347304987575626e-07
mutation O 0 3.790087355071137e-09
, O 0 7.438652471769558e-10
one O 0 4.469578318566647e-10
nonsense O 0 6.422305318665167e-07
mutation O 0 5.417835957644002e-09
, O 0 5.19846665714141e-10
one O 0 1.3340482885038085e-10
novel O 0 1.486097578329293e-09
splice O 0 2.9983993954374455e-07
site O 0 4.745828263708063e-08
mutation O 0 2.933700171681153e-09
, O 0 7.623367492826105e-10
and O 0 1.1168550528850574e-09
one O 0 3.038504559071953e-09
missense O 0 2.0437087187019642e-06
mutation O 0 2.5727487695803575e-07
. O 0 1.5403738018449076e-07

The O 0 4.958808403898729e-07
missense O 0 2.948933115476393e-06
mutation O 0 3.392712599747938e-08
was O 0 5.9487884840336847e-08
also O 0 7.813608093876212e-10
found O 0 1.0386889126579035e-09
in O 0 3.871317488801651e-09
2 O 0 1.4886195742747077e-07
. O 0 2.431767143207253e-08

8 O 0 9.482355949330667e-07
% O 0 1.3065204473861058e-09
of O 0 2.9600444317878782e-09
the O 0 6.095745574974387e-10
general O 0 7.736863372187486e-10
population O 0 8.399286474669587e-12
, O 0 1.5431423500134045e-11
suggesting O 0 6.426977006146473e-11
that O 0 2.4837100692093328e-12
it O 0 1.5966155481050848e-11
is O 0 4.262760630591167e-11
not O 0 5.333003483265486e-10
disease O 0 2.790152393572498e-06
associated O 0 6.178827050007385e-08
. O 0 7.537707347182732e-08

The O 0 9.786889165752655e-08
average O 0 3.983030794074693e-09
age O 0 4.111622153857297e-09
of O 0 9.136209655480343e-08
disease O 0 0.005313459783792496
onset O 0 2.360974031034857e-05
in O 0 3.5664368680521363e-10
those O 0 9.497930220092599e-11
families O 0 2.747278272929865e-11
harbouring O 0 3.912593626864691e-07
causative O 0 1.4669879533357744e-07
mutations O 0 2.0907878095499655e-08
was O 0 1.7462964763126365e-07
between O 0 2.4216307181745833e-08
32 O 0 3.9430020137842803e-07
. O 0 3.610311694046686e-08

3 O 0 6.993118859099923e-06
and O 0 1.853021416309275e-07
37 O 0 7.547741347480041e-07
. O 0 3.56433922377164e-08

4 O 0 2.61685750047036e-06
years O 0 1.6487396337083737e-08
, O 0 3.417558458451708e-10
whereas O 0 4.5508530277516e-10
the O 0 6.355727055762372e-10
family O 0 6.104413641239148e-10
harbouring O 0 1.3484852843248518e-06
the O 0 1.102802116292878e-08
missense O 0 1.3251563757421536e-07
mutation O 0 1.1349731154908227e-09
had O 0 2.767121531910277e-10
an O 0 1.945776179068659e-11
average O 0 3.9988240496668936e-10
age O 0 8.956654862224411e-10
of O 0 9.731786931865827e-09
onset O 0 3.495368218864314e-05
of O 0 1.0137422350453562e-06
51 O 0 6.766441629224573e-07
. O 0 5.0140947394083923e-08

2 O 0 1.1732298844435718e-05
years O 0 1.5625285243459075e-07
. O 0 3.260836223262231e-08

These O 0 2.920024755326267e-08
findings O 0 3.127487246956662e-08
show O 0 7.587222405902594e-09
that O 0 2.56362459039039e-10
BRCA1 O 0 8.621559999255624e-08
is O 0 5.021775217883828e-10
implicated O 0 2.8392628692586186e-08
in O 0 1.1742262717717722e-09
a O 0 1.9597855283048915e-10
small O 0 8.125699418881638e-11
fraction O 0 4.280973076031813e-10
of O 0 1.2578475434565917e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.150636973536791e-10
suggesting O 0 9.537910461432375e-10
the O 0 6.213306535940433e-10
involvement O 0 2.2118054054942604e-09
of O 0 1.1244049247238763e-08
another O 0 2.4026007849897724e-09
susceptibility O 0 2.0616151630292734e-07
gene O 0 3.0373588089105397e-08
( O 0 1.218032341654407e-08
s O 0 2.538191665735212e-06
) O 0 1.8394709400126885e-07

Paternal O 0 0.00019057607278227806
transmission O 1 0.7512243986129761
of O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.1431819349527359

We O 0 2.422495128939772e-07
report O 0 1.0656683535614775e-08
a O 0 1.5262394681414548e-09
rare O 0 4.549987497881602e-09
case O 0 1.4731411646096149e-09
of O 0 2.593738201994711e-07
paternally O 1 0.9999998807907104
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999644756317139
DM B-Disease 1 1.0
) O 0 1.2475604762585135e-06
. O 0 1.8425575376568304e-07

The O 0 3.3541766697453568e-06
proband O 0 0.0002801896189339459
is O 0 8.946551055544205e-09
a O 0 3.6019116578245303e-09
23 O 0 2.6868582025940668e-08
year O 0 3.4317213515322464e-09
old O 0 2.238221668449114e-06
, O 0 3.986080443496576e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 5.815663826069795e-06
who O 0 6.620523436140502e-07
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 0.12903450429439545

He O 0 9.779944321053335e-07
presented O 0 6.98056567216554e-07
with O 0 2.806766303820041e-07
respiratory O 1 1.0
and O 0 1.8507814729673555e-06
feeding O 0 1.4799418750044424e-05
difficulties O 0 8.880232940100541e-07
at O 0 4.135374638281064e-06
birth O 0 2.255328809042112e-06
. O 0 2.5644144585612594e-08

His O 0 1.8940423615276814e-05
two O 0 6.612131073779892e-07
sibs O 1 0.999422550201416
suffer O 0 6.991492227825802e-06
from O 0 1.008185108730686e-06
childhood O 1 0.9999905824661255
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 5.176144441065844e-06

Their O 0 1.3582437929926527e-07
late O 0 1.9951708054577466e-06
father O 0 1.7865973234165722e-07
had O 0 7.004380409014743e-10
the O 0 3.8757336229267025e-10
adult O 0 2.8485955261281504e-10
type O 0 4.857470869978897e-09
of O 0 4.1906162095983746e-07
DM B-Disease 1 1.0
, O 0 7.886593067496506e-08
with O 0 2.257508180392165e-09
onset O 0 0.0014731494011357427
around O 0 7.220802178409258e-09
30 O 0 7.851543415426931e-09
years O 0 2.062207293818119e-09
. O 0 2.81483503172808e-09

Only O 0 1.1874747407603081e-08
six O 0 2.220627459692537e-09
other O 0 1.6502346364410947e-11
cases O 0 1.3836524981325482e-10
of O 0 4.5758352662517154e-09
paternal O 0 3.631521394709125e-07
transmission O 0 0.0013082143850624561
of O 1 0.9999852180480957
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.934087379140692e-07
been O 0 1.4406121628951496e-08
reported O 0 1.7431407428603052e-08
recently O 0 3.1834282765430544e-08
. O 0 2.0423936319957647e-08

We O 0 1.7716892841690424e-08
review O 0 6.921394124503877e-09
the O 0 1.2845436936359533e-09
sex O 0 5.128415470068148e-10
related O 0 1.6845763672890257e-09
effects O 0 4.428157041047598e-08
on O 0 1.3844273283325492e-08
transmission O 0 1.737930801937182e-06
of O 0 1.0894784281845205e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 1.8936612832476385e-05

Decreased O 0 7.749237624921079e-07
fertility O 0 3.593809481117205e-07
of O 0 1.7398292584402952e-08
males O 0 3.193792799671691e-11
with O 0 5.77165225335019e-11
adult O 0 1.944246896812274e-08
onset O 0 0.31323304772377014
DM B-Disease 1 1.0
and O 0 1.2926703618632018e-07
contraction O 0 1.3851119717855909e-07
of O 0 1.4077182974858715e-08
the O 0 9.784901777720734e-10
repeat O 0 4.133118736149299e-09
upon O 0 9.135608380894666e-10
male O 0 1.6166952221396969e-09
transmission O 0 2.3764719081498242e-09
contribute O 0 3.274561871657866e-11
to O 0 6.254347734158117e-11
the O 0 4.950969079153822e-10
almost O 0 6.352161158185154e-11
absent O 0 5.588801088585171e-10
occurrence O 0 6.478994007963479e-10
of O 0 6.316185352517323e-10
paternal O 0 3.7331588487177214e-08
transmission O 0 4.673504008678719e-06
of O 0 0.13976746797561646
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00010201345139648765

Also O 0 7.236357646434044e-08
the O 0 8.290984787606703e-09
fathers O 0 5.449760109854651e-08
of O 0 1.3585464309073814e-08
the O 0 4.016698085251846e-09
reported O 0 2.5692418859080135e-08
congenitally O 0 1.281534514419036e-05
affected O 0 3.1572511716149165e-08
children O 0 3.214054133948707e-09
showed O 0 7.716500327603626e-09
, O 0 2.2789306552972732e-10
on O 0 1.414837358382215e-09
average O 0 1.7225458837089036e-09
, O 0 6.905513938448848e-10
shorter O 0 3.203306278010132e-07
CTG O 0 0.028389237821102142
repeat O 0 3.9634511495023617e-07
lengths O 0 5.98229746628931e-07
and O 0 2.5674671277897687e-09
hence O 0 5.713737483148407e-09
less O 0 4.624196581204387e-09
severe O 0 0.07191994786262512
clinical O 1 0.9999644756317139
symptoms O 0 0.0008982204017229378
than O 0 6.135601055001771e-11
the O 0 1.6032666305676457e-09
mothers O 0 1.037512853407918e-09
of O 0 7.42673345044409e-09
children O 0 8.898253689437752e-09
with O 0 6.823362923569221e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00028157734777778387

We O 0 5.6860720576423773e-08
conclude O 0 5.841076955448443e-08
that O 0 1.5135846742619918e-10
paternal O 0 5.5298826850957994e-08
transmission O 0 6.840989044576418e-06
of O 1 0.8807088136672974
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 8.944214755501889e-07
rare O 0 1.0856886234478225e-07
and O 0 1.7159678122879995e-09
preferentially O 0 3.4502292134419577e-09
occurs O 0 4.1671463502090944e-10
with O 0 1.3222258010703314e-10
onset O 0 3.374993320903741e-05
of O 0 1.858510950114578e-05
DM B-Disease 1 1.0
past O 0 1.0712379889810109e-06
30 O 0 7.000083623864839e-09
years O 0 5.6460017217041525e-11
in O 0 5.001822567241021e-11
the O 0 2.2730135829096554e-10
father O 0 1.0373945258379536e-08
. O 0 6.766746052377925e-10
. O 0 8.74083827540062e-09

The O 0 5.1960014388896525e-06
RB1 O 0 0.03734509274363518
gene O 0 2.5220868948849784e-08
mutation O 0 6.581211686729205e-10
in O 0 5.141725933910379e-10
a O 0 1.953144090904857e-09
child O 0 1.5889749249708984e-07
with O 0 1.005306984325216e-07
ectopic B-Disease 1 0.9999598264694214
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999996423721313
. O 0 1.231845817528665e-05

The O 0 4.172012268099934e-06
RB1 O 0 0.049055568873882294
gene O 0 9.067531436812715e-08
mutation O 0 5.143670822604918e-09
was O 0 6.6668492948451785e-09
investigated O 0 2.6181622203580446e-08
in O 0 1.6556906956566309e-09
a O 0 2.0802612965553635e-09
child O 0 4.6382879759221396e-08
with O 0 3.571326123719132e-09
ectopic B-Disease 0 0.00012924143811687827
intracranial I-Disease 0 0.010490219108760357
retinoblastoma I-Disease 0 8.811481166048907e-06
using O 0 4.2938714805984546e-09
DNA O 0 9.818636925729152e-08
obtained O 0 1.2302124874352671e-09
from O 0 1.0889416035553268e-09
both O 0 2.530516907128799e-10
the O 0 7.865542883678245e-09
pineal B-Disease 1 0.8049702048301697
and I-Disease 0 7.087776339176344e-07
retinal I-Disease 1 0.999995231628418
tumours I-Disease 1 1.0
of O 0 0.000258851534454152
the O 0 9.022071026265621e-06
patient O 0 9.836121171247214e-05
. O 0 2.689427560653712e-07

A O 0 1.8611644918564707e-05
nonsense O 0 4.7470775825786404e-06
mutation O 0 1.2145177308298116e-08
in O 0 1.1864695004248915e-08
exon O 0 2.741985554166604e-07
17 O 0 1.2514398406437977e-07
( O 0 1.2809495686383343e-09
codon O 0 4.4308265501058486e-08
556 O 0 4.8007446906694895e-08
) O 0 1.3246162500202274e-10
of O 0 4.811697262852022e-09
the O 0 1.1413169076490703e-08
RB1 O 1 0.9892361760139465
gene O 0 5.1788342503300555e-09
was O 0 5.051664420108182e-09
found O 0 1.962965207047418e-10
to O 0 1.9029115089219673e-11
be O 0 2.721752857814952e-11
present O 0 1.1214466022479996e-09
homozygously O 0 1.7025067791109905e-06
in O 0 3.2315421449879977e-09
both O 0 1.0573263375945885e-09
the O 0 2.2811683209056355e-08
retinal B-Disease 0 1.326111305388622e-05
and I-Disease 0 1.202392070354108e-07
the I-Disease 0 6.9430011535587255e-06
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 3.0035359941393835e-06

The O 0 8.525488937038972e-08
same O 0 1.5617211968077527e-09
mutation O 0 6.453513279325307e-10
was O 0 3.056384034749726e-09
present O 0 1.6217942544471953e-09
heterozygously O 0 1.5085532822922687e-06
in O 0 1.7301258203872294e-09
the O 0 1.2110658031971866e-09
DNA O 0 4.436390810269586e-08
from O 0 6.9012873193941e-10
the O 0 1.541284044836999e-10
constitutional O 0 6.105822514257397e-10
cells O 0 3.244120250212035e-10
of O 0 2.2496420282180907e-09
the O 0 1.6861096963083355e-09
patient O 0 6.513122485785061e-08
, O 0 2.7889998643892966e-10
proving O 0 1.6281861192624092e-08
it O 0 5.447504426714378e-12
to O 0 7.236232880264426e-12
be O 0 4.8293181953429354e-11
of O 0 4.717802593035003e-09
germline O 0 1.3552045174947125e-07
origin O 0 4.410217968597863e-09
. O 0 2.185529623943694e-08

The O 0 7.941174118286654e-08
initial O 0 2.2229208695989655e-08
mutation O 0 4.95899499242114e-09
was O 0 1.017818629378553e-08
shown O 0 2.833363266230293e-10
to O 0 3.387483002437186e-11
have O 0 8.212811507257722e-12
occurred O 0 1.5631576033570127e-09
in O 0 2.0559383362428463e-10
the O 0 1.3336648452266786e-09
paternally O 0 4.986399062545388e-07
derived O 0 2.0728803917791083e-07
RB1 O 0 0.0008042867411859334
allele O 0 2.3610131449913752e-07
. O 0 9.165111691800121e-08

The O 0 2.096470694823438e-07
mutation O 0 3.0816600382621573e-09
is O 0 3.617060817528994e-11
in O 0 5.106538802923666e-11
an O 0 5.546932271144334e-12
area O 0 9.1099250365545e-10
of O 0 1.398351434644951e-09
the O 0 8.167798104530277e-10
gene O 0 9.361957736819804e-11
that O 0 4.775483827823557e-12
encodes O 0 4.783535720309651e-11
the O 0 4.089298899501159e-10
protein O 0 2.2932324095226164e-10
- O 0 8.577925036945544e-09
binding O 0 2.847744040579414e-09
region O 0 2.6862367885627236e-09
known O 0 1.6554949633373894e-09
as O 0 2.4555724120745026e-10
the O 0 1.7552508335683115e-09
pocket O 0 1.245274575012445e-06
region O 0 6.7941932080373135e-09
and O 0 6.668143259780379e-10
has O 0 4.67718364038916e-11
been O 0 2.7502718852323582e-11
detected O 0 9.125507571816627e-10
in O 0 2.1037773953458405e-11
other O 0 1.8073915628025183e-11
cases O 0 4.623056382158097e-10
of O 0 3.32653300461061e-08
retinoblastoma B-Disease 0 2.3953003619681112e-05
. O 0 1.8487950725898372e-08
. O 0 1.4974689577229583e-07

Low O 0 3.85591101803584e-06
levels O 0 3.368063516973052e-08
of O 0 1.1859128790092655e-08
beta O 0 3.3060267412565736e-08
hexosaminidase O 0 8.586291073697794e-07
A O 0 3.4399999293555084e-08
in O 0 3.83514220381187e-10
healthy O 0 1.0110113857209058e-09
individuals O 0 3.48097418945148e-12
with O 0 5.899022381683494e-10
apparent O 0 0.002465712372213602
deficiency O 1 0.9988272786140442
of O 0 0.0031385752372443676
this O 0 1.7800420692992702e-08
enzyme O 0 1.743221389460814e-07
. O 0 1.0731341149039508e-07

Appreciable O 0 2.319957457075361e-05
beta O 0 2.6609811811795225e-06
hexosaminidase O 0 5.587138366536237e-05
A O 0 5.113553015689831e-06
( O 0 1.1775821207038462e-08
hex O 0 9.12215455173282e-07
A O 0 2.9117776989551203e-07
) O 0 5.7161948785466876e-11
activity O 0 7.021274117668952e-10
has O 0 5.8717830944687854e-12
been O 0 1.93905187045873e-11
detected O 0 2.160012835261682e-09
in O 0 1.0369766156870242e-09
cultured O 0 2.8708970489788044e-07
skin O 0 6.362173007801175e-05
fibroblasts O 0 4.835113713852479e-07
and O 0 7.57275927298906e-07
melanoma B-Disease 1 0.9999996423721313
tissue O 0 0.00710318423807621
from O 0 3.1456318083655788e-06
healthy O 0 1.0155986274185125e-07
individuals O 0 4.9246051680995606e-11
previously O 0 1.8930711220832563e-08
reported O 0 3.966238892871843e-09
as O 0 4.631672823052213e-09
having O 0 2.434812529372721e-07
deficiency B-Disease 0 0.016533682122826576
of I-Disease 0 0.0007653294014744461
hex I-Disease 0 2.718475843721535e-05
A I-Disease 0 8.556846182727895e-07
activity O 0 4.305607426147162e-09
indistinguishable O 0 3.625906019877334e-09
from O 0 6.340032665530515e-11
that O 0 1.6392729187963972e-12
of O 0 3.666022208026476e-10
patients O 0 1.359061418959584e-09
with O 0 1.3533976073176746e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.6419787647901103e-06
TSD B-Disease 1 1.0
) O 0 5.107628098244277e-08
. O 0 3.506322698854092e-08

Identification O 0 4.0079598875308875e-06
and O 0 5.404751490800663e-08
quantitation O 0 0.00012114743731217459
of O 0 5.542963208426954e-06
hex O 0 2.277050953125581e-05
A O 0 6.180292984936386e-06
, O 0 3.433109130313028e-09
amounting O 0 4.737631620344018e-09
to O 0 2.720069058881336e-09
3 O 0 1.2372565549867431e-07
. O 0 1.6033776972790292e-08

5 O 0 4.829126737604383e-06
% O 0 2.480755867395601e-08
- O 0 8.329812999363639e-07
6 O 0 4.3439169417069934e-07
. O 0 3.33676410946282e-08

9 O 0 3.070161938012461e-06
% O 0 8.582895505426791e-10
of O 0 3.439328821741583e-09
total O 0 3.685280691723136e-10
beta O 0 1.1811227551561387e-08
hexosaminidase O 0 3.299916500054678e-07
activity O 0 3.355334454724357e-09
, O 0 9.361796754481233e-11
has O 0 5.032432370127848e-12
been O 0 5.312774092186556e-12
obtained O 0 9.423441887923545e-11
by O 0 3.7853892242978304e-10
cellulose O 0 7.2753541644487996e-06
acetate O 0 6.702986183881876e-07
gel O 0 2.8875479074486066e-07
electrophoresis O 0 7.978903227012779e-08
, O 0 3.111515933795772e-09
DEAE O 0 0.0012634003069251776
- O 0 5.243263103693607e-07
cellulose O 0 1.4388308500201674e-06
ion O 0 9.774482379043548e-08
- O 0 1.7174167510347615e-07
exchange O 0 1.3057638525992843e-08
chromatography O 0 1.5891735074546887e-06
, O 0 1.1539315281083873e-08
radial O 0 1.043700763148081e-06
immunodiffusion O 0 2.193172804254573e-05
, O 0 1.0912520664874137e-08
and O 0 3.149522598278054e-08
radioimmunoassay O 0 0.00026228281785734
. O 0 1.7656515183261945e-07

Previous O 0 1.0179428500123322e-06
family O 0 2.6203341718655793e-09
studies O 0 1.983837316643644e-09
suggested O 0 1.1362895346866964e-10
that O 0 1.0735450072310582e-12
these O 0 5.349369384954894e-12
individuals O 0 1.1887775919899868e-12
may O 0 6.929603418859287e-11
be O 0 4.036246684102629e-11
compound O 0 9.135542988758516e-09
heterozygotes O 0 5.678655767837881e-09
for O 0 9.417440438586056e-11
the O 0 5.359475641064648e-10
common O 0 1.5647833029319713e-09
mutant O 0 1.0771081804250571e-07
TSD B-Disease 0 0.27054065465927124
gene O 0 4.444383527868467e-09
and O 0 7.593892736856844e-10
a O 0 6.773822613936886e-10
rare O 0 1.1106800812399342e-08
( O 0 2.587707825796315e-09
allelic O 0 2.074174972221954e-06
) O 0 4.043293699851347e-09
mutant O 0 2.234671683254419e-07
gene O 0 4.157409350113994e-08
. O 0 1.136910654508938e-08

Thus O 0 3.0715335697095725e-07
, O 0 3.734232478791455e-09
the O 0 9.704311798586218e-10
postulated O 0 1.8542298363399823e-08
rate O 0 1.320847764496591e-09
mutant O 0 1.1158101109742802e-08
gene O 0 4.5606460274960625e-10
appears O 0 5.704399452799436e-11
to O 0 5.197549422103487e-12
code O 0 9.445751472658692e-12
for O 0 6.695613681551027e-12
the O 0 2.2508330269066512e-11
expression O 0 4.976538625633964e-11
of O 0 5.291663218720544e-10
low O 0 1.3930139264317631e-09
amounts O 0 3.2056465815166746e-10
of O 0 1.198709487226779e-08
hex O 0 2.1879627638554666e-06
A O 0 1.8898334701589192e-06
. O 0 3.712821339263428e-08

Heterozygotes O 0 1.243623501068214e-05
for O 0 1.2263615012386708e-08
the O 0 9.805270373419717e-09
rare O 0 3.082866584236399e-08
mutant O 0 2.485743522129269e-08
may O 0 2.134806081910412e-10
be O 0 2.0856705251759422e-11
indistinguishable O 0 4.896549388178073e-09
from O 0 3.2166036501024564e-10
heterozygotes O 0 2.1924466686584765e-09
for O 0 8.671319218223061e-11
the O 0 2.562653200754994e-09
common O 0 7.23685431580634e-08
TSD B-Disease 1 0.9992043375968933
mutant O 0 1.0106494983119774e-06
. O 0 5.165578542687399e-08

However O 0 5.442811001898917e-08
, O 0 2.861463010983556e-10
direct O 0 1.4363799039074365e-10
visualization O 0 7.09685394895132e-08
and O 0 4.991849156255057e-09
quantitation O 0 3.259363802499138e-05
of O 0 1.5227371932269307e-06
hex O 0 3.367092404005234e-06
A O 0 9.520506694116193e-08
by O 0 8.968958215005429e-11
the O 0 1.531338805760285e-10
methods O 0 2.4938722198442065e-09
described O 0 4.853183188657795e-09
may O 0 3.9509398530590545e-10
prevent O 0 1.58280277773315e-09
false O 0 1.5691448140842112e-08
- O 0 6.016431086663943e-08
positive O 0 4.0236278198158004e-10
prenatal O 0 1.030598895113144e-07
diagnosis O 0 1.8526291967191355e-07
of O 0 1.047135995690951e-07
TSD B-Disease 1 0.9999958276748657
in O 0 8.628370551377884e-08
fetuses O 0 6.36149991350976e-07
having O 0 4.3126346938038296e-09
the O 0 3.2906246616448698e-09
incomplete O 0 2.9592724786198232e-06
hex B-Disease 0 0.0002737480099312961
A I-Disease 1 0.9224817156791687
deficiency I-Disease 0 0.04762955382466316
of O 0 4.33554623668897e-06
the O 0 5.785989998230434e-08
type O 0 4.7289674398598436e-07
described O 0 2.4582508473258713e-08
in O 0 1.2591362397174066e-09
the O 0 3.309179597010825e-09
four O 0 8.479589475030025e-09
healthy O 0 9.721474469870373e-08
individuals O 0 1.827935669496128e-08

The O 0 1.4336628737510182e-06
tumor B-Disease 0 8.02537670097081e-06
suppressor O 0 1.3191775906307157e-05
gene O 0 6.055164476492791e-07
Smad4 O 0 0.041792385280132294
/ O 0 2.3819540729164146e-05
Dpc4 O 0 0.00012805202277377248
is O 0 2.177143743065102e-10
required O 0 2.88953305727091e-10
for O 0 5.509758205235471e-10
gastrulation O 0 8.695181350049097e-06
and O 0 2.827091893919942e-09
later O 0 8.573803000899716e-09
for O 0 4.007956189155948e-10
anterior O 0 1.7298560806011665e-08
development O 0 6.638489313814944e-09
of O 0 1.3214133787187166e-07
the O 0 1.7662526374806475e-07
mouse O 0 4.3774858227152436e-07
embryo O 0 3.0761242442167713e-07
. O 0 3.320523944694287e-08

Mutations O 0 2.9456739980560087e-07
in O 0 3.020120686869632e-08
the O 0 1.393610489230923e-07
SMAD4 O 1 1.0
/ O 0 0.00020579458214342594
DPC4 O 1 0.9999257326126099
tumor B-Disease 0 1.0290367526977207e-06
suppressor O 0 3.6949555237697496e-07
gene O 0 4.8452846179714015e-09
, O 0 1.909318397830262e-10
a O 0 7.500198240251166e-10
key O 0 1.4794548697238952e-08
signal O 0 5.772861300101795e-08
transducer O 0 1.8613208396800474e-07
in O 0 1.5903106609371775e-09
most O 0 6.069525437801815e-10
TGFbeta O 0 1.3517581464839168e-05
- O 0 2.0957550361799804e-07
related O 0 1.5751757587167958e-07
pathways O 0 4.0026588266073304e-08
, O 0 8.287118213878841e-11
are O 0 3.1604441286248175e-12
involved O 0 4.532071246066138e-11
in O 0 6.408273217628491e-11
50 O 0 1.2754373113210704e-09
% O 0 6.303329386225798e-11
of O 0 8.236295911956404e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 1.340070525657211e-06

Homozygous O 0 7.982563693076372e-05
Smad4 O 0 0.006772890221327543
mutant O 0 3.193146767443977e-05
mice O 0 3.56524810740666e-06
die O 0 1.3865171695215395e-06
before O 0 3.825684657954298e-08
day O 0 9.650992893739385e-08
7 O 0 4.113318823328882e-07
. O 0 2.7682064640544013e-08

5 O 0 4.006663857580861e-06
of O 0 1.8462511661709868e-06
embryogenesis O 0 5.7888482842827216e-05
. O 0 5.122819288772007e-07

Mutant O 0 8.848345487422193e-07
embryos O 0 5.0375902560517716e-08
have O 0 1.5095281968857677e-10
reduced O 0 8.02872435201607e-10
size O 0 1.2552158201728503e-09
, O 0 7.538678015173161e-10
fail O 0 5.788967527564637e-09
to O 0 5.282456139177327e-10
gastrulate O 0 3.4316917663090862e-06
or O 0 3.297900619259053e-09
express O 0 2.0092714159147818e-09
a O 0 1.8233453635829733e-09
mesodermal O 0 2.0399777440616162e-06
marker O 0 4.4141083321846963e-07
, O 0 3.943127158123616e-09
and O 0 6.336170255138995e-09
show O 0 4.9633221976819186e-08
abnormal O 0 1.982198455152684e-06
visceral O 0 8.553030966140795e-06
endoderm O 0 0.1208907887339592
development O 0 2.845370090653887e-06
. O 0 1.2378868063933623e-07

Growth B-Disease 1 0.9999992847442627
retardation I-Disease 1 1.0
of O 0 5.17642438353505e-05
the O 0 5.306354182721407e-07
Smad4 O 1 0.9969485402107239
- O 0 8.579925633966923e-06
deficient O 0 1.362223542855645e-07
embryos O 0 5.42186784358023e-09
results O 0 1.0626658442092207e-09
from O 0 1.5710995837636688e-09
reduced O 0 5.07338082655906e-09
cell O 0 1.0439332953637859e-07
proliferation O 0 5.791675903310534e-07
rather O 0 3.37896044477759e-10
than O 0 1.8437636833956716e-11
increased O 0 3.163444506348867e-10
apoptosis O 0 5.8698128668766e-07
. O 0 1.1758539919526356e-08

Aggregation O 0 2.124764023392345e-06
of O 0 2.080333615595009e-06
mutant O 0 1.4496636140393093e-06
Smad4 O 0 0.00011091894702985883
ES O 0 0.0001573018089402467
cells O 0 1.5574176615018587e-08
with O 0 6.31676322360164e-10
wild O 0 4.3901366097998107e-07
- O 0 6.037520279278397e-07
type O 0 2.7048605488744215e-07
tetraploid O 0 4.7048119995452e-06
morulae O 0 0.0001819386670831591
rescues O 0 1.4761628335691057e-05
the O 0 5.47851414012257e-07
gastrulation B-Disease 1 0.9735557436943054
defect I-Disease 0 0.00011568732588784769
. O 0 5.765026003246021e-07

These O 0 5.705180683435174e-08
results O 0 3.738517406759456e-08
indicate O 0 1.0165517316806927e-08
that O 0 1.9618462410164739e-10
Smad4 O 0 7.50327581044985e-06
is O 0 1.8326537509771867e-10
initially O 0 2.967233125872326e-10
required O 0 5.103131112127457e-11
for O 0 2.377199305458877e-11
the O 0 1.825031792357379e-10
differentiation O 0 1.11933529112207e-09
of O 0 2.657606135159085e-09
the O 0 1.8151042890934832e-09
visceral O 0 3.0762123515160056e-07
endoderm O 0 0.0001902478252304718
and O 0 2.875591542661482e-09
that O 0 8.953439378789341e-11
the O 0 1.3303087520455392e-09
gastrulation B-Disease 0 4.437783354660496e-05
defect I-Disease 0 2.2266982568908134e-07
in O 0 1.723597597980131e-09
the O 0 8.124235506556943e-09
epiblast O 0 0.00022349647770170122
is O 0 3.404078408042466e-10
secondary O 0 2.4891120276038237e-08
and O 0 1.373417268801802e-09
non O 0 4.1851549212879036e-06
- O 0 1.11378367364523e-05
cell O 0 7.160800237215881e-07
autonomous O 0 8.929011414693377e-07
. O 0 5.8219455922881025e-08

Rescued O 0 3.766093141166493e-05
embryos O 0 3.883103545376798e-06
show O 0 1.3551918982557254e-06
severe O 1 0.5318957567214966
anterior O 0 0.00040775653906166553
truncations O 1 0.9999978542327881
, O 0 3.0515803928210516e-07
indicating O 0 2.0315953008775978e-07
a O 0 7.52080175914216e-09
second O 0 3.6265301872617783e-08
important O 0 3.4294962425462927e-09
role O 0 3.808668047611263e-09
for O 0 2.4069950477212387e-09
Smad4 O 0 0.0008708025561645627
in O 0 6.421545606372092e-08
anterior O 0 1.9503440853441134e-06
patterning O 0 3.0697625334141776e-05
during O 0 6.499250048364047e-06
embryogenesis O 0 0.00012059995060553774
. O 0 2.887916821237013e-07

Prevalence O 0 1.6476338714710437e-05
of O 0 8.682997645337309e-07
p16 O 0 9.404957381775603e-07
and O 0 1.5801468578047206e-07
CDK4 O 1 0.9999985694885254
germline O 0 4.2396072785777505e-06
mutations O 0 3.078642052400937e-08
in O 0 1.8980786720135256e-08
48 O 0 5.485909696290037e-06
melanoma B-Disease 1 0.9999992847442627
- O 0 0.03782128542661667
prone O 0 0.000564226764254272
families O 0 2.6558781840435586e-09
in O 0 3.514739432830538e-08
France O 0 7.982052011357155e-06
. O 0 4.31222986208013e-07

The O 0 8.227924581660773e-07
French O 0 0.00012261107622180134
Familial B-Disease 1 0.9999933242797852
Melanoma I-Disease 1 1.0
Study O 0 3.3284422897850163e-06
Group O 0 7.547432119281439e-07
. O 0 1.2699331364274258e-07

Germline O 0 2.681933983694762e-05
mutations O 0 5.732592356366695e-08
in O 0 1.1478269001941044e-08
the O 0 9.859487448693471e-09
p16 O 0 1.1591323811899201e-07
and O 0 1.5747334103366484e-08
CDK4 O 1 0.9998800754547119
genes O 0 2.7114652745297008e-09
have O 0 7.891502035173303e-11
been O 0 1.8498971798841524e-10
reported O 0 3.100820433754592e-10
in O 0 1.2532534732212497e-10
a O 0 1.2674920835120673e-10
subset O 0 6.312563360921786e-09
of O 0 2.971399908346939e-07
melanoma B-Disease 1 0.5971187353134155
pedigrees O 0 6.731274879712146e-07
, O 0 1.64584501582965e-09
but O 0 6.68632649247769e-11
their O 0 7.463124562789858e-10
prevalence O 0 1.309949748673489e-08
is O 0 1.0201415233390687e-11
not O 0 5.0477556162720205e-12
well O 0 1.274318872646063e-09
known O 0 5.120269364056185e-08
. O 0 3.4366554046982856e-08

We O 0 1.7084444081660877e-08
searched O 0 2.2629153662023782e-08
for O 0 1.0874197375887462e-10
such O 0 6.810965680337233e-10
germline O 0 1.3175301205592405e-07
mutations O 0 4.000595854591893e-09
in O 0 1.8348476071849973e-09
48 O 0 1.0044043108337064e-07
French O 0 7.633994391653687e-05
melanoma B-Disease 1 1.0
- O 0 0.44975265860557556
prone O 0 0.0002725602244026959
families O 0 2.0850987603182602e-10
selected O 0 4.1030436825906236e-09
according O 0 2.4410401477936716e-10
to O 0 1.0340826112065216e-10
two O 0 1.8281638702877245e-10
major O 0 5.142513082034839e-09
criteria O 0 4.281759391489004e-09
families O 0 2.970986651140706e-11
with O 0 1.6200094044016566e-10
at O 0 3.4871543874714916e-08
least O 0 7.557548337144837e-11
three O 0 2.0035224868042434e-10
affected O 0 1.0446892240167927e-09
members O 0 5.193610541631699e-10
( O 0 3.607190102172808e-10
n O 0 2.139005195189725e-09
= O 0 1.6883398012979e-09
20 O 0 2.27936647334559e-09
) O 0 1.1826268263293027e-11
or O 0 3.503757006750874e-11
families O 0 1.125112806740769e-12
with O 0 8.651407715221104e-12
two O 0 8.568546566722901e-11
affected O 0 1.0501132186035989e-09
members O 0 2.392233355852369e-10
, O 0 7.641123844770448e-11
one O 0 4.159259048286401e-11
of O 0 1.478018596401398e-09
them O 0 1.5251475082855848e-10
affected O 0 6.075560610163677e-10
before O 0 6.399396568212978e-10
the O 0 1.2566260532143048e-10
age O 0 1.0462420513279724e-10
of O 0 2.577583424479002e-10
50 O 0 2.721977365727213e-10
( O 0 5.112893441960864e-11
n O 0 4.304570588864465e-10
= O 0 1.1933228849514421e-09
28 O 0 1.2153543060833272e-08
) O 0 3.61483343258584e-11
, O 0 2.8885231012631962e-11
and O 0 5.058205937436e-11
one O 0 1.6664832708235267e-11
additional O 0 3.014472005347102e-10
minor O 0 4.241467649990227e-06
criterion O 0 1.979425360332243e-05
. O 0 1.2694633255705412e-07

Sixteen O 0 1.4775599993299693e-05
different O 0 1.9213759472336278e-08
p16 O 0 3.5992562175124476e-07
germline O 0 3.223633768811851e-07
mutations O 0 4.017586707760756e-09
were O 0 3.598924491754474e-09
found O 0 3.8662978374404133e-10
in O 0 1.3118135744338844e-10
21 O 0 3.494083689048466e-09
families O 0 8.618781036084933e-12
, O 0 6.687295855956066e-11
while O 0 7.055974554637245e-11
one O 0 1.1176407715973724e-10
germline O 0 9.159310820905375e-08
mutation O 0 6.468118929348066e-09
, O 0 3.973174678151281e-09
Arg24His O 0 9.0344030468259e-05
, O 0 7.999486406617962e-09
was O 0 1.4323460639786845e-08
detected O 0 1.374411073840065e-08
in O 0 7.580593930356372e-10
the O 0 9.689298252624212e-09
CDK4 O 1 0.9999943971633911
gene O 0 4.029484728107491e-07
. O 0 6.747021075170778e-08

The O 0 2.8131513118978546e-08
frequency O 0 1.3891144234889907e-08
of O 0 9.470173090164735e-09
p16 O 0 2.4595827596840536e-08
gene O 0 1.0136722572440249e-09
mutation O 0 8.791005423613996e-11
in O 0 1.5281322041094114e-10
our O 0 3.461604614063418e-10
sample O 0 2.4644875029622426e-10
( O 0 5.832262450766734e-11
44 O 0 7.736863372187486e-10
% O 0 8.751968767761742e-12
) O 0 5.3763321919420015e-12
is O 0 5.240343315532359e-12
among O 0 2.7732385832202056e-11
the O 0 2.7508137434573143e-10
highest O 0 1.0522048121686112e-08
rates O 0 3.282361327183736e-10
yet O 0 6.1511386262314e-11
reported O 0 1.7602386215287424e-10
and O 0 1.3993324554650854e-10
the O 0 2.1107207093251645e-09
CDK4 O 1 0.9997475743293762
mutation O 0 6.788359874221328e-10
is O 0 8.60132364638444e-12
the O 0 5.978900707859225e-11
second O 0 1.8102327414837305e-09
mutation O 0 2.0840251746534477e-10
detected O 0 2.2253168197039486e-09
in O 0 6.742625208167041e-11
this O 0 3.6557350896471164e-11
gene O 0 1.6932385493717561e-09
worldwide O 0 4.8250230477719924e-09
. O 0 2.4938547227293384e-08

In O 0 2.5615602794459846e-07
summary O 0 4.822908863388875e-07
, O 0 6.9748145037351605e-09
our O 0 3.364755363222116e-09
results O 0 1.7168648724918967e-09
show O 0 8.042456700607659e-10
frequent O 0 5.801742419819789e-10
involvement O 0 1.6379533285260095e-09
of O 0 3.2068405708685077e-09
the O 0 1.2470188215374378e-09
p16 O 0 1.447876218918509e-08
gene O 0 3.268181947291282e-09
in O 0 1.6119134915726363e-09
familial B-Disease 0 7.89698515291093e-06
melanoma I-Disease 1 0.5321325659751892
and O 0 5.234716660140748e-09
confirm O 0 9.941195422413784e-09
the O 0 6.434796695486966e-09
role O 0 3.1446167891857613e-09
of O 0 6.191733348259731e-08
the O 0 4.484612503574681e-08
CDK4 O 1 1.0
gene O 0 1.0430033725583598e-08
as O 0 8.107111648669729e-10
a O 0 9.225458619255278e-09
melanoma B-Disease 0 0.08755248785018921
- O 0 8.034956408664584e-06
predisposing O 0 7.791880307195242e-06
gene O 0 6.165711852190725e-08
. O 0 3.959104155626392e-09
. O 0 2.7817243619665533e-08

Progression O 0 4.700067802332342e-05
of O 0 2.8263818876439473e-06
somatic O 0 7.59379836381413e-05
CTG O 0 0.04009106382727623
repeat O 0 2.555504181600554e-07
length O 0 3.1260543043032385e-09
heterogeneity O 0 2.627822937029123e-08
in O 0 1.0201794964359578e-09
the O 0 1.3458024694656956e-09
blood O 0 3.2076499678623804e-08
cells O 0 3.26749791668135e-08
of O 0 0.00027912150835618377
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.19480784237384796
. O 0 5.790339514533116e-07

The O 0 1.3445234969822195e-07
genetic O 0 1.396124105212948e-08
basis O 0 1.7747195713013753e-08
of O 0 3.876261871482711e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.010578639805316925
DM B-Disease 1 1.0
) O 0 4.573828427112403e-09
is O 0 2.8300672569314678e-11
the O 0 6.640698407833767e-11
expansion O 0 1.6115937473415443e-09
of O 0 1.3207375637591667e-08
an O 0 4.5430736950180517e-10
unstable O 0 5.159417924005538e-06
CTG O 0 0.05124542489647865
repeat O 0 1.4080814025874133e-07
in O 0 1.3927615727382658e-09
the O 0 3.280335114652644e-09
34 O 0 1.614366418323243e-08
UTR O 0 3.3681226341286674e-05
of O 0 8.477184110233793e-08
the O 0 2.5180252549716897e-08
DM B-Disease 1 1.0
protein O 0 1.1895239460102403e-08
kinase O 0 3.884455779257223e-08
gene O 0 5.86626214271746e-09
on O 0 1.4645745949337652e-08
chromosome O 0 2.430250845009141e-08
19 O 0 1.2974302876500587e-07
. O 0 1.1767490981640094e-08

One O 0 4.830596367355611e-08
of O 0 4.0912375709467597e-08
the O 0 3.3378193542432655e-09
principal O 0 3.5961949862439724e-08
features O 0 6.73132349859884e-09
of O 0 1.7857004763754958e-08
the O 0 9.284509161489041e-08
DM B-Disease 1 1.0
mutation O 0 1.1895919804771893e-08
is O 0 6.07010205988523e-11
an O 0 1.3283298072597205e-11
extraordinarily O 0 3.765159206636781e-08
high O 0 2.2794854714902613e-07
level O 0 2.082922634372153e-08
of O 0 8.962059538930589e-09
somatic O 0 1.4755892152606975e-06
mosaicism O 0 0.00010153451876249164
, O 0 1.4026600991812188e-09
due O 0 5.947129455563527e-09
to O 0 1.157004839158482e-10
an O 0 3.384918734194997e-11
extremely O 0 1.116897685449203e-09
high O 0 1.666060001070946e-08
degree O 0 6.890873649467721e-09
of O 0 3.7062182212110883e-09
somatic O 0 3.611090448885079e-07
instability O 0 1.2569988605548588e-08
both O 0 5.354836574156252e-10
within O 0 2.2209660777150475e-09
and O 0 3.1205305006665185e-10
between O 0 6.000301921993412e-10
different O 0 1.6342116548884178e-09
tissues O 0 1.6451449482701719e-06
. O 0 9.997769723213423e-08

This O 0 5.9397407881078834e-08
instability O 0 2.7165145866092644e-07
appears O 0 2.044025393388438e-09
to O 0 4.2968576613455767e-11
be O 0 1.519055888021814e-11
biased O 0 1.2528430515246214e-09
towards O 0 9.193256156336815e-10
further O 0 4.535193054433506e-11
expansion O 0 4.4819395417228236e-10
and O 0 4.3292449486420637e-11
continuous O 0 4.650375085013536e-10
throughout O 0 1.4882953203176896e-10
the O 0 8.355939551396574e-11
life O 0 9.99888088992762e-11
of O 0 1.73203992814841e-10
an O 0 1.4811826895208546e-12
individual O 0 1.2266543683581155e-11
, O 0 6.80165437860758e-11
features O 0 1.2709642227548557e-09
that O 0 4.009336265764496e-12
could O 0 3.915065494020098e-11
be O 0 2.3197676418673652e-11
associated O 0 3.1024180446870275e-10
with O 0 9.693577190938996e-11
the O 0 6.285615139489664e-09
progressive O 0 2.0014853419070278e-07
nature O 0 3.222827871240952e-08
of O 0 5.674100478358923e-08
the O 0 1.1988613550784066e-06
disease O 0 0.021418554708361626
. O 0 2.0482609386363038e-08

Although O 0 6.052410128631891e-08
increasing O 0 2.1868460375884524e-09
measured O 0 7.846857386084594e-09
allele O 0 3.6083255827712435e-10
size O 0 5.601158981072274e-10
between O 0 1.38350808587262e-09
patients O 0 6.663747331714376e-09
clearly O 0 1.0511270742696865e-09
correlates O 0 4.917307894203304e-09
with O 0 2.6447543807761598e-11
an O 0 1.2033464502625435e-11
increased O 0 1.7436378729751567e-10
severity O 0 7.339511967074941e-07
of O 0 7.032571716081293e-07
symptoms O 0 8.850928679748904e-06
and O 0 3.9977030019677784e-10
an O 0 5.393371513284784e-12
earlier O 0 2.939652965494588e-10
age O 0 2.4149213184720963e-10
of O 0 1.4321295260799616e-09
onset O 0 3.481676458250149e-06
, O 0 7.277345392964207e-11
this O 0 3.2076186325113998e-12
correlation O 0 4.026927055700291e-11
is O 0 2.4179378117772377e-12
not O 0 7.828528407125002e-13
precise O 0 6.240040151261894e-10
and O 0 1.3508168195119907e-10
measured O 0 1.5635452932372118e-09
allele O 0 6.896586773885716e-11
length O 0 3.4744221388827157e-11
cannot O 0 9.849153610741457e-12
be O 0 3.693489090961233e-12
used O 0 4.719310012224476e-11
as O 0 3.545301552332347e-11
an O 0 3.821898960504333e-12
accurate O 0 5.005015069059482e-09
predictor O 0 2.578071303105389e-07
of O 0 2.0152675972440193e-08
age O 0 1.2136679217178425e-08
of O 0 8.406755114265252e-08
onset O 0 0.0004234183288644999
. O 0 1.1308922154285028e-07

In O 0 4.494939886967586e-08
order O 0 2.7358240117791865e-09
to O 0 1.1833944935091267e-10
further O 0 7.953258884807468e-11
characterize O 0 7.168901916543291e-09
the O 0 2.251015596144157e-09
dynamics O 0 2.4824939259815437e-07
of O 0 2.802119979605777e-06
DM B-Disease 1 1.0
CTG O 1 0.999984860420227
repeat O 0 9.488651926403691e-07
somatic O 0 2.7605037757894024e-06
instability O 0 1.0886227386208702e-07
, O 0 1.138707017567242e-09
we O 0 6.111307293554802e-11
have O 0 5.876690627182324e-12
studied O 0 2.731110892995048e-09
repeat O 0 1.998142540315939e-09
length O 0 1.636107083147209e-10
changes O 0 3.129374190335987e-11
over O 0 7.10510539292386e-11
time O 0 1.1403736288606581e-10
in O 0 7.352438102792291e-10
111 O 0 0.004058279562741518
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.6089954613107693e-07
with O 0 3.6709552064806417e-10
varying O 0 1.0463049981979111e-08
clinical O 0 3.4841799788409844e-05
severity O 0 6.628030678257346e-05
and O 0 1.7334073731944954e-07
CTG O 0 0.0017288231756538153
repeat O 0 5.188378082721101e-08
size O 0 1.8069350460336864e-09
over O 0 5.512417744490961e-10
time O 0 7.37262820238449e-11
intervals O 0 5.078722997708951e-10
of O 0 1.0566972852288359e-09
1 O 0 3.9918686134399195e-09
- O 0 3.7893737925287496e-08
7 O 0 2.7378769473784814e-08
years O 0 2.6253919038765616e-09
. O 0 2.1596830990233684e-09

We O 0 2.4095960782233306e-08
have O 0 1.3636436424491194e-10
found O 0 1.313541081460201e-10
a O 0 4.287197680197252e-11
direct O 0 2.1957013984774676e-10
progression O 0 9.107793630391825e-09
of O 0 4.395010133606547e-09
the O 0 5.324435337072941e-10
size O 0 4.2624132001733983e-10
heterogeneity O 0 1.1253639797814685e-08
over O 0 8.83666806394956e-10
time O 0 8.092214398569553e-11
related O 0 1.0918345116905925e-09
to O 0 2.673003207664948e-10
initial O 0 7.202768603775667e-09
CTG O 0 1.604449425940402e-05
repeat O 0 9.095017183824439e-09
size O 0 7.473180962946913e-10
and O 0 4.5468878662191514e-10
the O 0 2.6581875589570814e-10
time O 0 5.1934692657518156e-11
interval O 0 4.190923441615979e-10
and O 0 3.615591853689537e-11
always O 0 1.7577324318285292e-10
biased O 0 1.41687361843168e-09
towards O 0 1.6706669381250094e-09
further O 0 7.369848065152951e-10
expansion O 0 1.1864179327858437e-07
. O 0 2.9330529116577964e-08

Attempts O 0 4.2636617081370787e-07
to O 0 2.619020111893633e-09
mathematically O 0 3.0172419229757e-08
model O 0 1.378637426441287e-09
the O 0 5.015307280586967e-09
dynamics O 0 1.1303164626497164e-07
have O 0 1.5460036029146806e-10
proved O 0 1.3157515965644961e-08
only O 0 5.453349577466682e-11
partially O 0 2.4699110312553785e-08
successful O 0 3.965285877427505e-09
suggesting O 0 4.857487190257359e-10
that O 0 1.134614320899563e-12
individual O 0 2.134176732906945e-12
specific O 0 4.872145395462546e-11
genetic O 0 3.3625482398491613e-09
and O 0 1.009990402423e-08
/ O 0 3.4724803299468476e-07
or O 0 8.372790794020091e-10
environmental O 0 8.746675383974889e-09
factors O 0 2.840912227686232e-10
also O 0 7.232759530184651e-11
play O 0 2.692612799393146e-09
a O 0 3.1983543591351804e-10
role O 0 6.802488017321195e-10
in O 0 3.3130824750315924e-09
somatic O 0 4.405698291520821e-06
mosaicism O 0 0.00010939878120552748
. O 0 6.032495036834007e-08
. O 0 1.438040442280908e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 3.2491402635059785e-07
Palestinian O 0 1.9863616671500495e-06
Arabs O 0 3.7215423276393267e-07
. O 0 1.1680419476078896e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9925468564033508
AGU B-Disease 1 1.0
) O 0 6.021942056122498e-08
is O 0 4.5874909426757426e-10
a O 0 1.3066999704491877e-09
rare O 0 1.4052671986064524e-06
disorder B-Disease 1 0.9999994039535522
of I-Disease 1 0.9999980926513672
glycoprotein I-Disease 1 0.9999997615814209
metabolism I-Disease 1 1.0
caused O 0 2.089047120534815e-05
by O 0 7.72072450416772e-09
the O 0 4.833499588130508e-06
deficiency B-Disease 1 0.9855824708938599
of I-Disease 0 0.0013189297169446945
the I-Disease 0 2.444050778649398e-06
lysosomal I-Disease 0 0.2935495674610138
enzyme I-Disease 0 3.0273042739281664e-07
aspartylglucosaminidase I-Disease 0 0.0018363180570304394
( O 0 3.414929139466949e-08
AGA O 1 0.99998939037323
) O 0 4.146235710322799e-08
. O 0 5.2666166538983816e-08

AGU B-Disease 1 1.0
is O 0 2.3552563561679563e-06
inherited O 0 8.10553174233064e-05
as O 0 5.53504042599684e-09
an O 0 1.181065911737278e-09
autosomal O 0 0.00017693196423351765
recessive O 0 3.975768413511105e-05
trait O 0 4.6887933535799675e-08
and O 0 2.7539979186030905e-08
occurs O 0 1.5464379776730652e-09
with O 0 1.3893726447111732e-10
a O 0 8.70967964416991e-10
high O 0 8.643655746709555e-08
frequency O 0 5.011453474423888e-09
in O 0 5.953242898648625e-10
Finland O 0 4.56354847244711e-08
because O 0 1.4435759532194226e-10
of O 0 3.802063108793163e-09
a O 0 1.6073726794019194e-09
founder O 0 1.1766469469876029e-06
effect O 0 9.472886119965551e-08
. O 0 5.276902825812613e-08

While O 0 1.2696681324086967e-06
very O 0 1.4545248561148583e-08
few O 0 1.0323631727260363e-08
patients O 0 2.631835549493644e-08
with O 0 2.6212601866859586e-08
AGU B-Disease 1 1.0
have O 0 1.6317013296074379e-09
been O 0 6.903078109132821e-10
reported O 0 1.5797627650471213e-09
from O 0 1.0729795940633835e-09
non O 0 1.2017019912491378e-07
- O 0 1.4203762077613646e-07
Finnish O 0 8.412515853706282e-06
origin O 0 2.204683102746685e-09
, O 0 9.625890085018796e-10
we O 0 1.5035721556699855e-09
diagnosed O 0 1.0501623364689294e-05
the O 0 4.682912191356081e-08
disorder O 0 0.0004879706248175353
in O 0 9.37309785342677e-09
8 O 0 5.8600697627753107e-08
patients O 0 4.2136064082320956e-10
originating O 0 1.5869411340574402e-09
from O 0 1.1534820876235585e-09
3 O 0 6.950140907235891e-09
unrelated O 0 4.8862585089182176e-09
families O 0 1.7901480645066137e-11
, O 0 2.946117655389102e-11
all O 0 1.4504971876383443e-11
Palestinian O 0 1.512281189164355e-09
Arabs O 0 2.1433575747575873e-10
from O 0 7.364592824465888e-10
the O 0 1.337338018103651e-09
region O 0 4.642453976799743e-09
of O 0 1.765657486885175e-08
Jerusalem O 0 7.371312676696107e-06
. O 0 3.0988314847490983e-07

The O 0 4.784099587595847e-07
clinical O 0 3.0800852982793e-05
diagnosis O 1 0.9924837946891785
of O 1 0.9999890327453613
AGU B-Disease 1 1.0
is O 0 7.705281745984394e-08
often O 0 1.0344303191800464e-09
difficult O 0 2.8267146401361742e-09
, O 0 1.0470186523336977e-10
in O 0 4.42561716440526e-11
particular O 0 1.0563295030352471e-11
early O 0 6.539805363914297e-10
in O 0 4.7465448238526164e-11
the O 0 1.7317228206970015e-10
course O 0 1.2890358114248102e-08
of O 0 8.712940591237839e-09
the O 0 1.1818330847290781e-07
disease O 0 0.0038022538647055626
, O 0 1.9017984409508415e-10
and O 0 1.7706031085751306e-10
most O 0 1.34287372888231e-10
of O 0 5.12230835525429e-09
the O 0 9.942787926320307e-09
patients O 0 1.501956425897788e-08
are O 0 6.721851963931158e-10
diagnosed O 0 4.248351785918203e-07
after O 0 4.659291175101998e-09
the O 0 2.1479178435868107e-09
age O 0 1.613808531253369e-09
of O 0 8.090186298659319e-09
5 O 0 1.658909454249624e-08
years O 0 5.295815785899549e-09
. O 0 1.5899564331789406e-08

However O 0 1.8164044490731612e-07
, O 0 4.435652289913605e-09
since O 0 3.147555549531944e-10
these O 0 7.331386886466618e-11
patients O 0 5.768430733077423e-10
excrete O 0 1.1961697410356464e-08
early O 0 3.239645440800132e-09
large O 0 9.402668921243418e-11
amounts O 0 4.801802289122747e-10
of O 0 2.0385172661008255e-08
aspartylglucosamine O 0 2.00798695004778e-06
in O 0 5.162276384140796e-09
urine O 0 4.3136978433722106e-08
, O 0 5.295187066600704e-10
biochemical O 0 7.995935646931684e-08
screening O 0 8.973933773859244e-08
is O 0 4.20808055068278e-10
easy O 0 2.106120167155723e-09
by O 0 4.218849436465888e-10
urine O 0 8.026128739402338e-08
chromatography O 0 1.58341720180033e-06
. O 0 2.8582695321688334e-08
. O 0 7.249522582242207e-08

Detection O 0 1.48688650369877e-05
of O 0 2.6754497639558394e-07
heterozygous O 0 6.376250638595593e-09
carriers O 0 1.8315573502292182e-09
of O 0 2.2141744437931266e-08
the O 0 3.09219245764325e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.1988889759304584e-07
ATM O 1 0.9720025062561035
) O 0 4.467526348861384e-09
gene O 0 1.1632498297942107e-09
by O 0 4.310124201989396e-10
G2 O 0 0.00022412296675611287
phase O 0 1.469034941692371e-06
chromosomal O 0 1.923963282024488e-06
radiosensitivity O 0 2.8824499167967588e-05
of O 0 2.7123360268888064e-06
peripheral O 1 0.7662699222564697
blood O 0 0.0005580361466854811
lymphocytes O 0 5.651485480484553e-05
. O 0 3.811003068676655e-07

In O 0 3.2750453101471066e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0006843167939223349
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.317743217465477e-09
patients O 0 1.1363291418930999e-09
, O 0 4.86355712647768e-11
mutations O 0 6.056316559366337e-11
in O 0 1.5161417954434597e-10
a O 0 3.421340988296606e-10
single O 0 2.582515756799353e-09
gene O 0 1.2556875539360135e-09
, O 0 4.164738831580195e-10
ATM O 0 0.0006138853495940566
, O 0 8.954075259026695e-10
result O 0 2.8798219364745137e-10
in O 0 3.040503127049732e-10
an O 0 4.865213565352633e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 3.3934959731141134e-08
embraces O 0 3.462239703821979e-07
a O 0 2.3458839315537716e-09
variety O 0 1.782841785313849e-08
of O 0 2.103078884374554e-07
clinical O 0 4.489475395530462e-05
features O 0 2.6985171075466496e-07
and O 0 6.449775824535209e-09
manifests O 0 1.726802594248511e-07
extreme O 0 2.947293978650123e-06
radiosensitivity O 0 0.00011149828787893057
and O 0 1.2037546071042016e-08
a O 0 3.919223168225017e-09
strong O 0 9.568690728656293e-09
pre O 0 0.26184865832328796
- O 0 8.887366675480735e-06
disposition O 0 2.449836756568402e-05
to O 0 1.3772194051853148e-07
malignancy B-Disease 1 0.7937129139900208
. O 0 1.2416418826433073e-07

Heterozygotes O 0 4.460816853679717e-06
for O 0 1.5219583815451188e-08
the O 0 1.1787101961147073e-08
ATM O 0 4.283255111658946e-05
gene O 0 3.8498604304493256e-09
have O 0 9.240431336765553e-12
no O 0 4.198810396593977e-11
clinical O 0 6.591692081059364e-09
expression O 0 4.1559383712197473e-10
of O 0 2.0877598672086606e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.7219217990648303e-09
may O 0 1.3070116100522e-09
be O 0 1.2494139056684617e-09
cancer B-Disease 0 2.1249838027870283e-05
prone O 0 3.739205851616134e-07
with O 0 2.748081484593712e-10
a O 0 1.2869003640503252e-09
moderate O 0 3.790528335656518e-09
increase O 0 2.163611373395824e-10
in O 0 7.418446967832892e-10
in O 0 2.912025065526791e-09
vitro O 0 1.3380412156038801e-06
radiosensitivity O 0 6.59842771710828e-05
. O 0 7.662881529313381e-08

We O 0 3.416258778088377e-07
performed O 0 2.4494295303156832e-06
a O 0 1.5936302943941882e-08
blind O 0 4.172590877260518e-07
chromosomal O 0 1.2449262953850848e-07
analysis O 0 6.125609353091477e-09
on O 0 3.332820597279351e-08
G2 O 0 2.7643985959002748e-05
- O 0 4.805719200362546e-08
phase O 0 5.530188929014912e-08
lymphocytes O 0 5.372066347320015e-09
from O 0 5.958048499010715e-10
7 O 0 9.659055777433423e-09
unrelated O 0 1.3362364370550495e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.184229828117168e-07
, O 0 1.2394590909181602e-09
13 O 0 1.0719022114358268e-08
obligate O 0 1.0641495151730851e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 1.6330243397533195e-06
( O 0 9.678192691708887e-10
parents O 0 1.34119701455937e-10
of O 0 3.9340823931866e-09
the O 0 1.6388563839342396e-09
patients O 0 1.1208777239701817e-09
) O 0 5.67597496781147e-11
, O 0 1.2301133722747437e-10
and O 0 8.541626850266937e-10
14 O 0 6.719227396700944e-09
normal O 0 1.2619806311064963e-09
controls O 0 7.345527519575512e-10
following O 0 7.994007122924529e-10
X O 0 1.7179277733703202e-07
- O 0 9.496038622103242e-09
irradiation O 0 1.0305591047199414e-08
with O 0 1.1369399172123096e-10
1 O 0 1.5128466257507966e-09
Gy O 0 8.484162208333146e-07
in O 0 9.00962776606562e-11
order O 0 4.374966361408994e-11
to O 0 1.5979865000681492e-11
evaluate O 0 1.0809991790594609e-09
this O 0 1.4495541919568034e-11
cytogenetic O 0 1.644182106019798e-07
method O 0 5.382586598656758e-10
as O 0 4.233388639640623e-11
a O 0 3.8553531894747195e-11
tool O 0 4.688144872311284e-10
for O 0 9.566559350249193e-12
detection O 0 4.987663970723588e-08
of O 0 1.3985788527293153e-08
ATM O 0 7.622914563398808e-05
carriers O 0 2.031393648849189e-07
. O 0 7.354618958288484e-08

Both O 0 1.8260177512274822e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999974966049194
T I-Disease 1 1.0
homozygotes O 0 2.4927952836151235e-05
and O 0 1.4100426604102267e-08
heterozygotes O 0 3.7111087181074254e-07
showed O 0 9.175707305075775e-09
significantly O 0 1.4665857417384132e-10
increased O 0 7.908000643208624e-11
levels O 0 8.712205401550932e-10
of O 0 1.0004150841069759e-09
radiation O 0 0.0008392903255298734
- O 0 3.858879608742427e-06
induced O 0 0.00021035829558968544
chromatid O 0 1.3580040103988722e-05
damage O 0 5.54335713331966e-07
relative O 0 1.8334797013963566e-09
to O 0 8.630398479203549e-11
that O 0 1.6743433028931776e-11
of O 0 3.73652664364954e-09
normal O 0 1.7585055189783816e-08
controls O 0 1.2930132697874797e-07
. O 0 3.330431397330358e-08

These O 0 1.4009068571851913e-08
results O 0 7.276700575431505e-09
show O 0 2.6610196268705977e-09
that O 0 1.4966094336044122e-11
the O 0 1.023096718455463e-09
G2 O 0 0.00010755367839010432
- O 0 2.411274522273743e-07
phase O 0 3.842281444121909e-07
chromosomal O 0 3.2308170716532914e-07
radiosensitivity O 0 5.488114993568161e-07
assay O 0 7.94647370128132e-09
can O 0 1.184315232688471e-11
be O 0 4.577469479849494e-12
used O 0 1.5675179904084402e-11
for O 0 1.011384552496164e-11
the O 0 2.620516303952769e-11
detection O 0 2.3093612355751247e-08
of O 0 1.7184447642648593e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
heterozygotes O 0 2.21981608774513e-05
. O 0 6.114429140779976e-08

In O 0 1.703544825204517e-07
combination O 0 4.725577440467532e-08
with O 0 7.609711749623216e-10
molecular O 0 1.5237192485528794e-07
genetic O 0 1.511203606696654e-08
analyses O 0 3.864687059262906e-08
, O 0 2.4409421706117485e-10
this O 0 5.474429503465883e-12
test O 0 1.2409896443799084e-09
may O 0 3.5299846379288624e-11
be O 0 4.209417103079316e-12
of O 0 1.3258599773635638e-10
value O 0 4.183236222699005e-12
in O 0 1.3676178245436432e-11
studies O 0 3.288337310780598e-11
of O 0 3.67908620235724e-10
familial B-Disease 0 1.507409308487695e-08
and I-Disease 0 5.186436169424269e-09
sporadic I-Disease 0 3.465576082817279e-05
cancers I-Disease 0 7.20432581147179e-05
aimed O 0 2.1839044350713266e-08
at O 0 1.2535679161373992e-08
determination O 0 1.734679067055822e-09
of O 0 3.599158082678855e-09
the O 0 1.0384353377190791e-09
potential O 0 1.573225660855826e-09
involvement O 0 5.296755034578382e-09
of O 0 2.98915132646016e-08
ATM O 0 0.0010577127104625106
mutations O 0 4.784482499076148e-08
in O 0 4.300528999579001e-08
tumor B-Disease 0 0.00011787366383941844
risk O 0 3.940212423003686e-08
or O 0 5.6627560418576195e-09
development O 0 7.11667098585167e-08
. O 0 3.0854241384048464e-09
. O 0 8.798814121746545e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 6.284898290687124e-08
identification O 0 3.768651168911674e-08
and O 0 1.4058474384626152e-09
detection O 0 3.495472356007667e-07
of O 0 1.3953791722087772e-07
founder O 0 7.456189905497013e-06
- O 0 6.835595200982425e-08
effect O 0 1.2764668211318053e-09
mutations O 0 5.3855517267997755e-11
in O 0 4.237508954840763e-11
the O 0 1.7325883783225748e-10
ATM O 0 2.3702839371253503e-06
gene O 0 1.36272393369552e-09
in O 0 1.985982767127581e-10
ethnic O 0 9.87046624989496e-11
populations O 0 5.076920550628472e-10
. O 0 3.5090841343787815e-09

To O 0 8.787175431734795e-09
facilitate O 0 8.711677601525025e-09
the O 0 1.6308147054999722e-09
evaluation O 0 1.8082529251728374e-08
of O 0 2.5408741777255273e-08
ATM O 0 9.078394941752777e-05
heterozygotes O 0 5.027655447520374e-07
for O 0 3.4320224440165248e-09
susceptibility O 0 1.586924440744042e-07
to O 0 1.7651717865163619e-09
other O 0 6.379172390325039e-08
diseases O 1 0.9999998807907104
, O 0 8.571313103722389e-10
such O 0 2.609252369722981e-09
as O 0 2.638752789607679e-07
breast B-Disease 1 0.9999990463256836
cancer I-Disease 0 0.45864927768707275
, O 0 1.0696306063096017e-09
we O 0 3.6689234983455776e-11
have O 0 6.977411703967817e-12
attempted O 0 3.5875340476110296e-09
to O 0 5.161296390276959e-11
define O 0 5.357482235623934e-10
the O 0 2.9470523243979585e-10
most O 0 3.463062475672629e-11
common O 0 1.1100224905913336e-10
mutations O 0 5.938938923977233e-11
and O 0 7.867981266507229e-11
their O 0 1.3828135858595658e-10
frequencies O 0 1.2311755170912875e-08
in O 0 1.689239326196912e-08
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
telangiectasia I-Disease 1 1.0
( O 0 3.289758979008184e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.437201273077562e-09
homozygotes O 0 1.0134216665846907e-07
from O 0 6.148209164003049e-10
10 O 0 2.7569801996918386e-10
ethnic O 0 2.6766545577205925e-11
populations O 0 1.9834996145551287e-10
. O 0 1.7135115548683189e-09

Both O 0 5.085541943117278e-08
genomic O 0 1.3427475664684607e-07
mutations O 0 4.771020911675805e-09
and O 0 7.248285860406156e-10
their O 0 2.3272686000552767e-09
effects O 0 9.978604254001766e-08
on O 0 1.1470171479288638e-08
cDNA O 0 3.7328028668071056e-08
were O 0 5.801955804685122e-09
characterized O 0 1.0245113912787929e-07
. O 0 2.6838002042950393e-08

Protein O 0 3.3084114647863316e-07
- O 0 3.3297175150437397e-07
truncation O 0 3.2859730936252163e-07
testing O 0 1.4126976566330995e-07
of O 0 1.1715647119103778e-08
the O 0 1.4134132753085282e-09
entire O 0 8.606588330906106e-09
ATM O 0 6.655238848907175e-07
cDNA O 0 2.3109961944101087e-08
detected O 0 1.169182706206584e-08
92 O 0 2.8924638684202364e-08
( O 0 2.2147467193533998e-10
66 O 0 2.273566579447106e-08
% O 0 3.947111387736513e-11
) O 0 2.502661272663076e-11
truncating O 0 2.596732429083204e-08
mutations O 0 1.272254523954075e-09
in O 0 1.586883735527067e-09
140 O 0 1.585175368745695e-08
mutant O 0 3.537808979103829e-08
alleles O 0 1.7371722949022228e-09
screened O 0 2.22398597315987e-07
. O 0 5.897385690900592e-08

The O 0 2.6965360575559316e-06
haplotyping O 0 0.00023721062461845577
of O 0 1.2167527074780082e-06
patients O 0 1.2391524251142982e-08
with O 0 5.234803701625879e-10
identical O 0 5.928411042077641e-07
mutations O 0 1.6895004506523037e-08
indicates O 0 4.0288057334691985e-09
that O 0 2.044280716928526e-11
almost O 0 4.804557446336233e-11
all O 0 2.235140718342965e-11
of O 0 1.939899907377196e-10
these O 0 5.58618429291613e-12
represent O 0 2.7831849672144138e-11
common O 0 2.7050686690621717e-10
ancestry O 0 9.459187599869523e-11
and O 0 1.1109925479590999e-10
that O 0 1.5438960873637164e-11
very O 0 9.317706328726416e-11
few O 0 1.6548793446702348e-09
spontaneously O 0 1.981724864208445e-07
recurring O 0 2.5636550162744243e-06
ATM O 0 0.000560110667720437
mutations O 0 2.7236481514592015e-07
exist O 0 8.299721798721293e-08
. O 0 9.092089214846055e-08

Assays O 0 2.1920857307122787e-06
requiring O 0 4.6086491067853785e-08
minimal O 0 6.789933593154274e-08
amounts O 0 3.2320910392513724e-09
of O 0 6.49043796485671e-09
genomic O 0 1.4573017459440507e-08
DNA O 0 6.62186181443758e-08
were O 0 3.711727314392732e-10
designed O 0 5.91942583838545e-09
to O 0 8.311528548743397e-11
allow O 0 1.0245920084583915e-10
rapid O 0 5.047513074174503e-09
screening O 0 2.0446415671671048e-09
for O 0 3.993410116476248e-11
common O 0 2.4712376589519636e-10
ethnic O 0 4.999399852434472e-11
mutations O 0 3.926211800120427e-09
. O 0 1.1032060598381577e-08

These O 0 1.7126238205378286e-08
rapid O 0 2.561394296662911e-07
assays O 0 1.6271715708171541e-07
detected O 0 7.240720378831611e-08
mutations O 0 4.4578121749516697e-10
in O 0 3.3092031892500984e-10
76 O 0 1.2081963873811219e-08
% O 0 5.781369827317917e-11
of O 0 2.0212371776295868e-09
Costa O 0 1.9533877093635965e-07
Rican O 0 1.2035064855808741e-06
patients O 0 4.039532264243917e-09
( O 0 1.3725967584754528e-10
3 O 0 4.253002838794373e-09
) O 0 4.435809011771319e-11
, O 0 2.5710858789218527e-11
50 O 0 1.1600784916021567e-10
% O 0 2.7919138355370077e-12
of O 0 3.3690691902954484e-10
Norwegian O 0 3.382788236194756e-07
patients O 0 4.860538638240541e-09
( O 0 1.1246870101899731e-10
1 O 0 1.052309173132926e-08
) O 0 3.851090626949549e-11
, O 0 2.5929421804127273e-11
25 O 0 2.393291953506349e-10
% O 0 5.644017805200852e-12
of O 0 2.550884226071304e-10
Polish O 0 2.087730899802409e-05
patients O 0 3.491473776762177e-08
( O 0 5.733822305842295e-10
4 O 0 5.1331571881974014e-08
) O 0 8.42716452176262e-11
, O 0 8.450809496629574e-11
and O 0 1.7677988239928055e-10
14 O 0 2.319898273484e-09
% O 0 1.286786215776159e-11
of O 0 6.741033287127607e-10
Italian O 0 7.02138720498624e-07
patients O 0 1.7013391584441706e-08
( O 0 5.35108901633663e-10
1 O 0 3.055120600947703e-08
) O 0 1.1574991659601963e-10
, O 0 3.447002752676731e-11
as O 0 3.1644752790382924e-11
well O 0 1.0268889211184629e-10
as O 0 7.700627635554014e-11
in O 0 3.407396240162619e-11
patients O 0 8.67787092184713e-11
of O 0 2.6869131364293253e-09
Amish O 0 6.006587227602722e-06
/ O 0 7.232093253151106e-07
Mennonite O 0 9.557525117998011e-06
and O 0 1.9327629274812352e-08
Irish O 0 2.7912437872146256e-06
English O 0 3.0174263088156295e-07
backgrounds O 0 1.1133211330616177e-07
. O 0 2.9449763516709027e-08

Additional O 0 1.8640061938413055e-08
mutations O 0 7.81043851816321e-09
were O 0 1.5707908307405205e-09
observed O 0 7.122014644700414e-10
in O 0 3.6908237577293335e-10
Japanese O 0 6.88907562107488e-08
, O 0 1.729814763651305e-10
Utah O 0 2.1099127778256843e-08
Mormon O 0 9.238718234882981e-09
, O 0 1.0519227849892232e-10
and O 0 2.793312248172697e-10
African O 0 4.600083869377158e-09
American O 0 2.68453241858424e-08
patients O 0 2.7269742020052945e-08
. O 0 2.3954088490540926e-08

These O 0 5.704819283636198e-09
assays O 0 3.60946472710566e-08
should O 0 1.3812924415379513e-10
facilitate O 0 4.450922130860846e-10
screening O 0 5.1320876437443985e-09
for O 0 1.0081921963944751e-09
A B-Disease 1 0.9999970197677612
- I-Disease 1 0.9995744824409485
T I-Disease 1 1.0
heterozygotes O 0 7.840951354864956e-08
in O 0 1.9687396157763715e-10
the O 0 1.1716372316783463e-10
populations O 0 2.4719575345000244e-11
studied O 0 2.428382162023013e-09
. O 0 2.153668077209403e-10
. O 0 3.6789336022025054e-09

The O 0 5.470961241371697e-06
von B-Disease 1 0.9994507431983948
Hippel I-Disease 1 0.9999842643737793
- I-Disease 1 0.5338057279586792
Lindau I-Disease 1 0.9652268290519714
tumor I-Disease 0 1.4192039998306427e-05
suppressor O 0 1.6990745734801749e-06
gene O 0 1.0222311885854651e-08
is O 0 2.5102865966464272e-11
required O 0 1.3650644503648834e-10
for O 0 3.5401948039748277e-10
cell O 0 1.8440266202901512e-08
cycle O 0 1.3780781848993229e-08
exit O 0 1.450402553615504e-08
upon O 0 2.7294497773056037e-09
serum O 0 1.15797774924431e-07
withdrawal O 0 1.5924490526231239e-07
. O 0 1.2792050085863593e-07

The O 0 7.246169957397797e-07
inactivation O 0 2.1386518710642122e-05
of O 0 6.062601300982351e-07
the O 0 4.4397090448455856e-08
von B-Disease 1 0.9990286827087402
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.9996770620346069
Lindau I-Disease 1 0.9999896287918091
( I-Disease 0 5.688555120286765e-07
VHL I-Disease 1 1.0
) I-Disease 0 1.4458396258021367e-08
tumor I-Disease 0 2.684182982193306e-05
suppressor O 0 0.0002522028225939721
gene O 0 3.9811308738535445e-07
predisposes O 0 6.741052516190393e-07
affected O 0 6.516512218723847e-09
individuals O 0 1.855352330104587e-11
to O 0 5.742600284186494e-10
the O 0 5.42278080217784e-08
human O 1 0.9255571961402893
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999994039535522
and O 0 6.5310703512011514e-09
is O 0 1.285847262000317e-10
associated O 0 4.02663946630355e-09
with O 0 1.193123289056075e-08
sporadic B-Disease 1 0.9999775886535645
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 6.665979890385643e-05
RCC B-Disease 1 1.0
) O 0 3.6294618439569604e-06
and O 0 6.855218089185655e-05
brain B-Disease 1 1.0
hemangioblastomas I-Disease 1 0.9999934434890747
. O 0 1.331309135821357e-06

VHL O 1 0.9995638728141785
- O 0 1.8186061424785294e-05
negative O 0 8.767742798454492e-08
786 O 0 1.8200925069322693e-06
- O 0 5.594074536929838e-07
0 O 0 8.530547290774848e-08
RCC B-Disease 1 0.9925541281700134
cells O 0 3.2248816950186665e-08
are O 0 5.209513931347942e-10
tumorigenic O 0 3.848545020446181e-06
in O 0 8.097225112635442e-09
nude O 0 1.028077349474188e-06
mice O 0 1.1970347379985924e-08
which O 0 1.1274468858513131e-10
is O 0 2.1283121098836233e-11
suppressed O 0 3.3134615051721994e-09
by O 0 9.299064296364179e-11
the O 0 5.434537819759555e-10
reintroduction O 0 2.806956160839036e-07
of O 0 1.1921500231437676e-07
VHL B-Disease 1 0.9995844960212708
. O 0 2.1683815987216803e-07

Remarkably O 0 2.9864422685932368e-05
, O 0 1.1175183445288894e-08
this O 0 1.0004909400951334e-10
occurs O 0 1.7405045460439084e-10
without O 0 6.626768578321673e-11
affecting O 0 2.99841040884985e-10
the O 0 2.1921529869128875e-10
growth O 0 1.1364498925248157e-10
rate O 0 4.9006833313658404e-11
and O 0 4.8259847507114984e-11
cell O 0 3.6666185643241533e-09
cycle O 0 8.740250190264476e-10
profile O 0 9.937602130083434e-11
of O 0 2.2713321501388606e-10
these O 0 2.1290713983490583e-11
cells O 0 2.1834899166517374e-10
in O 0 4.062253589065534e-10
culture O 0 2.048784430996875e-08
. O 0 9.650897858648477e-09

The O 0 8.61419323427981e-07
786 O 0 3.717396339197876e-06
- O 0 3.950206064473605e-07
0 O 0 7.541212987405288e-09
cell O 0 1.197669607932994e-08
line O 0 1.5450885015866334e-08
, O 0 1.4490930677624192e-10
like O 0 2.1750685974541994e-10
many O 0 1.4197783226865823e-10
cancer B-Disease 0 5.717778890357295e-07
cells O 0 5.818845405514139e-09
, O 0 5.737804120720114e-10
fails O 0 3.0669302653052455e-09
to O 0 2.983122360245005e-10
exit O 0 2.1522371440596544e-08
the O 0 1.6056476148662568e-09
cell O 0 1.3413032462494812e-08
cycle O 0 2.974578583447851e-09
upon O 0 9.770168007960933e-10
serum O 0 4.1522898897028426e-08
withdrawal O 0 4.016784416194241e-08
. O 0 3.7073018432920435e-08

Here O 0 6.122680247244716e-07
, O 0 3.848032559261583e-09
it O 0 1.4473335030462664e-10
is O 0 1.617729908365284e-11
shown O 0 2.6599208946542774e-11
that O 0 2.6062689333083977e-12
reintroduction O 0 4.736041336883545e-09
of O 0 1.3717783575728504e-09
the O 0 1.038007568787691e-09
wild O 0 2.2063170490582706e-07
- O 0 1.4266862535805558e-07
type O 0 6.270457788559725e-07
VHL B-Disease 1 0.9999983310699463
gene O 0 9.103174214430965e-09
restores O 0 1.1520517517737972e-07
the O 0 3.272648152474744e-09
ability O 0 3.9785965633143405e-09
of O 0 1.500207673643672e-07
VHL O 1 1.0
- O 0 6.704204133711755e-05
negative O 0 1.2379119880279177e-06
RCC B-Disease 1 1.0
cancer I-Disease 0 0.0017181147122755647
cells O 0 2.3026482942611892e-09
to O 0 2.2983119574160327e-10
exit O 0 9.230299191642644e-09
the O 0 1.193650733810614e-09
cell O 0 9.642543652432778e-09
cycle O 0 1.4946853754693734e-09
and O 0 2.073704125082898e-10
enter O 0 2.3271896409937654e-08
G0 O 1 0.5246724486351013
/ O 0 2.3092650280887028e-07
quiescence O 0 4.6065309788900777e-07
in O 0 6.044655442849489e-09
low O 0 3.8346783526321815e-07
serum O 0 1.868133381321968e-06
. O 0 6.245808492622018e-08

Both O 0 8.882138899934944e-06
VHL O 1 0.9999082088470459
- O 0 1.4444924090639688e-05
positive O 0 4.133057629474024e-08
and O 0 6.011269704231381e-08
VHL O 1 0.9999417066574097
- O 0 4.04304455514648e-06
negative O 0 1.4365778611136193e-07
RCC B-Disease 1 0.9999837875366211
cells O 0 8.798885176020121e-08
exit O 0 1.1364255669832346e-07
the O 0 5.2579016696086e-09
cell O 0 2.6012534348751615e-08
cycle O 0 8.100144555100997e-09
by O 0 5.902668909207875e-10
contact O 0 4.448685686497811e-08
inhibition O 0 1.4458085217938788e-07
. O 0 5.2578442932826874e-08

The O 0 1.1261132613071823e-06
cyclin O 0 6.923733053554315e-07
- O 0 2.579131148650049e-07
dependent O 0 1.8250023714472263e-08
kinase O 0 5.438473138497102e-08
inhibitor O 0 4.237208273139004e-08
, O 0 1.5238571515752142e-09
p27 O 0 8.047236832453564e-08
, O 0 2.1139751060772483e-10
accumulates O 0 1.5863207414312797e-09
upon O 0 4.43939995875553e-10
serum O 0 3.092234690527107e-09
withdrawal O 0 1.5860091018282674e-09
, O 0 1.0256380467144055e-10
only O 0 3.867230754378559e-12
in O 0 3.7902569971492994e-11
the O 0 1.0368970265739463e-10
presence O 0 2.2074168881669465e-10
of O 0 4.2292388258147184e-08
VHL B-Disease 1 0.9999998807907104
, O 0 1.9383810112572064e-09
as O 0 1.4513502899493602e-10
a O 0 8.735362433398564e-11
result O 0 3.4688682482020283e-10
of O 0 4.586591995092704e-09
the O 0 1.0430863950361413e-09
stabilization O 0 3.422063059588254e-07
of O 0 2.3243822511176404e-07
the O 0 2.867541581963451e-08
protein O 0 2.4563806988453507e-08
. O 0 1.824866657784696e-08

We O 0 6.442917310778284e-08
propose O 0 2.772676843676436e-08
that O 0 1.376093683447266e-10
the O 0 1.4443587437185101e-09
loss O 0 1.0908113523555585e-07
of O 0 1.1356085849456576e-07
wild O 0 2.6080381303472677e-06
- O 0 2.5334420570288785e-06
type O 0 5.203410182730295e-06
VHL B-Disease 1 0.9999998807907104
gene O 0 4.863320857140252e-09
results O 0 2.383708119779726e-09
in O 0 4.957545485240189e-10
a O 0 3.236604873002591e-10
specific O 0 1.257226101003539e-09
cellular O 0 8.641942258691415e-06
defect O 0 5.028517534810817e-06
in O 0 2.957861866548228e-08
serum O 0 2.5439831574658456e-07
- O 0 5.756933205702808e-07
dependent O 0 3.206879028994081e-08
growth O 0 3.553415339752064e-09
control O 0 5.752600618080805e-09
, O 0 8.766642273227987e-11
which O 0 7.919880029572113e-11
may O 0 3.34314409489167e-10
initiate O 0 4.1358255487011775e-08
tumor B-Disease 0 1.1110530977020971e-05
formation O 0 0.0001002049320959486
. O 0 2.2659392584500893e-07

This O 0 4.785477969448948e-08
is O 0 3.0612730128609655e-09
corrected O 0 2.9474431784137778e-08
by O 0 3.641331680626081e-10
the O 0 4.69606520336896e-10
reintroduction O 0 1.7285467279748445e-08
of O 0 2.131421927842325e-09
wild O 0 1.2836312635045033e-07
- O 0 1.1686721563819447e-06
type O 0 2.3699813027633354e-05
VHL B-Disease 1 1.0
, O 0 1.2973264063020906e-07
implicating O 1 0.9967993497848511
VHL B-Disease 1 1.0
as O 0 1.3898882933460754e-08
the O 0 3.92673582538805e-09
first O 0 7.908083965446622e-09
tumor B-Disease 0 5.3448008685563764e-08
suppressor O 0 7.181755989904559e-08
involved O 0 3.0782059123879435e-09
in O 0 6.279009534537749e-10
the O 0 1.2272618477027208e-09
regulation O 0 2.6823162357914043e-08
of O 0 5.500303146277474e-08
cell O 0 2.299296397723083e-08
cycle O 0 3.5038538737097724e-09
exit O 0 4.624664207142359e-09
, O 0 3.807095264041216e-11
which O 0 3.52591358887544e-11
is O 0 1.8378579907940562e-11
consistent O 0 3.083929778213701e-09
with O 0 4.305192313758255e-11
its O 0 5.85237913686143e-10
gatekeeper O 0 2.362264694966143e-08
function O 0 1.17466258942045e-10
in O 0 4.274519349589667e-10
the O 0 1.0660159865949481e-08
kidney O 0 2.0116125597269274e-05
. O 0 3.5763294548019076e-09
. O 0 3.687787497597128e-08

Piebaldism B-Disease 1 1.0
with O 0 0.000946239975746721
deafness B-Disease 1 1.0
: O 0 1.5220460625187116e-07
molecular O 0 4.0604336959404463e-07
evidence O 0 9.67467261858701e-09
for O 0 3.124008551846913e-10
an O 0 5.659211432806899e-10
expanded O 0 1.727896415104624e-05
syndrome O 1 0.9999849796295166
. O 0 1.1246242337392687e-07

In O 0 1.0902580527272221e-07
a O 0 9.576633708263671e-09
South O 0 9.27672161310511e-08
African O 0 2.330027726316075e-08
girl O 0 6.52229630304646e-08
of O 0 5.796925961476518e-08
Xhosa O 0 1.8682703739614226e-05
stock O 0 4.005148213082066e-08
with O 0 5.9404632324344675e-09
severe O 1 0.9988816380500793
piebaldism B-Disease 1 0.9999998807907104
and O 0 0.00010896921594394371
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 8.832309958961559e-07
identified O 0 2.246033226072086e-08
a O 0 2.035625668028729e-09
novel O 0 3.534474934951959e-09
missense O 0 1.685219785940717e-08
substitution O 0 2.077256944232886e-08
at O 0 5.649015477615649e-08
a O 0 9.232301589889857e-10
highly O 0 6.747365777215464e-09
conserved O 0 1.4799911518537101e-08
residue O 0 1.1479040296080711e-07
in O 0 4.686204757575752e-10
the O 0 2.3883078847930506e-10
intracellular O 0 4.264136821419129e-10
kinase O 0 2.0124240052155073e-09
domain O 0 7.992451700467029e-10
of O 0 5.3695257129504625e-09
the O 0 1.1719088810480116e-08
KIT O 1 0.9995837807655334
proto O 0 4.0713402995606884e-05
- O 0 2.4627643142594025e-06
oncogene O 0 1.039637572830543e-05
, O 0 2.2806418087384372e-08
R796G O 0 1.584242818353232e-05
. O 0 1.1174547864811757e-07

Though O 0 9.454282121623692e-07
auditory B-Disease 0 3.8433448935393244e-05
anomalies I-Disease 0 7.039918727969052e-06
have O 0 4.870326919537149e-10
been O 0 1.91828344875411e-10
observed O 0 4.837156231118911e-10
in O 0 3.5825539757006197e-10
mice O 0 2.29370167303955e-09
with O 0 1.4872850173652807e-10
dominant O 0 1.7102726701523352e-07
white O 0 1.3104645368855472e-08
spotting O 0 3.2232510420726612e-06
( O 0 1.1147996303861873e-08
W O 1 0.9938733577728271
) O 0 5.65185453993422e-10
due O 0 5.699881011622665e-09
to O 0 2.503298679457089e-09
KIT O 1 1.0
mutations O 0 1.0095186553371605e-06
, O 0 2.2337596305987972e-07
deafness B-Disease 1 1.0
is O 0 2.325786230272797e-09
not O 0 6.843765137931612e-11
typical O 0 2.680990318637555e-09
in O 0 6.802280405615591e-10
human O 0 1.4231335221381869e-08
piebaldism B-Disease 0 3.368861507624388e-05
. O 0 8.236594339905423e-08

Thus O 0 1.94881039305983e-07
, O 0 2.2976336389035623e-09
the O 0 5.942227820909807e-10
occurrence O 0 6.35524770586926e-08
of O 0 1.2413674994604662e-05
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 1.2770441344400751e-06
this O 0 1.2888681233391708e-09
patient O 0 4.836773825900309e-08
extends O 0 4.956716370685399e-09
considerably O 0 6.307084299272958e-10
the O 0 2.119902448027844e-10
phenotypic O 0 4.963404354185741e-09
range O 0 1.863305953975214e-08
of O 0 2.040423474625186e-08
piebaldism B-Disease 0 1.7615791421121685e-06
due O 0 1.8828911763080214e-08
to O 0 1.1831874369150341e-09
KIT O 1 0.9998202919960022
gene O 0 1.6856949169863356e-09
mutation O 0 8.043296584325788e-11
in O 0 6.231152399616136e-11
humans O 0 3.9962771980484035e-10
and O 0 2.991800418516988e-10
tightens O 0 2.153472955512825e-08
the O 0 9.659401056794081e-10
clinical O 0 4.397788089249843e-08
similarity O 0 3.514449398167585e-09
between O 0 1.944320260349741e-09
piebaldism B-Disease 0 2.259720531583298e-06
and O 0 4.778085149759193e-10
the O 0 2.049020814132163e-10
various O 0 1.6108951672588745e-10
forms O 0 7.665831525116573e-09
of O 0 1.5734516637166962e-05
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 6.691310971973508e-08
. O 0 8.6326011228266e-08

Cycloheximide O 0 0.00022211455507203937
facilitates O 0 1.6669618219111726e-07
the O 0 2.305883040065737e-09
identification O 0 1.675662097966324e-08
of O 0 2.4682440979972853e-08
aberrant O 0 2.584405081051955e-07
transcripts O 0 2.4104147655634733e-07
resulting O 0 1.3685801825147337e-08
from O 0 4.89706275530466e-09
a O 0 9.41866695747251e-10
novel O 0 4.27629132104812e-09
splice O 0 5.814776500301377e-07
- O 0 3.876240484146365e-08
site O 0 1.1773934716075019e-08
mutation O 0 1.5809231701524595e-09
in O 0 1.3033172319154573e-09
COL17A1 O 1 0.9997932314872742
in O 0 6.0723772676851695e-09
a O 0 5.145603942935395e-09
patient O 0 2.763174791198253e-07
with O 0 5.904780664423015e-08
generalized O 1 0.992741584777832
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999997615814209
. O 0 1.7574480807525106e-05

Patients O 0 1.5486531992792152e-05
with O 0 1.5128394181829208e-07
generalized O 1 0.9282432198524475
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999977350234985
often O 0 1.4804182058014703e-07
show O 0 1.5026126121142624e-08
decreased O 0 2.8559465903299497e-09
expression O 0 5.568807082134697e-10
of O 0 1.10604831959904e-08
type O 0 1.63148945375724e-06
XVII O 1 1.0
collagen O 1 0.9999228715896606
, O 0 8.207362611756253e-08
a O 0 7.120307454755448e-09
transmembrane O 0 2.0847237180987577e-07
hemidesmosomal O 0 8.52106859383639e-06
protein O 0 1.0033565089884178e-08
encoded O 0 9.280238799647123e-09
by O 0 2.102248330970724e-08
COL17A1 O 1 0.9995872378349304
. O 0 6.732584552082699e-07

This O 0 1.4458727548571915e-08
report O 0 3.5692833133538215e-09
documents O 0 1.0993411514448326e-08
a O 0 1.328533838496071e-09
novel O 0 3.8414400549413585e-09
splice O 0 8.149192467499233e-07
- O 0 5.1316106919330196e-08
site O 0 1.2973927709936106e-08
mutation O 0 6.378144679075604e-10
in O 0 1.854055797778642e-09
COL17A1 O 1 0.999688982963562
in O 0 3.2652036630054226e-09
a O 0 1.882207945058667e-09
patient O 0 5.341264852631866e-08
with O 0 3.989014007999003e-09
generalized O 1 0.7657861113548279
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 8.360510861393777e-08
and O 0 2.861748393812036e-09
applies O 0 1.0630388791454948e-09
a O 0 1.1196934351920262e-10
new O 0 1.2582786201864593e-10
methodology O 0 8.808280216321407e-10
to O 0 9.272710377317139e-11
define O 0 1.288963935586196e-09
and O 0 2.5029872618986815e-10
characterize O 0 1.0220888135847872e-08
the O 0 5.636621724924851e-10
resulting O 0 1.041748354246863e-09
mRNA O 0 1.4796016856166716e-08
splice O 0 1.3324396377356607e-06
variants O 0 1.1840329250389914e-07
. O 0 1.7047399936132024e-08

Mutational O 0 9.74993672571145e-05
analysis O 0 2.6578868528304156e-07
of O 0 2.225697016910999e-06
COL17A1 O 1 0.9999570846557617
identified O 0 1.184832711942363e-07
a O 0 1.9232604842045475e-08
maternally O 0 4.254498264799622e-07
inherited O 0 5.675859938492067e-06
G O 0 0.0009030255605466664
- O 0 8.897119187167846e-06
to O 0 3.7545312636666495e-08
- O 0 1.1570120477699675e-05
T O 0 0.00049575325101614
transversion O 0 5.768596111010993e-06
at O 0 2.1537113426006727e-08
the O 0 3.783411917090973e-10
- O 0 2.434838330955813e-09
1 O 0 4.979854306697007e-10
position O 0 6.027486842974383e-10
of O 0 3.386116942394324e-09
exon O 0 9.875997619701593e-08
32 O 0 1.1972726099429565e-07
. O 0 8.689887920354522e-09

This O 0 1.2804153293188847e-08
acceptor O 0 1.1197414551133988e-08
splice O 0 9.45845567912329e-06
- O 0 7.962011068229913e-07
site O 0 5.936105296200367e-08
mutation O 0 1.3864772663296776e-09
led O 0 3.795809888629265e-09
to O 0 1.689730716458726e-10
the O 0 1.6659478241365377e-09
formation O 0 2.27202178848529e-07
of O 0 1.4299635608949757e-07
aberrant O 0 3.1538661460217554e-07
transcripts O 0 2.7775422495324165e-07
present O 0 1.0036035114069364e-08
at O 0 1.2532026971712185e-07
extremely O 0 5.201358277417967e-08
low O 0 4.453449093944073e-07
levels O 0 9.126142686000094e-08
. O 0 9.749138385473088e-09

Based O 0 1.451504772376211e-06
on O 0 1.1724034010285322e-07
our O 0 6.3365694913386506e-09
recent O 0 1.6470352859343507e-09
finding O 0 2.3670758686478166e-09
that O 0 3.903701667473669e-11
cycloheximide O 0 1.5269631603587186e-06
stabilized O 0 4.909396693619783e-07
mutant O 0 2.2684774592107715e-07
COL17A1 O 0 0.0007341914460994303
transcripts O 0 2.3649340619158465e-07
in O 0 1.8139206803269303e-09
keratinocytes O 0 4.4085631145662774e-08
homozygous O 0 4.207215908991202e-09
for O 0 2.1503515634790915e-10
a O 0 1.989509668121059e-09
frameshift O 0 1.1924809939500847e-07
mutation O 0 3.010147242576977e-09
, O 0 1.7634477211814215e-10
the O 0 6.977072808389551e-10
effects O 0 6.589783652088954e-08
of O 0 2.106342122942806e-08
the O 0 1.3931441555925517e-09
splice O 0 3.2614309475320624e-07
- O 0 2.0488901242288193e-08
site O 0 3.390834946159771e-09
mutation O 0 4.4550731159720414e-11
on O 0 2.469899285095778e-10
splicing O 0 9.012181223511107e-09
of O 0 7.835090798380406e-08
COL17A1 O 1 0.7409440279006958
transcripts O 0 1.6949947223565687e-07
were O 0 1.0674804373778102e-09
determined O 0 3.7996250590310865e-10
using O 0 2.138979687815734e-10
reverse O 0 4.6177093260268975e-09
transcriptase O 0 4.598794678400964e-09
polymerase O 0 1.8296937298600824e-08
chain O 0 6.370998839599906e-09
reaction O 0 2.0133138212141688e-10
of O 0 3.526098746320372e-09
total O 0 2.780936314561444e-10
RNA O 0 1.1652755205204812e-08
from O 0 1.5477039649880453e-09
keratinocytes O 0 1.7743811753234695e-08
incubated O 0 3.6985137175093996e-09
for O 0 6.709529598580843e-10
2 O 0 5.325964380631376e-08
. O 0 1.1034186009339919e-08

5 O 0 8.711779173609102e-07
h O 0 9.923542876322244e-08
in O 0 1.1941676536508794e-09
the O 0 4.695483446504056e-10
presence O 0 2.7045940487191444e-10
or O 0 4.918027651790169e-10
absence O 0 1.7296812870881695e-08
of O 0 5.592059082459855e-08
10 O 0 3.7599775737362506e-08
microg O 0 1.2893727216578554e-05
cycloheximide O 0 5.8398682085680775e-06
per O 0 2.5530189518008228e-08
ml O 0 1.5042003269627457e-06
. O 0 7.075472296946828e-08

Using O 0 2.4969340373104387e-08
this O 0 3.8449052275346673e-10
approach O 0 3.5455620661650755e-09
, O 0 1.9884542623582746e-10
an O 0 4.378230417101392e-11
abnormally O 0 1.6327301466390054e-07
spliced O 0 1.722941931348032e-07
transcript O 0 3.336885754379182e-07
was O 0 1.5409858278303545e-08
identified O 0 5.104905387298686e-10
that O 0 9.888494537091397e-12
contains O 0 1.7275660069149268e-10
an O 0 4.043688561078396e-12
extra O 0 2.2884959205438093e-10
264 O 0 3.4614016097833655e-09
bases O 0 1.938535998391444e-09
upstream O 0 6.0746017105373085e-09
from O 0 1.6343364439563857e-09
exon O 0 7.797030576739417e-08
32 O 0 2.0185835225561277e-08
, O 0 1.2024109485864187e-10
resulting O 0 7.754074049515225e-10
in O 0 1.1859643267442266e-09
a O 0 1.6733744390151628e-09
premature O 0 1.730434320279528e-07
termination O 0 4.612320481101051e-07
codon O 0 7.122455372154946e-07
27 O 0 3.2428312124466174e-07
bp O 0 2.8231821147528535e-07
downstream O 0 5.787965662307215e-08
from O 0 1.1211263029053953e-08
the O 0 1.3829045464319734e-08
cryptic O 0 6.681089530502504e-07
splice O 0 7.2424504651280586e-06
site O 0 5.221417040957022e-07
. O 0 8.660488504119712e-08

Three O 0 1.945597283281586e-08
other O 0 2.0953687396296772e-10
splice O 0 1.4839548612144426e-07
variants O 0 1.3665038878230007e-08
, O 0 5.829173810312227e-10
including O 0 2.750488448111099e-10
one O 0 3.3019632167397006e-11
derived O 0 1.413736072652938e-10
from O 0 3.322319641618776e-10
the O 0 3.980469287512278e-10
skipping O 0 1.2660025916488848e-08
of O 0 1.3428546274951714e-08
exon O 0 6.25853289193401e-08
32 O 0 7.918800726258723e-09
, O 0 1.8008029789573499e-10
were O 0 5.634654964836727e-10
also O 0 5.070872055590314e-10
identified O 0 7.348348152191875e-09
. O 0 3.0793582794785834e-08

These O 0 4.050504998076576e-08
results O 0 1.7201434943103777e-08
indicate O 0 1.2800850379690587e-09
the O 0 5.596502705706996e-10
usefulness O 0 6.607779212686182e-09
of O 0 1.4412194992985405e-08
cycloheximide O 0 9.284046313950967e-07
treatment O 0 1.064636290237786e-08
in O 0 2.695375866945682e-10
evaluating O 0 4.4221279971168315e-09
the O 0 1.7424119924669412e-09
abnormal O 0 8.031944886965903e-09
processing O 0 1.9384039262604347e-08
of O 0 1.5388858187748156e-08
mRNA O 0 2.978615354365388e-09
due O 0 3.22852966583298e-09
to O 0 2.6477334214014547e-10
splice O 0 1.0066979712064494e-06
- O 0 8.469442747127687e-08
site O 0 1.8186364414418676e-08
mutations O 0 1.2250470637908961e-09
, O 0 2.0591406357794995e-10
because O 0 5.175632700193944e-10
( O 0 7.204922769510347e-10
i O 0 6.701078802962002e-09
) O 0 1.684848649485815e-10
aberrant O 0 3.3431984292064953e-08
splicing O 0 5.104170597292068e-08
often O 0 1.378468450496939e-10
generates O 0 7.645617472462618e-10
a O 0 4.1535694328409534e-10
premature O 0 2.7672140134882284e-08
termination O 0 1.6048224438236502e-07
codon O 0 2.1094221835937788e-07
, O 0 1.2725529519030943e-09
( O 0 4.591000912768095e-10
ii O 0 0.2256172001361847
) O 0 1.2770000612505328e-09
transcripts O 0 1.1218369877497025e-07
with O 0 7.219063680174997e-10
premature O 0 2.084552903625081e-07
termination O 0 2.1440226305458054e-07
codons O 0 2.7776632549603164e-08
can O 0 1.1198130617229296e-10
occur O 0 3.9066755386230057e-10
at O 0 5.5493001305251255e-09
low O 0 2.2479833106103797e-08
or O 0 1.960586581972734e-09
undetectable O 0 9.822529136727098e-07
levels O 0 1.8449578531587463e-09
due O 0 7.548793257150521e-10
to O 0 6.951432485191589e-11
nonsense O 0 2.1142634309967434e-08
- O 0 5.717880391387098e-09
mediated O 0 2.6517883444654444e-09
mRNA O 0 1.5296989230861868e-09
decay O 0 2.4263369979848903e-08
, O 0 8.880069596317597e-11
and O 0 1.8649964905748107e-10
( O 0 2.2647481112691992e-10
iii O 0 1.9832155885524116e-05
) O 0 3.718068908309391e-10
the O 0 8.196028300488933e-10
levels O 0 8.36945401871958e-10
of O 0 2.2021351409051704e-10
these O 0 6.10382534446674e-12
transcripts O 0 2.335276860776503e-09
can O 0 5.085114621050657e-12
be O 0 1.2144348027209872e-11
increased O 0 1.3640261142811028e-10
by O 0 1.1511281927667483e-09
cycloheximide O 0 1.3728773410548456e-05
. O 0 7.281423819449628e-08

A O 0 5.280907771521015e-06
deletion O 0 2.2558569412467477e-07
mutation O 0 7.170789295685154e-09
in O 0 1.0680898832049479e-08
COL17A1 O 1 0.99982088804245
in O 0 9.414450552469589e-09
five O 0 1.8815906610569755e-09
Austrian O 0 7.9502956396027e-07
families O 0 5.70733016402869e-10
with O 0 9.42546485305229e-09
generalized O 1 0.7939187288284302
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999813973903656
represents O 0 3.314165439860517e-07
propagation O 0 5.990443241898902e-06
of O 0 4.288291961529467e-07
an O 0 3.1884948015203918e-09
ancestral O 0 1.5081475339684403e-06
allele O 0 1.4299472184120532e-07
. O 0 6.661284146503021e-08

Patients O 0 1.0853986168513075e-05
with O 0 9.995557803677002e-08
generalized O 1 0.8840412497520447
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 1.93764321920753e-07
a O 0 5.928826762868766e-09
usually O 0 1.5666080654952452e-09
nonlethal O 0 6.247767032618867e-06
form O 0 3.3679424404908787e-07
of O 0 8.269785030279309e-05
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999991655349731
, O 0 2.0260480937395187e-07
have O 0 1.989585829420548e-09
generalized O 0 2.611205900393543e-07
blistering B-Disease 1 0.8920787572860718
, O 0 1.0741323421825655e-05
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.0022480858024209738
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 9.549765673000365e-05
and O 1 0.9983148574829102
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.0002775727480184287

Skin B-Disease 1 1.0
fragility I-Disease 0 0.4829706847667694
in O 0 4.193438130073446e-08
most O 0 3.026137673778351e-10
cases O 0 2.5814506088295275e-10
is O 0 4.239762187163709e-12
due O 0 8.405236229247492e-11
to O 0 3.4500086815159037e-11
mutations O 0 4.5891689753885245e-11
in O 0 4.921412583014373e-11
the O 0 2.928633446863671e-10
gene O 0 1.635274138322984e-10
encoding O 0 1.1115441900244605e-09
type O 0 7.325973570004862e-07
XVII O 1 1.0
collagen O 1 0.9999945163726807
( O 0 1.9616632016550284e-06
COL17A1 O 1 1.0
) O 0 3.347467369962942e-08
. O 0 1.8480054819747238e-08

Recently O 0 4.799111138709122e-06
, O 0 1.0488285795418051e-08
we O 0 2.2895436935232993e-10
reported O 0 1.0692410290502607e-09
five O 0 4.86463591631292e-10
Austrian O 0 2.497201307960495e-07
families O 0 5.026393745666269e-10
with O 0 9.055429295301565e-09
generalized O 0 0.07608497142791748
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999945163726807
who O 0 1.2203699384372158e-07
share O 0 5.1773327847115524e-09
the O 0 9.912378473586614e-09
same O 0 1.995089249362536e-08
COL17A1 O 1 0.9999988079071045
mutation O 0 2.776329210973927e-07
. O 0 9.189687943944591e-08

Affected O 0 2.7049381401411665e-07
individuals O 0 2.1523868798389856e-10
in O 0 8.985984178977446e-10
three O 0 1.6808203440188407e-10
families O 0 1.9003644144421905e-12
are O 0 3.397180323508331e-12
homozygous O 0 2.6894189653070555e-10
for O 0 3.4361472001087634e-10
4003delTC O 0 2.849327245257882e-07
, O 0 3.015898364377989e-10
whereas O 0 2.439392576825128e-10
those O 0 4.0718935168104764e-11
in O 0 1.193741216987121e-10
two O 0 1.0470346117896767e-10
others O 0 1.609494759691188e-10
are O 0 2.2741312305507577e-11
compound O 0 6.695766785469459e-08
heterozygotes O 0 1.4722677406098228e-06
. O 0 9.3862333017114e-08

To O 0 1.5546190113013836e-08
determine O 0 8.6299465351658e-09
if O 0 1.9312611232447097e-10
the O 0 9.655453520052149e-11
occurrence O 0 1.7186078116182557e-09
of O 0 4.3545327343963436e-09
4003delTC O 0 9.064574868489217e-08
in O 0 1.4313286667011482e-10
these O 0 1.9924395466830447e-11
unrelated O 0 1.816437666946058e-09
families O 0 1.4217367734492559e-11
signifies O 0 7.171455651544534e-10
propagation O 0 3.042194407498755e-08
of O 0 3.3606377680683863e-09
an O 0 4.227208513785108e-11
ancestral O 0 1.5864941360632656e-08
allele O 0 2.366171980572318e-10
or O 0 4.809574960518148e-10
a O 0 2.6361146598929963e-09
mutational O 0 8.24961534817703e-06
hot O 0 0.00020244612824171782
spot O 0 2.384037998126587e-06
, O 0 5.77284442471182e-10
haplotypes O 0 2.437812396394179e-09
were O 0 4.944316067678756e-10
determined O 0 4.856181012868888e-10
for O 0 3.0507210646568694e-10
polymorphisms O 0 9.400221934185993e-09
both O 0 4.046045998240544e-10
within O 0 1.3359237271970414e-08
and O 0 4.419828059099018e-08
flanking O 0 0.1010812297463417
COL17A1 O 1 0.9999998807907104
. O 0 3.0652938676212216e-06

Five O 0 1.71661895365105e-06
intragenic O 0 3.6338889913167804e-05
polymorphisms O 0 2.7114828071717056e-07
were O 0 4.1997596511578195e-09
chosen O 0 4.528835084727234e-09
based O 0 7.058202466936336e-09
on O 0 1.2896309797838512e-08
their O 0 1.5163227118364375e-08
informativeness O 0 3.068762453040108e-05
. O 0 7.882487551569284e-08

One O 0 4.714530987826038e-08
of O 0 2.798258336156323e-08
these O 0 1.936402843627505e-10
, O 0 6.924199408286924e-11
not O 0 3.0763991614585207e-12
previously O 0 3.939434334299108e-10
reported O 0 3.881637511415903e-10
, O 0 1.9990335775599277e-10
was O 0 9.763541974905365e-09
2988 O 0 1.2538055216282373e-06
A O 0 1.1161681356952613e-07
or O 0 9.465061623359361e-09
C O 0 2.4609869342384627e-06
that O 0 1.1814280109767594e-10
introduces O 0 1.6697399018994474e-09
a O 0 8.471288254208176e-11
new O 0 1.2857048758974088e-10
restriction O 0 7.437031546153605e-11
site O 0 2.256074660422769e-09
for O 0 3.1005958911478615e-10
Eco0109 O 0 2.6077195798279718e-06
I O 0 7.655410627194215e-06
. O 0 4.0407126533636983e-08

All O 0 9.166021186501894e-08
the O 0 4.466923542167933e-08
4003delTC O 0 1.5061366411828203e-06
alleles O 0 1.1995208160087145e-09
showed O 0 1.735764754151603e-09
the O 0 2.842885371556747e-10
same O 0 8.834759313014473e-11
haplotype O 0 1.238686375693021e-09
for O 0 3.9363453468999055e-11
these O 0 7.692862319386151e-11
five O 0 5.891218624043404e-10
polymorphic O 0 1.9522816785411123e-07
markers O 0 1.7356699117954122e-06
. O 0 1.1122980936306703e-07

Fourteen O 0 2.1168607418076135e-05
microsatellite O 0 2.8478025342337787e-06
polymorphisms O 0 2.8075399427507364e-07
were O 0 6.266796859222268e-09
selected O 0 5.075722953051809e-09
based O 0 3.4187073172375904e-09
on O 0 3.243880941639077e-09
their O 0 5.687356696704171e-10
high O 0 5.998590069111742e-08
heterozygosity O 0 6.32611374840053e-07
and O 0 8.639132187404641e-10
their O 0 4.093200223209692e-10
location O 0 8.397024409134701e-09
within O 0 5.429080740526615e-09
10q23 O 0 1.7371138483213144e-06
- O 0 1.017840872918896e-06
q25 O 0 1.794877061911393e-05
near O 0 1.6079895431175828e-05
COL17A1 O 1 0.9990278482437134
. O 0 3.929990270989947e-07

Three O 0 7.725899564547944e-08
families O 0 1.1371031893858685e-09
shared O 0 7.734506368706207e-09
microsatellite O 0 1.558566850690113e-06
polymorphisms O 0 3.2491712431692577e-07
covering O 0 3.1960150863596937e-06
at O 0 6.443433449021541e-07
most O 0 1.102814284337228e-09
19 O 0 1.797366344646889e-08
cM O 0 1.595132559373269e-08
, O 0 2.094425605170258e-10
whereas O 0 1.9404958195856636e-10
the O 0 3.757794353465016e-10
others O 0 1.423349216267411e-10
shared O 0 3.9766370751870284e-10
smaller O 0 1.1902723251466796e-09
regions O 0 5.5328972514701036e-09
consistent O 0 2.0961303803801457e-08
with O 0 7.866874374151678e-10
cross O 0 7.276259594846124e-08
- O 0 5.059236585225335e-08
over O 0 3.3894817508262065e-10
events O 0 1.6066668828695896e-10
during O 0 2.775711327451802e-10
passage O 0 7.74267525094352e-11
of O 0 5.303543368362362e-11
this O 0 1.2928029957323672e-12
mutation O 0 3.497467246371677e-11
through O 0 4.493852859277503e-11
several O 0 5.864469465599598e-10
generations O 0 2.7911365663157994e-08
. O 0 2.0388130295145857e-08

These O 0 2.047143787820005e-08
results O 0 2.0442955772637106e-08
indicate O 0 1.7770693805374549e-09
that O 0 6.713955086334877e-11
4003delTC O 0 9.127151656684873e-08
occurs O 0 4.4275272337301885e-10
on O 0 4.2770148533932684e-10
a O 0 1.8656262645855293e-10
single O 0 9.881980789216982e-10
ancestral O 0 8.827895747742787e-09
allele O 0 1.0040241971154273e-09
. O 0 4.1115569282546005e-10
. O 0 5.416761705845374e-09

The O 0 9.973845180866192e-07
haptoglobin O 0 2.572072480688803e-05
- O 0 2.1393486804299755e-06
gene O 0 1.0900643054867487e-08
deletion O 0 9.808188039528432e-09
responsible O 0 4.808882891893518e-08
for O 0 1.754692746658293e-08
anhaptoglobinemia B-Disease 0 0.0022233149502426386
. O 0 2.863050099222164e-07

We O 0 3.368005607740088e-08
have O 0 1.7974674526577417e-10
found O 0 1.5578290046835974e-10
an O 0 4.85601836519578e-12
allelic O 0 1.7363152693405937e-08
deletion O 0 4.12491241164048e-09
of O 0 3.167251705349372e-08
the O 0 1.379227221320889e-08
haptoglobin O 0 1.9657195480249356e-06
( O 0 2.6282327425519725e-09
Hp O 0 5.2100464387194734e-08
) O 0 2.8399155249658747e-10
gene O 0 1.732773508011931e-10
from O 0 1.3292934808450951e-10
an O 0 1.3007804035292114e-11
individual O 0 5.7675256931455365e-11
with O 0 1.4038009865657841e-08
anhaptoglobinemia B-Disease 1 0.9599053263664246
. O 0 8.947883429755166e-07

The O 0 9.644116971685435e-07
Hp O 0 8.495035217492841e-07
gene O 0 2.340575377957066e-08
cluster O 0 2.559550864589255e-07
consists O 0 1.274484695557021e-08
of O 0 1.755047485119121e-08
coding O 0 2.31247323512207e-08
regions O 0 3.510001400641727e-09
of O 0 1.9194969169689102e-08
the O 0 3.0733131595184204e-09
alpha O 0 1.1065083072026027e-08
chain O 0 4.113426044227708e-09
and O 0 2.1739321454106175e-10
beta O 0 2.55398679982477e-09
chain O 0 3.1676850031914228e-09
of O 0 8.580964272475455e-10
the O 0 9.566277769934572e-10
haptoglobin O 0 3.820857727987459e-07
gene O 0 3.5719938118461414e-09
( O 0 3.0637598014138234e-10
Hp O 0 2.4847764734658995e-08
) O 0 1.656558501483829e-10
and O 0 3.9463382561777394e-10
of O 0 8.41358538394843e-09
the O 0 2.56990717595329e-09
alpha O 0 2.2972622915062857e-08
chain O 0 1.1094139829026517e-08
and O 0 1.168782570726279e-10
beta O 0 3.790376457146749e-09
chain O 0 4.7204760100783005e-09
of O 0 2.1684090079077123e-09
the O 0 9.16608233758609e-10
haptoglobin O 0 3.1580046311319165e-07
- O 0 2.5401279302172952e-08
related O 0 1.8672693613552838e-08
gene O 0 2.985537372879321e-09
( O 0 4.967370959008122e-10
Hpr O 0 5.234729201220034e-07
) O 0 5.833600269511408e-10
, O 0 1.26316720971964e-10
in O 0 4.959040400542847e-10
tandem O 0 5.835909888673996e-08
from O 0 6.601355018176491e-09
the O 0 1.7870396717967196e-08
5 O 0 1.4385685176421248e-07
side O 0 2.223829085323814e-07
. O 0 3.9746243629679157e-08

Southern O 0 6.920551641087513e-06
blot O 0 1.3803630281472579e-05
and O 0 1.6202831076839175e-08
PCR O 0 7.806016810718575e-07
analyses O 0 3.3565971335747236e-08
have O 0 9.66142235658829e-11
indicated O 0 2.736600390740307e-10
that O 0 4.630208542966141e-12
the O 0 7.433911125565018e-11
individual O 0 6.136701563574931e-11
with O 0 2.878838833986208e-10
anhaptoglobinemia B-Disease 0 1.2214276466693264e-05
was O 0 5.0588891298275485e-08
homozygous O 0 1.054438314440631e-09
for O 0 6.295807625233962e-11
the O 0 7.504548094061647e-10
gene O 0 2.9966379377910357e-10
deletion O 0 9.147307911128166e-10
and O 0 2.793738296258397e-10
that O 0 1.5477348569437055e-11
the O 0 3.605346576840418e-10
gene O 0 3.002227355608511e-10
deletion O 0 7.073441277150039e-10
was O 0 3.280040905551118e-09
included O 0 2.1433956831629075e-09
at O 0 6.316622336299815e-09
least O 0 1.2772473183264577e-11
from O 0 1.57094004471503e-10
the O 0 1.1790108889186968e-09
promoter O 0 3.099439709330909e-06
region O 0 3.003587778493966e-08
of O 0 6.948327779809915e-08
Hp O 0 1.9166475340171019e-07
to O 0 9.91816495599096e-09
Hpr O 0 5.610274911305169e-06
alpha O 0 1.2785683622951183e-07
but O 0 1.0857513499384908e-10
not O 0 1.3714159148581206e-11
to O 0 3.0672211992488485e-10
Hpr O 0 1.0200924407399725e-06
beta O 0 2.7988033934889245e-07
( O 0 6.599063961942875e-09
Hpdel O 0 4.092910967301577e-05
) O 0 2.587411618293345e-09
. O 0 9.076421392251177e-09

In O 0 9.265492195709157e-08
addition O 0 8.819396768444676e-09
, O 0 7.769174192873152e-10
we O 0 4.3950815209470306e-11
found O 0 5.5419013128554795e-11
seven O 0 9.314046062192105e-11
individuals O 0 7.78193156615592e-13
with O 0 5.835967820111421e-11
hypohaptoglobinemia B-Disease 0 4.297931809560396e-06
in O 0 2.0163122282923496e-09
three O 0 5.345753839591794e-10
families O 0 2.2884423522828712e-11
, O 0 1.28016985900814e-10
and O 0 1.7244944361394232e-10
the O 0 1.8849490857064666e-09
genotypes O 0 1.6835750571431163e-08
of O 0 1.1627002471925607e-08
six O 0 5.1459374539319924e-09
of O 0 2.7400711033465086e-08
the O 0 7.330233753322091e-09
seven O 0 1.563861484754625e-09
individuals O 0 1.920511059211316e-12
were O 0 4.184421698028018e-10
found O 0 3.0948882345782636e-10
to O 0 3.371961876386109e-10
be O 0 5.085180720953986e-09
Hp2 O 1 0.9865200519561768
/ O 0 0.00020102947019040585
Hpdel O 0 0.004417638294398785
. O 0 3.0157522701301787e-07

The O 0 5.786938572782674e-07
phenotypes O 0 1.0584587926132372e-06
and O 0 2.106567009718674e-08
genotypes O 0 7.685510183819133e-08
in O 0 1.9915333826503456e-09
one O 0 1.6138629321815756e-10
of O 0 1.931973026003675e-09
these O 0 9.448098553521689e-11
three O 0 3.2034888630683156e-10
families O 0 1.7855140976852368e-11
showed O 0 7.521600564608377e-10
the O 0 1.1385202780545e-09
father O 0 3.702946838046728e-09
to O 0 1.5776961681535084e-10
be O 0 4.180839840994821e-10
hypohaptoglobinemic B-Disease 0 3.487891262921039e-06
( O 0 2.6876922909480072e-09
Hp2 O 0 1.8969489246956073e-05
) O 0 3.578879970156379e-10
and O 0 1.4938759118621192e-09
Hp2 O 0 0.0012436024844646454
/ O 0 2.2292106223176233e-06
Hpdel O 0 0.00010086644033435732
, O 0 2.1674659844705957e-09
the O 0 2.2030437474285236e-09
mother O 0 1.6184475981617652e-09
to O 0 1.294025442355462e-10
be O 0 2.375772634177764e-10
Hp2 O 0 5.0704989007499535e-06
- O 0 2.2842557712010603e-07
1 O 0 1.628201573566912e-08
and O 0 2.565851753288939e-09
Hp1 O 0 7.597862713737413e-05
/ O 0 4.5826942596249864e-07
Hp2 O 0 5.928653081355151e-06
, O 0 5.678771897166257e-10
one O 0 7.691233067097514e-11
of O 0 1.579298691822828e-09
the O 0 6.982278089040506e-10
two O 0 1.6990511775283323e-10
children O 0 2.228075016152964e-11
to O 0 2.0423321020479612e-11
be O 0 2.2455641512930669e-10
hypohaptoglobinemic B-Disease 0 2.3630118448636495e-06
( O 0 2.33189401122047e-09
Hp2 O 0 4.33381246693898e-05
) O 0 3.9980457833266314e-10
and O 0 2.8870223989230226e-09
Hp2 O 0 0.009842087514698505
/ O 0 4.8296751629095525e-06
Hpdel O 0 0.00040056073339655995
, O 0 1.9652142135839767e-09
and O 0 4.1527847827182995e-10
the O 0 3.3664609988548477e-10
other O 0 7.281927144608957e-11
child O 0 8.295457099016801e-10
to O 0 4.290445429488976e-11
be O 0 2.0708780523737147e-10
Hp1 O 0 1.9746268662856892e-05
and O 0 2.1144046513654757e-08
Hp1 O 0 0.3477960228919983
/ O 0 9.432781553186942e-06
Hpdel O 0 9.649091953178868e-05
, O 0 1.1466381177882567e-09
showing O 0 2.827944101113644e-09
an O 0 3.492814024119717e-11
anomalous O 0 1.1751929207548528e-07
inheritance O 0 5.595227392518609e-08
of O 0 1.2399750630720519e-06
Hp O 0 9.343290230390267e-07
phenotypes O 0 2.249691135602916e-07
in O 0 5.145770920478299e-09
the O 0 1.491735446279563e-08
child O 0 8.970032183697185e-08
with O 0 7.684422875797736e-09
Hp1 O 0 0.10672488808631897
. O 0 6.800300980103202e-07

The O 0 4.928220732836053e-06
Hp2 O 1 0.9955775737762451
/ O 0 7.194535282906145e-05
Hpdel O 0 2.6481651730136946e-05
individuals O 0 1.480181671675851e-10
had O 0 1.1049997583612026e-09
an O 0 1.005437955114985e-10
extremely O 0 4.734415970375494e-09
low O 0 8.067106449516359e-08
level O 0 1.6271274105861266e-08
of O 0 2.0190457306057397e-08
Hp O 0 7.043036021059379e-08
( O 0 1.886567568831765e-09
mean O 0 3.44580963762553e-09
+ O 0 2.101810059329523e-09
/ O 0 2.2380408637445726e-08
- O 0 2.3016703210032574e-08
SD O 0 1.9716856058948906e-06
= O 0 1.5840592171301182e-09
0 O 0 2.2279869615893233e-10
. O 0 1.5360476779413546e-11
049 O 0 2.49699585452845e-08
+ O 0 8.869646683784538e-10
/ O 0 5.635775401913179e-09
- O 0 2.9625975006553062e-09
0 O 0 4.5390030622982636e-10
. O 0 2.7967012386498347e-11
043 O 0 4.477509918388023e-08
mg O 0 7.987917882701367e-08
/ O 0 2.0283170698576214e-08
ml O 0 3.5809026854849435e-09
; O 0 7.943950358635377e-11
n O 0 4.875289616457223e-10
= O 0 4.089376892668639e-10
6 O 0 3.6096212685521323e-09
) O 0 1.7202066160404428e-11
, O 0 1.849113223650889e-11
compared O 0 2.687622693842151e-11
with O 0 1.2564768669953708e-11
the O 0 2.7506666389065515e-10
level O 0 8.064688472586568e-09
( O 0 6.480955355714357e-11
1 O 0 3.6143871229299407e-10
. O 0 1.934463700337119e-11
64 O 0 1.1075148576011884e-09
+ O 0 4.3476341970993815e-10
/ O 0 6.480208369907814e-09
- O 0 7.188440953598274e-09
1 O 0 1.4589084385008277e-09
. O 0 5.3048381659648314e-11
07 O 0 2.4342357463069675e-08
mg O 0 3.8356581910647947e-08
/ O 0 7.108081678808276e-09
ml O 0 1.3063211623531856e-09
) O 0 3.795803948936083e-12
obtained O 0 3.516215790755339e-11
from O 0 2.6775343053841993e-10
52 O 0 2.6185154045066383e-09
healthy O 0 1.4909923296002603e-09
volunteers O 0 4.3027750251667385e-09
having O 0 2.6244355577631495e-09
phenotype O 0 1.6005268221874758e-08
Hp2 O 0 7.689000085520092e-06
, O 0 9.226228114833646e-10
whereas O 0 1.2818123229507705e-09
the O 0 1.499797175341655e-09
serum O 0 2.6458026880504804e-08
Hp O 0 3.661071446003916e-08
level O 0 1.7364541804454348e-08
of O 0 5.030741601075306e-09
an O 0 9.10725835023829e-12
individual O 0 2.5716796747676796e-11
with O 0 7.471485097276798e-10
Hp1 O 1 0.7317512035369873
/ O 0 6.669167760264827e-06
Hpdel O 0 9.862654405878857e-05
was O 0 1.4269609494022006e-07
0 O 0 3.459865638433257e-08
. O 0 3.575756801765806e-09

50 O 0 2.3968523237272166e-06
mg O 0 7.23486391507322e-06
/ O 0 1.2404067319948808e-06
ml O 0 2.099283591405765e-07
, O 0 4.5713319241080796e-10
which O 0 8.45211539646229e-11
was O 0 1.0868685951237467e-09
approximately O 0 3.879119248040297e-11
half O 0 8.698319842181945e-11
the O 0 1.1879333627895505e-10
level O 0 2.5857982421939596e-09
of O 0 2.8850353217535485e-09
Hp O 0 1.0078024637039107e-08
in O 0 1.1012210032745884e-09
control O 0 2.4420158339921727e-08
sera O 0 7.652480462638778e-07
from O 0 3.99939059647636e-09
the O 0 2.793537179357486e-09
Hp1 O 0 4.695354164141463e-06
phenotype O 0 7.1607022533726195e-09
( O 0 2.7865965090967393e-10
1 O 0 2.693100853434771e-09
. O 0 1.275096139785603e-10
26 O 0 6.978367217413961e-09
+ O 0 1.0588278032130916e-09
/ O 0 6.2083578278304685e-09
- O 0 6.198773938592694e-09
0 O 0 5.203149022747766e-10
. O 0 1.7262510865201364e-11
33 O 0 9.284554791655353e-10
mg O 0 3.3360066709064995e-08
/ O 0 2.4279898980239523e-08
ml O 0 7.487452435839259e-09
; O 0 6.926511447735706e-11
n O 0 4.136949949273827e-10
= O 0 4.993941371544963e-10
9 O 0 3.798120040698905e-09
) O 0 2.3648081756699746e-11
, O 0 1.7848533415132373e-11
showing O 0 4.901443140248318e-10
a O 0 2.5458829489011237e-10
gene O 0 3.206155785306919e-09
- O 0 7.251445310885174e-08
dosage O 0 4.971849989487964e-07
effect O 0 7.331844642521901e-08
. O 0 1.704649044143025e-08

The O 0 2.039889039906484e-07
other O 0 7.209407737462925e-09
allele O 0 3.937040027324201e-09
( O 0 1.3364761519696344e-09
Hp2 O 0 5.352576863515424e-06
) O 0 3.058470143812997e-10
of O 0 2.041107505235118e-09
individuals O 0 4.539180229606865e-12
with O 0 6.796314622192767e-10
Hp2 O 1 0.9999902248382568
/ O 0 0.00015902952873148024
Hpdel O 0 0.22838616371154785
was O 0 3.276371884908258e-08
found O 0 1.2881866406910802e-10
to O 0 1.4633466313695997e-11
have O 0 1.0592044602519834e-11
, O 0 4.2464087801619144e-11
in O 0 7.980063138068871e-11
all O 0 2.3222390677091198e-10
exons O 0 6.087232051754654e-09
, O 0 7.597409507065223e-11
no O 0 1.419312584127752e-10
mutation O 0 1.4883010102106908e-10
, O 0 2.5693261754278218e-11
by O 0 6.138328040306007e-11
DNA O 0 2.0261640543139947e-07
sequencing O 0 7.225199993854403e-08
. O 0 2.4046558522172745e-08

On O 0 1.7512863337287854e-07
the O 0 1.921514281022496e-09
basis O 0 5.182883566767771e-10
of O 0 1.2385846792639654e-09
the O 0 7.59625071178327e-11
present O 0 8.573957516189168e-11
study O 0 1.4479162313563165e-10
, O 0 9.076373333471999e-12
the O 0 2.6782276049686082e-11
mechanism O 0 1.0540320838359207e-09
of O 0 1.779142522195798e-08
anhaptoglobinemia B-Disease 0 5.3541953093372285e-06
and O 0 7.726039252808903e-10
the O 0 8.434195564177571e-10
mechanism O 0 2.5423223526388483e-09
of O 0 3.23768101218036e-09
anomalous O 0 5.0584450406176984e-08
inheritance O 0 9.606563544650726e-09
of O 0 1.351248926084736e-07
Hp O 0 1.4967322670145222e-07
phenotypes O 0 1.2410475846991176e-07
were O 0 1.1584590176028087e-08
well O 0 1.7022642850861303e-08
explained O 0 1.3882065275083733e-07
. O 0 4.327542768578496e-08

However O 0 4.364962791214566e-08
, O 0 1.2840390972712612e-09
the O 0 1.0537165584523223e-09
mechanism O 0 1.122542769849133e-08
of O 0 7.163614412775132e-08
hypohaptoglobinemia B-Disease 0 0.0010831166291609406
remains O 0 1.2873376817879034e-06
unknown O 0 1.547422129988263e-06

ATM O 0 0.0005799662321805954
mutations O 0 2.0326203298282053e-07
and O 0 2.9662968970001202e-08
phenotypes O 0 8.825658142086468e-07
in O 0 5.804575948786805e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 1.5894471516730846e-08
in O 0 8.979871068959255e-09
the O 0 1.0280952089658513e-08
British O 0 5.6925397728946336e-08
Isles O 0 4.654470728837623e-07
: O 0 3.6530323210826054e-10
expression O 0 2.4442875501407e-10
of O 0 2.3919286551432606e-09
mutant O 0 5.786671142260502e-09
ATM O 0 1.1211091077711899e-06
and O 0 8.761264491674581e-10
the O 0 6.558792953192949e-10
risk O 0 2.9906268572688077e-09
of O 0 3.862233768359147e-07
leukemia B-Disease 1 1.0
, O 0 7.446166273439303e-05
lymphoma B-Disease 1 1.0
, O 0 1.5060813893796876e-05
and O 0 0.21225132048130035
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 1.1279361160632106e-06

We O 0 3.072857523989114e-08
report O 0 2.8220816794544135e-09
the O 0 8.332389778153981e-10
spectrum O 0 1.760713885801124e-08
of O 0 1.3255679220947059e-08
59 O 0 1.7379353067781267e-08
ATM O 0 1.90312675840687e-06
mutations O 0 2.490639694485708e-09
observed O 0 8.321957345458486e-09
in O 0 3.391897251958653e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.077856308664195e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 5.316705298241686e-09
patients O 0 8.434918874478115e-10
in O 0 2.0586457538662728e-10
the O 0 1.5514279860795455e-09
British O 0 2.122484374922351e-07
Isles O 0 3.0193401471478865e-05
. O 0 1.1325597881750582e-07

Of O 0 8.500906915287487e-06
51 O 0 9.79174046733533e-07
ATM O 0 3.4696833608904853e-05
mutations O 0 1.680536776405006e-08
identified O 0 2.3461836917704204e-09
in O 0 5.345019982172516e-10
families O 0 1.9429503145262927e-11
native O 0 2.3725305053901025e-10
to O 0 6.742187363961705e-11
the O 0 1.2810228433579596e-09
British O 0 4.2605478256518836e-08
Isles O 0 4.931719104206422e-07
, O 0 7.89935228340255e-10
11 O 0 2.9686499924963528e-09
were O 0 5.445889295074835e-10
founder O 0 1.5336617309458234e-07
mutations O 0 1.4923181579362677e-09
, O 0 7.534294299560429e-10
and O 0 1.1093393981198574e-09
2 O 0 1.4780165535910328e-08
of O 0 7.862513307088648e-09
these O 0 2.924464004294691e-10
11 O 0 8.597351275341225e-09
conferred O 0 1.6164895200176943e-08
a O 0 1.6377252887167515e-09
milder O 0 1.9449818466910074e-07
clinical O 0 3.1650296250518295e-07
phenotype O 0 2.307396496092906e-09
with O 0 1.1085286855117005e-10
respect O 0 6.644909067432536e-10
to O 0 8.973737308792806e-10
both O 0 3.184685226642614e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 4.622475444193697e-06
cellular O 0 6.801381096011028e-05
features O 0 2.4661746920173755e-06
. O 0 1.3509345819784357e-07

We O 0 6.611652025867443e-08
report O 0 9.839630443764236e-09
, O 0 1.5781113915647182e-10
in O 0 1.9009172014250453e-10
two O 0 3.432059914043606e-10
A B-Disease 1 0.9999947547912598
- I-Disease 1 0.9975858926773071
T I-Disease 1 1.0
families O 0 3.8307335081810834e-10
, O 0 6.454913686892993e-11
an O 0 1.8265144605122963e-11
ATM O 0 6.717129508615471e-06
mutation O 0 6.455153744866493e-09
( O 0 5.19899234774357e-10
7271T O 0 5.085105954094615e-07
- O 0 1.7282079056712973e-07
- O 0 1.2489765310874645e-07
> O 0 3.5303941103848047e-08
G O 0 2.741279331530677e-06
) O 0 7.171000598882316e-11
that O 0 2.745469867074246e-12
may O 0 1.3804225991453922e-11
be O 0 5.467198742337143e-12
associated O 0 1.282799838575599e-10
with O 0 1.3664497484910942e-11
an O 0 1.3742437743324842e-11
increased O 0 7.35911262483846e-11
risk O 0 1.924624459803681e-09
of O 0 3.14154959824009e-07
breast B-Disease 1 0.9871354699134827
cancer I-Disease 0 1.8023412167167407e-06
in O 0 1.404110938629799e-09
both O 0 5.889241316836547e-10
homozygotes O 0 9.48726182059545e-08
and O 0 1.8459646033974764e-09
heterozygotes O 0 9.557240332469519e-08
( O 0 8.882411473010166e-10
relative O 0 1.1621349216284216e-08
risk O 0 1.2002926652598944e-08
12 O 0 1.2578743380231572e-08
. O 0 1.313686520676427e-10
7 O 0 4.009173881769357e-09
; O 0 1.8727602801860144e-10
P O 0 3.070948082495306e-07
= O 0 7.813299340853064e-09
. O 0 4.1206954515260463e-10
0025 O 0 1.330534814769635e-06
) O 0 1.4352022348340654e-10
, O 0 1.9639904286217202e-11
although O 0 1.2144557061388728e-11
there O 0 7.459445387769659e-12
is O 0 5.571691545636082e-12
a O 0 7.855550238078379e-11
less O 0 1.306837082992729e-09
severe O 1 0.9298670887947083
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 5.0871982182343345e-09
in O 0 6.59215043663508e-11
terms O 0 7.604832735763623e-11
of O 0 2.491047090824594e-10
the O 0 6.802770152747328e-11
degree O 0 1.514351488651755e-08
of O 0 3.676543940400734e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 2.037516196651268e-06

This O 0 2.9801396905781985e-08
mutation O 0 2.347559124871168e-08
( O 0 2.010897004467438e-09
7271T O 0 3.7362718785516336e-07
- O 0 1.7519613493277575e-07
- O 0 6.86596237642334e-08
> O 0 1.558909623611271e-08
G O 0 6.21142817180953e-07
) O 0 4.094315164682172e-11
also O 0 4.8152246079347094e-12
allows O 0 2.7267292156823997e-12
expression O 0 4.4557444539572444e-11
of O 0 8.363629233620884e-10
full O 0 5.25867127620927e-10
- O 0 2.900467643840443e-09
length O 0 4.8822102610701634e-11
ATM O 0 9.565647474119032e-08
protein O 0 5.638923217254899e-10
at O 0 2.048631042583793e-09
a O 0 9.845007448161525e-11
level O 0 5.644798517501215e-10
comparable O 0 1.4347295573813312e-09
with O 0 1.0239546190116133e-11
that O 0 4.922912338195529e-12
in O 0 3.2277214234710527e-10
unaffected O 0 2.7185301121335215e-08
individuals O 0 1.3141776555869455e-10
. O 0 1.553024553402338e-08

In O 0 1.4000499959365698e-07
addition O 0 6.320623580080564e-09
, O 0 5.784019929677697e-10
we O 0 2.2181445916147347e-11
have O 0 5.034996291425342e-12
studied O 0 6.5483716227277e-09
18 O 0 2.0634557174048496e-08
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 2.1197227084712722e-08
, O 0 3.8985523143075795e-11
in O 0 4.1727992589057905e-11
15 O 0 1.357288864634043e-10
families O 0 1.499591791888355e-12
, O 0 1.930210505318719e-11
who O 0 1.0673780609371519e-10
developed O 0 1.4402996384887956e-05
leukemia B-Disease 1 1.0
, O 0 0.0015418526018038392
lymphoma B-Disease 1 1.0
, O 0 4.099285888514714e-06
preleukemic O 1 0.9999998807907104
T O 1 1.0
- O 0 0.006603514309972525
cell O 0 2.331226278329268e-05
proliferation O 0 0.2561880350112915
, O 0 4.407981091247848e-09
or O 0 1.8348422599956393e-05
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 9.743045126242578e-08
mostly O 0 3.609270216031746e-09
in O 0 7.726780104633235e-09
childhood O 0 4.6118595491861925e-05
. O 0 9.4706457787197e-08

A O 0 7.33556908016908e-06
wide O 0 1.320780853575343e-07
variety O 0 2.7856799533765297e-08
of O 0 7.304068816438303e-08
ATM O 0 7.101716619217768e-05
mutation O 0 4.5224304301427765e-09
types O 0 1.4055210328933754e-08
, O 0 5.19694010048255e-10
including O 0 2.1700969909943524e-09
missense O 0 2.8806331897612836e-07
mutations O 0 6.881416769743964e-09
and O 0 5.381860290754048e-09
in O 0 1.935219451354442e-08
- O 0 4.3067268507002154e-07
frame O 0 5.118648616075916e-08
deletions O 0 3.218184119191392e-08
, O 0 1.088034329299603e-09
were O 0 1.1998708693283788e-09
seen O 0 1.7787481487729906e-09
in O 0 3.026137673778351e-10
these O 0 4.4830511525262295e-10
patients O 0 9.41906641571677e-09
. O 0 2.256252251697788e-08

We O 0 1.158276035084782e-07
also O 0 8.706524390333925e-10
show O 0 5.501839539512332e-10
that O 0 3.4736716541389212e-12
25 O 0 1.8451505601202456e-10
% O 0 3.26537299803753e-12
of O 0 2.4897836570225707e-10
all O 0 1.1655906240193303e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.1353591844454058e-08
carried O 0 3.566914985597691e-09
in O 0 1.297431606595012e-09
- O 0 2.6288656584938508e-08
frame O 0 5.3237272368278354e-09
deletions O 0 7.426605996840863e-09
or O 0 2.9406583834656885e-09
missense O 0 1.165168299621655e-07
mutations O 0 3.6389520285950994e-09
, O 0 2.0848760218239448e-10
many O 0 4.281787771565071e-11
of O 0 2.6824429344429745e-09
which O 0 5.062163188629398e-11
were O 0 3.751620958336588e-10
also O 0 1.8319850844661367e-11
associated O 0 9.318772836719447e-11
with O 0 2.7497160798306552e-11
expression O 0 3.2828556539854503e-10
of O 0 1.2828720308277752e-08
mutant O 0 7.021133541229574e-08
ATM O 0 1.5761655959067866e-05
protein O 0 1.3995907011121744e-07
. O 0 7.719977190845384e-08

The O 0 3.47846048498468e-06
DMPK O 1 0.9999926090240479
gene O 0 4.458965179310326e-07
of O 0 1.5247119335981552e-06
severely O 1 0.9999843835830688
affected O 1 0.9999842643737793
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9408117532730103
is O 0 4.424079236287071e-08
hypermethylated O 0 0.009601571597158909
proximal O 0 5.026494363846723e-06
to O 0 1.1673800592859607e-08
the O 0 4.309150369863346e-08
largely O 0 5.6157343664153814e-08
expanded O 0 2.0078938689493953e-07
CTG O 0 0.0007215534569695592
repeat O 0 3.352126896061236e-06
. O 0 9.788961108370131e-08

Using O 0 1.6319394546826516e-07
methylation O 0 4.144829119923088e-07
- O 0 9.210746299004313e-08
sensitive O 0 2.504403084913065e-08
restriction O 0 3.366641132540593e-10
enzymes O 0 4.724671209821452e-10
, O 0 1.1036153241272828e-10
we O 0 9.118816812758723e-12
characterized O 0 1.6356641041603837e-10
the O 0 9.33293234361976e-11
methylation O 0 4.169295131362105e-09
pattern O 0 4.320892976750201e-09
on O 0 8.274076979120082e-10
the O 0 1.889227801976645e-10
5 O 0 7.733174656188169e-10
side O 0 8.365910186824976e-10
of O 0 1.9146364493849433e-09
the O 0 3.3745630734216547e-09
CTG O 0 0.00011570840433705598
repeat O 0 1.87852915445319e-08
in O 0 5.3398840904606e-10
the O 0 9.37304012182949e-10
DMPK O 0 0.3020637333393097
gene O 0 1.2438333696351833e-09
of O 0 1.3361677320133936e-09
normal O 0 1.06730324578308e-09
individuals O 0 2.7421465705751435e-12
and O 0 2.1713876530160547e-10
of O 0 3.9850085897796816e-08
patients O 0 1.0105954295624997e-08
affected O 0 4.5193200293169866e-08
with O 0 1.1475596011223388e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 7.189306927557482e-08
showing O 0 2.4237886364630867e-08
expansions O 0 9.329651362577351e-08
of O 0 1.5046710188926227e-07
the O 0 9.1622460729468e-08
repetitive O 0 7.530132279498503e-05
sequence O 0 1.4295326877800107e-07
. O 0 3.359978961725574e-08

The O 0 1.094405774892948e-06
gene O 0 3.880819576806971e-08
segment O 0 1.0030007047134859e-08
analyzed O 0 2.598583792590148e-09
corresponds O 0 7.57500062675831e-10
to O 0 1.49599652110588e-10
the O 0 1.356107004468754e-09
genomic O 0 3.055412278740732e-08
SacI O 0 8.790815627435222e-06
- O 0 2.0345829909729218e-07
HindIII O 0 2.0002539713459555e-06
fragment O 0 2.009004340663978e-08
carrying O 0 2.8509029803558406e-08
exons O 0 1.8218415220871975e-07
11 O 0 1.2832444440391555e-07
- O 0 2.4953445176834066e-07
15 O 0 5.263884972350752e-08
. O 0 1.3282506650114101e-08

There O 0 8.53207708928494e-08
is O 0 1.0597046573579405e-09
constitutive O 0 9.535081346712104e-08
methylation O 0 9.25791354688954e-08
in O 0 8.321751288065116e-09
intron O 0 5.47860793176369e-07
12 O 0 3.241303403456186e-08
at O 0 1.4848764440245077e-09
restriction O 0 3.300294759700506e-11
sites O 0 7.22637838457274e-10
of O 0 7.082976427597032e-09
SacII O 0 6.343552740872838e-06
and O 0 1.69830762786205e-08
HhaI O 0 2.6994670406566e-05
, O 0 2.5196191799636836e-09
localized O 0 7.000953416991251e-08
1 O 0 1.9424270192303084e-08
, O 0 3.427363115537929e-10
159 O 0 1.3087409378442771e-08
- O 0 2.2055463233527917e-08
1 O 0 6.156379406263568e-09
, O 0 2.254008923952e-10
232 O 0 3.7027136912115566e-09
bp O 0 1.2071044608319426e-08
upstream O 0 7.628258025249579e-09
of O 0 5.922068613273268e-09
the O 0 1.1488431539419253e-08
CTG O 0 0.000515259278472513
repeat O 0 1.0772684788662445e-07
, O 0 4.1317452237343844e-10
whereas O 0 2.127903270254805e-10
most O 0 3.0006455653541764e-11
, O 0 1.1845141187349917e-11
if O 0 3.436445355706197e-12
not O 0 3.4261959588888224e-12
all O 0 4.300826014769221e-11
, O 0 5.016287385473106e-11
of O 0 4.893792038274114e-10
the O 0 5.3042414210890954e-11
other O 0 2.987771488549562e-12
sites O 0 5.252786539067245e-10
of O 0 4.108454909612647e-09
SacII O 0 1.2028893252136186e-05
, O 0 3.3018217049374243e-09
HhaI O 0 1.6998044884530827e-05
, O 0 2.2206103622579576e-09
and O 0 2.6117317197815737e-09
HpaII O 0 1.4167752851790283e-05
in O 0 1.871918398066441e-09
this O 0 3.087298819370865e-11
region O 0 8.263668083152709e-10
are O 0 7.089186182529517e-11
unmethylated O 0 4.819507353204244e-07
, O 0 1.8054287231894506e-10
in O 0 1.4545815940625317e-10
normal O 0 9.958859292780176e-10
individuals O 0 8.906696560839755e-12
and O 0 2.56786258923114e-10
most O 0 4.230307493191532e-10
of O 0 1.4493627631395611e-08
the O 0 1.2671621085758034e-08
patients O 0 1.9528545891489557e-08
. O 0 9.755109608988732e-09

In O 0 8.160300524195918e-08
a O 0 1.1405503208550272e-09
number O 0 1.0091383284560607e-10
of O 0 7.093007514669125e-09
young O 0 7.528925038968737e-09
and O 0 6.960886533846633e-09
severely O 0 0.00026358163449913263
affected O 0 8.463613454523511e-08
patients O 0 1.9318525446010426e-08
, O 0 4.27692520288403e-10
however O 0 2.0843909931400617e-10
, O 0 3.777626475520712e-11
complete O 0 9.2620910940866e-10
methylation O 0 5.9498406201896614e-09
of O 0 1.0799646732451151e-09
these O 0 3.593609784746654e-12
restriction O 0 1.1050449617855396e-11
sites O 0 2.620562655764047e-10
was O 0 4.09953682112274e-10
found O 0 1.1548347347845045e-11
in O 0 1.7570946433953516e-11
the O 0 2.21143298118065e-10
mutated O 0 2.9899553055656725e-08
allele O 0 1.1060377502758456e-08
. O 0 2.4832367273575073e-08

In O 0 6.404677321825147e-08
most O 0 6.740262237237005e-10
of O 0 4.198229763829886e-09
these O 0 9.300483994056918e-11
patients O 0 1.2756513623202181e-09
, O 0 3.8763086490645193e-11
the O 0 5.643442380076635e-10
onset O 0 3.382881550351158e-05
of O 0 5.6762438305213436e-08
the O 0 8.873214483173797e-07
disease O 1 0.9999998807907104
was O 0 0.24340657889842987
congenital O 1 1.0
. O 0 2.272878646181198e-06

Preliminary O 0 4.479945346247405e-06
in O 0 6.974111954605178e-08
vivo O 0 1.1623353657341795e-06
footprinting O 0 9.330270586360712e-06
data O 0 1.7299351284805198e-08
gave O 0 3.5208633786254495e-09
evidence O 0 1.0246004045200152e-09
for O 0 8.609682411453434e-11
protein O 0 2.7321150897208213e-10
- O 0 3.949323712504338e-08
DNA O 0 9.855937577185614e-08
contact O 0 1.3542872379090909e-09
in O 0 2.1653823178979792e-10
normal O 0 6.50347109498739e-10
genes O 0 9.840765008428676e-11
at O 0 2.5174573536901335e-09
an O 0 5.4061453230724865e-11
Sp1 O 0 1.9053828737014555e-07
consensus O 0 2.1244572767642467e-09
binding O 0 6.695850540694437e-10
site O 0 1.2148327677152793e-08
upstream O 0 7.0575829624885955e-09
of O 0 6.307400823857279e-09
the O 0 8.7426723638373e-09
CTG O 0 0.0002822024398483336
repeat O 0 4.251877783190139e-08
and O 0 3.011546845232971e-10
for O 0 4.7306741857156e-11
a O 0 2.679228887358942e-11
significant O 0 2.952846300807721e-11
reduction O 0 1.3301717505243005e-09
of O 0 9.197921868597803e-10
this O 0 2.1985991586342957e-12
interaction O 0 1.7606272342818308e-11
in O 0 6.931123730513633e-11
cells O 0 1.7806549290622087e-10
with O 0 8.851727684167088e-11
a O 0 5.277111192469874e-09
hypermethylated O 0 0.0003120753390248865
DMPK O 1 0.9999994039535522
gene O 0 6.123485718489974e-08
. O 0 2.6818292031549618e-09
. O 0 1.5210877890581287e-08

The O 0 3.265723353251815e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.4601013731407875e-07
product O 0 9.571319736778605e-09
complexes O 0 1.1457402138148609e-08
with O 0 6.456541412624972e-10
the O 0 1.7797832096988486e-09
transferrin O 0 2.8280101815880698e-08
receptor O 0 1.1635515884123038e-09
and O 0 1.0885138346239387e-09
lowers O 0 1.4854691698928946e-08
its O 0 1.1583672215875751e-10
affinity O 0 5.035719063961608e-11
for O 0 3.596944270212177e-11
ligand O 0 1.0122062299444679e-08
binding O 0 4.024982658279441e-08
. O 0 5.59643389408393e-08

We O 0 1.6076317876922985e-07
recently O 0 3.0521444926989716e-08
reported O 0 9.228182107356986e-10
the O 0 3.692534888966037e-10
positional O 0 2.169920776395884e-07
cloning O 0 9.391619926191197e-09
of O 0 4.353394977840708e-09
a O 0 2.0132677469586469e-10
candidate O 0 8.977691923206521e-10
gene O 0 2.0312283410817145e-08
for O 0 1.2539378246856359e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999946355819702
HFE O 1 1.0
. O 0 3.0599314868595684e-06

The O 0 8.89065518094867e-07
gene O 0 1.9413787910593783e-08
product O 0 4.5372305912394495e-09
, O 0 1.6656358237110425e-10
a O 0 2.465347925806327e-10
member O 0 1.0026406371821395e-09
of O 0 5.7773523742810085e-09
the O 0 8.634754244951637e-09
major O 0 2.6269867703376804e-07
histocompatibility O 0 0.0006672044401057065
complex O 0 1.1428250218159519e-05
class O 0 2.5468622766311455e-07
I O 0 5.8500577324593905e-06
- O 0 1.3070076931853691e-07
like O 0 2.6931419316866823e-09
family O 0 3.489446509519212e-10
, O 0 1.6446362327560138e-10
was O 0 1.765501633776978e-09
found O 0 6.144114383932475e-11
to O 0 2.5125380942458975e-11
have O 0 2.901953156941861e-11
a O 0 7.426602111060276e-10
mutation O 0 1.4821882610149828e-09
, O 0 6.552856923747186e-09
Cys O 0 0.0002257331507280469
- O 0 1.2340835837676423e-06
282 O 0 6.359443318615376e-07
- O 0 1.101521888813295e-06
- O 0 5.17115836373705e-07
> O 0 1.6526303170394385e-07
Tyr O 0 0.00011387583799660206
( O 0 2.520041952891461e-09
C282Y O 0 2.777997849534586e-07
) O 0 4.9034040716655625e-11
, O 0 1.4545392668097179e-11
in O 0 4.384129864698494e-11
85 O 0 2.098537565942138e-09
% O 0 2.7069770036636243e-11
of O 0 1.444554365015449e-09
patient O 0 7.404035784475127e-08
chromosomes O 0 9.788681154532242e-08
. O 0 1.1803012966993265e-07

This O 0 2.083935868313347e-08
mutation O 0 5.5637565665733746e-09
eliminates O 0 3.0240574488971106e-08
the O 0 2.3650090774651744e-09
ability O 0 1.303195440449656e-09
of O 0 2.047143787820005e-08
HFE O 0 0.02487843483686447
to O 0 3.77870401635505e-09
associate O 0 4.955792576311069e-08
with O 0 1.063771071230235e-09
beta2 O 0 0.00012139143655076623
- O 0 1.0473408110556193e-05
microglobulin O 0 9.133656567428261e-05
( O 0 1.0690437868277058e-08
beta2m O 0 3.196958277840167e-05
) O 0 7.55717766143249e-10
and O 0 9.526637256840331e-10
prevents O 0 4.80198814045707e-09
cell O 0 3.3706317026371835e-07
- O 0 6.854133403066953e-07
surface O 0 4.391326058339473e-07
expression O 0 2.9114101351979116e-08
. O 0 3.145716220842587e-08

A O 0 1.427481220162008e-05
second O 0 2.2139553834676917e-07
mutation O 0 1.23350651914933e-09
that O 0 3.548616608894939e-11
has O 0 4.166548356332456e-11
no O 0 6.89352255833775e-11
effect O 0 1.8473206297997535e-09
on O 0 1.8073908591986765e-08
beta2m O 0 2.4608563762740232e-05
association O 0 1.4598855102576636e-07
, O 0 1.5359173932694148e-09
H63D O 1 0.9999984502792358
, O 0 1.8172485738432442e-09
was O 0 4.39316627520725e-09
found O 0 1.423892392882209e-10
in O 0 1.0577695663815945e-10
eight O 0 2.263186082984703e-09
out O 0 4.771782413648396e-10
of O 0 8.902735437743559e-09
nine O 0 7.950127667299967e-09
patients O 0 9.531163636111728e-10
heterozygous O 0 6.51870890600037e-10
for O 0 6.747362113479483e-10
the O 0 2.2011462874615972e-08
C282Y O 0 1.6680060070939362e-05
mutant O 0 2.550153567426605e-06
. O 0 1.3918385377564846e-07

In O 0 4.434098244132656e-08
this O 0 3.569894102550819e-10
report O 0 6.442161804010027e-10
, O 0 1.5536925912496002e-10
we O 0 1.3591404043888922e-11
demonstrate O 0 2.904413376469961e-10
in O 0 2.630889395227598e-10
cultured O 0 1.0526846061509332e-08
293 O 0 5.7711769585466755e-08
cells O 0 5.54762813465004e-09
overexpressing O 0 7.238565444822598e-07
wild O 0 1.4525846836477285e-07
- O 0 8.548024510446339e-08
type O 0 2.1569878327909464e-08
or O 0 5.154729532108604e-09
mutant O 0 8.211402757751785e-08
HFE O 0 1.1574203199415933e-05
proteins O 0 3.106432611144072e-10
that O 0 2.357530490271209e-11
both O 0 5.4351051437251385e-11
the O 0 7.470872254167205e-10
wild O 0 6.705441535359569e-08
- O 0 3.7192499746652175e-08
type O 0 5.706236549940513e-08
and O 0 8.371377191451757e-08
H63D O 1 0.9999997615814209
HFE O 0 0.0021834580693393946
proteins O 0 4.390477315041608e-09
form O 0 5.7215130411236714e-09
stable O 0 1.1285517409476142e-08
complexes O 0 5.95961990867977e-09
with O 0 4.2564499147523804e-10
the O 0 6.701910137962841e-09
transferrin O 0 2.0129344591168774e-07
receptor O 0 2.182022384999982e-08
( O 0 5.2171631459430046e-09
TfR O 0 4.163832272752188e-06
) O 0 1.5400329900217002e-09
. O 0 3.768979794926963e-09

The O 0 3.5182549709134037e-06
C282Y O 0 2.7701782528311014e-05
mutation O 0 1.7249369932414993e-08
nearly O 0 4.217805660289287e-09
completely O 0 2.457931813637515e-08
prevents O 0 1.989965303650365e-09
the O 0 1.4731158515246534e-09
association O 0 3.0029847497559103e-09
of O 0 4.904120221027597e-09
the O 0 3.629345046718413e-09
mutant O 0 9.188250515990148e-08
HFE O 0 6.38442361378111e-05
protein O 0 6.726677437285389e-09
with O 0 1.817640260526332e-09
the O 0 1.063502139686534e-07
TfR O 0 0.0001624991709832102
. O 0 1.2589032394316746e-07

Studies O 0 2.692900125111919e-07
on O 0 4.527878871840585e-08
cell O 0 7.881465080572525e-08
- O 0 6.430554577718794e-08
associated O 0 2.510432750568725e-09
transferrin O 0 4.607418446767042e-08
at O 0 4.893610494605127e-08
37 O 0 2.2166453117478113e-09
degrees O 0 1.9958580566026285e-08
C O 0 2.0230649511177035e-07
suggest O 0 3.172466178646971e-10
that O 0 2.646046055876372e-11
the O 0 1.935624771576272e-09
overexpressed O 0 1.0572421160759404e-06
wild O 0 2.978092084049422e-07
- O 0 1.570870296063731e-07
type O 0 1.243743099621497e-07
HFE O 0 6.303768896032125e-05
protein O 0 2.749115823874604e-09
decreases O 0 3.6272601589004694e-10
the O 0 1.1400756033674853e-10
affinity O 0 1.9959019159632163e-10
of O 0 2.5190951546960605e-09
the O 0 2.7186632944875555e-09
TfR O 0 1.1036459000024479e-06
for O 0 3.7516376671931084e-09
transferrin O 0 1.2441540775398607e-06
. O 0 4.7957389170960596e-08

The O 0 1.0418817510071676e-05
overexpressed O 0 0.00036097990232519805
H63D O 1 0.9995951056480408
protein O 0 2.764428508328365e-08
does O 0 1.704504315469535e-10
not O 0 9.349104823641596e-12
have O 0 3.3451689768898563e-12
this O 0 3.905956287575396e-12
effect O 0 2.579781943623516e-10
, O 0 2.8568208562673725e-11
providing O 0 3.006701138064116e-11
the O 0 5.212125522846556e-11
first O 0 4.524315644349741e-11
direct O 0 1.2391695308755502e-11
evidence O 0 1.1477972738926923e-10
for O 0 1.1712188510704102e-11
a O 0 3.270086632034541e-11
functional O 0 5.491407883972954e-10
consequence O 0 3.1653717424973138e-09
of O 0 1.1546272382645384e-08
the O 0 2.4484194227625267e-08
H63D O 1 0.9999978542327881
mutation O 0 7.92084335898835e-08
. O 0 2.2225055573699137e-08

Addition O 0 2.1272850858622405e-07
of O 0 3.997402586719545e-07
soluble O 0 2.1266248495521722e-06
wild O 0 1.4421661944652442e-05
- O 0 8.531947059964295e-06
type O 0 2.4899251002352685e-05
HFE O 1 1.0
/ O 0 0.0005437917425297201
beta2m O 0 5.468915696837939e-05
heterodimers O 0 2.6807445010490483e-06
to O 0 2.1363264490759093e-09
cultured O 0 3.80126721211127e-08
cells O 0 7.0274137620174315e-09
also O 0 3.5052158398052313e-10
decreased O 0 9.31373089763099e-10
the O 0 2.544329469333917e-10
apparent O 0 8.783551663782418e-10
affinity O 0 1.465601390249205e-10
of O 0 2.8361113457719966e-09
the O 0 2.755178751812082e-09
TfR O 0 1.7996001133724349e-07
for O 0 1.1785067366432145e-10
its O 0 2.2431582979987041e-10
ligand O 0 3.305583806678669e-09
under O 0 1.6460186103017804e-08
steady O 0 4.874792480791257e-08
- O 0 8.9604865749493e-09
state O 0 2.2641305497117514e-10
conditions O 0 6.929623541651608e-09
, O 0 4.472313491765689e-11
both O 0 1.9800928258151274e-11
in O 0 3.264005038472462e-11
293 O 0 2.676882049357232e-09
cells O 0 3.076185417505428e-10
and O 0 1.0216769652515723e-09
in O 0 1.1331308336082202e-08
HeLa O 0 0.00011013807670678943
cells O 0 1.772447006942457e-07
. O 0 7.885058295187264e-08

Furthermore O 0 1.224405082211888e-06
, O 0 1.336938204588023e-08
at O 0 2.671420773481259e-08
4 O 0 5.0437214405008035e-09
degrees O 0 4.8130214480579525e-08
C O 0 7.527778507210314e-07
, O 0 1.9025567232766605e-10
the O 0 4.713078260998316e-10
added O 0 4.768662131837687e-10
soluble O 0 4.843343948124357e-09
complex O 0 4.4324412584728634e-08
of O 0 1.9941995788030908e-07
HFE O 1 0.9999865293502808
/ O 0 5.243855866865488e-06
beta2m O 0 3.0561866424250184e-06
inhibited O 0 1.3062571468935857e-08
binding O 0 1.0189238786040278e-08
of O 0 5.5463086567897335e-08
transferrin O 0 3.0929948025004705e-07
to O 0 8.677499607756545e-09
HeLa O 0 2.3443015379598364e-05
cell O 0 4.418943717610091e-07
TfR O 0 1.381776883135899e-06
in O 0 1.2159704354530732e-09
a O 0 4.117851337692713e-10
concentration O 0 7.736545626357838e-08
- O 0 1.2492029100030777e-07
dependent O 0 7.970640147902941e-09
manner O 0 2.3398708037802862e-07
. O 0 2.8343173141820444e-08

Scatchard O 0 1.1572956282179803e-05
plots O 0 3.4478173915886146e-07
of O 0 1.3503419893368118e-07
these O 0 3.000452664103648e-10
data O 0 1.7147572251019483e-09
indicate O 0 3.425409123014589e-10
that O 0 8.07999587376651e-12
the O 0 9.755048990811588e-10
added O 0 1.0658731675050603e-09
heterodimer O 0 5.349431120293957e-08
substantially O 0 1.4680222593099757e-09
reduced O 0 9.162814396113106e-10
the O 0 1.6375620304209804e-10
affinity O 0 4.197515113268935e-10
of O 0 4.952435350702444e-09
TfR O 0 1.8521180891184486e-06
for O 0 3.510617130331184e-09
transferrin O 0 1.8128098417946603e-06
. O 0 1.2058129073011514e-07

These O 0 3.2780850034441755e-08
results O 0 1.3476038063231499e-08
establish O 0 8.334538392773538e-09
a O 0 7.803703794273531e-10
molecular O 0 5.091151678016104e-08
link O 0 1.2412340488765494e-08
between O 0 2.897349027364271e-09
HFE O 0 0.16437377035617828
and O 0 7.880348817934646e-09
a O 0 1.327599141731639e-09
key O 0 1.3097298356967713e-08
protein O 0 1.543485450561377e-09
involved O 0 1.3533189013870128e-09
in O 0 1.6501859878559344e-09
iron O 0 2.2081787847128e-06
transport O 0 6.698653720604852e-08
, O 0 7.240051336232511e-10
the O 0 2.0449264503952236e-09
TfR O 0 2.948114797618473e-06
, O 0 3.0948646423389903e-10
and O 0 2.1591549381749786e-10
raise O 0 4.561550859261132e-10
the O 0 3.988084307238182e-10
possibility O 0 1.3904019047217275e-09
that O 0 7.463999904255836e-12
alterations O 0 8.095480730219151e-09
in O 0 2.167704765687617e-10
this O 0 6.914297693422222e-12
regulatory O 0 6.699465981974129e-10
mechanism O 0 1.0336044020675672e-08
may O 0 6.715483169550396e-10
play O 0 3.764159206554041e-09
a O 0 1.7011524133803135e-10
role O 0 2.4150917377063763e-10
in O 0 8.701638715136184e-11
the O 0 1.2196892384963576e-09
pathogenesis O 0 8.941198029788211e-05
of O 0 0.0002975925162900239
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.3867525012756232e-06
. O 0 2.549010105212801e-07

Genomic O 0 1.4470666656052344e-06
organization O 0 8.039964427553059e-08
of O 0 1.0525965876695409e-07
the O 0 1.2038032082273276e-07
UBE3A O 1 0.9999886751174927
/ O 0 7.4940367085218895e-06
E6 O 0 0.0007326147169806063
- O 0 2.876909775295644e-06
AP O 0 2.7461948775453493e-05
gene O 0 5.866955810063246e-09
and O 0 4.343009285534549e-10
related O 0 2.641290031135668e-08
pseudogenes O 0 3.0336068448377773e-06
. O 0 1.2277334349164448e-07

The O 0 1.0253367690893356e-05
UBE3A O 0 0.01717807725071907
gene O 0 8.511483429174405e-08
encodes O 0 8.505717907780763e-09
the O 0 1.2636214741235108e-08
E6 O 0 0.00010512638982618228
- O 0 2.9347597774176393e-06
AP O 0 1.1810768228315283e-05
ubiquitin O 0 1.80337963229249e-07
- O 0 4.959129995540934e-08
protein O 0 5.508822842337224e-10
ligase O 0 1.3401423970549331e-08
and O 0 1.753326817066636e-09
has O 0 8.022764397264126e-11
recently O 0 5.09770503587248e-10
been O 0 3.7006200187539307e-11
shown O 0 1.5104808029353656e-11
to O 0 1.5504472705707428e-11
be O 0 8.514052657337956e-11
mutated O 0 1.3052751057784917e-07
in O 0 3.793293217313476e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 6.697580374748213e-07
who O 0 4.393811536829162e-09
lack O 0 2.139724983862834e-07
15q11 O 0 8.982996951090172e-05
- O 0 1.0412490155431442e-05
q13 O 0 4.87754596179002e-06
deletions O 0 2.530056804062042e-07
or O 0 1.0115851267755716e-07
chromosome O 0 7.126015475478198e-07
15 O 0 1.2555501598399132e-06
paternal O 0 2.7311616577208042e-05
uniparental B-Disease 1 0.9798134565353394
disomy I-Disease 0 0.41901111602783203
. O 0 2.561819883339922e-06

Previous O 0 2.1871199351153336e-05
UBE3A O 0 0.001262869918718934
cDNA O 0 2.0548237955608784e-07
analysis O 0 6.82130485429866e-09
has O 0 1.0640505837544723e-10
shown O 0 1.4191121888718072e-10
a O 0 2.07401665286433e-10
coding O 0 1.5202523684365588e-08
region O 0 9.915932963622254e-09
of O 0 1.2612978217418913e-08
approximately O 0 4.413348353438096e-09
2 O 0 9.659980548804015e-08
. O 0 3.133278880795842e-08

6 O 0 3.3567968785064295e-05
kb O 0 3.0621082260040566e-05
and O 0 3.9903021331610944e-08
a O 0 1.5658201846235897e-08
3 O 0 1.3531420961498952e-07
- O 0 6.087258270781604e-07
untranslated O 0 0.0004642672720365226
region O 0 4.8619039461073044e-08
( O 0 2.0456518701195137e-09
UTR O 0 0.0015447703190147877
) O 0 6.182546141708656e-10
of O 0 1.273388861022795e-08
< O 0 3.5262416986370226e-08
50 O 0 1.0027195074258088e-08
bp O 0 2.3049608444125624e-08
, O 0 1.708830438262865e-10
whereas O 0 2.7351182430024323e-10
Northern O 0 9.342251416910585e-10
analysis O 0 4.9294263115839954e-11
has O 0 2.926927580512717e-12
indicated O 0 1.1062766154534831e-11
mRNA O 0 5.879855630164244e-11
sizes O 0 2.594234826958086e-10
of O 0 3.1091311747388772e-09
5 O 0 1.3822532451968073e-08
- O 0 9.502926445748017e-08
8 O 0 1.1624556606193437e-07
kb O 0 3.753608325496316e-06
. O 0 3.977892859552412e-08

We O 0 2.395884202144316e-08
have O 0 4.9763675818992326e-11
analyzed O 0 4.475840253981289e-10
additional O 0 1.9246529370242627e-10
cDNA O 0 1.722523812475174e-08
clones O 0 3.8599132778927014e-08
and O 0 3.0660457506215266e-10
provide O 0 3.7713488582058474e-11
evidence O 0 4.296286104654712e-10
for O 0 3.019781993907067e-11
an O 0 8.367578331613945e-12
additional O 0 2.2744839345278933e-10
0 O 0 1.591880405271695e-08
. O 0 5.312447814986854e-09

5 O 0 2.8226295398781076e-06
kb O 0 4.223054929752834e-06
of O 0 8.615146498414106e-07
5 O 0 2.2441669500494754e-07
- O 0 4.602122771757422e-07
UTR O 0 0.00013657768431585282
and O 0 9.360288544257855e-09
> O 0 9.084683227911228e-09
2 O 0 8.165714326935358e-09
kb O 0 2.0918413667914137e-07
of O 0 5.767413213675354e-08
3 O 0 3.8372610333681223e-07
- O 0 2.814839490383747e-06
UTR O 1 0.5878432989120483
. O 0 2.4366173079215514e-07

We O 0 2.04431493955326e-08
have O 0 6.733576890516346e-11
established O 0 6.576066913233092e-10
the O 0 1.1765728669121955e-10
genomic O 0 1.0843755893219509e-09
organization O 0 3.274896132055005e-09
of O 0 2.180562042042311e-08
UBE3A O 0 0.002545436844229698
and O 0 2.545874400183834e-09
the O 0 3.8193159745958383e-10
sequence O 0 4.13396816778544e-10
of O 0 6.118568318669304e-09
intron O 0 1.0894240176639869e-06
- O 0 2.138118816219503e-06
exon O 0 1.5980612033672514e-06
borders O 0 4.596148528435151e-08
. O 0 3.263872727643502e-08

We O 0 7.23743411867872e-08
have O 0 3.6647429535463516e-10
also O 0 2.527747733349628e-10
mapped O 0 6.2816720713954055e-09
two O 0 1.5345609505335034e-10
highly O 0 3.786163826902111e-09
homologous O 0 2.437184676296056e-09
processed O 0 3.4628563128080714e-08
pseudogenes O 0 2.7255813961346576e-07
, O 0 6.006109831702133e-09
UBE3AP1 O 0 0.027708854526281357
and O 0 6.037018351889856e-08
UBE3AP2 O 1 0.9895477294921875
, O 0 2.9874400730989237e-09
to O 0 2.6981586409569047e-10
chromosomes O 0 4.31030516834241e-10
2 O 0 5.116156387430237e-09
and O 0 2.899824547153429e-10
21 O 0 5.159372484797586e-09
, O 0 5.810133971162479e-11
respectively O 0 6.108349936972957e-10
, O 0 1.8851449914980556e-11
and O 0 7.296469678452766e-11
determined O 0 1.309434338736537e-09
their O 0 2.3465596132865585e-09
genomic O 0 1.5997446212168143e-07
organization O 0 5.927868684807436e-08
. O 0 3.3935606325030676e-08

These O 0 2.724031844536512e-08
results O 0 1.0509953796145055e-08
will O 0 2.2072653427240851e-10
form O 0 1.5617025728165146e-10
the O 0 5.0760565889484965e-11
basis O 0 1.1344135700253055e-11
for O 0 5.968776362920425e-13
studies O 0 1.6832514548870137e-11
of O 0 4.624597579883094e-11
mutation O 0 4.1123861260761174e-11
and O 0 1.574083224875622e-10
imprinting O 0 8.216366609303805e-07
of O 0 6.735121473866457e-07
UBE3A O 1 0.9997197985649109
. O 0 3.0783428428549087e-07

Mutation O 0 8.656977570353774e-07
spectrum O 0 1.3099768239044352e-06
and O 0 1.3654565478304903e-08
genotype O 0 4.6645266138511943e-07
- O 0 3.728690103343979e-07
phenotype O 0 1.5631345107181005e-08
analyses O 0 2.2857806314391382e-08
in O 0 1.1763026108724262e-08
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9972376823425293
and O 0 3.0958779007050907e-07
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.4656937824829583e-08
two O 0 9.906239739621014e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 0.9999995231628418
with O 0 8.173233254638035e-06
germline O 1 0.9999872446060181
PTEN O 1 1.0
mutation O 0 9.100162060349248e-06
. O 0 3.7983471656843903e-07

The O 0 4.806627202924574e-06
tumour B-Disease 1 0.9999998807907104
suppressor O 0 4.995709969080053e-05
gene O 0 1.3210697034082841e-06
PTEN O 0 0.03086518496274948
, O 0 3.3977363145254458e-09
which O 0 6.358488735536127e-11
maps O 0 6.369249128113097e-09
to O 0 3.0159861275080857e-09
10q23 O 0 1.8265582184540108e-05
. O 0 1.1976929670254322e-07

3 O 0 2.2561678179044975e-06
and O 0 8.97372398611651e-09
encodes O 0 8.174718124642766e-10
a O 0 3.791227887184334e-10
403 O 0 1.546001549002085e-09
amino O 0 7.492048648138905e-10
acid O 0 1.1990404225059592e-09
dual O 0 2.1417689843872267e-09
specificity O 0 7.2334565004439355e-09
phosphatase O 0 9.292930940318911e-07
( O 0 3.420938199383272e-09
protein O 0 2.5274211612469344e-09
tyrosine O 0 6.526365581294158e-08
phosphatase O 0 1.37978190650756e-06
; O 0 2.723391512304829e-09
PTPase O 0 7.805780114722438e-06
) O 0 2.0333972006181256e-10
, O 0 5.904501193532141e-11
was O 0 1.6051912021808334e-09
shown O 0 4.582007828712875e-10
recently O 0 4.905240102992536e-10
to O 0 4.899197367236319e-11
play O 0 8.204463775030035e-09
a O 0 7.423430203878922e-10
broad O 0 5.675353076384226e-09
role O 0 3.295291373106579e-09
in O 0 6.443664268829252e-09
human O 0 8.721440991621421e-08
malignancy B-Disease 0 0.0041129086166620255
. O 0 5.857711471435323e-08

Somatic O 0 0.0024842089042067528
PTEN O 1 0.940881609916687
deletions O 0 6.831789960415335e-06
and O 0 2.3648439650969522e-07
mutations O 0 2.217606365206848e-08
were O 0 4.008455345427819e-09
observed O 0 6.5062413234784344e-09
in O 0 6.712576050560415e-10
sporadic B-Disease 0 4.171598902757978e-06
breast I-Disease 0 0.006139017175883055
, I-Disease 0 4.878112846995464e-08
brain I-Disease 1 0.9999997615814209
, I-Disease 0 1.0944600035145413e-06
prostate I-Disease 1 1.0
and I-Disease 1 0.9930585622787476
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.005905154161155224
lines O 0 3.079364887526026e-07
and O 0 1.5280892107227828e-09
in O 0 2.7148946979416166e-10
several O 0 1.2698059270732642e-09
primary O 0 1.3208493783167796e-06
tumours B-Disease 1 1.0
such O 0 1.770162505465578e-08
as O 0 2.58284302390166e-07
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 1 0.9999953508377075
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.00015558219456579536

In O 0 1.576823080995382e-07
addition O 0 4.496654781860343e-08
, O 0 1.978725272522297e-08
PTEN O 1 0.8088745474815369
was O 0 2.2033647439911874e-07
identified O 0 2.75247358239028e-09
as O 0 2.021039585686779e-10
the O 0 4.560602728798102e-10
susceptibility O 0 2.7273955538476002e-08
gene O 0 1.6542577307987472e-09
for O 0 4.759311833524293e-10
two O 0 1.6964817106668306e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.01739412029201e-08
CD B-Disease 1 1.0
; O 0 1.066142445438345e-07
MIM O 1 0.9983338713645935
158350 O 0 7.694135274505243e-05
) O 0 1.6785786094430932e-09
and O 0 5.831100047259952e-09
Bannayan B-Disease 0 0.11820587515830994
- I-Disease 0 0.0002415630588075146
Zonana I-Disease 1 0.9979653358459473
( I-Disease 0 1.5141469589252665e-07
BZS I-Disease 1 0.999492883682251
) I-Disease 0 1.2466745857864225e-08
or I-Disease 0 1.4110407953182857e-08
Ruvalcaba I-Disease 0 8.12349098850973e-05
- I-Disease 0 3.7029938539490104e-05
Riley I-Disease 0 0.0038863883819431067
- I-Disease 1 0.9488303065299988
Smith I-Disease 1 0.9839787483215332
syndrome I-Disease 1 0.9999997615814209
( O 0 1.09665108993795e-06
MIM O 1 1.0
153480 O 1 0.9966206550598145
) O 0 4.6640234785400025e-08
. O 0 5.345228970554672e-08

Constitutive O 0 1.5693291061325e-05
DNA O 0 2.9158284178265603e-06
from O 0 2.115304198468948e-08
37 O 0 8.943517570969561e-08
CD B-Disease 0 4.7057183110155165e-05
families O 0 1.4070590526049642e-10
and O 0 8.158907993660591e-10
seven O 0 6.948788211502688e-09
BZS B-Disease 0 0.0006250740843825042
families O 0 2.1000098882062446e-10
was O 0 9.233697362276416e-09
screened O 0 2.398298271089061e-08
for O 0 1.3591114012001526e-08
germline O 0 3.504085907479748e-05
PTEN O 1 0.8792682886123657
mutations O 0 1.626211087568663e-06
. O 0 3.905726373432117e-07

PTEN O 0 0.02749447338283062
mutations O 0 1.5964998567596922e-07
were O 0 1.726303011650998e-08
identified O 0 2.991043190903042e-09
in O 0 9.526275324134303e-10
30 O 0 1.2272056704176748e-09
of O 0 5.659873014707273e-09
37 O 0 9.408831935786566e-09
( O 0 1.0326752647449311e-10
81 O 0 2.0020690882915915e-08
% O 0 4.6978899936878094e-11
) O 0 4.1018424767891304e-11
CD B-Disease 0 3.531177208060399e-05
families O 0 5.278092546356916e-11
, O 0 7.461739559566638e-11
including O 0 1.155051831958076e-09
missense O 0 1.074358806363307e-07
and O 0 1.8973691950918692e-08
nonsense O 0 3.4779893667291617e-06
point O 0 8.487765512654732e-08
mutations O 0 3.605286513774786e-09
, O 0 4.333708669701508e-10
deletions O 0 2.8725834155807206e-08
, O 0 2.028792023267556e-09
insertions O 0 1.0831279695366902e-07
, O 0 2.658990361226188e-09
a O 0 1.1295913093789522e-09
deletion O 0 5.274085168593956e-08
/ O 0 2.1034600194980158e-07
insertion O 0 2.552731537264208e-08
and O 0 1.0424644258932858e-08
splice O 0 2.444656092848163e-05
site O 0 3.0304695428640116e-06
mutations O 0 5.634304898194387e-07
. O 0 1.870306647333564e-07

These O 0 4.339511150419639e-08
mutations O 0 1.5305957390410185e-08
were O 0 5.485109255687348e-09
scattered O 0 6.46030500206507e-08
over O 0 1.5365503314157536e-09
the O 0 5.639783084987471e-10
entire O 0 1.9934678352484525e-09
length O 0 2.3406668270276043e-10
of O 0 1.2854291853159339e-08
PTEN O 0 0.0032817129977047443
, O 0 1.0200920108616174e-09
with O 0 4.588836255425832e-11
the O 0 2.5696264560615134e-10
exception O 0 1.545670536007293e-10
of O 0 2.86444601371727e-09
the O 0 7.714759386878711e-10
first O 0 5.519468881942657e-09
, O 0 5.474090625234851e-10
fourth O 0 1.413986154830127e-07
and O 0 4.1485197499468995e-09
last O 0 6.930525131565446e-08
exons O 0 1.9357053133717272e-06
. O 0 1.0688035700923137e-07

A O 0 6.80733792250976e-05
hot O 0 7.638654642505571e-05
spot O 0 2.028760036409949e-06
for O 0 7.480686292637984e-09
PTEN O 0 8.01069472800009e-05
mutation O 0 5.035877492787222e-09
in O 0 2.3374513435925337e-09
CD B-Disease 0 0.011674201115965843
was O 0 1.287605755351251e-08
identified O 0 2.75178962949596e-10
in O 0 2.469691950945929e-10
exon O 0 8.960880037989227e-09
5 O 0 2.692905676227042e-09
that O 0 1.1234043209573663e-11
contains O 0 5.852390239091676e-10
the O 0 1.5592924729190827e-09
PTPase O 0 1.563379555591382e-05
core O 0 1.8558168903837213e-06
motif O 0 3.163792072768956e-08
, O 0 1.726090381737322e-10
with O 0 1.6492718649119276e-11
13 O 0 1.5348835535888838e-09
of O 0 8.979199606073962e-10
30 O 0 4.793191399343755e-10
( O 0 5.738523892184766e-11
43 O 0 1.3650833796674533e-09
% O 0 1.4071820098049415e-11
) O 0 3.133859838300168e-11
CD B-Disease 0 0.0003630745050031692
mutations O 0 2.3803505833086547e-09
identified O 0 9.88062409668089e-10
in O 0 4.504762673995799e-10
this O 0 3.787902769225582e-10
exon O 0 7.856907586756279e-07
. O 0 3.842695051048395e-08

Seven O 0 1.7724955796438735e-06
of O 0 3.5674139553520945e-07
30 O 0 2.4163616885175543e-08
( O 0 5.826794602370455e-10
23 O 0 1.4675721971002531e-08
% O 0 1.6618933659784396e-11
) O 0 3.5856677869927633e-12
were O 0 4.2724386528636416e-11
within O 0 4.3960560192068954e-10
the O 0 1.6742874864306145e-09
core O 0 9.028956924339582e-07
motif O 0 2.6483524706577555e-08
, O 0 9.934797429167475e-11
the O 0 1.6687966286621503e-10
majority O 0 7.893063806718725e-12
( O 0 1.202729235649791e-11
five O 0 1.7709779476238197e-10
of O 0 3.5834444300775203e-09
seven O 0 2.9196109974094497e-09
) O 0 3.583030747100757e-11
of O 0 1.168765306758246e-09
which O 0 1.174176311735664e-10
were O 0 1.9091408454130487e-09
missense O 0 1.808750198506459e-07
mutations O 0 1.0403271133441194e-08
, O 0 2.1905990355008953e-09
possibly O 0 2.494563489108259e-08
pointing O 0 1.9919637495036113e-08
to O 0 3.393272329788033e-10
the O 0 7.159592918526414e-10
functional O 0 2.0329018468601134e-09
significance O 0 2.8102751237213397e-09
of O 0 4.104906192736735e-09
this O 0 2.467102633296747e-10
region O 0 2.4533138187621262e-08
. O 0 2.8646006455801398e-08

Germline O 0 0.004060068167746067
PTEN O 0 0.33545321226119995
mutations O 0 2.488949064627377e-07
were O 0 2.078065364230497e-08
identified O 0 2.543054655745891e-09
in O 0 7.611380414829227e-10
four O 0 3.2874111766112435e-10
of O 0 1.3508103080539513e-08
seven O 0 1.1640893582409717e-08
( O 0 3.602328990659487e-10
57 O 0 2.759439965416277e-08
% O 0 1.3516285313208698e-10
) O 0 3.124079883676245e-10
BZS B-Disease 0 0.0022717025130987167
families O 0 1.2635027468732574e-09
studied O 0 4.6777438456047093e-07
. O 0 5.54557857412874e-08

Interestingly O 0 2.4612709239590913e-06
, O 0 1.2910461144599594e-08
none O 0 2.2679609301690107e-09
of O 0 2.176231639339221e-09
these O 0 9.252569543871658e-11
mutations O 0 1.3494345640907568e-09
was O 0 5.4401505522605476e-09
observed O 0 2.343187421871562e-09
in O 0 1.0384274551356043e-09
the O 0 1.4325209463095234e-08
PTPase O 0 0.00016375735867768526
core O 0 4.298640851629898e-05
motif O 0 2.262787120344001e-06
. O 0 7.452121764117692e-08

It O 0 3.516368707323636e-08
is O 0 5.448881901237712e-10
also O 0 8.653425198623665e-11
worthy O 0 1.4419510030450056e-08
of O 0 1.9723085387113315e-08
note O 0 1.0218894619384855e-09
that O 0 9.072876998306167e-12
a O 0 1.7415406616816398e-10
single O 0 2.0252930443831474e-09
nonsense O 0 3.833990547263966e-08
point O 0 2.8901683268856004e-09
mutation O 0 3.003527426770347e-10
, O 0 2.0618681761952473e-10
R233X O 0 2.6490249638300156e-07
, O 0 6.210083558499946e-10
was O 0 5.337116970594025e-09
observed O 0 6.883697500903452e-10
in O 0 1.0819021373231763e-10
the O 0 3.189289665694872e-10
germline O 0 1.878496824758713e-08
DNA O 0 3.4277196192533665e-08
from O 0 5.67511204696558e-10
two O 0 2.2550453171454876e-10
unrelated O 0 1.830384732670609e-08
CD B-Disease 0 0.4281178414821625
families O 0 1.9504850512497285e-10
and O 0 2.7066597851899132e-09
one O 0 1.1221532147942526e-08
BZS B-Disease 1 0.9981574416160583
family O 0 2.9199310347394203e-07
. O 0 1.876023105751301e-07

Genotype O 0 2.0667426724685356e-05
- O 0 2.0145084818068426e-06
phenotype O 0 2.660630471496006e-08
studies O 0 1.4873452469643667e-09
were O 0 1.6940872316073552e-10
not O 0 1.0017277805862701e-11
performed O 0 9.728037930756273e-09
on O 0 8.864098899330486e-10
this O 0 5.059901716369941e-12
small O 0 1.3027846856861203e-10
group O 0 1.0786512794069836e-09
of O 0 3.1328845295774954e-08
BZS B-Disease 1 0.9998931884765625
families O 0 1.2723328168817716e-08
. O 0 5.836344030285545e-08

However O 0 1.3000213527902815e-07
, O 0 6.0435025872607184e-09
genotype O 0 5.396438851335006e-08
- O 0 5.2652101345529445e-08
phenotype O 0 4.948327969600541e-09
analysis O 0 2.01626626505913e-09
inthe O 0 7.200017648756329e-07
group O 0 2.0834578506878643e-09
of O 0 2.7887578468721586e-08
CD B-Disease 1 0.999866247177124
families O 0 1.173213887151192e-10
revealed O 0 2.6772088990156817e-09
two O 0 2.1809914985126966e-11
possible O 0 1.2011136529821442e-10
associations O 0 4.53414861212309e-10
worthy O 0 6.87369308138841e-08
of O 0 6.486282444484459e-08
follow O 0 1.179146469354464e-08
- O 0 3.332013420731528e-08
up O 0 1.7292745013719468e-09
in O 0 2.536112153617154e-10
independent O 0 5.203992792246481e-10
analyses O 0 8.493255165831215e-08
. O 0 1.936641069733014e-08

The O 0 2.8883357572340174e-07
first O 0 3.574476181711361e-08
was O 0 3.225662936756635e-08
an O 0 2.133568460793711e-10
association O 0 9.580470639036776e-09
noted O 0 7.34632632504173e-10
in O 0 2.2094641394243553e-10
the O 0 1.7172970823153832e-09
group O 0 7.530242540632059e-10
of O 0 1.2017014938692228e-08
CD B-Disease 1 0.9999936819076538
families O 0 2.42145248297021e-10
with O 0 2.88074240017977e-08
breast B-Disease 1 1.0
disease I-Disease 1 0.9999910593032837
. O 0 1.8195616746652377e-07

A O 0 3.7593576962535735e-06
correlation O 0 1.9226442660169596e-08
was O 0 1.563695306572299e-08
observed O 0 1.353182121910379e-09
between O 0 5.79866397953932e-11
the O 0 3.8027933579876105e-10
presence O 0 1.165017304849414e-09
/ O 0 6.00079914647722e-08
absence O 0 1.5376212303408465e-08
of O 0 1.568016827491192e-08
a O 0 2.7350779419066384e-09
PTEN O 0 0.025203172117471695
mutation O 0 2.1631874069782953e-09
and O 0 2.239913254875603e-10
the O 0 5.310125117397035e-10
type O 0 6.919417216977308e-08
of O 0 2.4435594241367653e-06
breast O 0 0.011752859689295292
involvement O 0 3.0016121854714584e-07
( O 0 9.248132926131802e-09
unaffected O 0 1.9554133814381203e-06
versus O 0 9.818120815907605e-06
benign O 0 0.009301726706326008
versus O 0 0.00017402270168531686
malignant O 1 0.976975679397583
) O 0 3.038216433992602e-08
. O 0 4.494759764384071e-08

Specifically O 0 2.385292532380845e-07
and O 0 5.893042498428258e-09
more O 0 1.5670785849519753e-11
directly O 0 4.967948830092439e-10
, O 0 9.527105493400967e-11
an O 0 5.5368716556092323e-11
association O 0 1.552965223083902e-08
was O 0 1.0369514136243652e-08
also O 0 4.900253119943798e-11
observed O 0 9.017862845350777e-11
between O 0 1.3514267829806137e-11
the O 0 3.539193590973433e-11
presence O 0 6.577643985039572e-11
of O 0 1.635412139044945e-09
a O 0 4.390778851615096e-09
PTEN O 1 0.9999971389770508
mutation O 0 1.7905798586070887e-06
and O 0 1.5684343452448957e-05
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.611790581700916e-07

Secondly O 0 1.6022018826333806e-05
, O 0 4.5271193016560574e-08
there O 0 9.478824392061824e-10
appeared O 0 3.744417220730156e-09
to O 0 3.435830786546745e-11
be O 0 5.5217483363456665e-11
an O 0 1.1412679135069936e-10
interdependent O 0 1.2995792531000916e-06
association O 0 3.061403504034388e-07
between O 0 2.4874411863606838e-08
mutations O 0 1.5837791522699263e-08
upstream O 0 3.1262587185665325e-08
and O 0 3.4649290103772046e-09
within O 0 5.991167117969098e-09
the O 0 8.665243633743103e-09
PTPase O 0 6.67032873025164e-05
core O 0 5.999058885208797e-06
motif O 0 6.090196080776877e-08
, O 0 3.9682193642143204e-10
the O 0 5.893208143703532e-10
core O 0 6.636352622990671e-08
motif O 0 3.4662444026167805e-09
containing O 0 1.008973238292299e-09
the O 0 1.8649255750791127e-10
majority O 0 7.477721566950812e-12
of O 0 6.124660223427725e-10
missense O 0 2.223103301446372e-08
mutations O 0 3.450485897005251e-09
, O 0 1.6262887703177853e-09
and O 0 1.741272459554466e-09
the O 0 3.18935855503355e-09
involvement O 0 4.069886649915588e-09
of O 0 1.247319136865599e-08
all O 0 6.18346651659607e-10
major O 0 1.3764683615136164e-07
organ O 1 0.999970555305481
systems O 1 0.9999884366989136
( O 0 1.8130573664620897e-07
central O 0 0.005736044142395258
nervous O 0 0.00023302318004425615
system O 0 0.0016527214320376515
, O 0 2.658829998836154e-06
thyroid O 1 1.0
, O 0 8.70002531883074e-06
breast O 1 1.0
, O 0 4.44126344518736e-05
skin O 1 1.0
and O 1 0.9999958276748657
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 2.1110977286298294e-06
. O 0 1.522273919363215e-06

However O 0 1.6249416034952446e-07
, O 0 9.106433940253567e-10
these O 0 5.405526720680953e-11
observations O 0 7.53845164069844e-09
would O 0 4.942088405179845e-11
need O 0 4.395316055560983e-11
to O 0 5.973429390015994e-11
be O 0 3.3306423591339396e-11
confirmed O 0 1.4482835763995894e-10
by O 0 3.0000561063170395e-11
studying O 0 1.5073798875775424e-09
a O 0 2.837948279155178e-11
larger O 0 2.637334101107669e-11
number O 0 8.793789307848243e-11
of O 0 6.795903839673656e-09
CD B-Disease 0 0.002363729989156127
families O 0 1.7001866581267677e-09
. O 0 1.4514652590946753e-08

Molecular O 1 0.9998716115951538
defects O 1 0.9999979734420776
leading O 0 2.610680667203269e-06
to O 0 3.5361340522399587e-09
human O 0 2.1373260494783608e-08
complement B-Disease 0 5.32754120285972e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.304561761538707e-09
an O 0 1.641780877914556e-10
African O 0 6.0675611202043456e-09
- O 0 4.5214235910862044e-08
American O 0 1.7009270436574297e-08
family O 0 3.950354265924716e-09
. O 0 1.6014398696029275e-08

Complement B-Disease 0 0.00020246447820682079
component I-Disease 1 0.9999980926513672
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.038290460859571e-07
C6D B-Disease 1 1.0
) O 0 5.449466211615572e-09
was O 0 8.761924874534088e-08
diagnosed O 0 1.4095915901179978e-07
in O 0 5.072778308523596e-10
a O 0 4.754548421637139e-10
16 O 0 1.9262012429521747e-08
- O 0 2.7614143860432705e-08
year O 0 2.8862461309842047e-09
- O 0 1.205220740985169e-07
old O 0 2.3165131324276445e-07
African O 0 7.837120286069421e-09
- O 0 1.5276935272368064e-08
American O 0 5.826141791231976e-09
male O 0 4.506466311227086e-09
with O 0 2.0180754845000592e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.629671970704294e-07

The O 0 8.02519309672789e-07
patients O 0 1.8357310693772888e-07
father O 0 1.7117885420248058e-07
and O 0 8.083337554865011e-09
two O 0 7.925449629908599e-09
brothers O 0 6.88517411617795e-06
also O 0 1.1918472431204918e-08
had O 0 6.659644924411623e-08
C6D B-Disease 1 1.0
, O 0 3.1462066285570245e-09
but O 0 2.996870807070451e-11
gave O 0 4.2029307811830563e-10
no O 0 9.098806430518636e-11
history O 0 6.934965046667685e-09
of O 0 4.289065032025974e-07
meningitis B-Disease 1 1.0
or O 0 6.9267294122710155e-09
other O 0 4.906377171209897e-08
neisserial B-Disease 1 0.9999971389770508
infection I-Disease 0 0.05349351465702057
. O 0 2.1948123674064846e-07

By O 0 1.677299366065199e-08
using O 0 5.348530507376381e-09
exon O 0 5.574104733341301e-08
- O 0 9.939374656653399e-09
specific O 0 7.244260052940987e-11
polymerase O 0 3.809409232502503e-09
chain O 0 4.118748897496971e-09
reaction O 0 5.092787858096415e-10
( O 0 2.561708623005643e-10
PCR O 0 2.7033030391976354e-07
) O 0 3.1583322068762243e-10
/ O 0 8.265090833958766e-09
single O 0 1.787444414702577e-09
- O 0 2.6109350237391027e-09
strand O 0 1.162766216644684e-09
conformation O 0 3.4303845874994465e-10
polymorphism O 0 2.1629387170207792e-10
as O 0 2.359248733874164e-11
a O 0 1.2562875219279679e-11
screening O 0 3.9464434498093226e-10
step O 0 1.0539874528703308e-10
and O 0 1.571949341527823e-11
nucleotide O 0 1.5261485131201624e-10
sequencing O 0 1.2984960884310226e-09
of O 0 2.606834526019952e-09
target O 0 2.3871660204122236e-09
exons O 0 3.5768156436688514e-08
, O 0 2.097115953114681e-10
we O 0 2.155323142183363e-11
determined O 0 1.8523334255338142e-10
that O 0 6.43945227002396e-12
the O 0 6.609957026171287e-10
proband O 0 1.9234717001381796e-06
was O 0 6.712259636998397e-09
a O 0 2.1323155741104216e-10
compound O 0 5.842455852445028e-09
heterozygote O 0 3.571968321125496e-08
for O 0 3.813274140895828e-10
two O 0 8.845357335474091e-09
C6 O 1 0.9999852180480957
gene O 0 1.1773428241212969e-06
mutations O 0 4.1639734149612195e-07
. O 0 2.330644122139347e-07

The O 0 3.229720277886372e-07
first O 0 6.484328451961119e-08
, O 0 7.061955464848779e-10
1195delC O 0 6.534399688007397e-08
located O 0 9.054221372650773e-09
in O 0 1.164119800556307e-09
exon O 0 7.354267950177018e-08
7 O 0 1.1512894815268737e-07
, O 0 6.712294609023672e-10
is O 0 2.9297942544248556e-11
a O 0 5.503211775170769e-11
novel O 0 3.979847007506976e-10
mutation O 0 1.5700532540741108e-10
, O 0 5.307409026156229e-11
while O 0 1.3166490120397611e-10
the O 0 4.715928758614041e-10
second O 0 6.853281497853914e-09
, O 0 1.9583432098180253e-10
1936delG O 0 3.57428540098681e-08
in O 0 1.8234496135249856e-09
exon O 0 6.077165437545773e-08
12 O 0 1.919500469682589e-08
, O 0 2.1174940967316758e-10
has O 0 8.069922334541513e-12
been O 0 5.1473166007287574e-11
described O 0 2.430591561353168e-10
before O 0 6.885759185060181e-10
to O 0 2.139775301390756e-10
cause O 0 7.905312315870106e-08
C6D B-Disease 1 0.9999961853027344
in O 0 3.4305953633406716e-09
an O 0 7.491744724585914e-11
unrelated O 0 3.714032459356531e-08
African O 0 2.5828521543758143e-08
- O 0 1.2428266416009137e-07
American O 0 1.2364233192840857e-08
individual O 0 1.378135272567249e-09
. O 0 1.5651274054562236e-08

Both O 0 9.586012339468652e-08
mutations O 0 4.991479940485988e-08
result O 0 1.4026634964636742e-08
in O 0 1.1674601729794176e-08
premature O 0 5.482789333655091e-07
termination O 0 1.007872697300627e-06
codons O 0 6.858959409328236e-07
and O 0 1.0255788396307253e-07
C6 O 0 0.49156415462493896
null O 0 3.0768273973080795e-06
alleles O 0 2.5449192975202095e-08
. O 0 1.7311235112060785e-08

Allele O 0 1.5925826346574468e-07
- O 0 6.62403536466627e-08
specific O 0 4.5311920882085133e-10
PCR O 0 2.728270374063868e-07
indicated O 0 1.3376568741563233e-09
that O 0 7.080507187506857e-12
the O 0 3.595690967195253e-10
probands O 0 9.212965892402281e-07
two O 0 2.6826116883427176e-09
brothers O 0 6.560412089129386e-07
also O 0 3.700221684610483e-09
inherited O 0 3.1060213245837076e-07
the O 0 4.1832766584093406e-08
1195delC O 0 5.739287303185847e-07
mutation O 0 1.0855200072157345e-09
from O 0 7.986020733596888e-10
their O 0 6.791546214302002e-10
heterozygous O 0 2.4985096214180658e-09
mother O 0 2.251320463386719e-09
and O 0 3.436959883362789e-10
the O 0 3.0913560600254186e-09
1936delG O 0 1.0761143443005494e-07
mutation O 0 2.0512770648739576e-10
from O 0 2.0811016798738535e-10
their O 0 5.764922428319608e-10
homozygous O 0 2.1226599145052205e-08
father O 0 1.236778786051218e-07
. O 0 5.173838690808452e-09
. O 0 4.2346709250296044e-08

PAX6 O 1 0.9996520280838013
mutations O 0 7.2176217145170085e-06
reviewed O 0 9.488231626164634e-06
. O 0 9.19605099625187e-07

Mutations O 0 1.1111769708804786e-06
in O 0 2.365258922054636e-07
PAX6 O 1 0.57938152551651
are O 0 1.6582191175729122e-09
responsible O 0 2.743559157636355e-08
for O 0 3.4097598078375313e-09
human O 0 7.909053323373882e-08
aniridia B-Disease 1 1.0
and O 0 8.482937907672294e-09
have O 0 3.795509045945167e-11
also O 0 3.713991614251455e-11
been O 0 2.1049653339821894e-11
found O 0 3.6476974218935254e-11
in O 0 8.017013441996568e-11
patients O 0 7.233232346415264e-10
with O 0 1.5754687554547786e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.39033960017332e-07
with O 1 0.9386382102966309
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 5.769371909991605e-06
with O 0 5.917069074712344e-07
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9999996423721313
keratitis I-Disease 1 1.0
, O 0 1.202871544592199e-07
and O 0 4.026142264024202e-08
with O 0 2.0555803814659157e-07
isolated B-Disease 1 0.9999995231628418
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 5.359211718314327e-05

No O 0 4.30294136322118e-07
locus O 0 3.542927373700877e-08
other O 0 2.537282883796621e-10
than O 0 8.907873050301163e-11
chromosome O 0 4.521524932243892e-09
11p13 O 0 2.205622706696886e-07
has O 0 1.7905760207881372e-10
been O 0 3.936520276415223e-10
implicated O 0 2.696196155227426e-08
in O 0 1.8223065723077525e-08
aniridia B-Disease 1 1.0
, O 0 1.898237833586336e-08
and O 0 1.188467102508639e-08
PAX6 O 1 0.9999957084655762
is O 0 7.231083731795707e-09
clearly O 0 2.229684215038219e-09
the O 0 1.2078317235264535e-09
major O 0 3.771728529500251e-08
, O 0 4.234763928412377e-10
if O 0 8.467892186059256e-12
not O 0 1.8062981665956102e-12
only O 0 7.958489769976929e-12
, O 0 1.3577083901594733e-10
gene O 0 3.427501837904856e-09
responsible O 0 7.987734562675541e-08
. O 0 8.99190624181756e-08

Twenty O 0 1.8961169189424254e-05
- O 0 4.934997832606314e-07
eight O 0 6.1572720255753666e-09
percent O 0 4.599108038849664e-10
of O 0 1.3599871229175164e-09
identified O 0 3.1138314149359303e-09
PAX6 O 0 0.054924964904785156
mutations O 0 1.5228120986421345e-08
are O 0 2.6679771725213186e-09
C O 0 0.00035860546631738544
- O 0 3.09127863147296e-05
T O 0 8.991404320113361e-05
changes O 0 7.720857730930675e-09
at O 0 1.0399644878589243e-07
CpG O 0 9.907710136758396e-07
dinucleotides O 0 1.0166351103180205e-06
, O 0 6.223541682004452e-10
20 O 0 5.538459135756568e-10
% O 0 3.382671096355261e-12
are O 0 1.3146301538688454e-12
splicing O 0 8.332218470741282e-09
errors O 0 1.0011076483351644e-06
, O 0 1.3047748437244877e-09
and O 0 2.93298274556264e-10
more O 0 5.775800844542989e-12
than O 0 1.236980483321215e-11
30 O 0 4.871376635406932e-10
% O 0 8.183133858030711e-12
are O 0 2.0549952798459836e-12
deletion O 0 5.792332724574578e-10
or O 0 5.317685736194733e-10
insertion O 0 2.098578555376207e-08
events O 0 8.039074828047887e-08
. O 0 9.224212504932439e-08

There O 0 1.1782408648741693e-07
is O 0 1.508127511762325e-09
a O 0 2.7434270410964245e-09
noticeably O 0 2.0513894583018555e-07
elevated O 0 7.350859618782124e-07
level O 0 1.644832181568745e-08
of O 0 4.44173942071302e-09
mutation O 0 1.1517556353091152e-10
in O 0 1.809210281589202e-10
the O 0 9.460653371817784e-10
paired O 0 1.8636958643014623e-09
domain O 0 1.8405706125879107e-10
compared O 0 1.3066245307946645e-10
with O 0 2.850610372751028e-11
the O 0 8.59633031424778e-10
rest O 0 9.952578317040661e-09
of O 0 5.2672062267333786e-09
the O 0 1.0993201904341277e-08
gene O 0 1.803994997828795e-08
. O 0 1.8576566063188693e-08

Increased O 0 6.840029698196304e-08
mutation O 0 5.3322128934496504e-09
in O 0 1.320424547479604e-09
the O 0 7.457176542935429e-10
homeodomain O 0 1.1921750342480664e-07
is O 0 3.51725558400684e-11
accounted O 0 1.7318723122272672e-09
for O 0 3.665244149853031e-11
by O 0 2.2329858795355761e-10
the O 0 1.3182761549046518e-08
hypermutable O 0 2.2692294805892743e-05
CpG O 0 7.592155725433258e-06
dinucleotide O 0 1.2111042906326475e-06
in O 0 2.0202397976731845e-08
codon O 0 3.65450716799387e-07
240 O 0 1.1384062759134395e-07
. O 0 1.8990707673083307e-08

Very O 0 2.5679833015601616e-07
nearly O 0 9.90640547371413e-09
all O 0 1.0185833287934543e-09
mutations O 0 9.791435440220653e-10
appear O 0 1.1316140247075168e-09
to O 0 4.6215223314938214e-10
cause O 0 2.4631553685594554e-08
loss O 0 2.6516991624703223e-07
of O 0 3.922284008694987e-08
function O 0 2.0939823486276765e-10
of O 0 2.3527173542703395e-09
the O 0 7.927243861338695e-10
mutant O 0 3.3491387441131337e-09
allele O 0 6.490678827741903e-11
, O 0 2.899579534809682e-11
and O 0 3.331417433583006e-11
more O 0 2.7211804858040534e-12
than O 0 6.426446180762824e-12
80 O 0 6.060976720512201e-10
% O 0 1.226930536335491e-11
of O 0 4.846317236406605e-10
exonic O 0 1.4319641650217818e-07
substitutions O 0 3.711971530151459e-08
result O 0 8.630441250545573e-09
in O 0 1.5892167581910144e-08
nonsense O 0 2.739554474828765e-06
codons O 0 1.5172041685218574e-06
. O 0 1.1425108681351048e-07

In O 0 1.9009958407423255e-07
a O 0 8.344846591512578e-09
gene O 0 1.3099314966069642e-09
with O 0 5.0934655798640094e-11
such O 0 1.1424444723573401e-09
extraordinarily O 0 1.3767021300736815e-07
high O 0 3.44938939633721e-07
sequence O 0 8.208012047816737e-10
conservation O 0 5.665378721708692e-10
throughout O 0 5.85237622252599e-11
evolution O 0 4.092700900404367e-10
, O 0 1.6472880351448005e-11
there O 0 8.428188702502837e-12
are O 0 9.94106706675435e-12
presumed O 0 1.26748611606331e-08
undiscovered O 0 1.020313266053563e-05
missense O 0 4.816694740839012e-07
mutations O 0 9.068133799416955e-09
, O 0 3.593229602749659e-10
these O 0 4.9912157740195084e-11
are O 0 2.4555149580329783e-11
hypothesized O 0 5.760602550530791e-10
to O 0 4.231451300462652e-11
exist O 0 3.2212882361548623e-10
in O 0 3.3924116293881923e-10
as O 0 2.868847603920699e-09
- O 0 3.536581161256436e-08
yet O 0 8.841540277693127e-10
unidentified O 0 9.74110836438058e-09
phenotypes O 0 7.707883753482747e-08
. O 0 9.999268080207457e-10
. O 0 1.1763721552426887e-08

Genetic O 0 6.668557489319937e-06
heterogeneity O 0 2.643069819896482e-06
and O 0 4.535511166636752e-08
penetrance O 0 3.220155520011758e-07
analysis O 0 4.5103965007342595e-09
of O 0 2.4254211083984956e-08
the O 0 2.247271702060516e-08
BRCA1 O 0 6.170471920086129e-07
and O 0 7.016153347194631e-08
BRCA2 O 0 1.8602379441290395e-06
genes O 0 1.0050957399698746e-08
in O 0 1.8413805946693174e-07
breast B-Disease 1 0.9999982118606567
cancer I-Disease 0 0.0216739010065794
families O 0 1.8927632794429883e-09
. O 0 2.9155501124478178e-08

The O 0 0.12388312816619873
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0003075570857618004
Consortium O 0 3.053395857932628e-06
. O 0 2.227858004744121e-07

The O 0 9.236624975983432e-08
contribution O 0 3.002242010552436e-08
of O 0 3.798441241542605e-07
BRCA1 O 0 1.5766170236020116e-06
and O 0 1.6438120553630142e-07
BRCA2 O 0 1.3517014849639963e-05
to O 0 9.403432841281756e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.4140160803654e-06
assessed O 0 3.35226566505753e-08
by O 0 3.1786137610900767e-10
linkage O 0 1.5783900408905538e-08
and O 0 1.750115191656576e-10
mutation O 0 3.8324565743153016e-11
analysis O 0 2.992843473048623e-11
in O 0 2.9777829507748876e-11
237 O 0 7.834202175871496e-10
families O 0 6.537366568221126e-12
, O 0 2.577365924849584e-11
each O 0 4.15459507074889e-12
with O 0 8.111670363186718e-11
at O 0 1.625867973586992e-08
least O 0 1.572888000400674e-11
four O 0 6.659725548807671e-11
cases O 0 1.7398639473586996e-10
of O 0 5.279596280161059e-07
breast B-Disease 1 1.0
cancer I-Disease 1 0.9089086651802063
, O 0 4.069675152429397e-10
collected O 0 7.466940399325495e-10
by O 0 4.831126054760659e-10
the O 0 1.990397095141816e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.0918043446727097e-05
Consortium O 0 1.1853734349642764e-06
. O 0 5.3732780003201697e-08

Families O 0 4.551393484319988e-09
were O 0 5.13498621401709e-09
included O 0 4.829378230652992e-09
without O 0 2.4467688986007374e-10
regard O 0 3.269414738937826e-10
to O 0 2.921853384241224e-11
the O 0 1.8163812121052558e-10
occurrence O 0 4.119678109759661e-08
of O 0 2.3151712866820162e-06
ovarian B-Disease 1 0.9973044395446777
or I-Disease 0 7.45840651461549e-08
other I-Disease 0 5.885485165890714e-07
cancers I-Disease 1 0.9999992847442627
. O 0 1.9291466912818578e-07

Overall O 0 0.00013643410056829453
, O 0 8.376023288292345e-07
disease O 0 0.0216849185526371
was O 0 1.2651123881823878e-07
linked O 0 6.387244155803273e-08
to O 0 1.0859113608319149e-09
BRCA1 O 0 1.685853234789647e-08
in O 0 7.163717952174409e-10
an O 0 1.4909936132956325e-11
estimated O 0 1.1434199941040557e-11
52 O 0 2.862631243161218e-10
% O 0 1.9629521532532612e-12
of O 0 1.7450585421130427e-10
families O 0 7.922097873536149e-12
, O 0 8.462439082812523e-11
to O 0 2.3503704538185843e-10
BRCA2 O 0 1.5205047887434375e-08
in O 0 1.0991036969443257e-09
32 O 0 1.7135671770418526e-09
% O 0 5.949956239509335e-12
of O 0 1.0520632975907773e-10
families O 0 5.804592483754645e-12
, O 0 7.311027477863163e-11
and O 0 1.4966701489260714e-10
to O 0 2.398506115941501e-10
neither O 0 3.292244477037798e-09
gene O 0 4.4331890936000207e-10
in O 0 2.8309754540600807e-10
16 O 0 2.4837372158970084e-09
% O 0 1.4106511965483737e-11
( O 0 7.134407214309801e-12
95 O 0 2.863534076524843e-09
% O 0 3.855470803726391e-11
confidence O 0 6.995385160024625e-09
interval O 0 1.395680016003098e-07
[ O 0 1.4012120175266318e-07
CI O 0 0.009673998691141605
] O 0 9.794264599349845e-08
6 O 0 2.8928225148661113e-08
% O 0 3.949588919804903e-11
- O 0 1.4537752113241709e-09
28 O 0 2.311466573701182e-09
% O 0 1.2168254251432309e-11
) O 0 7.646514497972046e-12
, O 0 2.320595104965406e-11
suggesting O 0 5.859751017744941e-10
other O 0 1.6485470766269827e-09
predisposition O 0 3.241410695409286e-06
genes O 0 8.67012488470209e-08
. O 0 1.8473502905180794e-07

The O 0 3.8379491229534324e-07
majority O 0 1.8295950310331932e-09
( O 0 5.297095539980035e-10
81 O 0 3.987099361779656e-08
% O 0 1.8978440347039438e-11
) O 0 7.097949832057804e-12
of O 0 2.2151955825222558e-09
the O 0 5.576262651629804e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.083374164995604e-11
were O 0 5.458701268779009e-10
due O 0 3.842341556037354e-09
to O 0 9.353929852906617e-10
BRCA1 O 0 6.752492964778867e-08
, O 0 4.5078052401947843e-10
with O 0 4.9371891991389916e-11
most O 0 2.158759560000334e-10
others O 0 5.036672190428249e-10
( O 0 1.444658420668432e-10
14 O 0 7.341119712123145e-09
% O 0 3.2167615793277093e-11
) O 0 2.3816060235049008e-11
due O 0 3.382121471773303e-09
to O 0 1.733138788040378e-08
BRCA2 O 0 1.524149593024049e-05
. O 0 1.8637329901594057e-07

Conversely O 0 2.5083338641707087e-06
, O 0 6.587016709858062e-09
the O 0 6.000083763169073e-10
majority O 0 9.23606070096783e-12
of O 0 2.4610583015949317e-10
families O 0 8.451353332439293e-12
with O 0 1.010671546453068e-10
male B-Disease 0 4.723934576844613e-09
and I-Disease 0 1.1249605691432407e-08
female I-Disease 0 1.066304662344919e-06
breast I-Disease 1 0.9999967813491821
cancer I-Disease 0 0.07228459417819977
were O 0 2.492114248298094e-08
due O 0 2.1627433000048768e-07
to O 0 1.543341987542135e-08
BRCA2 O 0 4.755192719585466e-07
( O 0 2.280349242766988e-09
76 O 0 1.9513807103521685e-07
% O 0 1.6970108651648275e-10
) O 0 5.059018759467904e-10
. O 0 1.0706068920285361e-08

The O 0 9.750868912306032e-07
largest O 0 1.9860991073983314e-07
proportion O 0 6.594697676831629e-09
( O 0 7.086189413030297e-10
67 O 0 1.2060689336124142e-08
% O 0 1.3001999650541496e-11
) O 0 4.2214855743016866e-12
of O 0 1.7052392831118368e-10
families O 0 2.2592620049083356e-12
due O 0 5.13739328855678e-10
to O 0 8.921050703714073e-11
other O 0 1.2025372364554698e-10
genes O 0 7.814304758824164e-11
was O 0 2.4074631177484207e-09
found O 0 7.232124621392444e-11
in O 0 2.340781735110653e-11
families O 0 1.261754806539117e-12
with O 0 9.314823218309343e-12
four O 0 3.3798561172027064e-10
or O 0 4.5284964667047234e-10
five O 0 5.897863308845785e-10
cases O 0 5.680115267026054e-10
of O 0 1.347003006912928e-07
female O 0 3.962350547226379e-06
breast B-Disease 1 0.9999991655349731
cancer I-Disease 0 0.02424631267786026
only O 0 7.66074492730695e-09
. O 0 4.59124187557336e-08

These O 0 3.662887593236519e-08
estimates O 0 1.4597109299074873e-08
were O 0 2.139772359299741e-09
not O 0 5.043937836846091e-11
substantially O 0 1.0282652507243029e-09
affected O 0 1.8330940931843287e-10
either O 0 5.612791828535357e-11
by O 0 4.422672297832442e-11
changing O 0 5.880677056424588e-10
the O 0 3.193837139203737e-10
assumed O 0 9.180324833657494e-10
penetrance O 0 1.0294785468545342e-08
model O 0 1.5088978677635367e-10
for O 0 9.92527032783741e-11
BRCA1 O 0 1.082024958520833e-08
or O 0 4.6419032506683777e-10
by O 0 2.342399885169044e-10
including O 0 3.109231982989513e-09
or O 0 5.089993759810341e-09
excluding O 0 4.966078108736838e-07
BRCA1 O 0 1.3751368896919303e-06
mutation O 0 1.8333336626596974e-08
data O 0 9.503107634145636e-08
. O 0 4.4049908609622435e-08

Among O 0 8.376760263217875e-08
those O 0 2.8155868747603563e-09
families O 0 2.0654539190090304e-10
with O 0 6.674585328880767e-09
disease O 0 0.00019920287013519555
due O 0 4.104822437511757e-08
to O 0 2.186032688200612e-09
BRCA1 O 0 3.890558275543299e-08
that O 0 5.0880865493097005e-11
were O 0 9.53447210072511e-10
tested O 0 1.4196056552506775e-09
by O 0 2.857344048867727e-11
one O 0 5.070154365793833e-11
of O 0 3.5748409787927926e-10
the O 0 9.262033501267197e-11
standard O 0 1.9720469701667298e-10
screening O 0 1.3520257136079294e-10
methods O 0 1.2524792314394517e-10
, O 0 1.93561538325282e-11
mutations O 0 3.5706142903491056e-11
were O 0 1.7788252815176264e-10
detected O 0 3.6295593197621656e-09
in O 0 1.9973107889814656e-10
the O 0 3.1620814300303834e-10
coding O 0 2.133333509846125e-09
sequence O 0 9.70312233339321e-11
or O 0 6.096486510065446e-11
splice O 0 2.0124289790146577e-08
sites O 0 1.819169814787358e-09
in O 0 2.2522557430182388e-10
an O 0 6.874217774871516e-12
estimated O 0 4.0097206804867724e-11
63 O 0 4.062015168670996e-09
% O 0 1.4416710013287481e-11
( O 0 5.14746370527952e-11
95 O 0 1.867793031351539e-08
% O 0 5.05329056377235e-10
CI O 0 4.750491279992275e-05
51 O 0 3.2982104158918446e-08
% O 0 1.6513312939281377e-10
- O 0 8.946687835020839e-09
77 O 0 2.5617550747369933e-08
% O 0 1.1187199777662471e-10
) O 0 2.2265256305331604e-10
. O 0 3.621724253832781e-09

The O 0 1.9881382229414157e-07
estimated O 0 1.7712931121849351e-09
sensitivity O 0 6.147438114112447e-09
was O 0 3.824975003396958e-09
identical O 0 6.988286616049777e-10
for O 0 7.571251785243316e-12
direct O 0 1.722202415399554e-11
sequencing O 0 5.883178944010581e-10
and O 0 1.0320549970188608e-10
other O 0 1.9767541770132624e-10
techniques O 0 1.447302651058635e-07
. O 0 1.5189074886734488e-08

The O 0 8.742439945308433e-07
penetrance O 0 2.1976868083584122e-05
of O 0 2.727531182245002e-06
BRCA2 O 0 2.473181439199834e-06
was O 0 6.906206095891321e-08
estimated O 0 2.671086962724445e-10
by O 0 8.898347336749879e-11
maximizing O 0 3.064879194880632e-08
the O 0 1.903894641941406e-08
LOD O 0 0.07038868218660355
score O 0 2.0922124122080277e-07
in O 0 9.006390300214662e-09
BRCA2 O 0 2.8706671173495124e-07
- O 0 5.509826550564867e-08
mutation O 0 2.3146549954500273e-10
families O 0 1.2838271244708377e-11
, O 0 5.779187198240443e-11
over O 0 1.8162704673585495e-10
all O 0 9.117917532108777e-11
possible O 0 1.7899894899642277e-09
penetrance O 0 6.668440732937597e-07
functions O 0 2.196248161112635e-08
. O 0 2.8589237643927845e-08

The O 0 4.0537443624089065e-07
estimated O 0 4.734217018409481e-09
cumulative O 0 7.767417997683879e-08
risk O 0 1.4495783240420224e-08
of O 0 7.827158015061286e-07
breast B-Disease 1 0.999496579170227
cancer I-Disease 0 2.5201665266649798e-05
reached O 0 1.9080717450492557e-08
28 O 0 1.2971898222247091e-08
% O 0 7.450685901577714e-12
( O 0 9.725462622733883e-12
95 O 0 5.109622946974923e-09
% O 0 6.554862902463654e-11
CI O 0 9.891425179375801e-06
9 O 0 3.089052924565294e-08
% O 0 2.922438679942019e-11
- O 0 9.264405909092943e-10
44 O 0 5.186720497540875e-10
% O 0 6.839494682414626e-12
) O 0 1.0500835227397753e-12
by O 0 8.375002948091126e-12
age O 0 3.144303428737061e-10
50 O 0 2.910402197020545e-10
years O 0 8.916559851579464e-11
and O 0 1.1123411219893242e-10
84 O 0 7.309222116447245e-09
% O 0 9.643595817732109e-12
( O 0 2.3786960248739497e-11
95 O 0 5.490479182412855e-09
% O 0 9.772903319937853e-11
CI O 0 8.256998626166023e-06
43 O 0 1.490450074470573e-08
% O 0 2.572950186241485e-11
- O 0 4.454004942644474e-10
95 O 0 2.440101010137141e-09
% O 0 8.082215452454022e-12
) O 0 1.5099989401218261e-12
by O 0 1.6738005079175444e-11
age O 0 1.1991364567975893e-09
70 O 0 4.833948796800769e-09
years O 0 1.3552846622744141e-09
. O 0 1.2729397091959527e-08

The O 0 5.936432899034116e-06
corresponding O 1 0.9959142804145813
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 2.0347083591332193e-06
were O 0 7.546281466375149e-08
0 O 0 8.78692816286275e-08
. O 0 1.3567751366849734e-08

4 O 0 2.1229488993412815e-06
% O 0 2.482974714723696e-09
( O 0 1.6964153692899941e-10
95 O 0 1.4083225252647935e-08
% O 0 1.5018518373377532e-10
CI O 0 3.809690952039091e-06
0 O 0 1.7171365440660225e-09
% O 0 1.2966337205322365e-11
- O 0 5.013190973457426e-10
1 O 0 3.278894655789344e-10
% O 0 3.2437026155351933e-12
) O 0 4.922450251229615e-13
by O 0 3.024339893104022e-12
age O 0 1.2764247991903233e-10
50 O 0 1.3714715474399952e-10
years O 0 3.966704048563585e-11
and O 0 3.171913773303281e-11
27 O 0 1.6866629204415062e-09
% O 0 4.416827580761007e-12
( O 0 6.109660520559057e-12
95 O 0 1.7651043959787671e-09
% O 0 3.304993778652232e-11
CI O 0 1.7557274532009615e-06
0 O 0 1.5052680213401004e-09
% O 0 1.6226218285675387e-11
- O 0 9.212494656019032e-10
47 O 0 1.4150101090848466e-09
% O 0 1.2092365303528751e-11
) O 0 2.574868486829307e-12
by O 0 1.6843304528890712e-11
age O 0 8.594493450253538e-10
70 O 0 5.098165001271582e-09
years O 0 1.8505686982805969e-09
. O 0 9.192910432886947e-09

The O 0 4.346668731614045e-07
lifetime O 0 5.929146027483512e-07
risk O 0 1.7970310750570206e-07
of O 0 0.00015214586164802313
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999935626983643
appears O 0 1.5342221937331146e-09
similar O 0 1.547481726094091e-10
to O 0 9.418769930658044e-11
the O 0 1.8914749766452132e-09
risk O 0 2.4415303112590436e-09
in O 0 1.297822627144285e-09
BRCA1 O 0 1.5621479221294976e-08
carriers O 0 1.1553051848522955e-09
, O 0 2.7792182444308366e-10
but O 0 1.9836422435193235e-11
there O 0 2.607239771301728e-11
was O 0 4.782078621978769e-10
some O 0 6.222966152796827e-12
suggestion O 0 7.700234894159053e-10
of O 0 9.302338455086101e-09
a O 0 9.270167966590748e-10
lower O 0 1.150702217955768e-07
risk O 0 7.711467908677605e-09
in O 0 6.885749748164471e-09
BRCA2 O 0 6.598097002097347e-08
carriers O 0 2.6868465230478478e-09
< O 0 2.11429167507049e-08
50 O 0 5.160602611908871e-09
years O 0 9.579844695295492e-10
of O 0 4.516542695398584e-09
age O 0 9.415851209837456e-09
. O 0 6.33754826395716e-09

Eye B-Disease 1 0.9999990463256836
movement I-Disease 0 0.0018955247942358255
abnormalities I-Disease 1 0.9995859265327454
correlate O 0 1.0673098813640536e-06
with O 0 1.2969844753740745e-08
genotype O 0 2.370760739722755e-06
in O 0 5.107452594188544e-08
autosomal O 0 0.25595077872276306
dominant O 1 0.9943923354148865
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.6176392819033936e-05

We O 0 3.4152358807659766e-07
compared O 0 1.5414686060921667e-07
horizontal O 0 1.1608652812356013e-06
eye O 0 5.5515651183668524e-05
movements O 0 1.8737771370069822e-06
( O 0 1.875425148512022e-08
visually O 0 4.667272079927898e-08
guided O 0 3.093167833867483e-06
saccades O 0 2.7779398806160316e-05
, O 0 1.503831192906091e-08
antisaccades O 0 4.946829449181678e-06
, O 0 7.722076311722503e-10
and O 0 7.195666285042535e-10
smooth O 0 1.5520059903906258e-08
pursuit O 0 7.506029220394339e-08
) O 0 6.595671925291313e-11
in O 0 1.6183664131030895e-10
control O 0 1.2324271603247894e-09
subjects O 0 1.678736438748274e-08
( O 0 2.9404828572054953e-10
n O 0 1.3494345640907568e-09
= O 0 2.080757566247371e-09
14 O 0 4.331876191088213e-09
) O 0 5.061294092167934e-11
and O 0 1.6848068773445135e-10
patients O 0 2.9088206843219666e-10
with O 0 3.62930657749061e-11
three O 0 2.5027915850905913e-10
forms O 0 1.2723036846296054e-08
of O 0 1.6025267086661188e-06
autosomal O 0 0.0033711977303028107
dominant O 0 0.005741088185459375
cerebellar B-Disease 1 0.9999929666519165
ataxias I-Disease 1 0.9958840012550354
type I-Disease 1 0.9848372340202332
I I-Disease 1 0.9999986886978149
spinocerebellar B-Disease 1 0.999993085861206
ataxias I-Disease 0 0.0009484147885814309
1 I-Disease 0 6.504569114440528e-07
and I-Disease 0 1.5385483109753295e-08
2 I-Disease 0 7.57474722945517e-08
( O 0 2.5344402132532196e-09
SCA1 B-Disease 1 0.9277969002723694
, O 0 4.194796066059325e-09
n O 0 2.0779573617346614e-09
= O 0 1.7906587324034717e-09
11 O 0 4.4746646388205136e-09
; O 0 2.0663720734503954e-10
SCA2 B-Disease 0 6.907110218890011e-05
, O 0 7.861160056243932e-10
n O 0 4.523161289959887e-10
= O 0 5.006702274990005e-10
10 O 0 5.26874099904262e-10
) O 0 3.938372891698627e-11
and O 0 2.3715045482930464e-09
SCA3 B-Disease 1 1.0
/ O 0 5.829212568642106e-06
Machado B-Disease 0 1.3739859241468366e-06
- I-Disease 0 9.769746611709706e-07
Joseph I-Disease 0 0.0031713799107819796
disease I-Disease 0 0.02574208751320839
( O 0 1.3990376857009323e-08
MJD B-Disease 1 1.0
) O 0 4.300395595180362e-09
( O 0 3.823703853544913e-10
n O 0 2.7088391529872524e-09
= O 0 7.457734874094513e-09
16 O 0 4.131717901145748e-08
) O 0 5.652243117992839e-10
. O 0 4.117209240206421e-09

In O 0 2.555295168349403e-06
SCA1 B-Disease 1 0.9984281063079834
, O 0 1.769743995794215e-08
saccade O 0 5.121563617649372e-07
amplitude O 0 2.448223312967457e-08
was O 0 4.853609070210041e-09
significantly O 0 1.7018080000763547e-10
increased O 0 7.816899211254835e-11
, O 0 5.0743142326892254e-11
resulting O 0 7.365842935591616e-10
in O 0 1.605806820847988e-09
hypermetria B-Disease 0 2.35171100939624e-05
. O 0 9.780058718433793e-08

The O 0 3.4852178032451775e-06
smooth O 0 1.763737600413151e-06
pursuit O 0 1.4625529729528353e-06
gain O 0 7.917172695215413e-08
was O 0 2.622050772060902e-07
decreased O 0 2.1826681972925144e-07
. O 0 1.3170144974594677e-08

In O 0 3.5283721899759257e-06
SCA2 B-Disease 1 0.9987022876739502
, O 0 4.922405949514541e-08
saccade O 0 2.4215742087108083e-06
velocity O 0 1.9307867660245392e-07
was O 0 1.0991423948780721e-07
markedly O 0 9.985706128645688e-08
decreased O 0 7.162344672906329e-08
. O 0 1.6984341044690154e-08

The O 0 3.278541953477543e-07
percentage O 0 5.842469974481901e-08
of O 0 4.7041829986937955e-08
errors O 0 1.6127480648719938e-06
in O 0 3.134271153726331e-08
antisaccades O 0 0.00026199367130175233
was O 0 3.556474936772247e-08
greatly O 0 9.46153821956841e-10
increased O 0 7.393963219470834e-11
and O 0 4.025945965491218e-10
was O 0 1.3809823284915979e-09
significantly O 0 5.327358346129962e-11
correlated O 0 7.132999191306055e-10
with O 0 7.929160800168589e-11
age O 0 5.300706984456838e-09
at O 0 1.091931835617288e-06
disease O 0 0.00023440764925908297
onset O 0 0.0002121372235706076
. O 0 5.202400288339959e-08

In O 0 1.206773418971352e-07
addition O 0 1.8109208355099327e-08
, O 0 3.9349509761699153e-10
a O 0 1.8867861439897382e-10
correlation O 0 2.963590761684287e-10
between O 0 3.3447006275721947e-10
smooth O 0 7.2140298179590445e-09
pursuit O 0 2.515687391735355e-08
gain O 0 7.407659485814122e-10
and O 0 8.381127042378367e-11
the O 0 9.271224760132313e-11
number O 0 1.1071637356918629e-10
of O 0 7.739700436104613e-09
trinucleotide O 0 2.9461751182680018e-05
repeats O 0 1.3251083430532162e-07
was O 0 8.305533327757075e-08
found O 0 1.4458672481509893e-08
. O 0 1.0515467607774553e-08

In O 0 1.617532871023286e-05
SCA3 B-Disease 1 1.0
, O 0 6.90060858232755e-07
gaze B-Disease 0 2.0436176782823168e-05
- I-Disease 0 5.042049451731145e-06
evoked I-Disease 0 3.884803390974412e-06
nystagmus I-Disease 0 0.0005618765135295689
was O 0 1.9013005214674195e-07
often O 0 5.936337532652658e-10
present O 0 9.307675186143172e-10
as O 0 1.5530355890192027e-09
was O 0 2.5120289848246102e-08
saccade O 0 1.382350205858529e-06
hypometria O 0 5.502555723069236e-06
and O 0 1.3681547450516973e-08
smooth O 0 1.1833319035758905e-07
pursuit O 0 2.611674290164956e-07
gain O 0 5.176368134129916e-08
was O 0 7.961617853879943e-08
markedly O 0 1.2929392312344135e-07
decreased O 0 8.259956985057215e-08
. O 0 1.452822484537819e-08

Three O 0 2.503448683910392e-07
major O 0 1.9412979668231856e-07
criteria O 0 7.335803786645556e-08
, O 0 6.663006812956951e-10
saccade O 0 6.98052673442362e-08
amplitude O 0 3.7449172651804474e-09
, O 0 2.854986802525161e-10
saccade O 0 1.4028588068981662e-08
velocity O 0 5.6026041583834285e-09
, O 0 1.902690921484762e-10
and O 0 7.158278136909502e-11
presence O 0 6.223090931456454e-10
of O 0 3.680002080841405e-08
gaze B-Disease 0 3.2811863093229476e-06
- I-Disease 0 7.850930501263065e-07
evoked I-Disease 0 1.6508927274117013e-06
nystagmus I-Disease 0 1.3961680451757275e-05
, O 0 8.379916205392135e-10
permitted O 0 6.512482775278272e-10
the O 0 5.933054048057329e-10
correct O 0 2.9981028770720286e-09
assignment O 0 1.9743437995600743e-09
of O 0 9.094682229537909e-10
90 O 0 4.718528900937713e-10
% O 0 4.88349334928917e-12
of O 0 1.812014427393649e-10
the O 0 1.4694537808779273e-09
SCA1 B-Disease 1 0.9642789959907532
, O 0 4.8509968264554e-10
90 O 0 3.1098232322612773e-10
% O 0 3.571143597849713e-12
of O 0 1.2294260054446227e-10
the O 0 6.941366925694581e-10
SCA2 B-Disease 1 0.9964699745178223
, O 0 8.697660369705318e-10
and O 0 2.2762242091189933e-10
93 O 0 7.088111875219738e-09
% O 0 9.44870570673828e-12
of O 0 2.434855650434997e-10
the O 0 1.3470892179512362e-09
patients O 0 3.22860360668642e-09
with O 0 6.773128280457286e-09
SCA3 B-Disease 1 1.0
to O 0 7.129058676724753e-09
their O 0 2.969306800437721e-09
genetically O 0 1.201906059122848e-07
confirmed O 0 2.1730429011768138e-08
patient O 0 8.373645243864303e-08
group O 0 3.8433896065726e-09
and O 0 2.3678072835764397e-09
, O 0 3.0326319233608956e-10
therefore O 0 6.613021241719252e-10
, O 0 4.956855481630384e-10
may O 0 5.575290229486995e-10
help O 0 1.0706838748930636e-09
orient O 0 2.311094476681319e-06
diagnoses O 0 2.0234617750247708e-06
of O 0 1.3165633845346747e-06
SCA1 B-Disease 1 1.0
, O 0 1.0323518040422641e-07
SCA2 B-Disease 1 0.9999998807907104
, O 0 1.604705346380797e-08
and O 0 4.462070180011324e-08
SCA3 B-Disease 1 1.0
at O 0 2.2596681503728178e-07
early O 0 8.844277310515736e-09
clinical O 0 6.612408753881027e-08
stages O 0 2.2430371870996169e-07
of O 0 1.1367962571284806e-07
the O 0 2.5545982680341695e-06
diseases O 1 1.0
. O 0 1.9141699780789168e-08
. O 0 3.249833824270354e-08

Genetic O 0 5.194002596908831e-07
basis O 0 1.4476497334214855e-08
and O 0 9.875197326536522e-10
molecular O 0 9.436206482860143e-08
mechanism O 0 3.8673570657010714e-07
for O 0 2.0709398995677475e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 4.599583553499542e-05

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 5.312487701303326e-06
more O 0 7.735328488855941e-10
than O 0 2.084379058242547e-10
300 O 0 4.359343996895859e-09
, O 0 3.399484860278079e-10
000 O 0 5.1579949200686315e-09
sudden O 0 1.4392197655865857e-08
deaths O 0 1.3235814666501255e-09
each O 0 8.0148231801358e-12
year O 0 6.986737577374669e-11
in O 0 1.9713022880729625e-10
the O 0 5.986677820146724e-09
USA O 0 0.00023076489742379636
alone O 0 2.6552060106155295e-08
. O 0 8.98370888791078e-09

In O 0 2.0450841020647204e-07
approximately O 0 9.14814979324774e-09
5 O 0 1.8707915216964466e-08
- O 0 2.205702109847607e-08
12 O 0 1.996656839864386e-09
% O 0 2.125045582210272e-12
of O 0 1.2455033532310367e-11
these O 0 2.7235744042009014e-12
cases O 0 5.4292303292013955e-11
, O 0 2.2364585877676646e-11
there O 0 1.3794829861746294e-11
are O 0 1.455105393816103e-11
no O 0 6.295714505277772e-10
demonstrable O 0 0.00010181364632444456
cardiac O 1 0.9999946355819702
or O 0 8.028683282645943e-07
non O 1 0.9999972581863403
- O 1 0.9999982118606567
cardiac O 1 1.0
causes O 0 6.546537889562387e-08
to O 0 1.281339895298217e-10
account O 0 7.877020563595849e-11
for O 0 4.385911772653017e-11
the O 0 7.721295824936192e-10
episode O 0 3.779042856422166e-09
, O 0 1.904807041264167e-11
which O 0 5.4284714744168294e-12
is O 0 1.7969720763483243e-12
therefore O 0 8.238981545616308e-12
classified O 0 7.054231865311067e-09
as O 0 4.4537628696161846e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 4.638429527403787e-05
IVF B-Disease 1 1.0
) O 0 4.111435458753476e-08
. O 0 4.091542038509033e-08

A O 0 5.956388577033067e-06
distinct O 0 5.306202410793048e-08
group O 0 2.3635040591329926e-08
of O 0 5.577145998358901e-07
IVF B-Disease 1 1.0
patients O 0 1.453091869052514e-07
has O 0 3.223905170601782e-11
been O 0 2.5141102741321752e-11
found O 0 1.2037780494633665e-11
to O 0 4.997623842539767e-12
present O 0 9.721016352992606e-11
with O 0 1.7484967640424287e-10
a O 0 7.84778553253318e-09
characteristic O 0 3.325996658531949e-05
electrocardiographic O 1 0.9728630781173706
pattern O 0 1.13723244794528e-05
. O 0 1.1162895674488027e-07

Because O 0 1.4564881212209002e-07
of O 0 8.47067056497508e-08
the O 0 1.230843760247069e-09
small O 0 1.130787130598776e-10
size O 0 3.074572263450648e-10
of O 0 3.948621429827881e-09
most O 0 2.645063335027231e-10
pedigrees O 0 1.2050342057534635e-08
and O 0 5.045739936981875e-10
the O 0 1.6836929628283315e-09
high O 0 6.054499834817761e-08
incidence O 0 1.648569813994527e-08
of O 0 2.4875872473018035e-09
sudden B-Disease 0 2.836859636090594e-08
death I-Disease 0 1.280401136227738e-07
, O 0 7.250743061515408e-11
however O 0 3.183405275497542e-11
, O 0 1.485019399116716e-11
molecular O 0 3.2247631231996365e-09
genetic O 0 1.5227676897211495e-09
studies O 0 6.31463159539436e-10
of O 0 1.0250229998121085e-08
IVF B-Disease 1 1.0
have O 0 1.0783647585999034e-10
not O 0 3.247090096802907e-11
yet O 0 2.6582180900902586e-10
been O 0 6.620555770275871e-10
done O 0 4.674842735141738e-09
. O 0 1.3567182044482706e-08

Because O 0 9.487092029303312e-06
IVF B-Disease 1 1.0
causes O 0 0.12352614849805832
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999997615814209
, O 0 8.111879168382075e-09
we O 0 1.6232880317712528e-10
investigated O 0 6.246843042845285e-09
whether O 0 3.84527187868855e-10
malfunction O 0 0.00011021656246157363
of O 0 4.33648281727983e-08
ion O 0 3.706672657699528e-08
channels O 0 5.146634673991457e-09
could O 0 1.2857742648364479e-09
cause O 0 1.8967252657375866e-08
the O 0 2.6595090574232927e-08
disorder O 0 3.093953466759558e-07
by O 0 9.526415073457528e-11
studying O 0 3.945008320016541e-09
mutations O 0 1.8050877459430126e-10
in O 0 2.878822458196595e-10
the O 0 2.0456285554359965e-09
cardiac O 0 5.869449068995891e-06
sodium O 0 5.938211700140528e-08
channel O 0 1.9475916701594542e-07
gene O 0 3.835365873783303e-07
SCN5A O 1 0.9775393009185791
. O 0 2.149308642174219e-07

We O 0 4.507199591330391e-08
have O 0 6.675193175986749e-10
now O 0 2.9633928644301477e-10
identified O 0 4.0954653557356835e-10
a O 0 4.3580536401854886e-10
missense O 0 7.763419063167021e-08
mutation O 0 4.401965014722009e-09
, O 0 6.862251322736768e-10
a O 0 7.590301165372182e-10
splice O 0 9.971695362764876e-07
- O 0 8.621049829571348e-08
donor O 0 3.00676150644108e-09
mutation O 0 3.7301317590276994e-09
, O 0 6.855592760146578e-10
and O 0 9.227055230986991e-10
a O 0 1.8185800643166772e-09
frameshift O 0 3.072500476264395e-07
mutation O 0 1.7680694686106335e-09
in O 0 4.788120455678779e-10
the O 0 1.1745734385115725e-09
coding O 0 2.52480152340695e-08
region O 0 5.361686206128979e-09
of O 0 3.6922287449669966e-08
SCN5A O 1 0.9999555349349976
in O 0 4.31017577184889e-09
three O 0 5.065548425164934e-09
IVF B-Disease 1 0.9999998807907104
families O 0 3.1532174649129274e-09
. O 0 2.6305761124945093e-08

We O 0 3.5651755325716294e-08
show O 0 2.82866707834728e-09
that O 0 4.7983826113873196e-12
sodium O 0 4.4641235152909076e-11
channels O 0 5.2231021591131466e-11
with O 0 1.2047473262055686e-11
the O 0 4.437046563499081e-10
missense O 0 6.950381248316262e-08
mutation O 0 2.6706399314235796e-09
recover O 0 3.523834735119635e-08
from O 0 7.470192464609227e-09
inactivation O 0 6.370685241563478e-07
more O 0 4.009513901448436e-11
rapidly O 0 2.524620790200771e-10
than O 0 6.334734820034882e-12
normal O 0 2.2241444797010956e-10
and O 0 6.198933033552123e-11
that O 0 4.358531330989068e-12
the O 0 3.642359747146884e-10
frameshift O 0 8.725784539365122e-08
mutation O 0 5.718651663322305e-10
causes O 0 5.096247313041147e-10
the O 0 6.195448598589337e-10
sodium O 0 3.735113884850705e-10
channel O 0 1.3371154183872136e-10
to O 0 1.7570174482006706e-11
be O 0 3.49368034502362e-11
non O 0 7.427246373481466e-08
- O 0 2.599116442070226e-07
functional O 0 4.619958104967736e-08
. O 0 5.125494251245755e-09

Our O 0 3.7418348597384465e-07
results O 0 1.203708777097745e-08
indicate O 0 1.6658335821873038e-09
that O 0 1.9714741991694318e-11
mutations O 0 2.7672167335346387e-10
in O 0 1.2003950056183044e-09
cardiac O 0 2.1876498976780567e-06
ion O 0 1.8701781812069385e-07
- O 0 2.7290559501125244e-06
channel O 0 4.9593920081747456e-09
genes O 0 7.331708157254369e-11
contribute O 0 1.921409732708046e-11
to O 0 2.6723491475255656e-11
the O 0 2.796670672822188e-10
risk O 0 4.2749354056681454e-10
of O 0 3.6994241003895922e-09
developing O 0 2.2421511758352608e-08
IVF B-Disease 1 1.0
. O 0 7.53883977466785e-09
. O 0 1.812299643688675e-08

Molecular O 0 9.022474841913208e-06
heterogeneity O 0 4.118615834158845e-06
in O 0 1.5412804543757375e-07
mucopolysaccharidosis B-Disease 0 0.002481686184182763
IVA I-Disease 1 1.0
in O 0 3.043140139880052e-08
Australia O 0 5.588920881649528e-09
and O 0 3.9849434863015176e-10
Northern O 0 1.9983186660965657e-08
Ireland O 0 4.648960683084624e-08
: O 0 6.060456025913652e-10
nine O 0 3.4134883808434324e-09
novel O 0 1.0676860506819708e-09
mutations O 0 1.1706794422750022e-09
including O 0 3.228049383352527e-09
T312S O 0 1.0151749847864266e-05
, O 0 2.1184485277103704e-09
a O 0 5.646812462067885e-10
common O 0 1.895002821328262e-09
allele O 0 3.414515614696967e-10
that O 0 1.1029056140587912e-11
confers O 0 8.425146802437666e-09
a O 0 1.5382958906684507e-08
mild O 0 5.3168798331171274e-05
phenotype O 0 9.574096111464314e-07
. O 0 8.000497331295264e-08

Mucopolysaccharidosis B-Disease 1 0.9999969005584717
IVA I-Disease 1 1.0
( O 0 0.00036514727980829775
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 8.98381529168546e-08
is O 0 1.7167035848419943e-10
an O 0 2.6803140262821046e-10
autosomal B-Disease 1 0.9999544620513916
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 0.18941722810268402
by O 0 2.3199525855943648e-08
a O 0 4.988681894246838e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.2330907256673527e-07
N O 0 3.92638548873947e-06
- O 0 1.0585293921394623e-06
acetylgalactosamine O 0 7.360306335613132e-05
- O 0 2.6481257009436376e-06
6 O 0 1.7466924191467115e-06
- O 0 1.6662687585267122e-06
sulfate O 0 5.355669827622478e-07
sulfatase O 0 0.00030229362891986966
( O 0 9.493125219250942e-08
GALNS O 1 0.9999998807907104
) O 0 2.9140824864271053e-08
. O 0 1.8496169928994277e-08

Previous O 0 5.231225941315643e-07
studies O 0 1.2479902444795243e-08
of O 0 7.734889173605097e-09
patients O 0 9.119243693511692e-10
from O 0 8.458714839676418e-10
a O 0 7.389060474594089e-10
British O 0 5.1950031831893284e-08
- O 0 3.4019018357867026e-07
Irish O 0 2.601675141988835e-08
population O 0 1.8025777268407261e-12
showed O 0 6.517599654420891e-11
that O 0 1.297815804476854e-12
the O 0 1.643789410143981e-10
I113F O 0 2.744695848377887e-07
mutation O 0 1.5766350447421473e-09
is O 0 3.5772398931932514e-11
the O 0 8.439581672403662e-11
most O 0 4.977620399193583e-11
common O 0 3.2467448174422486e-10
single O 0 4.975746037416684e-09
mutation O 0 6.377077976793544e-09
among O 0 1.837552154881905e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.00013406875950749964
and O 0 1.5939045283630549e-07
produces O 0 2.2283808220890933e-07
a O 0 5.158696225748827e-08
severe O 1 0.9248543381690979
clinical O 1 0.9594026207923889
phenotype O 0 1.936373564603855e-06
. O 0 9.499392916723082e-08

We O 0 3.1993032223454065e-08
studied O 0 6.250456863199361e-08
mutations O 0 1.005150851440817e-09
in O 0 1.0561391761143568e-09
the O 0 4.620282378908769e-09
GALNS O 1 0.9995947480201721
gene O 0 1.5069342440554578e-09
from O 0 7.685679315194704e-10
23 O 0 4.287079580223008e-09
additional O 0 2.763462347843415e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.922409294114914e-06
( O 0 1.7091279502778889e-09
15 O 0 3.6331195829575336e-09
from O 0 8.603547319019356e-10
Australia O 0 1.0129184158103044e-09
, O 0 4.001232678518818e-11
8 O 0 6.891737736047787e-10
from O 0 1.146342326618921e-10
Northern O 0 3.5391973796095044e-09
Ireland O 0 1.5840418754464736e-08
) O 0 6.818852427148414e-11
, O 0 2.4295102388216527e-11
with O 0 8.852026750494346e-12
various O 0 2.310038604846909e-09
clinical O 0 0.0002085159212583676
phenotypes O 0 8.055026228248607e-06
( O 0 5.308004347170936e-08
severe O 1 0.9999629259109497
, O 0 1.4606522213966855e-08
16 O 0 2.5835269923391024e-08
cases O 0 1.4429894779066643e-10
; O 0 3.402058149082343e-11
intermediate O 0 5.8189154827914535e-08
, O 0 1.9292398234505015e-10
4 O 0 2.8619886460745647e-09
cases O 0 2.6823596122049764e-10
; O 0 3.4456240638469637e-10
mild O 0 9.499009365754318e-07
, O 0 8.301218601403093e-10
3 O 0 1.1160144808286532e-08
cases O 0 1.4768040124124582e-09
) O 0 4.820963628304753e-10
. O 0 6.1335008183505124e-09

We O 0 5.0962523090447576e-08
found O 0 2.410210697689763e-09
two O 0 8.242978521977307e-11
common O 0 2.792150954888939e-10
mutations O 0 3.574786577864586e-10
that O 0 2.2412753944434094e-11
together O 0 1.4390261204866306e-10
accounted O 0 9.069581752285671e-10
for O 0 4.424114893875064e-11
32 O 0 2.3401860449467904e-09
% O 0 7.364500502482496e-12
of O 0 3.667630921189158e-10
the O 0 4.886601123743617e-10
44 O 0 3.6796212743439582e-09
unrelated O 0 4.2410710499041215e-09
alleles O 0 1.1736144001073257e-10
in O 0 4.0744438378759185e-10
these O 0 1.2573123653325524e-09
patients O 0 1.64656501766558e-08
. O 0 4.020617083710931e-08

One O 0 3.1528648491985223e-07
is O 0 1.5482796156263134e-09
the O 0 1.731733534349189e-09
T312S O 0 1.1902318419743096e-06
mutation O 0 1.881497402322907e-09
, O 0 1.4343785881276716e-10
a O 0 4.6290984934138635e-11
novel O 0 8.137351348302957e-10
mutation O 0 7.58270113365711e-11
found O 0 2.505847265799055e-11
exclusively O 0 3.4101677037767786e-10
in O 0 1.546228589610621e-09
milder O 0 3.3276426165684825e-06
patients O 0 1.5091360694441391e-07
. O 0 1.0425861773910583e-07

The O 0 7.154165473366447e-07
other O 0 8.715117516544524e-09
is O 0 2.34050612224479e-10
the O 0 9.152770208409322e-10
previously O 0 7.600142737373972e-09
described O 0 1.16325926668992e-08
I113F O 0 4.1893932234415843e-07
that O 0 1.887952572054985e-10
produces O 0 1.5840539546729815e-08
a O 0 2.3250246172779043e-08
severe O 0 0.06395018845796585
phenotype O 0 2.7868254619534127e-06
. O 0 2.8139086793999013e-07

The O 0 1.3257268847155501e-06
I113F O 0 4.8467377382621635e-06
and O 0 1.3113821140109394e-08
T312S O 0 4.240879150074761e-07
mutations O 0 1.1331950933168855e-09
accounted O 0 3.914979895824899e-09
for O 0 3.140964710546257e-10
8 O 0 7.756696618343994e-09
( O 0 1.2040128616330747e-10
18 O 0 1.881816702464789e-09
% O 0 8.787161970280621e-12
) O 0 4.8333975710690424e-12
and O 0 1.8162496506768377e-10
6 O 0 1.7752409320337392e-08
( O 0 1.4037994378046648e-10
14 O 0 3.0878026802128034e-09
% O 0 7.810813627828761e-12
) O 0 2.4043896214298588e-12
of O 0 6.731166735107763e-10
44 O 0 1.132866578323899e-09
unrelated O 0 5.9024243270755505e-09
alleles O 0 7.917089761555474e-10
, O 0 1.5878161008231473e-09
respectively O 0 8.105046589435005e-08
. O 0 2.773740170880501e-08

The O 0 3.3776305485844205e-07
relatively O 0 6.702309462980338e-08
high O 0 5.764053412349313e-07
residual O 0 5.760460226156283e-06
GALNS O 1 0.7818431854248047
activity O 0 3.0679672136102454e-08
seen O 0 2.3334023602217258e-09
when O 0 1.8306205162854639e-10
the O 0 3.595341246942496e-10
T312S O 0 6.387293183252041e-08
mutant O 0 7.141811142474808e-09
cDNA O 0 1.01355661641378e-08
is O 0 1.5067408432045681e-10
overexpressed O 0 7.855471295670213e-08
in O 0 1.3738782334016264e-09
mutant O 0 8.064718670652837e-09
cells O 0 4.68932503938646e-10
provides O 0 3.223978722877163e-11
an O 0 2.6916023663364763e-12
explanation O 0 7.157745923747072e-11
for O 0 4.524531443950153e-11
the O 0 3.062224918082279e-09
mild O 0 4.58078147858032e-06
phenotype O 0 5.206427733384089e-09
in O 0 7.136306545696414e-10
patients O 0 1.7544934949320634e-10
with O 0 4.876877721105011e-11
this O 0 1.7305241961640405e-10
mutation O 0 1.1565183477557639e-08
. O 0 3.2045310405237615e-08

The O 0 3.040221940864285e-08
distribution O 0 1.6521511936318234e-09
and O 0 5.99029228998127e-11
relative O 0 7.426032011537131e-11
frequencies O 0 9.800572575713318e-10
of O 0 1.0727198018756212e-09
the O 0 3.5247454954756563e-10
I113F O 0 8.444263244200556e-08
and O 0 6.145923214795346e-10
T312S O 0 1.0676931339048679e-07
mutations O 0 3.8297401361298e-10
in O 0 1.2010127614647814e-10
Australia O 0 3.4924760305976577e-10
corresponded O 0 7.94567814321745e-11
to O 0 2.299608767297734e-11
those O 0 1.982787371790362e-11
observed O 0 2.240323482283202e-10
in O 0 7.348396197093265e-11
Northern O 0 6.8181309487158615e-09
Ireland O 0 1.6459495100207278e-08
and O 0 3.219771116391712e-10
are O 0 7.324185528900795e-12
unique O 0 2.5800415623389306e-11
to O 0 1.7449944267333706e-11
these O 0 1.6272242234216527e-11
two O 0 2.553341392486086e-11
populations O 0 1.7938874344314293e-11
, O 0 8.070323055664463e-12
suggesting O 0 2.2098297150496826e-11
that O 0 3.5179227152876136e-13
both O 0 1.777766128752134e-11
mutations O 0 5.098568442440943e-11
were O 0 4.4769415952217173e-10
probably O 0 1.8815428382001897e-10
introduced O 0 1.5144452358839544e-10
to O 0 5.5310558216836725e-11
Australia O 0 7.237179189267806e-10
by O 0 6.301345556458671e-11
Irish O 0 6.500522786723195e-09
migrants O 0 4.899048181017385e-11
during O 0 2.833833445681222e-10
the O 0 1.5421720844788211e-10
19th O 0 1.0024521657214791e-07
century O 0 1.4608257004056213e-07
. O 0 9.066022599313328e-09

Haplotype O 0 3.655005912150955e-06
analysis O 0 5.0946294294362815e-08
using O 0 1.061845900096614e-08
6 O 0 4.505110950958624e-07
RFLPs O 0 5.32752574144979e-06
provides O 0 1.8977690252608426e-10
additional O 0 2.9486024732960914e-11
data O 0 2.7961585824520796e-10
that O 0 2.599105609554786e-12
the O 0 8.856794464495721e-11
I113F O 0 7.261092349608589e-08
mutation O 0 2.036645990743935e-10
originated O 0 3.9422382025477987e-10
from O 0 1.228308010858825e-10
a O 0 2.0178964055261872e-10
common O 0 1.0719773957390544e-09
ancestor O 0 7.673631330362696e-08
. O 0 2.115627140142351e-08

The O 0 2.0918932364111242e-07
other O 0 2.2955179979078366e-09
9 O 0 3.0880393353527325e-08
novel O 0 1.2075092037378e-09
mutations O 0 1.3693281231130783e-10
identified O 0 1.017340170439418e-10
in O 0 7.913130567471782e-11
these O 0 1.0549447426733138e-10
23 O 0 1.7184447642648593e-08
patients O 0 2.2202620297839815e-10
were O 0 1.2918452418908544e-10
each O 0 8.616792175619725e-12
limited O 0 5.2193780547549196e-11
to O 0 1.2451049913320134e-10
a O 0 1.2963728979187294e-09
single O 0 1.5413679221865095e-08
family O 0 6.4953176170945426e-09
. O 0 1.3211356453268763e-08

These O 0 1.1374876152103752e-08
data O 0 5.8953810722073285e-09
provide O 0 2.2723764536713986e-10
further O 0 7.602569962461558e-11
evidence O 0 2.8409449792654584e-10
for O 0 4.377646162234683e-11
extensive O 0 6.453688694563198e-09
allelic O 0 3.931392313916149e-07
heterogeneity O 0 4.06005028708023e-07
in O 0 3.744383292314524e-08
MPS B-Disease 1 0.999998927116394
IVA I-Disease 1 1.0
in O 0 1.4703830686357833e-07
British O 0 7.43386465273943e-07
- O 0 6.320141437754501e-06
Irish O 0 1.450302420380467e-06
patients O 0 1.7227956838894443e-09
and O 0 7.530841922287479e-11
provide O 0 6.628955023790795e-11
evidence O 0 2.057900960750203e-09
for O 0 1.6163520522027852e-10
their O 0 6.151552045530195e-10
transmission O 0 5.690984128392529e-09
to O 0 1.1139376920876742e-10
Australia O 0 4.3478246003481047e-10
by O 0 4.4357920114812543e-11
British O 0 1.2819450390111342e-08
- O 0 6.851820444353507e-08
Irish O 0 1.735805277292002e-08
migrants O 0 8.858754008134184e-11
. O 0 7.590775230603697e-11
. O 0 1.849968622735787e-09

Identification O 0 1.3045001878708717e-06
of O 0 4.562160142995708e-07
constitutional O 0 1.4161537364998367e-06
WT1 O 1 0.999997615814209
mutations O 0 7.19508221891374e-08
, O 0 1.1263769916780575e-09
in O 0 9.116844501555477e-10
patients O 0 2.1603876465547955e-09
with O 0 1.740256383442329e-09
isolated O 0 0.00020282037439756095
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 8.461737088794052e-09
and O 0 3.9083822289676107e-10
analysis O 0 5.386139867447071e-10
of O 0 1.5210645187835325e-08
genotype O 0 3.2096821200866543e-07
/ O 0 4.5270718374013086e-07
phenotype O 0 1.299769847307175e-09
correlations O 0 8.479602020550203e-10
by O 0 3.024849121180395e-11
use O 0 4.980756918016027e-10
of O 0 5.527981628006273e-09
a O 0 1.8489879627381356e-09
computerized O 0 1.5101758435775992e-05
mutation O 0 2.2009446709603253e-08
database O 0 2.3335502419286058e-08
. O 0 3.4700565976208964e-08

Constitutional O 0 2.0479562863329193e-06
mutations O 0 5.640929501282699e-08
of O 0 1.6705217831258778e-07
the O 0 3.7293084176326374e-08
WT1 O 0 0.1986120492219925
gene O 0 1.3469511728203543e-08
, O 0 3.6114514156970756e-10
encoding O 0 9.78503278403764e-10
a O 0 8.135927487273875e-09
zinc O 0 3.431069899306749e-06
- O 0 1.745566692079592e-06
finger O 0 1.022597643896006e-06
transcription O 0 5.576582751132264e-08
factor O 0 2.0967851899200696e-09
involved O 0 9.505837228473979e-10
in O 0 6.556419851477813e-09
renal O 1 0.98479163646698
and O 0 1.739455086635644e-07
gonadal O 1 0.9954224228858948
development O 0 1.0091973479120497e-07
, O 0 3.1075644835176774e-10
are O 0 7.287064181238367e-12
found O 0 4.420504587376861e-11
in O 0 7.310553551409527e-11
most O 0 1.2051477871199978e-10
patients O 0 1.0622788204628364e-09
with O 0 3.94652088786529e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.846156010287814e-05
DDS B-Disease 1 1.0
) O 0 3.773779511107023e-08
, O 0 1.914921332613062e-09
or O 0 2.8894865167217176e-08
diffuse B-Disease 1 0.999966025352478
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.3312698001755052e-06
DMS B-Disease 1 1.0
) O 0 3.290191452620661e-09
associated O 0 1.154907014466744e-08
with O 0 7.784352717976617e-09
pseudohermaphroditism B-Disease 1 1.0
and O 0 7.407336852338631e-06
/ O 0 8.318918844452128e-05
or O 0 3.838358964003419e-07
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9998214840888977
( O 0 1.027225835059653e-06
WT B-Disease 1 1.0
) O 0 4.3812697470002604e-08
. O 0 3.670223591711874e-08

Most O 0 9.357614061400454e-08
mutations O 0 1.297197798066918e-07
in O 0 4.3805846416944405e-07
DDS B-Disease 1 1.0
patients O 0 4.777115464094095e-06
lie O 0 1.6306775023622322e-06
in O 0 1.650035841294084e-08
exon O 0 2.738264299750881e-07
8 O 0 1.22455517725939e-07
or O 0 1.6737805808020312e-08
exon O 0 1.5589577628816187e-07
9 O 0 2.68919166046544e-07
, O 0 1.7744750113735108e-09
encoding O 0 1.7596697432509245e-08
zinc O 0 8.571632861276157e-06
finger O 0 1.4158688827592414e-05
2 O 0 4.055777935718652e-07
or O 0 9.705911452329019e-08
zinc O 0 1.424663423676975e-05
finger O 0 1.4839429240964819e-05
3 O 0 1.6682611203577835e-07
, O 0 7.932673962152137e-10
respectively O 0 2.3027009188325565e-09
, O 0 7.013453706683492e-11
with O 0 3.746599211429391e-11
a O 0 1.2633967205744057e-09
hot O 0 4.09026552006253e-06
spot O 0 7.975370976964768e-07
( O 0 4.674652887004527e-10
R394W O 0 1.6783721434876497e-07
) O 0 1.385635911566041e-10
in O 0 1.2912129143671791e-09
exon O 0 4.835749223275343e-07
9 O 0 9.72169459600991e-07
. O 0 2.632182116713011e-08

We O 0 5.148021742229503e-08
analyzed O 0 5.047409956659976e-08
a O 0 5.712165740412445e-10
series O 0 6.2508958009743765e-09
of O 0 6.331652091517981e-09
24 O 0 1.638194646602642e-08
patients O 0 7.503403454123259e-10
, O 0 1.5035772626958988e-10
10 O 0 1.6144149350694192e-09
with O 0 7.822226755216377e-10
isolated B-Disease 0 7.176016424637055e-06
DMS I-Disease 1 1.0
( O 0 8.78273624493886e-07
IDMS B-Disease 1 1.0
) O 0 1.2308092323110031e-08
, O 0 6.576844624461842e-10
10 O 0 2.7499127419616798e-09
with O 0 1.671352167775808e-09
DDS B-Disease 1 1.0
, O 0 1.1162486046600861e-08
and O 0 2.3441395491374806e-09
4 O 0 6.814246233943777e-08
with O 0 8.097225112635442e-09
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 0 0.00017053421470336616
/ O 0 0.4882529079914093
or O 0 2.853992373275105e-05
WT B-Disease 1 1.0
. O 0 1.8512105270929169e-06

We O 0 3.211470129826921e-07
report O 0 1.61819912136707e-07
WT1 O 0 0.0008662054315209389
heterozygous O 0 4.325265123839017e-08
mutations O 0 5.915892664631883e-09
in O 0 5.082863019367778e-09
16 O 0 6.068061253472479e-08
patients O 0 5.6279012561333275e-09
, O 0 4.752154780796047e-10
4 O 0 1.6572743177789562e-08
of O 0 2.369349338948723e-08
whom O 0 4.453242663515766e-09
presented O 0 2.3492034983974008e-07
with O 0 4.830591819882102e-07
IDMS B-Disease 1 1.0
. O 0 6.4299315454263706e-06

One O 0 1.4694187200348097e-07
male O 0 2.7635167043627007e-08
and O 0 8.154411590410859e-10
two O 0 9.629029795732436e-10
female O 0 5.348288567574855e-08
IDMS B-Disease 1 1.0
patients O 0 7.929291427899443e-07
with O 0 1.6476101905027463e-07
WT1 O 1 1.0
mutations O 0 1.094345407182118e-05
underwent O 0 0.22545568645000458
normal O 0 3.301949618617073e-05
puberty O 0 0.0014163540909066796
. O 0 3.7171790978618446e-08

Two O 0 1.606791784070083e-07
mutations O 0 1.4827126904037868e-07
associated O 0 9.069417217233422e-08
with O 0 3.9640930538098473e-08
IDMS B-Disease 1 1.0
are O 0 2.8841920518551944e-10
different O 0 5.544702891269182e-11
from O 0 2.835385259913892e-10
those O 0 1.0893398683098354e-10
described O 0 5.541304304301775e-09
in O 0 1.1638833541383065e-07
DDS B-Disease 1 1.0
patients O 0 1.0476695933903102e-05
. O 0 1.4644605528246757e-07

No O 0 6.942147138033761e-06
WT1 O 1 0.9650963544845581
mutations O 0 4.9931657031265786e-08
were O 0 9.129029088228435e-09
detected O 0 2.840985580121469e-08
in O 0 1.561339113553828e-10
the O 0 5.863932117655679e-10
six O 0 2.0793489152737266e-09
other O 0 4.864712188634712e-09
IDMS B-Disease 1 1.0
patients O 0 4.1133387185254833e-07
, O 0 1.6186390006112106e-09
suggesting O 0 4.605360537368597e-09
genetic O 0 1.4697852712686199e-08
heterogeneity O 0 1.1138670430455022e-07
of O 0 3.903953995632037e-07
this O 0 2.7423821435945683e-08
disease O 0 0.008597596548497677
. O 0 1.821333661666813e-08

We O 0 4.277239540328992e-08
analyzed O 0 2.0891778262921434e-07
genotype O 0 1.1046314511986566e-06
/ O 0 5.476706519402796e-07
phenotype O 0 8.429648090668707e-09
correlations O 0 1.2525306125610314e-08
, O 0 3.7500114125066375e-10
on O 0 5.968034400005706e-10
the O 0 1.0794883736897631e-10
basis O 0 1.439059010843735e-10
of O 0 3.805107895438198e-10
the O 0 2.1476380396290295e-10
constitution O 0 6.485135345402071e-11
of O 0 9.958232016771262e-10
a O 0 1.1847276493170966e-09
WT1 O 0 5.703607894247398e-05
mutation O 0 6.536438057480609e-10
database O 0 5.355122456585093e-10
of O 0 8.782282456820667e-09
84 O 0 1.3800159592847194e-07
germ O 0 0.008139638230204582
- O 0 3.321238182252273e-06
line O 0 3.403199855256389e-07
mutations O 0 8.43134839723092e-10
, O 0 6.271800440105224e-11
to O 0 9.70933750066294e-12
compare O 0 7.192894613261558e-10
the O 0 2.450023794953182e-10
distribution O 0 2.2798435361792713e-10
and O 0 9.69511138038115e-11
type O 0 8.276337837287429e-09
of O 0 4.361808692010527e-08
mutations O 0 1.6025879512326924e-09
, O 0 8.474584922701922e-11
according O 0 3.53083326465331e-11
to O 0 6.822989395693924e-11
the O 0 1.025709073232406e-09
different O 0 9.36089517011851e-09
symptoms O 0 4.109375731786713e-05
. O 0 9.965233971342968e-08

This O 0 1.4355953759093154e-08
demonstrated O 0 7.579718186434548e-08
( O 0 1.9327175415639886e-09
1 O 0 8.273828733251776e-09
) O 0 8.251629934896698e-11
the O 0 2.330127757410594e-10
association O 0 1.2686390826743832e-09
between O 0 1.0143988427024908e-10
mutations O 0 2.731823378621101e-10
in O 0 1.3233594220452005e-09
exons O 0 2.3872127385970998e-08
8 O 0 1.2462680665237258e-08
and O 0 1.4340127973966332e-09
9 O 0 2.7924571099902096e-08
and O 0 3.4300262630182488e-09
DMS B-Disease 1 0.8064450025558472
; O 0 2.010413835407121e-09
( O 0 9.774381304339386e-10
2 O 0 2.6663760976930462e-08
) O 0 8.3041122589389e-11
among O 0 7.745171864970146e-11
patients O 0 4.5172643403645907e-10
with O 0 7.120466438692574e-10
DMS B-Disease 1 1.0
, O 0 2.0527497479605472e-09
a O 0 1.556952761161412e-10
higher O 0 8.120761285645983e-10
frequency O 0 6.998811530323223e-10
of O 0 2.7387270229439764e-09
exon O 0 2.2091208862207168e-08
8 O 0 8.475596224855053e-09
mutations O 0 7.425100534419471e-10
among O 0 2.8807062291136276e-10
46 O 0 1.6645447686869375e-08
, O 0 1.8980197413753785e-09
XY O 0 3.314866262371652e-05
patients O 0 1.2112043590306598e-09
with O 0 8.750387914258084e-11
female O 0 1.2476206734390871e-09
phenotype O 0 7.048741035298178e-10
than O 0 6.146962799880029e-11
among O 0 7.326945716812361e-10
46 O 0 2.0444359094540232e-08
, O 0 3.6402363345899857e-09
XY O 0 0.00026140708359889686
patients O 0 1.3265638587611761e-09
with O 0 1.0622398100013086e-10
sexual O 0 1.6437274874547825e-09
ambiguity O 0 1.7614150138456353e-09
or O 0 9.494457442471571e-10
male O 0 1.0230146729739431e-09
phenotype O 0 2.018989836427565e-10
; O 0 5.4856584552620546e-11
and O 0 9.548521973101742e-10
( O 0 3.0321345434458635e-10
3 O 0 5.256397539454838e-09
) O 0 1.164089831473536e-11
statistically O 0 2.971383208927314e-11
significant O 0 2.2210740191486167e-11
evidence O 0 4.703110678683231e-10
that O 0 6.066452461900296e-12
mutations O 0 2.2890721262935898e-10
in O 0 6.787946316144655e-10
exons O 0 1.4791417868309509e-08
8 O 0 2.6438049971488908e-08
and O 0 1.1088127083169752e-09
9 O 0 1.495159374087507e-08
preferentially O 0 3.3802063370558244e-09
affect O 0 2.630168305373104e-09
amino O 0 1.6821875004069398e-09
acids O 0 2.1705967578888874e-10
with O 0 1.6139884567722973e-11
different O 0 2.6389291793438296e-11
functions O 0 6.503644289779231e-10
. O 0 5.368805955363598e-10
. O 0 3.7027347854490245e-09

The O 0 1.2455383284759591e-06
185delAG O 0 1.3192039659770671e-05
BRCA1 O 0 5.699236567124899e-07
mutation O 0 2.8689679520965683e-09
originated O 0 2.2701855950657546e-09
before O 0 4.410518061881419e-10
the O 0 3.223628308735016e-11
dispersion O 0 1.688639339469944e-09
of O 0 7.661953294046953e-10
Jews O 0 3.2884270306787755e-10
in O 0 7.966483028809535e-11
the O 0 1.0469048544736737e-10
diaspora O 0 2.0660724520116247e-10
and O 0 1.538452837346327e-10
is O 0 2.482508296153263e-11
not O 0 6.456399651022515e-12
limited O 0 4.2713002579297665e-10
to O 0 3.4708091956048293e-09
Ashkenazim O 0 3.251453745178878e-05
. O 0 2.3223306300224067e-07

The O 0 1.5638927379768575e-06
185delAG O 0 5.441971552500036e-06
mutation O 0 1.5304001621530006e-08
in O 0 8.262458273122775e-09
BRCA1 O 0 3.705301310219511e-08
is O 0 8.702734366483611e-11
detected O 0 2.8709221666645135e-09
in O 0 1.8245549515683024e-10
Ashkenazi O 0 6.109926786734832e-09
Jews O 0 1.6067258634677728e-09
both O 0 4.0354022901034625e-10
in O 0 4.198630332297171e-09
familial B-Disease 0 0.1538463979959488
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.110627488922546e-08
in O 0 1.2861764986382695e-09
the O 0 1.7620432890552706e-09
general O 0 3.3933129639507342e-09
population O 0 1.180930075950215e-10
. O 0 4.85076778744542e-09

All O 0 2.056329435617954e-07
tested O 0 4.2791083387783146e-07
Ashkenazi O 0 6.359874191730341e-07
mutation O 0 4.967609879003021e-09
carriers O 0 1.1449924341988549e-09
share O 0 2.9440186399831703e-10
the O 0 6.344959557758045e-10
same O 0 3.1370250841433744e-10
allelic O 0 5.260041007204563e-07
pattern O 0 9.256589805772819e-08
at O 0 7.767388865431712e-08
the O 0 2.676041077620539e-08
BRCA1 O 0 9.575264812156092e-07
locus O 0 2.990908285482874e-07
. O 0 5.6705840023596465e-08

Our O 0 1.3052306258032331e-06
previous O 0 1.4884307120155427e-07
study O 0 5.728741925281611e-09
showed O 0 8.767884196458908e-10
that O 0 2.2477685945182513e-12
this O 0 4.306783662338942e-12
Ashkenazi O 0 2.505564289378981e-08
mutation O 0 6.686406428535463e-10
also O 0 7.275568342235417e-11
occurs O 0 5.181141279897439e-11
in O 0 2.7812533526239136e-11
Iraqi O 0 1.1140657285579891e-09
Jews O 0 9.909254528039924e-10
with O 0 1.040068170476971e-10
a O 0 2.5887580967776103e-10
similar O 0 2.1849448916810843e-09
allelic O 0 6.856448180769803e-06
pattern O 0 2.8157066935818875e-06
. O 0 7.154110903684341e-08

We O 0 3.6386555990475244e-08
extended O 0 1.7120587614272154e-08
our O 0 2.546117094937017e-09
analysis O 0 1.2099593549308452e-10
to O 0 4.7554619964085276e-11
other O 0 1.3293771639055763e-10
non O 0 8.06319988555515e-08
- O 0 3.919195634694006e-08
Ashkenazi O 0 2.0262291400285903e-08
subsets O 0 2.7620307818665424e-08
354 O 0 2.700298118440969e-08
of O 0 4.734894698543712e-09
Moroccan O 0 3.2154659379557415e-08
origin O 0 4.186401503236681e-10
, O 0 2.7290683601854937e-10
200 O 0 3.5562157663093785e-09
Yemenites O 0 1.4839351933915168e-06
and O 0 6.094388993460598e-09
150 O 0 8.813695551168621e-09
Iranian O 0 4.1813780882193896e-08
Jews O 0 1.1050302362036746e-07
. O 0 6.201614155543211e-08

Heteroduplex O 0 0.00019888364477083087
analysis O 0 4.2514965770124036e-08
complemented O 0 6.207531555446621e-08
by O 0 8.92731444324113e-11
direct O 0 3.43575390360229e-10
DNA O 0 1.2050019648768284e-08
sequencing O 0 4.3884935685412074e-09
of O 0 6.253233042485817e-09
abnormally O 0 7.996789719300068e-08
migrating O 0 3.801511994083739e-09
bands O 0 1.336852051281312e-07
were O 0 9.78732761502954e-10
employed O 0 5.226727850526913e-08
. O 0 2.5928027724830827e-08

Four O 0 4.5936772608001775e-07
of O 0 2.6529892238613684e-07
Moroccan O 0 2.949513486782962e-07
origin O 0 6.655770601327049e-09
( O 0 2.170166268911089e-10
1 O 0 1.4351401178558376e-09
. O 0 2.793118861199595e-11
1 O 0 4.017293719904558e-10
% O 0 6.057849968182927e-12
) O 0 4.248375522902803e-12
and O 0 6.7874636466847e-11
none O 0 1.2199499188625396e-09
of O 0 3.944466531180524e-09
the O 0 1.0425857510654168e-08
Yemenites O 0 2.6400366550660692e-06
or O 0 2.659294562334935e-09
Iranians O 0 1.4948250415258713e-09
was O 0 3.9373708737855395e-09
a O 0 9.559469882347571e-11
carrier O 0 8.774810322798032e-10
of O 0 6.705413113650138e-09
the O 0 7.372157106999566e-09
185delAG O 0 4.138408712606179e-06
mutation O 0 4.464513381208235e-08
. O 0 3.659298286606827e-08

BRCA1 O 0 6.366914021782577e-05
allelic O 0 2.154596586478874e-05
patterns O 0 4.138643703299749e-07
were O 0 4.571203415792979e-09
determined O 0 4.331419667380487e-10
for O 0 4.255676366859973e-11
four O 0 1.0692669666356736e-10
of O 0 3.5503988637941575e-10
these O 0 1.0422680947475005e-11
individuals O 0 1.6261220885452343e-12
and O 0 1.7938234231351657e-10
for O 0 1.9374113424674988e-10
12 O 0 2.0115491494721027e-09
additional O 0 1.792243298215368e-10
non O 0 1.945152519056137e-07
- O 0 4.433608182807802e-07
Ashkenazi O 0 3.189749975263112e-07
185delAG O 0 5.728044811803557e-07
mutation O 0 2.8276312402653048e-09
carriers O 0 1.6545638192866363e-09
who O 0 3.273184834284848e-09
had O 0 5.026677740715968e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.765564760120469e-07

Six O 0 3.604870016715722e-06
non O 0 1.5614201402058825e-05
- O 0 2.7625869734038133e-06
Ashkenazi O 0 4.293677591249434e-07
individuals O 0 1.3346897198562857e-10
shared O 0 2.388008457643309e-09
the O 0 4.08729672329855e-09
common O 0 5.131725266949161e-09
Ashkenazi O 0 2.9202928431004693e-07
haplotype O 0 9.634403141944858e-08
, O 0 1.1071389360850503e-09
four O 0 5.871520492028992e-10
had O 0 5.236411304565536e-10
a O 0 4.103456463511179e-10
closely O 0 1.3835660395145055e-09
related O 0 1.0957847962345113e-07
pattern O 0 5.530520184038323e-07
, O 0 5.727515683950912e-10
and O 0 5.04727981631703e-10
the O 0 2.077588767690486e-09
rest O 0 1.0631914904024597e-08
( O 0 2.474723204137774e-10
n O 0 1.7712455946394812e-09
= O 0 3.111456647886257e-09
6 O 0 1.8267611423539165e-08
) O 0 6.609864738882365e-11
displayed O 0 4.854275648114026e-09
a O 0 8.21711254594959e-10
distinct O 0 4.751205651132295e-09
BRCA1 O 0 9.64307787398866e-07
allelic O 0 1.6186888387892395e-05
pattern O 0 4.75075057693175e-06
. O 0 1.5074732573339134e-07

We O 0 5.6158196315436726e-08
conclude O 0 7.412599245526508e-08
that O 0 9.005057810540507e-11
the O 0 1.973489149875718e-09
185delAG O 0 2.157022436222178e-06
BRCA1 O 0 1.8385905775630818e-07
mutation O 0 9.356625474410407e-10
occurs O 0 1.489311868274612e-10
in O 0 2.936098933425946e-11
some O 0 2.4682497365424716e-11
non O 0 1.0422521512509775e-07
- O 0 1.2278319161396212e-07
Ashkenazi O 0 5.3814734002344267e-08
populations O 0 3.31270816333884e-10
at O 0 2.2718142922428797e-09
rates O 0 1.9732358802482253e-10
comparable O 0 1.4086602995178055e-09
with O 0 3.648769134056984e-11
that O 0 2.16518730028481e-11
of O 0 2.001110743776735e-08
Ashkenazim O 0 3.675793777802028e-05
. O 0 1.6010862680104765e-07

The O 0 1.6794191992630658e-07
majority O 0 8.927864558749832e-10
of O 0 3.567744988330901e-09
Jewish O 0 4.808929077171342e-08
185delAG O 0 2.855553475455963e-06
mutation O 0 6.918873030059558e-09
carriers O 0 6.640525351819804e-10
have O 0 4.749832818728983e-11
a O 0 2.1306729991454887e-10
common O 0 1.681270123121692e-09
allelic O 0 6.651824833170394e-07
pattern O 0 2.0794736599327734e-07
, O 0 8.820384977958895e-10
supporting O 0 1.5793618635129292e-09
the O 0 3.840920026476624e-09
founder O 0 1.2205433108647412e-07
effect O 0 4.491029770292698e-09
notion O 0 2.548779853839278e-09
, O 0 6.813417885442874e-11
but O 0 4.844722713281957e-12
dating O 0 3.990336117087878e-10
the O 0 3.7348981546392324e-11
mutations O 0 1.662543366864888e-11
origin O 0 1.0961798309339077e-11
to O 0 9.323924445026055e-12
an O 0 6.502472605501852e-12
earlier O 0 4.775789208544268e-10
date O 0 3.396304570912889e-09
than O 0 3.657897248987574e-11
currently O 0 4.582453583257262e-10
estimated O 0 2.730958514884918e-10
. O 0 1.8208197616331745e-08

However O 0 1.3452032021632476e-07
, O 0 1.1825377344010235e-09
the O 0 2.673706811506804e-10
different O 0 6.490753073906674e-11
allelic O 0 3.5980278312308656e-07
pattern O 0 1.0345062406713623e-07
at O 0 4.4837396018237996e-08
the O 0 7.620841735445083e-09
BRCA1 O 0 6.089824466926075e-08
locus O 0 2.349703764892297e-09
even O 0 6.179431272235192e-11
in O 0 2.471500261391757e-11
some O 0 3.135101770204707e-12
Jewish O 0 1.878399213950388e-09
mutation O 0 3.59038659913935e-10
carriers O 0 3.530653269745443e-10
, O 0 1.7049593681317532e-10
might O 0 2.703908208445682e-10
suggest O 0 1.8015106073576703e-10
that O 0 5.792316279396026e-12
the O 0 4.812364395867519e-10
mutation O 0 3.6392763802517436e-10
arose O 0 8.331800804839418e-10
independently O 0 1.7354335746233573e-09
. O 0 1.0785381476807743e-09
. O 0 9.52782475138747e-09

Crystal O 0 0.0013678695540875196
structure O 0 1.6373518292311928e-06
of O 0 2.6247805635648547e-06
the O 0 1.5966826367730391e-06
hemochromatosis B-Disease 1 1.0
protein O 0 2.7697441851159965e-07
HFE O 1 0.9814552664756775
and O 0 8.605012702389558e-09
characterization O 0 1.202577415426731e-08
of O 0 2.8863082590646627e-08
its O 0 1.3263057319079508e-09
interaction O 0 8.748807234226774e-10
with O 0 8.132634565782837e-10
transferrin O 0 4.381202813874552e-07
receptor O 0 4.101816841739492e-08
. O 0 2.5038444206870736e-08

HFE O 1 0.9976874589920044
is O 0 5.0880451851753605e-08
an O 0 2.5542497006370013e-09
MHC O 0 0.00012066298222634941
- O 0 4.1863286242005415e-06
related O 0 2.3229064538554667e-07
protein O 0 2.269038512636712e-09
that O 0 3.7269708152987135e-11
is O 0 1.0221613486183223e-11
mutated O 0 5.93460502962273e-10
in O 0 5.401190605880402e-10
the O 0 2.9749658736477613e-08
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0001613662752788514

HFE O 0 0.007166444789618254
binds O 0 4.515166835972195e-07
to O 0 1.2661016235426814e-08
transferrin O 0 2.6460355684321257e-07
receptor O 0 1.9127099903926137e-08
( O 0 3.3879388183777337e-09
TfR O 0 1.1670304047584068e-06
) O 0 1.2303151553094693e-10
and O 0 1.930278020756404e-10
reduces O 0 1.198167121074789e-09
its O 0 1.942169342017408e-10
affinity O 0 7.463323847822778e-10
for O 0 8.689005626116852e-10
iron O 0 1.6803272728793672e-06
- O 0 7.823532399697797e-08
loaded O 0 6.950660491611416e-08
transferrin O 0 2.0190039151657402e-07
, O 0 5.01070784864055e-09
implicating O 0 5.4502619605045766e-05
HFE O 1 0.9999678134918213
in O 0 3.8067237255745567e-06
iron O 1 0.9999860525131226
metabolism O 0 0.03347967565059662
. O 0 3.4382952662781463e-07

The O 0 6.597079845960252e-06
2 O 0 4.418431217345642e-06
. O 0 1.1688999990155935e-07

6 O 0 5.7443550758762285e-05
A O 0 1.2023927411064506e-05
crystal O 0 3.7764941225759685e-05
structure O 0 8.987377100311278e-07
of O 0 5.0745961743814405e-06
HFE O 1 0.9999985694885254
reveals O 0 7.294198667295859e-08
the O 0 9.585218174734678e-10
locations O 0 1.3947480503873066e-08
of O 0 2.013215862461948e-06
hemochromatosis B-Disease 1 1.0
mutations O 0 3.0811125384389015e-07
and O 0 9.419824920087194e-08
a O 0 4.0718924765315023e-07
patch O 1 0.9999980926513672
of O 1 0.9773002862930298
histidines O 1 0.9997568726539612
that O 0 5.063633401469758e-10
could O 0 1.2034365171054162e-10
be O 0 5.5859317171780276e-11
involved O 0 8.523740602228713e-10
in O 0 3.9204941515436076e-09
pH O 0 9.704215244710213e-07
- O 0 4.0629709019412985e-07
dependent O 0 2.236739327088344e-08
interactions O 0 5.4094545731686594e-08
. O 0 4.6606622561284894e-08

We O 0 9.081325913484761e-08
also O 0 1.5112373574766025e-09
demonstrate O 0 6.292572241051175e-09
that O 0 1.4215666144234973e-10
soluble O 0 1.69412842865313e-07
TfR O 0 1.2260337825864553e-05
and O 0 2.1693530527500116e-08
HFE O 0 0.0005221369792707264
bind O 0 8.366568771123184e-09
tightly O 0 2.982465474588025e-08
at O 0 1.2608192712093569e-08
the O 0 3.09343634041781e-10
basic O 0 1.4969849804202795e-09
pH O 0 1.3596300085794155e-08
of O 0 9.331214911867391e-09
the O 0 1.569604890505616e-09
cell O 0 1.5494681093741747e-08
surface O 0 4.073764259260315e-08
, O 0 2.8813545993600087e-10
but O 0 1.166984304329377e-11
not O 0 1.0711689348019693e-11
at O 0 1.8606414187161135e-09
the O 0 6.583044109831349e-10
acidic O 0 5.728974628027572e-08
pH O 0 2.492742510185053e-07
of O 0 1.4951771731830377e-07
intracellular O 0 9.095659265767608e-07
vesicles O 0 4.3787116737803444e-05
. O 0 5.273688543638855e-07

TfR O 0 0.007909701205790043
HFE O 0 0.010741453617811203
stoichiometry O 0 1.430553038517246e-05
( O 0 1.2700154172762268e-07
2 O 0 6.844166478003899e-08
1 O 0 1.3229588091689948e-08
) O 0 4.369379164037568e-11
differs O 0 6.10460848537997e-11
from O 0 2.9769267606560845e-10
TfR O 0 1.2795003101473412e-07
transferrin O 0 7.447202410304499e-09
stoichiometry O 0 1.3410142329917107e-08
( O 0 2.0745308249026095e-10
2 O 0 4.07858991025023e-09
2 O 0 2.9190374561949284e-09
) O 0 2.603423379654579e-11
, O 0 9.596513687870623e-12
implying O 0 8.478627522290338e-11
a O 0 1.866184116960934e-11
different O 0 3.9846125531040055e-12
mode O 0 8.325494182948034e-10
of O 0 4.0356795683038627e-10
binding O 0 2.8998908829791503e-10
for O 0 7.945151758725899e-10
HFE O 0 0.017202341929078102
and O 0 7.061016660259156e-09
transferrin O 0 1.0335674005546025e-07
to O 0 2.992903702647709e-09
TfR O 0 3.792399638768984e-06
, O 0 2.1146011608408344e-09
consistent O 0 6.48217390875061e-09
with O 0 1.645778374692597e-10
our O 0 4.007148390883231e-09
demonstration O 0 6.616256342795168e-08
that O 0 1.9994682298740685e-10
HFE O 0 0.0005487647140398622
, O 0 2.364098028451167e-09
transferrin O 0 7.465266804729254e-08
, O 0 8.175809473875972e-10
and O 0 2.6877178260775736e-09
TfR O 0 2.324753268112545e-06
form O 0 2.8876834257118844e-09
a O 0 1.6347168063646222e-09
ternary O 0 6.420871727641497e-07
complex O 0 4.16460261476459e-06
. O 0 2.3599955056852195e-07

Identification O 0 9.254044357476232e-07
of O 0 2.8091574222344207e-07
three O 0 2.3956816530557035e-09
novel O 0 3.422164995825483e-09
mutations O 0 3.9077710511925545e-10
and O 0 3.36556255087217e-10
a O 0 3.4730920916992147e-10
high O 0 1.8727407180563205e-08
frequency O 0 4.273681852851041e-09
of O 0 1.531485604999716e-09
the O 0 5.164391136958102e-10
Arg778Leu O 0 2.5708725388540188e-06
mutation O 0 5.068889752379846e-10
in O 0 3.300390793992136e-10
Korean O 0 7.278902671714604e-07
patients O 0 2.5987425544826692e-09
with O 0 2.2561177370761243e-09
Wilson B-Disease 1 0.9652385115623474
disease I-Disease 1 0.7810622453689575
. O 0 1.0319363497046652e-07

Four O 0 8.946671528065053e-07
mutations O 0 3.6773780465182426e-08
- O 0 1.159052203547617e-06
- O 0 7.181063210737193e-07
R778L O 0 2.152760089302319e-06
, O 0 2.3721469233350945e-09
A874V O 0 6.89460932790098e-07
, O 0 1.2606958810224e-09
L1083F O 0 1.2891003109416488e-07
, O 0 4.403777065231651e-10
and O 0 5.702955885311667e-10
2304delC O 0 1.8404114143777406e-07
- O 0 5.0358224257252004e-08
- O 0 1.6929584845115642e-08
in O 0 3.958852690111314e-10
the O 0 2.122480857735809e-09
copper O 0 1.1464532434501962e-07
- O 0 3.026579165066323e-08
transporting O 0 8.840233078899473e-08
enzyme O 0 2.623024242254246e-09
, O 0 1.8635291088031636e-09
P O 0 3.765568976632494e-07
- O 0 3.088893762992484e-08
type O 0 1.7544651953471657e-08
ATPase O 0 7.622443831678538e-08
( O 0 6.753958281535688e-09
ATP7B O 1 0.9999920129776001
) O 0 2.532825060796995e-10
, O 0 3.8108221439570045e-11
were O 0 4.993157970423212e-11
identified O 0 1.1221521628579367e-10
in O 0 3.6757263899289683e-10
Korean O 0 1.147871557805047e-06
Patients O 0 2.2456134729509358e-08
with O 0 9.761828678733764e-09
Wilson B-Disease 1 0.9997686743736267
disease I-Disease 1 0.9930869936943054
. O 0 6.21324147687119e-08

Arg778Leu O 0 0.18776854872703552
, O 0 4.974457823436751e-08
the O 0 3.4254039604775244e-09
most O 0 8.701124543097905e-11
frequently O 0 6.896099663533661e-11
reported O 0 1.436114144270917e-10
mutation O 0 2.0482737034255294e-11
of O 0 4.186473112621769e-10
this O 0 1.1393294294115286e-11
enzyme O 0 2.9279914603996815e-10
, O 0 5.974867822722274e-10
was O 0 2.9574374060814534e-09
found O 0 9.151997909517817e-11
in O 0 5.916191148092054e-11
six O 0 1.8634463416766778e-10
of O 0 2.3964130679843265e-09
eight O 0 3.942210113905276e-09
unrelated O 0 4.0547483592945355e-08
patients O 0 1.3595359282803088e-09
studied O 0 3.6476471620972006e-08
, O 0 3.640177048680471e-11
an O 0 5.142682286962685e-12
allele O 0 4.384698853998614e-11
frequency O 0 1.075142974649168e-09
of O 0 9.605684248015223e-09
37 O 0 1.658840602658529e-07
. O 0 1.304340102592505e-08

5 O 0 1.3340555824470357e-06
% O 0 2.3544861615931723e-09
, O 0 2.056553954910001e-10
which O 0 2.5929669869584338e-11
is O 0 4.543458925060362e-12
considerably O 0 1.1017875500840546e-10
higher O 0 2.483797889585304e-10
than O 0 2.3880595851483166e-12
those O 0 4.543355275332672e-12
in O 0 3.408273663296768e-11
other O 0 9.434161091226301e-11
Asian O 0 1.6833878735411645e-09
populations O 0 2.1991466980786356e-10
. O 0 2.8859596934438514e-09

The O 0 1.9812448215361655e-07
novel O 0 2.5486061261403847e-08
single O 0 1.8136334656304598e-09
nucleotide O 0 2.9330737838506593e-09
deletion O 0 4.440443568398678e-09
, O 0 7.308869620636926e-10
2304delC O 0 4.523942607193021e-07
, O 0 8.97628749108037e-10
was O 0 4.165773503927994e-09
found O 0 2.225239298381254e-10
in O 0 2.7674171287905835e-10
one O 0 1.053212184132235e-09
patient O 0 4.1628177882557793e-07
. O 0 8.804190088085306e-08

Since O 0 1.0549824480676762e-07
a O 0 4.03445765684296e-09
mutation O 0 6.685960118879564e-10
at O 0 1.3366782347645767e-08
cDNA O 0 1.6641067190903414e-08
nucleotide O 0 6.221803516837099e-08
2302 O 0 1.1103010365332011e-05
( O 0 2.0515169563140034e-09
2302insC O 0 1.82139331172948e-07
) O 0 1.646155017853701e-10
had O 0 1.8023080250451073e-10
been O 0 4.144577042675124e-11
previously O 0 5.700910854500307e-10
described O 0 5.98697202924825e-10
, O 0 2.8011055280829922e-11
this O 0 3.712792660121034e-12
region O 0 3.6057523633559185e-10
of O 0 3.4053142528023272e-09
the O 0 5.649680279162794e-09
ATP7B O 1 1.0
gene O 0 7.714910488232363e-09
may O 0 2.3154365924593634e-10
be O 0 1.3732959214252105e-10
susceptible O 0 4.417038823589792e-08
to O 0 3.1726612448323976e-09
gene O 0 2.3295574180792755e-07
rearrangements O 0 0.3729400038719177
causing O 1 0.9999427795410156
Wilson B-Disease 1 0.9999892711639404
disease I-Disease 1 0.9175609946250916
. O 0 9.049579574593736e-08

Disruption O 0 2.4437633328489028e-05
of O 0 9.210743314724823e-07
splicing O 0 1.3273343313358055e-07
regulated O 0 2.2027718316053324e-08
by O 0 1.0046946607999985e-09
a O 0 6.737849389537587e-09
CUG O 1 0.7287214994430542
- O 0 2.5005951442835794e-07
binding O 0 1.7261646334532088e-08
protein O 0 7.23402564517528e-08
in O 0 2.671811216714559e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.6316034816554748e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9802480340003967
DM B-Disease 1 1.0
) O 0 3.961266941132635e-07
is O 0 9.70731051097573e-10
caused O 0 5.043461648313041e-09
by O 0 3.889856770022959e-10
a O 0 2.3912809510306943e-09
CTG O 0 5.2217597840353847e-05
expansion O 0 2.4324535274899972e-08
in O 0 1.1084616557965887e-09
the O 0 1.4796264213856603e-09
3 O 0 1.6178404393940582e-08
untranslated O 0 1.3270373528939672e-05
region O 0 9.099371922616228e-09
of O 0 3.150585925482119e-08
the O 0 1.3977046364743728e-07
DM B-Disease 1 1.0
gene O 0 3.208857378922403e-06
. O 0 9.262470967996705e-08

One O 0 5.600448815812342e-08
model O 0 6.271426400417113e-08
of O 0 2.0237089302099776e-06
DM B-Disease 1 1.0
pathogenesis O 1 0.9921453595161438
suggests O 0 2.866338633111809e-08
that O 0 5.515990442184204e-11
RNAs O 0 2.3270033011613123e-08
from O 0 1.6705872241118414e-09
the O 0 2.117910014032276e-10
expanded O 0 4.831310351782747e-10
allele O 0 4.770733808001637e-11
create O 0 3.196626990886742e-11
a O 0 8.948470436864753e-11
gain O 0 1.8342202756649328e-10
- O 0 3.6482021847916712e-09
of O 0 3.874213394539083e-09
- O 0 2.2983919212293813e-09
function O 0 2.6171896247428883e-11
mutation O 0 8.765183023839995e-12
by O 0 3.746868700721384e-12
the O 0 9.822219426691703e-11
inappropriate O 0 4.917924401048879e-10
binding O 0 5.060795116307304e-10
of O 0 3.535318038316859e-09
proteins O 0 7.073869268126032e-11
to O 0 2.793312248172697e-10
the O 0 2.5239204504146073e-08
CUG O 1 0.9999768733978271
repeats O 0 2.019760131588555e-06
. O 0 5.35029869297432e-08

Data O 0 6.964460794733895e-07
presented O 0 2.637977729591512e-07
here O 0 4.3920356240789715e-09
indicate O 0 6.1322108502182e-10
that O 0 1.3107924468069854e-11
the O 0 2.302137647181013e-10
conserved O 0 1.4070337783778086e-08
heterogeneous O 0 2.2362577567491826e-07
nuclear O 0 1.453166623832658e-05
ribonucleoprotein O 0 2.7335852792020887e-05
, O 0 3.18440598334746e-08
CUG O 0 0.0019575944170355797
- O 0 6.460009416286994e-08
binding O 0 5.342301268029814e-09
protein O 0 4.3339420940924356e-09
( O 0 1.6129622082416972e-09
CUG O 1 0.9983225464820862
- O 0 1.8301320778846275e-06
BP O 0 4.290429933462292e-05
) O 0 1.058428011901924e-09
, O 0 2.646920460591673e-10
may O 0 5.061490115920719e-10
mediate O 0 2.1339003453135774e-08
the O 0 1.618139755521497e-08
trans O 0 1.3637625784213014e-07
- O 0 1.8476569607628335e-07
dominant O 0 1.56606816403837e-08
effect O 0 8.103029913719695e-10
of O 0 2.682453148494801e-09
the O 0 1.8142666258214035e-09
RNA O 0 1.407308047873812e-07
. O 0 4.599829406259914e-09

CUG O 1 0.9999957084655762
- O 0 0.0004209269827697426
BP O 0 0.0004332509124651551
was O 0 2.5123316049757705e-07
found O 0 5.438477446162437e-10
to O 0 4.0774893877992824e-11
bind O 0 1.1499250163193864e-10
to O 0 1.1852197001616105e-10
the O 0 4.291112354337656e-09
human O 0 6.42262349970224e-08
cardiac O 1 0.9999992847442627
troponin O 1 0.9999978542327881
T O 1 0.999990701675415
( O 0 3.988179386738011e-08
cTNT O 0 4.1038233575818595e-06
) O 0 2.945630683814926e-10
pre O 0 8.177218546734366e-07
- O 0 5.7207195425235113e-08
messenger O 0 7.94970311801535e-09
RNA O 0 1.7454730993904377e-08
and O 0 2.729869941209273e-10
regulate O 0 8.518881156049929e-10
its O 0 5.183496409877364e-10
alternative O 0 1.111610536952412e-08
splicing O 0 3.2345536737921066e-07
. O 0 1.4433901185384457e-08

Splicing O 0 1.3032918104727287e-05
of O 0 6.990891961322632e-06
cTNT O 0 0.00017073679191526026
was O 0 6.424375555980077e-07
disrupted O 0 5.201683052291628e-06
in O 0 1.1551872347581593e-07
DM B-Disease 1 1.0
striated O 0 0.40527239441871643
muscle O 0 5.7903343986254185e-06
and O 0 8.377251781155337e-09
in O 0 3.1081823781420326e-09
normal O 0 9.272400625093269e-09
cells O 0 1.2108787306175373e-09
expressing O 0 2.1118844450995766e-09
transcripts O 0 1.1755764006693425e-07
that O 0 5.015228232707614e-10
contain O 0 5.289338105285424e-07
CUG O 1 0.9999943971633911
repeats O 0 5.779124421678716e-06
. O 0 1.0039732956101943e-07

Altered O 0 2.685670096980175e-06
expression O 0 1.1198999771977469e-07
of O 0 7.180755545732609e-08
genes O 0 4.014606869162662e-09
regulated O 0 1.8814591840055073e-07
posttranscriptionally O 0 8.031807738007046e-06
by O 0 2.2653553699569784e-08
CUG O 1 0.9999998807907104
- O 0 3.2396426831837744e-05
BP O 0 1.4210608242137823e-05
therefore O 0 1.7336800883782644e-09
may O 0 3.1188046589747387e-10
contribute O 0 1.7119981821078767e-10
to O 0 9.693549962719317e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9872996211051941
. O 0 1.2952959593803826e-08
. O 0 1.906554558672724e-08

Identification O 0 2.6932261789625045e-06
of O 0 5.91041441566631e-07
a O 0 4.847253265438667e-09
novel O 0 2.6506366879175403e-08
nonsense O 0 4.903692456537101e-07
mutation O 0 1.365562662947184e-09
and O 0 3.3875233174107677e-10
a O 0 3.2222652324165324e-10
missense O 0 4.237715067745285e-09
substitution O 0 1.2492406220587782e-08
in O 0 4.136036846347224e-09
the O 0 4.523345253915068e-09
vasopressin O 0 3.2591080412203155e-07
- O 0 6.726846777382889e-07
neurophysin O 0 4.142939724260941e-05
II O 1 1.0
gene O 0 6.272716124300359e-09
in O 0 2.3407561999810866e-10
two O 0 1.1002126293346848e-10
Spanish O 0 3.7588879564509625e-08
kindreds O 0 1.8166364270655322e-06
with O 0 9.66323820961179e-09
familial B-Disease 1 0.9994576573371887
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999957084655762
. O 0 4.302697107050335e-06

Familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.007808507885783911
FNDI B-Disease 1 1.0
) O 0 5.373216893644894e-08
is O 0 1.952290273887769e-10
an O 0 5.437689742926466e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.4232439696788788
by O 0 4.318447963669314e-07
deficiency O 1 0.9977332353591919
in O 0 1.2903350921078527e-07
the O 0 6.941689889572444e-07
antidiuretic O 0 9.837368270382285e-05
hormone O 0 1.238016011484433e-06
arginine O 0 3.174732228217181e-06
vasopressin O 0 1.4482512824542937e-06
( O 0 2.5140327153394537e-08
AVP O 0 0.045815154910087585
) O 0 1.8397212919740724e-10
encoded O 0 6.332587926261013e-11
by O 0 5.6491682859372006e-11
the O 0 3.358029854183542e-09
AVP O 1 0.9454759955406189
- O 0 2.2333217657433124e-06
neurophysin O 0 0.00037082398193888366
II O 1 1.0
( O 0 3.457016362062859e-07
AVP O 1 0.9999920129776001
- O 0 6.812362244090764e-06
NPII O 1 0.999180257320404
) O 0 1.1238447950034924e-09
gene O 0 8.56456350284418e-10
on O 0 1.2104798940981709e-08
chromosome O 0 3.773254420025296e-08
20p13 O 0 2.9960292522446252e-06
. O 0 3.980739293751867e-08

In O 0 4.2302069402921916e-08
this O 0 7.755490000205256e-11
study O 0 5.901318322898419e-10
, O 0 4.595545818886215e-11
we O 0 8.8002443873747e-12
analyzed O 0 5.894276178253222e-10
two O 0 2.6654770404754835e-11
families O 0 3.4645140489092396e-12
with O 0 1.0134551531315594e-10
FNDI B-Disease 1 1.0
using O 0 3.855634700400401e-10
direct O 0 1.293341822528049e-10
automated O 0 4.901102101939614e-08
fluorescent O 0 1.55990974803899e-07
, O 0 1.0763864244367483e-09
solid O 0 2.386015474087344e-08
phase O 0 3.8396692048081604e-08
, O 0 1.3984734203997817e-10
single O 0 3.504848078428324e-10
- O 0 8.509283833113557e-10
stranded O 0 3.6742192621730396e-10
DNA O 0 9.802105793710325e-10
sequencing O 0 4.960960531263936e-10
of O 0 2.920223618474438e-09
PCR O 0 1.8223453253085609e-06
- O 0 2.430511813145131e-06
amplified O 0 7.00730161042884e-05
AVP O 1 0.9999300241470337
- O 0 2.227399090770632e-05
NPII O 1 0.9956218600273132
DNA O 0 7.693151019338984e-06
. O 0 4.965291466874078e-08

In O 0 1.2984057207177102e-07
one O 0 1.914125080659801e-09
of O 0 8.516400029634497e-09
the O 0 1.1213439066182218e-09
families O 0 1.9161103259612844e-11
, O 0 3.7387894863405435e-11
affected O 0 2.400684928627328e-10
individuals O 0 1.0028748664847598e-11
presented O 0 4.4551966560391065e-09
a O 0 1.291028284278184e-09
novel O 0 3.3343832139820506e-09
nonsense O 0 2.2408940481000172e-08
mutation O 0 1.8778643917638504e-10
in O 0 2.857694358926466e-10
exon O 0 9.604639750193655e-09
3 O 0 2.9815310220726587e-09
of O 0 2.0990420512845276e-09
the O 0 9.03589425504947e-10
gene O 0 2.092668816011667e-10
, O 0 6.559452980781089e-11
consisting O 0 8.271237028623091e-10
in O 0 2.077468891359402e-10
a O 0 1.1435302704754235e-09
G O 0 3.456779950283817e-06
to O 0 1.8730585082948892e-08
T O 0 0.00016102936933748424
transition O 0 5.13471434260282e-08
at O 0 3.0963676067585766e-08
nucleotide O 0 2.9357616782021978e-08
2101 O 0 7.66769971960457e-06
, O 0 2.828099143759033e-10
which O 0 5.4275733213371424e-11
produces O 0 5.055739160653161e-10
a O 0 2.932820653001045e-10
stop O 0 1.9449730714882207e-09
signal O 0 7.809127566815732e-09
in O 0 7.617989017383309e-10
codon O 0 4.555747068479832e-08
82 O 0 9.866621297760503e-08
( O 0 2.6790019092004513e-09
Glu O 0 0.3921281397342682
) O 0 8.83502160320404e-09
of O 0 7.196392743935576e-07
NPII O 1 0.9999998807907104
. O 0 7.162234396673739e-07

The O 0 2.0538336684694514e-06
premature O 0 2.2500396426039515e-06
termination O 0 8.176079973054584e-07
eliminates O 0 1.9704646092577605e-07
part O 0 1.8833974380072505e-08
of O 0 2.5874326681218918e-08
the O 0 5.402326586079198e-09
C O 0 3.5154550914739957e-06
- O 0 1.0678536277453077e-08
terminal O 0 1.965577700602239e-09
domain O 0 1.3803022613778637e-10
of O 0 2.19575291282581e-09
NPII O 0 0.10781034827232361
, O 0 3.9214273495069563e-10
including O 0 4.2688569346083227e-10
a O 0 3.0648703019942047e-10
cysteine O 0 4.738951453475693e-09
residue O 0 8.826300756936689e-08
in O 0 8.281039742819019e-10
position O 0 2.4477970761438428e-09
85 O 0 1.4514625057415742e-08
, O 0 1.1636286378902128e-10
which O 0 2.394624082358021e-11
could O 0 5.98594160350352e-11
be O 0 4.905209224914664e-11
involved O 0 2.7480237529964313e-10
in O 0 6.749255043736468e-10
the O 0 1.1184004833353356e-09
correct O 0 3.339635767929394e-08
folding O 0 3.799752903432818e-07
of O 0 1.5990842427981988e-07
the O 0 2.469191144882643e-07
prohormone O 0 0.005482861306518316
. O 0 2.3865987941462663e-07

In O 0 8.457997324740063e-08
the O 0 1.279573069723483e-08
second O 0 2.250600417141868e-08
family O 0 2.9969979276067704e-10
, O 0 9.082959384620892e-11
a O 0 1.1545357031517156e-10
G279A O 0 2.174398794352328e-08
substitution O 0 3.790448399598745e-09
at O 0 1.1656045906249801e-08
position O 0 2.1390296200962666e-09
- O 0 5.416079584819045e-09
1 O 0 1.2481610189851722e-09
of O 0 4.630575367592371e-10
the O 0 2.367661622315609e-10
signal O 0 8.402519569017386e-09
peptide O 0 1.8002852542053915e-09
was O 0 9.114810017862851e-10
observed O 0 1.9260265604614801e-10
in O 0 2.714706931472577e-11
all O 0 3.115782631901709e-11
affected O 0 6.40995145850809e-10
individuals O 0 1.0351363516347689e-10
. O 0 1.5309957746012515e-08

This O 0 1.1698452873076803e-08
missense O 0 1.7646208334554103e-06
mutation O 0 2.926185516116675e-08
, O 0 3.752989918837102e-09
which O 0 3.634512912853438e-09
replaces O 0 2.2453523342846893e-05
Ala O 0 0.0004084716201759875
with O 0 4.57973214906815e-08
Thr O 1 0.9997437596321106
, O 0 1.4429689443318239e-08
is O 0 2.842359403398831e-10
frequent O 0 2.9686839653209063e-09
among O 0 2.2830398904716276e-08
FNDI B-Disease 1 1.0
patients O 0 3.3260641885135556e-07
and O 0 5.711667139252086e-09
is O 0 4.098465733459733e-10
thought O 0 4.469578318566647e-10
to O 0 5.173725337037638e-11
reduce O 0 3.799038028606816e-10
the O 0 2.458881431799398e-10
efficiency O 0 3.6083822596566506e-09
of O 0 7.656479006357131e-09
cleavage O 0 3.750578514427616e-09
by O 0 4.0418418612020446e-10
signal O 0 1.635448114711835e-07
peptidases O 0 2.580331738499808e-06
. O 0 3.955594518600947e-09
. O 0 1.581138064921106e-08

Genetic O 0 3.1123956887313398e-06
heterogeneity O 0 1.1597782759054098e-05
of O 0 1.962890564755071e-05
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.0309562981092313e-08
due O 0 6.452042100590916e-08
to O 0 5.023214733057557e-09
TWIST O 0 0.008118608966469765
and O 0 2.3426305517659785e-07
FGFR O 1 1.0
mutations O 0 1.887225607788423e-06
. O 0 1.8941372559311276e-07

Thirty O 0 1.4822853700025007e-05
- O 0 1.0845384394997382e-06
two O 0 1.3013771171799249e-09
unrelated O 0 5.458228002908072e-08
patients O 0 2.395905696062073e-09
with O 0 1.4875629894550713e-10
features O 0 5.6913997070751066e-08
of O 0 2.7911242796108127e-05
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.030068527313915e-09
a O 0 3.918655622214828e-09
common O 0 1.5773161976539996e-07
autosomal B-Disease 0 0.03824213147163391
dominant I-Disease 0 0.002599540399387479
condition I-Disease 0 0.00047581145190633833
of O 1 0.9999768733978271
craniosynostosis B-Disease 1 1.0
and O 1 0.9981963038444519
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999998807907104
, O 0 1.224006496158836e-07
were O 0 7.163407644839026e-09
screened O 0 2.4529253295213493e-08
for O 0 3.415485949620489e-10
mutations O 0 2.4947570675948327e-09
in O 0 1.0103756942214659e-08
TWIST O 0 0.00016710419731680304
, O 0 3.754774624553647e-08
FGFR2 O 1 0.9999984502792358
, O 0 2.431062107177695e-08
and O 0 9.501876263584563e-08
FGFR3 O 1 0.9999914169311523
. O 0 4.418851062837348e-07

Nine O 0 3.836759788100608e-06
novel O 0 7.457468598204287e-08
and O 0 3.077395671624572e-09
three O 0 2.024597822725127e-09
recurrent O 0 1.2599974070326425e-05
TWIST O 0 0.0001200464612338692
mutations O 0 9.345304086139095e-09
were O 0 2.5141608794854164e-09
found O 0 5.624228860412472e-10
in O 0 5.8578736306103e-10
12 O 0 1.7252002493250984e-08
families O 0 3.3858180148449435e-10
. O 0 2.07964347964662e-08

Seven O 0 5.160192131370422e-07
families O 0 2.177193564323332e-10
were O 0 1.0500790237344404e-09
found O 0 2.0783844090210835e-10
to O 0 8.940571893933935e-11
have O 0 4.2471214045658456e-11
the O 0 3.2817553119457443e-09
FGFR3 O 1 0.9999667406082153
P250R O 0 7.923259204289934e-07
mutation O 0 2.0207553408368994e-09
, O 0 9.258924876798247e-11
and O 0 5.951390075198404e-11
one O 0 2.5731073521884085e-11
individual O 0 7.549912084403587e-11
was O 0 8.40117309053312e-09
found O 0 2.860350012401369e-10
to O 0 7.809581453743775e-11
have O 0 4.6878827208995943e-11
an O 0 8.067407297751572e-10
FGFR2 O 1 0.999319314956665
VV269 O 0 1.3407221558736637e-05
- O 0 8.582917985222593e-07
270 O 0 2.308349138502308e-07
deletion O 0 4.864803031523479e-07
. O 0 1.1156402734968651e-07

To O 0 2.242052765666358e-08
date O 0 2.8720225486722484e-07
, O 0 1.4404191173156278e-09
our O 0 6.991473511241963e-10
detection O 0 5.023600735398759e-08
rate O 0 4.717197188419675e-10
for O 0 1.4237157286434154e-10
TWIST O 0 1.1404658835090231e-06
or O 0 1.2096744050893449e-08
FGFR O 1 0.9940886497497559
mutations O 0 5.502440725280167e-09
is O 0 2.2829853285610824e-10
68 O 0 8.427478270789379e-09
% O 0 2.6364591065863863e-11
in O 0 2.3668444981694847e-10
our O 0 3.235528112099928e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.306614987901412e-07
, O 0 1.0571690189919991e-09
including O 0 1.0512940740170507e-08
our O 0 6.248394868180185e-08
five O 0 1.4339041953803644e-08
patients O 0 2.610327509700028e-09
elsewhere O 0 4.965781563726068e-09
reported O 0 4.4046442049250345e-09
with O 0 2.571417301311385e-09
TWIST O 0 0.004159074276685715
mutations O 0 6.522993771795882e-07
. O 0 7.016889469468879e-08

More O 0 2.9332989370800533e-08
than O 0 1.454457443372803e-09
35 O 0 4.307841638961918e-09
different O 0 1.5891364613107584e-10
TWIST O 0 3.4371410606581776e-07
mutations O 0 6.742859604003115e-10
are O 0 1.530181710507339e-11
now O 0 9.065167366761884e-11
known O 0 2.875743532193553e-10
in O 0 1.598645799072429e-10
the O 0 5.895074428607927e-10
literature O 0 9.435016323777745e-09
. O 0 6.267537600024298e-09

The O 0 4.4992546577304893e-07
most O 0 1.6982809603049986e-09
common O 0 1.6195593754986248e-09
phenotypic O 0 1.0659489291242608e-08
features O 0 1.6742244923761973e-08
, O 0 2.759410755448499e-10
present O 0 3.53015450205163e-10
in O 0 1.517191927646877e-10
more O 0 3.590964981967093e-12
than O 0 6.965444714068791e-12
a O 0 1.3180032065740477e-10
third O 0 5.236314049028579e-09
of O 0 1.0585355703085497e-08
our O 0 3.6429730343456868e-09
patients O 0 5.586487938913365e-10
with O 0 3.534999237775338e-10
TWIST O 0 0.00031115731690078974
mutations O 0 1.1360068441490512e-08
, O 0 2.098161422381395e-09
are O 0 9.577267867655337e-10
coronal B-Disease 0 0.06763513386249542
synostosis I-Disease 0 0.0022155041806399822
, O 0 9.841717485414847e-08
brachycephaly B-Disease 0 0.0006549633690156043
, O 0 6.108530925530431e-08
low B-Disease 0 0.0002443807024974376
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 1.020422246256203e-06
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9304832816123962
, O 0 3.929696958948625e-06
ptosis B-Disease 1 0.9999994039535522
, O 0 8.203964512176753e-07
hypertelorism B-Disease 1 0.8726574182510376
, O 0 3.5199795433982217e-07
broad B-Disease 0 2.6727602744358592e-05
great I-Disease 1 0.5048561096191406
toes I-Disease 1 0.995824933052063
, O 0 7.789672906710621e-08
and O 0 2.1827139562446973e-07
clinodactyly B-Disease 0 0.11235304921865463
. O 0 7.012326364019827e-07

Significant O 0 2.4602547910035355e-06
intra O 0 0.00041098330984823406
- O 0 6.541853053931845e-06
and O 0 6.738388957927555e-09
interfamilial O 0 4.670826001529349e-06
phenotypic O 0 1.6151801673913724e-07
variability O 0 5.043281348093842e-08
is O 0 4.069571762910229e-11
present O 0 1.0836182645634906e-10
for O 0 1.1970335833666468e-10
either O 0 6.411128516958797e-09
TWIST O 0 9.222655353369191e-05
mutations O 0 9.438619485990785e-08
or O 0 1.4734628450696619e-07
FGFR O 1 0.9999998807907104
mutations O 0 6.221173975973215e-07
. O 0 1.2257598314135976e-07

The O 0 1.2254642456355214e-07
overlap O 0 6.506874594691681e-09
in O 0 1.5052853408192846e-09
clinical O 0 1.262964275383638e-07
features O 0 1.0114188597754037e-08
and O 0 1.3823210354146909e-09
the O 0 1.1615248762808505e-09
presence O 0 3.6658404090061936e-10
, O 0 4.3449542574958144e-11
in O 0 2.51004737827909e-11
the O 0 3.87049420291774e-11
same O 0 8.131788645227012e-12
genes O 0 1.2194043517987918e-11
, O 0 2.1787212658996857e-11
of O 0 4.3705900010237997e-10
mutations O 0 7.142471336596401e-11
for O 0 5.90977405900972e-11
more O 0 5.946836339337791e-12
than O 0 6.394634821660361e-11
one O 0 4.640991202453648e-10
craniosynostotic B-Disease 0 1.86384454536892e-06
condition I-Disease 0 5.569800620719434e-08
- O 0 2.7683595860139576e-08
such O 0 1.312192132729706e-09
as O 0 5.8648299550156935e-09
Saethre B-Disease 0 8.619514846941456e-05
- I-Disease 0 1.140636641139281e-06
Chotzen I-Disease 0 3.739859312190674e-05
, I-Disease 0 3.4639575652306576e-09
Crouzon I-Disease 0 3.2618045224808156e-05
, I-Disease 0 4.1538483763758904e-09
and I-Disease 0 4.422754429356246e-08
Pfeiffer I-Disease 0 0.16272754967212677
syndromes I-Disease 1 0.8372609615325928
- O 0 2.0835420855291886e-06
support O 0 4.274855580632675e-09
the O 0 4.151202936952814e-09
hypothesis O 0 3.0315927546098465e-09
that O 0 3.2672187871840563e-11
TWIST O 0 6.714258802276163e-07
and O 0 4.136951670119515e-09
FGFRs O 0 2.942564378827228e-06
are O 0 4.2232672220476886e-11
components O 0 2.1906211955524668e-08
of O 0 1.0645753611981945e-08
the O 0 4.5042558571850577e-10
same O 0 3.344940990857026e-11
molecular O 0 3.557185879188296e-09
pathway O 0 4.233665640285267e-10
involved O 0 9.253522254004665e-11
in O 0 5.104649689058327e-11
the O 0 1.3354027605938512e-10
modulation O 0 9.482644003355745e-09
of O 0 2.743225309131958e-07
craniofacial O 1 1.0
and O 0 1.6537351257284172e-05
limb O 1 0.999995231628418
development O 0 6.045475942073608e-08
in O 0 7.776280064319963e-09
humans O 0 2.933303155927547e-09
. O 0 1.0030938302207915e-09
. O 0 6.040045352762036e-09

Mutation O 0 9.822326063613218e-08
analysis O 0 2.010618160852573e-08
of O 0 7.2224781888508e-07
UBE3A O 1 1.0
in O 1 0.9827352166175842
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0001364602503599599
. O 0 5.675441911989765e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.520620728319045e-05
AS B-Disease 1 1.0
) O 0 5.972672134646473e-09
is O 0 1.005867611425515e-10
caused O 0 1.957261241969377e-09
by O 0 8.551586661020849e-10
chromosome O 0 4.033782374790462e-08
15q11 O 0 2.7250534913036972e-06
- O 0 4.154493069563614e-07
q13 O 0 4.530440378403e-07
deletions O 0 2.7793484846938554e-08
of O 0 1.7227504756078815e-08
maternal O 0 2.6588901747004456e-08
origin O 0 7.13938297369765e-10
, O 0 1.4721544816520549e-10
by O 0 8.505275372883148e-10
paternal O 0 2.189931365137454e-06
uniparental B-Disease 1 0.9107548594474792
disomy I-Disease 1 0.9990160465240479
( O 0 2.94302185466222e-06
UPD B-Disease 1 1.0
) O 0 1.3506918250527633e-08
15 O 0 1.512397318492731e-08
, O 0 1.0303183306525909e-10
by O 0 3.2953337281149686e-10
imprinting O 0 0.0035564559511840343
defects O 1 0.9813358783721924
, O 0 3.4687179795156453e-09
and O 0 1.3064581638744244e-09
by O 0 4.0619202446023905e-10
mutations O 0 3.0654856431056032e-09
in O 0 3.3737521665244685e-09
the O 0 5.1439382531270894e-08
UBE3A O 1 0.9999688863754272
gene O 0 4.775548063662427e-07
. O 0 5.009611214745746e-08

UBE3A O 0 0.028854086995124817
encodes O 0 3.200939602265862e-07
a O 0 2.9216401742360176e-08
ubiquitin O 0 1.3348520155886945e-07
- O 0 1.2348141353868414e-07
protein O 0 1.1875647132342237e-09
ligase O 0 2.6620416093692256e-08
and O 0 5.2095958658071595e-09
shows O 0 3.396675296585272e-08
brain O 0 2.3208169750432717e-06
- O 0 1.6796498414350935e-07
specific O 0 8.25124502057406e-09
imprinting O 0 1.821303339966107e-05
. O 0 8.122751893324676e-08

Here O 0 4.466114660317544e-07
we O 0 1.361737300697996e-08
describe O 0 3.2745174394221976e-07
UBE3A O 0 0.03213772550225258
coding O 0 2.278377905895468e-06
- O 0 7.910861086202203e-07
region O 0 1.5701985489613435e-08
mutations O 0 1.419356632226254e-09
detected O 0 6.180781220166409e-09
by O 0 3.6384642521092303e-10
SSCP O 0 0.0017806190298870206
analysis O 0 6.518448003589583e-10
in O 0 2.242341312630458e-10
13 O 0 7.755246222984624e-09
AS B-Disease 1 0.8023031949996948
individuals O 0 1.7330437432350188e-11
or O 0 6.823565601443704e-10
families O 0 4.072470416449647e-10
. O 0 1.967825546955737e-08

Two O 0 7.88981324717497e-08
identical O 0 2.9186057304286805e-07
de O 0 8.071960110100918e-06
novo O 0 4.5445963223755825e-06
5 O 0 2.036256319115637e-07
- O 0 1.420374786675893e-07
bp O 0 4.2797612564982046e-08
duplications O 0 1.657885349004573e-07
in O 0 7.67354002562115e-09
exon O 0 1.8587842021133838e-07
16 O 0 4.390245322838382e-08
were O 0 2.776459506748097e-09
found O 0 1.0604574107730969e-08
. O 0 2.3489610256888227e-08

Among O 0 1.5004194153789285e-07
the O 0 1.4446708718196533e-08
other O 0 3.033152895515201e-10
11 O 0 1.6874416308709783e-09
unique O 0 1.5194652480676751e-10
mutations O 0 3.3961858325604055e-10
, O 0 2.2541166155853887e-10
8 O 0 5.642605493960673e-09
were O 0 3.190829267474271e-10
small O 0 1.0756819740498358e-10
deletions O 0 3.94133792269713e-09
or O 0 3.2531315419248585e-09
insertions O 0 1.9603713496962882e-07
predicted O 0 1.1888428019801722e-07
to O 0 3.32743921305223e-09
cause O 0 3.1329267358159996e-07
frameshifts O 0 0.00016940041678026319
, O 0 3.552026228703653e-09
1 O 0 5.100722955120318e-09
was O 0 1.3079866079124258e-09
a O 0 7.318937816913618e-11
mutation O 0 2.5791362101568183e-11
to O 0 1.6781895317841133e-11
a O 0 1.5614910753303235e-10
stop O 0 2.056500303382336e-09
codon O 0 1.3508310026111303e-08
, O 0 1.5427693844660695e-10
1 O 0 2.148151434511192e-09
was O 0 2.097624962615896e-09
a O 0 1.8110227206769025e-10
missense O 0 1.6804373004219997e-08
mutation O 0 6.099153404548474e-10
, O 0 1.8328634443509628e-10
and O 0 5.090263210938417e-10
1 O 0 1.1057424309512953e-08
was O 0 1.0351353552096043e-08
predicted O 0 1.5774261896694952e-09
to O 0 7.37513106141563e-11
cause O 0 5.130851854495688e-10
insertion O 0 2.066152582358427e-09
of O 0 1.0166855801685415e-08
an O 0 2.708099022807886e-10
isoleucine O 0 2.7436124128144e-06
in O 0 2.257232400992848e-09
the O 0 3.6040763706779444e-09
hect O 0 8.376087521355657e-07
domain O 0 5.73779357360138e-10
of O 0 4.867775516004258e-09
the O 0 2.7705346905548822e-09
UBE3A O 0 0.00016876214067451656
protein O 0 1.2120410231020173e-09
, O 0 6.614796904669262e-11
which O 0 3.1139396616808313e-12
functions O 0 1.9100969070318108e-11
in O 0 2.871983206809148e-10
E2 O 0 7.368757906078827e-07
binding O 0 3.086177535749357e-09
and O 0 3.023917560796008e-09
ubiquitin O 0 2.1082840362396382e-07
transfer O 0 2.1117531900927133e-07
. O 0 1.1172374314583067e-07

Eight O 0 1.0742005542851985e-06
of O 0 1.1490035944916599e-07
the O 0 2.0826196323042723e-09
cases O 0 2.4483143290510156e-10
were O 0 7.323969208883341e-10
familial O 0 8.384608918277081e-08
, O 0 9.161887359887544e-10
and O 0 1.0369627378992163e-09
five O 0 1.5506971262624347e-09
were O 0 4.86723683579271e-09
sporadic O 0 1.8023016536972136e-06
. O 0 4.1170149955860325e-08

In O 0 1.892339014375466e-07
two O 0 3.7313845346886865e-09
familial O 0 1.3888393368688412e-07
cases O 0 1.9766421832656533e-09
and O 0 1.3681984434299466e-09
one O 0 3.222603295327531e-10
sporadic O 0 4.883894533236344e-08
case O 0 1.685546924257153e-09
, O 0 5.389654278431522e-10
mosaicism O 0 1.498537585575832e-06
for O 0 9.40621269762687e-09
UBE3A O 1 0.9991119503974915
mutations O 0 1.386628767363618e-08
was O 0 1.2290545470250436e-08
detected O 0 1.5858496738019312e-08
in O 0 2.5354832122737037e-10
the O 0 3.0935778938534497e-10
mother O 0 1.1093753693458552e-09
of O 0 7.130880774752768e-09
three O 0 3.045316221417238e-09
AS B-Disease 1 1.0
sons O 0 3.793488303927006e-06
, O 0 8.42164116221511e-10
in O 0 3.572291629172497e-10
the O 0 1.7175558753024234e-09
maternal O 0 5.895293853086514e-08
grandfather O 0 4.643740965093457e-07
of O 0 2.940116701211082e-07
two O 0 5.998782359739607e-09
AS B-Disease 1 0.9999998807907104
first O 0 1.4587261887299974e-07
cousins O 0 1.0213253176516446e-07
, O 0 3.3281291611508834e-10
and O 0 1.7403717356145876e-10
in O 0 4.2248565756963785e-10
the O 0 2.026908418883977e-09
mother O 0 1.7724387513240458e-09
of O 0 1.1823963141921467e-08
an O 0 7.10053016383938e-10
AS B-Disease 1 1.0
daughter O 0 6.630078860325739e-05
. O 0 1.9192191302863648e-07

The O 0 1.1072053496263834e-07
frequencies O 0 1.5698812916298266e-08
with O 0 8.341910495701654e-11
which O 0 2.1650715942289622e-11
we O 0 1.3863171895167614e-11
detected O 0 9.552402202572807e-10
mutations O 0 6.596150015081292e-11
were O 0 2.957520339741393e-10
5 O 0 1.821871431495481e-09
( O 0 8.770623116660659e-11
14 O 0 1.5692217525398178e-09
% O 0 3.667802173090706e-12
) O 0 2.6819529670013553e-12
of O 0 4.243852491647715e-10
35 O 0 9.014308188781683e-10
in O 0 1.2331108356633536e-10
sporadic O 0 1.4639070400335186e-08
cases O 0 4.672701114927236e-10
and O 0 7.585886918626272e-10
8 O 0 8.613961988146457e-09
( O 0 9.95361293387731e-11
80 O 0 2.046100622266067e-09
% O 0 7.44186570006411e-12
) O 0 3.595241509016245e-12
of O 0 5.826650273377254e-10
10 O 0 8.52543202700673e-10
in O 0 3.8159952975291844e-10
familial O 0 5.912398748364467e-08
cases O 0 5.306482808720148e-09
. O 0 1.4069310161346493e-09
. O 0 1.1731948745818954e-08

The O 0 3.4484990464989096e-05
hemochromatosis B-Disease 1 1.0
845 O 0 2.4835600925143808e-05
G O 0 5.524605148821138e-05
- O 0 3.804049129030318e-06
- O 0 5.102851901028771e-07
> O 0 2.1906963354467734e-08
A O 0 4.1738879019703745e-08
and O 0 4.581701962269591e-10
187 O 0 3.5922997909665355e-09
C O 0 9.06689194835053e-08
- O 0 3.020880967596895e-08
- O 0 1.9827526287485853e-08
> O 0 2.371248086774358e-08
G O 0 1.934765805344796e-06
mutations O 0 4.005650477978406e-09
: O 0 5.690221627219216e-10
prevalence O 0 2.5515278778698303e-09
in O 0 9.82855394293658e-11
non O 0 8.470622248069049e-08
- O 0 2.662631288785633e-07
Caucasian O 0 1.0657947768777376e-07
populations O 0 2.84750489853991e-09
. O 0 1.0997207589014124e-08

Hemochromatosis B-Disease 1 0.9999992847442627
, O 0 4.426054545092484e-07
the O 0 4.327825536165619e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.3495442746934714e-07
leads O 0 7.209416708064964e-07
, O 0 5.229098487546935e-09
if O 0 1.763663881604316e-09
untreated O 1 0.9998797178268433
, O 0 1.9385286709194816e-09
to O 0 1.7716859090910475e-08
progressive O 1 0.9999996423721313
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 1.0155740710615646e-05
premature B-Disease 0 0.0011582705192267895
death I-Disease 0 2.855538514268119e-05
. O 0 1.6233121868935996e-07

The O 0 2.657804543559905e-05
hemochromatosis B-Disease 1 1.0
gene O 0 5.7122798580167e-07
, O 0 1.3005094778861803e-08
HFE O 1 0.9999814033508301
, O 0 1.1654223364132577e-08
recently O 0 3.0623477087488027e-09
has O 0 2.4158324646306184e-11
been O 0 1.626172460578168e-11
identified O 0 8.053781253014591e-11
, O 0 3.3630386669925016e-11
and O 0 1.1273157407565293e-10
characterization O 0 8.49399661717598e-09
of O 0 2.2098204155440726e-08
this O 0 3.1467572991772386e-10
gene O 0 1.408515193368487e-09
has O 0 2.2518077680278026e-11
shown O 0 6.926630102821463e-11
that O 0 2.329929868830072e-12
it O 0 1.2263597255757208e-11
contains O 0 4.845187098756476e-11
two O 0 1.1019215921670433e-11
mutations O 0 5.472114775195713e-11
that O 0 7.040322751866723e-12
result O 0 2.2933768772936958e-10
in O 0 4.4044742852911156e-10
amino O 0 4.930519326151739e-10
acid O 0 7.860140316395814e-10
substitutions O 0 2.16091624594128e-08
- O 0 4.369319128727511e-08
cDNA O 0 6.862935109097634e-09
nucleotides O 0 2.2202883975808163e-09
845 O 0 5.5895956307949746e-08
G O 0 8.023356485864497e-07
- O 0 1.9511497839630465e-07
- O 0 6.64772841219019e-08
> O 0 1.1014672729459107e-08
A O 0 6.276955133444062e-08
( O 0 1.8037799032200041e-10
C282Y O 0 6.965390753066458e-08
) O 0 1.8553344624527845e-11
and O 0 4.314432144880698e-11
187 O 0 1.145193384566312e-09
C O 0 1.1618050876904817e-07
- O 0 2.7752694364835406e-08
- O 0 6.84233967263026e-08
> O 0 6.266930796527959e-08
G O 0 1.2544798664748669e-05
( O 0 2.1338230737910635e-08
H63D O 1 0.9999901056289673
) O 0 1.6937400815209003e-08
. O 0 1.541553196204859e-08

Although O 0 2.800725633278489e-05
hemochromatosis B-Disease 1 1.0
is O 0 4.402007203196945e-09
common O 0 1.388552051118097e-09
in O 0 2.640628826711122e-09
Caucasians O 0 1.7667295537648897e-07
, O 0 2.135874144215677e-09
affecting O 0 5.935615554619744e-09
> O 0 2.5655104707311693e-08
= O 0 1.0208049516791107e-08
1 O 0 1.6360338861431956e-08
/ O 0 5.664646529623951e-09
300 O 0 7.945814145537966e-11
individuals O 0 7.699752836189122e-13
of O 0 2.7093802201783035e-10
northern O 0 8.284563035587666e-10
European O 0 5.766835342591037e-10
origin O 0 1.6552731407770693e-10
, O 0 3.4546376176392e-11
it O 0 4.112038834436227e-12
has O 0 5.902705082529158e-13
not O 0 8.967512604880767e-13
been O 0 6.332995326069346e-12
recognized O 0 9.788143906508395e-11
in O 0 6.273379732357753e-11
other O 0 8.492190284314916e-11
populations O 0 3.1255223409409894e-10
. O 0 2.638911977825842e-09

The O 0 1.5413392873142584e-07
present O 0 2.5076332121898304e-09
study O 0 3.235968992765237e-10
used O 0 2.960822143016628e-10
PCR O 0 8.714590649105958e-08
and O 0 2.4824525768352146e-10
restriction O 0 6.756067927327081e-10
- O 0 3.3030060908600944e-09
enzyme O 0 3.134106585367391e-10
digestion O 0 1.572970531604767e-09
to O 0 4.709598336316567e-11
analyze O 0 2.1851280784801475e-09
the O 0 3.133497072926872e-10
frequency O 0 7.132835988521435e-10
of O 0 7.47074402340786e-10
the O 0 4.2871178829173573e-10
845 O 0 4.7240359180023006e-08
G O 0 4.5863146169722313e-07
- O 0 1.1383585274415964e-07
- O 0 4.2217838114311235e-08
> O 0 3.090400824135031e-09
A O 0 7.829067172338e-09
and O 0 1.7258929008168167e-10
187 O 0 2.3049069319824866e-09
C O 0 5.079628451198914e-08
- O 0 9.041001725051956e-09
- O 0 1.0733179678368288e-08
> O 0 9.265576750294713e-09
G O 0 3.2816262773849303e-07
mutations O 0 1.2100245250223907e-09
in O 0 1.0576227671421634e-09
HLA O 0 4.831545652450586e-07
- O 0 1.474429378589548e-08
typed O 0 9.568613679178384e-10
samples O 0 6.43204489669813e-10
from O 0 2.614382044185959e-10
non O 0 3.236089796132546e-08
- O 0 6.681197817215434e-08
Caucasian O 0 8.387115890684527e-09
populations O 0 4.432967187772974e-11
, O 0 9.654362378985759e-12
comprising O 0 6.266578367331022e-10
Australian O 0 8.510716575926836e-09
Aboriginal O 0 2.2201753324679885e-08
, O 0 2.7770973021201684e-11
Chinese O 0 1.631684926062249e-10
, O 0 9.795465827355798e-11
and O 0 8.812094942634019e-10
Pacific O 0 3.5920140817324864e-07
Islanders O 0 7.819734264558065e-07
. O 0 1.604784927167202e-08

Results O 0 1.8914579413831234e-06
showed O 0 2.596435990653845e-07
that O 0 2.1237836489440554e-10
the O 0 4.277482368308938e-09
845 O 0 2.1208272471540113e-07
G O 0 3.444239382588421e-06
- O 0 7.960363745951327e-07
- O 0 1.088249064196134e-07
> O 0 1.003406335797763e-08
A O 0 8.588205702153573e-09
mutation O 0 1.3385623165440563e-10
was O 0 1.657996795412231e-10
present O 0 8.209584921592405e-12
in O 0 8.842510057505137e-12
these O 0 2.692295388365129e-12
populations O 0 7.399051857315264e-12
( O 0 4.159804445347248e-12
allele O 0 4.469982977511888e-12
frequency O 0 3.464132800057307e-11
0 O 0 1.830549600789766e-11
. O 0 2.3625617521366715e-12
32 O 0 6.831714360888697e-11
% O 0 1.4090236139310819e-12
) O 0 2.248763458431724e-12
, O 0 1.462498351589847e-11
and O 0 5.3570911595635096e-11
, O 0 4.2067141436952227e-11
furthermore O 0 3.723895913854136e-10
, O 0 4.782769319477964e-11
it O 0 2.376292565497984e-11
was O 0 2.8097928428394425e-09
always O 0 2.366921103558184e-10
seen O 0 2.399586085388705e-10
in O 0 2.68257308727593e-11
conjunction O 0 1.8615148311695862e-09
with O 0 4.826042343530901e-10
HLA O 0 1.1385009202058427e-05
haplotypes O 0 3.944137105804657e-08
common O 0 1.4129872827339796e-09
in O 0 2.7921736034386413e-09
Caucasians O 0 1.3217636762874463e-07
, O 0 8.069561685530857e-10
suggesting O 0 1.1547588441018775e-09
that O 0 6.426204707254968e-11
845 O 0 2.7609411290541175e-07
G O 0 4.3263877159915864e-05
- O 0 2.0570820197463036e-05
- O 0 2.843766878868337e-06
> O 0 7.984261429783146e-08
A O 0 9.229123065779277e-08
may O 0 8.57662413311644e-11
have O 0 1.8341485014811143e-12
been O 0 5.34960400630502e-12
introduced O 0 1.2454938122519188e-11
into O 0 3.6880472634170935e-12
these O 0 6.667827097753265e-13
populations O 0 2.497486158853368e-12
by O 0 3.9290997538854455e-11
Caucasian O 0 5.296586280678639e-08
admixture O 0 1.0108541914632951e-07
. O 0 3.327129505237281e-08

187 O 0 1.7050771248250385e-06
C O 0 4.688382887252374e-06
- O 0 2.565291197242914e-07
- O 0 1.3479386495873769e-07
> O 0 3.5640944417991705e-08
G O 0 1.294423668696254e-06
was O 0 7.047629146939016e-09
present O 0 2.609928106966919e-10
at O 0 5.290825555448464e-10
an O 0 2.2516133922623194e-12
allele O 0 1.8942205443073235e-11
frequency O 0 7.588665806856909e-10
of O 0 6.337535829459284e-09
2 O 0 5.7099384775938233e-08
. O 0 2.6283091258960667e-08

68 O 0 5.58450801690924e-06
% O 0 4.689871269114576e-10
in O 0 1.950153927232634e-10
the O 0 1.0628903313047999e-10
two O 0 1.3835805764972342e-11
populations O 0 2.5086209151647942e-11
analyzed O 0 2.879400273769761e-09
( O 0 2.8322716394413305e-10
Australian O 0 7.06542522266318e-08
Aboriginal O 0 5.4142436312076825e-08
and O 0 4.3809894600954635e-10
Chinese O 0 2.517606345620038e-09
) O 0 6.138272667932654e-10
. O 0 3.54679308145478e-09

In O 0 3.69396900623542e-07
the O 0 7.376380040113872e-08
Australian O 0 1.2302393770369235e-07
Aboriginal O 0 3.2773471048130887e-08
samples O 0 6.533288132715143e-09
, O 0 1.88324120187211e-10
187 O 0 3.833864337110526e-09
C O 0 1.9161814179824432e-07
- O 0 3.4907145618490176e-08
- O 0 5.827000748581668e-08
> O 0 1.653643266763538e-08
G O 0 1.178723550765426e-06
was O 0 4.933635722181862e-09
found O 0 2.2523533385609973e-11
to O 0 2.9846216643980572e-12
be O 0 1.085384213062035e-11
associated O 0 3.4895131229006893e-10
with O 0 6.95469848377428e-10
HLA O 0 3.089840538450517e-05
haplotypes O 0 5.389238921793549e-08
common O 0 1.5006699216613129e-09
in O 0 1.0090579483090778e-09
Caucasians O 0 5.1818904722722436e-08
, O 0 2.2758943341028015e-10
suggesting O 0 2.2525434295594948e-10
that O 0 1.5701212899288386e-11
it O 0 2.214542785261564e-11
was O 0 8.084458658075278e-10
introduced O 0 2.9666333278832724e-10
by O 0 4.802450104257616e-11
recent O 0 1.383991032888332e-09
admixture O 0 5.7699331534877274e-08
. O 0 2.2392491416667326e-08

In O 0 1.5098601124918787e-07
the O 0 6.801557539404257e-09
Chinese O 0 1.0359803015447255e-09
samples O 0 6.843416389124002e-10
analyzed O 0 1.2181270436784075e-09
, O 0 4.395584243810369e-11
187 O 0 7.686499770009902e-10
C O 0 8.983420940467113e-08
- O 0 1.9667261597078323e-08
- O 0 2.1376562742148053e-08
> O 0 1.2081225797544448e-08
G O 0 7.673666573282389e-07
was O 0 1.3132294363060737e-08
present O 0 4.609910231323511e-10
in O 0 4.788759944140963e-10
association O 0 3.26806959272119e-09
with O 0 7.194180667857708e-11
a O 0 3.450780217129079e-10
wide O 0 9.101627895802267e-09
variety O 0 1.2401905280512437e-08
of O 0 4.1675724560263916e-07
HLA O 0 4.8060504923341796e-05
haplotypes O 0 9.952734103535477e-08
, O 0 5.643625011764186e-10
showing O 0 2.350384997740207e-09
this O 0 7.320834043145208e-12
mutation O 0 2.2914212194358186e-11
to O 0 4.014901605620125e-11
be O 0 4.9656816852872154e-11
widespread O 0 7.90003440442888e-09
and O 0 8.932599659949858e-10
likely O 0 7.285598235817758e-10
to O 0 2.0910409515018102e-10
predate O 0 1.2030803020479652e-07
the O 0 1.3711165536278713e-09
more O 0 1.4352919894267124e-11
genetically O 0 3.744452747866944e-09
restricted O 0 1.3665397702311566e-09
845 O 0 1.0080950829660651e-07
G O 0 6.033270892658038e-06
- O 0 1.7400602700945456e-06
- O 0 5.632827537738194e-07
> O 0 7.009425218029719e-08
A O 0 1.3401441378846357e-07
mutation O 0 8.917028004873373e-09
. O 0 6.154853071649313e-09

Genotype O 0 0.00018810044275596738
- O 0 2.6249204893247224e-05
phenotype O 0 5.908396474296751e-07
correlations O 0 9.93791672954103e-07
in O 0 5.20748358212586e-07
attenuated B-Disease 1 0.9997389912605286
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999992847442627
. O 0 2.92500817522523e-06

Germ O 1 0.999902606010437
- O 0 3.409624332562089e-05
line O 0 2.1713242404075572e-07
mutations O 0 3.5416554133860245e-09
of O 0 1.2603816657019706e-08
the O 0 1.2429066664765287e-08
tumor B-Disease 0 6.410301466530655e-06
suppressor O 0 6.748192390659824e-06
APC O 0 3.3379055821569636e-06
are O 0 4.126319008701529e-10
implicated O 0 5.148915249719721e-08
in O 0 6.922915218865455e-08
attenuated B-Disease 1 0.9999434947967529
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.206240919302218e-05
AAPC B-Disease 1 1.0
) O 0 3.488890953917689e-08
, O 0 6.737717050953052e-10
a O 0 3.9664257989180385e-10
variant O 0 1.1578534895306802e-06
of O 0 0.0029085390269756317
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.035423651454039e-05
FAP B-Disease 1 0.9999281167984009
) O 0 2.253306945476652e-07
. O 0 7.664868917345302e-08

AAPC B-Disease 1 1.0
is O 0 8.922425109858523e-08
recognized O 0 1.637101476603675e-08
by O 0 3.370997370133466e-10
the O 0 1.5155932064914168e-09
occurrence O 0 1.4555127769710907e-08
of O 0 3.2233504754231035e-08
< O 0 3.316517620532977e-07
100 O 0 1.6728749585581681e-07
colonic B-Disease 0 0.0008947414462454617
adenomas I-Disease 0 2.0587129256455228e-05
and O 0 3.92679577743138e-09
a O 0 4.771628092647973e-10
later O 0 1.134410965164534e-08
onset O 0 0.2037132978439331
of O 1 0.9999029636383057
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.373043704930524e-09
age O 0 4.632264793968943e-09
> O 0 4.5951993321580176e-09
40 O 0 1.1467321536784425e-09
years O 0 4.823300092660077e-10
) O 0 2.030877827019495e-10
. O 0 1.8625944120387317e-09

The O 0 2.8027724852108804e-07
aim O 0 8.39983087530527e-08
of O 0 8.719840849380489e-09
this O 0 1.1605271431347486e-11
study O 0 3.2674946082167367e-10
was O 0 7.22330584235209e-10
to O 0 6.806508134893363e-11
assess O 0 4.9404842883404854e-08
genotype O 0 3.9775750337867066e-07
- O 0 7.108849899850611e-07
phenotype O 0 2.4273555609966024e-08
correlations O 0 1.6924006729368557e-07
in O 0 9.039383996878314e-08
AAPC B-Disease 1 1.0
families O 0 8.467181089599762e-08
. O 0 1.77043347093786e-07

By O 0 9.922293031650042e-08
protein O 0 8.398514772522958e-09
- O 0 1.4135493131561816e-07
truncation O 0 6.360741622302157e-07
test O 0 1.6206654152028932e-07
( O 0 2.3929509485043354e-09
PTT O 0 3.5090104120172327e-06
) O 0 9.759323904567907e-11
assay O 0 3.5232416983888015e-09
, O 0 5.4482345718254166e-11
the O 0 1.1663685295371096e-10
entire O 0 3.1577376269353863e-09
coding O 0 7.1007102420139745e-09
region O 0 2.1551074258496783e-09
of O 0 8.207249102554215e-09
the O 0 6.0176335026085326e-09
APC B-Disease 0 1.1825461569969775e-06
gene O 0 5.944611469743677e-09
was O 0 5.0348210045569886e-09
screened O 0 1.0241866910121189e-08
in O 0 3.3825908740681143e-10
affected O 0 2.5181379204042287e-10
individuals O 0 9.921026673798128e-12
from O 0 1.4860728647647647e-08
11 O 0 3.845697847282281e-06
AAPC B-Disease 1 1.0
kindreds O 0 7.349154475377873e-05
, O 0 5.916874545874862e-09
and O 0 1.0920718773732574e-09
their O 0 1.0315576171038288e-09
phenotypic O 0 5.35257456135696e-08
differences O 0 7.121489176142859e-09
were O 0 1.0962547314363746e-08
examined O 0 2.8261069928703364e-06
. O 0 1.1737100180653215e-07

Five O 0 1.080094875760551e-06
novel O 0 2.674184429451998e-07
germ O 0 0.0014015911146998405
- O 0 7.964388714754023e-06
line O 0 1.0328250255042803e-06
APC B-Disease 0 1.9696597064466914e-06
mutations O 0 5.572220462823907e-09
were O 0 2.5088149335772414e-09
identified O 0 1.5860636137787765e-09
in O 0 2.5074848863937405e-09
seven O 0 8.308148125024672e-08
kindreds O 0 4.031284333905205e-05
. O 0 2.873663902391854e-07

Mutations O 0 1.3838233314800163e-07
were O 0 1.769504187620896e-08
located O 0 1.757278411673724e-08
in O 0 2.081125688446761e-10
three O 0 4.0618404473224956e-11
different O 0 1.9522371566549346e-11
regions O 0 7.070878327297692e-10
of O 0 9.346106111252084e-09
the O 0 1.62379443224836e-08
APC B-Disease 0 2.352950787098962e-06
gene O 0 1.162367713192225e-08
( O 0 6.06851846551848e-10
1 O 0 7.614870511929439e-09
) O 0 7.753197389659405e-11
at O 0 2.1904444924558675e-09
the O 0 4.528651620372415e-10
5 O 0 2.1431298957708123e-09
end O 0 2.2260637777549164e-09
spanning O 0 9.078967799780457e-09
exons O 0 4.261943686856284e-09
4 O 0 2.772252649663187e-09
and O 0 2.4166954548654473e-10
5 O 0 3.1368470043702246e-09
, O 0 1.5951247267498303e-10
( O 0 7.26744081580577e-11
2 O 0 1.8446131289096002e-09
) O 0 1.650744645143032e-11
within O 0 1.7827754550392427e-10
exon O 0 3.87682996816352e-09
9 O 0 8.64297700076122e-09
, O 0 8.090084852030444e-11
and O 0 1.9481166679824469e-10
( O 0 2.2066086458050194e-10
3 O 0 4.748224924355782e-09
) O 0 3.521833866204638e-11
at O 0 1.0017632279257782e-09
the O 0 4.550227972188736e-10
3 O 0 6.576220901166607e-09
distal O 0 1.497125623473039e-08
end O 0 3.462081954452856e-09
of O 0 1.0315974741104128e-08
the O 0 1.063051602301357e-08
gene O 0 3.493918754315928e-08
. O 0 3.377681068172933e-08

Variability O 0 2.154510366381146e-05
in O 0 3.540347037755964e-08
the O 0 1.7628903892230596e-09
number O 0 1.5140475539965337e-09
of O 0 4.014193473267369e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 9.201946227221924e-07
most O 0 2.471774729340126e-10
apparent O 0 2.847732938349168e-09
in O 0 3.296666273300275e-10
individuals O 0 1.7453031207759206e-12
with O 0 4.83512431481703e-11
mutations O 0 5.802716085412385e-10
in O 0 2.3792248171616848e-09
region O 0 1.9124765771039165e-08
1 O 0 6.88527990178045e-08
, O 0 1.3558173472816293e-09
and O 0 1.0147656048786757e-08
upper O 0 0.3574638068675995
- O 1 0.9976339340209961
gastrointestinal O 1 0.9999935626983643
manifestations O 1 0.9999316930770874
were O 0 1.1474180183768112e-07
more O 0 3.419370897539409e-10
severe O 0 3.484496801320347e-06
in O 0 1.5932199559642868e-08
them O 0 1.2159061313354869e-08
. O 0 3.0715625598531915e-08

In O 0 1.6966501092952058e-08
individuals O 0 6.396025375998704e-11
with O 0 2.533685206085323e-10
mutations O 0 2.0691219848600895e-09
in O 0 1.8323120798413584e-09
either O 0 4.510697593218538e-09
region O 0 1.7055628021012126e-08
2 O 0 2.0967862113252522e-08
or O 0 1.4154176719571865e-09
region O 0 4.95256724519777e-09
3 O 0 1.5793265362162856e-08
, O 0 7.055193929073056e-11
the O 0 9.547752172212043e-11
average O 0 7.312491584476888e-11
number O 0 1.817794352543256e-11
of O 0 9.089865748990178e-09
adenomas B-Disease 0 8.648437869851477e-06
tended O 0 3.1742789730060395e-08
to O 0 4.945882037254989e-10
be O 0 2.629514939123112e-10
lower O 0 1.324794585144673e-08
than O 0 1.2228840336192537e-11
those O 0 8.85618141321931e-12
in O 0 2.8584122915842336e-11
individuals O 0 4.898612982265349e-13
with O 0 1.044234056862825e-11
mutations O 0 2.571577673027292e-10
in O 0 1.1996489357457563e-09
region O 0 2.8486348835343733e-09
1 O 0 7.70967378826981e-09
, O 0 4.618779317344668e-11
although O 0 2.387391152824936e-11
age O 0 2.340595495198272e-10
at O 0 2.7735749252855157e-09
diagnosis O 0 1.0909986514207048e-07
was O 0 6.064448943021716e-09
similar O 0 9.744193008032198e-09
. O 0 3.1568777814072746e-08

In O 0 2.1803391518915305e-06
all O 0 9.398115707881516e-07
AAPC B-Disease 1 1.0
kindreds O 0 0.00013448193203657866
, O 0 7.969834570076273e-09
a O 0 1.261978188615842e-09
predominance O 0 4.4079919803152734e-07
of O 0 1.2221885299368296e-06
right O 1 0.7276025414466858
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9932013154029846
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9330868124961853
sparing O 0 4.419973265612498e-06
was O 0 8.285264243568236e-07
observed O 0 2.9499298648261174e-07
. O 0 5.5902351192571587e-08

No O 0 2.653800038387999e-05
desmoid B-Disease 1 0.9999978542327881
tumors I-Disease 1 1.0
were O 0 8.551220531671788e-08
found O 0 4.586285573537907e-09
in O 0 2.8311446520490335e-09
these O 0 6.00304028708365e-09
kindreds O 0 6.0144269809825346e-05
. O 0 4.964496156389941e-07

Our O 0 8.443504384558764e-07
data O 0 4.594421909587254e-08
suggest O 0 2.2433519486497744e-09
that O 0 5.5820972844067285e-11
, O 0 2.211163058207788e-10
in O 0 4.221958782579804e-09
AAPC B-Disease 1 1.0
families O 0 2.0276536005781054e-10
, O 0 2.9919417637858103e-11
the O 0 4.258631988718342e-11
location O 0 1.5768004679728165e-09
of O 0 3.5846339230261037e-09
the O 0 2.6549729525982002e-08
APC B-Disease 0 0.00011925306898774579
mutation O 0 4.445912082928771e-08
may O 0 5.460266017109916e-09
partially O 0 8.63536797623965e-08
predict O 0 1.1557090395797331e-08
specific O 0 2.193040637976651e-09
phenotypic O 0 1.9899820813407132e-07
expression O 0 1.2285509853882104e-07
. O 0 6.462448709498858e-08

This O 0 8.918218163955771e-09
should O 0 5.21182985657731e-10
help O 0 2.152169276126159e-10
in O 0 1.1773654273738998e-10
the O 0 4.3092179130566066e-11
design O 0 6.003922248254412e-09
of O 0 5.400740299421614e-09
tailored O 0 2.0965860159094518e-08
clinical O 0 2.915046934504062e-05
- O 0 4.870526936429087e-06
management O 0 1.2183825504052948e-07
protocols O 0 5.5289969935756744e-08
in O 0 1.0352745744013347e-10
this O 0 3.020506371062548e-12
subset O 0 4.4779580044007616e-10
of O 0 6.9406027591867314e-09
FAP B-Disease 0 0.00010132076567970216
patients O 0 5.470025854492633e-08
. O 0 1.9738166656679823e-09
. O 0 1.9028526310194138e-08

Wilms B-Disease 1 0.9999407529830933
' I-Disease 0 0.0010373074328526855
tumor I-Disease 0 3.3571872336324304e-05
1 O 0 3.967482200550876e-07
and O 0 1.6921640977329844e-08
Dax O 0 0.035215165466070175
- O 0 2.0986840354453307e-06
1 O 0 3.245689583764033e-08
modulate O 0 3.747534194076252e-08
the O 0 2.8296165410779395e-09
orphan O 0 2.506831187076841e-08
nuclear O 0 8.576881782573764e-08
receptor O 0 3.0103421977401013e-09
SF O 0 0.001646249322220683
- O 0 5.838782257683306e-08
1 O 0 2.7371656052821436e-09
in O 0 6.584522510566515e-11
sex O 0 1.1586610837444056e-10
- O 0 1.4957225735745538e-10
specific O 0 2.5625329982958966e-11
gene O 0 8.119878658341406e-10
expression O 0 3.224388089861918e-09
. O 0 1.3722421421391573e-08

Products O 0 7.3183596214221325e-06
of O 0 2.1893467874178896e-06
steroidogenic O 0 2.782808405754622e-05
factor O 0 6.070550284675846e-08
1 O 0 3.871792131349139e-08
( O 0 1.0197652722254702e-09
SF O 1 0.92612224817276
- O 0 4.343055479694158e-07
1 O 0 1.0515106119157736e-08
) O 0 1.0389143018096902e-10
and O 0 1.0130168925925886e-09
Wilms B-Disease 1 0.9763410687446594
tumor I-Disease 0 4.389652531244792e-06
1 O 0 8.835446152488657e-08
( O 0 1.7286909681502038e-09
WT1 O 0 0.013966967351734638
) O 0 2.408954979937761e-10
genes O 0 4.7082598236825035e-11
are O 0 5.209101813091754e-12
essential O 0 3.3803462806680784e-10
for O 0 1.4340777176879982e-10
mammalian O 0 5.232453403891668e-08
gonadogenesis O 0 8.341634156749933e-07
prior O 0 6.989916645494532e-09
to O 0 2.964020417994817e-10
sexual O 0 7.0137153862503965e-09
differentiation O 0 8.406659190995924e-08
. O 0 3.50433708717901e-08

In O 0 1.8710167637436825e-07
males O 0 3.735229459067568e-09
, O 0 2.323121695013697e-09
SF O 1 0.9487228989601135
- O 0 2.1296691556926817e-06
1 O 0 1.2055260789622935e-08
participates O 0 1.2682229710847537e-09
in O 0 5.451477810836103e-11
sexual O 0 5.166427702318899e-11
development O 0 7.268952800787432e-11
by O 0 1.6031244040592973e-11
regulating O 0 2.4710924417803426e-09
expression O 0 5.004554548548867e-10
of O 0 4.765499994618949e-09
the O 0 6.30786978206288e-09
polypeptide O 0 5.012966539652552e-07
hormone O 0 1.5178046908204124e-07
Mullerian O 0 7.096023909980431e-05
inhibiting O 0 4.957943247063668e-07
substance O 0 5.912731353419076e-07
( O 0 3.396662506816028e-08
MIS O 1 0.9999998807907104
) O 0 1.5160940947112067e-08
. O 0 3.2366639146630405e-08

Here O 0 6.948711188670131e-07
, O 0 8.816756214002908e-09
we O 0 7.975547999805599e-10
show O 0 1.542078797989177e-09
that O 0 2.487903771886124e-10
WT1 O 0 0.0017470554448664188
- O 0 6.479045623564161e-06
KTS O 1 0.8699286580085754
isoforms O 0 6.74232509823014e-08
associate O 0 1.2760054346472316e-07
and O 0 1.7838989174734365e-09
synergize O 0 2.9845650715287775e-06
with O 0 1.406733307618424e-08
SF O 1 0.9999996423721313
- O 0 6.356524409056874e-06
1 O 0 1.9588082267318896e-08
to O 0 4.317092794359212e-10
promote O 0 1.1495144036643978e-07
MIS O 1 0.9998980760574341
expression O 0 2.3109569724510948e-07
. O 0 3.2001210570342664e-08

In O 0 2.2250850406635436e-07
contrast O 0 1.3066886594970128e-07
, O 0 5.069407649216373e-08
WT1 O 0 0.48341578245162964
missense O 0 1.8770733731798828e-06
mutations O 0 4.1317413490560284e-08
, O 0 3.621517308260991e-09
associated O 0 9.636385023270577e-09
with O 0 3.7067271474455765e-09
male B-Disease 0 1.5764321403821668e-07
pseudohermaphroditism I-Disease 1 1.0
in O 0 3.6469589304033434e-07
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.4648797730387741e-07
fail O 0 2.2665983578917803e-07
to O 0 6.225860715858289e-09
synergize O 0 3.444039248279296e-05
with O 0 2.055527374977828e-07
SF O 1 1.0
- O 0 0.001175127224996686
1 O 0 1.7960715013032313e-06
. O 0 6.032954757984044e-08

Additionally O 0 7.757171260891482e-07
, O 0 5.47737322165176e-09
the O 0 1.2914223024296234e-09
X O 0 3.762503183679655e-06
- O 0 5.57249904886703e-07
linked O 0 7.420123893098207e-08
, O 0 1.1969923663368576e-10
candidate O 0 4.822101745682872e-11
dosage O 0 2.6612546832893713e-08
- O 0 3.027017925205655e-08
sensitive O 0 7.356302234029499e-08
sex O 0 2.991961789433617e-09
- O 0 3.5012952537272213e-09
reversal O 0 3.670354686846622e-09
gene O 0 3.830390171710718e-10
, O 0 3.2407990180338686e-10
Dax O 0 8.687029185239226e-05
- O 0 3.014371827703144e-07
1 O 0 1.7868179824631625e-08
, O 0 4.150179921946773e-10
antagonizes O 0 2.3040516339278838e-07
synergy O 0 1.202093926622183e-07
between O 0 7.578891292325807e-09
SF O 1 0.956290066242218
- O 0 7.92972969065886e-07
1 O 0 2.0232320707691542e-08
and O 0 3.8033540761261975e-09
WT1 O 0 0.2139398604631424
, O 0 3.5803410236567856e-10
most O 0 5.043014270067481e-11
likely O 0 1.797367116251891e-11
through O 0 2.1058569818488415e-11
a O 0 1.4821952692978257e-11
direct O 0 3.130078488067234e-11
interaction O 0 5.218773191373316e-10
with O 0 2.4236623819007264e-09
SF O 1 0.9999998807907104
- O 0 5.988147677271627e-05
1 O 0 9.170722705675871e-07
. O 0 3.378602642101214e-08

We O 0 6.464014745688473e-08
propose O 0 6.52199787509744e-08
that O 0 2.2904795837774827e-09
WT1 O 0 0.0008857997599989176
and O 0 1.3572442014719854e-07
Dax O 1 0.6851600408554077
- O 0 2.2707661173626548e-06
1 O 0 2.5510525247796068e-08
functionally O 0 1.8856296080116408e-08
oppose O 0 3.2560967810901786e-10
each O 0 3.7941173640365644e-12
other O 0 1.3724468610198937e-11
in O 0 3.7561173615863197e-10
testis O 0 3.065586540174081e-08
development O 0 1.0325142962841483e-09
by O 0 4.4549991473630257e-10
modulating O 0 1.8195735265180701e-06
SF O 1 0.9999282360076904
- O 0 2.4288665372296236e-06
1 O 0 9.693165026192219e-08
- O 0 9.129519895623162e-08
mediated O 0 1.352147336319831e-07
transactivation O 0 1.8215232557849959e-06
. O 0 2.370401208651174e-09
. O 0 8.609724488906068e-09

A O 0 1.9627164874691516e-05
mouse O 0 5.557999429584015e-07
model O 0 9.33000432468134e-09
for O 0 4.6602533387840595e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999995231628418
- O 1 0.994792640209198
centre O 0 0.01540857832878828
mutations O 0 7.858316735109838e-07
. O 0 9.551390434126006e-08

Imprinting O 0 5.556205360335298e-05
in O 0 5.883858023025823e-08
the O 0 4.665367470124693e-08
15q11 O 0 5.0554349400044885e-06
- O 0 1.1327979336783756e-06
q13 O 0 9.774154250408174e-07
region O 0 6.391910112313326e-09
involves O 0 6.356175585864321e-10
an O 0 2.6531818408948027e-11
imprinting O 0 5.842413770551502e-07
centre O 0 2.295003923791228e-06
( O 0 3.584804897371896e-09
IC O 1 0.9999630451202393
) O 0 1.629990586948793e-09
, O 0 1.557487472325647e-10
mapping O 0 8.762183201227458e-10
in O 0 1.8289311731756186e-10
part O 0 8.03629274237494e-10
to O 0 2.1406815209346064e-10
the O 0 6.725472179169856e-09
promoter O 0 6.211917479959084e-06
and O 0 4.603463388264117e-09
first O 0 3.118724833939268e-08
exon O 0 8.872952435012849e-07
of O 0 8.026631235225068e-07
SNRPN O 1 0.9999992847442627
. O 0 8.399941862080595e-07

Deletion O 0 1.793379169612308e-06
of O 0 4.812236511497758e-07
this O 0 3.2798719296067702e-09
IC O 1 0.568318784236908
abolishes O 0 2.0820446025027195e-06
local O 0 2.466272341905551e-08
paternally O 0 1.776379860984889e-07
derived O 0 4.748686777134026e-09
gene O 0 7.173698857165789e-10
expression O 0 2.7909474731302453e-10
and O 0 5.401798452986384e-10
results O 0 5.53166268346672e-09
in O 0 1.210522952987958e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999171495437622
PWS B-Disease 1 1.0
) O 0 1.5705692248957348e-06
. O 0 1.921775947266724e-07

We O 0 6.233289440160661e-08
have O 0 3.60906887708623e-10
created O 0 2.343804039739439e-09
two O 0 1.0479556805664814e-10
deletion O 0 2.0703101455410433e-09
mutations O 0 8.667487283453568e-10
in O 0 2.3485118294530594e-09
mice O 0 2.2268419996862576e-08
to O 0 2.2484367701025576e-09
understand O 0 2.166017054605618e-07
PWS B-Disease 1 1.0
and O 0 5.490387522399942e-08
the O 0 4.630692718166074e-09
mechanism O 0 1.4625562982928386e-08
of O 0 2.2752237427425825e-08
this O 0 5.916735990041389e-10
IC O 1 0.9976267218589783
. O 0 1.9076027513165172e-07

Mice O 0 0.000268258445430547
harbouring O 0 0.00012993962445762008
an O 0 1.0030867692023548e-08
intragenic O 0 2.7330273951520212e-05
deletion O 0 1.7842509691945452e-07
in O 0 1.5341877102059698e-08
Snrpn O 0 0.00056215695803985
are O 0 5.1815711721303614e-09
phenotypically O 0 3.5792636481346563e-06
normal O 0 9.725851413122655e-08
, O 0 7.992664863287757e-10
suggesting O 0 4.347990578690286e-10
that O 0 1.3502570589407625e-11
mutations O 0 1.0534814132157067e-09
of O 0 7.811455304818082e-08
SNRPN O 1 0.9999998807907104
are O 0 3.02944641594749e-10
not O 0 6.460196960711428e-11
sufficient O 0 2.554371603125105e-09
to O 0 1.253367098996705e-08
induce O 0 0.0007298711570911109
PWS B-Disease 1 1.0
. O 0 4.606602033163654e-06

Mice O 0 2.547572194089298e-06
with O 0 1.2214259603737787e-09
a O 0 9.173533599415862e-10
larger O 0 8.299334552930304e-10
deletion O 0 6.710595190639879e-09
involving O 0 1.6082259080008043e-08
both O 0 7.116328859524401e-09
Snrpn O 0 9.175016748486087e-05
and O 0 1.3703197687675583e-08
the O 0 4.015099364096386e-08
putative O 0 1.143122608482372e-05
PWS O 1 1.0
- O 0 0.0007214867509901524
IC O 1 0.999911904335022
lack O 0 7.531527757009826e-08
expression O 0 2.802294618575729e-09
of O 0 9.762908703692119e-09
the O 0 1.8076106167441708e-09
imprinted O 0 1.5468789626993384e-07
genes O 0 4.239728568222745e-09
Zfp127 O 0 1.6218671589740552e-05
( O 0 1.1209253081290171e-08
mouse O 0 6.287655907044609e-08
homologue O 0 3.7363540172918874e-07
of O 0 1.6232596067311533e-07
ZNF127 O 1 0.9999953508377075
) O 0 1.0410973416696834e-08
, O 0 8.46577297153317e-09
Ndn O 0 0.00033037090906873345
and O 0 3.786736257893608e-08
Ipw O 0 0.00020354763546492904
, O 0 6.385073803016894e-09
and O 0 6.042946143480776e-10
manifest O 0 3.346202959164657e-08
several O 0 1.7504532268119988e-09
phenotypes O 0 3.731023525688215e-07
common O 0 1.080251905705154e-07
to O 0 1.3199338582126074e-06
PWS B-Disease 1 1.0
infants O 1 0.6948590874671936
. O 0 2.854129945717432e-07

These O 0 2.1962231144811994e-08
data O 0 9.3609848761389e-09
demonstrate O 0 2.2535071586560207e-09
that O 0 1.7545459876644465e-11
both O 0 4.5271987547668147e-11
the O 0 2.2805655974789119e-10
position O 0 8.904701420675565e-10
of O 0 3.2866100951878252e-09
the O 0 2.276247190735603e-09
IC O 0 0.21476329863071442
and O 0 2.885524930107408e-09
its O 0 5.805971259320586e-10
role O 0 7.516294253662181e-10
in O 0 1.0737141037386877e-10
the O 0 9.448837545722455e-11
coordinate O 0 1.8992392381012024e-10
expression O 0 1.382510217418087e-10
of O 0 1.1874695671210134e-09
genes O 0 4.5000801696115644e-11
is O 0 1.684593957385072e-11
conserved O 0 1.3509693363999986e-09
between O 0 7.769885845831936e-10
mouse O 0 7.726986162026606e-09
and O 0 3.270294035573329e-10
human O 0 1.4558119154628457e-09
, O 0 1.2239206870212627e-10
and O 0 1.8059968798223025e-10
indicate O 0 1.4715059726277957e-10
that O 0 1.7153205938980065e-12
the O 0 3.22022547516454e-10
mouse O 0 2.6492352755980164e-09
is O 0 3.507225326132568e-12
a O 0 1.95967135747932e-12
suitable O 0 8.518080685249174e-11
model O 0 5.787979123761389e-11
system O 0 4.521427954262691e-10
in O 0 6.126456286725812e-11
which O 0 6.922452628482789e-12
to O 0 6.946630770610085e-12
investigate O 0 6.136540164902726e-10
the O 0 1.3150151800811472e-10
molecular O 0 3.433017425891194e-09
mechanisms O 0 3.625574063192971e-09
of O 0 1.0133014427538e-08
imprinting O 0 7.59437810415875e-08
in O 0 2.153051903430736e-10
this O 0 1.3453007804975492e-11
region O 0 6.074981073744823e-10
of O 0 2.046471436756292e-09
the O 0 5.322414731168124e-10
genome O 0 4.106728845876262e-10
. O 0 1.898735751959535e-10
. O 0 6.247903971967617e-09

Mutations O 0 1.338112269877456e-07
of O 0 1.7130557239397604e-07
the O 0 8.931530182110237e-09
ATM O 0 7.581006502732635e-05
gene O 0 9.52664258591085e-09
detected O 0 2.4916865015711664e-08
in O 0 1.321024178935204e-09
Japanese O 0 0.09216252714395523
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 2.815851621562615e-05
: O 0 1.4077337073814533e-09
possible O 0 3.3525195952677223e-09
preponderance O 0 3.355347416800214e-06
of O 0 1.3311552038430818e-07
the O 0 6.631845295146377e-09
two O 0 1.7848076350190922e-09
founder O 0 3.254329840274295e-06
mutations O 0 2.7895508125652668e-08
4612del165 O 0 4.086272838321747e-06
and O 0 2.881328100556857e-07
7883del5 O 0 7.261650171130896e-05
. O 0 4.701604154888628e-07

The O 0 1.9864678506564815e-06
ATM O 0 0.00034126476384699345
( O 0 3.199474747361819e-07
A O 1 1.0
- O 1 0.9999940395355225
T O 1 1.0
, O 0 1.6656238610579521e-09
mutated O 0 3.499198930612124e-09
) O 0 5.6703919337763864e-11
gene O 0 1.775029290218555e-10
on O 0 1.9771360104670066e-09
human O 0 3.900192613315312e-09
chromosome O 0 3.7990272261367863e-08
11q22 O 0 2.9934017220512033e-06
. O 0 3.63951606630053e-08

3 O 0 3.6091905712964945e-06
has O 0 2.294406220570977e-09
recently O 0 1.0164931119049925e-09
been O 0 4.5378839574894414e-11
identified O 0 2.968726306451508e-11
as O 0 1.4701727682475685e-11
the O 0 1.0142556933212532e-10
gene O 0 1.5186452095861114e-10
responsible O 0 3.3744324001716564e-10
for O 0 5.646852083152076e-11
the O 0 3.427403916234084e-09
human O 0 1.245151821649415e-07
recessive B-Disease 1 0.9999858140945435
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00011788445408456028
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5300562949960295e-07
. O 0 5.445427575523354e-08

In O 0 5.709121353447699e-08
order O 0 6.044701628127314e-09
to O 0 2.75459932641553e-10
define O 0 1.366213919773429e-09
the O 0 1.227961343719386e-10
types O 0 3.410228099909318e-09
of O 0 3.543286197782436e-07
disease O 0 0.012089354917407036
- O 0 5.011561370338313e-07
causing O 0 9.356649854908028e-08
ATM O 0 1.6124473404488526e-05
mutations O 0 4.883808024658265e-09
in O 0 1.562346807482129e-09
Japanese O 0 1.1420765076763928e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.0576743864353375e-08
as O 0 1.1550732592624513e-10
well O 0 4.232322825536983e-11
as O 0 1.757262217683131e-11
to O 0 1.071598105389926e-11
look O 0 1.8251605782282354e-10
for O 0 2.5422230293115078e-11
possible O 0 1.1394500898376236e-09
mutational O 0 2.1698681393900188e-06
hotspots O 0 8.527380828127207e-07
, O 0 1.203818378314736e-09
reverse O 0 5.5440634305625736e-09
- O 0 7.774440646812764e-09
transcribed O 0 8.413810093088614e-09
RNA O 0 4.577275891648469e-09
derived O 0 2.957165068373513e-10
from O 0 1.3348068483853837e-10
ten O 0 7.622815156871354e-10
patients O 0 7.215384539849268e-11
belonging O 0 3.8512704136905995e-09
to O 0 7.623222053609879e-10
eight O 0 2.4620938177122298e-08
unrelated O 0 1.655818522294794e-07
Japanese O 0 0.00010984722030116245
A B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
T I-Disease 1 1.0
families O 0 1.8491634612427532e-10
was O 0 1.1478087369454215e-09
analyzed O 0 5.653051915466278e-10
for O 0 1.3629097850298422e-11
mutations O 0 9.27718596388516e-11
by O 0 7.07084807372027e-11
the O 0 3.264074843745135e-10
restriction O 0 2.302620732974603e-10
endonuclease O 0 2.123085174332573e-08
fingerprinting O 0 3.917872604120021e-08
method O 0 1.0772311931361855e-08
. O 0 8.075616619862558e-09

As O 0 5.914192229283799e-07
has O 0 2.9697144743323634e-09
been O 0 4.1631345593096114e-10
reported O 0 1.7200237067971358e-10
by O 0 4.2839197467170465e-11
others O 0 4.688538446373514e-10
, O 0 3.3312602676360825e-10
mutations O 0 3.7585326517763917e-10
that O 0 8.165893655709411e-11
lead O 0 2.1883024281521557e-09
to O 0 3.951761418097277e-10
exon O 0 1.2436184704256448e-07
skipping O 0 2.3162345996752265e-07
or O 0 6.8374181871888595e-09
premature O 0 4.8003421682096814e-08
protein O 0 2.128582199389939e-09
truncation O 0 1.7860283207937755e-07
were O 0 8.40351344066903e-09
also O 0 4.3929462845149203e-10
predominant O 0 2.8632621607016517e-08
in O 0 1.5444454604107705e-09
our O 0 2.485624683856713e-08
mutants O 0 8.297931231027178e-07
. O 0 5.6807930803870477e-08

Six O 0 1.2954966166489612e-07
different O 0 4.758822225170434e-10
mutations O 0 7.960441195109524e-10
were O 0 5.308545825144506e-10
identified O 0 5.445505157908315e-10
on O 0 4.9942587843077035e-09
12 O 0 6.3938485617143215e-09
of O 0 3.909502499510609e-09
the O 0 3.5719460722560825e-09
16 O 0 5.845445727459264e-08
alleles O 0 2.456412184770329e-09
examined O 0 3.1745335604682623e-07
. O 0 1.1062132188044416e-07

Four O 0 4.395532471335173e-07
were O 0 1.2144297123484193e-08
deletions O 0 8.297980969018681e-08
involving O 0 1.4561854300154664e-07
a O 0 1.8062157991494132e-08
loss O 0 8.879690653884609e-07
of O 0 9.882410267891828e-07
a O 0 8.50940118368726e-09
single O 0 4.067165093601943e-08
exon O 0 1.8135207824343524e-07
exon O 0 2.835859618244285e-07
7 O 0 3.2085986845231673e-07
, O 0 2.6527291474565118e-09
exon O 0 1.1177553460584022e-07
16 O 0 8.37711127132934e-08
, O 0 3.07516612174652e-09
exon O 0 2.1978306108394463e-07
33 O 0 1.0973032260608306e-07
or O 0 1.1647201425546427e-08
exon O 0 1.1796435046562692e-06
35 O 0 2.9222206876511336e-07
. O 0 6.623972126362787e-08

The O 0 5.953810955361405e-07
others O 0 1.4954446569959146e-08
were O 0 3.7313845346886865e-09
minute O 0 2.0983824455811373e-08
deletions O 0 3.930087189019105e-08
, O 0 1.7649056660573592e-09
4649delA O 0 1.7140787633707077e-07
in O 0 7.064087981234479e-09
exon O 0 1.2038515251333592e-07
33 O 0 3.880212773310632e-08
and O 0 1.8997907691442606e-09
7883del5 O 0 6.009183266542095e-07
in O 0 1.072135358270998e-08
exon O 0 7.830891490812064e-07
55 O 0 3.9058457446117245e-07
. O 0 3.629768841051373e-08

The O 0 2.9197806838965334e-07
mutations O 0 3.277934723655562e-08
4612del165 O 0 1.3458695775625529e-06
and O 0 7.2936527928391115e-09
7883del5 O 0 3.1918190757096454e-07
were O 0 2.677729815658836e-09
found O 0 2.41708736359314e-10
in O 0 5.310912473688312e-11
more O 0 1.5803479401846343e-12
than O 0 3.3564943359432053e-12
two O 0 1.2612502188480423e-11
unrelated O 0 7.767247955925427e-10
families O 0 1.217761048249999e-11
; O 0 4.48605146086134e-11
44 O 0 1.0451256526877728e-09
% O 0 1.3052539084290604e-11
( O 0 4.411879195309609e-11
7 O 0 5.134770386661103e-09
of O 0 1.2624387757398381e-08
16 O 0 9.277354884318356e-09
) O 0 2.217666328352408e-11
of O 0 4.1444842002746896e-10
the O 0 4.0358871800094676e-10
mutant O 0 2.879960714352592e-09
alleles O 0 2.2630845114557374e-11
had O 0 3.9652892080965785e-11
one O 0 3.580284332893591e-11
of O 0 1.962790374676615e-09
the O 0 1.4891705646391529e-09
two O 0 8.563240116998827e-10
mutations O 0 2.5788105872948108e-08
. O 0 4.265678654746807e-08

The O 0 5.259730073703395e-07
4612del165 O 0 4.828394594369456e-06
mutations O 0 4.6941956988177935e-09
in O 0 6.342212865995123e-10
three O 0 3.152522687344117e-11
different O 0 5.439053287620288e-12
families O 0 1.7557303267495827e-12
were O 0 9.663246591795627e-11
all O 0 4.233534356412605e-11
ascribed O 0 2.1935719907162365e-09
to O 0 2.1753257528622783e-10
the O 0 1.3169032531124003e-09
same O 0 1.037449459673212e-09
T O 0 3.0111707474134164e-06
- O 0 1.2921280756472697e-07
- O 0 2.253731778978363e-08
> O 0 4.2101939712324565e-09
A O 0 2.9175122318036983e-09
substitution O 0 2.0355517271752888e-09
at O 0 3.862835384893515e-09
the O 0 1.2628732781738705e-10
splice O 0 5.47583987042799e-08
donor O 0 6.388956586000916e-10
site O 0 2.4185471403370684e-08
in O 0 5.870650188199988e-09
intron O 0 5.709573997592088e-06
33 O 0 1.2546655625556014e-06
. O 0 1.0407304529280736e-07

Microsatellite O 0 0.00013613898772746325
genotyping O 0 2.4161823603208177e-05
around O 0 6.18728250856293e-08
the O 0 1.7669881557935696e-08
ATM O 0 1.4841381016594823e-05
locus O 0 8.015924635174088e-08
also O 0 4.4792222708700535e-10
indicated O 0 7.580824856745494e-10
that O 0 1.102678452019612e-11
a O 0 1.503233232336143e-10
common O 0 1.0438208075669309e-09
haplotype O 0 1.9603071166329755e-08
was O 0 6.9653753875797975e-09
shared O 0 2.081649713714384e-10
by O 0 2.943702226421152e-11
the O 0 3.4716154950764633e-10
mutant O 0 1.5337188186137496e-09
alleles O 0 2.4948735785623732e-11
in O 0 7.072385732609376e-11
both O 0 3.30361543676716e-10
mutations O 0 1.69587348608502e-08
. O 0 4.270481568369178e-08

This O 0 1.4013131099943621e-08
suggests O 0 3.304612805621332e-09
that O 0 9.873719029884764e-12
these O 0 8.487214403496424e-12
two O 0 9.33952082338152e-11
founder O 0 4.099956072423083e-07
mutations O 0 1.1248741937919249e-09
may O 0 2.971560497666559e-10
be O 0 1.3540772669795587e-10
predominant O 0 1.4578438900514357e-08
among O 0 2.1886477352683897e-10
Japanese O 0 4.6807873133047906e-08
ATM O 0 1.059661190083716e-05
mutant O 0 2.2529374632540566e-07
alleles O 0 7.12696479610031e-09
. O 0 1.7799672846763315e-08

W474C O 0 0.00011762844223994762
amino O 0 2.5338985665257496e-07
acid O 0 3.28436193797188e-08
substitution O 0 1.0317666720993657e-08
affects O 0 2.5424435889931374e-09
early O 0 1.0154059815192795e-09
processing O 0 2.0738040173995387e-09
of O 0 1.0157604757310423e-09
the O 0 2.2034039870444388e-10
alpha O 0 1.772469060412618e-09
- O 0 6.413301556484896e-10
subunit O 0 4.550381946244464e-11
of O 0 4.739021397526244e-10
beta O 0 8.120811578748999e-09
- O 0 2.0652276333521513e-08
hexosaminidase O 0 3.573802018763672e-07
A O 0 2.0105721532104326e-08
and O 0 1.4738429920946317e-10
is O 0 1.756880231573721e-11
associated O 0 1.0366325575716928e-09
with O 0 3.013674643170816e-09
subacute O 1 0.85587078332901
G B-Disease 1 0.9993137121200562
( I-Disease 0 6.465414230660826e-07
M2 I-Disease 1 0.9999947547912598
) I-Disease 0 1.219762566506688e-07
gangliosidosis I-Disease 0 0.0003856830298900604
. O 0 2.0954553292540368e-07

Mutations O 0 2.8731594170494645e-07
in O 0 2.2264726950993463e-08
the O 0 1.9969355946614087e-08
HEXA O 1 0.8378630876541138
gene O 0 2.509743302070433e-09
, O 0 5.894149057716902e-11
encoding O 0 3.0545392604164334e-11
the O 0 4.2112924258930207e-10
alpha O 0 1.907386470989536e-09
- O 0 7.804656365628659e-10
subunit O 0 1.2873785371070312e-10
of O 0 9.413296808702398e-10
beta O 0 1.8404600510280034e-08
- O 0 7.173828464601684e-08
hexosaminidase O 0 2.4274843326566042e-06
A O 0 2.3363075740689965e-07
( O 0 7.526853584849391e-10
Hex O 0 6.626075332860637e-07
A O 0 3.474023912986013e-07
) O 0 2.773303531267146e-10
, O 0 3.27794250076785e-11
that O 0 4.4591856249165396e-12
abolish O 0 1.1231081842311141e-08
Hex O 0 3.562558958947193e-07
A O 0 4.388185814718781e-08
enzyme O 0 5.344431563969465e-09
activity O 0 5.487592247277462e-08
cause O 0 0.00044025733950547874
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.2034909363810584e-07
TSD B-Disease 1 1.0
) O 0 1.3605508719649606e-08
, O 0 8.735250855984589e-10
the O 0 4.762656047319069e-09
fatal O 0 9.188245167024434e-05
infantile B-Disease 0 9.437748303753324e-06
form I-Disease 0 4.5492349443065905e-08
of I-Disease 0 7.805495988577604e-05
G I-Disease 1 0.9998598098754883
( I-Disease 0 1.6371301114759262e-07
M2 I-Disease 1 0.9999986886978149
) I-Disease 0 1.0384576754063346e-08
gangliosidosis I-Disease 0 2.193448926846031e-05
, I-Disease 0 2.4851116720014943e-09
Type I-Disease 0 5.619778562504507e-07
1 I-Disease 0 8.9302028527527e-07
. O 0 3.617038757397495e-08

Less O 0 2.476535200912622e-06
severe O 1 0.9954251646995544
, O 0 7.052834689602605e-07
subacute O 1 0.9999154806137085
( O 0 1.5218515159176604e-07
juvenile O 1 0.9997193217277527
- O 0 0.0002859205415006727
onset O 1 0.9999964237213135
) O 0 1.7420664910616779e-09
and O 0 4.4656545128418657e-08
chronic O 1 0.9999990463256836
( O 0 6.494450310867705e-09
adult O 0 2.1860095955616998e-07
- O 0 7.958958576637087e-07
onset O 0 0.010222227312624454
) O 0 7.998989665081169e-11
variants O 0 8.737767176469902e-10
are O 0 1.7647053957015046e-11
characterized O 0 4.4100306739736084e-10
by O 0 4.472680559253206e-11
a O 0 3.876384491174889e-10
broad O 0 5.595000907021586e-09
spectrum O 0 3.998812658778661e-08
of O 0 4.298700062577154e-08
clinical O 0 1.0813625976879848e-06
manifestations O 0 6.234422926354455e-06
and O 0 1.89355775503941e-09
are O 0 4.0692227365468625e-11
associated O 0 1.9202610612722992e-09
with O 0 3.3307964719675454e-10
residual O 0 5.119615025250823e-07
levels O 0 4.907547079824326e-08
of O 0 4.8591878964998614e-08
Hex O 0 4.881575250692549e-07
A O 0 8.423255337675073e-08
enzyme O 0 6.203859648223897e-09
activity O 0 1.7894100423632153e-08
. O 0 7.75552688736525e-09

We O 0 2.8748038971571077e-07
identified O 0 6.239224603632465e-08
a O 0 1.0549417339689171e-08
1422 O 0 2.6857576813199557e-05
G O 0 2.7139372832607478e-05
- O 0 2.775381290121004e-06
- O 0 3.5491368066686846e-07
> O 0 5.388642421166878e-08
C O 0 1.2617497304745484e-06
( O 0 2.9256130851251783e-10
amino O 0 1.00945840575406e-09
acid O 0 1.1125772525488742e-09
W474C O 0 1.755459244634494e-08
) O 0 5.466562532502328e-12
substitution O 0 1.5660427121755305e-10
in O 0 2.6740113595602466e-11
the O 0 5.472334044243077e-11
first O 0 9.373642140264593e-11
position O 0 4.824026733629694e-10
of O 0 3.374292623092856e-09
exon O 0 2.9951266355965345e-08
13 O 0 3.419511429569866e-08
of O 0 5.7965831246065136e-08
HEXA O 1 0.999972939491272
of O 0 6.568776598214754e-07
a O 0 1.3081769445477676e-08
non O 0 2.396671561655239e-06
- O 0 2.817689619405428e-07
Jewish O 0 2.1667402450020745e-07
proband O 0 0.00043393581290729344
who O 0 5.637409650205427e-09
manifested O 0 9.513336607369638e-08
a O 0 7.682928071517381e-09
subacute O 0 1.8946493582916446e-05
variant O 0 1.3245615946289035e-06
of O 0 2.6623174562701024e-05
G B-Disease 1 0.9997889399528503
( I-Disease 0 5.036514494349831e-07
M2 I-Disease 1 0.9999997615814209
) I-Disease 0 1.001282612378418e-07
gangliosidosis I-Disease 0 0.00041754895937629044
. O 0 1.4283143912052765e-07

On O 0 7.66003040553187e-07
the O 0 3.3123953357971914e-08
second O 0 1.2982422958884854e-07
maternally O 0 9.149660513685376e-07
inherited O 0 5.144079295860138e-06
allele O 0 1.2136609051083269e-08
, O 0 9.196448047532613e-10
we O 0 6.151983089619506e-11
identified O 0 3.6621713994655636e-10
the O 0 1.1867178351110397e-09
common O 0 5.243762757345394e-07
infantile O 1 1.0
disease O 1 0.9998358488082886
- O 0 6.654111075476976e-06
causing O 0 2.404193992333603e-06
4 O 0 5.813168399981805e-07
- O 0 3.56277666924143e-07
bp O 0 6.933844076684181e-08
insertion O 0 6.184993850411047e-08
, O 0 5.295845983965819e-09
+ O 0 3.6303923423020024e-08
TATC O 1 0.973818302154541
1278 O 0 0.00010751203808467835
, O 0 3.2305500496931927e-09
in O 0 6.006121378021589e-09
exon O 0 8.345389801434067e-07
11 O 0 3.2819141893014603e-07
. O 0 4.0579053006695176e-08

Pulse O 0 0.00020740082254633307
- O 0 3.463587745500263e-06
chase O 0 7.494370635185987e-08
analysis O 0 7.736907225996958e-10
using O 0 1.2797700676969725e-09
proband O 0 4.457495833776193e-06
fibroblasts O 0 1.6378734812860785e-07
revealed O 0 6.010043307469459e-08
that O 0 6.33142843708967e-11
the O 0 6.266494545492662e-10
W474C O 0 4.586025781350145e-08
- O 0 4.664448383095987e-09
containing O 0 1.2400408477830638e-09
alpha O 0 2.3347512811966453e-09
- O 0 1.0848761888837544e-09
subunit O 0 3.04623243296831e-10
precursor O 0 1.578534636337281e-08
was O 0 3.748826138405548e-09
normally O 0 1.49236289992416e-10
synthesized O 0 1.0322882992852556e-08
, O 0 5.309413672605068e-11
but O 0 4.220785179698261e-12
not O 0 1.2945720884172118e-12
phosphorylated O 0 1.101204127884614e-09
or O 0 3.8854297557122663e-10
secreted O 0 1.4817276294820658e-09
, O 0 5.226403754221565e-10
and O 0 6.552728915032446e-10
the O 0 3.849948804202086e-09
mature O 0 2.4124011233084275e-08
lysosomal O 0 3.207087502232753e-07
alpha O 0 5.32319184287644e-08
- O 0 1.3246783225895342e-08
subunit O 0 1.12332620982869e-09
was O 0 8.075308421950922e-09
not O 0 3.038161111579285e-10
detected O 0 9.225743724528002e-08
. O 0 2.1682568629444177e-08

When O 0 3.3180614877892367e-07
the O 0 1.3395775155800038e-08
W474C O 0 3.8721472606084717e-07
- O 0 1.852405873137286e-08
containing O 0 3.3161677848170257e-09
alpha O 0 1.7120814987947597e-08
- O 0 6.5743392951844726e-09
subunit O 0 1.25503862857812e-09
was O 0 1.379958725067354e-08
transiently O 0 1.3482522831509414e-07
co O 0 3.504102963347577e-08
- O 0 1.7641964333847682e-08
expressed O 0 1.7698906229490774e-10
with O 0 4.131112812943982e-11
the O 0 2.1422090490386125e-10
beta O 0 9.845370074756943e-10
- O 0 4.87972717788665e-10
subunit O 0 3.903969855723055e-11
to O 0 1.3001503519627367e-11
produce O 0 7.459324824488078e-10
Hex O 0 3.379641100309527e-07
A O 0 3.297745649888384e-07
( O 0 1.2663303738946752e-09
alphabeta O 0 1.4734910109837074e-06
) O 0 2.2221174900138863e-10
in O 0 1.22005228142541e-09
COS O 0 0.0008042437257245183
- O 0 1.535176352263079e-06
7 O 0 1.52275319464934e-07
cells O 0 2.2336685834289938e-09
, O 0 1.3688920830201567e-10
the O 0 5.008956582841506e-10
mature O 0 6.792854612136523e-10
alpha O 0 1.1956308165750329e-09
- O 0 3.0281582796831685e-10
subunit O 0 7.0739365753969e-11
was O 0 4.143962673008872e-10
present O 0 8.571423432135461e-11
, O 0 1.539761200486378e-11
but O 0 1.4952162771808553e-12
its O 0 1.9589324953828147e-11
level O 0 1.6786330103712999e-09
was O 0 1.563467799670093e-09
much O 0 1.0709835795985612e-10
lower O 0 9.797264111099935e-10
than O 0 3.975291016505844e-12
that O 0 1.0025204407945743e-12
from O 0 5.7142110487795605e-11
normal O 0 3.530363501536016e-10
alpha O 0 2.3743920163354915e-09
- O 0 3.225273825790964e-09
subunit O 0 7.382482403173185e-10
transfections O 0 1.0225357982562855e-07
, O 0 9.560052749435499e-11
although O 0 1.5590261720488385e-11
higher O 0 6.591006213030326e-11
than O 0 1.6366361391129125e-12
in O 0 1.9519504068643556e-11
those O 0 1.9658044289605492e-11
cells O 0 1.9773954695878615e-10
transfected O 0 4.1114023296984215e-09
with O 0 1.4117844046590555e-11
an O 0 1.4225696141900723e-11
alpha O 0 6.11846306952657e-09
- O 0 6.127046425774552e-09
subunit O 0 1.3833892920089852e-09
associated O 0 5.977550010527466e-09
with O 0 5.272865255534498e-09
infantile O 1 0.9931621551513672
TSD B-Disease 1 0.9999979734420776
. O 0 4.063381595642568e-07

Furthermore O 0 6.134451382422412e-07
, O 0 6.371327021525985e-09
the O 0 1.380165981501591e-09
precursor O 0 5.737679131812001e-08
level O 0 3.1222242569128866e-08
of O 0 6.061870116980117e-09
the O 0 2.0771133701913413e-09
W474C O 0 6.009859276900897e-08
alpha O 0 2.4027657641312317e-09
- O 0 1.5428613941992353e-09
subunit O 0 2.2411826561263837e-10
was O 0 1.1502502283988747e-09
found O 0 5.2303796710395645e-11
to O 0 7.191981819115734e-12
accumulate O 0 8.736200651782156e-10
in O 0 1.4657636215886782e-10
comparison O 0 3.6036071349165866e-10
to O 0 7.384914207930748e-11
the O 0 5.164686456282652e-10
normal O 0 2.063647475125663e-09
alpha O 0 9.055050043116353e-09
- O 0 5.2215733958860255e-09
subunit O 0 9.663713163021725e-10
precursor O 0 3.986658114740749e-08
levels O 0 9.736019990214118e-09
. O 0 1.9840644682744824e-09

We O 0 1.3210680549491371e-07
conclude O 0 2.1047844711574726e-07
that O 0 3.522789282506267e-10
the O 0 4.665765551692402e-09
1422 O 0 1.754109325702302e-05
G O 0 1.3328295608516783e-05
- O 0 1.4385111626324942e-06
- O 0 3.1217246032611e-07
> O 0 3.809461901482791e-08
C O 0 1.4473276905846433e-06
mutation O 0 2.812472477131678e-10
is O 0 6.414004743993118e-12
the O 0 5.959874954664102e-11
cause O 0 2.0697417113524352e-09
of O 0 4.7767596100811716e-08
Hex B-Disease 0 0.022629650309681892
A I-Disease 1 0.9986588954925537
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.4586400709504233e-07
the O 0 1.790754140529316e-07
proband O 0 0.00016953339218162
. O 0 9.886684182447425e-08

The O 0 3.9185908917716006e-07
resulting O 0 1.0193538457770046e-07
W474C O 0 9.330271950602764e-07
substitution O 0 1.1292669910289987e-07
clearly O 0 1.5519940887998018e-08
interferes O 0 7.82343967387078e-09
with O 0 1.548662864614414e-10
alpha O 0 4.909951112352928e-09
- O 0 2.7327315965663956e-09
subunit O 0 2.5461061037290733e-10
processing O 0 2.2520978415485615e-09
, O 0 2.1833137728299867e-11
but O 0 1.4416070334005715e-12
because O 0 1.157778408734933e-12
the O 0 1.8615732219617875e-11
base O 0 6.24862772635737e-10
substitution O 0 3.950836546806613e-09
falls O 0 1.575824768451639e-07
at O 0 6.4123510945535145e-09
the O 0 2.612009497582335e-10
first O 0 7.142638147605851e-10
position O 0 1.3700341972011643e-09
of O 0 1.5706898892631216e-08
exon O 0 1.5476005899017764e-07
13 O 0 7.675256341599379e-08
, O 0 5.875632203000691e-10
aberrant O 0 1.6685650905401417e-07
splicing O 0 4.10553184337914e-07
may O 0 1.2173378749480435e-08
also O 0 6.211836600655829e-10
contribute O 0 1.1465571825297616e-09
to O 0 4.704817868628197e-09
Hex B-Disease 0 0.0010930945863947272
A I-Disease 1 0.9748224020004272
deficiency I-Disease 0 0.00037496769800782204
in O 0 6.791614381995714e-09
this O 0 7.554439296342252e-10
proband O 0 9.181870154861826e-06
. O 0 5.438065997509511e-09
. O 0 1.4359732070090558e-08

Two O 0 7.066772411690181e-08
frequent O 0 2.1283403839333914e-07
missense O 0 6.215093890205026e-06
mutations O 0 1.078155946743209e-06
in O 0 2.3461512682843022e-05
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 8.106830136966892e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 8.335178591778458e-08
an O 0 2.469567732532596e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9632609486579895
by O 0 3.568236550677284e-08
early O 1 0.9999707937240601
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999995231628418
goiter B-Disease 1 1.0
. O 0 0.0001678016415098682

A O 0 2.962700591524481e-06
century O 0 2.023703871145699e-07
after O 0 2.7834001770088435e-09
its O 0 3.417739008471088e-11
recognition O 0 2.74422123913709e-10
as O 0 3.464477871251148e-10
a O 0 1.3554585898134519e-08
syndrome O 0 5.991825673845597e-06
by O 0 3.126245262663474e-09
Vaughan O 0 0.10666928440332413
Pendred O 1 0.9618830680847168
, O 0 6.381433603763753e-09
the O 0 5.698264260445285e-08
disease O 0 4.1454371967120096e-05
gene O 0 6.886275105699724e-09
( O 0 5.204123798563387e-09
PDS O 1 0.9249939322471619
) O 0 3.751709165555894e-09
was O 0 2.4338087101227757e-08
mapped O 0 4.456303770439263e-08
to O 0 7.148925007527396e-09
chromosome O 0 6.907785632392915e-07
7q22 O 0 4.876226739725098e-05
- O 0 2.4778893930488266e-05
q31 O 0 4.575831553665921e-05
. O 0 1.5770440597862034e-07

1 O 0 7.201837206594064e-07
and O 0 2.1509896086513436e-08
, O 0 5.595306995509475e-10
recently O 0 1.9835044717808614e-09
, O 0 7.505603777380188e-11
found O 0 3.6744978587632815e-11
to O 0 2.0302995396015433e-11
encode O 0 1.3176018054394945e-09
a O 0 3.174398521821331e-09
putative O 0 3.6565501204677275e-07
sulfate O 0 1.7537042822368676e-06
transporter O 0 4.577660729410127e-05
. O 0 3.4682042837630433e-07

We O 0 9.913402720940212e-08
performed O 0 3.4295709383513895e-07
mutation O 0 5.5913812468944e-10
analysis O 0 4.889714744216178e-10
of O 0 2.1230719404741194e-09
the O 0 2.1372434932942497e-09
PDS B-Disease 0 0.0002477611997164786
gene O 0 2.0652777266150224e-09
in O 0 1.0111058657003014e-09
patients O 0 8.20054746331067e-10
from O 0 2.207982463531266e-09
14 O 0 3.511723889459972e-08
Pendred B-Disease 0 2.101367726936587e-06
families O 0 1.3358350883785342e-11
originating O 0 1.244462199956331e-09
from O 0 3.563941086692779e-10
seven O 0 4.241165751928122e-10
countries O 0 8.990466357494675e-12
and O 0 2.6656410412329024e-10
identified O 0 1.3598910886258864e-09
all O 0 3.310050900040551e-09
mutations O 0 1.1373861497077087e-07
. O 0 1.1014824252697508e-07

The O 0 5.369220730244706e-07
mutations O 0 2.3991949760215903e-08
include O 0 9.509795617645977e-09
three O 0 1.6360393040315557e-09
single O 0 2.3482249478234962e-09
base O 0 1.0385546644897659e-08
deletions O 0 3.039265550341952e-08
, O 0 2.3763493395279056e-09
one O 0 4.677257470220297e-10
splice O 0 4.2863538851634075e-07
site O 0 7.310187299935933e-08
mutation O 0 4.166742950673097e-09
and O 0 4.332289194053374e-09
10 O 0 5.290507942845579e-08
missense O 0 4.228559646435315e-06
mutations O 0 7.814650189175154e-07
. O 0 4.733772698273242e-07

One O 0 3.3688479561533313e-07
missense O 0 2.570700871729059e-06
mutation O 0 5.412147885408558e-08
( O 0 7.08138259142288e-09
L236P O 0 2.6192217319476185e-06
) O 0 1.2362032508761445e-09
was O 0 5.717051720921518e-09
found O 0 6.971083432727454e-11
in O 0 2.616950059430856e-11
a O 0 5.6563271427778616e-11
homozygous O 0 4.3877629307687016e-10
state O 0 2.14514891960782e-10
in O 0 2.1055768240074713e-10
two O 0 2.7051411111145285e-10
consanguineous O 0 2.646580696819001e-07
families O 0 3.2928312854174635e-11
and O 0 2.609828464450459e-10
in O 0 3.3692360013048983e-10
a O 0 1.8992500627756925e-10
heterozygous O 0 5.968725513838535e-11
state O 0 7.109389466020133e-11
in O 0 4.1940659278871806e-10
five O 0 6.090330462171778e-10
additional O 0 1.1234161378936847e-09
non O 0 3.910015038854908e-06
- O 0 1.0805052625073586e-05
consanguineous O 0 4.985240229871124e-05
families O 0 4.9318855666058425e-09
. O 0 5.980140826977731e-08

Another O 0 6.055932431081601e-07
missense O 0 2.407093916190206e-06
mutation O 0 4.318274804404609e-08
( O 0 6.401658314558745e-09
T416P O 0 1.338813490292523e-06
) O 0 7.749711983251473e-10
was O 0 5.425385030122243e-09
found O 0 2.080212807564763e-10
in O 0 6.570095856250902e-11
a O 0 5.4369397872733316e-11
homozygous O 0 3.3416969191790713e-10
state O 0 1.3802074760871363e-10
in O 0 2.1055848731243998e-10
one O 0 2.053547609737194e-10
family O 0 9.058530314742796e-11
and O 0 3.4557728900708184e-10
in O 0 3.0138053164208145e-10
a O 0 1.163941651394218e-10
heterozygous O 0 3.73160842503939e-11
state O 0 9.45190176127042e-11
in O 0 2.0262194699860459e-10
four O 0 6.593096624207817e-10
families O 0 2.267873389083519e-10
. O 0 8.938910056599525e-09

Pendred B-Disease 1 0.8747705817222595
patients O 0 1.3766183428742806e-06
in O 0 1.819899608790365e-08
three O 0 7.218351694149305e-09
non O 0 1.5641761592632974e-06
- O 0 9.022363656185917e-07
consanguineous O 0 1.640435471017554e-06
families O 0 1.935918092499378e-11
were O 0 2.0058012195622865e-10
shown O 0 3.333756534718013e-11
to O 0 2.817088229356557e-11
be O 0 4.7669042324560706e-11
compound O 0 1.0491506330367883e-08
heterozygotes O 0 1.0840001607448357e-07
for O 0 5.153441673400039e-09
L236P O 0 2.924999535025563e-06
and O 0 9.494193875525525e-08
T416P O 0 3.0974162655184045e-05
. O 0 1.0785267079427285e-07

In O 0 6.516862782746102e-08
total O 0 3.7020853049796187e-09
, O 0 1.6747912778836138e-10
one O 0 2.9042400429002413e-11
or O 0 6.004408775739378e-11
both O 0 5.7771259998062874e-11
of O 0 9.330159977949393e-10
these O 0 3.570893580828738e-11
mutations O 0 1.0500064706597811e-10
were O 0 3.691936201200008e-10
found O 0 2.1460205834600288e-10
in O 0 1.785038228341307e-10
nine O 0 1.515307102017971e-09
of O 0 5.210043507730688e-09
the O 0 2.0824686419729233e-09
14 O 0 5.6786015889542796e-09
families O 0 4.5796554049015725e-11
analyzed O 0 2.6730413438258438e-08
. O 0 2.6157513488556106e-08

The O 0 7.95539421005742e-08
identification O 0 6.610466840584195e-08
of O 0 3.3170866942100474e-08
two O 0 5.902736632812378e-10
frequent O 0 1.504284519171506e-08
PDS B-Disease 0 0.0021495323162525892
mutations O 0 5.845576467322644e-09
will O 0 2.1884807854810617e-10
facilitate O 0 5.3178004222331765e-09
the O 0 3.259261527333024e-09
molecular O 0 7.52501534861949e-07
diagnosis O 0 0.000599136867094785
of O 0 0.01072186790406704
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.3837411592685385e-06

Insertional O 0 0.0006697715725749731
mutation O 0 5.6896848121823496e-08
by O 0 3.783875435203754e-09
transposable O 0 6.4729251789685804e-06
element O 0 1.6445946471321804e-07
, O 0 1.0522891003006407e-08
L1 O 0 1.7767231838661246e-05
, O 0 9.802461065078205e-10
in O 0 5.353733567581287e-10
the O 0 1.2698574636260673e-08
DMD B-Disease 1 1.0
gene O 0 2.1675788275388186e-08
results O 0 1.889265810461893e-08
in O 0 2.5767063149828573e-08
X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999984502792358
dilated I-Disease 1 0.9994008541107178
cardiomyopathy I-Disease 1 1.0
. O 0 3.0784269711148227e-06

X B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999966621398926
linked I-Disease 1 0.9994526505470276
dilated I-Disease 1 0.9897691011428833
cardiomyopathy I-Disease 1 1.0
( O 0 4.490553692448884e-06
XLDCM B-Disease 1 1.0
) O 0 9.573090764547487e-09
is O 0 1.1649767261978639e-10
a O 0 2.720249303589384e-10
clinical O 0 9.108940730584436e-07
phenotype O 0 7.176730321134528e-08
of O 0 6.710431989631616e-06
dystrophinopathy B-Disease 1 0.8867129683494568
which O 0 3.1339826289666917e-09
is O 0 1.8866530560046613e-10
characterized O 0 7.895721854112026e-10
by O 0 2.544018884442778e-10
preferential O 0 2.2587848036437208e-07
myocardial B-Disease 1 0.9610727429389954
involvement I-Disease 0 7.745522623281431e-08
without O 0 1.3064956894126567e-09
any O 0 6.26984242302342e-10
overt O 0 8.531832662583838e-08
clinical O 0 8.61726948642172e-06
signs O 0 9.516596037428826e-06
of O 1 0.8559516072273254
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.001198486308567226

To O 0 1.1546294587105876e-08
date O 0 1.3214159366725653e-07
, O 0 2.1261588323273628e-10
several O 0 8.698652215199942e-11
mutations O 0 7.485649322624965e-10
in O 0 1.048757969357439e-09
the O 0 4.6788500185357407e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.5542653203010559
, O 0 1.149175841419492e-05
DMD O 1 1.0
, O 0 2.2065982818730845e-08
have O 0 7.902934556769381e-11
been O 0 7.00632746264418e-11
identified O 0 1.4122268632288382e-10
in O 0 3.891229560792908e-10
patients O 0 2.074025395870649e-09
with O 0 4.063518854735548e-09
XLDCM B-Disease 1 1.0
, O 0 1.2645425151447398e-08
but O 0 1.320310527574975e-10
a O 0 5.6289264915854176e-11
pathogenic O 0 3.5929781372345815e-09
correlation O 0 3.762082867453387e-10
of O 0 1.0606004963165105e-09
these O 0 3.150366356674539e-10
cardiospecific O 0 2.3691200112807564e-06
mutations O 0 6.742117086844246e-09
in O 0 4.0672500034588666e-08
DMD O 1 1.0
with O 0 1.1817762768373541e-08
the O 0 2.3383093150641798e-07
XLDCM B-Disease 1 1.0
phenotype O 0 8.765668724208808e-08
has O 0 2.9347679841862373e-10
remained O 0 1.1492990559247573e-08
to O 0 1.2719675313022094e-10
be O 0 3.388344327337478e-10
elucidated O 0 3.306350208731601e-06
. O 0 7.067676222050068e-08

We O 0 6.005482333648615e-08
report O 0 3.996561304120405e-09
here O 0 3.2416955231262534e-10
the O 0 3.735304079932611e-11
identification O 0 9.487597374402412e-10
of O 0 1.0097702674016773e-09
a O 0 1.8635386289655997e-10
unique O 0 6.866650581471845e-10
de O 0 5.340551751942257e-07
novo O 0 4.886653073299385e-07
L1 O 0 5.87527324569237e-07
insertion O 0 4.454058011305051e-09
in O 0 1.226309387369895e-09
the O 0 2.1898556301636063e-09
muscle O 0 6.946777375560487e-08
exon O 0 4.284808881038771e-07
1 O 0 9.643559195637863e-08
in O 0 3.268145931656363e-08
DMD O 1 1.0
in O 0 3.027722428328161e-08
three O 0 1.7716082822971657e-08
XLDCM B-Disease 1 0.9999997615814209
patients O 0 8.400853346302029e-09
from O 0 2.486889805197734e-09
two O 0 3.992353669879378e-10
unrelated O 0 5.195587604589491e-08
Japanese O 0 2.6361724394519115e-06
families O 0 2.113242469903298e-09
. O 0 5.069581732186634e-08

The O 0 2.0044748794134648e-07
insertion O 0 2.004981638492609e-07
was O 0 5.4079997369171906e-08
a O 0 1.028324092544608e-09
5 O 0 5.488583809665215e-09
- O 0 2.988671088388628e-09
truncated O 0 6.654179984799669e-10
form O 0 1.6459353324727033e-10
of O 0 2.8712068278480274e-09
human O 0 6.7616368060186e-10
L1 O 0 7.792732503730804e-07
inversely O 0 1.7253384498872038e-08
integrated O 0 1.6336117880655365e-07
in O 0 1.8273630386644868e-09
the O 0 1.3816303656710716e-09
5 O 0 9.8275325655095e-09
- O 0 2.8870294599414592e-08
untranslated O 0 1.0442799975862727e-05
region O 0 5.73487524135885e-09
in O 0 6.29014507147474e-10
the O 0 4.34873914656464e-09
muscle O 0 1.992301967845833e-08
exon O 0 1.586415976362332e-07
1 O 0 2.654932274026578e-08
, O 0 1.1112660097678528e-10
which O 0 1.591085596608366e-11
affected O 0 1.4252753144372576e-10
the O 0 2.0953926094247066e-10
transcription O 0 1.7751926595366285e-09
or O 0 1.1580601061433882e-10
the O 0 7.421108172422919e-10
stability O 0 1.9695218789195224e-09
of O 0 6.742592706387995e-09
the O 0 2.437263724175409e-09
muscle O 0 4.929271213427455e-09
form O 0 3.7073493164285765e-09
of O 0 2.0897239494388486e-07
dystrophin O 0 8.159356639225734e-07
transcripts O 0 1.8711700988660596e-07
but O 0 3.675787799140018e-11
not O 0 3.8792207293636416e-12
that O 0 1.167335325624741e-12
of O 0 4.914623707996668e-10
the O 0 1.0510474268699e-08
brain O 0 2.1691605070373043e-05
or O 0 3.089942524070466e-08
Purkinje O 1 0.9930757284164429
cell O 0 3.938870577258058e-06
form O 0 6.018049703016004e-08
, O 0 3.396699588265051e-09
probably O 0 2.82539391882608e-09
due O 0 2.7456048545815293e-09
to O 0 4.824650401413777e-11
its O 0 9.553782764903929e-11
unique O 0 7.163809823129696e-11
site O 0 6.203185520803345e-09
of O 0 7.4351662604499325e-09
integration O 0 5.8572982908344784e-08
. O 0 1.942756888695385e-08

We O 0 3.7612757353144843e-08
speculate O 0 6.961470955246796e-09
that O 0 3.22423095167057e-11
this O 0 5.1496315892074485e-12
insertion O 0 4.994608615582763e-10
of O 0 8.413580943056331e-10
an O 0 2.6708512138040597e-11
L1 O 0 1.9755141238420038e-06
sequence O 0 1.779820513192476e-09
in O 0 5.073331976745976e-09
DMD O 1 1.0
is O 0 1.2725991371809187e-09
responsible O 0 4.39283986963801e-09
for O 0 1.2498399537541616e-10
some O 0 2.99141683646198e-11
of O 0 9.161940650592726e-10
the O 0 1.520198689153318e-10
population O 0 7.123539496993458e-13
of O 0 1.3424460154620732e-10
Japanese O 0 6.766364890609111e-08
patients O 0 2.924799957781943e-09
with O 0 1.4617551613582691e-09
XLDCM B-Disease 1 1.0
. O 0 4.370694384192575e-08
. O 0 4.691539956525048e-08

Severe O 1 0.9988864064216614
early O 0 0.024026505649089813
- O 1 0.9979625940322876
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 5.47837544218055e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.002493970561772585
red O 1 0.9999998807907104
hair O 1 1.0
pigmentation O 1 0.9999676942825317
caused O 0 4.167065981164342e-06
by O 0 5.5903100815157813e-08
POMC O 1 1.0
mutations O 0 1.484611544810832e-07
in O 0 2.177461588814822e-08
humans O 0 7.078995167830726e-08
. O 0 2.985407832056808e-08

Sequential O 0 2.7430969566921704e-06
cleavage O 0 8.81319351719867e-07
of O 0 6.243146799533861e-07
the O 0 1.890779799396114e-08
precursor O 0 7.871354767985395e-08
protein O 0 3.0400928441309816e-09
pre O 0 6.023933565302286e-06
- O 0 9.949534387487802e-07
pro O 0 5.894050900678849e-06
- O 0 1.3593054291050066e-06
opiomelanocortin O 0 3.0355598937603645e-05
( O 0 1.3753157723783715e-08
POMC O 0 0.12510739266872406
) O 0 8.612348056935559e-10
generates O 0 1.5779798578918758e-09
the O 0 2.318080172258874e-09
melanocortin O 0 1.04280125015066e-05
peptides O 0 2.253624984405178e-07
adrenocorticotrophin O 0 3.6056797398487106e-05
( O 0 3.411472349057476e-08
ACTH O 0 9.36664582695812e-05
) O 0 1.8929111611498683e-09
, O 0 7.224821296780704e-10
melanocyte O 0 3.35047457156179e-06
- O 0 1.096535925171338e-06
stimulating O 0 5.675463512488932e-07
hormones O 0 1.941072156341761e-07
( O 0 2.395759590712032e-09
MSH O 0 9.841543214861304e-05
) O 0 6.783140715782565e-11
alpha O 0 1.0706919795211434e-09
, O 0 6.762094356682624e-12
beta O 0 8.170941701024503e-11
and O 0 7.103313163364655e-12
gamma O 0 1.089197065873293e-09
as O 0 2.7428278398522465e-11
well O 0 2.4530433240244065e-11
as O 0 2.2411300246161225e-11
the O 0 7.599032514349346e-11
opioid O 0 7.328136764073179e-09
- O 0 8.015492269919378e-09
receptor O 0 2.2850633885074245e-10
ligand O 0 2.3215063649217882e-08
beta O 0 4.433734943631862e-07
- O 0 1.1073971108999103e-06
endorphin O 0 1.9804034309345298e-05
. O 0 3.1150744206343006e-08

While O 0 4.6253146024355374e-07
a O 0 6.42628483760177e-09
few O 0 2.003514715243071e-10
cases O 0 3.716338903281269e-10
of O 0 1.4436385242788674e-07
isolated O 1 0.9999880790710449
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999603033065796
have O 0 1.2084400147216456e-09
been O 0 1.5808236941694531e-09
reported O 0 1.3610803151209439e-08
( O 0 1.1962518975394687e-08
OMIM O 1 0.9999843835830688
201400 O 0 0.0003847739426419139
) O 0 3.4764804368592195e-09
, O 0 7.453820893843499e-10
an O 0 8.431171316658492e-10
inherited O 1 0.999993085861206
POMC O 1 1.0
defect O 1 0.9999860525131226
has O 0 6.617806747044597e-09
not O 0 7.213392660965212e-10
been O 0 1.4410483917259853e-09
described O 0 6.032113031295694e-09
so O 0 5.985977824529698e-10
far O 0 6.249250450451882e-09
. O 0 2.121207032246275e-08

Recent O 0 1.2688484218870144e-07
studies O 0 5.34613420200003e-09
in O 0 2.834303902687907e-10
animal O 0 5.204461306362873e-09
models O 0 1.1003894462291441e-09
elucidated O 0 9.731418515457335e-08
a O 0 7.419862502189289e-10
central O 0 2.093484274823254e-09
role O 0 8.377343263532566e-10
of O 0 1.2987742437076122e-08
alpha O 0 1.1275710676272865e-07
- O 0 3.7944116115795623e-07
MSH O 0 0.0006306036375463009
in O 0 1.7703033483584818e-09
the O 0 2.277227295621742e-10
regulation O 0 1.906044655441974e-09
of O 0 1.3804714038556654e-09
food O 0 1.0888974444345223e-10
intake O 0 2.633077089697622e-11
by O 0 5.536224690488867e-12
activation O 0 7.598515150419871e-10
of O 0 8.694712505530333e-09
the O 0 1.9641507975620698e-08
brain O 0 6.723306569256238e-07
melanocortin O 0 7.686193384870421e-06
- O 0 2.5215825871782727e-07
4 O 0 2.857430025926533e-08
- O 0 9.15291487046943e-09
receptor O 0 3.439648843528431e-10
( O 0 3.6606070952238667e-10
MC4 O 0 8.690510003361851e-05
- O 0 3.9604054791197996e-07
R O 0 4.3835265728375816e-07
; O 0 1.8674027602028076e-10
refs O 0 3.4422775740949874e-08
3 O 0 3.4361291589846132e-09
- O 0 3.095421252652386e-09
5 O 0 8.715994592733978e-10
) O 0 4.374438745263776e-12
and O 0 6.0253312755831345e-12
the O 0 3.344175630859425e-11
linkage O 0 3.213459498496718e-09
of O 0 1.0386834503606224e-08
human O 0 1.0916667747551401e-07
obesity B-Disease 1 0.9999949932098389
to O 0 6.740107916236582e-10
chromosome O 0 8.791664063423354e-10
2 O 0 1.097331558952419e-09
in O 0 1.3965674450222565e-10
close O 0 2.6898805405295434e-10
proximity O 0 2.3005060079128725e-09
to O 0 5.861178903332487e-11
the O 0 2.434406454199234e-09
POMC O 0 0.2444925457239151
locus O 0 9.477852280781462e-09
, O 0 1.977316227419479e-10
led O 0 5.145866510680719e-10
to O 0 4.296644637302727e-11
the O 0 9.137834239281162e-11
proposal O 0 6.775124905544772e-11
of O 0 7.605721052961201e-10
an O 0 5.890507526196131e-11
association O 0 2.3169675955614366e-08
of O 0 7.677348889956193e-07
POMC O 1 1.0
with O 0 1.8142716839975037e-07
human O 0 0.0005869552260264754
obesity B-Disease 1 1.0
. O 0 2.334405735382461e-07

The O 0 1.3870126736037491e-07
dual O 0 3.485000377168035e-08
role O 0 3.2822704554291704e-08
of O 0 2.1279606698954012e-07
alpha O 0 1.8219542425867985e-06
- O 0 4.145056209381437e-06
MSH O 0 0.03850456699728966
in O 0 7.496913312365905e-09
regulating O 0 4.650273410788941e-08
food O 0 4.7537982439394e-09
intake O 0 5.934460922674134e-09
and O 0 3.6083684928911453e-09
influencing O 0 1.879803335214092e-06
hair O 0 0.0001477753248764202
pigmentation O 0 2.210247293987777e-05
predicts O 0 4.832900657447681e-08
that O 0 5.501658503770379e-11
the O 0 6.654852779952591e-10
phenotype O 0 2.1480162093467925e-09
associated O 0 1.2113361425036828e-09
with O 0 2.7993496409806085e-10
a O 0 8.572789589322838e-09
defect O 0 5.642452833853895e-06
in O 0 9.493234642832249e-08
POMC O 1 0.9999982118606567
function O 0 3.0624878188945104e-09
would O 0 4.0643227672276794e-10
include O 0 1.0218411716778064e-06
obesity B-Disease 1 1.0
, O 0 2.7606230634802387e-09
alteration O 0 3.5784810847871995e-07
in O 0 4.535381492587476e-08
pigmentation O 1 0.9998823404312134
and O 0 0.0146776819601655
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999924898147583
. O 0 9.422607263331884e-07

The O 0 1.7763663606729097e-07
observation O 0 2.3668865196668776e-06
of O 0 2.9832509085281345e-07
these O 0 8.045375032850188e-09
symptoms O 0 1.5923433238640428e-05
in O 0 4.734849401444308e-09
two O 0 2.5521995627997285e-09
probands O 0 1.0000618203775957e-05
prompted O 0 3.2816007689007165e-08
us O 0 1.3083584216033728e-09
to O 0 8.039354598698978e-11
search O 0 7.529897816382913e-10
for O 0 1.283524259099167e-10
mutations O 0 2.525517794893517e-09
within O 0 8.250064631454279e-09
their O 0 2.9026441694668392e-08
POMC O 1 0.982216477394104
genes O 0 1.3936303844275244e-07
. O 0 9.023501945648604e-08

Patient O 0 3.936484063160606e-05
1 O 0 6.941755827938323e-07
was O 0 2.4433997936057494e-08
found O 0 1.7407103536370983e-10
to O 0 2.2875304081515502e-11
be O 0 1.27756884932273e-11
a O 0 8.49191411633754e-11
compound O 0 1.1185973924909831e-08
heterozygote O 0 2.5905485756538837e-08
for O 0 1.462122506401542e-10
two O 0 1.0545665729555509e-10
mutations O 0 2.730031478659356e-10
in O 0 2.233140339313877e-09
exon O 0 1.0161449637280384e-07
3 O 0 7.712147720440043e-08
( O 0 1.5566714584025476e-09
G7013T O 0 8.690071808814537e-07
, O 0 3.5665204123347394e-09
C7133delta O 0 1.0624722563079558e-05
) O 0 1.8440599047764294e-10
which O 0 2.8285509351411164e-11
interfere O 0 5.922968782101634e-10
with O 0 2.5001851283734666e-11
appropriate O 0 1.4337721010448945e-09
synthesis O 0 5.246614165343999e-08
of O 0 1.957800463969761e-07
ACTH O 0 4.760323281516321e-05
and O 0 1.0981553799638277e-07
alpha O 0 4.411630925460486e-06
- O 0 1.0653263416315895e-05
MSH O 0 0.496709406375885
. O 0 9.577952653216926e-08

Patient O 0 2.455008143442683e-05
2 O 0 7.616556558787124e-07
was O 0 4.5615209387506184e-08
homozygous O 0 2.0453945204224055e-09
for O 0 9.200373796147687e-11
a O 0 1.5507023443106505e-10
mutation O 0 1.3443729462991882e-10
in O 0 5.166401195744186e-10
exon O 0 4.511301909815302e-08
2 O 0 4.224506255923188e-08
( O 0 2.005461796628083e-09
C3804A O 0 6.736123054906784e-07
) O 0 3.0527932959323323e-10
which O 0 9.560203739766848e-10
abolishes O 0 5.637864887830801e-06
POMC O 1 0.9969314336776733
translation O 0 1.6888741356524406e-06
. O 0 1.2946543392899912e-07

These O 0 3.302320905618217e-08
findings O 0 1.3086211225754596e-08
represent O 0 1.180901487707331e-09
the O 0 4.776399276096299e-10
first O 0 2.9730909401060046e-10
examples O 0 1.124202841928934e-09
of O 0 7.314396199831208e-09
a O 0 9.105309395351924e-09
genetic B-Disease 1 0.9999998807907104
defect I-Disease 1 0.9999998807907104
within O 0 2.4781028784559567e-08
the O 0 3.6359359967264027e-08
POMC O 1 0.9999934434890747
gene O 0 1.686312955939684e-08
and O 0 1.4830705552526524e-09
define O 0 3.060391495779413e-09
a O 0 8.770225656817843e-10
new O 0 1.342409490234786e-07
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
resulting O 0 1.0804497208027897e-07
in O 0 2.7691240411797935e-09
early O 0 3.630133733167895e-06
- O 0 0.00020424791728146374
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.888086103463138e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.0013322978047654033
red O 1 0.999997615814209
hair O 1 0.999993085861206
pigmentation O 1 0.7776320576667786
. O 0 4.3701358976022675e-08
. O 0 9.462466721288365e-08

A O 0 9.022836820804514e-06
European O 0 2.021360359094615e-07
multicenter O 0 1.2612789760169107e-05
study O 0 5.240693567998278e-08
of O 0 2.4859295081114396e-05
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.1141815292603496e-07
classification O 0 8.784177225606982e-07
of O 0 2.8963182785446406e-07
105 O 0 4.092635492725094e-07
mutations O 0 1.8655490485741666e-09
and O 0 2.665183629346757e-10
a O 0 2.6851443291064925e-10
general O 0 1.1245223641154212e-09
system O 0 2.010881683389698e-09
for O 0 1.591799747568956e-10
genotype O 0 2.479822791556785e-09
- O 0 5.755454335343302e-09
based O 0 2.7571500638146063e-09
prediction O 0 3.556937144821859e-07
of O 0 5.097768962514238e-07
metabolic O 1 0.6347413063049316
phenotype O 0 9.57743850449333e-07
. O 0 1.724454250506824e-07

Phenylketonuria B-Disease 1 0.9995222091674805
( O 0 9.69899156189058e-06
PKU B-Disease 1 1.0
) O 0 1.1009068856537851e-07
and O 0 1.1316539172412377e-07
mild B-Disease 1 0.9999986886978149
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.5701950192451477
MHP B-Disease 1 1.0
) O 0 1.1430140389734333e-08
are O 0 1.0091927293842673e-09
allelic B-Disease 1 1.0
disorders I-Disease 1 1.0
caused O 0 7.74208820075728e-06
by O 0 2.1740327316166486e-09
mutations O 0 1.2568760476838747e-09
in O 0 3.1858488069858026e-10
the O 0 1.2413045036296921e-09
gene O 0 1.0822061025095309e-09
encoding O 0 8.491436886970405e-09
phenylalanine O 0 1.618807618797291e-05
hydroxylase O 0 0.00048313033767044544
( O 0 1.844310077103728e-06
PAH O 1 1.0
) O 0 3.9426674902642844e-07
. O 0 8.414391317046466e-08

Previous O 0 1.8131055412595742e-06
studies O 0 2.457819370249581e-08
have O 0 4.293678954048197e-11
suggested O 0 2.6612617665122684e-10
that O 0 3.3699332387115977e-12
the O 0 9.564485314861315e-11
highly O 0 1.8321932859777235e-09
variable O 0 1.8818784752738793e-08
metabolic O 0 0.00014748505782335997
phenotypes O 0 3.380414273124188e-05
of O 1 0.9998289346694946
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 1.1662898941722233e-05
with O 0 7.497386604882195e-07
PAH O 1 1.0
genotypes O 0 0.002886193571612239
. O 0 5.729389158659615e-07

We O 0 3.4136657944827675e-08
identified O 0 4.957387389481482e-09
both O 0 7.489762143819689e-10
causative O 0 1.1383563247591155e-07
mutations O 0 4.293224442619703e-09
in O 0 3.978239959678831e-09
686 O 0 3.5725722682400374e-06
patients O 0 1.5359269411874266e-08
from O 0 7.401491419756212e-09
seven O 0 2.9842862403484105e-08
European O 0 2.429644325729896e-07
centers O 0 9.822567790251924e-07
. O 0 1.6108668887682143e-07

On O 0 3.052686565752083e-07
the O 0 1.9371906301302033e-09
basis O 0 8.472375578882918e-10
of O 0 1.5725296620416884e-09
the O 0 8.493356712380162e-11
phenotypic O 0 5.384211743120204e-09
characteristics O 0 8.419172026208344e-09
of O 0 2.1417131179646276e-08
297 O 0 2.918527854944841e-07
functionally O 0 1.1865666920130025e-06
hemizygous O 0 1.3914598639530595e-05
patients O 0 4.779964868362185e-09
, O 0 3.8251482536999504e-10
105 O 0 2.8976765875654564e-08
of O 0 6.024673648852286e-09
the O 0 5.14434495002547e-10
mutations O 0 1.5132960162755893e-10
were O 0 2.788552999621885e-10
assigned O 0 2.719254599270471e-09
to O 0 1.0659803595380879e-10
one O 0 1.1600675281497885e-10
of O 0 1.1308977088120287e-09
four O 0 1.2218354106252605e-10
arbitrary O 0 9.897940245195969e-10
phenotype O 0 2.3580016161872663e-08
categories O 0 5.65963844678663e-08
. O 0 3.907655710122526e-08

We O 0 4.566421551999156e-08
proposed O 0 1.9412306428989723e-08
and O 0 2.7919713208035546e-09
tested O 0 8.193172362780388e-09
a O 0 6.459728585372915e-11
simple O 0 7.03605715357547e-11
model O 0 3.2775549635433165e-11
for O 0 5.382601482584182e-12
correlation O 0 4.546252610482249e-11
between O 0 4.063374983709345e-11
genotype O 0 3.4468878862270458e-09
and O 0 2.6099578054328276e-10
phenotypic O 0 4.4344876215518525e-08
outcome O 0 1.0576358278058251e-07
. O 0 8.727814559961189e-08

The O 0 4.3492229906405555e-07
observed O 0 6.079796577296293e-08
phenotype O 0 2.77684737426398e-08
matched O 0 5.092190846767153e-08
the O 0 1.9065462542044997e-09
predicted O 0 2.595399006821708e-09
phenotype O 0 5.778374445597478e-10
in O 0 2.1535859207055807e-10
79 O 0 2.9769795517609055e-09
% O 0 5.7196387383273706e-12
of O 0 8.880578217240753e-11
the O 0 5.964355398457855e-11
cases O 0 7.979850114026021e-11
, O 0 4.905275144406751e-11
and O 0 1.6007510594828744e-10
in O 0 1.6907558686440893e-10
only O 0 1.4192306184435122e-11
5 O 0 3.168426354616116e-10
of O 0 5.037479322567151e-10
184 O 0 5.816171100292422e-09
patients O 0 1.3990022473819863e-09
was O 0 1.2398924553735924e-08
the O 0 2.4114799046515145e-09
observed O 0 4.240439999136925e-09
phenotype O 0 7.11559255961447e-10
more O 0 6.752801443021816e-12
than O 0 1.1366704452675513e-11
one O 0 5.346689063712162e-11
category O 0 1.2999011866909882e-09
away O 0 1.3717311730943038e-09
from O 0 3.443823559656778e-10
that O 0 1.7988726827566914e-11
expected O 0 5.485977894181815e-09
. O 0 2.583975700076735e-08

Among O 0 1.278807388871428e-07
the O 0 2.4285640165544464e-08
seven O 0 3.816128746336744e-09
contributing O 0 3.886297117450255e-10
centers O 0 2.7886128961540635e-09
, O 0 3.7936705860053266e-11
the O 0 7.440408011927246e-11
proportion O 0 1.4525881886218173e-10
of O 0 1.7253869444289194e-09
patients O 0 2.693094636185833e-10
for O 0 4.775934647760494e-10
whom O 0 1.1572149904992557e-09
the O 0 5.4320739018010045e-09
observed O 0 9.423414937259622e-09
phenotype O 0 6.6834768830403846e-09
did O 0 7.600456930489941e-10
not O 0 8.216027858054531e-11
match O 0 4.1818964291451266e-08
the O 0 1.7321728496000333e-09
predicted O 0 3.93295751521805e-09
phenotype O 0 5.731244812068326e-09
was O 0 6.930918949876741e-09
4 O 0 3.072340160059639e-09
% O 0 3.2770858943154124e-11
- O 0 1.6656079848687e-09
23 O 0 3.7003273778424273e-09
% O 0 1.71622802774829e-11
( O 0 1.193531662391223e-10
P O 0 3.120242695331399e-07
< O 0 2.8745947844299735e-08
. O 0 3.801857995089364e-10
0001 O 0 1.8563076764621655e-07
) O 0 7.337640217652819e-11
, O 0 1.487374980124745e-11
suggesting O 0 4.5559573474962534e-11
that O 0 9.341060910883492e-13
differences O 0 1.4040291498873536e-11
in O 0 3.1510542872897895e-12
methods O 0 4.519054574991799e-11
used O 0 1.084477906782011e-11
for O 0 7.732576731700469e-12
mutation O 0 9.868753036990086e-11
detection O 0 1.1223013984817953e-07
or O 0 1.1964451651635954e-09
phenotype O 0 8.409013041443814e-09
classification O 0 2.318346759011547e-08
may O 0 1.0446010723086374e-10
account O 0 2.3496430495706377e-11
for O 0 3.159240577477185e-11
a O 0 6.892522663726197e-11
considerable O 0 2.5373314560539484e-10
proportion O 0 1.4144272419969184e-09
of O 0 1.7150460607240348e-08
genotype O 0 4.4294074541539885e-07
- O 0 5.562104888667818e-06
phenotype O 0 4.788536784872122e-07
inconsistencies O 0 2.392843953202828e-06
. O 0 2.1735991140303668e-07

Our O 0 8.54904840252857e-07
data O 0 3.8877391972391706e-08
indicate O 0 1.9465651313055332e-09
that O 0 4.821632676454968e-11
the O 0 9.228908304237393e-09
PAH O 1 1.0
- O 0 7.470047876267927e-06
mutation O 0 3.0178619603304924e-09
genotype O 0 5.869507990752254e-09
is O 0 4.6275445281240835e-11
the O 0 2.1683498052649242e-10
main O 0 3.5417500043877226e-09
determinant O 0 1.2013943617716905e-08
of O 0 6.83257113109903e-08
metabolic O 0 0.00010156424104934558
phenotype O 0 2.163039880542783e-08
in O 0 5.939145841793447e-10
most O 0 8.822706454303386e-10
patients O 0 8.543769780544608e-08
with O 0 4.054165037814528e-05
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.1267536794766784e-05

In O 0 8.135543794196565e-08
the O 0 4.478327486623357e-09
present O 0 6.559706111630703e-10
study O 0 5.242977718644681e-10
, O 0 2.8770916205012043e-11
the O 0 3.534404019456261e-11
classification O 0 3.0651701177220048e-09
of O 0 1.1945053834949704e-08
105 O 0 7.085139259288553e-06
PAH O 1 1.0
mutations O 0 2.8755874126318304e-08
may O 0 2.634555074099154e-10
allow O 0 6.439394156787515e-11
the O 0 4.5961265349170333e-10
prediction O 0 1.740712107789477e-08
of O 0 5.7945572784490196e-09
the O 0 1.3319640945752553e-09
biochemical O 0 1.094266366408192e-07
phenotype O 0 6.6080065863616255e-09
in O 0 2.159242562527197e-09
> O 0 1.4640829881784612e-08
10 O 0 4.877961590210589e-09
, O 0 1.539550570361925e-10
000 O 0 4.8455244261447206e-09
genotypes O 0 2.234965101877151e-08
, O 0 1.974858748754471e-10
which O 0 1.9032744130731416e-11
may O 0 5.257274823811109e-11
be O 0 4.571065748137926e-12
useful O 0 5.408424402775225e-11
for O 0 3.860261069132953e-11
the O 0 6.785240702633644e-10
management O 0 5.7651586615747874e-08
of O 0 3.29232193507778e-07
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.479190387954077e-07
newborns O 0 1.4996427353253239e-06
. O 0 3.201916243256164e-08

Somatic O 0 0.0001504746760474518
instability O 0 5.89523142480175e-06
of O 0 2.9525433546950808e-06
the O 0 5.259514637145912e-07
CTG O 0 0.03402186557650566
repeat O 0 5.087555337013328e-07
in O 0 1.5107250561641195e-08
mice O 0 1.9685314711637147e-08
transgenic O 0 9.479971652126551e-08
for O 0 1.9777057769232442e-09
the O 0 1.5517742895099218e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 3.6382960388436913e-05
is O 0 2.0342634243775137e-09
age O 0 1.3030240220146538e-09
dependent O 0 1.7295508081272004e-10
but O 0 5.996645454503513e-12
not O 0 3.0308479250645837e-12
correlated O 0 1.6909235123208077e-10
to O 0 2.2634040475200123e-11
the O 0 3.9631969928066724e-10
relative O 0 2.239760821254322e-09
intertissue O 0 7.788512448314577e-07
transcription O 0 7.802877632911986e-08
levels O 0 2.7782883549321014e-08
and O 0 1.502136903752671e-08
proliferative O 0 0.00029922465910203755
capacities O 0 6.710663001285866e-06
. O 0 4.708514325102442e-07

A O 0 0.0001021470088744536
( O 0 2.977572535201034e-07
CTG O 0 0.011763804592192173
) O 0 4.4675947385997006e-09
nexpansion O 0 1.7601416857360164e-06
in O 0 1.1498905161388961e-09
the O 0 1.408719474405018e-09
3 O 0 2.2358264573085762e-08
- O 0 9.399042255608947e-08
untranslated O 0 0.00020611114450730383
region O 0 9.571378001282937e-08
( O 0 2.1353283585767713e-09
UTR O 0 0.0011409802827984095
) O 0 5.215907150635246e-10
of O 0 1.0331294042487116e-08
the O 0 1.368279978208875e-08
DM O 1 1.0
protein O 0 9.396371325465225e-08
kinase O 0 2.8437730748009926e-07
gene O 0 3.304866780240445e-08
( O 0 4.087912675032612e-09
DMPK O 1 0.9999983310699463
) O 0 6.135252861305673e-10
is O 0 2.7269906818783163e-11
responsible O 0 1.736512933447898e-09
for O 0 6.915033878840404e-09
causing O 1 0.9999994039535522
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9143536686897278
DM B-Disease 1 1.0
) O 0 5.472477369039552e-07
. O 0 1.4529172176480643e-07

Major O 0 5.1337829063413665e-05
instability O 0 1.816773306018149e-06
, O 0 2.993223446878801e-09
with O 0 1.1335338917506377e-10
very O 0 6.711023403660477e-11
large O 0 2.852444946910282e-10
expansions O 0 3.9065973567176115e-08
between O 0 1.6240694344915596e-09
generations O 0 3.2024578544564974e-09
and O 0 5.584442908102005e-10
high O 0 1.248471193093792e-08
levels O 0 1.876086175300884e-09
of O 0 1.4751966315174059e-09
somatic O 0 2.548266593294102e-07
mosaicism O 0 8.758933290664572e-06
, O 0 5.40543665383808e-10
is O 0 2.973565838004788e-11
observed O 0 6.186840484367906e-10
in O 0 9.328665617758247e-10
patients O 0 9.046452476013656e-09
. O 0 2.6496913108076114e-08

There O 0 1.4629628708462405e-07
is O 0 7.898884879509183e-10
a O 0 9.973857295619837e-10
good O 0 3.602880660480423e-09
correlation O 0 5.445494055678068e-10
between O 0 2.3547677696633684e-10
repeat O 0 2.7738866759108305e-09
size O 0 1.6919439183027407e-09
( O 0 4.789142971084459e-10
at O 0 7.348194053236057e-09
least O 0 1.3534181587948613e-11
in O 0 1.0567774433312138e-10
leucocytes O 0 1.318234353675507e-06
) O 0 2.4006022170119934e-10
, O 0 7.051777217714772e-11
clinical O 0 4.644538265097253e-08
severity O 0 6.449864144997264e-07
and O 0 9.200418205068672e-09
age O 0 2.6773991024242605e-08
of O 0 1.2718771813524654e-07
onset O 0 0.0013904882362112403
. O 0 1.069429629296792e-07

The O 0 9.203041372529697e-06
trinucleotide O 1 0.9957242012023926
repeat O 0 7.144550181692466e-06
instability O 0 2.8910307037222083e-07
mechanisms O 0 4.884695670170913e-08
involved O 0 3.770575851547164e-09
in O 0 1.4303667583703827e-08
DM B-Disease 1 1.0
and O 0 4.621738725063551e-08
other O 0 4.057106206545313e-09
human O 0 4.7141938921413384e-06
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.0814379253210049e-10
unknown O 0 8.893723091318861e-09
. O 0 8.081842750584656e-09

We O 0 7.470764984418565e-08
studied O 0 4.83629378322803e-07
somatic O 0 1.1322860018481151e-06
instability O 0 6.539386987469697e-08
by O 0 3.0727327349211464e-09
measuring O 0 7.649629878869746e-06
the O 0 3.155508920826833e-07
CTG O 0 0.0017725382931530476
repeat O 0 9.758778674040514e-08
length O 0 7.663897294563071e-10
at O 0 1.3629111172974717e-09
several O 0 5.411468842475564e-11
ages O 0 2.52966259051135e-10
in O 0 4.6942175840891665e-11
various O 0 3.854737640196504e-10
tissues O 0 3.485950728077114e-08
of O 0 7.218202568992638e-08
transgenic O 0 1.1809660236394848e-06
mice O 0 4.590416491367932e-09
carrying O 0 3.118598268514461e-09
a O 0 1.5058222446739933e-09
( O 0 2.283500277755479e-09
CTG O 0 0.0023685768246650696
) O 0 3.701880357809273e-09
55expansion O 0 1.2335917745076586e-06
surrounded O 0 1.59482738126826e-07
by O 0 8.094163672645038e-10
45 O 0 6.9970402805097365e-09
kb O 0 2.2991633841229486e-07
of O 0 6.989186118744328e-08
the O 0 4.243087659006051e-08
human O 0 6.55744145205972e-07
DM B-Disease 1 1.0
region O 0 3.907298662397807e-07
, O 0 4.893185856502669e-10
using O 0 2.396302045681864e-10
small O 0 1.600422239178556e-09
- O 0 9.624687180576075e-08
pool O 0 2.3304194485262997e-07
PCR O 0 1.1976914720435161e-05
. O 0 5.0802679396610984e-08

These O 0 7.53148512444568e-08
mice O 0 4.829049160548493e-08
have O 0 5.166831892888801e-11
been O 0 7.639753413224426e-11
shown O 0 2.7210988670645087e-11
to O 0 1.497677502848571e-11
reproduce O 0 3.572838691567881e-09
the O 0 2.4428939426890395e-10
intergenerational O 0 4.513132534356146e-09
and O 0 5.020233118102624e-10
somatic O 0 2.853389844403864e-07
instability O 0 4.6357850891354246e-08
of O 0 4.177854506792755e-08
the O 0 1.0766723512745102e-08
55 O 0 4.8881066305739296e-08
CTG O 0 6.070839663152583e-05
repeat O 0 3.850868779409211e-08
suggesting O 0 1.3570513601735001e-09
that O 0 4.695603281201777e-12
surrounding O 0 1.6838697103338518e-09
sequences O 0 2.5523930191617694e-10
and O 0 6.227290905158611e-11
the O 0 4.57078021265378e-11
chromatin O 0 3.957428162948418e-09
environment O 0 1.4194215802731946e-09
are O 0 7.161742986844244e-12
involved O 0 1.3314656321927743e-10
in O 0 7.509057819987675e-10
instability O 0 2.986216429690103e-08
mechanisms O 0 2.81129359791521e-07
. O 0 4.9642405741678886e-08

As O 0 2.4668979747843878e-08
observed O 0 9.519050436779253e-09
in O 0 1.9930410100066354e-10
some O 0 2.0624689456294476e-11
of O 0 1.1244987163649967e-09
the O 0 1.0395331262458285e-09
tissues O 0 4.653942369259312e-07
of O 0 2.4638806280563585e-05
DM B-Disease 1 1.0
patients O 0 6.350707280944334e-06
, O 0 8.414527963296337e-10
there O 0 1.4008867676995607e-10
is O 0 2.556601458314489e-11
a O 0 8.250245625562869e-11
tendency O 0 4.1405021078411153e-10
for O 0 2.505738672109459e-10
repeat O 0 1.2673773142068967e-08
length O 0 9.465003225628266e-10
and O 0 6.871720414913796e-10
somatic O 0 3.3640645824561943e-07
mosaicism O 0 1.3346652849577367e-06
to O 0 4.3548462058673465e-10
increase O 0 4.723749863488891e-11
with O 0 4.0376098298100516e-11
the O 0 8.774727056071185e-10
age O 0 8.172348353596703e-10
of O 0 9.38747857226474e-10
the O 0 2.660126785514194e-09
mouse O 0 1.6519149426130753e-07
. O 0 1.0364294311671074e-08

Furthermore O 0 2.1097675926284865e-06
, O 0 9.815019019754345e-09
we O 0 9.415716123450935e-11
observed O 0 2.697299605891601e-10
no O 0 3.971768747224047e-11
correlation O 0 2.4979733559415962e-11
between O 0 1.1579358999425082e-11
the O 0 4.864642369484251e-11
somatic O 0 2.0742163542308845e-08
mutation O 0 8.359849479333548e-10
rate O 0 1.4942520554228622e-09
and O 0 3.6336671449532787e-09
tissue O 0 2.856987703125924e-05
proliferation O 0 0.0006469723302870989
capacity O 0 3.125251453184319e-07
. O 0 5.1445862681021026e-08

The O 0 3.917133710729104e-07
somatic O 0 2.535114617785439e-06
mutation O 0 1.4132630177243755e-08
rates O 0 2.5366504452506433e-09
in O 0 2.4447210922318163e-10
different O 0 8.051231903394296e-11
tissues O 0 9.13564779381204e-09
were O 0 9.050520888287394e-10
also O 0 3.691659825055815e-11
not O 0 4.1196143718558176e-12
correlated O 0 4.0440933934959844e-10
to O 0 4.6323660185532134e-11
the O 0 8.123302031037838e-10
relative O 0 2.7750564068895756e-09
inter O 0 6.694043008792505e-07
- O 0 8.986197030935728e-08
tissue O 0 1.8315512662070432e-08
difference O 0 2.3751656197390503e-10
in O 0 2.5736225650607736e-11
transcriptional O 0 6.09631511938602e-10
levels O 0 1.4777762347151224e-09
of O 0 5.336452946202996e-10
the O 0 1.0864203980887055e-10
three O 0 7.762001458244683e-11
genes O 0 1.8095898390857457e-10
( O 0 9.385634491820838e-10
DMAHP O 1 0.9999978542327881
, O 0 2.5412765225496514e-08
DMPK O 1 0.9998576641082764
and O 0 1.8900585985193175e-08
59 O 0 5.986886009168302e-08
) O 0 8.440531606979107e-11
surrounding O 0 7.898828258134927e-09
the O 0 3.20673065878907e-09
repeat O 0 8.950019037001766e-08
. O 0 2.6792879026515948e-09
. O 0 7.151775616165423e-09

A O 0 7.75475382397417e-06
novel O 0 2.961119776045962e-07
missense O 0 1.3718557738684467e-06
mutation O 0 1.3066358661717459e-08
in O 0 3.097476497515572e-09
patients O 0 6.637084215554978e-09
from O 0 1.0740142109000317e-08
a O 0 4.602385672569653e-08
retinoblastoma B-Disease 0 0.04481249675154686
pedigree O 0 9.993600542657077e-06
showing O 0 2.3471791621432203e-07
only O 0 1.1889949025345459e-09
mild O 0 3.684940566017758e-07
expression O 0 2.6502662286986833e-09
of O 0 1.0238667158546377e-07
the O 0 1.391428554597951e-07
tumor B-Disease 0 0.0004768466460518539
phenotype O 0 4.1445287024544086e-07
. O 0 1.1052094350816333e-07

We O 0 5.983917361618296e-08
have O 0 2.5753327248523306e-10
used O 0 1.2139520499943046e-09
single O 0 1.8506322030376054e-09
strand O 0 2.0619479457195666e-09
conformation O 0 3.644187174245417e-10
polymorphism O 0 3.2063068866605704e-10
analysis O 0 3.556741359767024e-11
to O 0 1.930114748582845e-11
study O 0 1.438005547971244e-10
the O 0 2.684191757751364e-10
27 O 0 4.180706447698412e-09
exons O 0 1.8268333512594381e-09
of O 0 1.6419413606527655e-09
the O 0 1.7867524126913281e-09
RB1 O 0 0.00013222683628555387
gene O 0 3.7451292067558484e-10
in O 0 4.150375529365924e-11
individuals O 0 9.298275040550696e-13
from O 0 4.955872934253591e-10
a O 0 1.2309212538141878e-09
family O 0 1.1513739961444003e-09
showing O 0 1.8835951465234757e-08
mild O 0 2.484985657247307e-07
expression O 0 2.321518310921533e-09
of O 0 3.6252579604934e-08
the O 0 4.331754155373346e-08
retinoblastoma B-Disease 0 7.82525385147892e-05
phenotype O 0 4.6909985940146726e-07
. O 0 8.310303201142233e-08

In O 0 5.435953198684729e-08
this O 0 2.976847379709824e-10
family O 0 2.37277475445552e-10
affected O 0 6.306230537767021e-10
individuals O 0 2.012310804100359e-11
developed O 0 5.990060714111678e-08
unilateral B-Disease 0 0.0002548486809246242
tumors I-Disease 1 1.0
and O 0 4.777647859555145e-07
, O 0 2.300093449036922e-09
as O 0 3.9913561344917525e-10
a O 0 1.1619962630993186e-10
result O 0 4.667418673776069e-10
of O 0 5.062930963362078e-09
linkage O 0 9.766204733807626e-09
analysis O 0 1.6328004504018168e-09
, O 0 1.747456623846233e-10
unaffected O 0 1.2520051662079368e-08
mutation O 0 1.4922690860785792e-10
carriers O 0 7.236498900109467e-11
were O 0 1.6678100567268928e-10
also O 0 4.878645404327031e-11
identified O 0 7.797435613854375e-11
within O 0 6.931285545519472e-10
the O 0 2.0510395604134146e-09
pedigree O 0 5.258777378003288e-07
. O 0 3.7012185316598334e-08

A O 0 1.8981252651428804e-05
single O 0 3.077068981838238e-07
band O 0 7.382051308013615e-07
shift O 0 4.28505986249661e-09
using O 0 2.2095747453931835e-09
SSCP O 0 0.045514896512031555
was O 0 2.1062978916575048e-08
identified O 0 5.863272645179052e-10
in O 0 3.126988945556519e-10
exon O 0 3.5648557883405374e-08
21 O 0 1.2360720447190943e-08
which O 0 4.327082095412216e-11
resulted O 0 5.875059883031497e-10
in O 0 7.824745018591983e-11
a O 0 2.1256923998791422e-10
missense O 0 2.7495522303411235e-08
mutation O 0 4.5821764160791645e-09
converting O 0 2.1040979447661812e-07
a O 0 3.028178596764519e-08
cys O 0 8.212495595216751e-05
- O 0 2.030637688221759e-06
- O 0 4.595960376718722e-07
> O 0 4.41890932734168e-08
arg O 0 2.8739289064105833e-06
at O 0 5.556462667755113e-08
nucleotide O 0 5.047185780426844e-09
position O 0 1.083423040171283e-08
28 O 0 9.165352921058911e-09
in O 0 6.160087995255026e-10
the O 0 5.523355106618055e-09
exon O 0 1.2302222103244276e-06
. O 0 5.384481482906267e-08

The O 0 5.839305572408193e-07
mutation O 0 5.498813493431953e-08
destroyed O 0 1.5333679357354413e-06
an O 0 3.5324803082659173e-09
NdeI O 0 4.886092938249931e-06
restriction O 0 1.84468795794146e-08
enzyme O 0 1.662241366773287e-08
site O 0 1.8748175989458105e-07
. O 0 2.863278858455942e-08

Analysis O 0 8.547518604018478e-08
of O 0 1.2952594374837645e-07
all O 0 1.1434124758125108e-09
family O 0 4.044387047485998e-10
members O 0 1.5163123534556178e-10
demonstrated O 0 7.557466319418893e-10
that O 0 1.4520861943423391e-11
the O 0 1.58024782148658e-09
missense O 0 3.2158837370843685e-07
mutation O 0 1.605443245011884e-08
co O 0 3.4005913107648666e-07
- O 0 1.013966539176181e-06
segregated O 0 1.3657296449309797e-06
with O 0 6.309755495870206e-10
patients O 0 1.2480568578610018e-08
with O 0 2.9471621587617847e-08
tumors B-Disease 1 1.0
or O 0 2.5969188754970673e-06
who O 0 3.9156315523314333e-08
, O 0 1.3455561109765313e-09
as O 0 2.458918901826479e-10
a O 0 7.533428048045465e-11
result O 0 3.0936486705712696e-10
of O 0 5.167349215184913e-09
linkage O 0 9.832032077383701e-09
analysis O 0 4.736816494599339e-10
had O 0 2.624113981664067e-10
been O 0 1.3765137640842084e-10
predicted O 0 7.151744751965339e-10
to O 0 4.332681782792669e-11
carry O 0 2.3444122199123285e-09
the O 0 1.3121401742921535e-08
predisposing O 0 2.560662096584565e-06
mutation O 0 9.87490551551673e-08
. O 0 4.456397206809015e-08

These O 0 1.4411782878198665e-08
observations O 0 2.3179472918855026e-07
point O 0 6.133255237017465e-09
to O 0 6.661478313407798e-11
another O 0 2.1716982379071936e-10
region O 0 8.519482341817763e-10
of O 0 3.169334572561411e-09
the O 0 8.43215630652594e-09
RB1 O 0 0.09283725917339325
gene O 0 2.214997074645453e-09
where O 0 3.135362247608242e-10
mutations O 0 4.197849359788286e-11
only O 0 3.891849082587884e-12
modify O 0 4.27568536132128e-10
the O 0 4.470311620874412e-10
function O 0 8.777367027645866e-11
of O 0 8.704747478383013e-10
the O 0 4.395368513598896e-10
gene O 0 2.6653054763237094e-10
and O 0 1.2849940556058925e-10
raise O 0 4.0073602769474803e-10
important O 0 3.006828952489826e-10
questions O 0 3.203189657963179e-10
for O 0 1.2351586420322747e-10
genetic O 0 2.2408459532385905e-09
counseling O 0 9.942309198152088e-10
in O 0 4.0084741081969355e-11
families O 0 2.062078589479266e-12
with O 0 1.2556143624831151e-11
these O 0 2.8883814784386175e-10
distinctive O 0 2.3905531065793184e-07
phenotypes O 0 3.5641559748000873e-07
. O 0 7.603332186079115e-09
. O 0 4.4943227806015784e-08

Maternal B-Disease 0 0.0005052032065577805
disomy I-Disease 1 0.8642362356185913
and O 0 9.756512008607388e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.23028776049613953
with O 0 8.4768444708061e-08
gamete O 0 4.29061365139205e-05
complementation O 1 0.9322752356529236
in O 0 1.53866555052673e-08
a O 0 1.3020301503630094e-09
case O 0 2.2670312294081896e-09
of O 0 1.9560424391329434e-07
familial O 0 7.177811198744166e-07
translocation O 0 4.976816967428022e-07
( O 0 3.535445936009296e-09
3 O 0 1.953860362391424e-08
; O 0 9.144355411772054e-11
15 O 0 1.5359349347932039e-09
) O 0 4.4646512181723e-11
( O 0 1.1247942161007884e-10
p25 O 0 1.415362334000747e-07
; O 0 4.5620293653847455e-10
q11 O 0 2.253960360576457e-07
. O 0 5.160274985094304e-10
2 O 0 2.2055001380749673e-08
) O 0 1.1066195737541307e-09
. O 0 4.470842807080544e-09

Maternal B-Disease 0 0.0018291405867785215
uniparental I-Disease 1 0.9986302852630615
disomy I-Disease 1 0.9995406866073608
( I-Disease 0 7.047166945994832e-06
UPD I-Disease 1 1.0
) I-Disease 0 3.7934231755798464e-08
for I-Disease 0 3.746017274153246e-09
chromosome I-Disease 0 1.833435270270911e-08
15 I-Disease 0 1.380174641241183e-08
is O 0 1.1256871129683432e-10
responsible O 0 1.7958405873486072e-09
for O 0 1.3673341625608515e-10
an O 0 2.7010253408898954e-11
estimated O 0 4.5067113235708334e-11
30 O 0 1.8275886359830906e-10
% O 0 2.297292781353044e-12
of O 0 1.4789730204411988e-11
cases O 0 7.970708121307624e-11
of O 0 2.1993947996179486e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9990406632423401
PWS B-Disease 1 1.0
) O 0 7.999136641956284e-07
. O 0 1.361088663998089e-07

We O 0 7.97157113652247e-08
report O 0 5.877865305592422e-09
on O 0 2.2319608383725154e-09
an O 0 1.1699149461696923e-11
unusual O 0 2.464562720572161e-10
case O 0 5.350211385035664e-10
of O 0 2.35319888020058e-08
maternal B-Disease 0 4.2923019805130025e-07
disomy I-Disease 0 4.78824986203108e-05
15 I-Disease 0 8.508123983119731e-08
in O 0 1.0304962216878266e-08
PWS B-Disease 1 1.0
that O 0 1.3436968204771915e-09
is O 0 4.4964594547725056e-11
most O 0 3.41288559913e-11
consistent O 0 1.6926605672651363e-09
with O 0 4.346777798813761e-11
adjacent O 0 7.305629168286032e-08
- O 0 6.975269428721731e-08
1 O 0 1.3647561303287148e-08
segregation O 0 6.083833881120881e-08
of O 0 2.0476427220472715e-09
a O 0 3.0322272470684197e-10
paternal O 0 8.12377010106502e-09
t O 0 3.553654437382647e-08
( O 0 4.280859000616033e-10
3 O 0 4.111927687233674e-09
; O 0 4.1415662566102185e-11
15 O 0 1.3356759032134846e-09
) O 0 4.1662461675029405e-11
( O 0 5.148092022122519e-11
p25 O 0 5.01221144588726e-08
; O 0 1.713598984931508e-10
q11 O 0 5.991329743437745e-08
. O 0 7.347891739506451e-11
2 O 0 8.157647335416129e-10
) O 0 3.4199804446743975e-12
with O 0 2.5467156595376794e-12
simultaneous O 0 7.535533086411306e-09
maternal O 0 4.1915592419172754e-07
meiotic O 0 6.233874591998756e-05
nondisjunction O 0 3.52011265931651e-05
for O 0 3.254510971828495e-08
chromosome O 0 1.3400635623384005e-07
15 O 0 9.308535453556033e-08
. O 0 2.021831768672655e-08

The O 0 9.418887430001632e-07
patient O 0 1.4056423651709338e-06
( O 0 1.5508872408531715e-08
J O 0 0.13245058059692383
. O 0 2.106308905069909e-09
B O 0 3.520107156873564e-07
. O 0 3.017334992971854e-11
) O 0 6.456128600479394e-12
, O 0 7.679809913008206e-12
a O 0 6.099255128733105e-11
17 O 0 4.853460744413951e-09
- O 0 5.138355962941432e-09
year O 0 9.548777324397406e-10
- O 0 5.101990652178756e-08
old O 0 1.0330845867656535e-07
white O 0 1.8086866448996375e-09
male O 0 5.703129635215021e-10
with O 0 8.190356171056123e-10
PWS B-Disease 1 1.0
, O 0 3.541467918921626e-08
was O 0 2.9229946463260603e-08
found O 0 3.382700508591796e-10
to O 0 1.1071721317534866e-10
have O 0 8.870607026700839e-11
47 O 0 3.695192818398141e-09
chromosomes O 0 4.861593350113935e-10
with O 0 8.59086760063299e-11
a O 0 1.751248035475328e-09
supernumerary O 0 2.8773815756721888e-06
, O 0 3.972992601575243e-09
paternal O 0 7.243110644594708e-08
der O 0 0.0017438725335523486
( O 0 2.404737298178361e-09
15 O 0 7.634051613081283e-09
) O 0 5.099084002258003e-11
consisting O 0 1.3452918778966705e-09
of O 0 1.64567008908989e-08
the O 0 4.237369566340021e-08
short O 0 2.492699593403813e-07
arm O 0 0.00014121447748038918
and O 0 7.079332675630212e-08
the O 0 1.7426795295705233e-07
proximal O 0 7.427726814057678e-05
long O 0 5.447535613711807e-07
arm O 0 0.00026038274518214166
of O 0 0.00026380238705314696
chromosome O 0 4.7610328124392254e-07
15 O 0 1.3929739850482292e-07
, O 0 3.812992588336783e-09
and O 0 1.679953598454631e-08
distal O 0 7.554485637228936e-05
chromosome O 0 0.00011254779383307323
arm O 1 0.9982175230979919
3p O 1 0.9998313188552856
. O 0 7.5506236498767976e-06

The O 0 7.137365628295811e-06
t O 0 1.4613734720114735e-06
( O 0 3.757681721339168e-09
3 O 0 7.476692154284592e-09
; O 0 5.3691103646391625e-11
15 O 0 7.810136426478209e-10
) O 0 7.312614055954292e-12
was O 0 1.683704980992573e-10
present O 0 3.147644297984975e-11
in O 0 3.803669532120857e-11
the O 0 8.324919226199157e-11
balanced O 0 2.713295144118888e-10
state O 0 3.006586646314702e-11
in O 0 4.1163572550573235e-11
the O 0 2.233079554603279e-10
patients O 0 4.4313544500518276e-10
father O 0 6.950153785822977e-09
and O 0 3.833680928266858e-09
a O 0 1.993860543336723e-08
sister O 0 1.702130020930781e-06
. O 0 1.3353205474686547e-07

Fluorescent O 0 1.3899717487220187e-05
in O 0 4.211368676010352e-08
situ O 0 3.6734317632181046e-07
hybridization O 0 3.2992975018686366e-09
analysis O 0 1.1588472403900596e-09
demonstrated O 0 2.57674925840945e-09
that O 0 4.921703669613642e-11
the O 0 7.41367012224714e-09
PWS B-Disease 1 1.0
critical O 0 3.8826487980259117e-07
region O 0 1.5290462229700097e-08
resided O 0 4.721288604514484e-08
on O 0 6.446110756286316e-09
the O 0 4.744067361173165e-10
derivative O 0 9.770434239442238e-09
chromosome O 0 3.184240426890028e-09
3 O 0 1.5606046455118872e-09
and O 0 6.334230362448068e-11
that O 0 4.66371169113855e-12
there O 0 1.94326534030953e-11
was O 0 9.013689239445455e-10
no O 0 7.113268307712417e-11
deletion O 0 4.2738998451419263e-10
of O 0 5.077717801782455e-09
the O 0 6.225673132576048e-08
PWS B-Disease 1 1.0
region O 0 3.818184381998435e-07
on O 0 3.550876570557193e-08
the O 0 3.6979987960705785e-09
normal O 0 4.484310700547667e-09
pair O 0 4.824222354926633e-09
of O 0 7.73733876968663e-09
15s O 0 6.423879312933423e-07
present O 0 1.5185598556399782e-08
in O 0 1.24540605384027e-07
J O 1 0.9998201727867126
. O 0 4.136173572533153e-07

B O 0 0.005844009108841419
. O 0 1.4092757965045166e-06

Methylation O 0 1.1412339517846704e-06
analysis O 0 7.537923352174403e-08
at O 0 6.205898017697109e-08
exon O 0 5.828323423884285e-08
alpha O 0 1.2996390630348742e-08
of O 0 4.878650372575066e-09
the O 0 6.470385893742048e-10
small O 0 2.9527688627517534e-10
nuclear O 0 7.515913580391498e-07
ribonucleoprotein O 0 1.0505620593903586e-05
- O 0 4.138714757573325e-07
associated O 0 1.3687733613210185e-08
polypeptide O 0 2.354896651013405e-07
N O 0 3.93526335074057e-07
( O 0 2.083215600023891e-09
SNRPN O 1 0.9936336278915405
) O 0 9.260589517445794e-10
gene O 0 1.6177191808353086e-09
showed O 0 8.241913818096691e-10
a O 0 3.0076319212923863e-10
pattern O 0 9.00192453912041e-09
characteristic O 0 5.6493032474236315e-09
of O 0 6.282318665284947e-09
only O 0 6.629220783427314e-11
the O 0 1.0436217445786156e-09
maternal O 0 1.567403806745915e-08
chromosome O 0 4.221395233372505e-09
15 O 0 6.6303149637292336e-09
in O 0 2.00423535545724e-08
J O 1 0.9855124354362488
. O 0 1.1125379018039894e-07

B O 0 0.005287786014378071
. O 0 1.2629704997380031e-06

Maternal B-Disease 0 8.895037899492308e-05
disomy I-Disease 0 0.001759401522576809
was O 0 6.451685408137564e-07
confirmed O 0 3.201627407634078e-09
by O 0 1.202979937886539e-10
polymerase O 0 2.424717848725777e-08
chain O 0 1.4249832425150544e-08
reaction O 0 4.2566772329166724e-10
analysis O 0 6.228006999009494e-10
of O 0 7.59117391169184e-09
microsatellite O 0 1.525738895225004e-07
repeats O 0 2.4095776041122008e-08
at O 0 1.4533157788321205e-08
the O 0 4.4736384041677013e-10
gamma O 0 5.8444200590201945e-08
- O 0 4.6605379111497314e-08
aminobutyric O 0 7.454352726199431e-07
acid O 0 9.109096588133525e-09
receptor O 0 1.884205014235363e-09
beta3 O 0 8.305943879349797e-07
subunit O 0 1.1984122139097053e-08
( O 0 6.082787162853265e-09
GABRB3 O 0 0.08216910064220428
) O 0 4.080994653321568e-09
locus O 0 8.602145129543715e-08
. O 0 2.6625542659530765e-08

A O 0 7.689755875617266e-05
niece O 0 5.0493672461016104e-05
( O 0 9.638466025307935e-08
B O 0 6.475141617556801e-06
. O 0 6.956025755400219e-10
B O 0 7.755989628321913e-08
. O 0 1.7431514565124928e-11
) O 0 1.899610460251444e-12
with O 0 1.0377453237009338e-11
45 O 0 2.493861506192019e-10
chromosomes O 0 8.599326806191243e-11
and O 0 1.277747352368408e-10
the O 0 2.6296753663501704e-10
derivative O 0 2.001315779764923e-09
3 O 0 2.2727417725576515e-09
but O 0 7.859592317249753e-12
without O 0 2.8502950000230953e-11
the O 0 4.4578207791801105e-10
der O 0 1.0743853636085987e-05
( O 0 9.094682229537909e-10
15 O 0 5.819278392493743e-09
) O 0 1.0608972728087807e-10
demonstrated O 0 9.847210824531771e-10
a O 0 3.1231264796538483e-10
phenotype O 0 3.7057232837867105e-09
consistent O 0 4.698073929887414e-09
with O 0 1.1722520176782325e-10
that O 0 3.25497163944366e-11
reported O 0 2.6061075519834276e-10
for O 0 2.833093204479553e-10
haploinsufficiency O 0 1.0854007086891215e-05
of O 0 7.282255864993203e-07
distal O 0 2.8479357752075884e-06
3 O 0 1.0826937568708672e-06
p O 0 1.0114517863257788e-06
. O 0 4.889710680799908e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.5514457345489063e-06
with O 0 9.173327875089399e-09
unbalanced O 0 1.8000446289079264e-06
segregation O 0 9.424437848792877e-06
of O 0 1.090728147801201e-07
non O 0 6.609725460293703e-06
- O 0 7.164624094002647e-06
Robertsonian O 0 0.00042141173616982996
translocations O 0 1.4309678135759896e-06
has O 0 1.3118317543359126e-09
been O 0 4.822683363769897e-10
reported O 0 1.3718672864371229e-09
previously O 0 1.9756321023578494e-09
but O 0 2.341223742652332e-11
has O 0 5.32903235428428e-12
not O 0 4.300298832304872e-12
, O 0 9.3679369816968e-12
to O 0 1.7877152883039038e-11
our O 0 1.8188912875860552e-10
knowledge O 0 2.166858470431521e-09
, O 0 9.897443281614571e-11
been O 0 1.8075915764192985e-11
observed O 0 1.344272887449094e-10
in O 0 6.227552501458788e-11
a O 0 1.6251995582639012e-10
case O 0 2.5327584474155174e-09
of O 0 9.157386102742748e-07
PWS B-Disease 1 1.0
. O 0 3.282939360360615e-06

Furthermore O 0 3.7943389088468393e-06
, O 0 1.873841171118329e-08
our O 0 7.35547178720708e-09
findings O 0 1.6062877694622557e-09
are O 0 3.076700005877342e-11
best O 0 3.7905839578300515e-10
interpreted O 0 4.837082401287773e-10
as O 0 3.830697148377027e-10
true O 0 5.5280873212382176e-09
gamete O 0 3.434257678236463e-07
complementation O 0 1.7317384845227934e-05
resulting O 0 4.999407465788863e-08
in O 0 3.6092032473789004e-08
maternal B-Disease 0 4.943131352774799e-05
UPD I-Disease 1 1.0
15 I-Disease 0 3.820243364316411e-05
and O 0 2.6662224627216347e-05
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.7569515109062195
- I-Disease 1 0.9998030066490173
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.999887228012085
type I-Disease 0 7.718850611126982e-06
2 I-Disease 0 3.708480107889045e-06
and O 0 6.463398705136569e-08
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 5.980218542589455e-09
a O 0 7.802781198940067e-10
case O 0 1.1126090049273785e-09
for O 0 1.0021186103159607e-09
" O 0 1.4415550531055032e-08
lumping O 0 7.878065844124649e-07
" O 0 9.408172019220729e-08
. O 0 3.4841427520859725e-08

Recent O 0 6.963160359418907e-08
studies O 0 1.2419445027944676e-08
demonstrated O 0 2.238949026178716e-09
the O 0 2.371815521762244e-10
existence O 0 5.689744231318627e-10
of O 0 1.1831604584955357e-09
a O 0 2.496760020953559e-10
genetically O 0 2.5718062346413717e-08
distinct O 0 3.683434224299731e-09
, O 0 1.6153380022476682e-10
usually O 0 8.452147315374248e-11
lethal O 0 4.423427402144853e-09
form O 0 4.2650316611769767e-10
of O 0 3.402353732084862e-09
the O 0 7.140953162121377e-09
Schwartz B-Disease 0 0.00025449247914366424
- I-Disease 1 0.9992287158966064
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.679134129517479e-07
SJS B-Disease 1 1.0
) O 0 6.094156290714636e-09
of O 0 1.26841553083068e-06
myotonia B-Disease 1 1.0
and O 0 0.021464640274643898
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.217752808064688e-07
which O 0 1.0400731831339272e-08
we O 0 2.8669384644075535e-09
called O 0 2.0659216204421682e-07
SJS B-Disease 1 0.999996542930603
type I-Disease 0 1.662868271523621e-05
2 I-Disease 0 3.6885235203953926e-06
. O 0 7.908992216698607e-08

This O 0 1.9962699582265486e-07
disorder O 1 0.9945822358131409
is O 0 7.034843374498223e-09
reminiscent O 0 0.00012278143549337983
of O 0 1.2258351489435881e-06
another O 0 1.2474072441648332e-08
rare O 0 3.1683333645560197e-07
condition O 0 2.735518364715972e-06
, O 0 6.57233334422358e-09
the O 0 1.9232646764066885e-07
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.043221906613326e-06
SWS B-Disease 1 1.0
) O 0 8.400244055906114e-09
, O 0 7.263107337784902e-10
which O 0 1.4291216821060715e-10
comprises O 0 1.3787617270111241e-08
campomelia B-Disease 0 1.925715150719043e-05
at O 0 3.1847892500991293e-07
birth O 0 7.003224027357646e-07
with O 0 1.731367760271496e-08
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.2641108444076963e-05
contractures B-Disease 1 1.0
, O 0 2.7958847681475163e-07
and O 0 3.752276001023347e-08
early B-Disease 0 1.1389680594220408e-06
death I-Disease 0 2.4367361675103894e-06
. O 0 4.7921911772164094e-08

To O 0 3.8642667732347036e-08
test O 0 3.888436239662951e-08
for O 0 1.4855951191439232e-10
possible O 0 3.346297239303908e-09
nosologic O 0 3.1763120205141604e-05
identity O 0 2.803604459700182e-09
between O 0 1.4287764305009887e-09
these O 0 8.441393362090821e-09
disorders O 1 0.9999996423721313
, O 0 3.4026264028597097e-09
we O 0 1.3479059535193016e-10
reviewed O 0 1.5995067492724502e-09
the O 0 4.1151973495523464e-10
literature O 0 2.597690673677988e-10
and O 0 1.7198915902572054e-11
obtained O 0 6.200659430355415e-11
a O 0 1.185075093612653e-10
follow O 0 6.289545551041442e-10
- O 0 5.165329053369305e-09
up O 0 3.4788402714092115e-10
of O 0 1.0921552551224067e-09
the O 0 9.555897045876449e-11
only O 0 4.813957392435508e-12
two O 0 2.7599620505691647e-11
surviving O 0 6.839468369435053e-08
patients O 0 1.2012379979609022e-09
, O 0 1.350904388353058e-10
one O 0 3.776965684654243e-10
with O 0 2.1592507781775794e-09
SJS B-Disease 1 0.999922513961792
type I-Disease 0 3.3177147997776046e-06
2 I-Disease 0 2.1082317402942863e-07
at O 0 1.0046112208783597e-07
age O 0 1.2114909075933156e-09
10 O 0 1.1171911312723992e-10
years O 0 3.2309779851580345e-11
and O 0 5.5998421177871904e-11
another O 0 5.4580245878455e-10
with O 0 1.1420436818454505e-09
SWS B-Disease 1 0.9999997615814209
at O 0 1.3400857596934657e-06
age O 0 1.719526743215738e-08
7 O 0 3.670223591711874e-08
years O 0 2.5060840069812684e-09
. O 0 4.039416801049356e-09

Patients O 0 2.228777020718553e-06
reported O 0 2.0081577289943198e-08
as O 0 2.661755704735924e-09
having O 0 1.308136976518881e-08
either O 0 3.1713958037471457e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 3.116506559308618e-05
SWS B-Disease 1 1.0
presented O 0 2.4729334313633444e-07
a O 0 8.323085332051505e-09
combination O 0 9.415316526428796e-08
of O 0 5.883537710360542e-07
a O 0 4.324135005617791e-08
severe O 1 0.9985301494598389
, O 0 6.72311486482613e-08
prenatal O 1 0.9999545812606812
- O 1 0.9999737739562988
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 3.019688665517606e-05
with O 1 0.9998629093170166
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9967020153999329
feeding O 1 0.9992600083351135
difficulties O 0 0.10546225309371948
, O 0 5.2552675100514534e-08
tendency O 0 2.1200946775934426e-08
to O 0 4.979999523868628e-09
hyperthermia B-Disease 1 0.9991574287414551
, O 0 1.3830708134321412e-08
and O 0 2.064182824668137e-09
frequent O 0 8.308445487159588e-09
death O 0 1.1542027777977637e-07
in O 0 4.923614849161595e-09
infancy O 0 1.6170203025467345e-06
) O 0 4.137484452271245e-11
with O 0 3.9433636911390124e-11
a O 0 1.4013016302882875e-09
distinct O 0 1.0588731669258777e-07
campomelic B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999997615814209
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 1.793655610526912e-05

The O 0 8.849799826293747e-08
similarity O 0 2.7498668231373813e-08
of O 0 3.645880397584733e-08
the O 0 8.010250240886307e-09
clinical O 0 2.1916132482147077e-06
and O 0 4.372476158920335e-09
radiographic O 0 0.0001941350201377645
findings O 0 7.533208901122634e-08
is O 0 2.0827140012613654e-10
so O 0 2.1937746758071697e-11
extensive O 0 2.770677243191244e-09
that O 0 6.008934322343507e-11
these O 0 1.0496911784230178e-08
disorders O 1 1.0
appear O 0 1.0045342335729401e-08
to O 0 5.684385739890274e-10
be O 0 2.1800110328040745e-10
a O 0 2.4387702968198255e-09
single O 0 7.177356931009626e-09
entity O 0 2.109305654585114e-07
. O 0 1.5383787399514404e-07

The O 0 4.1215335500055517e-07
follow O 0 5.8194366658881336e-08
- O 0 1.0277798878632893e-07
up O 0 2.1048631726472422e-09
observation O 0 4.959262511761153e-08
of O 0 2.8867086498962635e-09
an O 0 3.802341774772344e-11
identical O 0 3.2836025010141157e-09
and O 0 2.908654150868273e-10
unique O 0 5.249902179649268e-10
pattern O 0 3.0342437895569674e-08
of O 0 5.449234663501556e-07
progressive O 1 0.9999998807907104
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 1.1671401267676629e-07
the O 0 6.551309894575752e-08
two O 0 3.6305012329762576e-09
patients O 0 1.152161122064399e-08
( O 0 8.38831171190435e-10
one O 0 1.7509274030658162e-09
with O 0 6.9874377395251486e-09
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 1.886323661892675e-05
2 I-Disease 0 8.013124670469551e-07
, O 0 8.423118313949374e-10
one O 0 2.3204237142859796e-10
with O 0 7.041296989918067e-10
SWS B-Disease 1 1.0
) O 0 2.8343432045829786e-09
surviving O 0 9.323761105406447e-07
beyond O 0 3.3060462101275334e-07
infancy O 0 2.5244457901862916e-07
adds O 0 2.621732553276246e-10
to O 0 2.6536373792795942e-11
the O 0 1.8965928827441303e-10
evidence O 0 3.0221805613628305e-10
in O 0 6.045686867794942e-11
favor O 0 4.227645733489993e-10
of O 0 3.23249760292299e-09
identity O 0 3.1855220683496555e-09
. O 0 1.1343569639166162e-08

The O 0 2.9212176855253347e-07
hypothesis O 0 1.14415300345172e-07
that O 0 1.8353656372482874e-09
SWS B-Disease 1 0.9999934434890747
and O 0 3.030941115866881e-07
SJS B-Disease 1 0.9999864101409912
type I-Disease 0 1.4368247320817318e-06
2 I-Disease 0 3.903692658013824e-08
are O 0 2.4640539608711265e-11
the O 0 1.0300334196688965e-10
same O 0 3.248702418190419e-10
disorder O 0 6.276093245105585e-07
should O 0 9.276300561023021e-11
be O 0 3.397635645052688e-11
testable O 0 2.3705741369894895e-08
by O 0 7.712121913305836e-11
molecular O 0 1.0803381300661385e-08
methods O 0 1.1741642325091561e-08
. O 0 1.773676427951898e-09
. O 0 1.180289466162776e-08

A O 0 1.792527109500952e-05
mouse O 0 2.2979862990268884e-07
model O 0 5.748038489628016e-09
of O 0 9.798170452768318e-08
severe O 1 0.9999995231628418
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.32469213008880615
defects O 1 1.0
in O 0 1.9713547771971207e-06
hemostasis O 1 0.9999997615814209
and O 0 3.1255578505806625e-05
thrombosis B-Disease 1 0.9999982118606567
. O 0 3.401915591894067e-06

von B-Disease 1 0.9990339279174805
Willebrand I-Disease 1 0.9999970197677612
factor I-Disease 0 4.420660116011277e-05
( I-Disease 0 4.486803391046124e-06
vWf I-Disease 1 0.9999938011169434
) I-Disease 0 0.0014039690140634775
deficiency I-Disease 1 1.0
causes O 1 0.9999758005142212
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 8.8391789176967e-05
humans O 0 5.775206091129803e-07
. O 0 5.2383349213869224e-08

We O 0 5.1800128630929976e-08
generated O 0 4.375913853493785e-09
a O 0 1.5646400841617947e-09
mouse O 0 3.842334006520787e-09
model O 0 8.800785794571553e-11
for O 0 4.414858756351947e-11
this O 0 5.7273595588380743e-11
disease O 0 1.2020218154162876e-09
by O 0 2.5253356263771343e-12
using O 0 9.04766886411501e-11
gene O 0 1.5324790325621507e-09
targeting O 0 1.9058637334978812e-08
. O 0 1.2643568858550225e-08

vWf B-Disease 0 0.005812129005789757
- I-Disease 0 0.41463640332221985
deficient I-Disease 0 0.001565044280141592
mice O 0 3.1369751241072663e-07
appeared O 0 1.250680625730638e-08
normal O 0 5.766167543441725e-09
at O 0 7.142968883044887e-09
birth O 0 3.03932767842241e-09
; O 0 1.3883918320578559e-11
they O 0 1.8770505982868002e-11
were O 0 4.73213856988508e-10
viable O 0 6.536257046718674e-08
and O 0 1.3766069173470896e-08
fertile O 0 1.2101471611458692e-06
. O 0 1.7600129353922966e-07

Neither O 0 2.529291668906808e-05
vWf O 0 0.00013817856961395591
nor O 0 4.55598319604178e-06
vWf O 0 7.7144788519945e-05
propolypeptide O 0 0.00020885221601929516
( O 0 4.995623115178205e-08
von B-Disease 0 0.05395461991429329
Willebrand I-Disease 1 0.9983116388320923
antigen O 0 1.846571649366524e-05
II O 1 1.0
) O 0 4.6421000376994925e-09
were O 0 1.1731605686904345e-09
detectable O 0 6.711532307690504e-08
in O 0 1.9499418746349306e-10
plasma O 0 1.5506092410078054e-08
, O 0 2.723073155852518e-10
platelets O 0 2.148263078538548e-08
, O 0 7.796309708929527e-10
or O 0 3.547082350063846e-10
endothelial O 0 1.1231339414052854e-08
cells O 0 1.0108186510038308e-09
of O 0 6.8611423209574696e-09
the O 0 4.69429428662238e-09
homozygous O 0 9.743174445020486e-08
mutant O 0 3.7787714290971053e-07
mice O 0 2.1735284860824322e-07
. O 0 2.2030826940522275e-08

The O 0 2.3877241801528726e-06
mutant O 0 8.268417332146782e-06
mice O 0 2.6391960545879556e-06
exhibited O 0 2.0483079424593598e-05
defects O 1 0.7598868012428284
in O 0 2.534181362534582e-07
hemostasis O 0 0.0019006485817953944
with O 0 8.01098387626098e-09
a O 0 1.5270060771399585e-08
highly O 0 5.720706030842848e-05
prolonged O 1 1.0
bleeding O 1 0.9999344348907471
time O 0 3.398917769459331e-08
and O 0 2.236845908498708e-08
spontaneous O 0 4.510150120040635e-06
bleeding O 0 5.210001108935103e-05
events O 0 1.533301485778793e-08
in O 0 2.0485255713964534e-09
approximately O 0 6.689812592775013e-10
10 O 0 1.2762428891477384e-09
% O 0 7.219252973200696e-11
of O 0 4.917120488556748e-09
neonates O 0 1.359585439786315e-06
. O 0 1.7952358177808492e-07

As O 0 6.028526655654787e-08
in O 0 4.837001466029278e-09
the O 0 5.8596643093267176e-09
human O 0 5.024251947816083e-08
disease O 0 3.536183612595778e-07
, O 0 4.2384141335505277e-11
the O 0 1.2459103193585008e-10
factor O 0 6.913777328421133e-10
VIII O 1 0.9997954964637756
level O 0 6.505561600533838e-08
in O 0 2.1709568864825002e-10
these O 0 6.387503720395316e-11
mice O 0 3.146320759483956e-09
was O 0 1.164279672671853e-09
reduced O 0 3.3679253830243283e-10
strongly O 0 8.415406566042449e-11
as O 0 3.1000150363391654e-11
a O 0 3.807850562642656e-11
result O 0 8.898550646341263e-11
of O 0 1.5549266318970467e-09
the O 0 5.938251002035599e-10
lack O 0 3.0690603392002913e-09
of O 0 3.4972373885722163e-09
protection O 0 2.8246141425825044e-08
provided O 0 1.4285310712125465e-09
by O 0 2.8035938015591455e-09
vWf O 0 6.268793185881805e-06
. O 0 1.3206171445290238e-07

Defective O 1 0.9985766410827637
thrombosis B-Disease 0 0.023344019427895546
in O 0 3.804909169957682e-07
mutant O 0 1.6177252746274462e-06
mice O 0 1.596082768173801e-07
was O 0 2.1351787893308938e-08
also O 0 1.3376919016927502e-10
evident O 0 2.2358637163932826e-09
in O 0 1.1152111178969193e-10
an O 0 3.2970340867188863e-12
in O 0 5.0382649441349514e-11
vivo O 0 3.4588871766771945e-09
model O 0 1.3092871231634717e-09
of O 0 1.5922074680929654e-06
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 9.56981057242956e-06

In O 0 3.363852130178202e-08
this O 0 5.57454325755824e-11
model O 0 8.133053674974633e-10
, O 0 1.8220232267385228e-10
the O 0 6.722428724792451e-10
exteriorized O 0 4.833798811887391e-06
mesentery O 0 1.8295220797881484e-05
was O 0 1.2724606790470716e-07
superfused O 0 4.649781658372376e-06
with O 0 3.2700648855410464e-09
ferric O 0 4.97994415127323e-06
chloride O 0 8.585196553667629e-08
and O 0 1.311762432010255e-08
the O 0 1.988004960651324e-08
accumulation O 0 9.739075039760792e-07
of O 0 1.353560605821258e-06
fluorescently O 0 9.360475814901292e-05
labeled O 0 1.6606385315753869e-06
platelets O 0 5.493686217050708e-07
was O 0 2.8485168002134742e-08
observed O 0 1.3977620172411775e-09
by O 0 3.74354408583244e-10
intravital O 0 2.956581283797277e-06
microscopy O 0 1.2108710052416427e-06
. O 0 1.338086832447516e-07

We O 0 7.0118986172929e-08
conclude O 0 1.3913343366311892e-07
that O 0 7.70772543012832e-11
these O 0 2.9833271963930486e-10
mice O 0 1.9014050778309866e-08
very O 0 3.123269420868269e-10
closely O 0 1.844163755038153e-08
mimic O 0 0.0009562401683069766
severe O 0 0.13006387650966644
human O 0 6.925503384991316e-06
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 2.9496712272703007e-07
will O 0 1.3344307880913675e-09
be O 0 1.4691951821799165e-10
very O 0 6.286327708382444e-11
useful O 0 9.807168965814128e-11
for O 0 4.1790040178346644e-11
investigating O 0 2.4840454138086443e-09
the O 0 8.23889623191576e-10
role O 0 9.426682767710304e-10
of O 0 8.37854674529126e-09
vWf O 0 6.216667003400289e-08
in O 0 9.405848322430188e-10
normal O 0 6.096551263823358e-09
physiology O 0 1.0017124196792793e-07
and O 0 4.1265707517723627e-10
in O 0 4.431263800341867e-09
disease O 0 1.334111203732391e-07
models O 0 1.9474564183497023e-09
. O 0 1.8071107943384845e-09
. O 0 1.6527824442391648e-08

Oral O 1 0.9942189455032349
contraceptives O 0 0.000963641912676394
and O 0 4.472721215620368e-08
the O 0 3.9393555084643594e-08
risk O 0 5.073804345556709e-07
of O 0 0.008139693178236485
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.833453658648068e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9994369149208069
Study O 0 2.0226998458383605e-06
Group O 0 3.466180942268693e-07
. O 0 7.142508451352114e-08

BACKGROUND O 0 0.00012953679834026843
Women O 0 1.07688604700229e-08
with O 0 7.476431695963015e-10
mutations O 0 1.1109211328630408e-09
in O 0 4.646155127296936e-10
either O 0 8.079079072409456e-10
the O 0 1.3171200130557281e-08
BRCA1 O 0 1.0436605180075276e-07
or O 0 7.2411041607267634e-09
the O 0 7.164079107724319e-08
BRCA2 O 0 9.643482599130948e-07
gene O 0 2.5338988685064123e-09
have O 0 3.1757034502089e-11
a O 0 5.620989784738128e-10
high O 0 2.1945736250472692e-07
lifetime O 0 1.2730446030673193e-07
risk O 0 5.991432203700242e-07
of O 1 0.9342637062072754
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.610871648466855e-07

Oral O 1 0.9996337890625
contraceptives O 1 0.9993435740470886
protect O 0 0.09587930887937546
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.079160451757161e-09
general O 0 1.564638019146969e-08
, O 0 3.5247924023984467e-10
but O 0 9.710689717612464e-12
it O 0 7.416628942935599e-12
is O 0 1.9654998115181677e-12
not O 0 9.956546221170925e-13
known O 0 5.589171486741762e-11
whether O 0 4.1288441415821e-11
they O 0 2.854712993771713e-11
also O 0 6.109932004783047e-11
protect O 0 4.8446744393970675e-09
against O 0 2.0458604410578118e-07
hereditary B-Disease 1 0.9840864539146423
forms I-Disease 0 0.0001560442615300417
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.067274966881087e-07

METHODS O 0 2.1675226889783517e-05
We O 0 1.0949695372630686e-08
enrolled O 0 9.649722443327846e-08
207 O 0 6.479420022742488e-08
women O 0 1.1599463611844385e-09
with O 0 2.5670033210190013e-08
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.3697513285014793e-08
161 O 0 4.926689101125703e-08
of O 0 9.165811576394844e-08
their O 0 9.437157721947642e-09
sisters O 0 1.4163967989588855e-06
as O 0 3.3091163142984215e-09
controls O 0 2.2253859199850012e-08
in O 0 2.8978741628549187e-09
a O 0 1.8340113872028496e-09
case O 0 7.685243552657539e-09
- O 0 2.743026357165945e-07
control O 0 4.156870048177552e-08
study O 0 8.64892957253005e-09
. O 0 5.127000157756356e-09

All O 0 9.593968997023694e-08
the O 0 1.721285691758112e-08
patients O 0 1.1774445862755556e-09
carried O 0 9.960701152778029e-10
a O 0 2.0157268909581916e-10
pathogenic O 0 1.227166457340445e-08
mutation O 0 2.638688989531346e-10
in O 0 3.0135349771143183e-10
either O 0 3.433659134799427e-09
BRCA1 O 0 1.3891309436075971e-07
( O 0 2.1856410015175243e-09
179 O 0 3.872744969157793e-08
women O 0 8.865249090383998e-10
) O 0 3.7273706343654567e-10
or O 0 1.0174129982942759e-08
BRCA2 O 0 1.456042696190707e-06
( O 0 8.496005676761342e-09
28 O 0 3.6352048482513055e-07
women O 0 1.22577625827347e-09
) O 0 6.894524950951109e-10
. O 0 1.4260735703430782e-08

The O 0 4.347390074599389e-07
control O 0 8.328583334105133e-08
women O 0 2.414972111175473e-10
were O 0 1.7527039541942457e-10
enrolled O 0 1.9834780484728753e-09
regardless O 0 6.997863954971706e-10
of O 0 1.4488811261870183e-09
whether O 0 6.586746426062717e-11
or O 0 4.0485081953534063e-10
not O 0 3.00985139589649e-11
they O 0 3.3161452750452014e-11
had O 0 2.0635834707682932e-10
either O 0 2.425322609411751e-09
mutation O 0 1.079258815650519e-08
. O 0 1.9599369238676445e-08

Lifetime O 0 2.4812043193378486e-06
histories O 0 6.36381173535483e-07
of O 0 4.824178745366225e-07
oral O 0 6.0316982853692025e-05
- O 0 6.869577191537246e-07
contraceptive O 0 7.29113835973294e-08
use O 0 4.686214194471461e-10
were O 0 1.940251431742368e-10
obtained O 0 1.3107606666729055e-10
by O 0 4.6758992511275466e-11
interview O 0 7.719395678229546e-10
or O 0 7.041185690059848e-11
by O 0 2.1811536951577004e-11
written O 0 7.299936349847158e-11
questionnaire O 0 2.6504820560546705e-10
and O 0 1.2298857765546956e-10
were O 0 8.060793144082368e-10
compared O 0 7.230197551777451e-10
between O 0 4.795404628943345e-10
patients O 0 1.293379514599735e-09
and O 0 1.4207108822716918e-09
control O 0 1.2652233749577135e-07
women O 0 5.212824061295862e-10
, O 0 8.384420935314552e-11
after O 0 5.208450892801864e-10
adjustment O 0 7.72883979038852e-10
for O 0 3.2909789476898155e-11
year O 0 1.0829798169353921e-10
of O 0 1.368660407230493e-09
birth O 0 6.466197532972728e-08
and O 0 6.146359865510931e-09
parity O 0 1.1230695236008614e-06
. O 0 4.144812493223071e-08

RESULTS O 0 3.577170355129056e-05
The O 0 1.131463989167969e-07
adjusted O 0 2.6855624923882715e-07
odds O 0 1.5971181710483506e-07
ratio O 0 2.4525370179162564e-08
for O 0 3.9586910816069576e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 2.973332158262565e-08
with O 0 9.017502022867774e-11
any O 0 1.3916588714746325e-10
past O 0 5.594869567637772e-10
use O 0 3.9497041748326467e-10
of O 0 4.701148803576416e-09
oral O 0 2.852717216228484e-06
contraceptives O 0 3.5736286463361466e-06
was O 0 9.008901713514206e-08
0 O 0 2.6302348743456605e-08
. O 0 4.264513187024477e-09

5 O 0 1.9710914784809574e-06
( O 0 7.567783733009037e-09
95 O 0 6.56464322901229e-08
percent O 0 2.135992271945497e-09
confidence O 0 1.0894551927265184e-08
interval O 0 1.2808110128048611e-08
, O 0 1.3538448140337778e-10
0 O 0 1.530010285133443e-10
. O 0 1.537815361163375e-11
3 O 0 1.2556246320460929e-10
to O 0 1.7560628298718406e-11
0 O 0 2.808784316243873e-10
. O 0 1.5538161035610898e-11
8 O 0 2.192764414488124e-09
) O 0 1.3886361505122125e-10
. O 0 1.897552781571221e-09

The O 0 1.930723556142766e-06
risk O 0 8.490761160828697e-08
decreased O 0 4.814487919446719e-09
with O 0 2.6054949864295907e-11
increasing O 0 1.627792345360035e-11
duration O 0 8.687978114707562e-10
of O 0 2.5747728948921633e-10
use O 0 2.0386202448374746e-10
( O 0 1.0995077764919259e-10
P O 0 1.2887684874840488e-07
for O 0 3.558330852193592e-10
trend O 0 4.9864246065567386e-09
, O 0 2.839984324098932e-11
< O 0 3.2453767451201543e-10
0 O 0 1.0172742509473309e-10
. O 0 4.793168899980271e-12
001 O 0 3.9215191094399415e-09
) O 0 4.388846491093501e-12
; O 0 1.0003410860076611e-12
use O 0 9.59031031672053e-12
for O 0 4.1495525765489205e-11
six O 0 6.152021669869612e-10
or O 0 1.0559734336945681e-10
more O 0 4.580701269685239e-12
years O 0 2.3343268984454824e-10
was O 0 1.990086762049259e-09
associated O 0 5.275770376123035e-10
with O 0 7.387097877842308e-11
a O 0 4.060944358563745e-10
60 O 0 1.4002329296047833e-09
percent O 0 2.3102136870178924e-10
reduction O 0 3.989074848220753e-09
in O 0 6.495032511821819e-09
risk O 0 9.132550360391178e-08
. O 0 6.000501429070937e-08

Oral O 0 0.24007132649421692
- O 0 2.0784278603969142e-05
contraceptive O 0 3.0442834031418897e-06
use O 0 2.2642796082550376e-08
protected O 0 7.373470725724474e-05
against O 1 0.9999997615814209
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 3.372566670378774e-10
for O 0 3.612193877344794e-11
carriers O 0 1.1535584987232284e-10
of O 0 4.313646329023868e-09
the O 0 5.7755897842071136e-09
BRCA1 O 0 8.864817857556773e-08
mutation O 0 9.23830789645308e-10
( O 0 2.486404693247124e-10
odds O 0 1.4046045215820868e-08
ratio O 0 5.633322142095665e-10
, O 0 8.345586721691944e-11
0 O 0 1.3224780992526775e-10
. O 0 7.921054437365349e-12
5 O 0 4.994282071235645e-11
; O 0 3.771720782919097e-12
95 O 0 6.195531865316184e-10
percent O 0 1.5199029534951336e-10
confidence O 0 1.8450880823195348e-09
interval O 0 3.1377269671395425e-09
, O 0 1.2908059343619271e-10
0 O 0 7.131880502830867e-11
. O 0 3.2686321097680215e-12
3 O 0 3.957567260015615e-11
to O 0 3.4361437306618114e-12
0 O 0 4.18733381302161e-11
. O 0 3.4735456698464784e-12
9 O 0 5.218016574382034e-10
) O 0 4.233451263158106e-12
and O 0 1.510042958730029e-11
for O 0 1.8916822969172742e-11
carriers O 0 1.9728219058379182e-10
of O 0 5.309186423829715e-09
the O 0 5.288477211706777e-09
BRCA2 O 0 2.290966421014673e-07
mutation O 0 1.8658692368944685e-09
( O 0 4.883656812282311e-10
odds O 0 1.4228539235716653e-08
ratio O 0 1.5016720089633395e-09
, O 0 1.0161339825121019e-10
0 O 0 1.3150401600992012e-10
. O 0 7.009439036143039e-12
4 O 0 9.459422134483475e-11
; O 0 5.507913569680056e-12
95 O 0 4.1219846980133923e-10
percent O 0 1.3704699874939053e-10
confidence O 0 2.2879951266929766e-09
interval O 0 4.195340075341392e-09
, O 0 1.737824190106707e-10
0 O 0 1.7691682840936807e-10
. O 0 8.235226736652557e-12
2 O 0 8.763900022357163e-11
to O 0 1.9058900291302194e-11
1 O 0 6.043315292636464e-10
. O 0 2.7113590886362893e-11
1 O 0 1.847384134556762e-09
) O 0 1.9519177940630072e-10
. O 0 1.538632554698438e-09

CONCLUSIONS O 0 7.191189069999382e-05
Oral O 0 0.03412485495209694
- O 0 2.8223253139003646e-06
contraceptive O 0 3.7888972315158753e-07
use O 0 3.342227605784842e-09
may O 0 5.24943200019834e-10
reduce O 0 1.4012829785414738e-09
the O 0 1.331860066677848e-09
risk O 0 3.192731767853729e-08
of O 0 0.04331270232796669
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.72977598911217e-09
women O 0 1.0118707954864803e-11
with O 0 8.815078007817778e-12
pathogenic O 0 1.6884502684888503e-08
mutations O 0 1.0479502821070241e-09
in O 0 1.0622219770439756e-09
the O 0 1.8166325332913402e-08
BRCA1 O 0 1.740440325193049e-06
or O 0 7.1838371695776e-07
BRCA2 O 0 0.0001722777815302834
gene O 0 1.183502081403276e-05

A O 0 1.3844619388692081e-05
Japanese O 0 1.3443518582789693e-05
family O 0 8.066967893682886e-08
with O 0 7.831295789628712e-08
adrenoleukodystrophy B-Disease 1 1.0
with O 0 5.3614130024470796e-08
a O 0 1.710788843922728e-08
codon O 0 5.190209435568249e-07
291 O 0 1.6729133278658992e-07
deletion O 0 2.3639730173385942e-08
: O 0 6.978855826567099e-10
a O 0 8.938922935186611e-10
clinical O 0 1.3648858612214099e-06
, O 0 1.4207434118063134e-09
biochemical O 0 3.68294095096644e-05
, O 0 1.8119193256893595e-08
pathological O 0 0.2371561974287033
, O 0 9.021364100192386e-09
and O 0 2.773491480922985e-08
genetic O 0 7.729796607236494e-07
report O 0 6.89596504344081e-08
. O 0 1.1563115265289525e-07

We O 0 9.962344904579368e-08
report O 0 4.669584718897113e-09
a O 0 1.9206787271741632e-09
Japanese O 0 7.919347666529575e-08
family O 0 4.071788684001376e-09
with O 0 3.999331354975766e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.002200673334300518
ALD B-Disease 1 1.0
) O 0 8.124111161578185e-09
with O 0 4.1455358590347657e-10
a O 0 6.147787279253691e-10
three O 0 7.534552426413654e-10
base O 0 3.1318151627601765e-08
pair O 0 9.295583680568598e-08
deletion O 0 8.052641220501755e-08
( O 0 7.225734233173853e-09
delGAG O 0 1.075837280950509e-05
291 O 0 1.3232040885213792e-07
) O 0 3.521546665385955e-10
in O 0 1.481521239021788e-09
the O 0 1.011155035257616e-07
ALD B-Disease 1 1.0
gene O 0 5.962992872809991e-06
. O 0 1.1748545603040839e-07

A O 0 2.1037501483078813e-06
variety O 0 6.33433643315584e-08
of O 0 3.739801002211607e-08
phenotypes O 0 5.8297910499049976e-08
were O 0 2.332823934025896e-09
observed O 0 1.9904435877293736e-09
within O 0 1.054068388128826e-09
this O 0 8.532161782648373e-11
family O 0 2.1569579455871235e-09
. O 0 1.4275839177457783e-08

While O 0 4.866826088800735e-07
the O 0 6.567010757407843e-08
proband O 0 8.073617937043309e-05
( O 0 9.846745641084453e-09
patient O 0 1.8737398477242095e-07
1 O 0 6.373030458917128e-08
) O 0 3.548049909429807e-10
was O 0 7.86209319869613e-09
classified O 0 7.186343520260152e-09
as O 0 2.8890259629044124e-10
having O 0 1.759916379295845e-10
a O 0 1.4000960113502714e-10
rare O 0 1.3133137910514847e-09
intermediate O 0 2.7173014061077083e-08
type O 0 1.4119508229271105e-08
of O 0 2.1941299621630606e-07
adult O 0 1.7848364564088115e-07
cerebral O 0 2.2673859803035157e-06
and O 0 5.285716753178349e-08
cerebello O 1 0.9999905824661255
- O 1 0.9940766096115112
brain O 0 0.019507499411702156
stem O 0 1.8697676296142163e-08
forms O 0 1.2121433634604273e-08
, O 0 8.004137352912721e-10
his O 0 2.6269109554277748e-08
younger O 0 5.7859679714056256e-08
brother O 0 2.2667959456157405e-06
( O 0 6.232204974310207e-09
patient O 0 2.1953775330985081e-07
2 O 0 2.1787708703868702e-07
) O 0 8.719137634116692e-10
and O 0 6.475365132985189e-09
nephew O 0 0.00012181943020550534
( O 0 1.5292417998580277e-08
patient O 0 1.101982093132392e-06
3 O 0 2.787982396057487e-07
) O 0 5.474957154305571e-10
had O 0 1.7181687184120165e-09
a O 0 5.395728663870614e-08
childhood O 1 0.9999946355819702
ALD B-Disease 1 1.0
type O 1 0.5264602899551392
. O 0 1.6691632254151045e-06

Another O 0 3.2826071674207924e-06
nephew O 0 0.0001407531090080738
( O 0 3.246172397552982e-08
patient O 0 3.420816767629731e-07
4 O 0 1.4488948352209263e-07
) O 0 1.5443209211429831e-10
of O 0 2.393577602788355e-08
patient O 0 1.7668239138401987e-07
1 O 0 9.890965912973115e-08
was O 0 2.899440154635613e-08
classified O 0 6.165333577001775e-09
as O 0 1.637474461579913e-10
having O 0 2.2754428896654133e-10
an O 0 3.8598339802131676e-11
adolescent O 0 2.509912917503243e-07
form O 0 1.6966597016221385e-08
. O 0 2.067994664400885e-08

The O 0 4.042316845698224e-07
tau O 0 2.0302103109770542e-07
level O 0 1.4580358254079329e-08
in O 0 2.2803915700198019e-10
the O 0 4.725878577360731e-10
cerebrospinal O 0 7.170162774627897e-08
fluid O 0 4.8507704519806794e-08
( O 0 2.0154597990540424e-08
CSF O 1 1.0
) O 0 4.2385801535260725e-09
in O 0 4.365535044570379e-09
patient O 0 5.999014263124991e-08
1 O 0 2.423400324857994e-08
was O 0 7.125170675692516e-09
as O 0 1.1683255751737676e-10
high O 0 9.073929163605499e-09
as O 0 4.3492823925683766e-11
that O 0 1.8604896269425186e-12
of O 0 5.909382427837784e-10
patients O 0 1.1014897882688501e-09
with O 0 2.3448830432926115e-08
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999969005584717
( O 0 2.6925102147856705e-09
AD B-Disease 0 5.630509349430213e-06
) O 0 3.4947100768789596e-09
. O 0 1.2184669273551663e-08

His O 0 2.65674516413128e-05
brain O 0 1.3589627997134812e-05
magnetic O 0 3.3392777822882636e-06
resonance O 0 5.979274533274292e-07
image O 0 5.607545290331473e-07
( O 0 4.021266875042784e-09
MRI O 1 0.9999369382858276
) O 0 4.494560279511006e-09
showed O 0 3.204641174647804e-08
abnormalities B-Disease 0 3.781608393182978e-05
in I-Disease 0 2.9982687443919076e-09
the I-Disease 0 1.2056503351232095e-08
bilateral I-Disease 0 3.899022885889281e-06
cerebellar I-Disease 1 0.9999983310699463
hemispheres I-Disease 0 3.0449626137851737e-05
and O 0 2.096959633490769e-06
brain O 1 0.9996966123580933
stem O 0 4.2425864421602455e-07
, O 0 7.960107573090625e-10
but O 0 2.4311233581819636e-11
not O 0 8.841936731396327e-12
in O 0 2.6575286415919663e-10
the O 0 6.989929968170827e-09
cerebral O 0 1.9540693756425753e-05
white O 0 7.90841614417559e-09
matter O 0 1.125393445100542e-09
, O 0 4.929256655628045e-11
where O 0 9.516862298220019e-11
marked O 0 2.8994592837783273e-10
reductions O 0 1.0472873235300995e-08
of O 0 1.9791857042150696e-08
the O 0 8.134501072731837e-09
cerebral O 0 1.5397980632769759e-06
blood O 0 2.0309650849981153e-08
flow O 0 4.743056614131547e-09
and O 0 2.5377777657098477e-09
oxygen O 0 3.31816885079661e-08
metabolism O 0 2.863929466911941e-07
were O 0 4.1993271082674255e-09
clearly O 0 1.0279319617723104e-09
demonstrated O 0 2.342846749936456e-10
by O 0 1.9249825691791678e-11
positron O 0 7.986238337309715e-09
emission O 0 5.059313679112165e-08
tomography O 0 5.812592007714557e-07
( O 0 3.233948575598333e-08
PET O 0 0.0007510479190386832
) O 0 1.433603369349612e-08
. O 0 3.7496075577792e-08

In O 0 4.685096826051449e-07
patients O 0 1.2024809592503516e-08
2 O 0 2.5934408398597952e-08
and O 0 3.01732083762829e-09
3 O 0 1.571373076103555e-08
, O 0 1.2560845419340438e-10
the O 0 1.9665254147316347e-10
autopsy O 0 1.9931842132336897e-07
findings O 0 4.372276318775903e-09
showed O 0 7.938596446877e-09
massive O 0 1.936543412739411e-06
demyelination B-Disease 1 1.0
of I-Disease 0 0.057258520275354385
the I-Disease 0 2.3267266442417167e-05
cerebral I-Disease 0 0.4032708406448364
white I-Disease 0 1.1635570729140454e-07
matter I-Disease 0 3.1300995129157627e-09
with O 0 1.593428028412447e-10
sparing O 0 1.1020703460928871e-08
of O 0 9.940686851450664e-08
the O 0 7.79543967155405e-08
U O 1 0.9663407802581787
- O 0 4.788971637026407e-05
fibers O 0 5.377323759603314e-05
, O 0 4.392353591953224e-09
compatible O 0 6.887473347205741e-08
with O 0 1.6100412669750597e-10
the O 0 4.910276074632236e-10
findings O 0 3.0406088757928273e-09
of O 0 2.526088564991369e-07
childhood O 1 0.9999963045120239
ALD B-Disease 1 1.0
. O 0 1.786850816642982e-06

Oleic O 0 0.0016004263889044523
and O 0 3.7584902656817576e-06
erucic O 0 0.0005550743080675602
acids O 0 7.27094516150828e-07
( O 0 2.7068832508803098e-08
Lorenzos O 0 4.2765328544192016e-05
Oil O 0 9.98170719412883e-08
) O 0 7.71577038372051e-11
were O 0 8.716090349469852e-11
administered O 0 6.06072192432805e-10
to O 0 7.669070239968434e-11
patients O 0 2.1309290443305429e-10
1 O 0 2.2642265840033815e-09
and O 0 6.236220984057184e-10
4 O 0 1.2828500928208086e-08
, O 0 3.4728785819337915e-11
but O 0 2.438166855911472e-12
sufficient O 0 1.2535905646871015e-10
effectiveness O 0 5.00223773514108e-09
was O 0 3.6685909865497024e-09
not O 0 2.7124760770824707e-11
obtained O 0 3.737766540723442e-09
. O 0 5.541695102806443e-09

The O 0 2.2585348347092804e-07
findings O 0 2.1895351309808575e-08
in O 0 6.780984107557231e-10
this O 0 1.4303727473297112e-11
family O 0 2.9071552457016203e-11
suggest O 0 5.096089175649077e-11
that O 0 6.829548645365113e-12
delGAG291 O 0 2.1560870422376865e-08
is O 0 4.6371576717385565e-11
part O 0 3.396742886963011e-10
of O 0 2.018120781599464e-09
the O 0 1.2626427681183827e-09
cause O 0 1.2112790770402171e-08
of O 0 3.41636990697225e-07
Japanese O 1 0.9874300360679626
ALD B-Disease 1 1.0
with O 0 1.797414306281553e-08
phenotypic O 0 3.566376562957885e-07
variations O 0 6.352926789077173e-07
. O 0 8.731594647315433e-08

Moreover O 0 1.4246986665966688e-06
, O 0 5.918748158251219e-09
although O 0 2.9074725960143155e-10
the O 0 1.7555948361724916e-10
scale O 0 8.612992097312144e-09
of O 0 2.8973601295945173e-09
the O 0 4.041487144945677e-10
study O 0 3.0082114577112407e-10
is O 0 6.254535517974391e-12
limited O 0 5.96864571655864e-11
, O 0 3.5441320017648437e-11
there O 0 2.6238173092552053e-11
is O 0 9.660311613146622e-12
a O 0 3.4568920642685796e-11
possibility O 0 9.92001480959459e-10
that O 0 2.8554331121810606e-10
PET O 0 0.23234550654888153
can O 0 1.2322461939717755e-09
detect O 0 1.7016560605043196e-06
an O 0 1.5880554649072565e-09
insidious B-Disease 0 9.26409938983852e-06
lesion I-Disease 0 3.5424254747340456e-05
which O 0 9.108292453596789e-10
is O 0 1.321688730682169e-10
undetectable O 0 2.5913346135553184e-08
by O 0 3.530038414356618e-11
computed O 0 1.3951649835419744e-09
tomogram O 0 4.843374199481332e-07
( O 0 8.250374827767359e-10
CT O 0 0.06523831933736801
) O 0 1.942680738498126e-10
or O 0 1.9810646179063696e-10
MRI O 0 4.83974909002427e-05
analysis O 0 6.439360711318898e-10
, O 0 3.651553712180622e-11
and O 0 2.486450975669463e-11
that O 0 1.759615782075119e-12
the O 0 9.13902009624934e-11
higher O 0 6.275609476524835e-10
level O 0 1.0583371956585097e-09
of O 0 1.3447403190980367e-09
tau O 0 1.9115931060298408e-09
reflects O 0 9.860586652754577e-11
the O 0 3.3705326724087215e-11
process O 0 5.6005686199789295e-11
of O 0 5.070178499266831e-09
neuronal B-Disease 0 3.865899998345412e-06
degeneration I-Disease 1 0.9999958276748657
in O 0 2.4890607619454386e-06
ALD B-Disease 1 1.0
. O 0 1.219406044583593e-06

Lorenzos O 0 0.0023894747719168663
Oil O 0 7.808704367562314e-07
should O 0 1.697659124388906e-09
be O 0 7.162866827448156e-11
given O 0 3.9790403610906466e-11
in O 0 9.450981663938762e-11
the O 0 1.51089640798574e-10
early O 0 4.045484391923537e-09
stage O 0 4.1525986205215304e-08
. O 0 3.405098147890584e-10
. O 0 3.9527812134565465e-09

Nonsense O 0 3.4643995604710653e-05
mutation O 0 1.835236851377431e-08
in O 0 8.068365531244126e-09
exon O 0 8.864040523803851e-08
4 O 0 3.862233199924958e-08
of O 0 1.4271511084018584e-08
human O 0 1.5488230697968675e-09
complement O 0 1.383411643018917e-07
C9 O 1 0.9999994039535522
gene O 0 2.4891592786957517e-08
is O 0 1.0710672626590423e-10
the O 0 3.583497110160039e-10
major O 0 9.529060207569273e-09
cause O 0 1.48119987386508e-08
of O 0 4.392925632146216e-07
Japanese O 0 0.0004878132021985948
complement B-Disease 0 0.2816469371318817
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9999988079071045
. O 0 1.3252641792860231e-06

Deficiency B-Disease 1 0.9999608993530273
of I-Disease 0 0.001586184953339398
the I-Disease 0 5.736886123486329e-06
ninth I-Disease 0 0.04349295422434807
component I-Disease 0 6.253211495277355e-07
of I-Disease 0 2.94126095923275e-07
human I-Disease 0 6.110917549762007e-09
complement I-Disease 0 5.9019093612278084e-08
( O 0 6.082288450670603e-09
C9 O 1 1.0
) O 0 7.147626379655492e-10
is O 0 1.0327910401897178e-11
the O 0 1.9651932858799626e-11
most O 0 4.1500667485872e-11
common O 0 2.0556580437869343e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1115998788113757e-08
Japan O 0 1.2292254041312844e-06
but O 0 1.258453757868594e-10
is O 0 2.5675038484163082e-11
rare O 0 4.955116317262309e-10
in O 0 9.663745498267318e-11
other O 0 1.4517073654296553e-10
countries O 0 2.3240913360478288e-10
. O 0 1.1753606976583342e-08

We O 0 2.8221261771932404e-08
studied O 0 4.7163382532744436e-08
the O 0 5.175928574630007e-10
molecular O 0 4.440722900511673e-09
basis O 0 1.2327397991285238e-09
of O 0 3.7471735936378536e-07
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9675630331039429
in O 0 2.6443144562904308e-08
four O 0 1.557016737763206e-08
Japanese O 0 8.619087748229504e-05
C9 B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
deficient I-Disease 1 0.9703091382980347
patients O 0 8.113167382362008e-08
who O 0 2.495452067208248e-09
had O 0 4.396396136030489e-08
suffered O 1 0.9999945163726807
from O 1 0.9996339082717896
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.401658889539249e-07

Direct O 0 2.912726593251591e-08
sequencing O 0 8.104181858925585e-08
of O 0 2.1941008299108944e-07
amplified O 0 2.8083052256988594e-06
C9 O 0 0.003017007140442729
cDNA O 0 3.685319995838654e-07
and O 0 5.963178839607508e-09
DNA O 0 3.53335877889549e-07
revealed O 0 1.884435896215564e-08
a O 0 1.0023442076345646e-09
nonsense O 0 3.6563612582085625e-08
substitution O 0 1.788406933656006e-08
( O 0 2.3761681511302868e-09
CGA O 0 7.649111466889735e-06
- O 0 3.143761375667964e-07
- O 0 1.1398901733628009e-07
> O 0 1.7513757555320808e-08
TGA O 0 4.1997296307272336e-07
) O 0 4.4545461069800396e-11
at O 0 9.940166467714562e-10
codon O 0 3.3033586976927154e-09
95 O 0 1.931788951026192e-09
in O 0 2.893879025300805e-10
exon O 0 1.3753052030551771e-08
4 O 0 9.614831597559714e-09
in O 0 7.180954164631714e-10
the O 0 2.2465120874670674e-09
four O 0 9.302213221928923e-09
C9 B-Disease 1 1.0
- I-Disease 0 0.00047323317267000675
deficient I-Disease 0 6.855741958133876e-06
individuals O 0 1.1975183067391981e-09
. O 0 4.119080898590255e-08

An O 0 3.0834605979634944e-08
allele O 0 1.1039995584383178e-08
- O 0 1.6872911956511416e-08
specific O 0 4.708657352914258e-10
polymerase O 0 3.208592147529998e-08
chain O 0 4.142393805750544e-08
reaction O 0 9.94039406343461e-10
system O 0 5.613139730797911e-09
designed O 0 2.4546570998040806e-08
to O 0 3.8493594423094635e-10
detect O 0 4.4211859062670555e-08
exclusively O 0 8.942060425454201e-10
only O 0 7.86596655866223e-12
one O 0 8.832295138316848e-12
of O 0 8.308390087030659e-11
the O 0 9.037199460992795e-11
normal O 0 8.005542340150384e-10
and O 0 9.608477902212087e-11
mutant O 0 8.038039678304187e-10
alleles O 0 1.1199918596715985e-11
indicated O 0 8.662690009764162e-11
that O 0 6.163842439926848e-12
all O 0 7.265556212221469e-11
the O 0 2.33688401962695e-10
four O 0 1.8810944468761193e-10
patients O 0 3.831133674192522e-11
were O 0 8.317729144335928e-11
homozygous O 0 2.475832872050887e-10
for O 0 2.70351987324835e-11
the O 0 5.66440616633912e-10
mutation O 0 8.379433258376423e-11
in O 0 2.759005524044511e-10
exon O 0 1.3626363148944165e-08
4 O 0 5.115473822314698e-09
and O 0 9.303605802424286e-11
that O 0 2.896703493390773e-12
the O 0 1.903591173579855e-10
parents O 0 3.539875337299492e-11
of O 0 2.5063087161214526e-09
patient O 0 1.3831974676747905e-08
2 O 0 2.3497408463413194e-08
were O 0 1.0264590954989217e-08
heterozygous O 0 1.3550269351014776e-08
. O 0 1.3427393419362943e-08

The O 0 4.868409178016009e-07
common O 0 1.3941788168381208e-08
mutation O 0 2.318663927525222e-09
at O 0 1.4149757809889252e-08
codon O 0 1.658358961265094e-08
95 O 0 7.884979780214962e-09
in O 0 5.595040541983565e-10
exon O 0 3.13764481063572e-08
4 O 0 1.0497752001015215e-08
might O 0 1.394916959718273e-10
be O 0 3.608082929651424e-11
responsible O 0 1.643595815004062e-09
for O 0 2.7935784241428507e-10
most O 0 3.0157385477735943e-09
Japanese O 0 0.0135381780564785
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.999921441078186
. O 0 7.345941099856645e-08
. O 0 1.1095350771483936e-07

BRCA1 O 0 2.9109494334988995e-06
required O 0 2.976776691809846e-08
for O 0 2.8692361819793177e-09
transcription O 0 6.334674367280968e-07
- O 0 1.0318611884940765e-06
coupled O 0 3.302724564946402e-07
repair O 0 4.935171455144882e-05
of O 0 3.0735378686586046e-07
oxidative O 0 1.3479617336997762e-05
DNA O 0 0.004531098064035177
damage O 0 0.0020427999552339315
. O 0 2.0303032499668916e-07

The O 0 3.1522769859293476e-05
breast B-Disease 1 0.9999961853027344
and I-Disease 1 0.9945886135101318
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 8.55276175570907e-06
gene O 0 3.92232877288734e-08
BRCA1 O 0 7.75207027459146e-08
encodes O 0 7.2054762156881225e-09
a O 0 1.3598996595476365e-08
zinc O 0 1.0415071301395074e-05
finger O 0 5.337106813385617e-06
protein O 0 7.485538411344805e-09
of O 0 6.919206185784788e-08
unknown O 0 2.1676202166531766e-08
function O 0 2.1574764197396235e-09
. O 0 1.134186078388666e-08

Association O 0 1.1444292795204092e-05
of O 0 8.387661978304095e-07
the O 0 6.020414389240614e-08
BRCA1 O 0 2.8816653951935223e-08
protein O 0 6.683983366784219e-10
with O 0 1.921997005993603e-10
the O 0 4.5960586447790774e-09
DNA O 0 9.959188673747121e-07
repair O 0 9.96050857793307e-06
protein O 0 2.4598174164225384e-08
Rad51 O 0 2.6951581730827456e-06
and O 0 1.822921147365264e-09
changes O 0 2.071727511765431e-10
in O 0 1.7595974677320214e-10
the O 0 4.2205055422739335e-11
phosphorylation O 0 1.0766718627763794e-09
and O 0 9.317071558712087e-10
cellular O 0 2.374239471691908e-08
localization O 0 1.3724940117754159e-07
of O 0 5.7392304242398495e-09
the O 0 8.641538040699004e-10
protein O 0 4.118322627366666e-10
after O 0 1.5796692842684479e-09
exposure O 0 6.836713861702037e-09
to O 0 1.0519528997887662e-10
DNA O 0 1.0616026884235907e-06
- O 0 2.3687442762820865e-07
damaging O 0 5.431034537650703e-07
agents O 0 1.8550426750252313e-09
are O 0 6.050278333891157e-11
consistent O 0 3.0372993009564198e-09
with O 0 6.360356685775059e-11
a O 0 2.4817048416281295e-10
role O 0 5.457452267876306e-10
for O 0 4.608644299519682e-10
BRCA1 O 0 4.688963528565182e-08
in O 0 8.514483340604784e-09
DNA O 0 3.463355824351311e-05
repair O 0 0.3019265830516815
. O 0 6.775475185349933e-07

Here O 0 5.81949223033007e-07
, O 0 2.420950551140777e-09
it O 0 9.421034091738889e-11
is O 0 1.879171297736182e-11
shown O 0 3.521887295687698e-11
that O 0 8.038921091302331e-12
mouse O 0 1.0536045813580586e-08
embryonic O 0 2.3113441827149472e-08
stem O 0 1.3427853495784348e-08
cells O 0 5.392238211499034e-09
deficient B-Disease 0 2.0267515310479212e-07
in I-Disease 0 7.518793587735217e-09
BRCA1 I-Disease 0 2.751168004522242e-08
are O 0 2.0015515633797776e-10
defective O 0 4.116348293337069e-07
in O 0 2.0877222173254495e-09
the O 0 1.237647206941972e-09
ability O 0 1.597999510494219e-10
to O 0 3.2258917759264705e-11
carry O 0 4.95260332744607e-10
out O 0 5.394941160474787e-10
transcription O 0 4.043966583822112e-08
- O 0 1.1069541727692922e-07
coupled O 0 9.131940714723896e-08
repair O 0 2.2665888536721468e-05
of O 0 1.8329758688651054e-07
oxidative O 0 1.7288046194607887e-07
DNA O 0 3.949498204747215e-05
damage O 0 4.048485425300896e-05
, O 0 2.0515129595111148e-09
and O 0 8.474719259687902e-10
are O 0 6.715249190047956e-11
hypersensitive O 0 2.7278699121779937e-07
to O 0 4.196076375251323e-09
ionizing O 0 0.00010387758811702952
radiation O 0 0.00019950300338678062
and O 0 1.7715743538815332e-08
hydrogen O 0 1.2144857919338392e-07
peroxide O 0 2.9532532153098145e-06
. O 0 7.92654120118641e-08

These O 0 2.3476083299556194e-08
results O 0 2.5262755443122842e-08
suggest O 0 2.0574222325819846e-09
that O 0 1.3513243302121225e-10
BRCA1 O 0 3.2503979952025475e-08
participates O 0 8.683608498927242e-09
, O 0 2.8267346796617687e-10
directly O 0 1.3391879272184326e-10
or O 0 9.292770719593335e-11
indirectly O 0 4.828832333991784e-10
, O 0 7.249747330240197e-11
in O 0 9.777396947630024e-11
transcription O 0 2.6800405450444487e-08
- O 0 1.373258697867641e-07
coupled O 0 9.119304422711139e-08
repair O 0 1.4756421478523407e-05
of O 0 2.0102983455672074e-07
oxidative O 0 3.75001945940312e-06
DNA O 0 0.000864463159814477
damage O 0 0.0005025182035751641
. O 0 1.6210343289913e-08
. O 0 2.6804649166933814e-08

Truncation O 0 2.563083944551181e-05
mutations O 0 6.605324642805499e-08
in O 0 1.4102309542352032e-08
the O 0 9.878989182254827e-09
transactivation O 0 2.2917015485290904e-06
region O 0 4.4752127337233105e-08
of O 0 2.1694654606108088e-07
PAX6 O 1 0.999265730381012
result O 0 1.1664229582208918e-08
in O 0 2.9703604020880903e-09
dominant O 0 5.449573237115146e-08
- O 0 1.334414037046372e-07
negative O 0 9.322284277857307e-09
mutants O 0 2.2614833028455905e-07
. O 0 2.2058662452195676e-08

PAX6 O 1 0.9929439425468445
is O 0 5.7962402877365093e-08
a O 0 2.6012916265472086e-09
transcription O 0 1.8161163239938105e-08
factor O 0 9.008979673374995e-10
with O 0 4.9703061111294744e-11
two O 0 4.952109208811173e-11
DNA O 0 1.852882824948665e-08
- O 0 7.047682881733408e-09
binding O 0 2.0942829692671694e-09
domains O 0 6.889651515962214e-09
( O 0 1.3356581396450906e-09
paired O 0 6.50608242835915e-08
box O 0 8.780809821473667e-07
and O 0 1.0477868350733388e-08
homeobox O 0 2.962549103813217e-07
) O 0 4.714768575553308e-10
and O 0 9.55061696394921e-10
a O 0 2.729496406672638e-09
proline O 0 1.7215094203493209e-06
- O 0 8.854845532368927e-07
serine O 0 1.0783884363263496e-06
- O 0 1.5455268567166058e-06
threonine O 0 3.694018460009829e-06
( O 0 3.531835091052926e-08
PST O 1 0.9998929500579834
) O 0 3.1956869150917555e-08
- O 0 2.807721841691091e-07
rich O 0 1.847444863756209e-08
transactivation O 0 4.7460362111451104e-06
domain O 0 1.451510200922712e-07
. O 0 4.831213828992986e-08

PAX6 O 1 0.9999967813491821
regulates O 0 9.592679998604581e-05
eye O 0 0.07539373636245728
development O 0 3.694151828881331e-08
in O 0 1.7758904347076054e-09
animals O 0 1.2101790680674185e-09
ranging O 0 3.616287003183061e-08
from O 0 1.95701477245791e-09
jellyfish O 0 1.1329940319271259e-09
to O 0 1.05136122030558e-10
Drosophila O 0 1.7116636996661327e-08
to O 0 6.086880999234268e-10
humans O 0 1.4106102952382571e-08
. O 0 8.5237941149785e-09

Heterozygous O 0 9.55099608290766e-07
mutations O 0 1.8201529172756636e-08
in O 0 2.2236110730489145e-09
the O 0 3.944812476674997e-09
human O 0 1.1042543768269297e-08
PAX6 O 1 0.9979761242866516
gene O 0 2.446718827542327e-09
result O 0 1.9654716743033873e-10
in O 0 5.0599812534413147e-11
various O 0 2.450201430637122e-10
phenotypes O 0 2.4374601892418468e-08
, O 0 6.63678945134194e-10
including O 0 3.2342139633101397e-08
aniridia B-Disease 1 1.0
, O 0 5.578592663368909e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.8126250722616533e-07
autosomal B-Disease 0 0.04161006584763527
dominant I-Disease 0 0.004463427700102329
keratitis I-Disease 1 0.9999614953994751
, O 0 8.237112325559792e-08
and O 0 9.380037795381213e-07
familial B-Disease 1 0.9999998807907104
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.0002072805946227163

It O 0 5.326350560608262e-08
is O 0 8.244743776586461e-10
believed O 0 6.933678631249052e-10
that O 0 4.539283879334555e-12
the O 0 8.535189915948038e-11
mutated O 0 2.4081061589242836e-09
allele O 0 1.0854930287962361e-09
of O 0 2.523684550226335e-08
PAX6 O 0 0.05010920390486717
produces O 0 1.898317592008425e-08
an O 0 2.682415956023476e-10
inactive O 0 1.5877783710038784e-07
protein O 0 1.24467405271389e-08
and O 0 6.529865004267776e-08
aniridia B-Disease 1 1.0
is O 0 4.410242837593614e-09
caused O 0 4.0354521502194984e-08
due O 0 3.276459636936124e-08
to O 0 4.4747330285588305e-09
genetic O 0 5.499815074472281e-07
haploinsufficiency O 0 9.678479545982555e-05
. O 0 1.4258564817737351e-07

However O 0 9.22929856983501e-08
, O 0 5.485472631683308e-10
several O 0 3.091949751787837e-10
truncation O 0 6.899333016008313e-08
mutations O 0 1.1332296212529513e-09
have O 0 3.6587417123756794e-11
been O 0 9.764220681995894e-11
found O 0 6.307803585015037e-11
to O 0 7.923487387040407e-12
occur O 0 5.4294579249214436e-11
in O 0 1.1222291845802701e-10
the O 0 9.90107329457146e-10
C O 0 2.3829286419640994e-06
- O 0 3.892413857897736e-08
terminal O 0 4.5587609243114e-09
half O 0 2.6045271495078737e-10
of O 0 2.330670989536543e-09
PAX6 O 0 0.0034901227336376905
in O 0 3.330582254434944e-09
patients O 0 1.7585785050400204e-09
with O 0 9.32738442038783e-10
Aniridia B-Disease 1 1.0
resulting O 0 5.980334805144594e-08
in O 0 2.8160271892119226e-09
mutant O 0 2.5379716106499473e-09
proteins O 0 6.088352738631286e-11
that O 0 1.0270725242511602e-11
retain O 0 2.820036870687659e-09
the O 0 3.4743397048231373e-09
DNA O 0 1.5238644834880688e-07
- O 0 1.1394202026338007e-08
binding O 0 6.912168615258452e-10
domains O 0 3.518008662162231e-10
but O 0 1.3201764334502819e-11
have O 0 1.5144243498133036e-11
lost O 0 1.1072276429047179e-09
most O 0 8.207992618913806e-11
of O 0 3.2405846894789647e-09
the O 0 6.144285080722511e-09
transactivation O 0 1.948141061802744e-06
domain O 0 2.5986846452497048e-08
. O 0 1.257859860714916e-08

It O 0 4.531110064931454e-08
is O 0 5.011460690873548e-10
not O 0 2.0231750302857066e-11
clear O 0 4.252392604708888e-10
whether O 0 5.657891863353193e-11
such O 0 1.2587521025508863e-09
mutants O 0 2.87167466694882e-07
really O 0 9.478178242261492e-09
behave O 0 1.1674173849840486e-09
as O 0 1.7061607682222757e-09
loss O 0 8.793567474185693e-08
- O 0 8.767207049231729e-08
of O 0 8.558024688909427e-08
- O 0 5.4485653322444705e-08
function O 0 5.956798387884987e-10
mutants O 0 1.1963157575678451e-08
as O 0 6.093094917503095e-10
predicted O 0 4.310003021146258e-09
by O 0 2.101276930233098e-09
haploinsufficiency O 0 3.2569063478149474e-05
. O 0 1.026359655043052e-07

Contrary O 0 6.557459641953756e-07
to O 0 7.818497516076661e-10
this O 0 4.0148710744869476e-11
theory O 0 2.645755836638841e-09
, O 0 1.463456161809873e-10
our O 0 4.2150372081550813e-10
data O 0 4.2064435268329703e-10
showed O 0 1.8933041245894344e-10
that O 0 1.0142275474328555e-12
these O 0 7.500820277395182e-12
mutants O 0 2.0451838000923317e-09
are O 0 1.9748954208087532e-11
dominant O 0 2.9596831652156652e-09
- O 0 2.366416840260399e-09
negative O 0 7.852554023690672e-11
in O 0 5.861938712214965e-11
transient O 0 2.3737400933754316e-09
transfection O 0 5.936750824275805e-08
assays O 0 7.850435856937565e-09
when O 0 3.5154062993925095e-10
they O 0 3.020830460775947e-11
are O 0 1.5491052884897272e-11
coexpressed O 0 3.017691199147521e-07
with O 0 1.7480176195405761e-09
wild O 0 3.332336291350657e-06
- O 0 6.43021348878392e-06
type O 0 2.1440837372210808e-05
PAX6 O 1 0.9999974966049194
. O 0 1.0087103419209598e-06

We O 0 2.1797678328994152e-08
found O 0 1.7069777813460973e-09
that O 0 1.582605053951358e-11
the O 0 6.825466303261862e-10
dominant O 0 2.4216769034524077e-08
- O 0 3.094714529083831e-08
negative O 0 1.1343650463402355e-09
effects O 0 1.5258327934475346e-08
result O 0 1.1731980664730912e-10
from O 0 1.700899421308577e-10
the O 0 4.2095799068775364e-11
enhanced O 0 1.5056441649008434e-09
DNA O 0 1.0571171493722886e-08
binding O 0 2.7283969528113516e-10
ability O 0 1.5141968234821945e-10
of O 0 2.7069901875620417e-09
these O 0 8.928239259020643e-10
mutants O 0 4.776094328917679e-07
. O 0 3.807624082696748e-08

Kinetic O 0 3.1422973734152038e-06
studies O 0 7.002102364594975e-08
of O 0 1.6553000747876467e-08
binding O 0 1.108358649304364e-08
and O 0 3.86151688402947e-09
dissociation O 0 6.087351067662894e-08
revealed O 0 1.5820461385374074e-08
that O 0 1.2844174508697126e-11
various O 0 4.3607228938924436e-10
truncation O 0 1.6324500506925688e-07
mutants O 0 2.8994181278108044e-08
have O 0 1.3283406319342106e-10
3 O 0 2.5740278797314886e-09
- O 0 6.315237222054293e-09
5 O 0 2.7565398852402723e-09
- O 0 4.180132240350076e-09
fold O 0 3.622634692224125e-10
higher O 0 1.9155776964652205e-10
affinity O 0 2.2247542350029015e-11
to O 0 1.3197584518287453e-11
various O 0 2.678658128640876e-10
DNA O 0 3.589383723578976e-08
- O 0 2.105168261934409e-09
binding O 0 1.3053068348423125e-10
sites O 0 2.2991450410181358e-10
when O 0 4.14897491363142e-11
compared O 0 1.9012208474222803e-11
with O 0 5.494346731055311e-12
the O 0 5.960708038266205e-10
wild O 0 2.876482199098973e-07
- O 0 5.384562768995238e-07
type O 0 3.889140771207167e-06
PAX6 O 1 0.9999843835830688
. O 0 5.518924126590719e-07

These O 0 2.3815688976469573e-08
results O 0 6.5694760742474045e-09
provide O 0 8.576693244499722e-10
a O 0 6.588961043441088e-10
new O 0 7.325561823812166e-10
insight O 0 2.318159886272042e-09
into O 0 1.7111917438583646e-10
the O 0 1.247734277010082e-10
role O 0 5.973956329619057e-10
of O 0 9.721693672304355e-09
mutant O 0 1.2278857752789918e-07
PAX6 O 1 0.6445227861404419
in O 0 4.509985274125938e-08
causing O 0 6.1944074332132e-06
aniridia B-Disease 1 1.0
. O 0 7.179358618714105e-08
. O 0 4.171237932837357e-08

Reversal O 0 2.594896432128735e-05
of O 0 0.00036374435876496136
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.6376833319664001
excellent O 0 0.011162331327795982
neuropsychologic O 1 0.9400932192802429
outcome O 0 5.171340831111593e-07
in O 0 1.4317674867925234e-07
very B-Disease 0 1.679091710116154e-08
- I-Disease 0 3.964988991356222e-06
long I-Disease 0 2.2949900824187353e-07
- I-Disease 0 1.3228018360678107e-06
chain I-Disease 0 3.4308862950638286e-07
acyl I-Disease 0 3.536355848154926e-07
- I-Disease 0 3.410286581129185e-06
coenzyme I-Disease 0 3.8090553289293894e-07
A I-Disease 0 0.0004955747281201184
dehydrogenase I-Disease 0 0.0965835303068161
deficiency I-Disease 1 0.9994164705276489
. O 0 6.214722247932514e-07

Very B-Disease 0 1.5669428421460907e-06
- I-Disease 0 8.473831258015707e-06
long I-Disease 0 5.9129177998329396e-08
- I-Disease 0 3.221709903300507e-07
chain I-Disease 0 3.403608062058083e-08
acyl I-Disease 0 3.4550250660458914e-08
- I-Disease 0 1.641273001951049e-07
coenzyme I-Disease 0 1.2697799256500275e-08
A I-Disease 0 1.3665592746292532e-07
dehydrogenase I-Disease 0 1.2965101348072494e-07
( I-Disease 0 7.88402161333579e-08
VLCAD I-Disease 1 1.0
) I-Disease 0 1.0120481874764664e-06
deficiency I-Disease 0 0.31079787015914917
is O 0 6.824398823823685e-10
a O 0 5.933736169083659e-09
disorder O 1 0.9953920841217041
of O 1 0.9988447427749634
fatty O 0 0.0002872479090001434
acid O 0 5.998808205731621e-07
beta O 0 4.310506795945912e-08
oxidation O 0 1.0250504445252773e-08
that O 0 1.222294765401699e-10
reportedly O 0 3.6758407429005047e-09
has O 0 3.127393136126422e-11
high O 0 1.7902328508512255e-08
rates O 0 1.4889206534363097e-09
of O 0 1.1100575569855664e-08
morbidity O 0 1.1194808394066058e-05
and O 0 3.439127382875995e-08
mortality O 0 2.533207862143172e-06
. O 0 2.9682155400223564e-08

We O 0 4.336681413974475e-08
describe O 0 1.771527102789605e-08
the O 0 1.324334086838519e-09
outcome O 0 4.3852383946330065e-09
of O 0 1.5546101295171866e-08
a O 0 1.7883514669136957e-09
5 O 0 8.909496251874316e-09
- O 0 2.6663505181545588e-08
year O 0 1.105353919506058e-09
- O 0 8.083047475793137e-08
old O 0 7.469567435691715e-07
girl O 0 2.1215474532709777e-07
with O 0 3.6700978256476446e-08
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.8450121785917872e-07
was O 0 2.3582765606988687e-07
first O 0 1.8042978666699128e-08
seen O 0 4.521274910018747e-09
at O 0 1.4624586874845136e-08
5 O 0 1.265654137050376e-09
months O 0 6.034396593523894e-11
of O 0 7.315592576162544e-10
age O 0 2.16613527115328e-09
with O 0 3.2679885464403924e-09
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999980926513672
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 0 2.829682853189297e-05
and O 0 0.004310650285333395
hypotonia B-Disease 1 1.0
. O 0 3.114988430752419e-05

Biochemical O 0 0.0005843076505698264
studies O 0 7.999724402907304e-06
indicated O 1 0.9174250364303589
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.0005416885833255947
by O 0 4.000267672665814e-09
a O 0 7.466531393163223e-09
stable O 0 4.4045371794254606e-08
yet O 0 6.567872024021426e-09
inactive O 0 5.856923621649912e-07
enzyme O 0 1.0116777815483147e-07
. O 0 6.89405794673803e-08

Molecular O 0 1.610493313819461e-06
genetic O 0 4.3445631092708936e-08
analysis O 0 5.608762787545629e-09
of O 0 5.7909474548978324e-08
her O 0 8.421022101856579e-08
VLCAD O 1 1.0
gene O 0 1.1362185148300341e-07
revealed O 0 6.663686491492626e-08
a O 0 6.295885590645867e-09
T1372C O 0 1.981013610929949e-06
( O 0 1.012629091690087e-08
F458L O 0 1.8952553091367008e-06
) O 0 1.4564174311004763e-09
missense O 0 2.769313596218126e-07
mutation O 0 5.617541543045945e-09
and O 0 8.889704083969718e-09
a O 0 8.204951740253819e-08
1668 O 1 0.9445710778236389
ACAG O 1 0.9999998807907104
1669 O 0 0.0011590641224756837
splice O 0 0.00011684678611345589
site O 0 1.0659508689059294e-06
mutation O 0 1.3545182753205154e-07
. O 0 4.744986270566187e-08

After O 0 1.863747201014121e-07
initial O 0 2.4275498944348328e-08
treatment O 0 8.334208700944146e-08
with O 0 2.129926457428155e-09
intravenous O 0 8.694515827301075e-07
glucose O 0 3.198095873813145e-05
and O 0 1.0231015323824977e-07
carnitine O 0 1.2930535376654007e-05
, O 0 5.570881089766999e-09
the O 0 7.130908752372989e-09
patient O 0 7.624537801120823e-08
has O 0 2.1850438125525784e-10
thrived O 0 1.1337167649116964e-08
on O 0 2.3687198869026815e-09
a O 0 6.060121293671727e-10
low O 0 6.69848816414742e-08
- O 0 1.1455320247932832e-07
fat O 0 9.468171668913783e-08
diet O 0 2.0043042781026088e-08
supplemented O 0 5.609639419645873e-09
with O 0 2.6570420863514244e-10
medium O 0 1.9076190937994397e-07
- O 0 1.586944193832096e-07
chain O 0 3.557078898097643e-08
triglyceride O 0 7.177332861374452e-08
oil O 0 1.599998711299122e-08
and O 0 2.9750779617643275e-09
carnitine O 0 3.9707452970105805e-07
and O 0 1.923285308791378e-09
avoidance O 0 5.519152182387188e-06
of O 0 5.348503009372507e-07
fasting O 0 4.5206692789179215e-07
. O 0 1.0881261225392791e-08

Her O 0 6.6123298893217e-05
ventricular O 1 0.9999992847442627
hypertrophy O 1 0.9998817443847656
resolved O 0 3.7539841741818236e-06
significantly O 0 2.0126631028460906e-08
over O 0 6.215324699354596e-09
1 O 0 2.551445277276798e-09
year O 0 3.049610008964976e-10
, O 0 3.600238857037752e-11
and O 0 2.139199928308244e-10
cognitively O 0 8.148788310791133e-07
, O 0 9.486529339852723e-10
she O 0 6.396086438265058e-11
is O 0 2.951983059037988e-12
in O 0 3.854860528007542e-11
the O 0 2.854480263270176e-10
superior O 0 1.491835632805305e-07
range O 0 1.4446577267790417e-07
for O 0 3.2627196500101263e-09
age O 0 5.118687695926383e-08
. O 0 9.62005852755965e-09

Clinical O 0 4.8088564653880894e-05
recognition O 0 4.866617473453516e-06
of O 1 0.999998927116394
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.372713936438231e-08
important O 0 2.669229282048491e-09
because O 0 1.173428715306457e-10
it O 0 1.2460855264295745e-11
is O 0 5.349134763604768e-12
one O 0 3.665997626994821e-12
of O 0 2.923136732668752e-10
the O 0 3.8045711026057916e-10
few O 0 6.040756228564703e-10
directly O 0 2.8300661369939917e-08
treatable O 1 1.0
causes O 0 1.6203036921069724e-06
of O 1 0.8973795771598816
cardiomyopathy B-Disease 1 1.0
in O 0 3.2014572752814274e-06
children O 0 3.008702265105967e-08
. O 0 4.336348613520613e-09
. O 0 2.8034241594809828e-08

Cloning O 0 3.420481334615033e-06
of O 0 2.7811307745650993e-07
a O 0 4.237747486257604e-09
novel O 0 7.868889539963675e-09
member O 0 2.967019741006993e-09
of O 0 5.04145125646005e-09
the O 0 2.0228454467030588e-09
low O 0 2.3092908918442845e-08
- O 0 9.891338415002338e-09
density O 0 8.411318308532145e-10
lipoprotein O 0 7.65163406413194e-07
receptor O 0 1.3663552955733849e-08
family O 0 1.4289133432043855e-08
. O 0 2.4989969205080342e-08

A O 0 5.6946355471154675e-06
gene O 0 6.0960276826449444e-09
encoding O 0 1.3219920713680722e-09
a O 0 6.409437425247688e-10
novel O 0 1.9309858156901782e-09
transmembrane O 0 4.267800335355787e-09
protein O 0 1.338019250951561e-09
was O 0 5.309925388274905e-09
identified O 0 1.27893001744539e-10
by O 0 1.4585731927807544e-11
DNA O 0 3.282256244574455e-09
sequence O 0 3.594914296800589e-11
analysis O 0 1.2552264783138867e-11
within O 0 6.346093789355578e-11
the O 0 2.507851981636833e-10
insulin B-Disease 0 1.1430300901338342e-06
- I-Disease 0 9.367798338644207e-05
dependent I-Disease 0 0.0006378157995641232
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 4.0993151628754276e-07
IDDM B-Disease 1 1.0
) O 0 5.121917112660412e-09
locus O 0 5.3453923953838967e-08
IDDM4 O 0 0.002261006273329258
on O 0 3.4646672020244296e-07
chromosome O 0 2.5396224145879387e-07
11q13 O 0 1.2089281881344505e-05
. O 0 6.887512427056208e-08

Based O 0 7.393846317427233e-07
on O 0 7.589758865833574e-08
its O 0 4.450678048328882e-09
chromosomal O 0 2.781470698209887e-07
position O 0 2.4837907730557163e-08
, O 0 1.6777967903891522e-10
this O 0 1.251358652115675e-11
gene O 0 9.290608560252878e-11
is O 0 3.2516686825773133e-12
a O 0 2.9954476399307595e-11
candidate O 0 5.174346714986733e-11
for O 0 2.3416046879276564e-10
conferring O 0 5.297152370076219e-07
susceptibility O 0 3.488867878331803e-05
to O 0 3.1324775591201615e-06
diabetes B-Disease 1 0.9999998807907104
. O 0 6.910592560416262e-07

The O 0 8.025361353247717e-07
gene O 0 5.0748059976513105e-08
, O 0 1.825488871176617e-09
termed O 0 1.1832540280920512e-07
low O 0 2.0887395635327266e-07
- O 0 1.080591527369279e-08
density O 0 3.3088873307995925e-10
lipoprotein O 0 5.4674703875434716e-08
receptor O 0 1.1679898159755453e-09
related O 0 1.209069999674739e-08
protein O 0 1.2670261506642078e-09
5 O 0 8.66377281028008e-09
( O 0 7.40891681338951e-10
LRP5 O 0 0.3985542953014374
) O 0 1.944712307855312e-10
, O 0 3.958163657946656e-11
encodes O 0 3.302763271206821e-11
a O 0 4.465085592930684e-11
protein O 0 2.462438863926053e-10
of O 0 7.042509242438655e-09
1615 O 0 7.804140977896168e-07
amino O 0 4.10391232108509e-09
acids O 0 5.516508916336704e-10
that O 0 5.457758810861746e-12
contains O 0 1.8249657340874137e-10
conserved O 0 5.06608699435418e-10
modules O 0 2.4286324062927633e-09
which O 0 3.311815405249163e-11
are O 0 3.7950875081405044e-12
characteristic O 0 6.1684590768607e-10
of O 0 1.6659607027236234e-09
the O 0 6.965491516908173e-10
low O 0 9.883644125352475e-09
- O 0 4.83512918592055e-09
density O 0 1.0355258872607465e-09
lipoprotein O 0 1.481021286053874e-06
( O 0 1.586025177857664e-08
LDL O 0 0.14318731427192688
) O 0 3.6230440869644553e-09
receptor O 0 6.822449716281653e-09
family O 0 4.8442125866188235e-09
. O 0 1.2816027350481818e-08

These O 0 2.939510324040384e-08
modules O 0 3.8823009163024835e-07
include O 0 2.0184835136660695e-08
a O 0 2.516540309471793e-09
putative O 0 3.945348581169128e-08
signal O 0 2.2088341822268376e-08
peptide O 0 3.844181417633763e-09
for O 0 4.0367570397492614e-10
protein O 0 2.469164317453476e-10
export O 0 5.812323067289071e-09
, O 0 1.961992096566334e-10
four O 0 3.9859091027771854e-10
epidermal O 0 7.3664367938874875e-09
growth O 0 4.4004855315193936e-10
factor O 0 9.046723925543176e-10
( O 0 3.303502194018648e-10
EGF O 0 2.602231688797474e-06
) O 0 2.303372076406518e-10
repeats O 0 1.0941798578301132e-09
with O 0 5.256351950921889e-11
associated O 0 2.899875672923713e-09
spacer O 0 8.166232134954043e-08
domains O 0 7.542464430798645e-09
, O 0 8.651069860476923e-10
three O 0 1.8108232691105286e-09
LDL O 0 7.110748993000016e-05
- O 0 1.4294197399067343e-06
receptor O 0 9.054772931449406e-09
( O 0 5.141895353943937e-09
LDLR O 1 0.9999743700027466
) O 0 1.3887798688827502e-09
repeats O 0 8.420360408933902e-09
, O 0 1.384573844465109e-10
a O 0 2.751202043960177e-10
single O 0 3.424202033031065e-09
transmembrane O 0 6.465543833655829e-08
spanning O 0 1.5169683820204227e-07
domain O 0 4.05782607515448e-09
, O 0 5.169042416319769e-10
and O 0 6.225988058439214e-10
a O 0 1.0455782906149125e-09
cytoplasmic O 0 7.325164119720284e-08
domain O 0 5.897081933881054e-08
. O 0 2.710913449277541e-08

The O 0 1.7911058591835172e-07
encoded O 0 6.753416936788881e-09
protein O 0 1.5871378655774038e-09
has O 0 4.3947456784820815e-11
a O 0 4.5130850445662674e-11
unique O 0 1.5758225280215754e-10
organization O 0 1.3610795823737476e-09
of O 0 2.2942279187532222e-08
EGF O 0 5.2389823395060375e-05
and O 0 3.803769388355249e-08
LDLR O 1 0.9999878406524658
repeats O 0 3.6232808753311474e-08
; O 0 1.7349065239979922e-10
therefore O 0 8.625268832496147e-10
, O 0 1.6305689021223202e-09
LRP5 O 1 0.9328176379203796
likely O 0 3.3570948243522025e-09
represents O 0 4.5670964232691347e-10
a O 0 6.024414994643124e-11
new O 0 1.901925422709283e-10
category O 0 2.1303163677544035e-09
of O 0 4.9630828335978094e-09
the O 0 8.997958822476448e-09
LDLR O 1 0.9999984502792358
family O 0 5.779791223403663e-08
. O 0 4.227545247204034e-08

Both O 0 2.394664875282615e-07
human O 0 1.2118178460696072e-07
and O 0 1.2108058911053377e-07
mouse O 0 1.6857149603310972e-05
LRP5 O 1 0.9999996423721313
cDNAs O 0 4.194040593574755e-05
have O 0 4.933012331953535e-10
been O 0 2.831116174828452e-10
isolated O 0 2.455681435975521e-09
and O 0 2.484925598622567e-10
the O 0 6.021224074892473e-10
encoded O 0 2.2849980241268497e-10
mature O 0 3.1250571574936714e-10
proteins O 0 8.745144365607249e-12
are O 0 9.015571275639012e-12
95 O 0 1.0113045956217093e-09
% O 0 4.472046864767432e-12
identical O 0 3.09274023058137e-10
, O 0 5.695050334098006e-11
indicating O 0 6.350274195376926e-10
a O 0 1.6164383720429498e-10
high O 0 3.804616621749801e-09
degree O 0 3.997407738154379e-09
of O 0 6.23367579777323e-10
evolutionary O 0 9.769907105550146e-10
conservation O 0 3.9076462066134354e-09
. O 0 3.256550584751494e-10
. O 0 2.2886106343378287e-09

The O 0 1.9581491415010532e-06
APC B-Disease 0 8.600455657870043e-06
variants O 0 3.17682349759707e-07
I1307K O 0 3.1314650641434127e-06
and O 0 3.89380083731794e-09
E1317Q O 0 2.0507985709627974e-07
are O 0 2.279035016261588e-10
associated O 0 2.0150068280599953e-07
with O 0 0.2036663144826889
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 8.064306911137464e-08
but O 0 2.0504949127531091e-10
not O 0 6.339984093273188e-11
always O 0 2.457718473181103e-10
with O 0 8.895496145244763e-11
a O 0 1.1322272008840173e-09
family O 0 3.0568152453724906e-09
history O 0 3.1890016316538095e-07
. O 0 4.693660926591292e-08

Classical O 1 0.9997420907020569
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.4812536392128095e-05
FAP B-Disease 1 0.9994264841079712
) O 0 1.3625063743916144e-08
is O 0 4.864579850050177e-10
a O 0 3.4133451620732558e-09
high O 1 0.9923545122146606
- O 1 0.9999880790710449
penetrance O 1 0.9999997615814209
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999988079071045
that O 0 8.64777083275925e-10
predisposes O 0 1.1842926994631853e-07
to O 0 8.372630921904545e-10
hundreds O 0 3.4978178131694904e-09
or O 0 7.987361883010635e-10
thousands O 0 4.204808945473815e-09
of O 0 0.27585309743881226
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999898672103882
carcinoma I-Disease 1 1.0
and O 0 2.671834238299198e-07
that O 0 3.127335057584446e-10
results O 0 4.272100895263975e-09
from O 0 4.387547658524227e-09
truncating O 0 2.926376225786953e-07
mutations O 0 2.1395274441005085e-09
in O 0 1.6408518987987009e-09
the O 0 4.489738714141822e-08
APC B-Disease 0 6.89694716129452e-05
gene O 0 1.0901878795266384e-06
. O 0 2.118272277584765e-07

A O 0 9.73034093476599e-06
variant O 0 2.2924402856006054e-06
of O 0 6.235786145225575e-07
FAP B-Disease 0 0.16626080870628357
is O 0 7.740383267673678e-08
attenuated B-Disease 1 0.9103248715400696
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999961853027344
coli I-Disease 1 0.9999313354492188
, O 0 1.7545152886100368e-08
which O 0 4.814549869891493e-10
results O 0 4.192748370712707e-09
from O 0 8.666797057799158e-09
germ O 1 0.9359108209609985
- O 0 3.6031892705068458e-06
line O 0 2.19994660710654e-07
mutations O 0 2.3748303323856135e-10
in O 0 1.8513657273899753e-10
the O 0 1.2251709646804443e-09
5 O 0 3.9664205253586715e-09
and O 0 2.429442202966925e-10
3 O 0 2.5692354910233917e-09
regions O 0 7.126417789216077e-10
of O 0 4.8572208477537515e-09
the O 0 2.604281768014971e-08
APC B-Disease 0 1.695815080893226e-05
gene O 0 2.5147838300654257e-07
. O 0 4.807809617091152e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 6.537007266160799e-06
have O 0 3.583075391944135e-09
" O 0 1.0718555643052241e-07
multiple O 0 0.000249058153713122
" O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 4.36841105511121e-08
typically O 0 1.7141293939815228e-09
fewer O 0 3.1343397322025623e-10
than O 0 4.373990059036714e-11
100 O 0 2.6308808465103084e-09
) O 0 2.6645772394084943e-11
without O 0 6.480263547992138e-11
the O 0 4.2566367097762736e-10
florid O 0 4.591596791669872e-07
phenotype O 0 1.4016819704920636e-08
of O 0 1.577610575509425e-08
classical O 0 2.566029934314429e-06
FAP B-Disease 0 0.00025089908740483224
. O 0 1.8337330232043314e-07

Another O 0 1.179115997729241e-06
group O 0 8.977049503755552e-08
of O 0 1.433731000588523e-07
patients O 0 9.746665696752643e-09
with O 0 2.136298027366479e-09
multiple O 0 2.3762027922202833e-05
adenomas B-Disease 1 0.9998351335525513
has O 0 3.5685820964914683e-09
no O 0 1.0338050415725775e-09
mutations O 0 4.113729634713792e-10
in O 0 4.3913966907283e-10
the O 0 2.2535586730043633e-09
APC B-Disease 0 6.015622489030648e-07
gene O 0 4.216655469235775e-09
, O 0 4.1166184350238666e-10
and O 0 5.22492882293335e-10
their O 0 1.544763650329628e-09
phenotype O 0 3.807157256119353e-09
probably O 0 9.55181933548488e-10
results O 0 8.825736252937588e-10
from O 0 1.403859140047814e-09
variation O 0 1.5404655329120942e-08
at O 0 1.4775373813336046e-08
a O 0 5.164253469303048e-10
locus O 0 2.217757533173881e-09
, O 0 1.6921108958456443e-10
or O 0 2.526032161220826e-10
loci O 0 2.2711210689863037e-09
, O 0 2.2085287765261086e-10
elsewhere O 0 2.1952752948806165e-09
in O 0 6.610700875597786e-10
the O 0 3.763642286713775e-09
genome O 0 9.980503534734453e-09
. O 0 1.3900499418184609e-08

Recently O 0 2.881335831261822e-06
, O 0 4.233756456528681e-09
however O 0 5.343022135839703e-10
, O 0 8.776228355156235e-11
a O 0 1.64468633157e-10
missense O 0 2.8980855049098864e-08
variant O 0 3.267890917868499e-07
of O 0 2.57773945122608e-06
APC B-Disease 0 0.0002736658207140863
( O 0 9.47836298337279e-08
I1307K O 0 2.7173560738447122e-05
) O 0 1.7422457920801548e-09
was O 0 8.529632999909609e-09
described O 0 1.5675376552337639e-09
that O 0 5.194844120842701e-12
confers O 0 2.9912014531952025e-10
an O 0 1.1290581317102699e-11
increased O 0 3.0514776816481515e-10
risk O 0 7.422855929917205e-08
of O 1 0.9983386993408203
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.3160402545508987e-08
including O 0 1.9277409890605668e-08
multiple O 0 8.187355433619814e-07
adenomas B-Disease 0 0.0025292313657701015
, O 0 2.9006736568248925e-08
in O 0 4.0871739770409476e-08
Ashkenazim O 0 0.00026370809064246714
. O 0 1.064957018570567e-06

We O 0 3.577627438744457e-08
have O 0 1.8570595061717654e-10
studied O 0 9.231460929015611e-09
a O 0 9.068314155147306e-11
set O 0 8.362033843134498e-10
of O 0 1.462293286458305e-09
164 O 0 1.7573688282368494e-08
patients O 0 7.028389537033775e-10
with O 0 1.046737585497226e-09
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.0024860177654772997
/ I-Disease 1 0.9990267753601074
or I-Disease 0 0.0012817394454032183
carcinoma I-Disease 1 1.0
and O 0 1.1821418866020394e-07
analyzed O 0 1.5500273775614914e-07
codons O 0 1.5426716970523557e-07
1263 O 0 5.249399691820145e-06
- O 0 2.9564753845079395e-07
1377 O 0 4.456785518414108e-06
( O 0 5.324346741275576e-09
exon O 0 2.6128898866772943e-07
15G O 0 1.482929292251356e-06
) O 0 2.5916926937874507e-10
of O 0 2.8323599021717882e-09
the O 0 3.741704279747182e-09
APC B-Disease 0 8.118366281451017e-07
gene O 0 6.8899934646537986e-09
for O 0 3.771237544469841e-09
germ O 1 0.9740264415740967
- O 0 3.2347190426662564e-05
line O 0 9.78212710833759e-07
variants O 0 3.17975150210259e-07
. O 0 2.873032833861089e-08

Three O 0 5.964950560155557e-07
patients O 0 1.3683322030999534e-08
with O 0 4.907776407492292e-10
the O 0 7.84073872495128e-09
I1307K O 0 8.719875381757447e-07
allele O 0 3.5675934428880396e-10
were O 0 3.770998235896883e-10
detected O 0 4.268158715348136e-09
, O 0 5.465303556939638e-11
each O 0 1.5574449716004857e-11
of O 0 5.650596435202715e-09
Ashkenazi O 0 1.6519619521204731e-06
descent O 0 6.242605081752117e-07
. O 0 1.6611915043540648e-07

Four O 0 2.0514592051767977e-06
patients O 0 1.1416962308885559e-07
had O 0 8.389676509068522e-09
a O 0 1.0233977221218993e-08
germ O 1 0.9975647926330566
- O 0 3.654482861747965e-05
line O 0 1.278317540709395e-06
E1317Q O 0 8.152177315423614e-07
missense O 0 1.2118154302243056e-07
variant O 0 1.16550062045917e-07
of O 0 5.321100502442278e-07
APC O 0 4.7551880015817005e-06
that O 0 2.222555472997101e-09
was O 0 1.3809962062794057e-08
not O 0 1.9404800682965018e-11
present O 0 4.0597799427777304e-11
in O 0 9.827485353275378e-11
controls O 0 1.4583408924906394e-09
; O 0 2.2951392522618796e-11
one O 0 1.3019247138701395e-11
of O 0 1.2996997922343212e-10
these O 0 1.8694117434603363e-11
individuals O 0 3.8975472155255986e-12
had O 0 9.102486819845268e-11
an O 0 1.49321353892784e-11
unusually O 0 5.807743175267888e-10
large O 0 1.3869844162073264e-10
number O 0 1.0542125505885735e-10
of O 0 1.7804563157142184e-08
metaplastic B-Disease 0 0.0001776792196324095
polyps I-Disease 0 5.752389142799075e-07
of I-Disease 0 1.3706183210615563e-07
the I-Disease 0 1.2061866527801612e-07
colorectum I-Disease 0 0.0002933935320470482
. O 0 2.4019016109377844e-07

There O 0 7.501506615881226e-08
is O 0 6.137664265715159e-10
increasing O 0 6.109558692291017e-11
evidence O 0 4.340135750791063e-10
that O 0 4.105620791255982e-12
there O 0 9.257648467264623e-12
exist O 0 2.449304370433225e-10
germ O 0 1.9829262782877777e-06
- O 0 4.681304943687792e-08
line O 0 7.564348258881637e-09
variants O 0 2.2246207098675086e-09
of O 0 3.1680655876442643e-09
the O 0 3.0095386183148776e-09
APC B-Disease 0 7.058393407533003e-07
gene O 0 2.033557322533852e-09
that O 0 2.4140269644368217e-11
predispose O 0 1.4759480304604722e-09
to O 0 5.889508325473969e-11
the O 0 5.974116201734603e-10
development O 0 1.4108489931885515e-09
of O 0 3.324484509903414e-08
multiple O 1 0.9999676942825317
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999949932098389
carcinoma I-Disease 1 1.0
, O 0 3.385757096907582e-08
but O 0 1.9025712949538587e-10
without O 0 3.3298944157600374e-10
the O 0 7.243503574727583e-10
florid O 0 5.793752961835708e-07
phenotype O 0 1.1576726244300062e-08
of O 0 3.168659645780281e-08
classical O 0 4.714836904895492e-06
FAP B-Disease 0 0.00013826291251461953
, O 0 3.2862590426674387e-09
and O 0 4.2462328098125113e-10
possibly O 0 6.089970194800287e-10
with O 0 8.849061067239816e-11
importance O 0 4.696714839269589e-08
for O 0 0.011138278059661388
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 7.159473458528964e-09
in O 0 1.6133613889302012e-10
the O 0 1.3825550426727062e-10
general O 0 2.793594522376708e-10
population O 0 3.850706645908142e-12
. O 0 1.4935788716918807e-10
. O 0 3.0619271562670747e-09

Genomic O 0 2.91489982373605e-06
structure O 0 1.864429748366092e-07
of O 0 1.80337963229249e-07
the O 0 9.757309271662962e-08
human O 1 0.8906948566436768
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.11344508081674576
CLD B-Disease 1 1.0
) O 0 2.033838057968751e-07
gene O 0 3.227328306820709e-07
. O 0 1.411274297424825e-07

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999605417251587
CLD B-Disease 1 1.0
) O 0 1.0787673687673305e-07
is O 0 4.212433180050823e-10
caused O 0 5.01968067112557e-09
by O 0 1.8642924703993202e-10
mutations O 0 1.0356642210496148e-09
in O 0 9.017180335746389e-10
a O 0 7.463636930715722e-10
gene O 0 5.896682031547584e-10
which O 0 1.6417182890915427e-10
encodes O 0 8.730737244277975e-10
an O 0 4.1873599032626885e-10
intestinal O 0 1.4876013665343635e-05
anion O 0 4.193720997136552e-06
transporter O 0 0.00014594063395634294
. O 0 6.496323408100579e-07

We O 0 1.1224511808904936e-07
report O 0 8.036112220111136e-09
here O 0 8.724128086612382e-10
the O 0 3.604659071232419e-10
complete O 0 3.1212346041087358e-09
genomic O 0 4.676099951694823e-09
organization O 0 7.423174852583259e-10
of O 0 3.0115137050756857e-09
the O 0 2.448735658688861e-09
human O 0 1.5333599279188093e-08
CLD B-Disease 1 0.9999967813491821
gene O 0 6.598006585534222e-09
which O 0 1.5657529439661033e-10
spans O 0 4.932563246740074e-09
approximately O 0 7.461117279561336e-10
39kb O 0 9.729448038342525e-07
, O 0 2.5319857321903783e-09
and O 0 5.101608024915549e-09
comprises O 0 1.4113456359154952e-07
21 O 0 1.0216170949206571e-06
exons O 0 3.163809196848888e-06
. O 0 4.011134180359477e-08

All O 0 1.8179101743953652e-06
exon O 0 2.766355282801669e-05
/ O 0 6.186083737702575e-06
intron O 0 1.2290472568565747e-06
boundaries O 0 1.4508231060972321e-08
conform O 0 5.900848254469793e-09
to O 0 8.527578643224842e-10
the O 0 4.683618115564059e-08
GT O 1 0.8300876617431641
/ O 0 0.000442011485574767
AG O 1 0.9999992847442627
rule O 0 2.4709322588023497e-06
. O 0 1.5544951281754038e-07

An O 0 7.48629602753681e-09
analysis O 0 6.364925475565997e-09
of O 0 1.9362682124324238e-08
the O 0 8.22636980757352e-09
putative O 0 5.46659350675327e-07
promoter O 0 1.7359003322781064e-05
region O 0 1.704681551473186e-08
sequence O 0 3.3601121884885288e-09
shows O 0 2.5668405179146703e-09
a O 0 2.4490720562653223e-09
putative O 0 1.065534092958842e-06
TATA O 1 0.9999978542327881
box O 0 1.133101341110887e-05
and O 0 2.5261984504254542e-08
predicts O 0 6.896017623603257e-08
multiple O 0 5.906884315010075e-09
transcription O 0 8.357178415963062e-08
factor O 0 5.627998067581075e-09
binding O 0 9.47788958427509e-09
sites O 0 9.158035396694686e-08
. O 0 3.7381607143061046e-08

The O 0 2.9125331479917804e-07
genomic O 0 1.503378541656275e-07
structure O 0 7.763641463043314e-08
was O 0 1.7443946731532378e-08
determined O 0 3.420545235943706e-10
using O 0 7.070133367648168e-11
DNA O 0 4.332115555172322e-09
from O 0 4.936247244291536e-11
several O 0 1.2592119187637696e-11
sources O 0 3.5971638862042354e-11
including O 0 9.535867928622821e-11
multiple O 0 7.697987802757211e-10
large O 0 9.783469145929757e-09
- O 0 6.160667453514179e-06
insert O 0 1.4135454193819896e-06
libaries O 0 5.657464498654008e-06
and O 0 2.5190183272627564e-09
genomic O 0 3.012922888956382e-08
DNA O 0 2.4658541519784194e-07
from O 0 1.4566126083082054e-08
Finnish O 1 0.9995521903038025
CLD B-Disease 1 1.0
patients O 0 9.944155863195192e-07
and O 0 3.356174360646946e-08
controls O 0 5.157287887413986e-06
. O 0 2.7938378366343386e-07

Exon O 0 2.6872436137637123e-05
- O 0 3.649603286248748e-07
specific O 0 1.00884434139914e-09
primers O 0 1.1477069250531713e-07
developed O 0 5.5963664813418745e-09
in O 0 7.667563112212505e-11
this O 0 1.9132425678469733e-12
study O 0 1.0348595244624725e-11
will O 0 4.322367388055054e-13
facilitate O 0 8.429800607556714e-11
mutation O 0 8.45367872925884e-11
screening O 0 4.0023723224535956e-10
studies O 0 1.217334427705552e-10
of O 0 2.348596039869477e-10
patients O 0 3.167810180837449e-10
with O 0 2.710119628712704e-10
the O 0 3.536585381880286e-06
disease O 1 0.9848132729530334
. O 0 6.35414494354336e-08

Genomic O 0 2.6302856781512673e-07
sequencing O 0 7.612970875925384e-08
of O 0 8.44887111384196e-08
a O 0 4.03396711590176e-08
BAC O 1 0.9999674558639526
clone O 0 5.77997270738706e-05
H O 1 1.0
_ O 0 4.198223990670158e-08
RG364P16 O 0 8.938502560340567e-07
revealed O 0 9.778450937858452e-09
the O 0 4.3168296715023757e-10
presence O 0 1.2152209794003e-10
of O 0 3.1927667176745445e-09
another O 0 6.82956802222634e-10
, O 0 8.065648843258444e-11
highly O 0 2.029585388640953e-09
homologous O 0 1.8094457043815737e-09
gene O 0 5.348650411463041e-10
3 O 0 4.2821843848628305e-09
of O 0 8.414628105413158e-09
the O 0 9.559588676211206e-09
CLD B-Disease 1 0.999998927116394
gene O 0 1.3583287383767129e-08
, O 0 2.7294483340156717e-10
with O 0 1.3831794216934146e-11
a O 0 3.5560356742569965e-11
similar O 0 5.767679736590203e-11
genomic O 0 5.131500113719767e-09
structure O 0 1.3788668873360166e-08
, O 0 3.314212237981451e-10
recently O 0 4.95977814374271e-10
identified O 0 1.170011587614539e-10
as O 0 1.2674751526109418e-10
the O 0 4.1730999100764166e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.3785642611073854e-07
( O 0 1.3984027269486887e-08
PDS B-Disease 1 0.9784733057022095
) O 0 4.595804181661833e-09
. O 0 3.755904476321348e-09
. O 0 2.3722657616076503e-08

The O 0 4.070047452842118e-06
APCI1307K O 1 0.9999994039535522
allele O 0 4.046297306103952e-07
and O 0 1.3757386341239908e-07
cancer B-Disease 0 4.9276943173026666e-05
risk O 0 3.794977221360796e-09
in O 0 9.300754610919171e-10
a O 0 6.134176500083299e-10
community O 0 1.534297411343033e-10
- O 0 4.892161342695545e-09
based O 0 4.932654840139605e-10
study O 0 9.61040205749164e-11
of O 0 8.651928617986471e-10
Ashkenazi O 0 1.9837291631574772e-07
Jews O 0 1.1315287196111967e-07
. O 0 1.1734145033415189e-07

Mutations O 0 5.50616960026673e-07
in O 0 1.0465448951890721e-07
APC O 0 9.48886554397177e-06
are O 0 5.311414419395533e-09
classically O 0 1.745022564136889e-05
associated O 0 2.742406479683268e-07
with O 0 1.1520686484800535e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.867996257322375e-06
FAP B-Disease 1 0.9999852180480957
) O 0 1.5566813615919273e-08
, O 0 1.0476863820940707e-09
a O 0 1.5687010579412686e-09
highly O 0 7.379253656836227e-05
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.957135021686554
by O 0 1.8768965048820974e-07
multiple O 1 0.9998107552528381
intestinal O 1 1.0
polyps B-Disease 1 0.9356136322021484
and O 0 1.9197096889911336e-07
, O 0 3.766909895119852e-09
without O 0 1.2148043682103093e-09
surgical O 1 0.9997991919517517
intervention O 0 1.0238320555799874e-06
, O 0 2.04353045596406e-09
the O 0 6.335034274940199e-09
development O 0 1.2264041515663848e-07
of O 1 0.9999656677246094
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.4692409422423225e-06
CRC B-Disease 1 1.0
) O 0 9.700318770455851e-09
. O 0 2.12915978181627e-08

APC B-Disease 0 0.00027810464962385595
is O 0 1.4801358361182793e-07
a O 0 5.728646712555019e-08
tumour O 1 0.9999996423721313
- O 0 2.091212081722915e-06
suppressor O 0 6.073851182009093e-07
gene O 0 4.762428673643626e-09
, O 0 1.588860570889139e-10
and O 0 6.238814465042708e-10
somatic O 0 9.814835721044801e-06
loss O 0 3.143127105431631e-05
occurs O 0 1.09409107551528e-07
in O 0 2.909526415351138e-07
tumours B-Disease 1 1.0
. O 0 8.875169896782609e-07

The O 0 3.967455086240079e-06
germline O 0 2.778310954454355e-05
T O 0 0.00018965249182656407
- O 0 2.928894673459581e-07
to O 0 2.1351613810338677e-09
- O 0 7.625032338864912e-08
A O 0 9.653699351019895e-08
transversion O 0 5.486304530677444e-07
responsible O 0 1.5809894504670297e-09
for O 0 1.433038687714827e-10
the O 0 2.9852811334052376e-09
APC O 0 6.552359650413564e-07
I1307K O 0 1.9645821680569497e-07
allele O 0 2.3299101536977673e-10
converts O 0 5.53462609076405e-10
the O 0 3.187994312980891e-10
wild O 0 2.9517806865442253e-08
- O 0 9.518505983407977e-09
type O 0 3.6294349747834076e-09
sequence O 0 2.2972250490749246e-10
to O 0 5.971732136567098e-11
a O 0 2.2623574125191226e-09
homopolymer O 0 0.003031738568097353
tract O 0 0.0001246253086719662
( O 0 3.335173559548821e-08
A8 O 1 0.9995852112770081
) O 0 9.063511607898533e-10
that O 0 7.70644589809244e-11
is O 0 6.467424928935372e-10
genetically O 0 1.3925770190326148e-06
unstable O 0 4.9607082473812625e-05
and O 0 2.563530188126606e-07
prone O 0 3.304888741695322e-05
to O 0 1.6004596758989464e-08
somatic O 0 6.224952085176483e-05
mutation O 0 8.391518235839612e-07
. O 0 2.1110081149799953e-07

The O 0 1.4440352060773876e-06
I1307K O 0 5.636994046653854e-06
allele O 0 1.2576871988301264e-08
was O 0 1.1608522143546907e-08
found O 0 6.184220913141303e-10
in O 0 1.1558385359933254e-09
6 O 0 2.2722340986547351e-07
. O 0 1.9688993546651545e-08

1 O 0 3.8747111830161884e-07
% O 0 5.198922403693018e-10
of O 0 2.7440132388534266e-09
unselected O 0 2.7714493626262993e-05
Ashkenazi O 0 4.7384068579958694e-07
Jews O 0 3.5286234378872905e-08
and O 0 2.5497524092088497e-09
higher O 0 3.978376295066255e-09
proportions O 0 8.059475753441347e-09
of O 0 1.3888229233316451e-08
Ashkenazim O 0 4.3800162075058324e-07
with O 0 7.001495494485255e-10
family O 0 1.4116781077433416e-09
or O 0 6.805551122646136e-10
personal O 0 2.5605094933212058e-08
histories O 0 6.898766287122271e-07
of O 0 1.1346888641128317e-05
CRC B-Disease 1 0.9999996423721313
( O 0 2.6370415184828744e-08
ref O 0 6.265267074923031e-06
. O 0 2.254181952210388e-09
2 O 0 3.380098334559989e-08
) O 0 6.333242819067664e-10
. O 0 4.9443933392012696e-09

To O 0 2.895522044354948e-08
evaluate O 0 1.1773355623745374e-07
the O 0 1.328704257730351e-08
role O 0 3.862717257163695e-09
of O 0 1.050428188875685e-08
I1307K O 0 1.219746650349407e-06
in O 0 8.849036170488489e-09
cancer B-Disease 0 1.4135104038359714e-06
, O 0 4.1706449405154444e-10
we O 0 3.560598482721389e-10
genotyped O 0 1.4149590015222202e-06
5 O 0 4.025566369136868e-08
, O 0 2.9071693941062904e-09
081 O 0 2.9893599275965244e-05
Ashkenazi O 0 4.3502848257048754e-07
volunteers O 0 1.731889653910912e-08
in O 0 5.815879999815365e-10
a O 0 6.930783169600829e-10
community O 0 1.229342294628566e-09
survey O 0 2.334627602351702e-08
. O 0 5.8731057350769333e-08

Risk O 0 5.035202320868848e-06
of O 0 8.877363143255934e-06
developing O 1 0.9631315469741821
colorectal B-Disease 1 1.0
, I-Disease 0 1.9076603621215327e-06
breast I-Disease 0 0.0431937649846077
and I-Disease 0 1.9715749033366592e-08
other I-Disease 0 7.723969019934884e-08
cancers I-Disease 1 0.9955152869224548
were O 0 1.3863351355780651e-08
compared O 0 6.57946985782587e-09
between O 0 4.828401678480532e-09
genotyped O 0 1.2815356967621483e-05
I1307K O 0 8.061643939072383e-07
carriers O 0 1.932500159895767e-09
and O 0 1.4090768551966448e-09
non O 0 1.2531118898095883e-07
- O 0 2.3235307011759687e-08
carriers O 0 5.096791322323213e-10
and O 0 1.1315465925365586e-10
their O 0 3.7108972145150076e-11
first O 0 5.182112516877169e-10
- O 0 5.769193123228433e-09
degree O 0 1.1999469862189471e-08
relatives O 0 1.0712196463202872e-08
. O 0 1.2773466728788208e-08

Sperm O 0 1.8708401228195726e-07
DNA O 0 3.066154476982774e-07
analysis O 0 2.3231041534899077e-09
in O 0 1.0021281582339725e-09
a O 0 1.1869856209045793e-08
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.9999849796295166
carrier O 0 2.314142648174311e-06
suggests O 0 2.3911864488468382e-08
both O 0 1.387043369049934e-09
meiotic O 0 2.025408093686565e-06
and O 0 8.095063286361892e-09
mitotic O 0 4.9045624450627656e-08
expansion O 0 4.3612509159629553e-08
in O 0 4.367558759099666e-09
the O 0 3.615238597376447e-08
FRDA B-Disease 1 0.9999583959579468
gene O 0 3.047148595669569e-07
. O 0 4.199553416128765e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 2.716304379646317e-06
usually O 0 2.0021573732265097e-07
caused O 0 9.084565988359827e-08
by O 0 4.305679146554553e-10
an O 0 3.4147937949535745e-11
expansion O 0 1.0405195816076684e-08
of O 0 8.301463338966641e-08
a O 0 2.45827873612825e-08
GAA O 0 0.4292892813682556
trinucleotide O 0 0.00014409681898541749
repeat O 0 3.762363576242933e-07
in O 0 1.0318650822682685e-08
intron O 0 3.3955683420572313e-07
1 O 0 2.273995924895189e-08
of O 0 2.035471347028306e-08
the O 0 2.6415317933015103e-08
FRDA B-Disease 1 0.9999996423721313
gene O 0 3.636210408330953e-07
. O 0 4.853167467899766e-08

Occasionally O 0 3.076085249631433e-06
, O 0 6.570014310369743e-09
a O 0 1.2001157845276111e-09
fully O 0 3.8339882380000745e-09
expanded O 0 8.338240098382244e-10
allele O 0 2.656302400261268e-10
has O 0 5.835742045851022e-12
been O 0 2.34209474730962e-11
found O 0 1.787875576753084e-11
to O 0 7.803190385513581e-12
arise O 0 3.502622636375463e-10
from O 0 8.54825987772756e-10
a O 0 7.806919555264358e-10
premutation O 0 1.5291855106625007e-06
of O 0 6.488880899269134e-08
100 O 0 1.6963555893312332e-08
or O 0 2.661273423854027e-09
less O 0 1.323612508485894e-08
triplet O 0 2.7009964469471015e-05
repeats O 0 3.3168385016324464e-06
. O 0 2.3615535837961943e-07

We O 0 4.184018820296842e-08
have O 0 1.8384022082429397e-10
examined O 0 1.5789952456657375e-08
the O 0 2.8253169248593224e-10
sperm O 0 3.0129543304724393e-10
DNA O 0 3.69343311490411e-08
of O 0 8.880129520605351e-09
a O 0 3.9730609913135595e-09
premutation O 0 2.9265085686347447e-05
carrier O 0 6.999885613367951e-07
. O 0 9.050270222132895e-08

This O 0 3.7055272628094826e-08
mans O 0 2.526963271520799e-06
leucocyte O 0 1.4964659385441337e-05
DNA O 0 1.189124532174901e-06
showed O 0 5.6279012561333275e-09
one O 0 7.034272470063385e-11
normal O 0 9.037031678538199e-10
allele O 0 1.093492865700263e-10
and O 0 1.2737397248052673e-10
one O 0 1.2724916953477106e-10
allele O 0 1.8624443653969536e-10
of O 0 2.0122437049963082e-09
approximately O 0 1.966098839289998e-09
100 O 0 2.3448562203043366e-08
repeats O 0 8.935231932127863e-08
. O 0 5.020152471502115e-08

His O 0 1.94931385522068e-06
sperm O 0 3.895288003263886e-08
showed O 0 1.1366549479419064e-08
an O 0 2.8772179083702554e-11
expanded O 0 5.019323845445456e-10
allele O 0 1.4332027231667155e-10
in O 0 2.5239130230225726e-10
a O 0 8.18884071662751e-10
tight O 0 5.8607962927226254e-08
range O 0 1.668556990352954e-07
centering O 0 2.2579965275326686e-07
on O 0 1.419395179169669e-08
a O 0 3.046383423299659e-10
size O 0 9.212248741619078e-10
of O 0 1.3369485074576914e-08
approximately O 0 1.649632963562908e-08
320 O 0 3.9797072304281755e-07
trinucleotide O 0 0.00012373461504466832
repeats O 0 3.16851946990937e-06
. O 0 2.3622652634003316e-07

His O 0 1.770778908394277e-05
affected O 0 3.4853107990784338e-06
son O 0 3.1039311579661444e-05
has O 0 1.4022989436313082e-09
repeat O 0 8.488797220707056e-09
sizes O 0 1.8206980811896756e-08
of O 0 2.8193241519147705e-07
1040 O 0 1.3373179399422952e-06
and O 0 3.6149074844615825e-08
540 O 0 1.6337580746039748e-06
. O 0 1.127513016285775e-07

These O 0 1.0189997290410702e-08
data O 0 1.5128300390188087e-08
suggest O 0 4.990666213622319e-10
that O 0 3.5415418427747758e-12
expansion O 0 5.807987424333305e-10
occurs O 0 3.49437354052462e-11
in O 0 6.9704415850413426e-12
two O 0 3.682543853189557e-12
stages O 0 7.293666559604617e-09
, O 0 4.7881545950367865e-11
the O 0 1.3142428811896423e-10
first O 0 2.457704595393295e-10
during O 0 6.346859704464691e-10
meiosis O 0 3.2967748531120833e-09
followed O 0 3.183789620830879e-10
by O 0 2.664928000495337e-11
a O 0 2.543436572466362e-10
second O 0 9.039777815189609e-09
mitotic O 0 2.422116267553065e-07
expansion O 0 1.3456410670187324e-06
. O 0 2.100240834579381e-07

We O 0 6.739060154359322e-08
also O 0 2.0361692332215853e-09
show O 0 6.100142058151903e-10
that O 0 2.697842166679565e-12
in O 0 3.2510688585674075e-11
all O 0 2.0376863391069477e-11
informative O 0 1.3614301908049242e-09
carrier O 0 2.4042052793049606e-09
father O 0 2.9657183375775276e-09
to O 0 1.112457834184788e-10
affected O 0 1.373970048845763e-09
child O 0 6.592521639703364e-09
transmissions O 0 2.989248315543591e-08
, O 0 1.0178040354968942e-10
with O 0 1.169212209689574e-11
the O 0 8.606611950900955e-11
notable O 0 3.297848660821501e-10
exception O 0 5.027679383928785e-10
of O 0 9.646553777997724e-09
the O 0 7.492866771485751e-09
premutation O 0 3.578587438823888e-06
carrier O 0 2.7542709446493063e-08
, O 0 2.530145259971306e-10
the O 0 3.264479797593367e-10
expansion O 0 4.515147811190445e-09
size O 0 2.186032688200612e-09
decreases O 0 1.3851405356035684e-08
. O 0 1.4380637791688855e-09
. O 0 1.5682740439615372e-08

The O 0 4.507758433192066e-07
R496H O 0 3.5737887174036587e-06
mutation O 0 1.3705994561519219e-08
of O 0 5.4665111548501955e-08
arylsulfatase O 0 0.0018317681970074773
A O 0 2.096945172525011e-05
does O 0 2.1429868990452405e-09
not O 0 2.3373756263822543e-09
cause O 0 0.0003763643908314407
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 9.228662634086504e-07

Deficiency B-Disease 1 0.9999980926513672
of I-Disease 0 0.13992728292942047
arylsulfatase I-Disease 1 0.9998282194137573
A I-Disease 0 0.1342637687921524
( O 0 2.3714656549600477e-07
ARSA O 1 0.9999996423721313
) O 0 8.554217778566908e-09
enzyme O 0 2.054242997928668e-08
activity O 0 1.6615733500202623e-07
causes O 0 5.1811006414936855e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.5599258404108696e-05
MLD B-Disease 1 1.0
) O 0 1.5756219795548532e-07
. O 0 1.5644021189586965e-08

A O 0 7.643866979378799e-07
number O 0 3.236872103684618e-09
of O 0 7.123882994619635e-08
ARSA O 1 0.9999790191650391
gene O 0 6.877233715840703e-08
mutations O 0 6.857152179406967e-09
responsible O 0 3.945296001006682e-08
for O 0 6.177436517873502e-08
MLD B-Disease 1 1.0
have O 0 2.9003901502733243e-09
been O 0 1.5941158393317778e-09
identified O 0 3.902365541819108e-09
. O 0 1.2597759280197351e-08

Recently O 0 2.786844106594799e-06
, O 0 9.230615383160057e-09
the O 0 4.916886009453947e-09
R496H O 0 7.868725333537441e-07
mutation O 0 7.145775970940349e-09
of O 0 2.92657148293074e-07
ARSA O 1 0.999994158744812
was O 0 2.1373713821049023e-07
proposed O 0 1.1350121953412895e-09
to O 0 1.3940897047870493e-10
be O 0 1.695852347438631e-10
a O 0 1.1811176481302255e-09
cause O 0 3.3475693328455236e-08
of O 0 4.94658434035955e-06
MLD B-Disease 1 1.0
( O 0 3.166146456123897e-08
Draghia O 0 3.159581319778226e-05
et O 0 1.3359742752072634e-06
al O 0 5.388528165894968e-07
. O 0 2.93592677946819e-10
, O 0 3.141372162396294e-10
1997 O 0 7.618603525827439e-09
) O 0 3.203629583836687e-10
. O 0 5.338665065579562e-09

We O 0 1.4031189721208648e-07
have O 0 7.655160394470784e-10
investigated O 0 5.1455671723488194e-08
the O 0 4.773988315776023e-09
R496H O 0 4.2065761363119236e-07
mutation O 0 5.042603556937308e-10
and O 0 2.22279167294559e-10
found O 0 3.921634891823622e-11
this O 0 2.7730944710674388e-12
mutation O 0 1.0542366979393591e-10
at O 0 9.96208893155881e-10
a O 0 3.592158862031347e-11
relatively O 0 1.1334064242696229e-10
high O 0 1.3962405676082312e-09
frequency O 0 1.117242270920471e-10
in O 0 8.765768493013137e-12
an O 0 3.5593791369165073e-12
African O 0 9.597012767814661e-11
American O 0 1.5878638681687818e-10
population O 0 5.206198428094055e-13
( O 0 6.885791849903233e-12
f O 0 3.537807158338069e-09
= O 0 1.1274452482723518e-09
0 O 0 7.315675842889391e-10
. O 0 6.517263811955942e-11
09 O 0 1.8992665218320326e-08
, O 0 4.85745679790206e-11
n O 0 2.2209904748660136e-10
= O 0 1.3482047700463795e-09
61 O 0 9.660031885516673e-09
subjects O 0 3.542758619801134e-08
) O 0 1.855902653780106e-09
. O 0 1.3465890624786425e-08

The O 0 1.2619336303032469e-05
ARSA O 0 0.0029870476573705673
enzyme O 0 1.873008592667702e-08
activity O 0 2.1861914500931334e-09
in O 0 3.357541467075009e-10
subjects O 0 2.5401507564026815e-09
with O 0 6.820412984387403e-11
and O 0 2.4015137101152106e-10
without O 0 2.1152898876941606e-10
the O 0 7.016922598523934e-10
R496H O 0 5.169393091364327e-08
mutation O 0 3.310270113576763e-10
was O 0 4.982163015476715e-10
determined O 0 2.547272115460686e-10
and O 0 2.8699514986740837e-10
found O 0 1.6648035727762078e-10
to O 0 6.92195467610901e-11
be O 0 2.894977868539428e-10
normal O 0 5.629343036162027e-08
. O 0 2.237242568980946e-08

It O 0 4.8830653298637117e-08
is O 0 6.373085947863899e-10
therefore O 0 2.606346249933722e-10
concluded O 0 1.3926950703790908e-09
that O 0 5.574125796353746e-12
the O 0 2.1061954957879436e-10
R496H O 0 7.984474592603874e-08
mutation O 0 7.78212161378633e-10
of O 0 1.8914722232921122e-08
ARSA O 1 0.9752794504165649
does O 0 1.045456721193716e-09
not O 0 3.093010569887866e-11
negatively O 0 4.46055109515342e-10
influence O 0 2.083643674266611e-10
the O 0 2.638477769600911e-10
activity O 0 6.515713524279931e-10
of O 0 5.630413912882659e-09
ARSA O 1 0.9660842418670654
and O 0 3.289400973827128e-09
is O 0 6.70729999319164e-11
not O 0 1.801344837182306e-11
a O 0 1.003015448475253e-09
cause O 0 3.956502041546628e-07
of O 0 9.205040259985253e-05
MLD B-Disease 1 1.0

Down O 0 8.338328916579485e-05
- O 0 1.0464646038599312e-06
regulation O 0 1.6281526882266917e-07
of O 0 1.1055003312776535e-07
transmembrane O 0 2.776088194877957e-06
carbonic O 0 0.002440564101561904
anhydrases O 0 0.0028960565105080605
in O 0 1.4049535366211785e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9996057152748108
lines O 0 5.633058322018769e-07
by O 0 7.401815604879403e-09
wild O 0 3.4147776659665396e-06
- O 0 1.718265139061259e-06
type O 0 2.1898206341575133e-06
von B-Disease 1 0.9999995231628418
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999618530273438
Lindau I-Disease 1 0.9999656677246094
transgenes O 0 0.0019688361790031195
. O 0 1.8456543102729484e-06

To O 0 7.939856772054554e-08
discover O 0 5.693267013384684e-08
genes O 0 1.3650939267861872e-09
involved O 0 4.595698932519099e-09
in O 0 6.082775172444599e-09
von B-Disease 1 0.8708547949790955
Hippel I-Disease 1 0.9999984502792358
- I-Disease 1 0.9994398951530457
Lindau I-Disease 1 0.9999905824661255
( O 0 5.746330202782701e-07
VHL B-Disease 1 1.0
) O 0 2.1043263132014545e-08
- O 0 4.549555967514607e-07
mediated O 0 1.5020874570836895e-06
carcinogenesis O 1 0.9533249139785767
, O 0 3.4353559996702643e-09
we O 0 2.6914717676795874e-10
used O 0 5.623644483421231e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9996181726455688
lines O 0 1.5305617125704885e-05
stably O 0 1.420487660652725e-05
transfected O 0 1.2795323982572882e-06
with O 0 3.694840433610125e-09
wild O 0 2.2301462649920722e-06
- O 0 6.330619271466276e-06
type O 0 7.742556772427633e-05
VHL O 1 1.0
- O 0 0.00013550838048104197
expressing O 0 1.1496210845507449e-06
transgenes O 0 0.00013151975872460753
. O 0 3.758006528187252e-07

Large O 0 1.748299354176197e-07
- O 0 1.4202556997133797e-07
scale O 0 1.1621929729699332e-07
RNA O 0 1.7514892647341185e-08
differential O 0 2.0418551294199005e-09
display O 0 7.370386079230684e-09
technology O 0 3.6304388384422737e-09
applied O 0 2.81500545096236e-10
to O 0 8.981073697233999e-12
these O 0 3.995680869506302e-11
cell O 0 5.453542506472786e-09
lines O 0 8.222004188596088e-10
identified O 0 1.1822799683702812e-10
several O 0 2.8377427144232747e-11
differentially O 0 2.1719188669777623e-09
expressed O 0 1.7356908965648898e-10
genes O 0 7.132941459708775e-11
, O 0 5.6557019484371196e-11
including O 0 2.6152799370571245e-10
an O 0 8.863418332616391e-11
alpha O 0 5.541603087522162e-08
carbonic O 0 5.6989651966432575e-06
anhydrase O 0 3.261605525040068e-05
gene O 0 3.991451791307554e-08
, O 0 6.561273302452264e-09
termed O 0 5.217412763158791e-06
CA12 O 1 0.9999979734420776
. O 0 4.990351953892969e-07

The O 0 5.16761360813689e-07
deduced O 0 1.7868222812467138e-07
protein O 0 6.284907705378373e-09
sequence O 0 4.6280876908610935e-09
was O 0 3.8087768494676766e-09
classified O 0 4.36316227592215e-09
as O 0 3.933810499567869e-10
a O 0 4.4762329953762503e-10
one O 0 6.496875259998092e-10
- O 0 9.910075959851383e-08
pass O 0 2.5342828280372487e-07
transmembrane O 0 2.0475363271543756e-06
CA O 0 0.0011658930452540517
possessing O 0 8.044180503929965e-07
an O 0 1.4994996355710555e-09
apparently O 0 1.4236356982166853e-08
intact O 0 4.241768536417112e-08
catalytic O 0 2.471508686596735e-08
domain O 0 4.454465685199693e-09
in O 0 1.4681790228010527e-09
the O 0 6.78555478472731e-09
extracellular O 0 1.4559024066329584e-06
CA O 0 0.001368732308037579
module O 0 8.68019287736388e-06
. O 0 9.021437108458485e-08

Reintroduced O 0 9.404882803210057e-06
wild O 0 7.947195626911707e-06
- O 0 3.0218866413633805e-06
type O 0 2.8122342428105185e-06
VHL B-Disease 1 0.999922513961792
strongly O 0 1.6886948728256357e-08
inhibited O 0 1.0918892456857066e-08
the O 0 1.1259302379329483e-09
overexpression O 0 2.4479852811509772e-08
of O 0 1.4307296680726722e-08
the O 0 1.0327156907408153e-08
CA12 O 1 0.9976527094841003
gene O 0 1.0293681462769655e-09
in O 0 1.133447433132595e-10
the O 0 1.1994223392264303e-09
parental O 0 1.4702696944368654e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999862909317017
lines O 0 0.00010463433136465028
. O 0 3.583637919746252e-07

Similar O 0 1.282239026068055e-07
results O 0 2.974807067346319e-08
were O 0 2.7673920932613782e-09
obtained O 0 3.6439249395670004e-09
with O 0 1.2131373683388347e-09
CA9 O 1 0.9880952835083008
, O 0 4.518300844580381e-09
encoding O 0 3.324501784973677e-09
another O 0 7.036588201003724e-09
transmembrane O 0 1.2129872857258306e-06
CA O 0 9.876563854049891e-05
with O 0 2.9075131191547143e-09
an O 0 7.73052011293629e-10
intact O 0 7.022070462880947e-07
catalytic O 0 1.5342176311605726e-06
domain O 0 2.8907936666655587e-07
. O 0 8.590241407091526e-08

Although O 0 5.664368174507217e-08
both O 0 1.7086684289679965e-09
domains O 0 2.126630205268043e-09
of O 0 2.164529711023988e-08
the O 0 2.5402151493381098e-08
VHL B-Disease 1 0.9028051495552063
protein O 0 3.133265424892784e-09
contribute O 0 2.530555487378905e-10
to O 0 1.680797862002592e-10
regulation O 0 3.415554417074418e-08
of O 0 1.1134846999993897e-07
CA12 O 1 0.9999951124191284
expression O 0 9.618188023807761e-09
, O 0 4.4414324995578625e-10
the O 0 1.2743213151367172e-09
elongin O 0 4.1724874222381914e-07
binding O 0 5.419510618054346e-09
domain O 0 5.64759039534124e-09
alone O 0 3.050618202493638e-09
could O 0 5.691708770960702e-10
effectively O 0 1.2839858953839212e-08
regulate O 0 4.628032854725461e-07
CA9 O 1 0.9569810628890991
expression O 0 1.5440581080383708e-07
. O 0 6.604921765074323e-08

We O 0 5.455999598780181e-07
mapped O 0 8.021818757697474e-06
CA12 O 1 0.999670147895813
and O 0 1.0929059044428868e-06
CA9 O 1 0.9557346105575562
loci O 0 1.20747557730283e-07
to O 0 1.097882673661843e-08
chromosome O 0 1.3976246293623262e-07
bands O 0 8.324576810991857e-06
15q22 O 0 8.702199920662679e-06
and O 0 1.3142322075054835e-07
17q21 O 0 2.5880559405777603e-05
. O 0 2.0042971016209776e-07

2 O 0 3.093701934631099e-06
respectively O 0 1.8604512774800241e-07
, O 0 1.8317110050958263e-09
regions O 0 1.5781370876766232e-08
prone O 0 8.696663371665636e-07
to O 0 2.5304214279486814e-09
amplification O 0 1.0182844789596857e-06
in O 0 5.311829642806742e-09
some O 0 1.3678148613749386e-09
human O 0 4.435138976077724e-07
cancers B-Disease 1 0.9801817536354065
. O 0 2.131464214016887e-07

Additional O 0 6.167594079897754e-08
experiments O 0 4.4317397396298475e-07
are O 0 1.5877245351791913e-10
needed O 0 8.547004770598221e-10
to O 0 5.0921249855617745e-11
define O 0 4.943637166299197e-10
the O 0 4.880155723974156e-10
role O 0 1.0296586916425099e-09
of O 0 1.8342081631317342e-08
CA O 0 3.7473244447028264e-05
IX O 1 0.9999997615814209
and O 0 5.375696332521329e-07
CA O 0 0.00022523995721712708
XII O 1 0.9999878406524658
enzymes O 0 2.3348669664358113e-09
in O 0 3.4008856841794e-10
the O 0 2.3027260653840642e-10
regulation O 0 4.801200326198796e-09
of O 0 7.032093130021622e-09
pH O 0 1.2879054267500578e-08
in O 0 7.07676139910518e-10
the O 0 8.857558575492419e-10
extracellular O 0 4.553807553264733e-09
microenvironment O 0 9.776627507562807e-08
and O 0 9.990098748247078e-10
its O 0 3.162425044056505e-10
potential O 0 3.1465952066156433e-10
impact O 0 1.2871048227225401e-08
on O 0 8.586651460973371e-07
cancer B-Disease 0 0.00018833159992936999
cell O 0 2.2925226517145347e-07
growth O 0 2.6830837995817092e-08
. O 0 1.7587536760288458e-08

A O 0 4.263468326826114e-06
gene O 0 1.106590552524267e-08
encoding O 0 3.650394653220701e-09
a O 0 2.6254070029096965e-09
transmembrane O 0 2.4186485703125982e-08
protein O 0 7.083463149371028e-09
is O 0 1.7352937142778302e-10
mutated O 0 1.4662564495893093e-09
in O 0 4.815505216804183e-10
patients O 0 8.119479311119449e-09
with O 0 1.6487607581439079e-06
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999973773956299
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 5.562273841519527e-08
. O 0 5.030667082905893e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0003181748033966869
WFS B-Disease 1 1.0
; O 0 3.3707808597682742e-06
OMIM O 1 1.0
222300 O 0 0.10511414706707001
) O 0 2.4838937573434805e-09
is O 0 2.7803833888007112e-11
an O 0 9.96966814659217e-11
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 7.420576366712339e-07
by O 0 2.8691774289768546e-08
young O 0 1.5295821640393115e-06
- O 0 1.628426070965361e-05
onset O 1 0.9999595880508423
non O 1 0.9996845722198486
- O 1 0.9916059970855713
immune O 0 0.26940202713012695
insulin B-Disease 1 0.9982255101203918
- I-Disease 1 0.9997926354408264
dependent I-Disease 1 0.9972997307777405
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9992470741271973
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 5.454727670439752e-06

Linkage O 0 6.729029792040819e-06
to O 0 9.765851238796586e-09
markers O 0 5.161619469618017e-07
on O 0 1.5980414502791973e-07
chromosome O 0 1.5018251531273563e-07
4p O 0 4.248509503668174e-05
was O 0 7.513492761290763e-08
confirmed O 0 1.9070591772418766e-09
in O 0 5.335974440079383e-10
five O 0 1.484675382634748e-09
families O 0 6.609692237979914e-10
. O 0 2.9079471275395008e-08

On O 0 4.1945983753066685e-07
the O 0 3.1506144360093913e-09
basis O 0 4.03620514788372e-09
of O 0 4.366844663650227e-08
meiotic O 0 0.0012280682567507029
recombinants O 1 0.9530319571495056
and O 0 7.968445174810768e-07
disease O 0 0.36312544345855713
- O 0 4.2714512460406695e-07
associated O 0 1.4028747941097208e-08
haplotypes O 0 6.562027010659222e-08
, O 0 8.585842592445658e-10
the O 0 1.0342019685083415e-08
WFS B-Disease 1 0.9999974966049194
gene O 0 4.117305962836326e-08
was O 0 2.2642407060402547e-08
localized O 0 1.495961754471864e-07
to O 0 3.774288437341511e-09
a O 0 8.898105363641662e-08
BAC O 1 0.9999985694885254
/ O 0 9.72386624198407e-06
P1 O 0 0.0002628934453241527
contig O 0 2.1808464225614443e-05
of O 0 2.206178066899156e-07
less O 0 2.064675097557256e-09
than O 0 2.0727827787503372e-10
250 O 0 1.5860706525927526e-08
kb O 0 7.427419404848479e-06
. O 0 7.443797045425526e-08

Mutations O 0 1.286847606252195e-07
in O 0 5.756091159270227e-09
a O 0 7.302682902832203e-10
novel O 0 3.5205343085209506e-09
gene O 0 4.3107184488633266e-09
( O 0 1.5879645376415397e-09
WFS1 O 1 0.9995810389518738
) O 0 5.094769606195371e-10
encoding O 0 4.3086120782298565e-10
a O 0 3.695331818320824e-10
putative O 0 7.457720663239797e-09
transmembrane O 0 1.1008225442310504e-08
protein O 0 1.3796553899325659e-09
were O 0 9.7552343980567e-10
found O 0 5.128402910670182e-11
in O 0 4.5998423819915146e-11
all O 0 3.841787998837276e-11
affected O 0 2.3335880450225943e-10
individuals O 0 6.649009468007172e-12
in O 0 7.26919191507136e-10
six O 0 3.035320261801644e-08
WFS B-Disease 1 0.9984787106513977
families O 0 3.1252597731956655e-10
, O 0 2.5837856854060703e-10
and O 0 3.914804244664616e-11
these O 0 1.9924926292214096e-11
mutations O 0 2.654316766381726e-10
were O 0 4.08808209506617e-10
associated O 0 1.2461366383220707e-09
with O 0 1.0750569323647596e-09
the O 0 2.522251406844589e-06
disease O 1 0.8709304332733154
phenotype O 0 9.905200215598597e-08
. O 0 3.595008735146621e-08

WFS1 O 1 0.9999967813491821
appears O 0 6.630165927390408e-08
to O 0 2.2655127773774097e-10
function O 0 7.020761749743087e-11
in O 0 1.1063868571303814e-10
survival O 0 9.398751998901389e-09
of O 0 2.847157398733202e-09
islet O 0 7.276383939824882e-08
beta O 0 2.148713917904388e-08
- O 0 2.724016390232009e-08
cells O 0 1.0548969475721037e-09
and O 0 3.1969775715623427e-09
neurons O 0 6.277889497141587e-08
. O 0 3.1372060504963883e-09
. O 0 1.284960937653068e-08

Stable O 0 4.6247951104305685e-06
interaction O 0 1.6356469956235742e-08
between O 0 3.004078985568981e-09
the O 0 2.1213839573874793e-09
products O 0 1.427475027071523e-08
of O 0 9.006372536646268e-09
the O 0 4.416834453735419e-09
BRCA1 O 0 4.816106979887991e-08
and O 0 1.1412886635753239e-08
BRCA2 O 0 6.277314810176904e-07
tumor B-Disease 0 2.2302580759969715e-07
suppressor O 0 1.8488397302007797e-07
genes O 0 1.7808358121484957e-09
in O 0 2.9138420565288925e-09
mitotic O 0 4.798822601514985e-07
and O 0 1.3879430582619534e-07
meiotic O 0 0.0003374996595084667
cells O 0 1.8635460037330631e-06
. O 0 1.9032198395052546e-07

BRCA1 O 0 0.00016159216465894133
and O 0 5.700448468815011e-07
BRCA2 O 0 5.212968972045928e-07
account O 0 1.471388899609849e-09
for O 0 2.424400957767858e-10
most O 0 8.309197774281074e-11
cases O 0 1.5360865357472164e-10
of O 0 5.131187030826823e-09
familial O 0 1.100153284028238e-07
, O 0 1.0629922497784605e-09
early O 0 1.589064311247057e-07
onset O 1 0.984284520149231
breast B-Disease 0 1.624735705263447e-05
and I-Disease 0 2.639482659105852e-07
/ I-Disease 1 0.9999959468841553
or I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.1055112077212925e-09
encode O 0 8.9912299827688e-10
products O 0 7.1356156539081894e-09
that O 0 1.2677162271323983e-11
each O 0 7.2267708310647105e-12
interact O 0 1.8266790857701665e-10
with O 0 6.835341737065903e-10
hRAD51 O 0 5.6351723287662026e-06
. O 0 7.699067339217436e-08

Results O 0 1.3845535704604117e-06
presented O 0 5.9988940392941e-07
here O 0 1.0429814345513932e-08
show O 0 3.722612440526518e-09
that O 0 1.0919797704955769e-10
BRCA1 O 0 4.95398744249087e-08
and O 0 7.652376510236536e-09
BRCA2 O 0 1.918135978939972e-07
coexist O 0 8.118287375680211e-09
in O 0 9.01711094680735e-10
a O 0 3.468425269215203e-10
biochemical O 0 2.1519544191050954e-07
complex O 0 7.869836053941981e-07
and O 0 3.354401911792593e-08
colocalize O 0 1.587932274560444e-05
in O 0 8.709318599642302e-09
subnuclear O 0 1.959417659236351e-06
foci O 0 4.0739979567661067e-07
in O 0 2.3018533745755576e-09
somatic O 0 1.1860490900517107e-07
cells O 0 6.79577416562438e-09
and O 0 3.6169955919262975e-09
on O 0 7.341203200894597e-09
the O 0 1.460503107342248e-10
axial O 0 3.2530861338031514e-10
elements O 0 1.8816119773390483e-09
of O 0 2.5113152446465392e-08
developing O 0 3.191861353002423e-08
synaptonemal O 0 1.2897171473014168e-05
complexes O 0 1.2100110780011164e-06
. O 0 9.07268713490339e-08

Like O 0 9.06482273421716e-06
BRCA1 O 0 1.975476334337145e-05
and O 0 1.1367988008714747e-06
RAD51 O 1 0.9999511241912842
, O 0 2.587162271083798e-07
BRCA2 O 0 1.513943402642326e-06
relocates O 0 3.938289410143625e-07
to O 0 1.480222699967726e-08
PCNA O 0 0.0001348835212411359
+ O 0 5.445081718846723e-09
replication O 0 7.241155453030501e-10
sites O 0 1.962029566593415e-10
following O 0 1.8758454511935696e-10
exposure O 0 4.936581810000007e-09
of O 0 4.794254326867531e-09
S O 0 2.7431124181021005e-06
phase O 0 2.7141217628923187e-07
cells O 0 9.400181744112501e-10
to O 0 3.973611995000681e-10
hydroxyurea O 0 3.7156274856897653e-07
or O 0 1.2029352625120282e-08
UV O 1 0.9256700277328491
irradiation O 0 5.616827820631443e-06
. O 0 5.892449905786634e-08

Thus O 0 5.25533778272802e-07
, O 0 2.2437125934970936e-08
BRCA1 O 0 1.5039924505799718e-07
and O 0 8.111105564978516e-09
BRCA2 O 0 1.0307796571851213e-07
participate O 0 7.432557680431273e-09
, O 0 1.0187581889198327e-09
together O 0 9.196764461094631e-10
, O 0 1.4564471850775362e-10
in O 0 1.4777641610397296e-10
a O 0 2.1090254542777132e-10
pathway O 0 3.497457656820302e-09
( O 0 3.203317611166767e-10
s O 0 2.6092537908084523e-08
) O 0 1.5359254146307677e-10
associated O 0 3.146451155178198e-10
with O 0 2.6763126437234774e-11
the O 0 3.9097991511027885e-10
activation O 0 6.991330181449484e-09
of O 0 8.392961348135941e-08
double O 0 1.7145038100352394e-07
- O 0 7.181892556218372e-07
strand O 0 1.501034887496644e-07
break O 0 7.916810318420175e-08
repair O 0 4.661961611418519e-06
and O 0 4.356503779945342e-08
/ O 0 1.4677436865895288e-07
or O 0 9.00554353311378e-10
homologous O 0 1.279724326508358e-08
recombination O 0 5.337282615869299e-08
. O 0 3.3325409987128296e-08

Dysfunction O 0 0.023483380675315857
of O 0 7.015301889623515e-06
this O 0 2.7533344493235745e-09
pathway O 0 7.659808787252587e-09
may O 0 2.682380151330932e-10
be O 0 2.2145512854065963e-11
a O 0 7.795458029091762e-11
general O 0 4.2944098277430953e-10
phenomenon O 0 5.154176530020038e-10
in O 0 4.0667011425021826e-11
the O 0 5.842583361559406e-11
majority O 0 3.405412887444448e-12
of O 0 6.624303883207006e-11
cases O 0 2.1222813784138594e-10
of O 0 9.957576452279682e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9973002076148987
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.412003562492828e-08
. O 0 3.859449648757618e-08

A O 0 1.3912939721194562e-05
novel O 0 3.639822239165369e-07
Arg362Ser O 0 1.173249984276481e-05
mutation O 0 3.5291802813475215e-09
in O 0 7.815828539925462e-10
the O 0 8.620318348029343e-10
sterol O 0 3.1054230476001976e-07
27 O 0 5.142300665283983e-07
- O 0 1.9491803016080667e-07
hydroxylase O 0 1.0215235306532122e-05
gene O 0 4.2148883494519396e-08
( O 0 2.4047188684761522e-09
CYP27 O 1 0.9999948740005493
) O 0 8.228608905369583e-10
: O 0 5.935338331930495e-11
its O 0 6.006000558000935e-11
effects O 0 9.811163437234427e-09
on O 0 2.535271770298664e-09
pre O 0 1.5701648692356684e-07
- O 0 4.513201812272882e-09
mRNA O 0 7.670580282059802e-10
splicing O 0 5.9315747868993185e-09
and O 0 3.533152104218118e-10
enzyme O 0 4.060620728552067e-09
activity O 0 1.896211543339632e-08
. O 0 2.6468475411434156e-08

A O 0 8.237399924837518e-06
novel O 0 1.7247305095224874e-07
C O 0 1.045502926899644e-06
to O 0 3.3427360879301204e-10
A O 0 1.9832519626561407e-08
mutation O 0 1.6427456617229552e-10
in O 0 1.034536345478898e-10
the O 0 4.728258895525528e-10
sterol O 0 1.6415171444350563e-07
27 O 0 1.8985716110364592e-07
- O 0 6.034186128545116e-08
hydroxylase O 0 3.3741739571269136e-06
gene O 0 1.3467379211817843e-08
( O 0 1.6699756022475754e-09
CYP27 O 1 0.9999711513519287
) O 0 3.730457331929671e-10
was O 0 2.5437485451362818e-09
identified O 0 7.248571881612875e-11
by O 0 2.1297861044211608e-11
sequencing O 0 8.584668087507907e-09
amplified O 0 1.1618753887887578e-06
CYP27 O 1 0.9946216344833374
gene O 0 2.2163632706906355e-08
products O 0 1.0160167818185073e-08
from O 0 2.6178064160831127e-09
a O 0 1.034481611483784e-09
patient O 0 7.983560834645687e-08
with O 0 2.105743490687928e-08
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.004411044254084e-06
CTX B-Disease 1 1.0
) O 0 1.5972385369877884e-07
. O 0 1.0053261689790816e-07

The O 0 7.468811986655055e-07
mutation O 0 4.023601007929756e-08
changed O 0 1.4092496058992765e-08
the O 0 7.55870921409496e-09
adrenodoxin O 0 1.181527068183641e-06
cofactor O 0 1.288440998337137e-08
binding O 0 2.2453692238855183e-08
residue O 0 8.997703275781532e-07
362Arg O 0 1.309339836552681e-06
to O 0 7.57932472339462e-09
362Ser O 0 4.060560513607925e-06
( O 0 3.00414342291333e-08
CGT O 0 0.013480343855917454
362Arg O 0 6.996527645242168e-06
to O 0 1.034801755395165e-08
AGT O 1 0.9999454021453857
362Ser O 0 8.150201210810337e-06
) O 0 1.1558738410855085e-09
, O 0 2.5392582481131853e-10
and O 0 1.9809738571741065e-10
was O 0 1.317914133380782e-08
responsible O 0 9.010654622443326e-08
for O 0 4.606012637964341e-08
deficiency O 0 8.531597995897755e-05
in O 0 1.5016700771752767e-08
the O 0 2.13423003714297e-08
sterol O 0 6.837237265244767e-07
27 O 0 2.6782581130646577e-07
- O 0 4.39951648445458e-08
hydroxylase O 0 4.0861652905732626e-07
activity O 0 3.5553273658450735e-09
, O 0 4.556530847077411e-11
as O 0 1.6003838879119492e-11
confirmed O 0 2.8956555903070225e-11
by O 0 8.870483340917001e-12
expression O 0 1.0322637189474904e-10
of O 0 9.092791519726973e-10
mutant O 0 1.4725006769467086e-09
cDNA O 0 2.9426667769172354e-09
into O 0 2.81890755182701e-09
COS O 0 0.00012063560279784724
- O 0 7.302626841010351e-07
1 O 0 1.2495888768171426e-07
cells O 0 2.003157639762776e-08
. O 0 1.4672868253740035e-08

Quantitative O 0 3.2313471365341684e-07
analysis O 0 2.148734168372357e-08
showed O 0 5.109973777450705e-09
that O 0 8.116494455701062e-12
the O 0 9.88469098239797e-11
expression O 0 1.4010817506182605e-10
of O 0 2.027805479087874e-09
CYP27 O 0 0.01925809122622013
gene O 0 3.988677443889088e-10
mRNA O 0 4.2328499039179235e-10
in O 0 1.8284707081761553e-10
the O 0 2.8813382235703955e-10
patient O 0 6.998321477880154e-09
represented O 0 3.3535558774389074e-09
52 O 0 7.079494679373965e-08
. O 0 1.873909027949594e-08

5 O 0 3.8759048948122654e-07
% O 0 1.0454247467706068e-09
of O 0 4.615860582646292e-09
the O 0 1.5203327485835416e-09
normal O 0 3.778309931590229e-08
level O 0 2.96346456707397e-07
. O 0 1.0168135666788203e-08

As O 0 5.7219633475824594e-08
the O 0 7.054622219726525e-09
mutation O 0 1.4282885985039684e-09
occurred O 0 8.35929547804426e-09
at O 0 5.361829646943761e-09
the O 0 1.013834571850225e-09
penultimate O 0 1.446215378564375e-07
nucleotide O 0 2.041711022471304e-09
of O 0 1.2125179083000148e-08
exon O 0 3.688702321369419e-08
6 O 0 8.09094515830111e-08
( O 0 7.597703022277358e-10
- O 0 2.4069594317666088e-08
2 O 0 4.692449984133873e-09
position O 0 1.314654718420627e-09
of O 0 3.0862952193899673e-09
exon O 0 2.5137065762237398e-08
6 O 0 7.182399031080422e-08
- O 0 8.093075365422919e-08
intron O 0 2.0013709445265704e-07
6 O 0 1.5960637256284826e-08
splice O 0 2.2727867587946093e-07
site O 0 2.909134266815272e-08
) O 0 6.098638261065048e-11
of O 0 1.900820389977298e-09
the O 0 1.1503950014812858e-09
gene O 0 1.539592453525529e-09
, O 0 1.3483480998388586e-10
we O 0 5.1045723203912985e-11
hypothesized O 0 2.1575576047982992e-10
that O 0 4.660102165265911e-12
the O 0 3.39067801613524e-10
mutation O 0 6.004960972916251e-10
may O 0 4.763335281765535e-10
partially O 0 2.6455504453792855e-08
affect O 0 5.913419198755321e-10
the O 0 4.194265768031613e-10
normal O 0 3.1813857104268095e-10
splicing O 0 7.298170956460126e-10
efficiency O 0 2.041925295515057e-09
in O 0 9.782736842822715e-10
exon O 0 3.393120451278264e-08
6 O 0 1.8827904568752274e-08
and O 0 3.760088629345404e-10
cause O 0 4.769817318894809e-10
alternative O 0 2.4472415205423204e-09
splicing O 0 5.0222661585053174e-09
elsewhere O 0 9.33715660345058e-10
, O 0 1.1312374648131396e-11
which O 0 3.044370528240692e-12
resulted O 0 2.964201106792075e-10
in O 0 1.377553765502526e-10
decreased O 0 1.2449417052806666e-09
transcript O 0 7.585356343042804e-09
in O 0 9.335607842331228e-10
the O 0 5.436178618367649e-09
patient O 0 1.9800511097400886e-07
. O 0 4.944613252177987e-08

Transfection O 0 0.0001509443245595321
of O 0 2.2889144020155072e-06
constructed O 0 1.1825296496681403e-05
minigenes O 0 0.0004689921624958515
, O 0 3.919447877365201e-09
with O 0 7.294507359256741e-11
or O 0 5.009205272799022e-10
without O 0 3.7463082636080003e-10
the O 0 1.285283879326471e-09
mutation O 0 8.153022701407053e-11
, O 0 4.338908746182035e-11
into O 0 1.0305861719572817e-09
COS O 0 0.0033629329409450293
- O 0 6.724961281179276e-07
1 O 0 1.1874837113623471e-08
cells O 0 1.55408977353666e-10
confirmed O 0 6.842956062902417e-11
that O 0 8.875555997621409e-13
the O 0 1.3517111041583263e-10
mutant O 0 1.3088408579164934e-08
minigene O 0 2.4186121549973905e-07
was O 0 6.960727105820297e-09
responsible O 0 2.528337317286855e-09
for O 0 5.89446408350014e-11
a O 0 7.809506513689612e-11
mRNA O 0 4.525707308911109e-10
species O 0 1.2133303910200066e-11
alternatively O 0 7.634193277539225e-10
spliced O 0 3.26798392791261e-08
at O 0 3.184655028576344e-08
an O 0 2.982633307002658e-10
activated O 0 9.890237379295286e-06
cryptic O 0 8.793212487034907e-07
5 O 0 3.201457943191599e-08
splice O 0 6.185335905684042e-07
site O 0 9.248895338487273e-08
88 O 0 1.0931940863656564e-07
bp O 0 4.97561600809604e-08
upstream O 0 8.686225960730098e-09
from O 0 1.5131524921940809e-09
the O 0 1.731248144842823e-09
3 O 0 4.026500910470077e-09
end O 0 2.7260262935868695e-09
of O 0 9.423254176965656e-09
exon O 0 2.406441410585103e-07
6 O 0 2.9507629051295226e-07
. O 0 1.9414750696000738e-08

Our O 0 6.340210347843822e-07
data O 0 1.0457243959649531e-08
suggest O 0 3.3676877952970585e-10
that O 0 7.1126412051758514e-12
the O 0 8.238577181574058e-11
C O 0 8.084188607426768e-08
to O 0 4.357020647050014e-11
A O 0 5.746568998432622e-09
mutation O 0 1.556890449894155e-10
at O 0 4.087382432516051e-09
the O 0 7.70401020755429e-10
penultimate O 0 4.649811913282065e-08
nucleotide O 0 2.1970514296754118e-09
of O 0 5.721218609977541e-09
exon O 0 2.7725235440811957e-08
6 O 0 2.9155335923292114e-08
of O 0 1.0289642915495278e-08
the O 0 8.273481455489673e-09
CYP27 O 1 0.999998927116394
gene O 0 2.4434916312543464e-09
not O 0 3.126379016782366e-11
only O 0 1.1076009553967481e-10
causes O 0 1.1608300987120401e-08
the O 0 1.0533819505553765e-07
deficiency B-Disease 0 1.3695615734832245e-06
in I-Disease 0 4.494611793859349e-09
the I-Disease 0 7.007350699694825e-09
sterol I-Disease 0 3.708844360517105e-07
27 I-Disease 0 2.0102619657791365e-07
- I-Disease 0 3.213111909872168e-08
hydroxylase I-Disease 0 4.06676207376222e-07
activity I-Disease 0 9.832013425636887e-09
, O 0 1.9394745531808866e-10
but O 0 3.580188923102412e-11
also O 0 7.626810294425468e-11
partially O 0 2.685438893479386e-08
leads O 0 1.6623927789893855e-09
to O 0 5.85150539134105e-11
alternative O 0 1.985635433854327e-09
pre O 0 2.153715996655592e-07
- O 0 5.609960940233805e-09
mRNA O 0 1.18722054409659e-09
splicing O 0 9.50952383504955e-09
of O 0 3.485337352060469e-09
the O 0 4.093858141374085e-09
gene O 0 2.215201000410616e-08
. O 0 1.087474643668429e-08

To O 0 4.127023700561949e-08
our O 0 1.880371591767016e-08
knowledge O 0 2.3024254502956865e-08
, O 0 2.3867094411933465e-10
this O 0 1.16857235693546e-11
is O 0 6.429192681706164e-12
the O 0 9.426246588839504e-11
first O 0 2.657847830711546e-10
report O 0 3.976172863184857e-11
regarding O 0 1.211837630243906e-09
effects O 0 2.5046947627060945e-08
on O 0 7.246962141493896e-09
pre O 0 1.830573950201142e-07
- O 0 4.505735784476883e-09
mRNA O 0 1.5123438612540951e-10
splicing O 0 1.5449640455855729e-09
of O 0 5.051112861309548e-10
a O 0 5.1971951048335185e-11
mutation O 0 1.0611300726992567e-10
at O 0 2.7456990014940175e-09
the O 0 7.194362328100112e-10
- O 0 1.069745447779269e-08
2 O 0 4.691179444904492e-09
position O 0 7.279764013823353e-10
of O 0 1.4930299219173548e-09
a O 0 6.038003985686657e-10
5 O 0 2.483383276796758e-08
splice O 0 3.504498863549088e-06
site O 0 4.222122242936166e-07
. O 0 3.43112098732945e-08

ATM O 0 0.0006598287145607173
germline O 0 6.118254532339051e-06
mutations O 0 9.536990575043092e-08
in O 0 1.4268244363790927e-08
classical O 1 0.9999511241912842
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 9.591190064384136e-06
in O 0 8.800357775839984e-09
the O 0 6.281204445457433e-09
Dutch O 0 6.306714567472227e-06
population O 0 8.208775326146167e-11
. O 0 2.449688674133199e-09

Germline O 0 4.9323203711537644e-05
mutations O 0 6.858502388240595e-08
in O 0 6.341345226701378e-09
the O 0 2.826493483709669e-09
ATM O 0 3.613235094235279e-05
gene O 0 2.484173311501081e-09
are O 0 9.039712554892443e-12
responsible O 0 6.537921870553021e-10
for O 0 2.3230585510791713e-10
the O 0 3.9634360859963635e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.7352436184883118
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.0477148154895985e-07
. O 0 3.759547340109748e-08

In O 0 2.393685463175643e-07
our O 0 9.974395531742175e-09
study O 0 2.8515703132114822e-09
, O 0 6.7010855198113e-11
we O 0 3.4520736963417065e-12
have O 0 8.899186183970731e-13
determined O 0 5.964913285527729e-11
the O 0 1.342671390736072e-10
ATM O 0 1.9563819364520896e-07
mutation O 0 2.663557430171437e-10
spectrum O 0 2.1540471628611613e-09
in O 0 6.325878709745325e-10
19 O 0 7.624563203023627e-09
classical O 0 8.959547130871215e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.281508481085439e-08
, O 0 7.791013667546309e-11
including O 0 4.4858713965645336e-11
some O 0 5.025852130302599e-12
immigrant O 0 5.3493820484362686e-11
populations O 0 3.838052792248803e-11
, O 0 1.1376508242399996e-11
as O 0 1.885641122412185e-11
well O 0 1.0640525960337044e-10
as O 0 1.3110981744723915e-10
12 O 0 1.20111887103036e-09
of O 0 8.213258406719603e-10
Dutch O 0 1.6865134000454418e-07
ethnic O 0 5.476782569124872e-11
origin O 0 8.634437054233501e-10
. O 0 2.313729430269973e-09

Both O 0 1.220062699758273e-07
the O 0 2.1128483851384772e-08
protein O 0 4.082551630091302e-09
truncation O 0 3.196126385773823e-07
test O 0 1.0915439929704007e-07
( O 0 2.900799600524806e-09
PTT O 0 1.5685091057093814e-05
) O 0 2.90620860710078e-10
and O 0 1.3646687946344827e-10
the O 0 1.1098446467405765e-10
restriction O 0 1.94112503848487e-10
endonuclease O 0 1.3572099888392586e-08
fingerprinting O 0 6.360474458233512e-08
( O 0 1.463602017359733e-09
REF O 0 1.3650844266521744e-05
) O 0 2.5552412616369757e-11
method O 0 2.921808628375544e-11
were O 0 1.0485270637849986e-11
used O 0 3.0841208059628755e-11
and O 0 4.814179957457476e-11
compared O 0 4.30704846787755e-11
for O 0 9.586159123442517e-12
their O 0 1.6433465699350336e-11
detection O 0 9.582682203301829e-09
efficiency O 0 3.383276325763518e-09
, O 0 6.26932464276031e-11
identifying O 0 3.497308831423851e-10
76 O 0 2.066546489487564e-09
% O 0 2.32745138266377e-12
and O 0 6.094170307280322e-12
60 O 0 7.870997603687258e-11
% O 0 1.1681194206358825e-12
of O 0 4.616806936752482e-11
the O 0 3.779156709793341e-10
mutations O 0 2.7317934581105874e-09
, O 0 1.7562856724495646e-09
respectively O 0 3.953348581831051e-08
. O 0 1.892814793791331e-08

Most O 0 1.4070693055145966e-07
patients O 0 2.229876905346373e-08
were O 0 4.663025077178418e-09
found O 0 7.22162551980432e-10
to O 0 1.6097158328509664e-10
be O 0 4.480333049006191e-10
compound O 0 7.278632097040827e-07
heterozygote O 0 7.274792096723104e-06
. O 0 2.5654964019850013e-07

Seventeen O 0 6.006323928886559e-06
mutations O 0 1.39652094333087e-08
were O 0 3.483237476231693e-09
distinct O 0 9.736497164070101e-10
, O 0 1.6479802245061848e-10
of O 0 6.484461412270548e-09
which O 0 1.0069637484955152e-10
10 O 0 8.287676100948715e-10
were O 0 4.6516879237401554e-10
not O 0 6.337010083345973e-11
reported O 0 3.1011888612653138e-09
previously O 0 7.122306300288983e-08
. O 0 3.922755453800164e-08

Mutations O 0 4.349446953710867e-07
are O 0 9.383325227929618e-10
small O 0 1.3024847866915934e-09
deletions O 0 3.3030264745548266e-08
or O 0 1.7071673852342428e-08
point O 0 3.2342200029233936e-08
mutations O 0 1.0187936716476997e-08
frequently O 0 2.705555113280411e-09
affecting O 0 2.3073182475741305e-08
splice O 0 2.1337473299354315e-06
sites O 0 1.5296609490178525e-07
. O 0 5.864318453063788e-08

Moreover O 0 5.0953958634636365e-06
, O 0 7.053777295595864e-08
a O 0 3.558578498541465e-08
16 O 0 3.622521091983799e-07
. O 0 5.5127802767174217e-08

7 O 0 1.4398918210645206e-05
- O 0 1.9289623196527828e-06
kb O 0 1.2763478025590302e-06
genomic O 0 5.806630554161529e-08
deletion O 0 2.3725915454519964e-08
of O 0 2.735449733393125e-08
the O 0 6.724535150937072e-09
3 O 0 6.148282327700372e-09
end O 0 9.161014169478676e-10
of O 0 5.022081639438625e-10
the O 0 3.3546543320994715e-10
gene O 0 1.1626902218786483e-10
, O 0 1.0861505271575478e-11
most O 0 1.6056458246316296e-11
likely O 0 4.891120841676866e-11
a O 0 4.206489670477431e-11
result O 0 1.3583326130550688e-10
of O 0 1.3662869724484494e-09
recombination O 0 1.926500486915117e-10
between O 0 7.199232182619753e-11
two O 0 7.796826378969612e-11
LINE O 0 7.486940489798144e-07
elements O 0 1.4151268601381162e-08
, O 0 8.255570116411093e-10
was O 0 1.0008889717028069e-08
identified O 0 1.0952077467152321e-08
. O 0 1.3501560758300002e-08

The O 0 1.4247662249999848e-07
most O 0 7.038262195280254e-10
frequently O 0 3.933682823920037e-10
found O 0 1.3553899669282998e-10
mutation O 0 1.5753656712469422e-10
, O 0 3.5230499073612975e-11
identified O 0 1.279549799448887e-10
in O 0 2.2546668698719685e-10
three O 0 2.501922835573822e-10
unrelated O 0 1.460256626728551e-08
Turkish O 0 1.7014015440963703e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
individuals O 0 7.614604502492739e-10
, O 0 7.057202600080359e-10
was O 0 4.235347628167574e-09
previously O 0 2.08520334332718e-09
described O 0 2.3920462832727196e-10
to O 0 1.5496550223592642e-11
be O 0 3.9435822662969855e-11
a O 0 3.7916617068312064e-10
Turkish O 0 3.069799348054403e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 0.4580478370189667
mutation O 0 1.9386449423564045e-07
. O 0 3.012153015902186e-08

The O 0 3.514787181302381e-07
presence O 0 1.813606687051106e-08
of O 0 7.08049441300318e-08
a O 0 1.0876841649576363e-08
founder O 0 2.1536867279792204e-05
mutation O 0 3.2554778872651013e-09
among O 0 9.692134594896373e-11
relatively O 0 7.298808085698383e-11
small O 0 3.351007665797212e-11
ethnic O 0 8.344941491295055e-13
population O 0 1.5842070765024335e-13
groups O 0 1.6463628962730403e-13
in O 0 1.0772088950006253e-11
Western O 0 2.4169917178795686e-09
Europe O 0 4.4769778995146225e-09
could O 0 2.353676697985918e-10
indicate O 0 1.7190855683413275e-10
a O 0 1.7019377573923578e-10
high O 0 5.362259081209686e-09
carrier O 0 3.545729265752584e-10
frequency O 0 9.915795962101015e-10
in O 0 1.553381451246949e-10
such O 0 4.377372908592747e-10
communities O 0 4.7162465044436885e-09
. O 0 1.5194029145959576e-08

In O 0 3.7710819356107095e-07
patients O 0 4.087587157641792e-08
of O 0 4.260555996893345e-08
Dutch O 0 1.3481202358889277e-06
ethnic O 0 8.399338863318562e-11
origin O 0 1.2973171148455975e-10
, O 0 2.275281005270635e-11
however O 0 2.3507772117792314e-11
, O 0 1.581853571741565e-11
no O 0 2.8214005784454876e-11
significant O 0 3.9362196835313057e-10
founder O 0 5.503062538991799e-07
effect O 0 1.1832626434227222e-08
could O 0 6.490880055665116e-10
be O 0 3.237592693938751e-10
identified O 0 7.751238761954937e-09
. O 0 1.4760923150447525e-08

The O 0 1.4811608650688868e-07
observed O 0 1.8636471921240627e-08
genetic O 0 2.8608098112670177e-09
heterogeneity O 0 6.946840436228285e-09
including O 0 6.553728115754609e-10
the O 0 1.0426189911427741e-09
relative O 0 4.7621107057693735e-09
high O 0 5.961168625390201e-08
percentage O 0 2.851189506714036e-09
of O 0 7.3651720278178345e-09
splice O 0 2.2490828541776864e-06
- O 0 1.782033507424785e-07
site O 0 3.3154037737403996e-08
mutations O 0 1.1551530842979219e-09
had O 0 3.049889230055669e-10
no O 0 1.6065809793630592e-10
reflection O 0 6.322987022855386e-09
on O 0 9.816441881582705e-09
the O 0 6.7548602267208935e-09
phenotype O 0 7.261576939754377e-08
. O 0 2.0672887401929074e-08

All O 0 1.6400868219079712e-07
patients O 0 2.1706361152951104e-08
manifested O 0 1.8671950385851233e-07
classical O 0 1.1484527021821123e-05
A B-Disease 1 1.0
- I-Disease 1 0.9999548196792603
T I-Disease 1 1.0
and O 0 5.674249514697749e-09
increased O 0 1.0927512228420255e-09
cellular O 0 1.203704584895604e-07
radioresistant O 0 2.0451282125577563e-06
DNA O 0 4.851639801017882e-07
synthesis O 0 1.9121198135962914e-07
. O 0 2.6945716768977945e-08

Determination O 0 1.2645903098018607e-06
of O 0 1.2379504710224865e-07
the O 0 1.7977016542047863e-09
genomic O 0 3.759509592526911e-09
structure O 0 3.122329950144831e-09
of O 0 1.583999598153696e-08
the O 0 7.0873822366479544e-09
COL4A4 O 1 0.9999992847442627
gene O 0 1.4527274938558321e-09
and O 0 8.266122508704399e-11
of O 0 2.339837879006268e-09
novel O 0 2.4676367615938943e-08
mutations O 0 3.814697322468419e-07
causing O 0 0.00031668649171479046
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.1908123269677162e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.7204625635258708e-07
a O 0 3.7611403058690485e-07
progressive O 1 0.9999994039535522
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.008691896684467793
by O 0 2.2265921018060908e-07
glomerular B-Disease 1 0.9999951124191284
basement I-Disease 1 1.0
membrane I-Disease 0 0.0015085878549143672
abnormalities I-Disease 1 0.9999998807907104
and O 0 5.70532208143959e-08
associated O 0 3.56276892432561e-08
with O 0 1.6118059109615501e-09
mutations O 0 3.826668315554116e-09
in O 0 1.9620194358083154e-09
either O 0 4.3262859961146205e-09
the O 0 5.524063695361292e-08
COL4A3 O 1 0.9999997615814209
or O 0 1.0952431850341782e-08
the O 0 1.663900306425603e-08
COL4A4 O 1 0.9999961853027344
gene O 0 5.140806891290595e-09
, O 0 1.0822426982359801e-10
which O 0 3.965160838559356e-11
encode O 0 3.985840546505415e-10
the O 0 2.28848850980512e-09
alpha3 O 0 2.218411509602447e-06
and O 0 1.1041301206660137e-08
alpha4 O 0 1.506986518506892e-05
type O 0 1.8600589100969955e-05
IV O 1 1.0
collagen O 1 1.0
chains O 0 0.231063112616539
, O 0 8.480063229399093e-08
respectively O 0 1.578977872895848e-07
. O 0 3.543136983807926e-08

To O 0 1.8482168684386124e-08
date O 0 2.2814037947682664e-07
, O 0 6.175027156274382e-10
mutation O 0 6.090036808181765e-11
screening O 0 8.809389329123007e-10
in O 0 9.003632561732644e-11
the O 0 1.2619534583979686e-10
two O 0 6.026782545243137e-11
genes O 0 1.16493439894505e-10
has O 0 6.284074649531846e-11
been O 0 3.607733556343362e-10
hampered O 0 7.776876032039581e-08
by O 0 1.4466519648870246e-10
the O 0 5.885670839589352e-10
lack O 0 5.816534476288382e-10
of O 0 9.901810482659812e-10
genomic O 0 2.9522129185721724e-09
structure O 0 1.0893887569807248e-08
information O 0 3.757552491379101e-09
. O 0 1.4533989123322044e-08

We O 0 9.958165492207627e-08
report O 0 6.43771880248778e-09
here O 0 5.790786739012788e-10
the O 0 2.832941936592448e-10
complete O 0 1.5719597845631483e-09
characterization O 0 4.941414388781595e-09
of O 0 8.29066770791087e-09
the O 0 3.22510773642648e-09
48 O 0 1.985155506645242e-08
exons O 0 2.140059152111462e-08
of O 0 8.955839625457429e-09
the O 0 1.3405564658341973e-08
COL4A4 O 1 0.9999998807907104
gene O 0 6.1482121616052154e-09
, O 0 1.0746688261509263e-10
a O 0 5.96617616421824e-11
comprehensive O 0 4.6459978086943465e-09
gene O 0 4.733492486863611e-10
screen O 0 2.718756775266229e-09
, O 0 9.905223863349022e-11
and O 0 1.1897292873097598e-10
the O 0 9.508480114384099e-11
subsequent O 0 7.451276262671058e-10
detection O 0 9.362488384567769e-08
of O 0 4.062115976921632e-09
10 O 0 4.273068565652238e-10
novel O 0 3.379443669349058e-10
mutations O 0 2.074380528460651e-10
in O 0 2.8689831066408544e-10
eight O 0 1.676627547908538e-08
patients O 0 3.403310131488979e-07
diagnosed O 0 0.02565852366387844
with O 0 4.033490768051706e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.014638787135482e-05

Furthermore O 0 1.8870437088480685e-06
, O 0 2.0841863346277023e-08
we O 0 2.447576585851152e-10
identified O 0 4.90195717350872e-10
a O 0 2.0677520806700045e-10
glycine O 0 8.298040476972801e-09
to O 0 2.1917766213075396e-10
alanine O 0 1.3460240033680293e-08
substitution O 0 1.2603816657019706e-08
in O 0 1.4454584196244014e-09
the O 0 2.85265855382022e-09
collagenous O 0 3.2146556350198807e-06
domain O 0 5.430703664544012e-10
that O 0 1.1224383401897686e-11
is O 0 2.2751420539202094e-11
apparently O 0 4.4975340118824647e-10
silent O 0 8.14521339265184e-09
in O 0 1.457508835844834e-10
the O 0 1.6170983996310895e-10
heterozygous O 0 1.8058385342634153e-10
carriers O 0 2.3470955734516963e-10
, O 0 2.3409391092243936e-10
in O 0 2.40580622090647e-09
11 O 0 1.0677236872425055e-07
. O 0 3.195119901988619e-08

5 O 0 6.858115852992341e-07
% O 0 8.70639116357097e-10
of O 0 1.3719432256920072e-09
all O 0 6.8878576453546e-11
control O 0 6.209526781653096e-10
individuals O 0 1.0471200295736338e-11
, O 0 7.908015908775212e-11
and O 0 1.3316789337913804e-10
in O 0 2.575598068155216e-10
one O 0 4.8054463186453233e-11
control O 0 1.8909329657645912e-10
individual O 0 7.423677124418493e-12
homozygous O 0 1.7319540246418796e-10
for O 0 4.565561123603956e-11
this O 0 6.804599939069789e-11
glycine O 0 1.1426133283976014e-07
substitution O 0 1.9272600582098676e-07
. O 0 8.338088264281396e-08

There O 0 1.8084242014992924e-07
has O 0 1.086553513829358e-09
been O 0 1.2855823350310658e-10
no O 0 4.1714780935064866e-11
previous O 0 3.0093477709769445e-10
finding O 0 2.162270501537833e-10
of O 0 7.203946883471701e-10
a O 0 1.335881683051099e-10
glycine O 0 6.537539398721037e-09
substitution O 0 1.2605979371471676e-08
that O 0 9.829734942679025e-11
is O 0 1.7540876737220934e-11
not O 0 6.860437998940094e-12
associated O 0 4.1238798487164274e-10
with O 0 6.61751001218569e-11
any O 0 5.427328031437639e-10
obvious O 0 7.670204027476757e-09
phenotype O 0 3.857571151399952e-09
in O 0 3.6142769332947466e-10
homozygous O 0 5.144416448388256e-09
individuals O 0 3.652370628159929e-10
. O 0 3.591273767256098e-08

Founder O 0 0.027097605168819427
BRCA1 O 0 3.846226536552422e-05
and O 0 1.7623173675929138e-07
BRCA2 O 0 1.4555816960637458e-06
mutations O 0 7.1539312251900355e-09
in O 0 3.0711566623153885e-09
French O 0 5.802982286695624e-06
Canadian O 1 0.9999090433120728
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.6272169974013195e-09
. O 0 3.043668783675457e-08

We O 0 3.351012622943017e-08
have O 0 1.9437185194703943e-10
identified O 0 5.758284404855374e-10
four O 0 1.8576830351779705e-10
mutations O 0 3.1828224084096135e-11
in O 0 5.902890676257044e-11
each O 0 1.1000505194258547e-11
of O 0 8.573083576379759e-09
the O 0 3.115196989256219e-07
breast B-Disease 1 0.9999988079071045
cancer I-Disease 0 0.4494245946407318
- O 0 2.7206936010770733e-06
susceptibility O 0 2.2529287946326804e-07
genes O 0 2.5270836534474483e-09
, O 0 2.328964798792299e-09
BRCA1 O 0 1.7980116240323696e-07
and O 0 2.0998918159875757e-08
BRCA2 O 0 4.061351432937954e-07
, O 0 2.569131574148287e-10
in O 0 7.135421697945787e-10
French O 0 1.492542992309609e-06
Canadian O 1 0.9046734571456909
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8229068517684937
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.502186484207527e-10
from O 0 1.2960571282860656e-08
Quebec O 0 6.90607339492999e-06
. O 0 1.8118802813660295e-07

To O 0 1.3334827997368848e-07
identify O 0 4.0891163166634215e-07
founder O 0 0.00011271930998191237
effects O 0 0.0002174952533096075
, O 0 4.837444222971499e-09
we O 0 2.7212040953905614e-10
examined O 0 1.4495092237609697e-08
independently O 0 2.8839843846384383e-09
ascertained O 0 3.528556291598761e-08
French O 0 3.949452889173699e-07
Canadian O 0 7.3477026489854325e-06
cancer B-Disease 0 8.533628488294198e-07
families O 0 5.555359991471498e-12
for O 0 1.6798068144807665e-11
the O 0 8.510740029388231e-11
distribution O 0 3.019794969638667e-10
of O 0 1.1121231713318025e-09
these O 0 1.2006945437903482e-10
eight O 0 7.509864730081972e-09
mutations O 0 2.3123364556454362e-08
. O 0 4.7556866888953664e-08

Mutations O 0 2.1984784837059124e-07
were O 0 1.0107033432404933e-08
found O 0 1.5703116584830923e-09
in O 0 6.285420517393447e-10
41 O 0 7.806208124350178e-09
of O 0 1.516614744900835e-08
97 O 0 2.5774590994842583e-07
families O 0 1.991127041023333e-09
. O 0 1.5317667134695512e-08

Six O 0 1.8808972299666493e-06
of O 0 2.3938977733450884e-07
eight O 0 4.049964275054663e-08
mutations O 0 2.140968513586472e-09
were O 0 1.2447802788528861e-09
observed O 0 1.220034295812411e-08
at O 0 4.0994862615661987e-08
least O 0 1.0077385592666133e-09
twice O 0 3.441509122126263e-08
. O 0 1.804697014051726e-08

The O 0 4.525968051893869e-06
BRCA1 O 0 8.181499651982449e-06
C4446T O 0 9.722068170958664e-06
mutation O 0 1.8748492536246886e-08
was O 0 2.581079172614409e-08
the O 0 5.192778429474743e-10
most O 0 8.212251711992025e-11
common O 0 1.3793180486665335e-10
mutation O 0 7.693536779873611e-11
found O 0 4.6565237776796664e-11
, O 0 4.823481544735664e-11
followed O 0 3.688628014142381e-10
by O 0 2.065950466256794e-10
the O 0 2.1335422317747543e-08
BRCA2 O 0 4.7365956561407074e-06
8765delAG O 0 1.042835083353566e-05
mutation O 0 2.1026177421390457e-07
. O 0 4.670994258049177e-08

Together O 0 3.8839303329041286e-07
, O 0 4.3698751284182435e-09
these O 0 1.1897452467657388e-10
mutations O 0 3.482558130762925e-10
were O 0 5.484918075282508e-10
found O 0 1.1220364914965586e-10
in O 0 9.390248301155424e-11
28 O 0 3.379522883761865e-09
of O 0 6.584542244780778e-09
41 O 0 2.396207454680166e-09
families O 0 5.6585370070139085e-12
identified O 0 6.986031197975251e-11
to O 0 4.224580754663698e-11
have O 0 6.062707974541226e-11
a O 0 4.517843876783445e-09
mutation O 0 4.935850128617858e-08
. O 0 3.091976807922947e-08

The O 0 5.393793571784045e-07
odds O 0 6.097129698900972e-07
of O 0 4.044714785322867e-08
detection O 0 2.4951137334028317e-07
of O 0 1.1368586072535436e-08
any O 0 2.428941769938575e-10
of O 0 6.611435399150878e-09
the O 0 3.231055423214002e-09
four O 0 3.3492728590545084e-09
BRCA1 O 0 7.119644607200826e-08
mutations O 0 8.920464367179193e-09
was O 0 2.2054963721984677e-07
18 O 0 2.7280518111183483e-07
. O 0 4.1354468294230173e-08

7x O 0 0.015302559360861778
greater O 0 4.386487262308947e-07
if O 0 2.7057822649112495e-09
one O 0 3.602274034619768e-10
or O 0 7.670108992385849e-11
more O 0 4.388159974277883e-12
cases O 0 6.661634022187002e-10
of O 0 2.0636072804336436e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.3758430839061475e-08
also O 0 7.830359277649634e-11
present O 0 1.4920384372452133e-10
in O 0 2.1365453850563654e-10
the O 0 4.854256996367212e-09
family O 0 1.3134197729414154e-08
. O 0 4.61959714925797e-08

The O 0 5.679210630660236e-07
odds O 0 3.010637215083989e-07
of O 0 1.74605254699145e-08
detection O 0 1.9565349873573723e-07
of O 0 4.7140518155686095e-09
any O 0 2.1599910748903994e-10
of O 0 1.0179389775544223e-08
the O 0 1.4891534672045736e-09
four O 0 6.531008622800982e-09
BRCA2 O 0 3.5204496384722006e-07
mutations O 0 1.345497846472199e-08
was O 0 2.641189951191336e-07
5 O 0 5.180986590858083e-07
. O 0 6.432296117964142e-08

3x O 0 0.00014499519602395594
greater O 0 1.1981269665284344e-07
if O 0 8.315655386503806e-10
there O 0 1.4589468522174798e-10
were O 0 5.872528574535352e-10
at O 0 2.9460196504516034e-09
least O 0 8.214206224932408e-12
five O 0 1.8126286929764923e-11
cases O 0 4.312046206211839e-11
of O 0 7.652043620964832e-08
breast B-Disease 1 0.9998916387557983
cancer I-Disease 0 5.878552474314347e-05
in O 0 3.5445884005724793e-09
the O 0 1.8754001018805866e-08
family O 0 9.870757544661046e-09
. O 0 2.406931898235598e-08

Interestingly O 0 5.114382020110497e-06
, O 0 6.8861965019095805e-09
the O 0 9.815183110717385e-10
presence O 0 9.355428653989861e-10
of O 0 5.354943510837984e-08
a O 0 2.0885723017727287e-07
breast B-Disease 1 0.9998737573623657
cancer I-Disease 0 3.3672233257675543e-05
case O 0 6.499580873509103e-09
< O 0 1.2067131294202227e-08
36 O 0 4.24942703247666e-09
years O 0 2.2333095095472544e-10
of O 0 9.03694563625379e-10
age O 0 1.1025702573164153e-09
was O 0 6.356515314109856e-10
strongly O 0 2.3573009863553374e-11
predictive O 0 6.460902923777212e-10
of O 0 1.4573510176418836e-09
the O 0 2.1267265726265805e-10
presence O 0 1.3057425973794778e-10
of O 0 1.2238279278875552e-09
any O 0 2.0057783212124036e-10
of O 0 3.127157421900506e-09
the O 0 1.3438787860309276e-09
eight O 0 4.104976802921101e-09
mutations O 0 4.464553615690647e-09
screened O 0 3.341178285154456e-07
. O 0 5.343211029185113e-08

Carriers O 0 9.252971011619593e-08
of O 0 1.5457200674973137e-07
the O 0 1.7795014350951988e-09
same O 0 2.2428973955879172e-10
mutation O 0 6.585024886485158e-11
, O 0 1.3016292037260069e-11
from O 0 1.0266573181871852e-11
different O 0 1.5943262335338382e-12
families O 0 1.2688526444815107e-12
, O 0 1.5097232491934065e-11
shared O 0 1.966003228270896e-11
similar O 0 1.2901316126523454e-10
haplotypes O 0 2.294296752580749e-09
, O 0 1.3237272389332588e-10
indicating O 0 4.466757796972587e-10
that O 0 3.575096165289726e-12
the O 0 1.53085391585428e-10
mutant O 0 1.6117535084347878e-09
alleles O 0 1.2631112301930703e-11
were O 0 9.26832499636987e-11
likely O 0 9.868075107055674e-11
to O 0 4.598947958567301e-11
be O 0 4.0207562973515465e-11
identical O 0 6.942690866651446e-10
by O 0 1.0261116262233472e-10
descent O 0 9.902093589531091e-10
for O 0 1.566899388016907e-11
a O 0 1.1334798377671262e-10
mutation O 0 1.550433254005057e-10
in O 0 2.1852147868983707e-10
the O 0 1.2262908466453837e-09
founder O 0 1.6172425887361896e-07
population O 0 3.866871059465815e-11
. O 0 2.567545731579912e-09

The O 0 6.838855881596828e-08
identification O 0 8.854847521888587e-08
of O 0 1.2336887778019445e-07
common O 0 7.840532845193593e-08
BRCA1 O 0 1.2272786307221395e-06
and O 0 5.591525464865299e-08
BRCA2 O 0 9.75060856944765e-07
mutations O 0 1.053527598493531e-09
will O 0 2.1229655533527847e-10
facilitate O 0 4.487339388958844e-09
carrier O 0 1.1695329149574718e-08
detection O 0 1.1302259395051806e-07
in O 0 8.745353330397165e-10
French O 0 4.1151787399940076e-07
Canadian O 0 0.0027651593554764986
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999970197677612
and O 0 0.06902740150690079
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.97564791193372e-08
. O 0 8.537676876585465e-08

Are O 0 2.184896459311858e-07
Dp71 O 0 0.0004231755738146603
and O 0 5.680223011950147e-07
Dp140 O 0 0.0002902538108173758
brain O 0 0.0001397819578414783
dystrophin O 0 4.756780072057154e-06
isoforms O 0 3.6159764960075336e-08
related O 0 1.3269850285269058e-07
to O 0 1.3629794182179467e-08
cognitive B-Disease 0 0.008880358189344406
impairment I-Disease 1 0.9999973773956299
in O 1 0.9096421599388123
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998797178268433

Molecular O 0 6.225546258065151e-06
study O 0 5.5725209335832915e-08
and O 0 2.201472781848679e-09
neuropsychological O 0 3.362086999914027e-06
analysis O 0 5.921458434698934e-09
were O 0 2.701131096571885e-09
performed O 0 3.693334704735207e-08
concurrently O 0 2.11982675857314e-09
on O 0 6.20743412227398e-09
49 O 0 1.6023442128698662e-08
patients O 0 5.362975397105174e-09
with O 0 9.980565351952464e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 4.948573106844378e-09
in O 0 6.372417593603075e-10
order O 0 5.050409535023448e-10
to O 0 6.495087800928445e-11
find O 0 9.382121468615168e-11
a O 0 6.137684110951724e-11
molecular O 0 1.6264812829902553e-09
explanation O 0 1.4977638573832053e-10
for O 0 1.6019482962370546e-10
the O 0 1.787956804832902e-08
cognitive B-Disease 0 5.951303683104925e-05
impairment I-Disease 0 0.0003655123000498861
observed O 0 5.3901430874248035e-08
in O 0 1.9244128068862665e-08
most O 0 1.2149862982369086e-07
DMD B-Disease 1 1.0
patients O 0 1.4402448869077489e-06
. O 0 7.60345102435167e-08

Complete O 0 6.196382855705451e-07
analysis O 0 1.2343733146735758e-08
of O 0 1.859053000430322e-08
the O 0 4.4063503956692784e-09
dystrophin O 0 1.2984072554900195e-06
gene O 0 1.2667030979685023e-08
was O 0 1.9483119118035575e-08
performed O 0 8.23400228000537e-08
to O 0 7.421330910917234e-11
define O 0 7.297837334441226e-10
the O 0 7.437034876822679e-10
localization O 0 4.637704265064713e-08
of O 0 1.3718516322924756e-09
deletions O 0 1.9774568649211233e-09
and O 0 8.619348013105821e-10
duplications O 0 7.115774991461876e-08
in O 0 1.132767213363195e-09
relation O 0 9.66590585349536e-10
to O 0 1.687144729478618e-10
the O 0 2.6541007169811337e-09
different O 0 2.6248475393231274e-08
DMD B-Disease 1 1.0
promoters O 0 0.0006870388169772923
. O 0 6.207341698427626e-07

Qualitative O 0 6.586403173969302e-07
analysis O 0 6.535496765991411e-08
of O 0 1.7784461192604795e-07
the O 0 3.154981698116899e-08
Dp71 O 0 6.289861630648375e-05
transcript O 0 1.8562900550023187e-07
and O 0 4.5337161802549986e-10
testing O 0 4.766263828059891e-09
for O 0 1.8383943672928282e-11
the O 0 1.8244740787598523e-11
specific O 0 1.0795393225182526e-11
first O 0 6.505443406190636e-10
exon O 0 1.4868950515278812e-08
of O 0 1.712293951072752e-08
Dp140 O 0 4.237450923483266e-07
were O 0 3.5104230633464795e-09
also O 0 2.4088583905346184e-10
carried O 0 4.723430091502223e-09
out O 0 4.660313468463073e-09
. O 0 1.086210144052302e-08

Neuropsychological O 0 0.0006211746367625892
analysis O 0 1.3943841281616187e-07
assessed O 0 1.0465903415024513e-06
verbal O 0 1.8171925830756663e-06
and O 0 8.205530832583463e-08
visuospatial O 0 1.3874000615032855e-05
intelligence O 0 1.1707854952192065e-07
, O 0 2.9271998158719725e-09
verbal O 0 5.391489139583427e-07
memory O 0 0.40279972553253174
, O 0 1.325949838815177e-08
and O 0 1.6269474656382954e-08
reading O 0 5.76697857468389e-06
skills O 0 1.061623038367543e-06
. O 0 5.457384588680725e-08

Comparison O 0 8.086847174126888e-07
of O 0 4.018018842089077e-07
molecular O 0 6.085772383812582e-07
and O 0 1.3623140837637493e-08
psychometric O 0 1.662259455770254e-05
findings O 0 4.010369281104431e-08
demonstrated O 0 1.1095917074044337e-08
that O 0 4.15912408679997e-11
deletions O 0 8.781093185916689e-09
and O 0 2.0488890584147157e-09
duplications O 0 9.235532871798569e-08
that O 0 1.18255516490251e-10
were O 0 9.038514936499098e-10
localized O 0 2.498201112643983e-08
in O 0 3.3411757804913123e-09
the O 0 3.861502229085545e-09
distal O 0 2.851076885690418e-08
part O 0 1.302256191770823e-09
of O 0 1.8638781185131847e-08
the O 0 2.0688467827767454e-08
gene O 0 3.3899945073301296e-09
seemed O 0 6.321343448689731e-10
to O 0 1.0363685604142248e-11
be O 0 8.684672772596436e-12
preferentially O 0 1.2954237682549774e-09
associated O 0 3.918035229588668e-09
with O 0 5.652127210709068e-09
cognitive B-Disease 1 0.7463890910148621
impairment I-Disease 1 0.9998694658279419
. O 0 1.7184141825055121e-06

Two O 0 2.974024937429931e-07
altered O 0 2.4505181954737054e-06
Dp71 O 0 8.267434895969927e-05
transcripts O 0 1.9565363800211344e-06
and O 0 1.284451300875844e-08
two O 0 9.826833791137801e-10
deleted O 0 6.636552196681578e-09
Dp140 O 0 9.885835083878192e-08
DNA O 0 1.3084738625934733e-08
sequences O 0 1.4152630456454318e-10
were O 0 7.359590020739049e-11
found O 0 1.9608687937267e-11
in O 0 3.6762221738984024e-11
four O 0 4.1868966627056636e-10
patients O 0 5.9763189952377616e-09
with O 0 4.8623029158534337e-08
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 1.405307739332784e-05

These O 0 1.670218452431982e-08
findings O 0 2.0380818810394885e-08
suggest O 0 6.143367481392659e-10
that O 0 3.5587138704634702e-12
some O 0 3.4275947965317632e-12
sequences O 0 1.0348323586928387e-10
located O 0 4.6440198908648256e-10
in O 0 5.606211675446282e-11
the O 0 2.638442242464123e-10
distal O 0 9.682647572617498e-09
part O 0 1.6242335254545992e-09
of O 0 1.65882720892796e-08
the O 0 5.331398877927995e-09
gene O 0 3.592256492268575e-10
and O 0 3.635835243986918e-10
, O 0 8.505368631617216e-11
in O 0 6.585301054462533e-11
particular O 0 1.0449398291090262e-10
, O 0 8.855679384245363e-11
some O 0 1.8840566606836973e-10
DMD B-Disease 1 1.0
isoforms O 0 4.740523973367772e-09
expressed O 0 4.929334718184464e-10
in O 0 1.575291452837746e-09
the O 0 4.2962085444742115e-08
brain O 0 0.0033169658854603767
may O 0 6.625318071940001e-10
be O 0 2.3228224899085603e-11
related O 0 9.020809654813888e-10
to O 0 2.5073546017218007e-10
the O 0 1.6207591713168767e-08
cognitive B-Disease 0 9.621768549550325e-05
impairment I-Disease 0 0.1633864939212799
associated O 0 2.3050281470204936e-06
with O 0 1.8768996596918441e-06
DMD B-Disease 1 1.0
. O 0 2.868751494133903e-07
. O 0 1.0567627128921231e-07

I1307K O 0 0.0005384609685279429
APC O 0 4.790433376911096e-05
and O 0 1.0296734131998164e-07
hMLH1 O 0 3.008862677233992e-06
mutations O 0 6.152529152814168e-09
in O 0 1.6384250622891727e-09
a O 0 1.0960053975495043e-09
non O 0 1.9731631084596302e-07
- O 0 8.887842994909079e-08
Jewish O 0 2.951302136011691e-08
family O 0 2.4146049604212294e-09
with O 0 2.204001869898775e-09
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3905903415434295e-06

We O 0 9.602170081279837e-08
describe O 0 8.482166435896943e-08
a O 0 5.512156953102476e-09
French O 0 2.196456989622675e-06
Canadian O 0 5.7098277466138825e-05
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.9039676519460045e-05
HNPCC B-Disease 1 1.0
) O 0 7.053549211377685e-08
kindred O 0 4.398679266159888e-06
which O 0 7.993762318747599e-10
carries O 0 3.1106437425876265e-09
a O 0 4.140675857744469e-10
novel O 0 2.655675679363867e-09
truncating O 0 1.1100006958031372e-07
mutation O 0 3.6791230062505065e-09
in O 0 5.460849550331659e-09
hMLH1 O 0 4.159648597124033e-06
. O 0 1.4623337563079986e-07

Interestingly O 0 1.5906563248790917e-06
, O 0 1.310299513335167e-08
the O 0 7.66512897598659e-09
I1307K O 0 1.0404521617601858e-06
APC O 0 7.087498943292303e-07
polymorphism O 0 2.925945352671988e-08
, O 0 3.88540782880753e-10
associated O 0 7.889278674788613e-10
with O 0 3.554076130618533e-11
an O 0 1.2764387637143049e-11
increased O 0 6.18535334062642e-10
risk O 0 5.2435030539754734e-08
of O 1 0.9660528898239136
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.5265290687647166e-09
is O 0 3.741015136560222e-11
also O 0 9.980622231453573e-12
present O 0 3.5685308874544575e-11
in O 0 1.2169211471846353e-10
this O 0 7.66810434593701e-11
family O 0 2.168528911994372e-09
. O 0 2.1130983185457808e-08

The O 0 7.807654469615954e-07
I1307K O 0 5.364392109186156e-06
polymorphism O 0 6.630292403997373e-08
has O 0 2.9024252445886134e-10
previously O 0 1.3499364959201898e-09
only O 0 5.20413660082264e-12
been O 0 3.9797518579243185e-12
identified O 0 1.520226999840446e-11
in O 0 1.2140202905464026e-11
individuals O 0 3.3713093081089163e-12
of O 0 8.997649736386393e-09
self O 0 4.955669510309235e-07
- O 0 1.3582169913206599e-06
reported O 0 6.3679737039024076e-09
Ashkenazi O 0 1.1526276466611307e-07
Jewish O 0 7.6147713912178e-08
origins O 0 3.173277605128533e-07
. O 0 3.152738159428736e-08

In O 0 1.656649430969992e-07
addition O 0 1.4850300544821948e-08
, O 0 6.740043523301154e-10
in O 0 1.985498154777332e-10
this O 0 1.8518166167158512e-11
family O 0 1.5725229451923894e-10
, O 0 1.2512448022139466e-10
there O 0 9.369460068908708e-11
appears O 0 8.11115966059539e-11
to O 0 1.5000303082990385e-11
be O 0 9.247682480895136e-11
no O 0 6.242945049805826e-10
relationship O 0 9.712342735612722e-11
between O 0 1.2491296885741576e-10
the O 0 5.408283265673219e-10
I1307K O 0 2.398055620744799e-08
polymorphism O 0 8.032124410028985e-10
and O 0 6.334291424714422e-11
the O 0 7.572194260507814e-11
presence O 0 1.669659410730162e-10
or O 0 7.651774214245677e-10
absence O 0 3.889252297994972e-08
of O 0 1.9942731341870967e-06
cancer B-Disease 0 5.7462726545054466e-05
. O 0 1.309426900242272e-09
. O 0 9.262043576541146e-09

Identification O 0 8.254828571807593e-07
of O 0 1.864017491470804e-07
a O 0 2.9204965112938908e-09
novel O 0 2.738094861953755e-09
mutation O 0 3.680447890896943e-10
of O 0 7.030243054373386e-09
the O 0 3.645519086603599e-08
CPO O 1 0.8626018166542053
gene O 0 8.615391955402174e-09
in O 0 1.2563488027694802e-09
a O 0 3.3428779744326675e-09
Japanese O 0 1.092600723495707e-05
hereditary B-Disease 1 0.9999983310699463
coproporphyria I-Disease 1 0.9999089241027832
family O 0 2.3671777853451204e-06
. O 0 5.061369847680908e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 0 5.8398087276145816e-05
HCP B-Disease 1 1.0
) O 0 4.988063295741085e-08
is O 0 4.571209799575371e-10
an O 0 9.101450149096024e-10
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 9.048533229361055e-07
by O 0 1.7918759809276708e-08
a O 0 1.2741221553369542e-06
deficiency B-Disease 1 0.9998220801353455
of I-Disease 1 0.9991822838783264
coproporphyrinogen I-Disease 1 0.9999948740005493
oxidase I-Disease 0 4.581467692332808e-06
( O 0 9.807818202034468e-08
CPO O 1 0.999998927116394
) O 0 3.494303513207342e-09
caused O 0 3.1531994792999285e-09
by O 0 1.7115737993567137e-10
a O 0 3.7972344713033124e-10
mutation O 0 5.011671078136715e-10
in O 0 7.652999900464863e-10
the O 0 2.4099406914501742e-08
CPO O 1 0.9979343414306641
gene O 0 3.35025902131747e-07
. O 0 5.038089767595011e-08

Only O 0 7.247311373248522e-08
11 O 0 5.9504682070610215e-08
mutations O 0 1.6397506685805752e-09
of O 0 6.627254744984157e-09
the O 0 2.276368649134497e-09
gene O 0 7.126594314676993e-10
have O 0 1.8121379397051385e-11
been O 0 1.1452278014800754e-10
reported O 0 1.206197142167298e-09
in O 0 1.3699173351255922e-08
HCP B-Disease 1 1.0
patients O 0 1.5625017795173335e-06
. O 0 1.6366104205189913e-07

We O 0 4.751090187937734e-08
report O 0 6.593942725174884e-09
another O 0 1.0222267476933666e-09
mutation O 0 3.6558275851028554e-10
in O 0 2.2925501774739843e-10
a O 0 1.0230732927496433e-09
Japanese O 0 1.0870910500671016e-06
family O 0 1.1145891321007184e-08
. O 0 6.203672597848708e-08

Polymerase O 0 1.7205727999680676e-05
chain O 0 1.200184783556324e-06
reaction O 0 3.1161501823362414e-08
- O 0 1.6896139243272046e-07
single O 0 3.1783726761602793e-09
strand O 0 8.847495513997217e-10
conformational O 0 4.4438813739944294e-10
polymorphism O 0 8.583091459790637e-10
and O 0 3.6703511757663065e-11
direct O 0 7.693419512566635e-11
sequence O 0 1.0084744844762739e-10
analyses O 0 7.618308761614401e-10
demonstrated O 0 5.814338455145673e-10
a O 0 4.213750737225297e-10
C O 0 1.850316095897142e-07
to O 0 8.040800247854918e-10
T O 0 2.289441880520826e-07
substitution O 0 2.7291009452312665e-09
in O 0 5.655876877952437e-10
exon O 0 4.318239987810557e-09
1 O 0 1.4848536844525029e-09
of O 0 1.6417190940032356e-09
the O 0 2.000491550191441e-09
CPO O 0 5.307781248120591e-05
gene O 0 8.679547081058558e-10
at O 0 2.70483280218059e-09
nucleotide O 0 9.065725392609636e-10
position O 0 9.163757530572525e-10
85 O 0 5.193741436926302e-09
, O 0 5.216212878300652e-11
which O 0 3.693793881875962e-11
lies O 0 2.9513738120101607e-09
in O 0 1.2089257372949191e-10
the O 0 7.698854331827931e-10
putative O 0 2.6556110199749128e-08
presequence O 0 6.722024750160926e-07
for O 0 5.165770033954686e-10
targeting O 0 2.2307731217807714e-09
to O 0 1.3485598193696546e-09
mitochondria O 0 3.542184856542008e-07
. O 0 4.756648408488218e-08

This O 0 6.738710034426276e-09
mutation O 0 2.1864665633586355e-09
changes O 0 4.149214305471105e-10
the O 0 5.959582827230747e-10
codon O 0 2.2851733838535893e-09
for O 0 5.44528380719278e-11
glutamine O 0 3.776326362725513e-09
to O 0 1.443162950254262e-10
a O 0 5.630142463353138e-10
termination O 0 7.106078214746958e-08
codon O 0 1.3675943932867085e-07
at O 0 5.405555469906176e-08
amino O 0 3.5530376862880075e-08
acid O 0 5.6436199713516544e-08
position O 0 5.81901495877446e-08
29 O 0 4.6610847448391723e-07
. O 0 2.7291491733194562e-08

MaeI O 0 0.0001515725743956864
restriction O 0 2.1936022776003483e-08
analysis O 0 2.119892528185119e-08
showed O 0 4.009243159686093e-09
two O 0 6.49138451325193e-11
other O 0 2.366612981974381e-11
carriers O 0 8.641368870465627e-11
in O 0 1.5901793770645156e-10
the O 0 1.6465075969307463e-09
family O 0 4.160175315348624e-09
. O 0 2.424981637716428e-08

The O 0 1.9742371932807146e-06
C O 0 0.03896116837859154
- O 0 8.413071191171184e-05
T O 0 0.00015504164912272245
mutation O 0 8.089332537153382e-10
is O 0 2.8747056818323458e-11
located O 0 1.0441871811650572e-09
within O 0 2.2898669072013433e-10
a O 0 1.3012003974299802e-10
recently O 0 7.304340465807968e-10
proposed O 0 5.822050619386232e-10
putative O 0 7.542320545894654e-09
alternative O 0 3.6861400598553473e-09
translation O 0 2.072182869738981e-09
initiation O 0 6.835318977493898e-09
codon O 0 3.279973626035826e-08
( O 0 3.6529207436686306e-10
TIC O 0 1.788374902389478e-06
- O 0 1.5569699485240562e-07
1 O 0 5.8604019415042785e-09
) O 0 4.4283868239070046e-11
, O 0 3.095070033598546e-11
supporting O 0 2.3219290379294932e-10
that O 0 6.420336484680433e-11
TIC O 0 4.567955784295918e-06
- O 0 1.6409005354489636e-07
1 O 0 4.316115465030634e-09
is O 0 1.393801827426211e-11
the O 0 2.7148480685745824e-10
real O 0 2.8176888378084186e-08
TIC O 0 7.056730282783974e-06
rather O 0 2.440250002067046e-09
than O 0 6.0985594352303e-10
TIC O 0 1.1279295904387254e-05
- O 0 5.414227643996128e-07
2 O 0 6.591367451846963e-08
. O 0 8.350924396438586e-10
. O 0 2.430801337993671e-09

Human B-Disease 0 5.011441999158706e-07
complement I-Disease 0 2.067771902147797e-06
factor I-Disease 0 7.405907672364265e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
associated O 0 5.0076534535037354e-05
with O 1 0.777437150478363
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.012865085154771805

This O 0 8.811107399253615e-09
study O 0 3.9788927708173105e-09
reports O 0 2.391627784703587e-09
on O 0 3.682352645029141e-09
six O 0 3.4535457826834204e-10
cases O 0 3.5404379428172206e-10
of O 0 1.6377923373056547e-07
deficiency B-Disease 0 0.0005817310884594917
in I-Disease 0 7.589914474692705e-09
the I-Disease 0 3.4621743250085046e-09
human I-Disease 0 2.4413102095444117e-10
complement I-Disease 0 7.019760883686388e-10
regulatory I-Disease 0 4.173026368903265e-09
protein I-Disease 0 1.8628147913091198e-09
Factor I-Disease 0 2.209179683632101e-08
H I-Disease 1 0.9999969005584717
( O 0 9.936872658045104e-09
FH O 0 4.58845570392441e-05
) O 0 3.882776045127656e-11
in O 0 8.453997051016682e-12
the O 0 1.5942691611314785e-11
context O 0 7.484674685587223e-11
of O 0 2.749304339744185e-09
an O 0 1.2811042005012041e-08
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.9656631593534257e-06

Five O 0 1.981634198955362e-07
of O 0 6.453210943391241e-08
the O 0 5.8629817667466e-10
cases O 0 1.1621138079620508e-10
were O 0 8.913244448072177e-11
observed O 0 2.2357901641179012e-10
in O 0 4.274721202013332e-11
children O 0 9.171079867753562e-11
presenting O 0 1.8946787250229136e-08
with O 0 7.254641332110623e-08
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
HUS B-Disease 1 1.0
) O 0 1.844544203777332e-05
. O 0 1.1693042551996768e-06

Two O 0 3.90422130180923e-08
of O 0 9.479808937840062e-08
the O 0 1.3417460031917017e-08
children O 0 9.684046897717735e-10
exhibited O 0 5.533005875690833e-08
a O 0 3.4692888561949076e-08
homozygous O 0 0.0001572069013491273
deficiency O 1 0.7518003582954407
characterized O 0 1.1749106221259353e-07
by O 0 1.023561235768966e-09
the O 0 1.4375325818605234e-08
absence O 0 1.1717371961594836e-07
of O 0 3.808088777645935e-08
the O 0 2.1712398545759015e-09
150 O 0 2.4277617693968523e-09
- O 0 1.1433388458215177e-08
kD O 0 1.6191128793252574e-07
form O 0 1.1064930083293234e-09
of O 0 1.4616444055093325e-08
Factor O 0 2.4868342052286607e-08
H O 1 1.0
and O 0 2.1130006633285348e-09
the O 0 7.154855596880338e-10
presence O 0 1.5875005476839732e-10
, O 0 1.7363291360261712e-11
upon O 0 1.7421318554422527e-10
immunoblotting O 0 4.806297226878087e-08
, O 0 1.365989127366518e-10
of O 0 1.3703922441266059e-09
the O 0 2.1707511344004615e-09
42 O 0 7.594533890653565e-09
- O 0 1.6586501061510717e-08
kD O 0 7.212504442577483e-07
Factor O 0 3.847638296861078e-08
H O 0 0.2004949450492859
- O 0 4.07325906337519e-08
like O 0 6.874408264856413e-10
protein O 0 2.1085951040777928e-10
1 O 0 5.1667976563862794e-09
( O 0 2.5904176026436687e-10
FHL O 0 7.175282371463254e-05
- O 0 6.009664588191299e-08
1 O 0 4.40687975000742e-09
) O 0 1.3779735165420082e-11
and O 0 2.0065464914620357e-11
other O 0 1.2926019976600145e-10
FH O 0 1.1833125427074265e-05
- O 0 4.7068756003909584e-08
related O 0 3.172094409364945e-08
protein O 0 9.666722533552274e-09
( O 0 4.311129675471648e-09
FHR O 1 0.9999725818634033
) O 0 3.4753935285181115e-09
bands O 0 3.8615376070083585e-06
. O 0 1.0685464069126738e-08

Southern O 0 7.3940118454629555e-06
blot O 0 8.14880240795901e-06
and O 0 5.547279080531098e-09
PCR O 0 1.1159296775531402e-07
analysis O 0 1.0421458140896789e-09
of O 0 1.5298534661312146e-09
DNA O 0 5.590032969848835e-08
of O 0 8.406879636879694e-09
one O 0 3.947203952581191e-10
patient O 0 3.2362933666263416e-08
with O 0 7.692311676521513e-09
homozygous O 0 0.0007702968432568014
deficiency O 1 0.8739463090896606
ruled O 0 6.566320962519967e-07
out O 0 4.890594151873984e-09
the O 0 1.0748415490979824e-09
presence O 0 5.742862851931818e-10
of O 0 4.12085476853008e-09
a O 0 6.927713264159863e-11
large O 0 7.657902090230095e-11
deletion O 0 1.5360844818346209e-09
of O 0 5.472266639827694e-09
the O 0 1.458725673586514e-08
FH O 0 0.013167747296392918
gene O 0 4.048062773875927e-09
as O 0 5.758910570641262e-10
the O 0 5.786858991996269e-09
underlying O 0 3.1719753224024316e-06
defect O 0 2.8489489523053635e-06
for O 0 2.5286183813477692e-08
the O 0 2.5100924176513217e-05
deficiency O 1 0.9999806880950928
. O 0 3.507353483200859e-07

The O 0 3.7393519392026064e-07
other O 0 2.0954697976804937e-09
four O 0 1.872372035194303e-09
children O 0 2.8662644480093036e-10
presented O 0 3.454957653303836e-09
with O 0 6.693503973309589e-09
heterozygous O 0 8.917786544770934e-07
deficiency O 0 0.00969476904720068
and O 0 4.554105359488858e-08
exhibited O 0 1.7727356862451416e-06
a O 0 1.242269132006868e-08
normal O 0 1.409665486562517e-07
immunoblotting O 0 1.5749503745610127e-06
pattern O 0 3.111119895038428e-08
of O 0 5.318094853379307e-09
proteins O 0 4.2990402904230507e-10
of O 0 2.9298099946117873e-08
the O 0 1.0544774653453715e-07
FH O 1 0.8224095702171326
family O 0 3.448606022971035e-08
. O 0 4.909232131922181e-08

Factor B-Disease 1 0.9988294243812561
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999996423721313
is O 0 4.061829095292069e-09
the O 0 3.730352471364995e-09
only O 0 2.131979037756082e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.0312224731023889e-05
with O 0 1.423085450369399e-06
HUS B-Disease 1 1.0
. O 0 6.2742533373238984e-06

These O 0 8.55960369250397e-09
observations O 0 9.056054750544718e-08
suggest O 0 1.5690722054984008e-09
a O 0 5.884278619916472e-10
role O 0 7.710022620344148e-10
for O 0 1.0294584074088675e-09
FH O 0 0.00018945871852338314
and O 0 3.5277352594675904e-08
/ O 0 1.7364781967899034e-07
or O 0 5.4605577837207875e-09
FH O 0 2.9025035473750904e-05
receptors O 0 5.495141230937861e-09
in O 0 1.00379438094933e-09
the O 0 6.721393663866593e-09
pathogenesis O 0 1.0479992852197029e-05
of O 0 5.133226181897044e-07
idiopathic O 1 0.9998828172683716
HUS B-Disease 1 1.0
. O 0 6.577740805369103e-07
. O 0 4.258703825144039e-07

Further O 0 5.971865846277069e-08
evidence O 0 2.3499245216385134e-08
for O 0 1.7537372942744156e-10
a O 0 1.421878587093417e-10
major O 0 1.488594025822465e-09
ancient O 0 2.999211403675872e-07
mutation O 0 1.709667571958562e-07
underlying O 0 0.04561404511332512
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.4466418178926688e-06
linkage O 0 1.1686954621836776e-06
disequilibrium O 0 1.956478627107572e-06
studies O 0 1.4363121803029344e-09
in O 0 2.099357215845643e-10
the O 0 9.464985462059872e-10
Japanese O 0 1.0624601287645419e-07
population O 0 4.41688907670823e-11
. O 0 2.5718389640161377e-09

The O 0 0.0018643902149051428
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.6355342864990234
DM B-Disease 1 1.0
) O 0 4.746959803014761e-08
mutation O 0 2.3274151494945272e-09
is O 0 5.829037252880198e-11
an O 0 9.171989556744364e-11
unstable O 0 1.720655859571707e-06
( O 0 2.0295168212669523e-08
CTG O 1 0.930298924446106
) O 0 1.0729858113123214e-09
n O 0 1.1619015749531059e-09
repeat O 0 5.159372484797586e-09
, O 0 1.4246204216306069e-10
present O 0 2.0577664572307697e-10
at O 0 4.195260139283619e-09
a O 0 7.611029168019812e-11
copy O 0 1.5551816501258031e-09
number O 0 8.185260802484606e-11
of O 0 1.1205935068758777e-09
5 O 0 4.891023142050699e-09
- O 0 1.767638835303842e-08
37 O 0 1.1626736018399697e-08
repeats O 0 1.3454021230430158e-09
on O 0 9.708069903524574e-10
normal O 0 8.372663118372259e-10
chromosomes O 0 1.0304578718089985e-10
but O 0 2.3490738867981698e-11
amplified O 0 6.658182449825745e-09
to O 0 2.036688734330383e-10
50 O 0 4.041366352680598e-09
- O 0 1.4358089828192533e-08
3000 O 0 4.997431357622872e-09
copies O 0 3.97803479046388e-09
on O 0 9.373798803835598e-08
DM B-Disease 1 0.9999998807907104
chromosomes O 0 2.9627807407450746e-07
. O 0 2.6046393486467423e-08

Previous O 0 1.025340793603391e-06
findings O 0 2.689339595463025e-08
in O 0 2.335682092180491e-09
Caucasian O 0 1.9021957342602036e-08
populations O 0 3.0001090500775263e-10
of O 0 7.639382459956323e-09
a O 0 8.697188036421721e-08
DM B-Disease 1 1.0
founder O 1 0.9999979734420776
chromosome O 0 3.172245897076209e-07
raise O 0 5.312640549703929e-09
a O 0 1.2310105157453677e-09
question O 0 3.7210484693517287e-10
about O 0 1.075123410437806e-11
the O 0 6.624354537132504e-11
molecular O 0 1.880055222613919e-09
events O 0 1.6722473406005633e-10
involved O 0 1.6412893266704032e-10
in O 0 1.3718272351415095e-10
the O 0 3.6737571318390394e-10
expansion O 0 9.840192660703906e-09
mutation O 0 5.567259542260672e-09
. O 0 8.342571078401306e-09

To O 0 5.63404825015823e-08
investigate O 0 7.890550079991954e-08
whether O 0 6.116818163093285e-09
a O 0 3.900043843430012e-09
founder O 0 2.123714466506499e-06
chromosome O 0 8.354098746110594e-09
for O 0 5.315384243864685e-10
the O 0 1.4356446698116088e-08
DM B-Disease 1 1.0
mutation O 0 3.4885232480519335e-09
exists O 0 1.2255793602200526e-10
in O 0 3.7142677822288306e-11
the O 0 9.365636738367655e-11
Japanese O 0 4.068939851720188e-09
population O 0 1.9489657283877637e-12
, O 0 2.5242294365845908e-11
we O 0 3.278555205099565e-11
genotyped O 0 6.269405616876611e-08
families O 0 5.505981087727818e-12
using O 0 6.380854872256592e-11
polymorphic O 0 2.8380609862210804e-08
markers O 0 1.214194043086536e-07
near O 0 3.739826297533e-07
the O 0 1.5045312551364987e-08
( O 0 6.19363271781026e-09
CTG O 0 0.0007710165809839964
) O 0 8.785696059554482e-10
n O 0 3.940999526719224e-09
repeat O 0 1.1944871758373665e-08
region O 0 3.958568139950103e-09
and O 0 1.3777778917756223e-09
constructed O 0 1.4292807009042008e-06
haplotypes O 0 8.433847256128502e-07
. O 0 7.482643837875003e-08

Six O 0 9.876676188014244e-08
different O 0 4.3997888665714413e-10
haplotypes O 0 9.444522497403796e-09
were O 0 2.0071724282644254e-09
found O 0 1.2735024146337537e-09
and O 0 7.446236516273075e-09
DM B-Disease 1 1.0
alleles O 0 1.2501963908562175e-08
were O 0 2.635703744147122e-08
always O 0 2.8244901528751143e-08
haplotype O 0 5.386139037000248e-07
A O 0 1.2128381285947398e-06
. O 0 1.1550374523494611e-07

To O 0 1.0484185963832715e-08
find O 0 5.157687055223903e-10
an O 0 7.2415762622513036e-12
origin O 0 9.713491122553819e-11
of O 0 2.5061366315526357e-09
the O 0 5.256377555440395e-09
( O 0 1.3417044142371992e-09
CTG O 0 0.0004608008894138038
) O 0 2.5027246941533576e-10
n O 0 6.882437397770502e-10
repeat O 0 2.9707796223021887e-09
mutation O 0 8.770956877457436e-11
and O 0 7.222985404231608e-11
to O 0 2.7419490289393167e-11
investigate O 0 1.4438876760891617e-09
the O 0 5.497696187184431e-10
mechanism O 0 7.211687358399388e-10
of O 0 9.091699060270741e-10
the O 0 2.359815814978461e-11
expansion O 0 4.5032591544647005e-10
mutation O 0 1.049301270872327e-11
in O 0 1.0829627992980928e-11
the O 0 2.919240543741708e-11
Japanese O 0 2.130170262404363e-09
population O 0 4.244517606312448e-13
we O 0 9.932191787770384e-13
have O 0 1.3666679550203287e-12
studied O 0 1.3262198006458448e-09
90 O 0 2.102387375302328e-09
Japanese O 0 3.0282717489171773e-07
DM B-Disease 1 1.0
families O 0 1.5035177547417788e-09
comprising O 0 2.1943597161566686e-08
190 O 0 2.330259007976565e-08
affected O 0 5.251827861485481e-09
and O 0 2.5800146463694773e-09
130 O 0 1.20317437790618e-07
unaffected O 0 1.642961109382668e-07
members O 0 2.997651016301006e-09
. O 0 1.9118420624408827e-08

The O 0 7.616528137077694e-07
results O 0 7.529847323439753e-08
suggest O 0 5.166541416912196e-09
that O 0 3.947224144762451e-11
a O 0 1.1277350581151424e-10
few O 0 1.0896079177813434e-10
common O 0 1.6232168387197987e-10
ancestral O 0 1.766360502308828e-09
mutations O 0 7.009669233948301e-11
in O 0 1.0895830071522283e-10
both O 0 2.2368223939750465e-10
Caucasian O 0 1.4028214145866968e-08
and O 0 9.239805587313299e-10
Japanese O 0 1.1361220941807915e-07
populations O 0 4.1711283732537296e-11
have O 0 1.6709160097216902e-12
originated O 0 7.949695068898421e-11
by O 0 9.018942710714573e-12
expansion O 0 1.1023851831382103e-09
of O 0 8.712222054896301e-10
an O 0 1.6207320208128095e-11
ancestral O 0 3.995288544444975e-09
n O 0 4.3793185744434027e-10
= O 0 4.642921325181959e-10
5 O 0 6.5130295601179e-10
repeat O 0 1.891016898625253e-09
to O 0 1.4679346627133327e-10
n O 0 1.1947576261661652e-09
= O 0 2.279905597646348e-09
19 O 0 2.055395498246071e-08
- O 0 2.3506506963144602e-08
37 O 0 1.1828676704794816e-08
copies O 0 1.0527909211077713e-08
. O 0 6.546822639563743e-09

These O 0 7.3088735064175125e-09
data O 0 6.429251797612778e-09
support O 0 2.887979300147947e-10
multistep O 0 7.846064242755801e-09
models O 0 9.017511182207727e-09
of O 0 2.8927837902870124e-08
triplet O 0 1.0490684871911071e-06
repeat O 0 3.6832254579621804e-08
expansion O 0 1.4784619750685124e-08
that O 0 2.855409832192013e-11
have O 0 2.9989788864065448e-12
been O 0 6.0118767603034584e-12
proposed O 0 2.3271506249811225e-11
for O 0 4.5176584695383326e-11
both O 0 5.6328950392980914e-09
DM B-Disease 1 1.0
and O 0 6.366413344949251e-06
Friedreichs B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999995231628418
. O 0 3.912683155249397e-07
. O 0 3.0542761919605255e-07

The O 0 1.6700502669664274e-07
molecular O 0 8.145030250261698e-08
basis O 0 4.585325896755421e-08
of O 0 0.004066679161041975
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 7.427824133543481e-09
the O 0 1.2175926933366554e-09
western O 0 1.0388816029660575e-08
Cape O 0 2.1393535121205787e-07
, O 0 3.2371172409284554e-10
South O 0 2.242022745235772e-08
Africa O 0 2.370158291853386e-08
. O 0 6.344466285668204e-09

Deficiency B-Disease 1 0.9996126294136047
of I-Disease 0 0.00016644933202769607
the I-Disease 0 6.794609817006858e-07
sixth I-Disease 0 4.7034616727614775e-05
component I-Disease 0 5.1463427297449016e-08
of I-Disease 0 2.278954625012375e-08
human I-Disease 0 1.2401331073164101e-09
complement I-Disease 0 5.456271168213789e-08
( O 0 8.919817773289651e-09
C6 O 1 0.9999761581420898
) O 0 9.192028804783092e-10
has O 0 2.8801334581163296e-11
been O 0 2.4624283515017886e-11
reported O 0 3.923003935590863e-11
in O 0 2.007660530878308e-11
a O 0 1.0482170686998415e-11
number O 0 6.814220628731382e-12
of O 0 2.0753541940532472e-10
families O 0 1.672532555160866e-12
from O 0 9.628713104614661e-11
the O 0 2.3672100391003426e-10
western O 0 1.1362820018234743e-08
Cape O 0 4.2075231476701447e-07
, O 0 9.887034524425076e-10
South O 0 2.401488607972624e-08
Africa O 0 1.532631799250339e-08
. O 0 6.03295324808073e-09

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999676942825317
is O 0 2.855047975813818e-09
endemic O 0 7.744160868128347e-09
in O 0 5.485525367276978e-10
the O 0 2.8075000102489867e-09
Cape O 0 1.2953337318322156e-06
and O 0 3.1124344768151957e-10
almost O 0 7.727965489756627e-11
all O 0 2.7249473510959632e-11
pedigrees O 0 9.195435524134155e-09
of O 0 3.1458363025649305e-08
total O 0 1.7448160178901162e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.962463213407318e-06
C6Q0 O 1 1.0
) O 0 1.2271144100850506e-09
have O 0 1.650732155134005e-11
been O 0 3.822972494127441e-11
ascertained O 0 4.095256134206693e-09
because O 0 9.224609409663742e-10
of O 0 2.9424168701552844e-07
recurrent O 1 1.0
disease O 1 0.9999821186065674
. O 0 2.1392514781837235e-07

We O 0 5.081809106854962e-08
have O 0 2.6640753492124247e-10
sequenced O 0 2.1615635503735575e-08
the O 0 1.8785459854342434e-09
expressed O 0 2.951000832585038e-10
exons O 0 4.1042820697612115e-08
of O 0 1.640768232391565e-08
the O 0 9.902306530307214e-09
C6 O 1 0.9202597141265869
gene O 0 2.4551662924920947e-09
from O 0 3.2420047202386115e-10
selected O 0 9.306344028736646e-10
cases O 0 4.6874001208285776e-11
and O 0 9.382210286457138e-11
have O 0 5.556345314405853e-12
found O 0 1.0249438797682586e-10
three O 0 1.952252942638566e-10
molecular O 0 1.0375090823799837e-05
defects O 1 0.9883982539176941
leading O 0 2.227068762294948e-06
to O 0 8.883059621211942e-09
total O 0 4.4731010007126315e-07
deficiency O 1 0.9950588941574097
879delG O 0 0.00022619852097705007
, O 0 1.501798130298937e-09
which O 0 1.3730706849290897e-10
is O 0 2.528812402535774e-11
the O 0 3.3355010420343945e-10
common O 0 3.180598451280048e-09
defect O 0 5.815774883899394e-08
in O 0 1.4523396929533305e-09
the O 0 6.764504512091207e-09
Cape O 0 1.7754427972249687e-06
and O 0 1.0544142226009967e-09
hitherto O 0 1.31303901085289e-08
unreported O 0 1.1283343148704716e-08
, O 0 1.587000947322892e-10
and O 0 4.561716004936045e-10
1195delC O 0 1.3374145169109397e-07
and O 0 3.270021142753876e-09
1936delG O 0 4.775520778821374e-07
, O 0 3.197945519506362e-10
which O 0 6.638735394748352e-11
have O 0 9.479628887421043e-12
been O 0 4.927931673837094e-11
previously O 0 7.89548038060417e-10
reported O 0 4.593847524603234e-10
in O 0 6.05711647505558e-10
African O 0 6.599768287429697e-09
- O 0 1.2900078161237616e-07
Americans O 0 2.397057441427819e-09
. O 0 7.4047954434774965e-09

We O 0 5.7735881853204774e-08
also O 0 1.4531624792368802e-09
show O 0 1.023574891512169e-09
that O 0 5.731804354064396e-12
the O 0 3.445203566876387e-10
879delG O 0 1.3515428065602464e-07
and O 0 1.0346872691968656e-08
1195delC O 0 2.0465000488911755e-05
defects O 0 2.5014012862811796e-05
are O 0 2.999668569092506e-10
associated O 0 1.163303675610905e-08
with O 0 1.2991434594766815e-08
characteristic O 0 0.2864284813404083
C6 O 1 1.0
/ O 1 0.9999939203262329
C7 O 1 0.9999970197677612
region O 0 2.3376226465643413e-07
DNA O 0 9.732140142659773e-07
marker O 0 1.7495987947313552e-07
haplotypes O 0 2.560943990204123e-08
, O 0 2.0892945706840749e-10
although O 0 5.992978335811472e-11
small O 0 2.7800546587020136e-11
variations O 0 7.152839653912224e-09
were O 0 6.651277750790996e-09
observed O 0 2.2879222072447192e-08
. O 0 3.0512946835870025e-08

The O 0 2.307700469827978e-06
1936delG O 0 9.011748625198379e-05
defect O 0 1.5788162272656336e-05
was O 0 9.509218301673172e-08
observed O 0 2.1978185937854278e-09
only O 0 2.8636839427553795e-11
once O 0 1.5065512726231134e-10
in O 0 5.826069487957497e-11
the O 0 7.303964655314132e-10
Cape O 0 2.1229439539638406e-07
, O 0 4.2353110601967003e-11
but O 0 2.812898785425899e-12
its O 0 1.9057809150235805e-11
associated O 0 9.504441678132025e-10
haplotype O 0 1.1392160104151117e-08
could O 0 1.068150567995474e-09
be O 0 6.605986868635227e-10
deduced O 0 4.0936501477517595e-07
. O 0 1.0577125664212872e-07

The O 0 1.6076914732821024e-07
data O 0 1.5791670193721075e-08
from O 0 1.3932078823941652e-09
the O 0 8.017690400485833e-10
haplotypes O 0 3.8651495337660435e-09
indicate O 0 1.6508903966094834e-10
that O 0 3.303183681441224e-12
these O 0 3.415432173192734e-11
three O 0 9.327633110345346e-10
molecular O 0 1.1781650073316996e-06
defects O 0 3.6028766317031113e-06
account O 0 2.18683668395947e-10
for O 0 5.43194655922008e-10
the O 0 5.542480252529458e-08
defects O 0 0.00011000582162523642
in O 0 1.3816726651683098e-09
all O 0 2.5795804381445464e-10
the O 0 1.842088592773905e-09
38 O 0 1.2660291481836339e-08
unrelated O 0 6.92570125693237e-08
C6Q0 O 1 0.9249882102012634
individuals O 0 5.5288197631231384e-11
we O 0 6.216337861131294e-11
have O 0 1.3220461184126897e-11
studied O 0 7.3228831887206525e-09
from O 0 7.54994511353857e-10
the O 0 7.586035799533875e-09
Cape O 0 2.223346427854267e-06
. O 0 2.6281087528445823e-08

We O 0 6.233182148207561e-08
have O 0 5.39276012734291e-10
also O 0 2.490667116994416e-10
observed O 0 1.0408862660682416e-09
the O 0 1.4298232597909077e-09
879delG O 0 7.432637971760414e-07
defect O 0 1.4062482023291523e-07
in O 0 1.301647900575631e-09
two O 0 2.41196751460393e-09
Dutch O 1 0.9994733929634094
C6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
kindreds O 0 3.06897891277913e-05
, O 0 1.916722780492819e-09
but O 0 6.195103458006557e-11
the O 0 8.091199932280801e-10
879delG O 0 3.891338167250069e-07
defect O 0 2.0891280883006402e-07
in O 0 3.198282971794697e-09
the O 0 8.672734530534854e-09
Cape O 0 2.5748695406946354e-06
probably O 0 1.7910379845886837e-09
did O 0 5.936130059724931e-11
not O 0 6.440791476547414e-12
come O 0 6.649557987570276e-11
from O 0 2.501846507740879e-10
The O 0 1.479874778276269e-09
Netherlands O 0 3.2967392371574533e-07
. O 0 1.6223480336918783e-09
. O 0 9.96093518779162e-09

Complement B-Disease 1 0.9999998807907104
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.5081087667567772e-07
seven O 0 1.7516228467684414e-08
further O 0 2.8105218152774114e-09
molecular O 0 1.00635324997711e-05
defects O 0 0.06908393651247025
and O 0 4.60416549330489e-09
their O 0 1.0088140101061072e-08
associated O 0 6.247155681649019e-08
marker O 0 3.415471383050317e-06
haplotypes O 0 1.4892871149640996e-06
. O 0 8.815801777473098e-08

Seven O 0 5.304381147652748e-07
further O 0 4.252443286389962e-09
molecular O 0 2.0191157545923488e-07
bases O 0 2.9934423650956887e-07
of O 1 0.8964591026306152
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.5482368215534734e-08
described O 0 4.214772104660369e-07
. O 0 3.538126236435346e-08

All O 0 1.6154938720092105e-08
these O 0 4.995475699764995e-10
new O 0 2.6979181111386197e-09
molecular O 0 1.0323237802367657e-06
defects O 0 2.0626293917302974e-06
involve O 0 1.1355627549392011e-08
single O 0 2.2429851753713592e-08
- O 0 2.161274892387155e-08
nucleotide O 0 4.505426698386827e-09
events O 0 9.092115393904976e-10
, O 0 6.869659702202213e-11
deletions O 0 1.0420703189240044e-09
and O 0 5.131144953374189e-10
substitutions O 0 2.591344383517935e-08
, O 0 1.9113807758763812e-10
some O 0 1.7312661720891853e-11
of O 0 8.65879590250529e-10
which O 0 7.076527558380619e-11
alter O 0 8.41743741375467e-09
splice O 0 2.447546876283013e-07
sites O 0 1.7230791016231706e-08
, O 0 9.403302581034723e-10
and O 0 1.2337841859277887e-09
others O 0 2.9369321197236786e-08
codons O 0 1.30436205836304e-06
. O 0 1.553908219875666e-07

They O 0 1.1903342311825327e-08
are O 0 7.884595754070745e-11
distributed O 0 2.2080486050679582e-10
along O 0 9.691769609077028e-10
the O 0 4.885578164248727e-09
C7 O 1 0.897498607635498
gene O 0 2.4534014819721506e-09
, O 0 4.332507963500376e-11
but O 0 4.087664668556146e-12
predominantly O 0 2.969417073339642e-11
towards O 0 2.985029168289799e-10
the O 0 8.535031015277639e-10
3 O 0 1.63022129129331e-08
end O 0 2.779491481419427e-08
. O 0 7.419625802640439e-09

All O 0 5.8808737435356306e-08
were O 0 8.451059407832417e-09
found O 0 9.798423183937643e-10
in O 0 1.8800326573309434e-10
compound O 0 1.875650568194942e-08
heterozygous O 0 2.267442011927301e-09
individuals O 0 4.400661779424553e-10
. O 0 3.515027557909889e-08

The O 0 4.2070030758623034e-05
C6 O 1 1.0
/ O 1 0.9963374137878418
C7 O 1 0.999955415725708
marker O 0 4.2963906707882416e-06
haplotypes O 0 3.2017945272855286e-07
associated O 0 2.531455933763027e-08
with O 0 4.7082289178490555e-09
most O 0 9.387644013258978e-07
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999991655349731
are O 0 1.0793576699086316e-08
tabulated O 0 3.503352672851179e-06
. O 0 1.2769422852443313e-08
. O 0 3.547545901483318e-08

A O 0 1.7798365661292337e-05
genome O 0 6.019174492166712e-08
- O 0 1.5776262785038853e-07
wide O 0 4.8343822278695825e-09
search O 0 5.316549978040541e-10
for O 0 1.5282138055017214e-10
chromosomal O 0 3.341337446727266e-07
loci O 0 6.233586447024209e-08
linked O 0 5.670578389072034e-07
to O 0 2.6600925906450357e-08
mental O 1 0.9999992847442627
health O 0 2.4283073798869736e-05
wellness O 0 8.579366112826392e-05
in O 0 3.576479556954837e-09
relatives O 0 5.007679604318582e-09
at O 0 9.566559810991748e-08
high O 0 2.7011897145712283e-06
risk O 0 4.07158147197606e-08
for O 0 1.9580693333409727e-07
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 5.531849751605478e-07
the O 0 2.288946348016907e-07
Old O 0 1.9116007024422288e-05
Order O 0 6.088768031986547e-07
Amish O 0 4.4669526687357575e-05
. O 0 2.2322093684579158e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9998372793197632
BPAD B-Disease 1 1.0
; O 1 0.9999871253967285
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.2014533840319928e-07
is O 0 8.504156823185838e-10
characterized O 0 3.157761607752718e-09
by O 0 2.2829592383200037e-10
episodes O 0 1.2546256300538516e-07
of O 0 1.871933818620164e-06
mania B-Disease 1 0.6847656965255737
and O 0 4.1545092699379893e-07
/ O 0 0.00010997204662999138
or O 0 1.458836180745493e-07
hypomania B-Disease 1 0.9999769926071167
interspersed O 0 2.9750819976470666e-06
with O 0 2.341851379483728e-09
periods O 0 2.2695819552609464e-06
of O 0 5.4383410315494984e-05
depression B-Disease 1 0.9999885559082031
. O 0 2.909257261762832e-07

Compelling O 0 1.7861301557786646e-06
evidence O 0 2.1211225487149932e-07
supports O 0 8.576240162483373e-09
a O 0 3.102820222977698e-10
significant O 0 4.940884923421152e-10
genetic O 0 4.668204489632899e-09
component O 0 8.505442572470656e-09
in O 0 3.918003144143256e-10
the O 0 5.904741140483338e-10
susceptibility O 0 1.8809204860303907e-08
to O 0 4.282494359131306e-09
develop O 0 5.7525176089257e-05
BPAD B-Disease 1 1.0
. O 0 1.5975278984114993e-06

To O 0 1.0848374643046554e-08
date O 0 1.336487542857867e-07
, O 0 3.567212358834837e-10
however O 0 5.7716633555804364e-11
, O 0 3.4293883705016626e-11
linkage O 0 7.141194857673838e-10
studies O 0 6.531188784242303e-11
have O 0 1.3096622310942996e-12
attempted O 0 1.0729940269627036e-09
only O 0 9.549805390918209e-12
to O 0 4.0976819160043476e-11
identify O 0 2.6484470172505326e-09
chromosomal O 0 8.996698852570262e-07
loci O 0 1.1041491276841953e-08
that O 0 2.3349949751505505e-10
cause O 0 7.390417167130181e-09
or O 0 8.1429257781096e-10
increase O 0 8.591440753269453e-11
the O 0 1.6056904694750074e-09
risk O 0 4.134206754713432e-09
of O 0 7.852580097278405e-08
developing O 0 5.498574410012225e-06
BPAD B-Disease 1 1.0
. O 0 7.012179139564978e-07

To O 0 1.761741685868401e-08
determine O 0 1.630407986397131e-08
whether O 0 8.803359152764756e-10
there O 0 1.594692849993251e-10
could O 0 6.695297788406052e-11
be O 0 6.56037862922787e-11
protective O 0 1.3651940378167637e-07
alleles O 0 9.358065711229102e-11
that O 0 9.070939312183501e-12
prevent O 0 1.5895190719206198e-09
or O 0 4.6536047237921707e-10
reduce O 0 1.4890142452372856e-09
the O 0 6.676886266099302e-10
risk O 0 4.293590760706678e-10
of O 0 6.424127896309528e-09
developing O 0 4.694717574693641e-07
BPAD B-Disease 1 1.0
, O 0 6.030879129426125e-10
similar O 0 1.3846583601928586e-10
to O 0 2.7749845823987762e-11
what O 0 4.249082682927785e-11
is O 0 4.387423584162331e-12
observed O 0 8.881898688750667e-11
in O 0 6.446349704036791e-11
other O 0 4.7053561047505355e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.826674100868786e-08
we O 0 7.009967051274657e-10
used O 0 4.9262940393646204e-08
mental O 1 0.9970433115959167
health O 0 7.224638466141187e-06
wellness O 0 0.04873894155025482
( O 0 3.2292626350738374e-09
absence O 0 9.101701436975418e-08
of O 0 8.460546041533235e-08
any O 0 5.9430160348483696e-08
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 2.453439007510383e-09
as O 0 8.437848197928588e-10
the O 0 3.928593894642063e-09
phenotype O 0 4.478216464320894e-09
in O 0 1.5871893799257464e-09
our O 0 5.144308978799472e-09
genome O 0 6.185628453891923e-09
- O 0 1.2964532913883886e-07
wide O 0 2.9420231584253997e-08
linkage O 0 1.0574240860705686e-07
scan O 0 2.705201325170492e-07
of O 0 2.7622888865153072e-08
several O 0 1.3212306804177842e-09
large O 0 1.7267376861695993e-08
multigeneration O 0 8.44488458824344e-05
Old O 0 1.0886119525821414e-06
Order O 0 3.128632997118075e-08
Amish O 0 8.437756946477748e-07
pedigrees O 0 3.480981547454576e-07
exhibiting O 0 5.818226966880502e-08
an O 0 5.635417688054645e-10
extremely O 0 1.5018368060282228e-07
high O 0 2.003422378038522e-05
incidence O 0 1.2989203241886571e-05
of O 0 1.1486871699162293e-05
BPAD B-Disease 1 1.0
. O 0 3.458148057688959e-06

We O 0 7.432248594341218e-08
have O 0 3.480267185551611e-10
found O 0 6.819584341677398e-10
strong O 0 5.254450208269645e-10
evidence O 0 7.263619705710767e-10
for O 0 5.4693288092932946e-11
a O 0 2.7769769816998746e-10
locus O 0 4.211342385929129e-09
on O 0 3.682459848164399e-08
chromosome O 0 5.8231009347764484e-08
4p O 0 2.2562844606e-05
at O 0 6.579774094461754e-07
D4S2949 O 0 1.5144561302804505e-06
( O 0 1.0272577233294555e-09
maximum O 0 7.199651541611729e-09
GENEHUNTER O 0 0.15772737562656403
- O 0 4.4909293706041353e-07
PLUS O 0 5.495447226167016e-07
nonparametric O 0 5.661268005496822e-07
linkage O 0 6.994560663997618e-08
score O 0 3.0132792261383656e-08
= O 0 1.5054920643464698e-09
4 O 0 2.9396545198068225e-09
. O 0 1.218223993904033e-10
05 O 0 5.656098878148441e-08
, O 0 3.5939357045933207e-10
P O 0 5.4615497901977506e-08
= O 0 1.3159893175185289e-09
5 O 0 1.1149330347848263e-09
. O 0 1.9687048866123824e-11
22 O 0 3.1954455748106625e-10
x O 0 3.2210115130659744e-10
10 O 0 8.610278046106146e-10
( O 0 6.497008486761047e-11
- O 0 4.58367077627031e-09
4 O 0 5.18418108441665e-09
) O 0 3.959809910525358e-11
; O 0 1.1400386884519165e-10
SIBPAL O 0 0.00018318378715775907
Pempirical O 0 1.008758431453316e-06
value O 0 1.0217082735408667e-09
< O 0 2.509073393497374e-09
3 O 0 1.292112083994823e-09
x O 0 2.3068860155461834e-09
10 O 0 5.973386785207424e-10
( O 0 6.443731659366847e-11
- O 0 3.4926044278904556e-09
5 O 0 1.1325490545388561e-09
) O 0 7.838303790752565e-12
) O 0 5.977734800211021e-12
and O 0 2.8813753466527814e-11
suggestive O 0 9.285533231206955e-09
evidence O 0 1.8054734096661917e-10
for O 0 2.7907067282062492e-11
a O 0 1.4429840655694193e-10
locus O 0 1.2694814088831663e-09
on O 0 1.9785440841246782e-08
chromosome O 0 9.819142121614277e-08
4q O 0 1.3487063370121177e-05
at O 0 1.68934320754488e-07
D4S397 O 0 4.30677602025753e-07
( O 0 1.1069066774282987e-09
maximum O 0 5.913884493224941e-09
GENEHUNTER O 0 0.36452311277389526
- O 0 6.516557959912461e-07
PLUS O 0 7.345954031734436e-07
nonparametric O 0 5.08488767536619e-07
linkage O 0 3.8922799205920455e-08
score O 0 1.2835941198829914e-08
= O 0 7.047719075004011e-10
3 O 0 1.1358350926471417e-09
. O 0 5.096098890100542e-11
29 O 0 5.626870969166475e-09
, O 0 2.1845437958578628e-10
P O 0 4.951219167992349e-08
= O 0 7.129735135613657e-10
2 O 0 1.5112171514175543e-09
. O 0 2.87444252428104e-11
57 O 0 7.20419390809468e-10
x O 0 1.0647169812472157e-09
10 O 0 5.838086125642405e-10
( O 0 4.802733905018286e-11
- O 0 4.996202118690007e-09
3 O 0 3.915965329781557e-09
) O 0 3.0263843514566346e-11
; O 0 1.2397755044801784e-10
SIBPAL O 0 0.0001326369820162654
Pempirical O 0 9.062670187631738e-07
value O 0 8.096804338109109e-10
< O 0 3.1357165752865512e-09
1 O 0 1.3643962626375128e-09
x O 0 2.7655557843786482e-09
10 O 0 8.861208433685874e-10
( O 0 9.958606855819951e-11
- O 0 4.746577353387238e-09
3 O 0 1.9247274885003662e-09
) O 0 1.4654107788336646e-11
) O 0 1.4273740609610508e-12
that O 0 1.4038161637915797e-13
are O 0 2.7427062357365806e-12
linked O 0 3.2540143024561985e-08
to O 0 1.1276092948264704e-08
mental O 1 0.9999994039535522
health O 0 0.0029478927608579397
wellness O 1 0.5774429440498352
. O 0 1.1661765597636986e-07

These O 0 6.422745713052791e-08
findings O 0 3.474831800076572e-08
are O 0 1.3826657874194126e-10
consistent O 0 6.9605148311779885e-09
with O 0 6.852124423417649e-11
the O 0 2.892014128175191e-10
hypothesis O 0 1.163826257588596e-10
that O 0 7.507514575288976e-13
certain O 0 2.1644439712753538e-11
alleles O 0 3.007171595070801e-11
could O 0 1.2144887873155596e-10
prevent O 0 2.6909698913613056e-09
or O 0 3.4600600162804085e-10
modify O 0 4.942300790844456e-09
the O 0 3.30904681433708e-09
clinical O 0 2.325952266346576e-07
manifestations O 0 1.1615847142820712e-05
of O 0 1.135037382482551e-05
BPAD B-Disease 1 1.0
and O 0 2.997795789383417e-08
perhaps O 0 5.288525173341441e-10
other O 0 5.333715691335783e-10
related O 0 9.147960372501984e-05
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 1.0676146303012501e-05

Segregation O 0 0.0063660284504294395
distortion O 0 0.04141823202371597
in O 0 3.4509135730331764e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 3.982348425779492e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9995926022529602
DM B-Disease 1 1.0
) O 0 1.5983097512162203e-07
is O 0 4.754194815603796e-10
an O 0 3.7786590523225527e-10
autosomal B-Disease 1 0.9999895095825195
dominant I-Disease 1 1.0
disease I-Disease 1 0.999998927116394
which O 0 1.742621269507083e-09
, O 0 1.390297738046442e-10
in O 0 2.4750773652826297e-10
the O 0 9.507488130111597e-10
typical O 0 2.311705848967449e-08
pedigree O 0 4.4505611640488496e-08
, O 0 3.5520786312304153e-10
shows O 0 5.992055740478008e-10
a O 0 2.0743408379875206e-10
three O 0 1.5718938373154856e-09
generation O 0 2.593861836430733e-07
anticipation O 0 6.640760602749651e-06
cascade O 0 0.030525369569659233
. O 0 1.4267884580476675e-06

This O 0 6.772056249104708e-09
results O 0 1.3360561545994187e-08
in O 0 3.051405172982413e-08
infertility B-Disease 1 0.969980001449585
and O 1 0.8140362501144409
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.13173238933086395
CDM B-Disease 1 1.0
) O 0 1.5978876000133369e-09
with O 0 3.913499524443864e-10
the O 0 3.915129109799409e-09
disappearance O 0 1.0274153794398444e-07
of O 0 1.2687168009506422e-06
DM B-Disease 1 1.0
in O 0 1.5635616534837027e-07
that O 0 1.192369647462499e-09
pedigree O 0 2.406478870398132e-06
. O 0 5.360451638125596e-08

The O 0 7.948402469537541e-08
concept O 0 3.3858988501833664e-08
of O 0 3.624455757744727e-08
segregation O 0 2.693020633159904e-06
distortion O 0 1.8242458281747531e-06
, O 0 2.0219032004220594e-10
where O 0 5.210634701491301e-11
there O 0 4.894189220561174e-12
is O 0 9.363663273573297e-13
preferential O 0 1.6400375502101383e-10
transmission O 0 5.198201424860827e-09
of O 0 1.3514539487502475e-09
the O 0 3.214052357591868e-10
larger O 0 3.841504059298728e-10
allele O 0 3.999273967547623e-10
at O 0 6.314129219475717e-09
the O 0 1.1614901040957193e-08
DM B-Disease 1 1.0
locus O 0 7.033464299865955e-08
, O 0 5.531016755710993e-10
has O 0 2.5529030278637066e-11
been O 0 2.8177652919292306e-11
put O 0 3.598696063367157e-10
forward O 0 7.415674740940403e-10
to O 0 1.3227302586571454e-10
explain O 0 9.620640950558368e-10
partially O 0 4.888256199819807e-08
the O 0 4.52407844520053e-09
maintenance O 0 1.301366683037486e-05
of O 0 1.9325602806929965e-06
DM B-Disease 1 1.0
in O 0 8.877012902530623e-09
the O 0 1.1801066790440018e-09
population O 0 2.8996128415004208e-11
. O 0 7.23215598519289e-10

In O 0 1.2912363445138908e-07
a O 0 5.174479955627476e-09
survey O 0 4.1629615310512236e-09
of O 0 6.042536426775769e-08
DM B-Disease 1 1.0
in O 0 4.633628236661025e-08
Northern O 0 1.8157878400870686e-07
Ireland O 0 2.727323362705647e-07
, O 0 1.7172381294727757e-09
59 O 0 2.7494893473090087e-08
pedigrees O 0 1.7856706335805939e-07
were O 0 1.9901181147474745e-08
ascertained O 0 1.0419554428153788e-06
. O 0 7.900609944044845e-08

Sibships O 0 0.00036566509515978396
where O 0 2.416172506514158e-08
the O 0 7.556745229564399e-10
status O 0 3.4917899127684393e-10
of O 0 1.0315616139067174e-09
all O 0 5.6524233210675234e-11
the O 0 3.3861410897451094e-10
members O 0 2.3326077180918503e-11
had O 0 1.6682991793581792e-11
been O 0 1.2316527138456212e-11
identified O 0 2.8893111861383325e-11
were O 0 9.507518383689018e-11
examined O 0 7.887868136435827e-09
to O 0 1.0132986116850873e-10
determine O 0 9.36474897628159e-10
the O 0 1.8482899655225538e-09
transmission O 0 2.5450017204775577e-08
of O 0 1.3300506473967744e-08
the O 0 1.3735094839262274e-08
DM B-Disease 1 1.0
expansion O 0 1.0971944419679858e-07
from O 0 7.505769339388735e-09
affected O 0 1.8072934260260354e-09
parents O 0 9.812294726740944e-11
to O 0 1.4502019030082636e-10
their O 0 1.8841905813360427e-09
offspring O 0 4.601806224968641e-08
. O 0 2.5786187407561556e-08

Where O 0 4.269215594376874e-07
the O 0 6.386050444007196e-08
transmitting O 0 1.563539080962073e-05
parent O 0 1.7703523269574362e-07
was O 0 2.1643816694449924e-07
male O 0 1.979922004125001e-08
, O 0 2.635129447980944e-09
58 O 0 1.833495133496399e-07
. O 0 1.368653279598675e-08

3 O 0 4.517609397680644e-07
% O 0 6.436143284993534e-10
of O 0 1.6368570943114946e-09
the O 0 3.417167382391284e-10
offspring O 0 8.959217812076758e-10
were O 0 5.238079969771547e-10
affected O 0 8.847546029144837e-10
, O 0 1.491091139449452e-10
and O 0 1.3793390041261233e-10
in O 0 2.2218421547037792e-10
the O 0 1.2543893701533193e-10
case O 0 8.423307190641438e-11
of O 0 6.903670413116458e-10
a O 0 2.1405059669188375e-10
female O 0 2.1503732128280717e-09
transmitting O 0 1.6525009414181113e-06
parent O 0 7.516373301541535e-08
, O 0 1.45469130075071e-08
68 O 0 1.4636594869443798e-06
. O 0 7.074486774172328e-08

7 O 0 4.004081802122528e-06
% O 0 5.802863523030055e-09
were O 0 5.822498039265156e-09
affected O 0 4.747783677316875e-08
. O 0 4.584573787269619e-08

Studies O 0 7.567265924990352e-07
on O 0 1.6337456543169537e-07
meiotic O 0 1.1974469998676796e-05
drive O 0 1.6577904204950755e-07
in O 0 2.0788581522879213e-08
DM B-Disease 1 1.0
have O 0 2.170228441400468e-10
shown O 0 8.944136403732372e-11
increased O 0 3.223831271381705e-11
transmission O 0 4.792608976345036e-09
of O 0 1.0731372457328803e-09
the O 0 6.51098966408803e-11
larger O 0 8.320092531599599e-11
allele O 0 1.0448660686668276e-10
at O 0 3.0796036831759466e-09
the O 0 2.6792317253665487e-09
DM B-Disease 1 1.0
locus O 0 1.5743010450819384e-08
in O 0 1.4876034848398945e-09
non O 0 1.9968688320659567e-06
- O 0 0.00011295851436443627
DM O 1 1.0
heterozygotes O 0 8.271595106634777e-06
for O 0 7.562317705378518e-08
CTGn O 0 0.0009878004202619195
. O 0 2.19781995269841e-07

This O 0 4.329356428911524e-09
study O 0 1.4319191388167951e-09
provides O 0 2.6398706137742423e-11
further O 0 1.4987204186023284e-11
evidence O 0 9.319697791276838e-11
that O 0 3.74765539781774e-12
the O 0 2.4081336924552943e-09
DM B-Disease 1 1.0
expansion O 0 1.9515108817813598e-07
tends O 0 1.7660237716654592e-09
to O 0 5.5291785039379704e-11
be O 0 8.126876949177131e-11
transmitted O 0 2.549680644392538e-08
preferentially O 0 2.9552904123875123e-08
. O 0 9.526534228143646e-09

Diagnosis O 1 0.9999939203262329
of O 1 0.9996569156646729
hemochromatosis B-Disease 1 1.0
. O 0 4.0457882278133184e-05

If O 0 8.339100531884469e-06
untreated O 1 1.0
, O 0 0.000250685348873958
hemochromatosis B-Disease 1 1.0
can O 0 8.92819298314862e-06
cause O 1 0.9999916553497314
serious O 1 1.0
illness O 1 0.9999998807907104
and O 0 1.427641116436007e-08
early B-Disease 0 1.5251671925398114e-07
death I-Disease 0 2.4649136776133673e-07
, O 0 2.0831986136116143e-10
but O 0 2.8433937496186168e-11
the O 0 1.018851936152032e-08
disease O 0 6.741470861015841e-05
is O 0 1.1036805497299795e-10
still O 0 1.3683229549421583e-10
substantially O 0 3.1828681912315915e-09
under O 0 2.501859626136138e-06
- O 1 0.999962568283081
diagnosed O 0 0.003403859445825219
. O 0 3.923653224546797e-08

The O 0 6.59227225696668e-07
cornerstone O 0 0.00015471379447262734
of O 0 1.0517075565985579e-07
screening O 0 2.283257671820138e-08
and O 0 1.1359341939298773e-10
case O 0 6.259813500886224e-11
detection O 0 1.5350776649825093e-08
is O 0 2.779554798132411e-12
the O 0 1.679211110439116e-11
measurement O 0 6.565742616260195e-09
of O 0 5.5385251940265334e-09
serum O 0 1.737010713043219e-08
transferrin O 0 1.7108312988511898e-08
saturation O 0 5.781684908612306e-09
and O 0 4.40523867384357e-10
the O 0 2.271493659833368e-09
serum O 0 1.4940056303203164e-07
ferritin O 0 3.521376584103564e-06
level O 0 3.66625016567923e-07
. O 0 2.412571298293642e-08

Once O 0 1.3548456081480253e-06
the O 0 3.830218986422551e-08
diagnosis O 0 6.616561222472228e-06
is O 0 2.082404249037495e-10
suspected O 0 5.755084231395813e-08
, O 0 5.76417413800101e-10
physicians O 0 1.4473626741562384e-08
must O 0 3.4950684013601574e-10
use O 0 1.3420018873944173e-08
serum O 0 1.7078193650377216e-06
ferritin O 0 3.4852368116844445e-05
levels O 0 5.415647592599271e-07
and O 0 3.136848647500301e-08
hepatic O 0 0.004491940140724182
iron O 0 0.02253769338130951
stores O 0 6.58528506392031e-07
on O 0 9.151938229479128e-07
liver O 0 0.0003751046024262905
biopsy O 0 4.385225565783912e-06
specimens O 0 2.6618790727184205e-08
to O 0 1.1772042229907242e-09
assess O 0 2.108388486021795e-07
patients O 0 1.552707651342189e-08
for O 0 9.024784808353559e-10
the O 0 1.5045340973074417e-08
presence O 0 6.576210864750465e-08
of O 0 8.506778613082133e-06
iron B-Disease 1 0.9999992847442627
overload I-Disease 1 0.9460262656211853
. O 0 5.324583298715879e-07

Liver O 1 0.999992847442627
biopsy O 1 0.9961487054824829
is O 0 8.756022573663813e-09
also O 0 3.349469313018716e-10
used O 0 1.8347873220747601e-10
to O 0 9.223777991396176e-11
establish O 0 6.835236820990076e-10
the O 0 3.7221345450255683e-10
presence O 0 2.3888455102927253e-10
or O 0 2.9443497640002647e-10
absence O 0 3.192025488374384e-08
of O 0 5.730165071327065e-07
cirrhosis B-Disease 1 1.0
, O 0 1.3975061108340014e-09
which O 0 1.5531533004153886e-10
can O 0 7.353822412126121e-11
affect O 0 2.728077141966878e-08
prognosis O 0 3.600876152631827e-05
and O 0 2.147231299431951e-07
management O 0 8.311394049087539e-05
. O 0 3.4429479001119034e-07

A O 0 4.101088961760979e-06
DNA O 0 1.142852511293313e-06
- O 0 4.777324491556101e-08
based O 0 2.2308499492140754e-09
test O 0 4.993810698294965e-09
for O 0 4.923985524873942e-11
the O 0 9.699555603148724e-10
HFE O 0 0.00377098610624671
gene O 0 2.4122619457500605e-09
is O 0 2.0630708946756116e-11
commercially O 0 8.684449270823791e-10
available O 0 1.0299804065194706e-10
, O 0 1.6703052135857988e-11
but O 0 1.402922808306506e-12
its O 0 1.1752377716833795e-11
place O 0 2.1120526161322317e-10
in O 0 2.8551865732806547e-11
the O 0 1.4728369912564432e-10
diagnosis O 0 1.3968160601507407e-06
of O 0 2.5515669221931603e-06
hemochromatosis B-Disease 1 1.0
is O 0 9.555778390790692e-09
still O 0 3.676254189954875e-09
being O 0 4.765836170150806e-09
evaluated O 0 4.3760164203376917e-07
. O 0 1.4147792626317823e-07

Currently O 0 1.3811511507810792e-06
, O 0 2.5639632639240517e-09
the O 0 1.0888522306018444e-09
most O 0 2.521597340654491e-11
useful O 0 1.534897486887843e-10
role O 0 1.8017100311684686e-10
for O 0 1.4793003627611157e-11
this O 0 3.058396851746137e-12
test O 0 1.1001628497098181e-09
is O 0 3.195150090687382e-12
in O 0 5.860750686842442e-12
the O 0 2.2339815761163173e-11
detection O 0 1.696003693041348e-07
of O 0 1.2377923042095063e-07
hemochromatosis B-Disease 1 1.0
in O 0 3.6971670169805293e-09
the O 0 1.7430867860213084e-09
family O 0 1.4141406101675358e-10
members O 0 1.302782326462193e-10
of O 0 1.687394046712143e-08
patients O 0 2.5370230360977075e-09
with O 0 3.159260075769055e-10
a O 0 5.096920219216372e-09
proven O 0 5.961902047602052e-07
case O 0 6.488556802963785e-09
of O 0 2.0215973961512645e-07
the O 0 3.4975773814949207e-06
disease O 0 0.03798799589276314
. O 0 2.034508739257035e-08

It O 0 1.338426187658115e-07
is O 0 3.850110008585261e-09
crucial O 0 7.573576965569373e-08
to O 0 9.676799095359456e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999998807907104
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.0015338785015046597
because O 0 3.5017919230995176e-07
phlebotomy O 1 1.0
therapy O 1 0.9999974966049194
can O 0 1.3441363932997774e-07
avert O 1 1.0
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 5.963260463204278e-08
can O 0 5.512133527396657e-10
even O 0 1.1062903926273293e-09
lead O 0 6.888692727358148e-09
to O 0 4.0355407904257845e-10
normal O 0 2.231008444653071e-08
life O 0 6.78022482603069e-09
expectancy O 0 5.243880440986004e-09
. O 0 3.0852928545321845e-10
. O 0 4.7229433697282275e-09

Prevalence O 0 1.145243822975317e-05
of O 0 3.525586862451746e-07
the O 0 3.136884529908457e-08
I1307K O 0 6.924763965798775e-06
APC B-Disease 0 4.572955276671564e-06
gene O 0 9.399020228784138e-09
variant O 0 1.241771574456152e-08
in O 0 6.283163572762263e-11
Israeli O 0 2.1056620891357625e-09
Jews O 0 1.5959777943663767e-09
of O 0 6.63400501199618e-10
differing O 0 1.7859100309713938e-10
ethnic O 0 1.1995058592229046e-11
origin O 0 6.035386773683982e-11
and O 0 4.259438357578915e-10
risk O 0 3.573487816765919e-08
for O 0 9.346139449917246e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.138986693964398e-07

BACKGROUND O 0 0.0026065644342452288
& O 0 0.00017130328342318535
AIMS O 0 1.5832602002774365e-06
Israeli O 0 3.2942562455673396e-08
Jews O 0 1.1972129065895842e-08
of O 0 2.434467916145877e-08
European O 0 4.575218071067866e-08
birth O 0 2.2286706098384457e-06
, O 0 1.773459934462096e-09
i O 0 2.855690572900471e-09
. O 0 5.1387623323240206e-11
e O 0 3.2779814973515897e-10
. O 0 4.790940560939205e-11
, O 0 8.673833873373837e-11
Ashkenazim O 0 1.5839729883282416e-07
, O 0 2.2173206326581152e-10
have O 0 1.8497833473296588e-11
the O 0 2.7201207952742834e-09
highest O 1 0.9999830722808838
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 3.258468268541037e-07
of O 0 2.264515908123599e-09
any O 0 5.2470465472520544e-11
Israeli O 0 2.1596759935960108e-08
ethnic O 0 1.2569575380538822e-09
group O 0 1.6741735109349065e-08
. O 0 2.0583966531262377e-08

The O 0 1.4317937484520371e-06
I1307K O 0 3.628982085501775e-05
APC B-Disease 0 7.495923910028068e-06
gene O 0 4.143587162275253e-08
variant O 0 1.5860619839713763e-07
was O 0 4.092127170451931e-08
found O 0 1.7551671227522547e-09
in O 0 2.9891726871511537e-09
6 O 0 3.249499513913179e-07
. O 0 4.244220974669588e-08

1 O 0 2.759529991180898e-07
% O 0 7.083148512165849e-10
of O 0 1.0022830343459077e-09
American O 0 6.265622465306819e-10
Jews O 0 3.362984557497839e-09
, O 0 1.761548407142044e-10
28 O 0 2.4414510413350854e-09
% O 0 9.385194878197556e-12
of O 0 1.6284328052673658e-10
their O 0 6.489769610595886e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.1318053100571888e-08
, O 0 1.5230980365821267e-10
but O 0 8.547257519808671e-12
not O 0 3.437146400830926e-12
in O 0 2.578409707965079e-10
non O 0 2.4594893943685747e-07
- O 0 1.282283079717672e-07
Jews O 0 2.8641908400572902e-08
. O 0 3.306544016368207e-08

We O 0 8.846745203072715e-08
assessed O 0 3.489790287858341e-07
the O 0 2.0117651544637738e-08
I1307K O 0 1.9711478671524674e-06
prevalence O 0 8.399763551381056e-09
in O 0 8.938862670893055e-12
Israeli O 0 3.966236783448096e-10
Jews O 0 7.221969688941954e-10
of O 0 3.177049734404136e-10
differing O 0 4.3431643698133016e-11
ethnic O 0 6.8124009038050826e-12
origin O 0 3.0307280990404806e-11
and O 0 2.9424915282127984e-10
risk O 0 1.636761126633246e-08
for O 0 4.208288373774849e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.5989475577480334e-07

METHODS O 0 7.697973160247784e-06
DNA O 0 5.084145868750056e-07
samples O 0 1.1024887669464078e-08
from O 0 1.0154039831178352e-09
500 O 0 9.9237618123027e-10
unrelated O 0 1.6657508705719692e-09
Jews O 0 1.3835976808707073e-09
of O 0 5.829153604253179e-09
European O 0 7.805672552763099e-09
or O 0 9.369357512056808e-10
non O 0 1.6178410078282468e-07
- O 0 1.562878182426175e-08
European O 0 5.575066519547534e-10
origin O 0 8.485778052458315e-11
, O 0 9.147438015388865e-12
with O 0 6.166300109411438e-12
or O 0 6.871140462161307e-11
without O 0 1.0146504469954465e-10
a O 0 5.3662439075674584e-11
personal O 0 2.1066102195987924e-09
and O 0 1.7595723988961254e-08
/ O 0 2.1143729611594608e-07
or O 0 8.114011129656262e-10
family O 0 1.6035074656972625e-10
history O 0 1.6112103651266807e-08
of O 0 4.996194746809124e-08
neoplasia B-Disease 0 0.003717301646247506
, O 0 1.8490021735928508e-09
were O 0 1.1367822239094494e-09
examined O 0 3.2596918941862896e-08
for O 0 3.433546225117823e-10
the O 0 2.9531870282539785e-09
I1307K O 0 2.9700794357268023e-07
variant O 0 1.2118127834526149e-08
by O 0 1.7755438785904687e-10
the O 0 2.540587074051359e-09
allele O 0 5.619381626686959e-10
- O 0 4.130423558734719e-09
specific O 0 7.490262299292283e-10
oligonucleotide O 0 4.826268309443549e-07
( O 0 2.189468339963696e-08
ASO O 1 0.956446647644043
) O 0 4.179303125795286e-09
method O 0 3.629880040989519e-08
. O 0 1.4408018778055975e-08

RESULTS O 0 1.5666613762732595e-05
In O 0 1.994035514485404e-08
persons O 0 2.360577566751232e-10
at O 0 4.8674597685760546e-09
average O 0 2.742677751577105e-10
risk O 0 5.606195951912696e-09
for O 0 6.948505415493855e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 6.399888174968282e-09
I1307K O 0 7.296152375602105e-07
was O 0 1.06602824345714e-08
found O 0 2.2794260923220122e-10
in O 0 7.637339094479501e-10
5 O 0 2.5795339197998146e-08
. O 0 1.0037163988840803e-08

0 O 0 1.6266920965790632e-07
% O 0 7.464576734506068e-10
of O 0 2.729303894000168e-09
120 O 0 4.014124588280765e-09
European O 0 2.185642067331628e-08
and O 0 2.5633191569340852e-08
1 O 0 2.759975075150578e-07
. O 0 3.1873469197307713e-08

6 O 0 3.0339424483827315e-06
% O 0 1.9264718709166573e-09
of O 0 7.577012794968141e-09
188 O 0 3.631735978615325e-08
non O 0 3.6673134218290215e-07
- O 0 1.157849709443326e-07
European O 0 1.1843034997127688e-08
Jews O 0 2.7295916638081508e-08
( O 0 1.9206787271741632e-09
P O 0 2.9112084121152293e-07
= O 0 1.9364814196620728e-09
0 O 0 5.690297677496403e-10
. O 0 4.8442076738819395e-11
08 O 0 9.345107798708341e-09
) O 0 1.90975901759316e-10
. O 0 1.8496935094702849e-09

It O 0 8.853480437664984e-08
occurred O 0 2.3464943410544947e-07
in O 0 7.532659829223576e-09
15 O 0 6.594763135581161e-08
. O 0 1.269269045423016e-08

4 O 0 1.0254296967104892e-06
% O 0 1.0164717956229197e-09
of O 0 4.1147756313364425e-09
52 O 0 5.619567478021281e-09
Ashkenazi O 0 4.405898579307177e-08
Israelis O 0 6.6152070488101344e-09
with O 0 7.849836336504268e-09
familial O 1 0.6608449816703796
cancer B-Disease 1 0.9711516499519348
( O 0 1.995743836857855e-08
P O 0 6.9816242103115655e-06
= O 0 7.803782509085977e-09
0 O 0 1.4495251665636033e-09
. O 0 2.697102610693669e-11
02 O 0 7.544161739758692e-09
) O 0 2.6513947287698514e-12
and O 0 1.7992159845325872e-11
was O 0 9.651555110679055e-10
not O 0 1.0785658824397082e-11
detected O 0 2.973444157561289e-09
in O 0 3.563975226050786e-10
51 O 0 1.7834056453835956e-09
non O 0 4.202902914585138e-08
- O 0 3.3472819183089086e-08
European O 0 5.150621706917491e-09
Jews O 0 1.0448053089362475e-08
at O 0 9.764458042127444e-08
increased O 0 2.4834355016878362e-08
cancer B-Disease 0 2.3292685000342317e-05
risk O 0 4.4770398943683176e-08
. O 0 3.7765374827358755e-08

Colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9999912977218628
occurred O 0 4.127552529098466e-05
personally O 0 5.274759473650192e-07
or O 0 3.778949153598887e-09
in O 0 5.210517572962203e-10
the O 0 4.127468089532016e-10
families O 0 8.646344057394728e-12
of O 0 3.002617932068574e-09
13 O 0 8.463092449062515e-09
of O 0 9.966446334885859e-09
20 O 0 5.852850648579988e-09
Ashkenazi O 0 5.741335584730223e-08
I1307K O 0 2.3256329484411253e-07
carriers O 0 1.8683656843876406e-09
, O 0 2.5091867472681884e-10
8 O 0 2.2878774430523663e-09
of O 0 3.550867821999759e-09
whom O 0 6.933705831713155e-10
also O 0 8.794296957326253e-10
had O 0 5.975107075784081e-10
a O 0 2.124902059863487e-10
personal O 0 5.877607733850709e-09
or O 0 4.031357914158207e-09
family O 0 2.2149504452784186e-09
history O 0 1.2927469583701168e-07
of O 0 5.218639103077294e-07
noncolonic O 1 0.898828387260437
neoplasia B-Disease 1 0.9999079704284668
. O 0 1.7426975773560116e-06

CONCLUSIONS O 0 4.826153235626407e-05
The O 0 2.866973090931424e-06
I1307K O 0 7.36020811018534e-05
APC O 0 2.2525198801304214e-05
variant O 0 2.4290613964694785e-06
may O 0 4.236292650006135e-09
represent O 0 5.97090377141285e-10
a O 0 1.8573226290286016e-09
susceptibility O 0 1.1858862336566744e-07
gene O 0 1.4699254258232486e-08
for O 0 1.3630573114653544e-08
colorectal B-Disease 1 1.0
, I-Disease 0 5.388372414927289e-09
or I-Disease 0 2.1223551804894214e-09
other I-Disease 0 1.4179009077963656e-09
, I-Disease 0 5.105599054644472e-09
cancers I-Disease 0 3.8714748370693997e-05
in O 0 9.733860384386617e-10
Ashkenazi O 0 5.214828391331139e-08
Jews O 0 2.5260492364509446e-08
, O 0 1.367441937460967e-09
and O 0 2.418767186540549e-09
partially O 0 4.873184593634505e-07
explains O 0 2.943015164902363e-09
the O 0 6.527380858045717e-10
higher O 0 1.0803854699759086e-08
incidence O 0 6.28724819762283e-07
of O 0 6.388973270077258e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.4374589013831383e-09
European O 0 1.3897794914896622e-08
Israelis O 0 2.9046544725019885e-08
. O 0 5.858471752162586e-08

Systematic O 0 3.0089952929301944e-07
analysis O 0 1.0146707474234518e-08
of O 0 7.548108982291524e-08
coproporphyrinogen O 0 0.00023635746038053185
oxidase O 0 2.1878186089452356e-05
gene O 0 2.5169940727209905e-06
defects O 0 0.0027728888671845198
in O 0 1.8073397711759753e-07
hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999356269836426
and O 0 5.208039510762319e-07
mutation O 0 1.0152636065186016e-07
update O 0 3.777265419557807e-06
. O 0 2.2952659151087573e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 0 0.0004624548018909991
HC B-Disease 1 1.0
) O 0 6.67503911699896e-07
is O 0 2.3865467380090877e-09
an O 0 2.9624844799513994e-09
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.01563410460948944
autosomal O 1 1.0
dominant O 1 0.9999802112579346
inheritance O 0 0.000128318220959045
caused O 0 3.5732704418478534e-05
by O 0 2.6242066297754718e-08
deficient B-Disease 0 1.3317815046320902e-06
activity I-Disease 0 2.1235507574601797e-08
of I-Disease 0 2.8883133040835673e-07
coproporphyrinogen I-Disease 0 0.00458845030516386
III I-Disease 1 1.0
oxidase I-Disease 0 2.071486051136162e-05
( O 0 3.0937704309508263e-07
CPO O 1 0.9746193289756775
) O 0 2.1645050196639204e-08
. O 0 3.8021156001377676e-08

Clinical O 0 0.0007698616827838123
manifestations O 0 0.11518701910972595
of O 0 0.00017187184130307287
the O 0 0.0006407219916582108
disease O 1 0.9999892711639404
are O 0 1.712723296520835e-10
characterized O 0 9.7764738526962e-09
by O 0 8.402275541996573e-10
acute O 0 0.00011771181016229093
attacks O 0 4.933685460173365e-08
of O 1 0.9988590478897095
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 2.0625631691473245e-07
precipitated O 0 3.1373099318443565e-07
by O 0 6.835266574967136e-09
drugs O 0 3.65282062375627e-07
, O 0 3.8565630688935926e-09
fasting O 0 3.2270051519844856e-07
, O 0 4.237868722611893e-09
cyclical O 0 0.00021174699941184372
hormonal O 0 0.00042367284186184406
changes O 0 9.790100108375555e-08
, O 0 4.270302866871134e-08
or O 0 0.00044155120849609375
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 2.1739803912623756e-07

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 1.8050383232548484e-06
also O 0 9.685677149207095e-09
be O 0 6.214906367318918e-10
present O 0 3.6419309790147736e-09
. O 0 2.4189532155105553e-08

The O 0 1.1340528089931468e-06
seven O 0 1.7128368767771462e-07
exons O 0 2.011285999969914e-07
, O 0 1.863077692121351e-09
the O 0 5.842544670286998e-09
exon O 0 4.074681783095002e-07
/ O 0 1.6172302252925874e-07
intron O 0 8.57419948374627e-08
boundaries O 0 2.971714874178133e-09
and O 0 6.172083955036101e-10
part O 0 2.4988147107052328e-09
of O 0 1.9686515528860582e-08
3 O 0 1.0591475252397231e-08
noncoding O 0 3.8497745435961406e-08
sequence O 0 4.669234998644356e-10
of O 0 1.5076816461956355e-09
the O 0 3.5728251468469807e-09
CPO O 0 0.0003876705013681203
gene O 0 1.4400785008916728e-09
were O 0 1.4803284986708576e-10
systematically O 0 1.401205484974355e-09
analyzed O 0 8.728439082617001e-10
by O 0 5.584387119395018e-11
an O 0 6.486421816331855e-11
exon O 0 4.3465274046639024e-08
- O 0 3.636948520124861e-08
by O 0 2.2215296269223472e-09
- O 0 3.5161147593498754e-07
exon O 0 2.8719870215354604e-07
denaturing O 0 3.934560936613707e-06
gradient O 0 1.1372234354212196e-07
gel O 0 1.591865981254159e-07
electrophoresis O 0 7.284076986024957e-08
( O 0 3.4466511866781957e-09
DGGE O 1 0.9999889135360718
) O 0 3.260111347547223e-10
strategy O 0 5.339089725886481e-10
followed O 0 7.219445874451225e-11
by O 0 4.242164779177937e-12
direct O 0 2.13386461278553e-11
sequencing O 0 3.967394468507024e-10
in O 0 1.2599861431983328e-10
seven O 0 3.7780031880707554e-10
unrelated O 0 2.6649981776927234e-08
heterozygous O 0 1.1618360673537609e-07
HC B-Disease 1 1.0
patients O 0 5.674219494267163e-08
from O 0 7.87307818939098e-09
France O 0 2.3488541955885012e-07
, O 0 4.8678865383067205e-09
Holland O 0 5.562746537179919e-06
, O 0 3.1852973592094713e-09
and O 0 3.2354645629339984e-09
Czech O 0 3.1189832952804863e-05
Republic O 0 1.331121166003868e-05
. O 0 5.543166707866476e-07

Seven O 0 2.019548219323042e-06
novel O 0 7.520431921648196e-08
mutations O 0 4.071229575686175e-09
and O 0 8.657540795375951e-10
two O 0 1.8899955211981734e-10
new O 0 2.8221462944344466e-09
polymorphisms O 0 8.246450278193151e-08
were O 0 1.3687576405629898e-08
detected O 0 7.569084914393898e-07
. O 0 4.5323460540203087e-08

Among O 0 9.327231964562088e-08
these O 0 1.0649120474326423e-09
mutations O 0 9.830321001658149e-10
two O 0 1.8302853677099051e-10
are O 0 8.606628604246325e-11
missense O 0 6.940658181520121e-08
( O 0 4.550282373116943e-09
G197W O 0 2.1948260382487206e-06
, O 0 4.008944731737074e-09
W427R O 0 1.323632318417367e-06
) O 0 3.9394268402936916e-10
, O 0 1.0857989507506716e-10
two O 0 6.796440493728184e-11
are O 0 1.0730466515340709e-10
nonsense O 0 2.996995647208678e-07
( O 0 5.998107788229845e-09
Q306X O 0 2.6725094812718453e-06
, O 0 3.4363587531061057e-09
Q385X O 0 6.726039032400877e-07
) O 0 4.013778198697082e-10
, O 0 7.233669913064844e-11
two O 0 2.7118659748359697e-11
are O 0 4.084633239281876e-12
small O 0 2.7163865601309567e-10
deletions O 0 1.9429235109669207e-08
( O 0 1.2182832520579723e-08
662de14bp O 0 2.043895847236854e-06
; O 0 4.972036560246806e-09
1168del3bp O 0 3.5234695587860188e-06
removing O 0 1.834814185031064e-07
a O 0 7.677200208888735e-09
glycine O 0 1.1959603796185547e-07
at O 0 6.527274365453195e-08
position O 0 8.164281695144382e-09
390 O 0 1.0052931820325739e-08
) O 0 8.63016810792594e-11
, O 0 5.72893260608609e-11
and O 0 1.1123262727563699e-10
one O 0 7.131077672806185e-11
is O 0 1.3541980037334866e-11
a O 0 1.1007836309140373e-10
splicing O 0 5.884138687406448e-08
mutation O 0 5.87103077265283e-09
( O 0 2.8001843066505216e-09
IVS1 O 0 0.0830378457903862
- O 0 3.657453362393426e-07
15c O 0 6.434382271436334e-07
- O 0 1.427391254082977e-07
- O 0 4.8758803217197055e-08
> O 0 1.61925122199591e-08
g O 0 2.123526599007164e-08
) O 0 1.2287953987666356e-10
which O 0 2.8785243286200135e-11
creates O 0 4.5159376238501636e-10
a O 0 4.7972594646727984e-11
new O 0 3.524032732293847e-10
acceptor O 0 1.900624546635754e-09
splice O 0 3.996771738457028e-06
site O 0 9.11544077553117e-07
. O 0 5.3049578951913645e-08

The O 0 3.2467241339873e-07
pathological O 0 4.283504040358821e-06
significance O 0 1.97588605033161e-07
of O 0 1.3815920851811825e-07
the O 0 1.0921641369066037e-08
point O 0 1.0009843620650827e-08
mutations O 0 1.695245277488766e-09
G197W O 0 2.190145380609465e-07
, O 0 1.2568592833162029e-09
W427R O 0 2.541093238050962e-07
, O 0 5.832298533015035e-10
and O 0 4.71936600909828e-10
the O 0 9.6169905372534e-10
in O 0 2.6250313034381634e-09
- O 0 7.082992681262112e-08
frame O 0 3.4899890977158066e-08
deletion O 0 1.8598262485625128e-08
390delGly O 0 1.796647097762616e-07
were O 0 2.360173834148327e-09
assessed O 0 1.1634411656302746e-08
by O 0 1.5089927918321422e-10
their O 0 2.6231930516651403e-10
respective O 0 2.611487692760761e-09
expression O 0 1.832856505457059e-10
in O 0 7.773973131897094e-11
a O 0 3.349914790007347e-11
prokaryotic O 0 1.1469420968523991e-09
system O 0 7.148894254349614e-10
using O 0 2.1776754011160193e-10
site O 0 2.3248340141890367e-08
- O 0 4.360419225690748e-08
directed O 0 9.359038877221337e-09
mutagenesis O 0 2.925549324572785e-06
. O 0 4.738980763363543e-08

These O 0 6.922136464027062e-08
mutations O 0 2.6364631366959657e-08
resulted O 0 1.0143631712367096e-08
in O 0 1.3249984442964546e-09
the O 0 3.0291187336217718e-09
absence O 0 1.7838384991364364e-08
or O 0 1.2928220716190708e-09
a O 0 8.742401247374687e-10
dramatic O 0 2.4326299197241497e-08
decrease O 0 3.788051117226132e-08
of O 0 3.805344590546156e-07
CPO O 1 0.7510178685188293
activity O 0 4.2700827407315955e-07
. O 0 2.025409884254259e-08

The O 0 5.51910318336013e-07
two O 0 4.988859991783556e-09
polymorphisms O 0 3.281969895851944e-08
were O 0 1.6804557745331294e-09
localized O 0 5.138397796145e-08
in O 0 3.4984715124863897e-09
noncoding O 0 1.2411943828283256e-07
part O 0 3.005316884241438e-09
of O 0 1.7005897134936276e-08
the O 0 3.92410015592759e-09
gene O 0 4.616659277090207e-10
1 O 0 1.6710683947707139e-09
) O 0 1.144700913918717e-11
a O 0 2.9685126579082066e-10
C O 0 1.9835335933748866e-06
/ O 0 1.0414354534304948e-07
G O 0 2.513745585019933e-07
polymorphism O 0 2.1370640812534702e-09
in O 0 2.313962077504783e-10
the O 0 1.7853455380745231e-09
promotor O 0 2.4668241167091765e-05
region O 0 7.762412224110449e-08
, O 0 1.9710475473999622e-09
142 O 0 3.6398077440935594e-08
bp O 0 2.5537786996210343e-08
upstream O 0 5.869496888522008e-09
from O 0 1.5665713171131301e-10
the O 0 1.4568084238941736e-10
transcriptional O 0 1.1138235889163184e-09
initiation O 0 4.781086637706267e-09
site O 0 9.254820909632144e-09
( O 0 1.0877723721769428e-10
- O 0 2.031561585624786e-08
142C O 0 3.9289560049837746e-07
/ O 0 7.458663020543099e-08
G O 0 7.234479539874883e-07
) O 0 2.1003863925894706e-10
, O 0 6.095986909704365e-11
and O 0 1.475896627134432e-10
2 O 0 2.589623404603003e-09
) O 0 4.224774002858922e-11
a O 0 9.748626905725644e-11
6 O 0 7.244115529658757e-09
bp O 0 1.9280058438653214e-08
deletion O 0 1.5350973825434266e-09
polymorphism O 0 2.2644253139247894e-09
in O 0 5.600699348740079e-10
the O 0 8.656021455166751e-10
3 O 0 3.3186924319750233e-09
noncoding O 0 3.5688831445668256e-08
part O 0 1.9664025963095355e-09
of O 0 3.1293772018159416e-09
the O 0 5.953269432978914e-09
CPO O 0 0.0015838750405237079
gene O 0 9.77134728685769e-09
, O 0 1.0890432999843824e-09
574 O 0 3.6401480940639885e-08
bp O 0 1.565769380817983e-08
downstream O 0 1.4675498150040767e-08
of O 0 1.7966362619858955e-08
the O 0 2.711284308176687e-09
last O 0 1.1011641598557276e-09
base O 0 4.432819444843972e-09
of O 0 2.4097923656540843e-09
the O 0 1.2540312122055752e-09
normal O 0 3.811988946722522e-09
termination O 0 5.4602793397862115e-08
codon O 0 5.761212307220376e-08
( O 0 1.1297248692088147e-09
+ O 0 2.2973718927232767e-08
574 O 0 1.6974322534224484e-06
delATTCTT O 0 1.58802758960519e-05
) O 0 5.460661700595892e-09
. O 0 9.938199596604136e-09

Five O 0 8.526790225005243e-06
intragenic O 0 0.0008066699374467134
dimorphisms O 0 8.895504288375378e-05
are O 0 1.2272922678135956e-09
now O 0 9.199887518462901e-10
well O 0 4.6080114723956456e-10
characterized O 0 1.6130913271794611e-09
and O 0 3.8348788033992776e-10
the O 0 5.353631427063021e-10
high O 0 5.924124302225664e-09
degree O 0 4.721772750571063e-09
of O 0 1.2349096190078512e-09
allelic O 0 8.453675093278434e-08
heterogeneity O 0 7.419529168828376e-08
in O 0 1.8763088860396238e-08
HC B-Disease 1 1.0
is O 0 1.1705104441261938e-08
demonstrated O 0 3.752259836176108e-09
with O 0 1.8884964425591733e-10
seven O 0 7.030789284101502e-10
new O 0 8.917477867242951e-11
different O 0 1.2305326896333568e-11
mutations O 0 1.040794533890832e-10
making O 0 1.0749974244106397e-09
a O 0 1.1838843794187426e-10
total O 0 1.3732226467055852e-10
of O 0 1.700061069698222e-08
nineteen O 0 1.923978743434418e-05
CPO O 1 1.0
gene B-Disease 0 6.864022725494578e-05
defects I-Disease 0 0.010102491825819016
reported O 0 2.5311951645790032e-08
so O 0 8.026962983187502e-10
far O 0 1.7571769594937336e-09
. O 0 7.290658077252488e-10
. O 0 9.138784839990421e-09

Coincidence O 0 4.122093741898425e-06
of O 0 5.559600140259136e-07
two O 0 1.6370256261666327e-09
novel O 0 8.261213046978355e-09
arylsulfatase O 0 1.2998617648918298e-06
A O 0 6.302136057456664e-08
alleles O 0 2.8954746933429476e-10
and O 0 8.210407909103878e-10
mutation O 0 1.449306674672357e-09
459 O 0 7.60513358954995e-08
+ O 0 4.239568696107199e-08
1G O 0 0.00016379015869461
> O 0 1.2181234865238366e-07
A O 0 4.041753243200219e-08
within O 0 1.1297378588182028e-09
a O 0 1.818315498169909e-10
family O 0 5.463076102607545e-10
with O 0 1.626835732793097e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 2.04247818658132e-09
molecular O 0 5.700816263498609e-09
basis O 0 8.485264713087304e-10
of O 0 3.5043954405011846e-09
phenotypic O 0 2.804403322897997e-07
heterogeneity O 0 4.060657374793664e-06
. O 0 1.7280100905736617e-07

In O 0 2.2711704161793023e-07
a O 0 1.935009130704657e-08
family O 0 1.551516692899213e-09
with O 0 5.011068227034343e-10
three O 0 2.1500328184487216e-09
siblings O 0 2.9570664139555447e-08
, O 0 4.125587094172545e-10
one O 0 7.608257079905201e-11
developed O 0 4.097029826510834e-09
classical O 0 8.452221891275258e-07
late O 0 0.0002554256934672594
infantile O 1 0.9999955892562866
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 9.466453434470168e-07
MLD B-Disease 1 1.0
) O 0 1.7415523245745135e-08
, O 0 9.418810176242687e-10
fatal O 0 5.606461400020635e-06
at O 0 2.889553343266016e-07
age O 0 3.957352667782743e-09
5 O 0 1.3149756838970461e-09
years O 0 2.7349303377555145e-10
, O 0 9.505324305436602e-11
with O 0 2.3236214341526562e-10
deficient O 0 9.920730917656329e-06
arylsulfatase O 0 0.0044826483353972435
A O 0 5.5694141337880865e-05
( O 0 2.9018025315963314e-08
ARSA O 1 0.9999326467514038
) O 0 1.3248292463075018e-09
activity O 0 2.013917921317443e-09
and O 0 2.0676887979576009e-10
increased O 0 7.955948677640379e-10
galactosylsulfatide O 0 7.124423973436933e-06
( O 0 8.013432761799777e-08
GS O 1 1.0
) O 0 3.117392566309718e-08
excretion O 0 4.0015524405134784e-07
. O 0 2.3140836802326703e-08

The O 0 2.748305121258454e-07
two O 0 2.747071459197059e-09
other O 0 2.2014392531133353e-09
siblings O 0 4.0788254551671344e-08
, O 0 2.6671274078182705e-09
apparently O 0 1.6802866653620185e-08
healthy O 0 1.6965916671551895e-08
at O 0 1.3055900183189806e-07
12 O 0 2.8536991436567405e-08
( O 0 5.09412845239865e-10
1 O 0 1.0638061098688922e-08
/ O 0 1.4040848483887203e-08
2 O 0 4.793797359070595e-09
) O 0 2.1710553493869966e-11
and O 0 5.038601480489291e-11
15 O 0 3.1427505042813664e-10
years O 0 1.0461722460552991e-10
, O 0 1.3976752914757196e-11
respectively O 0 2.940511167892623e-10
, O 0 2.400536887325888e-11
and O 0 4.706177114677246e-11
their O 0 3.689789307426139e-10
father O 0 3.7562930543799666e-08
, O 0 1.127301252346058e-09
apparently O 0 6.5340111099487785e-09
healthy O 0 5.050383222737764e-09
as O 0 6.854350420582023e-10
well O 0 2.001892429603913e-09
, O 0 8.212349689173948e-10
presented O 0 1.3940491783159814e-07
ARSA O 1 0.9999032020568848
and O 0 3.323534087940061e-07
GS O 1 1.0
values O 0 1.0112857218302906e-08
within O 0 1.6738691543949358e-09
the O 0 1.7667101115392825e-10
range O 0 2.9948868274232154e-08
of O 0 4.087923173301533e-07
MLD B-Disease 1 1.0
patients O 0 1.5868412219788297e-06
. O 0 3.185153119034112e-08

Mutation O 0 7.884727892815135e-08
screening O 0 1.566699125987725e-07
and O 0 1.5260881447431984e-09
sequence O 0 2.760210948693498e-10
analysis O 0 1.7825001197291357e-10
disclosed O 0 2.120910780334384e-09
the O 0 5.808895586767449e-10
involvement O 0 1.5809442643899274e-09
of O 0 1.3835871337519734e-09
three O 0 1.0193991484275244e-10
different O 0 1.3006049015551469e-10
ARSA O 1 0.624902069568634
mutations O 0 3.3245211028543054e-09
being O 0 6.815267239446143e-10
the O 0 2.1493511137560262e-10
molecular O 0 3.630473255356037e-09
basis O 0 1.3397379872159831e-09
of O 0 1.1252566878283687e-08
intrafamilial O 0 1.0796543392643798e-05
phenotypic O 0 1.584717892910703e-06
heterogeneity O 0 6.307045623543672e-06
. O 0 2.964213479117461e-07

The O 0 6.381107482411608e-07
late O 0 1.4558215298166033e-05
infantile O 0 0.40806102752685547
patient O 0 1.133008481701836e-05
inherited O 0 1.6618250811006874e-05
from O 0 3.607579230902047e-07
his O 0 2.3055513338476885e-06
mother O 0 1.1849004266650809e-07
the O 0 7.674111124345018e-09
frequent O 0 4.669344466634584e-09
0 O 0 6.5285674644144365e-09
- O 0 3.065978404492853e-08
type O 0 2.5310599838235248e-08
mutation O 0 3.6102685285754887e-09
459 O 0 1.0430793651039494e-07
+ O 0 1.1404834410200237e-08
1G O 0 3.324829231132753e-05
> O 0 4.9453586115077997e-08
A O 0 1.284194581785414e-07
, O 0 2.157787976075909e-10
and O 0 1.1506819802553636e-10
from O 0 4.921846818994879e-10
his O 0 2.6501802974365773e-09
father O 0 7.167151760967272e-09
a O 0 7.184311479058181e-10
novel O 0 3.204822851543554e-09
, O 0 2.9500893394818206e-10
single O 0 6.366698723780928e-09
basepair O 0 1.7041603541656514e-06
microdeletion O 0 4.64696222479688e-06
of O 0 5.086948817734083e-07
guanine O 0 3.7212549841569853e-07
at O 0 1.5953644094679476e-07
nucleotide O 0 8.331233480873834e-09
7 O 0 1.55229020748493e-08
in O 0 1.4700424211255836e-09
exon O 0 4.9556128089989215e-08
1 O 0 4.095703332041012e-08
( O 0 1.8147131575219078e-09
7delG O 0 1.8876196463679662e-06
) O 0 3.232287992815941e-09
. O 0 6.366018823200648e-09

The O 0 1.0793123692565132e-06
two O 0 4.966437572306859e-08
clinically O 0 2.254363971587736e-05
unaffected O 0 2.5593337795726256e-06
siblings O 0 1.1302064706342208e-07
carried O 0 6.183988876529156e-09
the O 0 5.399225955216025e-09
maternal O 0 2.2497376406249714e-08
mutation O 0 1.1915716191523984e-09
459 O 0 3.260226577594949e-08
+ O 0 1.1152611278930635e-08
1G O 0 3.4591244912007824e-05
> O 0 1.1095244900616308e-07
A O 0 1.5653102991564083e-07
and O 0 1.5792414043147573e-09
, O 0 1.795891074740652e-10
on O 0 3.687193050883053e-10
their O 0 1.2051662445777822e-10
paternal O 0 2.055759118491096e-09
allele O 0 2.1732646238170616e-10
, O 0 3.013211555269457e-11
a O 0 2.6615144116393097e-11
novel O 0 2.0353063678868466e-10
cytosine O 0 3.392866210205625e-09
to O 0 2.985853231329827e-11
thymidine O 0 2.5981989892898127e-08
transition O 0 1.7195793233781842e-08
at O 0 3.515892643690677e-08
nucleotide O 0 9.127322897484191e-09
2435 O 0 6.566085630765883e-06
in O 0 4.503708073144708e-09
exon O 0 6.176953348813186e-08
8 O 0 1.9791141170344417e-08
, O 0 3.6278393483746285e-11
resulting O 0 1.0414598350383386e-10
in O 0 5.870140484809383e-11
substitution O 0 2.811648025513591e-09
of O 0 1.6947998560112865e-08
alanine O 0 2.1661824689545028e-07
464 O 0 3.2480960499015055e-07
by O 0 8.725946187837508e-09
valine O 0 3.2602310966467485e-05
( O 0 6.802948604445191e-08
A464V O 0 3.3168682421091944e-05
) O 0 2.900784501491671e-08
. O 0 6.039552147285576e-08

The O 0 6.589456802430504e-07
fathers O 0 4.1205825596080103e-07
genotype O 0 5.76259751028374e-08
thus O 0 9.589538052523494e-09
was O 0 1.5904697647783905e-07
7delG O 0 1.627742858545389e-05
/ O 0 1.2187420907139312e-05
A464V O 0 2.9576658562291414e-05
. O 0 9.503778386488193e-08

Mutation O 0 1.0407458148620208e-06
A464V O 0 5.466262336994987e-06
was O 0 2.6445110989925524e-08
not O 0 4.4506565100022044e-11
found O 0 9.148978102890837e-11
in O 0 9.214669305368517e-11
18 O 0 1.2751704581148715e-08
unrelated O 0 4.45401110482635e-06
MLD B-Disease 1 1.0
patients O 0 2.4527810182917165e-07
and O 0 1.3137904986137983e-08
50 O 0 5.781841849739067e-08
controls O 0 4.3418876316536625e-07
. O 0 7.682638170081191e-08

A464V O 0 0.00012671505101025105
, O 0 3.4155025474547074e-08
although O 0 2.6054627344507253e-09
clearly O 0 6.1765388359447115e-09
modifying O 0 4.458582338884298e-07
ARSA O 1 0.9997485280036926
and O 0 1.202433736580133e-06
GS O 1 1.0
levels O 0 9.351188055006787e-07
, O 0 2.4999204928377594e-09
apparently O 0 4.140393805585063e-09
bears O 0 2.868903870023587e-08
little O 0 5.270851533012433e-10
significance O 0 1.9459565070434337e-09
for O 0 2.4743221360701284e-10
clinical O 0 9.706504044970643e-08
manifestation O 0 1.5538265643044724e-06
of O 0 4.1958210204029456e-05
MLD B-Disease 1 1.0
, O 0 1.0035005004738196e-07
mimicking O 0 3.1241897886502557e-06
the O 0 3.1288237778426264e-08
frequent O 0 8.654723728795943e-07
ARSA O 1 0.9999954700469971
pseudodeficiency O 0 0.0023585574235767126
allele O 0 6.520480724248046e-07
. O 0 6.568576083054722e-08

Our O 0 5.986281053083076e-07
results O 0 2.0331897943037802e-08
demonstrate O 0 3.9984140443038996e-09
that O 0 9.29877615879482e-12
in O 0 3.283110935892175e-11
certain O 0 2.1615942369379582e-10
genetic O 0 2.12785682407457e-08
conditions O 0 5.248278284852859e-06
MLD B-Disease 1 1.0
- O 0 0.0001883449003798887
like O 0 1.2143699734679103e-07
ARSA O 1 0.9999500513076782
and O 0 1.1294372370684869e-07
GS O 1 1.0
values O 0 2.8453441824893844e-09
need O 0 3.152632599423555e-10
not O 0 9.917506919865371e-12
be O 0 1.5817510495841347e-11
paralleled O 0 2.262383391737899e-09
by O 0 4.1338657497114184e-10
clinical O 1 0.7157184481620789
disease O 0 0.01023205928504467
, O 0 2.0183892057712427e-10
a O 0 2.3634205703615407e-10
finding O 0 7.382960354185286e-10
with O 0 2.132909404650718e-10
serious O 0 8.687321724210051e-07
diagnostic O 1 0.8220449686050415
and O 0 1.9382197535833257e-07
prognostic O 0 0.10743395984172821
implications O 0 3.7441695894813165e-06
. O 0 2.3340004418059834e-07

Moreover O 0 9.267610039387364e-07
, O 0 1.0460057708883141e-08
further O 0 1.4993517538641754e-08
ARSA O 0 0.07983281463384628
alleles O 0 9.59846779835516e-09
functionally O 0 4.9241993593795996e-08
similar O 0 1.2527259229955234e-09
to O 0 8.253396854840389e-10
A464V O 0 5.000018177270249e-07
might O 0 7.358484932495912e-10
exist O 0 1.6129622082416972e-09
which O 0 2.1812419925826276e-10
, O 0 1.3562201361949633e-10
together O 0 9.760273839143352e-11
with O 0 6.00679089801659e-11
0 O 0 2.7882034459025817e-09
- O 0 7.90175125331416e-09
type O 0 1.1845158631729191e-08
mutations O 0 7.908869115169637e-09
, O 0 2.108728747174382e-09
may O 0 9.933102340653477e-09
cause O 0 5.739681228078553e-07
pathological O 1 0.9825057983398438
ARSA O 1 1.0
and O 0 4.497398094827076e-06
GS O 1 1.0
levels O 0 9.557273870086647e-07
, O 0 3.2051511444919356e-10
but O 0 5.39396825816052e-12
not O 0 3.750715883710232e-12
clinical O 0 1.662013282555108e-08
outbreak O 0 1.2755596578983841e-08
of O 0 7.689421543943809e-09
the O 0 3.535300265866681e-07
disease O 0 0.015261522494256496
. O 0 1.5858094837284398e-09
. O 0 8.26146617782797e-09

Human O 1 0.9997586607933044
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.003579979296773672
to O 0 1.0710173228289932e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 3.4692109238676494e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.979582667350769
1 I-Disease 0 0.0004454975132830441
. O 0 6.917172754583589e-07

Heterozygous O 0 2.1592823031824082e-06
germ O 0 0.0022774431854486465
- O 0 3.959758942073677e-06
line O 0 2.005857595577254e-07
mutations O 0 7.072551433395802e-10
in O 0 2.551784616944275e-10
the O 0 1.7348279479634243e-09
DNA O 0 9.961895557353273e-06
mismatch O 0 0.14545422792434692
repair O 1 0.951968252658844
genes O 0 1.163082217203737e-07
lead O 0 1.72153590938251e-07
to O 0 7.931259915494593e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1962756616412662e-06

The O 0 1.6603471522103064e-05
disease O 0 0.0019386571366339922
susceptibility O 0 3.502526908505388e-07
of O 0 2.3503373824951268e-07
individuals O 0 1.9169667242469046e-10
who O 0 4.1139909257026375e-09
constitutionally O 0 5.757795520366926e-07
lack O 0 5.512107748018025e-08
both O 0 2.293224943272776e-09
wild O 0 3.947919822167023e-07
- O 0 8.054406919200119e-08
type O 0 2.5409566006828754e-08
alleles O 0 5.330156316318835e-10
is O 0 1.715021319403931e-10
unknown O 0 1.126532289674742e-08
. O 0 1.2507116231574855e-08

We O 0 4.3427238693993786e-08
have O 0 4.767852224141222e-10
identified O 0 1.6039181094384958e-09
three O 0 1.4509987655841883e-10
offspring O 0 1.831910179106444e-09
in O 0 6.204388669495131e-10
a O 0 1.9275352869385642e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.451023052823075e-07
who O 0 1.0672121852906002e-08
developed O 0 7.055673904687865e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9999995231628418
at O 0 3.5719760944630252e-06
a O 0 2.5556290417227956e-09
very O 0 2.6123833651858774e-10
early O 0 1.651200598473679e-08
age O 0 1.6595352869686053e-09
, O 0 3.4822641298282164e-11
and O 0 1.3024369083236564e-10
at O 0 3.153897365493208e-09
least O 0 8.905117095114878e-12
two O 0 3.024745384716532e-11
of O 0 2.1112602777151324e-09
them O 0 2.793637265963156e-10
displayed O 0 1.1270699928900285e-07
signs O 0 4.5218806121738453e-07
of O 0 1.4526251561619574e-06
neurofibromatosis B-Disease 1 0.999995231628418
type I-Disease 0 0.0002174512919737026
1 I-Disease 0 3.745427602552809e-05
( O 0 1.8145242108857929e-07
NF1 B-Disease 1 0.9999774694442749
) O 0 3.4311995023017516e-08
. O 0 5.744073661162474e-08

DNA O 0 1.747995383993839e-06
sequence O 0 5.1033697268110245e-09
analysis O 0 3.393123559902733e-10
and O 0 1.4815769444620486e-10
allele O 0 1.4746416587829714e-10
- O 0 1.2035726859593865e-09
specific O 0 6.220737813755761e-11
amplification O 0 2.883221306149153e-08
in O 0 4.0719735916461275e-10
two O 0 1.9322266009424993e-10
siblings O 0 1.24605410434242e-08
revealed O 0 1.8271547830295276e-08
a O 0 5.752216480914285e-09
homozygous O 0 6.618048473683302e-07
MLH1 O 1 0.9989767074584961
mutation O 0 1.2931981530073244e-07
( O 0 1.7874997482181243e-08
C676T O 0 1.2701423656835686e-05
- O 0 1.1629690561676398e-05
- O 0 5.745383532484993e-06
> O 0 8.761604703977355e-07
Arg226Stop O 0 0.000203265473828651
) O 0 1.2349855360582751e-08
. O 0 2.556868849978855e-08

Thus O 0 1.8218449326923292e-07
, O 0 6.0336780016712055e-09
a O 0 2.373513829923013e-09
homozygous O 0 1.7802261709221057e-07
germ O 1 0.9997026324272156
- O 0 0.0003663788374979049
line O 0 1.8607508536661044e-05
MLH1 O 1 0.9999997615814209
mutation O 0 3.8944040881006003e-08
and O 0 1.695307538795987e-08
consequent O 1 0.8765906691551208
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.0773984513434698e-06
in O 0 1.9872352652328118e-08
a O 0 1.8786723288144458e-08
mutator O 0 0.07398629188537598
phenotype O 0 3.450738290666777e-07
characterized O 0 2.4848095137031123e-08
by O 0 7.600953644271158e-09
leukemia B-Disease 1 1.0
and O 0 7.75133776187431e-06
/ O 1 0.9999884366989136
or O 1 0.9513909220695496
lymphoma B-Disease 1 1.0
associated O 0 0.00013309014320839196
with O 0 2.489169617092557e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.999614953994751
1 I-Disease 0 3.580550037440844e-05
. O 0 1.0252107607300331e-08
. O 0 6.170509880831787e-09

Missense O 0 3.3486183383502066e-05
mutations O 0 8.678496499214816e-08
in O 0 9.579921744773401e-09
the O 0 1.7253474204892427e-09
most O 0 1.4596120145871083e-10
ancient O 0 1.0957154294999327e-08
residues O 0 2.879308524939006e-08
of O 0 2.4918765717529823e-08
the O 0 2.5056216657048935e-08
PAX6 O 1 0.9999337196350098
paired O 0 4.267754434295057e-07
domain O 0 1.3628520534325617e-08
underlie O 0 2.0344842255326512e-07
a O 0 1.7365661131307775e-09
spectrum O 0 9.521868804540645e-08
of O 0 2.2179799543664558e-06
human O 1 0.9999915361404419
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 6.917458813404664e-05

Mutations O 0 9.711251323096803e-07
of O 0 5.739144626204506e-07
the O 0 2.7900561860860762e-08
human O 0 8.019365083100638e-08
PAX6 O 1 0.9999996423721313
gene O 0 8.172843081410974e-06
underlie O 1 0.9998760223388672
aniridia B-Disease 1 1.0
( O 1 0.7942299842834473
congenital B-Disease 1 1.0
absence I-Disease 0 0.009697805158793926
of I-Disease 0 0.004836427513509989
the I-Disease 0 2.8916697374370415e-06
iris I-Disease 0 0.0012672044103965163
) O 0 1.9578436649680953e-09
, O 0 5.393788748975226e-10
a O 0 1.5788830243224083e-09
rare O 0 1.6881366491361405e-06
dominant O 0 0.4988459646701813
malformation B-Disease 1 1.0
of I-Disease 1 0.9999977350234985
the I-Disease 1 0.9999134540557861
eye I-Disease 1 1.0
. O 0 1.7058221146726282e-06

The O 0 5.05838784192747e-07
spectrum O 0 1.4133890999801224e-06
of O 0 9.197199801747047e-07
PAX6 O 1 0.9999922513961792
mutations O 0 1.6342724507012463e-07
in O 0 1.466716526010714e-07
aniridia B-Disease 1 1.0
patients O 0 9.674196377318367e-08
is O 0 1.7906373606102477e-10
highly O 0 7.907329901968296e-09
biased O 0 1.540462690741151e-08
, O 0 4.461453151360928e-10
with O 0 6.478557967870557e-11
92 O 0 1.944113492413635e-08
% O 0 1.3875102455873645e-11
of O 0 5.972931038655815e-10
all O 0 1.5349531368169522e-10
reported O 0 2.7848656714013487e-09
mutations O 0 3.6855496432508517e-09
leading O 0 4.232014561011965e-08
to O 0 9.139163870131028e-10
premature O 0 1.0945419148811197e-07
truncation O 0 1.8648263733211934e-07
of O 0 1.450224687005175e-07
the O 0 1.329337973032807e-08
protein O 0 2.110672525645896e-09
( O 0 6.598632196208598e-10
nonsense O 0 1.4251659763431235e-07
, O 0 2.2210794314858617e-10
splicing O 0 8.465352863140652e-09
, O 0 2.575200330756644e-10
insertions O 0 8.46396464027066e-09
and O 0 4.4341783023149617e-10
deletions O 0 1.072016786451968e-08
) O 0 4.075547677118152e-10
and O 0 1.2262298954013318e-09
just O 0 1.7768492233116717e-09
2 O 0 3.431394057784587e-09
% O 0 1.833904555992305e-11
leading O 0 1.2783836489393963e-10
to O 0 5.177276142520615e-12
substitution O 0 2.387926523184092e-09
of O 0 2.4470329762493748e-08
one O 0 1.0060868804728784e-09
amino O 0 1.6638774802402168e-09
acid O 0 1.8431359771753364e-09
by O 0 7.825013553786064e-11
another O 0 1.8770347498531237e-09
( O 0 1.1991364567975893e-09
missense O 0 8.422530299867503e-07
) O 0 9.229453645787089e-09
. O 0 4.089989147360029e-08

The O 0 3.6036732353750267e-07
extraordinary O 0 9.058749839141456e-08
conservation O 0 5.194269903086024e-08
of O 0 9.107914422656904e-09
the O 0 4.855793989122503e-09
PAX6 O 0 0.00030951175722293556
protein O 0 9.553281721252915e-09
at O 0 3.991352670595916e-08
the O 0 2.506203466978718e-09
amino O 0 1.542023575495932e-08
acid O 0 1.4160502992410784e-08
level O 0 1.3529633413611464e-08
amongst O 0 4.6820436416794564e-09
vertebrates O 0 6.880763692151959e-08
predicts O 0 6.252613093948867e-09
that O 0 2.358411903269353e-11
pathological O 0 1.94946255760442e-06
missense O 0 2.1195128852014022e-07
mutations O 0 3.900929357314453e-09
should O 0 3.1573382797134286e-10
in O 0 1.4805777714954615e-09
fact O 0 4.5885759081265576e-10
be O 0 2.3182958330814074e-10
common O 0 8.426493391944234e-10
even O 0 5.842538952638421e-11
though O 0 2.0338770598260503e-11
they O 0 1.2642849440969162e-11
are O 0 1.0493493227126116e-11
hardly O 0 4.094748540239834e-09
ever O 0 3.939489179316524e-09
seen O 0 3.879167653764171e-09
in O 0 1.2275760852276107e-08
aniridia B-Disease 1 1.0
patients O 0 5.116784222991555e-07
. O 0 7.608630170352626e-08

This O 0 1.0661563187852607e-08
indicates O 0 4.085426219546662e-09
that O 0 1.4696233813227266e-11
there O 0 4.7512369039104385e-11
is O 0 1.7954551040366695e-11
a O 0 1.651967590499126e-10
heavy O 0 5.003155820304528e-06
ascertainment O 0 0.00018614213331602514
bias O 0 1.841661045887122e-08
in O 0 2.741077365087108e-10
the O 0 1.568909724358747e-10
selection O 0 1.1917307141118272e-09
of O 0 2.5793356339676166e-09
patients O 0 7.020417025493941e-10
for O 0 6.771070926170353e-10
PAX6 O 1 0.9949285984039307
mutation O 0 1.4075510756939025e-09
analysis O 0 3.6080982646069515e-10
and O 0 2.635384410698549e-10
that O 0 1.292335075758766e-11
the O 0 1.2385705794315527e-09
missing O 0 2.652467969710415e-07
PAX6 O 1 0.9999750852584839
missense O 0 9.61898058449151e-06
mutations O 0 1.1287458789865923e-07
frequently O 0 2.079937111432173e-08
may O 0 3.121319380738896e-08
underlie O 0 7.945187462610193e-06
phenotypes O 0 5.108008167553635e-07
distinct O 0 2.079048577741105e-08
from O 0 1.1576619840525382e-07
textbook O 0 0.0003144580405205488
aniridia B-Disease 1 1.0
. O 0 8.796097290542093e-07

Here O 0 3.4867395015680813e-07
we O 0 1.8211313568272658e-09
present O 0 1.5145038556596546e-09
four O 0 8.008871343889723e-10
novel O 0 2.1275239348028663e-08
PAX6 O 0 0.34974342584609985
missense O 0 1.600431232873234e-06
mutations O 0 2.8795390960567602e-08
, O 0 2.018544220661056e-09
two O 0 3.072608278920086e-10
in O 0 2.0418551294199005e-09
association O 0 2.6627271054735502e-08
with O 0 1.3250668340347715e-09
atypical O 0 5.234867785475217e-05
phenotypes O 0 4.770684608956799e-05
ectopia B-Disease 1 0.7429682016372681
pupillae I-Disease 0 0.0008176452247425914
( O 0 3.4071594434692543e-09
displaced B-Disease 0 1.6730457019775713e-09
pupils I-Disease 0 4.085825366928475e-08
) O 0 2.015159150658974e-09
and O 0 7.33005435904488e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999940395355225
( O 0 1.0189456389753104e-07
searching B-Disease 0 3.0102984283075784e-07
gaze I-Disease 0 2.445568725306657e-06
) O 0 6.902498572713966e-10
, O 0 2.35826913552728e-10
and O 0 1.5644992246155454e-10
two O 0 1.0374173048388613e-10
in O 0 1.5869865421791474e-09
association O 0 1.5384777896088053e-08
with O 0 2.761069151091533e-10
more O 0 5.455016993671791e-10
recognizable O 0 0.05481281876564026
aniridia B-Disease 1 1.0
phenotypes O 0 2.5213968910975382e-05
. O 0 3.893201210303232e-07

Strikingly O 0 2.2666688892059028e-05
, O 0 3.8028119320188125e-08
all O 0 1.4601306830286376e-09
four O 0 4.2945327849430726e-10
mutations O 0 1.6925273682577568e-10
are O 0 1.674426396147677e-11
located O 0 5.049361817555109e-09
within O 0 3.2582607722986268e-09
the O 0 1.9907407278196843e-08
PAX6 O 1 0.9838972687721252
paired O 0 2.0045456494699465e-07
domain O 0 5.2164672581511695e-09
and O 0 7.126172985039148e-10
affect O 0 1.4889547372831657e-09
amino O 0 1.2919223468799146e-09
acids O 0 1.295593632377745e-10
which O 0 8.02804264038448e-12
are O 0 1.0515105496392008e-12
highly O 0 3.013799487749935e-10
conserved O 0 8.693531450276737e-10
in O 0 1.5832518629466108e-10
all O 0 8.00375113407803e-11
known O 0 2.626178163822601e-09
paired O 0 7.236630406026734e-09
domain O 0 2.543389499010118e-09
proteins O 0 4.455884994314374e-09
. O 0 2.3397095816335423e-08

Our O 0 8.203854235944164e-07
results O 0 2.2116841691399713e-08
support O 0 7.60960960910495e-10
the O 0 3.547684368498949e-10
hypothesis O 0 1.9450757671179986e-10
that O 0 1.1042143761852419e-12
the O 0 2.5173491763341715e-11
under O 0 3.5579303392374584e-10
- O 0 8.572424436970039e-10
representation O 0 5.844043304836788e-11
of O 0 9.103984788261243e-10
missense O 0 7.520115730130783e-08
mutations O 0 4.752492621662441e-09
is O 0 2.0475403317288254e-10
caused O 0 1.0532107630467635e-08
by O 0 1.1730419968714045e-09
ascertainment O 0 0.00019330825307406485
bias O 0 6.33317682741108e-08
and O 0 8.641043991453046e-10
suggest O 0 3.1178651327401496e-10
that O 0 3.613294125709432e-12
a O 0 4.086739280317886e-11
substantial O 0 5.481592402212243e-10
burden O 0 7.509967758778657e-08
of O 0 6.933698387001641e-06
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999945163726807
related I-Disease 1 0.9999991655349731
disease I-Disease 1 0.9998106360435486
remains O 0 9.999959083017984e-09
to O 0 9.09256211989451e-11
be O 0 9.990359928213621e-11
uncovered O 0 8.524268935161672e-08
. O 0 1.2886762768005156e-09
. O 0 5.810837588882123e-09

The O 0 3.630289029388223e-07
chromosomal O 0 6.437782644752588e-07
order O 0 2.052140146702186e-08
of O 0 2.1210902900747897e-07
genes O 0 8.719324817718643e-09
controlling O 0 1.407098721983857e-07
the O 0 4.2476223427456716e-08
major O 0 5.21837534961378e-07
histocompatibility O 0 0.013560623861849308
complex O 0 8.322394023707602e-06
, O 0 5.844684292100055e-09
properdin O 0 5.867092909284111e-07
factor O 0 1.3250119224039736e-08
B O 0 4.097972578165354e-06
, O 0 4.749934889858309e-10
and O 0 2.6206739001111146e-09
deficiency B-Disease 0 1.2176186601209338e-06
of I-Disease 0 2.783864090361021e-07
the I-Disease 0 4.415741372554294e-08
second I-Disease 0 6.010375130927059e-08
component I-Disease 0 7.638993082537127e-08
of I-Disease 0 9.678589663053572e-08
complement I-Disease 0 6.289670864134678e-07
. O 0 1.766608193065622e-07

The O 0 4.399130659749062e-07
relationship O 0 5.908269873344807e-09
of O 0 3.0284500240895795e-08
the O 0 1.7875876334727536e-09
genes O 0 1.029968541010895e-10
coding O 0 3.423281214054441e-09
for O 0 6.689927500858062e-10
HLA O 0 1.1354180884382004e-07
to O 0 5.50132266130543e-11
those O 0 1.1512857334139426e-10
coding O 0 2.429874079723504e-09
for O 0 2.9477606466876694e-10
properdin O 0 1.1413950460337219e-06
Factor O 0 3.155722083647561e-08
B O 0 2.9505758902814705e-06
allotypes O 0 5.31801617853489e-07
and O 0 1.368271496104967e-09
for O 0 2.6861752822071594e-09
deficiency B-Disease 0 1.0828858876266167e-06
of I-Disease 0 3.400254229291022e-07
the I-Disease 0 2.029292289762452e-08
second I-Disease 0 1.5800408093014084e-08
component I-Disease 0 7.747499530808e-09
of I-Disease 0 1.1115235842851234e-08
complement I-Disease 0 2.399817411458116e-08
( O 0 7.991038053489774e-09
C2 O 0 0.0010207686573266983
) O 0 1.9817372742814143e-10
was O 0 5.940154479411319e-10
studied O 0 1.9524288852323934e-09
in O 0 3.187421160344428e-11
families O 0 2.3401465227418372e-12
of O 0 9.861664818089366e-10
patients O 0 5.47503331560506e-09
with O 0 7.764337084381623e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 0.06441625952720642

Patients O 0 1.4646899444414885e-06
were O 0 1.2757738865332158e-08
selected O 0 1.703485352777534e-08
because O 0 1.7009642305776396e-10
they O 0 2.7996847895561672e-11
were O 0 3.662527781056468e-10
heterozygous O 0 2.9807506463086497e-10
or O 0 5.498472233078644e-10
homozygous O 0 1.7444088484808162e-07
for O 0 8.820458788250107e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.1343660137063125e-06

12 O 0 3.8880689317011274e-06
families O 0 2.396239429103275e-09
with O 0 2.4870037140800605e-09
15 O 0 3.0253673344304843e-08
matings O 0 5.337405468708312e-07
informative O 0 4.045884338665928e-07
for O 0 3.0547851110895863e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.7719401057547657e-07
found O 0 1.8907329035755538e-08
. O 0 8.333665313386973e-09

Of O 0 3.754381395992823e-05
57 O 0 2.5636329610279063e-06
informative O 0 7.608324494867702e-07
meioses O 0 3.579699477995746e-05
, O 0 3.1026441416059924e-09
two O 0 4.722902971487919e-11
crossovers O 0 1.0091156799063583e-09
were O 0 2.025196454980005e-09
noted O 0 7.229714604761739e-10
between O 0 2.0111616816365085e-09
the O 0 1.2635427992790937e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.2958198070123217e-08
and O 0 1.2852005015773216e-09
the O 0 2.5492223887368937e-09
HLA O 0 8.13461042525887e-07
- O 0 2.507659075945412e-07
B O 0 2.349674787183176e-06
gene O 0 4.1588249510837727e-10
, O 0 1.3455163198894393e-11
with O 0 4.489532877405278e-12
a O 0 3.3887819633759975e-11
recombinant O 0 3.4185054786917135e-09
fraction O 0 9.45807432373158e-10
of O 0 1.838530394593363e-08
0 O 0 3.6615745102608344e-08
. O 0 8.258298933583319e-09

035 O 0 0.06891027092933655
. O 0 2.997407500515692e-05

A O 0 2.0560642951750197e-05
lod O 0 8.10185301816091e-05
score O 0 4.748082744754356e-07
of O 0 1.2482716726935905e-07
13 O 0 2.7532781388117655e-08
was O 0 1.7356025505677053e-09
calculated O 0 4.590992030983898e-10
for O 0 2.6963736798890636e-10
linkage O 0 6.740557410012116e-07
between O 0 8.080170118773822e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 7.491441067486448e-08
HLA O 0 7.54418169890414e-06
- O 0 3.564788357834914e-07
B O 0 7.510210480177193e-07
at O 0 2.7941873259607064e-09
a O 0 1.1872123943656998e-11
maximum O 0 3.3845055230630194e-11
likelihood O 0 3.145525506731417e-11
value O 0 4.018716956433188e-11
of O 0 7.232045518001939e-10
the O 0 1.2299490592670992e-10
recombinant O 0 5.961367510742832e-10
fraction O 0 1.2299279650296313e-10
of O 0 2.9617499563983074e-09
0 O 0 1.3536242349232452e-08
. O 0 7.064734575124021e-09

04 O 0 0.005084305070340633
. O 0 8.04949740995653e-06

18 O 0 1.351978880848037e-06
families O 0 9.528073885434196e-10
with O 0 9.48446654547297e-10
21 O 0 4.975530387696381e-08
informative O 0 1.8110625887857168e-08
matings O 0 5.205248854167621e-08
for O 0 5.295823224393814e-10
both O 0 1.062663734785474e-09
properdin O 0 2.5604226721043233e-06
Factor O 0 8.109330451588903e-08
B O 0 2.328645450688782e-06
allotype O 0 7.370234129666642e-07
and O 0 1.7243242389497482e-09
HLA O 0 1.4756693644812913e-06
- O 0 6.046411158422416e-07
B O 0 1.812196160244639e-06
were O 0 2.5012942828084306e-09
found O 0 4.043895440730694e-09
. O 0 4.08027833742608e-09

Of O 0 3.402163929422386e-05
72 O 0 2.8327206109679537e-06
informative O 0 2.1249492476727028e-07
meioses O 0 4.092988820048049e-05
, O 0 5.012849246810447e-09
three O 0 1.3062115833406551e-09
recombinants O 0 8.001105697985622e-07
were O 0 2.2796011744929956e-09
found O 0 1.0941485495408187e-09
, O 0 1.0034224839916561e-10
giving O 0 2.4567248235740635e-10
a O 0 1.8843478166719052e-10
recombinant O 0 3.4951965766083504e-09
fraction O 0 3.2249107828619117e-09
of O 0 4.01619466572356e-08
0 O 0 6.88430787931793e-08
. O 0 1.0332416700009617e-08

042 O 0 0.043196700513362885
. O 0 9.874621355265845e-06

A O 0 1.0060692147817463e-05
lod O 0 3.168572948197834e-05
score O 0 6.000701660013874e-07
of O 0 5.992289686673757e-08
16 O 0 2.7512518485650617e-08
between O 0 7.826584380588031e-10
HLA O 0 9.795794539968483e-07
- O 0 1.331180499164475e-07
B O 0 5.071265150036197e-07
and O 0 2.8952260033854316e-10
Factor O 0 2.49885290237728e-09
B O 0 3.364744713962864e-07
allotypes O 0 1.1534797295098542e-07
was O 0 4.5554907068812156e-10
calculated O 0 1.1639483127323658e-10
at O 0 5.793847068780167e-10
a O 0 9.197176006892072e-12
maximum O 0 3.158493605548429e-11
likelihood O 0 8.030006520831634e-11
value O 0 7.329359341667896e-11
of O 0 3.957516536701178e-10
the O 0 1.0340667905284207e-10
recombinant O 0 5.625108157047976e-10
fraction O 0 1.5728197910735986e-10
of O 0 4.373494011389312e-09
0 O 0 1.6207776454280065e-08
. O 0 6.559021326069114e-09

04 O 0 0.007957822643220425
. O 0 7.780845407978632e-06

A O 0 3.965072210121434e-06
crossover O 0 3.277579025962041e-07
was O 0 7.354815778626289e-08
shown O 0 2.686005029506333e-10
to O 0 3.601337977832131e-11
have O 0 4.691629029718314e-12
occurred O 0 3.7717826084637807e-10
between O 0 8.80736369252011e-12
genes O 0 2.045258710656195e-12
for O 0 6.735269460211857e-12
Factor O 0 1.2950382988208275e-09
B O 0 3.1421427593159024e-07
and O 0 8.27379331713729e-10
HLA O 0 3.095322824719915e-07
- O 0 1.6990503581837402e-07
D O 0 7.248534075188218e-07
, O 0 2.4155571987094504e-10
in O 0 6.482835102072926e-11
which O 0 7.224597309285485e-11
HLA O 0 7.270369906109408e-07
- O 0 1.023528398036433e-06
D O 0 8.746412277105264e-06
segregared O 0 5.6904714256234e-06
with O 0 4.75400652177882e-09
HLA O 0 6.991172085690778e-06
- O 0 2.4592833369752043e-07
A O 0 3.222895941235038e-07
and O 0 3.135735937576101e-08
B O 0 1.5688112398493104e-05
. O 0 1.397211057962977e-08

These O 0 1.102903102179198e-08
studies O 0 4.074523829444843e-09
suggest O 0 1.2808512583895038e-10
that O 0 1.9529252347216808e-12
the O 0 2.0122532112809566e-11
genes O 0 1.1892249338063543e-11
for O 0 5.077131770558907e-11
Factor O 0 1.549937955758196e-08
B O 0 0.36559343338012695
and O 0 2.0568404579535127e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.84313855581209e-11
located O 0 3.519769142812379e-09
outside O 0 1.8099047816022562e-09
those O 0 5.3097984342720395e-11
for O 0 3.8330652540885524e-10
HLA O 0 1.442327175027458e-06
, O 0 3.2752567324934034e-10
that O 0 7.288565584406825e-12
the O 0 5.5544305266330696e-11
order O 0 4.4036929658375357e-10
of O 0 9.999425287787744e-09
genese O 0 2.7558244255487807e-06
is O 0 8.409811180776217e-10
HLA O 0 2.2121191989299405e-07
- O 0 5.4311442454491043e-08
A O 0 7.920284872398042e-08
, O 0 6.248436767997134e-10
- O 0 3.663719283508726e-08
B O 0 4.524115411186358e-07
, O 0 1.711808889082178e-10
- O 0 1.3195037062985193e-08
D O 0 1.1164534896579426e-07
, O 0 1.6771632693757255e-10
Factor O 0 9.292071112554368e-09
B O 0 1.3593037692771759e-05
allotype O 0 0.0002666735672391951
, O 0 9.550085451337509e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.6079615416941806e-09
that O 0 8.472739003451135e-12
the O 0 7.496447212984592e-11
genes O 0 2.447025637675182e-10
coding O 0 5.8903935951093445e-08
for O 0 1.2776104085787665e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.8111559302601563e-08
Factor O 0 3.9262584294874614e-08
B O 0 1.714001655273023e-06
allotypes O 0 1.584912894259105e-07
are O 0 1.261413803271827e-11
approximately O 0 7.727214007546834e-11
3 O 0 1.0253314863817309e-09
- O 0 8.47679260118639e-09
- O 0 1.942786376218919e-08
5 O 0 3.581517526995981e-09
centimorgans O 0 7.516960920384008e-08
from O 0 2.8419908093546553e-10
the O 0 3.8246084077542264e-10
HLA O 0 1.8813516078353132e-07
- O 0 2.2473532368394444e-08
A O 0 4.082437143893003e-08
and O 0 7.512668265263756e-10
HLA O 0 8.605194352639955e-07
- O 0 1.4677408444185858e-07
B O 0 6.694285161756852e-07
loci O 0 6.774972249878886e-10
, O 0 3.445503951593487e-11
and O 0 2.7354301115889434e-11
that O 0 3.4508426931950664e-12
the O 0 3.5075031767917153e-10
apparent O 0 8.569225329324581e-09
lack O 0 8.347552871157404e-09
of O 0 9.46876710372635e-08
recombinants O 0 1.2396369584166678e-06
between O 0 5.718782114527698e-10
the O 0 1.4375481915962496e-09
Factor O 0 8.231957338011853e-09
B O 0 0.00011253791308263317
gene O 0 1.4658662905731035e-07
and O 0 2.6454652015672764e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 3.352905153519714e-08
suggests O 0 9.355143326672533e-10
that O 0 3.667144712893311e-12
these O 0 1.7882540934155422e-11
two O 0 4.458362845571884e-11
genes O 0 4.3646336544966857e-10
lie O 0 1.4496751354897697e-08
in O 0 8.221800462671069e-10
close O 0 2.6533364394509817e-09
proximity O 0 7.576347549331786e-09
to O 0 3.628422562407252e-10
one O 0 1.0972583952550963e-09
another O 0 1.059636467459768e-08
. O 0 3.110384483306916e-08

Distribution O 0 4.080468158917938e-07
of O 0 6.633542284362193e-07
emerin O 0 0.00011688443919410929
and O 0 3.150760363723748e-08
lamins O 0 2.4524808395653963e-05
in O 0 7.522422684758112e-09
the O 0 2.400440024530326e-08
heart O 0 1.187958423543023e-05
and O 0 3.5814629040231694e-09
implications O 0 4.773589878936946e-08
for O 0 3.668390036182245e-08
Emery B-Disease 1 0.9999568462371826
- I-Disease 1 0.9999988079071045
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0003442097513470799

Emerin O 0 0.002617277903482318
is O 0 1.767439883337829e-08
a O 0 3.746345900168535e-09
nuclear O 0 2.602539552754024e-07
membrane O 0 6.989636869292326e-09
protein O 0 8.962601771855816e-10
which O 0 1.58469612432377e-10
is O 0 1.1017539658375597e-10
missing O 0 1.201052368671185e-09
or O 0 4.544850606968964e-10
defective O 0 3.694381575769512e-06
in O 0 1.3440670443287672e-07
Emery B-Disease 1 0.9999586343765259
- I-Disease 1 0.9999972581863403
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999887943267822
EDMD B-Disease 1 1.0
) O 0 1.312055928792688e-06
. O 0 1.3367933604513382e-07

It O 0 3.93873200721373e-08
is O 0 3.1306890413418387e-10
one O 0 1.1355550527669678e-10
member O 0 4.1127803940277374e-10
of O 0 2.8920819072908444e-09
a O 0 1.6126022739371138e-09
family O 0 2.6190949409254927e-09
of O 0 3.0654058491563774e-07
lamina O 0 0.49386078119277954
- O 0 3.335560450068442e-06
associated O 0 1.147170358706262e-08
proteins O 0 4.275636511508196e-10
which O 0 3.292820183187217e-10
includes O 0 1.884400191443092e-08
LAP1 O 1 0.9999661445617676
, O 0 5.000838143587316e-08
LAP2 O 1 0.9905979037284851
and O 0 1.9308143350826867e-07
lamin O 0 2.4470515199936926e-05
B O 0 2.1449468476930633e-05
receptor O 0 3.664851178086792e-08
( O 0 1.3318988578703284e-08
LBR O 0 0.014619193971157074
) O 0 6.233634053387505e-08
. O 0 3.9628304193684016e-08

A O 0 1.2208127373014577e-05
panel O 0 1.7166242116672947e-07
of O 0 1.4772139422802866e-07
16 O 0 2.7778591871197023e-08
monoclonal O 0 1.875099719939044e-08
antibodies O 0 7.699798132421165e-09
( O 0 2.289344047667896e-09
mAbs O 0 8.082136560005893e-07
) O 0 3.740289467035751e-10
has O 0 2.0403269351820796e-11
been O 0 2.6438766106973155e-11
mapped O 0 9.437026715630736e-10
to O 0 2.902545565008907e-11
six O 0 5.184007736969143e-11
specific O 0 1.467721257031318e-11
sites O 0 7.602588558697221e-10
throughout O 0 5.556372584258895e-10
the O 0 1.057253729008778e-09
emerin O 0 9.917904009171252e-08
molecule O 0 7.900918808090296e-10
using O 0 7.797663070796546e-10
phage O 0 1.3464477532920682e-08
- O 0 9.310876514234678e-09
displayed O 0 7.2275536666666085e-09
peptide O 0 8.462895384475644e-10
libraries O 0 1.4253759283988643e-10
and O 0 3.2638305252907784e-11
has O 0 4.594596838408682e-12
been O 0 4.7758750079673895e-12
used O 0 3.92613302979683e-11
to O 0 1.2308690178208792e-10
localize O 0 1.4718788179379771e-06
emerin O 0 5.7879155974660534e-06
in O 0 3.1529590049927947e-09
human O 0 1.1266741317683682e-08
and O 0 9.972040260208814e-08
rabbit O 0 0.00037219852674752474
heart O 0 0.053699418902397156
. O 0 5.093929758004379e-07

Several O 0 8.480594715365442e-07
mAbs O 0 1.960454937943723e-05
against O 0 2.1018858831212128e-07
different O 0 4.452121338260895e-09
emerin O 0 1.2725903616228607e-05
epitopes O 0 8.93485434971808e-07
did O 0 3.2908442637591406e-09
not O 0 1.2070618116144516e-10
recognize O 0 2.537966725668639e-09
intercalated O 0 2.036956630036002e-06
discs O 0 7.086829100444447e-06
in O 0 4.3310666164586564e-09
the O 0 3.164655026921537e-08
heart O 0 1.2760223398800008e-05
, O 0 2.7710986283402406e-10
though O 0 2.5377320037045514e-11
they O 0 1.0153139613777729e-11
recognized O 0 1.0366285607688042e-09
cardiomyocyte O 0 1.0353160178055987e-06
nuclei O 0 9.587572549207835e-07
strongly O 0 2.6876678660414655e-08
, O 0 1.99623007013372e-09
both O 0 1.5112142648376903e-09
at O 0 8.243068805313669e-08
the O 0 1.8627446252139634e-08
rim O 0 6.561576242347655e-07
and O 0 3.0049156496403384e-09
in O 0 1.0273679684758008e-08
intranuclear O 0 2.931455492216628e-05
spots O 0 4.772816168951977e-07
or O 0 1.2543788230345854e-08
channels O 0 4.83328790323867e-08
. O 0 4.295143085641939e-08

A O 0 5.867451909580268e-05
polyclonal O 0 0.00022859340242575854
rabbit O 0 1.3534671779780183e-05
antiserum O 0 2.3295704522752203e-05
against O 0 4.0531399463361595e-06
emerin O 0 0.00012472804519347847
did O 0 1.7048929379370747e-08
recognize O 0 3.2135945016165124e-09
both O 0 3.9304656751504297e-10
nuclear O 0 3.7416066334117204e-07
membrane O 0 1.4422205651953846e-08
and O 0 3.664800463099027e-09
intercalated O 0 1.6953613339865115e-06
discs O 0 1.8027623127636616e-06
but O 0 3.325286712652087e-10
, O 0 4.8309578559724287e-11
after O 0 1.4221850086482135e-10
affinity O 0 1.148574707565686e-10
purification O 0 1.565169895911822e-07
against O 0 3.543306092979037e-08
a O 0 2.747862826169012e-09
pure O 0 7.61441413033026e-07
- O 0 6.536619139296818e-07
emerin O 0 5.0050464778905734e-05
band O 0 2.0014256278955145e-06
on O 0 2.4400172993210845e-09
a O 0 2.086351924557306e-10
western O 0 6.131091190297866e-09
blot O 0 1.4966970411478542e-05
, O 0 7.509864730081972e-09
it O 0 6.36296848544049e-10
stained O 0 0.00012164820509497076
only O 0 6.203880187349853e-10
the O 0 8.235538473400084e-09
nuclear O 0 2.865554279196658e-06
membrane O 0 8.663195671942958e-07
. O 0 1.0090780477867156e-07

These O 0 2.4118261165995136e-08
results O 0 6.9344627817713445e-09
would O 0 8.464891981807554e-11
not O 0 2.230001079628341e-11
be O 0 2.1180545164978248e-11
expected O 0 3.074578092121527e-10
if O 0 1.219172401922819e-10
immunostaining O 0 7.095134151313687e-07
at O 0 2.5992695995569193e-08
intercalated O 0 2.3666306958602945e-07
discs O 0 5.163593641555053e-07
were O 0 1.0733747224378476e-09
due O 0 1.568138729979296e-09
to O 0 8.322600941745861e-11
a O 0 2.1077224687804375e-10
product O 0 6.96876001349267e-10
of O 0 5.1089408259485936e-09
the O 0 2.0069581552206728e-09
emerin O 0 5.9662520470737945e-06
gene O 0 1.5737599001752756e-09
and O 0 8.327130651686332e-10
, O 0 2.2256381460028507e-10
therefore O 0 2.5244620283082497e-10
, O 0 8.656182715061078e-11
cast O 0 1.4995990560429107e-10
some O 0 3.08370308454986e-11
doubt O 0 1.007431027488792e-09
upon O 0 3.6760983146422177e-10
the O 0 2.5961799376972294e-10
hypothesis O 0 2.1119730408969417e-09
that O 0 3.34486632835862e-10
cardiac B-Disease 1 0.9999998807907104
defects I-Disease 1 0.9999922513961792
in O 0 4.338296548667131e-06
EDMD B-Disease 1 1.0
are O 0 6.304778477073114e-09
caused O 0 2.8887699343727036e-08
by O 0 4.5449022323396093e-10
absence O 0 9.384711319171402e-08
of O 0 8.492832535011985e-07
emerin O 0 0.00015884310414548963
from O 0 1.0554453666600239e-07
intercalated O 0 0.00012099619925720617
discs O 0 0.000565996509976685
. O 0 3.117800417840044e-07

Although O 0 4.4499421392174554e-07
emerin O 0 2.8291649869061075e-05
was O 0 7.793418177470812e-08
abundant O 0 7.65028929095024e-09
in O 0 4.188637769964032e-10
the O 0 5.848997952639934e-10
membranes O 0 1.2244917968473601e-08
of O 0 3.528293746057898e-08
cardiomyocyte O 0 6.863225735287415e-06
nuclei O 0 1.8415577187624876e-06
, O 0 2.3892248179890885e-09
it O 0 2.0867738093066635e-10
was O 0 7.131860435549697e-09
absent O 0 9.539807166447645e-09
from O 0 1.1117732290344406e-09
many O 0 8.083112651435798e-11
non O 0 3.4758465972117847e-07
- O 0 5.4724250730942e-07
myocyte O 0 3.509216185193509e-05
cells O 0 7.174181693159198e-09
in O 0 1.7938859286914521e-09
the O 0 3.898878375707682e-08
heart O 0 0.0004823400522582233
. O 0 8.192144917984479e-08

This O 0 6.8176628786886795e-09
distribution O 0 9.488379859590168e-09
of O 0 5.0344009849823124e-08
emerin O 0 6.519823728012852e-06
was O 0 4.611953041688821e-09
similar O 0 2.4011917454380693e-11
to O 0 8.937395962194117e-12
that O 0 4.60871878854574e-12
of O 0 5.752951892645797e-09
lamin O 0 2.555177900376293e-07
A O 0 1.8462267803442955e-07
, O 0 2.337361137971783e-10
a O 0 1.27316185372095e-10
candidate O 0 1.5168186151548468e-10
gene O 0 3.2063743327093164e-10
for O 0 8.466991691102876e-11
an O 0 6.608730923618467e-11
autosomal O 0 1.4404807302526024e-07
form O 0 1.808419085591595e-07
of O 1 0.9341181516647339
EDMD B-Disease 1 1.0
. O 0 6.73645809001755e-06

In O 0 1.7210467717632127e-07
contrast O 0 6.850984135553517e-08
, O 0 3.29526166353844e-08
lamin O 0 1.571980283188168e-05
B1 O 0 0.08061875402927399
was O 0 6.021798526489874e-07
absent O 0 1.178769153398207e-07
from O 0 8.332774470432014e-09
cardiomyocyte O 0 1.6880223938642303e-06
nuclei O 0 6.91837328758993e-07
, O 0 5.697315952346571e-09
showing O 0 3.9518479155731256e-08
that O 0 1.5027236122122645e-09
lamin O 0 6.452081834140699e-06
B1 O 0 0.00493913097307086
is O 0 2.3155383166439947e-10
not O 0 1.119601026472461e-11
essential O 0 3.656978053712123e-10
for O 0 1.6953802250974093e-10
localization O 0 1.357878574026472e-07
of O 0 1.0624961355176765e-08
emerin O 0 4.4307927282716264e-07
to O 0 8.389656191987171e-10
the O 0 1.2754915346135931e-08
nuclear O 0 4.748571154777892e-05
lamina O 1 0.9877853393554688
. O 0 3.500146021906403e-07

Lamin O 0 0.3452812135219574
B1 O 1 0.9998939037322998
is O 0 3.6783880830171256e-08
also O 0 2.2387696141379365e-09
almost O 0 6.74168942893516e-10
completely O 0 1.9206577661634583e-08
absent O 0 5.313859219313599e-08
from O 0 4.2155637203222796e-08
skeletal O 0 0.006627222523093224
muscle O 0 3.3827494917204604e-05
nuclei O 0 0.024928584694862366
. O 0 2.5305130293418188e-06

In O 0 1.0500812095415313e-05
EDMD B-Disease 1 1.0
, O 0 1.3995608227901357e-08
the O 0 8.416229380081575e-10
additional O 0 3.29616334227012e-10
absence O 0 9.49361478319588e-08
of O 0 6.265304932639992e-07
lamin O 0 5.691442493116483e-05
B1 O 1 0.9970529079437256
from O 0 3.646308869065251e-06
heart O 1 0.9980707764625549
and O 0 4.385271495266352e-06
skeletal O 1 0.9999997615814209
muscle O 0 0.026070524007081985
nuclei O 1 0.9731087684631348
which O 0 1.0063641298074799e-07
already O 0 1.159315914378567e-07
lack O 0 1.007055061563733e-06
emerin O 0 0.0006784875877201557
may O 0 4.5856013430878306e-10
offer O 0 3.47518437637806e-11
an O 0 4.658093789161599e-12
alternative O 0 4.415619259123815e-10
explanation O 0 2.63249089194062e-10
of O 0 9.423379410122834e-09
why O 0 6.409242025995354e-10
these O 0 2.4878279991646934e-10
tissues O 0 2.2607933658491675e-07
are O 0 3.7434297328609034e-10
particularly O 0 7.570988280747315e-09
affected O 0 1.364373503065508e-08
. O 0 1.8444231697500868e-09
. O 0 1.4993746688674037e-08

Genetic O 0 7.968437216732127e-07
mapping O 0 2.3113669556096283e-07
of O 0 1.976123513713901e-07
the O 0 1.0890007473562946e-07
copper B-Disease 0 0.0001687047042651102
toxicosis I-Disease 0 0.29034513235092163
locus O 0 1.6562987070756208e-07
in O 0 1.63943258968402e-08
Bedlington O 0 2.7416992452344857e-05
terriers O 0 2.093219336529728e-06
to O 0 1.8209620478160105e-08
dog O 0 3.5719999686989468e-06
chromosome O 0 3.229270362226089e-08
10 O 0 7.424906023345557e-09
, O 0 2.415483646434069e-10
in O 0 1.7731884016658483e-10
a O 0 5.960640314661703e-10
region O 0 1.1252996756638822e-08
syntenic O 0 4.725451162812533e-06
to O 0 2.076637972692197e-09
human O 0 1.3798482356719433e-08
chromosome O 0 6.004268016113201e-08
region O 0 3.257324010519369e-08
2p13 O 0 1.4642146197729744e-05
- O 0 6.8803296926489566e-06
p16 O 0 3.995556198788108e-06
. O 0 1.0177723908100234e-07

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9998914003372192
accumulation I-Disease 0 0.3373701870441437
is O 0 3.711106311143908e-09
recognized O 0 4.173201340051946e-09
as O 0 4.5244558100066e-10
an O 0 2.4015882615913142e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.620048917378881e-06
man O 0 4.258774879417615e-06
, O 0 1.2004552907285415e-08
mouse O 0 3.697539625591162e-07
, O 0 2.3769944235141338e-08
rat O 0 0.0001253040536539629
and O 0 2.6229113814224547e-07
dog O 0 0.0033643620554357767
. O 0 5.056458007857145e-07

The O 0 6.892604460517759e-07
major O 0 2.5239839942514664e-06
cause O 0 6.616258360736538e-06
of O 0 0.1353641152381897
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 1 0.9997052550315857
accumulation I-Disease 0 0.06595926731824875
in O 0 8.549847620997753e-07
man O 0 3.61338123866517e-07
is O 0 2.0237551912050122e-10
a O 0 1.0293681462769655e-09
dysfunctional O 0 1.0544414180913009e-05
ATP7B O 1 1.0
gene O 0 4.1791537341850926e-07
, O 0 1.5267877628843962e-08
causing O 0 7.254811498569325e-05
Wilson B-Disease 1 0.8797203898429871
disease I-Disease 1 0.8117199540138245
( O 0 3.152804239903162e-08
WD B-Disease 1 0.999971866607666
) O 0 3.791940272890315e-08
. O 0 3.219491873096558e-08

Mutations O 0 6.606722990909475e-07
in O 0 4.282472332306497e-08
the O 0 4.4751534034048746e-08
ATP7B O 1 0.9999738931655884
genes O 0 1.6216642473310117e-09
have O 0 3.312788585119186e-11
also O 0 5.99244126542331e-11
been O 0 7.232511117782892e-11
demonstrated O 0 1.1029699376052804e-09
in O 0 2.269150867206804e-09
mouse O 0 1.3386330977027683e-07
and O 0 4.068584757987992e-08
rat O 0 4.911846190225333e-05
. O 0 8.355664959935893e-08

The O 0 2.9005025226069847e-06
ATP7B O 1 0.999998927116394
gene O 0 1.059539940229115e-07
has O 0 2.935305332130156e-10
been O 0 1.1954934264757355e-10
excluded O 0 1.8907932997080934e-09
in O 0 2.6293242583186327e-10
the O 0 3.1509733711132526e-10
much O 0 4.001738662662291e-10
rarer O 0 4.534603021966177e-07
human O 0 7.026350772321166e-07
copper B-Disease 1 0.9993461966514587
overload I-Disease 1 0.9999996423721313
disease O 1 0.9408302307128906
non B-Disease 0 8.75211935635889e-06
- I-Disease 0 2.603155053293449e-06
Indian I-Disease 0 1.0747461942628433e-07
childhood I-Disease 1 0.6291906833648682
cirrhosis I-Disease 1 0.9999996423721313
, O 0 3.020833583278204e-09
indicating O 0 5.536711356057822e-08
genetic O 0 2.231472961966574e-07
heterogeneity O 0 4.667557732318528e-06
. O 0 3.0215329616112285e-07

By O 0 4.86388884723965e-08
investigating O 0 2.084461385720715e-07
the O 0 1.97406588853255e-08
common O 0 7.242142601171508e-07
autosomal O 0 0.312971293926239
recessive O 1 0.8806601762771606
copper B-Disease 1 0.9999957084655762
toxicosis I-Disease 1 0.9999988079071045
( O 0 7.44984802736326e-08
CT B-Disease 1 0.9996830224990845
) O 0 8.902459880388847e-10
in O 0 8.24087997841616e-09
Bedlington O 0 0.0014558433322235942
terriers O 0 3.330763865960762e-05
, O 0 6.452331446915593e-10
we O 0 4.6419895705085423e-11
have O 0 2.9747385110745483e-12
identified O 0 3.6037704070901455e-11
a O 0 1.4374042754672356e-11
new O 0 1.2088174905500182e-10
locus O 0 5.058121699264007e-10
involved O 0 2.0197947481204181e-10
in O 0 2.283684530368646e-08
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.515095272632607e-07

We O 0 1.0193596722274378e-07
examined O 0 2.6624329052538087e-07
whether O 0 2.0918158316618474e-09
the O 0 6.290556076038456e-09
WD B-Disease 0 0.031273070722818375
gene O 0 3.753293071895314e-07
ATP7B O 1 0.9998188614845276
was O 0 1.299163727708219e-07
also O 0 1.1081524586842306e-10
causative O 0 2.542962507234847e-09
for O 0 3.038288509671361e-10
CT B-Disease 0 5.785300527350046e-05
by O 0 2.369599794160848e-10
investigating O 0 7.85948461867747e-09
the O 0 1.171721120130087e-08
chromosomal O 0 1.7271153183173737e-06
co O 0 3.830716082120489e-07
- O 0 4.4701630486088106e-07
localization O 0 2.267535364808282e-06
of O 0 1.867688297352288e-07
ATP7B O 1 0.999958872795105
and O 0 6.911065053571974e-09
C04107 O 0 2.3548426497654873e-07
, O 0 4.0987293420391424e-11
using O 0 2.3247993807817835e-11
fluorescence O 0 3.195606002037721e-09
in O 0 4.0231518116939924e-10
situ O 0 1.0076028900130041e-07
hybridization O 0 5.995648422185695e-09
( O 0 1.0911744841024529e-09
FISH O 0 9.195331358569092e-07
) O 0 2.3866515430626123e-09
. O 0 6.426652543467526e-09

C04107 O 0 9.023451275425032e-05
is O 0 4.6853312340999764e-09
an O 0 1.8309520566361925e-10
anonymous O 0 5.130081248694296e-09
microsatellite O 0 6.78414608046296e-07
marker O 0 9.01699593214289e-07
closely O 0 1.1820112177929332e-07
linked O 0 3.317767323096632e-07
to O 0 4.54437838470767e-08
CT B-Disease 1 0.9999958276748657
. O 0 5.66313133276708e-07

However O 0 4.917943670079694e-07
, O 0 1.483482208186615e-07
BAC O 0 0.4564243257045746
clones O 0 1.781462174221815e-06
containing O 0 6.807425734223216e-07
ATP7B O 1 0.9999704360961914
and O 0 4.9100751908781604e-08
C04107 O 0 2.2114872990641743e-06
mapped O 0 1.1908103658697655e-07
to O 0 1.2755103639960907e-09
the O 0 1.1249777998045829e-08
canine O 0 2.8118720365455374e-06
chromosome O 0 2.8791767192615225e-08
regions O 0 1.3851906288664395e-08
CFA22q11 O 0 2.8107539037591778e-05
and O 0 2.561667322709127e-08
CFA10q26 O 0 0.00021948030916973948
, O 0 2.443967028753491e-09
respectively O 0 3.5924092589567636e-09
, O 0 1.8075166363651363e-10
demonstrating O 0 2.3407662474994595e-09
that O 0 4.640457809679255e-11
WD B-Disease 0 3.0264056476880796e-05
cannot O 0 3.4130978043833693e-09
be O 0 1.5647229345550073e-10
homologous O 0 2.6515252216086083e-09
to O 0 1.2589496556358881e-08
CT B-Disease 1 0.9940270185470581
. O 0 1.3133374920926144e-07

The O 0 4.007913503301097e-06
copper O 0 4.496021574595943e-06
transport O 0 4.6621383376077574e-07
genes O 0 9.744717033299821e-08
CTR1 O 1 0.9990969896316528
and O 0 5.9568158405909344e-08
CTR2 O 1 0.999886155128479
were O 0 8.57571613721575e-09
also O 0 1.526119369765766e-10
excluded O 0 8.708384013900172e-10
as O 0 5.2050322385532866e-11
candidate O 0 6.291533960478546e-11
genes O 0 2.466131986122999e-11
for O 0 1.8010228031162256e-10
CT B-Disease 0 0.4347049295902252
since O 0 1.0508524050933943e-09
they O 0 2.1371881694931538e-11
both O 0 4.05132559444521e-11
mapped O 0 5.654607004856871e-09
to O 0 2.664142906283473e-09
canine O 0 2.6518093363847584e-05
chromosome O 0 8.581428119214252e-07
region O 0 2.974564097257826e-07
CFA11q22 O 0 0.017676247283816338
. O 0 2.619931365188677e-07

2 O 0 1.3797615793009754e-05
- O 0 7.344802270381479e-06
22 O 0 6.896740387674072e-07
. O 0 2.8624212333738797e-08

5 O 0 4.9491034587845206e-05
. O 0 1.3964737490823609e-06

A O 0 4.009282292827265e-06
transcribed O 0 1.9071370616075e-07
sequence O 0 2.049584724161946e-09
identified O 0 5.69628122448762e-10
from O 0 6.838549171384045e-10
the O 0 2.4084920724476433e-09
C04107 O 0 2.3929004555611755e-07
- O 0 9.300708825321635e-08
containing O 0 6.01440035552514e-08
BAC O 1 0.9996557235717773
was O 0 1.8367007470487806e-08
found O 0 6.468704738527009e-11
to O 0 4.016799046158148e-12
be O 0 6.601546566342709e-12
homologous O 0 8.997246003783488e-11
to O 0 6.964491483518742e-11
a O 0 6.108839545326816e-10
gene O 0 3.328357867093956e-10
expressed O 0 1.4300570450043182e-10
from O 0 3.0396405392707493e-09
human O 0 1.736605859115059e-09
chromosome O 0 5.557541093992313e-09
2p13 O 0 2.544458652664616e-07
- O 0 1.4741628717729327e-07
p16 O 0 1.966474805215057e-08
, O 0 3.123710456964801e-10
a O 0 2.1045008791187314e-10
region O 0 8.135799811626043e-10
devoid O 0 5.433921046460455e-08
of O 0 3.2684437378804887e-09
any O 0 4.5311571161832376e-10
positional O 0 3.3012431686074706e-06
candidate O 0 4.333555736479866e-08
genes O 0 4.82177817673346e-08
. O 0 1.0123901006409142e-07

Molecular O 0 9.625473467167467e-07
analysis O 0 1.428967788541513e-08
of O 0 2.9741263674054608e-08
the O 0 5.724318352662294e-09
APC B-Disease 0 3.4630781442501757e-07
gene O 0 6.405404540110737e-10
in O 0 2.7494603815902963e-10
205 O 0 9.091179475895217e-10
families O 0 6.924539500824389e-12
: O 0 4.1121980820513215e-11
extended O 0 4.425174005007193e-09
genotype O 0 5.531412483605891e-08
- O 0 1.2370654189908237e-07
phenotype O 0 7.293388115670041e-09
correlations O 0 1.5905024852713723e-08
in O 0 2.162622081414156e-09
FAP B-Disease 0 7.773855941195507e-07
and O 0 4.2621203788506534e-10
evidence O 0 5.416654902390405e-10
for O 0 3.756810487698381e-11
the O 0 5.083587995002858e-10
role O 0 1.4996941466449698e-09
of O 0 2.438241430979815e-08
APC B-Disease 0 1.9496783352224156e-06
amino O 0 3.9870229784355615e-08
acid O 0 2.781586339040132e-08
changes O 0 6.105257455146784e-08
in O 0 0.00017496624786872417
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.0004779274167958647
. O 0 1.314645885486243e-07

BACKGROUND O 0 0.0022099665366113186
/ O 0 1.3206604307924863e-05
AIMS O 0 1.5554041965515353e-06
The O 0 9.781006227171929e-09
development O 0 1.51354289101846e-08
of O 0 0.00036689877742901444
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.143035970902929e-09
a O 0 1.8785306643565036e-10
variable O 0 6.552153819505691e-10
range O 0 6.87640806518175e-08
of O 0 1.5976071665591007e-07
extracolonic O 0 0.00014745707449037582
manifestations O 0 0.00012450154463294894
in O 0 4.6784040819147776e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.861996222236485e-07
FAP B-Disease 0 0.19556991755962372
) O 0 2.408551802446368e-09
is O 0 3.041725551988783e-11
the O 0 1.7476634028845695e-10
result O 0 1.8962058312421703e-10
of O 0 5.2572697306629834e-09
the O 0 2.3646571367663682e-09
dominant O 0 3.256559821807059e-08
inheritance O 0 2.939398058288134e-08
of O 0 9.4395318228635e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999922513961792
coli I-Disease 1 0.9996285438537598
( O 0 7.251099987115595e-08
APC B-Disease 0 7.016823656158522e-05
) O 0 1.9352121682914003e-08
gene O 0 9.289185953775814e-08
mutations O 0 2.838603165855602e-07
. O 0 2.202944529017259e-07

In O 0 6.676675923245057e-08
this O 0 1.0914966847019869e-10
study O 0 1.718502007364009e-10
, O 0 2.681001471174782e-12
direct O 0 1.1401359023555102e-11
mutation O 0 1.0704051360554967e-11
analysis O 0 1.7052447995324904e-11
of O 0 3.3151542622178454e-10
the O 0 5.14742692914183e-10
APC B-Disease 0 9.69732241173915e-07
gene O 0 6.266127616783024e-09
was O 0 9.42226563438453e-09
performed O 0 2.105406160524126e-08
to O 0 4.4060512183197176e-11
determine O 0 1.8208569096955785e-09
genotype O 0 5.494682753237612e-08
- O 0 9.090753394502826e-08
phenotype O 0 4.8058272916762235e-09
correlations O 0 1.1603763283574153e-08
for O 0 1.0605539779717787e-09
nine O 0 4.4562863621422366e-08
extracolonic O 0 1.0228327482764143e-05
manifestations O 0 1.523680202808464e-05
and O 0 2.4221835648319257e-09
to O 0 2.980790614337536e-10
investigate O 0 2.434935808537375e-09
the O 0 2.1417732032347203e-09
incidence O 0 1.5828216959334895e-08
of O 0 9.232200781639222e-09
APC B-Disease 0 8.616502213953936e-07
mutations O 0 5.7724505175826835e-09
in O 0 9.883700968771336e-09
non O 1 0.9890000224113464
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.497577208439907e-07

METHODS O 0 3.4359953133389354e-05
The O 0 4.884122972725891e-07
APC B-Disease 0 5.954196694801794e-06
gene O 0 3.1320841031856617e-08
was O 0 2.183683633916189e-08
analysed O 0 3.902828993318508e-08
in O 0 9.907346054660593e-10
190 O 0 1.36270905670699e-08
unrelated O 0 4.781380980034555e-08
FAP B-Disease 0 9.592378773959354e-06
and O 0 4.8630170113028726e-08
15 O 0 2.4024652134357893e-07
non O 0 0.15563321113586426
- O 1 0.9999982118606567
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.8282982239270495e-08
using O 0 3.6911353973323457e-09
denaturing O 0 1.1819783139799256e-05
gradient O 0 1.2899083401407552e-07
gel O 0 1.8771899590319663e-07
electrophoresis O 0 5.567241245785226e-08
, O 0 9.328701144895035e-10
the O 0 3.8085207210158956e-10
protein O 0 6.23246343423034e-10
truncation O 0 7.724219130977872e-08
test O 0 4.57506992290746e-08
, O 0 1.5427165100945217e-10
and O 0 1.2508438729241789e-10
direct O 0 3.4132718873536305e-10
sequencing O 0 8.230500725403544e-08
. O 0 2.0978982107067168e-08

RESULTS O 0 0.0002215057029388845
Chain O 0 4.249679022905184e-06
terminating O 0 2.0491525276611355e-07
signals O 0 3.630129086218403e-08
were O 0 8.819947550087193e-10
only O 0 9.059596822735827e-12
identified O 0 3.794756175956593e-11
in O 0 8.190196437718456e-11
patients O 0 2.3562504725127553e-10
belonging O 0 9.544867118904676e-09
to O 0 1.58208457445852e-09
the O 0 4.1982641363347284e-08
FAP B-Disease 0 0.0005178748979233205
group O 0 3.06669782901281e-08
( O 0 1.033321983534563e-09
105 O 0 4.0009570057009114e-07
patients O 0 1.7670624075094565e-08
) O 0 1.974151730976814e-09
. O 0 2.8801544260659284e-08

Amino O 0 1.3610163023258792e-06
acid O 0 6.849142408782427e-08
changes O 0 9.743296169872906e-10
were O 0 1.0346946632822096e-09
identified O 0 4.964936239915119e-10
in O 0 1.5629213201417969e-10
four O 0 2.228101869672372e-10
patients O 0 2.7075669484233345e-10
, O 0 5.497263408371644e-11
three O 0 1.9529569628140564e-10
of O 0 1.414724781767518e-08
whom O 0 2.0529182798156853e-09
belonged O 0 1.5811114906227886e-07
to O 0 1.0930513161255817e-09
the O 0 8.864712519596196e-09
non O 0 4.446722232387401e-05
- O 0 1.6210802641580813e-05
FAP O 0 0.008741065859794617
group O 0 4.590462765463599e-07
of O 1 0.9985438585281372
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.7740545445121825e-05
. O 0 1.3464867265611247e-07

Genotype O 0 0.00016055989544838667
- O 0 2.5054718207684346e-05
phenotype O 0 2.115655775014602e-07
correlations O 0 5.256991997271143e-08
identified O 0 2.877149407609636e-09
significant O 0 3.781348567599707e-10
differences O 0 8.773036186404681e-10
in O 0 2.272064342223601e-10
the O 0 2.4168522738676756e-10
nature O 0 1.0129532768132776e-09
of O 0 1.613337574646323e-09
certain O 0 4.751909976619118e-10
extracolonic O 0 9.707569915917702e-06
manifestations O 0 2.560080929470132e-06
in O 0 9.078569007670012e-09
FAP B-Disease 0 5.3032275900477543e-05
patients O 0 7.74755903876212e-09
belonging O 0 2.153156763995412e-08
to O 0 8.19323109357839e-10
three O 0 7.0112275984968164e-09
mutation O 0 4.5955346195114544e-08
subgroups O 0 4.801514705832233e-07
. O 0 1.5327231039918843e-07

CONCLUSIONS O 0 1.3459938600135501e-05
Extended O 0 6.9003715452709e-07
genotype O 0 6.270900030358462e-07
- O 0 6.146537998574786e-07
phenotype O 0 9.320951122049337e-09
correlations O 0 1.3705445667255844e-08
made O 0 1.8070246410317736e-09
in O 0 2.9324345729442314e-10
this O 0 1.0847840854755209e-11
study O 0 1.7715387490291334e-10
may O 0 2.74695873686559e-11
have O 0 3.8789249590109875e-12
the O 0 4.938074255056435e-11
potential O 0 6.695208276674691e-11
to O 0 2.0555295313084976e-11
determine O 0 4.714966195251691e-10
the O 0 2.2997589943507535e-10
most O 0 1.465715396276046e-11
appropriate O 0 2.7729174512103327e-10
surveillance O 0 6.554609655040622e-08
and O 0 8.371162096842966e-10
prophylactic O 0 1.4359945907926885e-06
treatment O 0 1.266993479021039e-07
regimens O 0 1.1735130556189688e-07
for O 0 1.597079274384683e-10
those O 0 1.0375954262453746e-10
patients O 0 1.7249747463754517e-10
with O 0 2.916291166887852e-11
mutations O 0 1.6056415086396214e-09
associated O 0 2.1181142173531953e-08
with O 0 5.180019968520355e-09
life O 0 1.7345844298688462e-06
threatening O 0 5.811965365865035e-06
conditions O 0 5.1715149311348796e-05
. O 0 4.058773015458428e-07

This O 0 1.2603719845571959e-08
study O 0 3.6247858048454873e-09
also O 0 3.7856183465745374e-11
provided O 0 9.564612296619757e-11
evidence O 0 3.006427606866424e-10
for O 0 3.811934448649801e-11
the O 0 4.407524623051273e-10
pathological O 0 3.012900435805932e-07
nature O 0 2.4235113471604564e-08
of O 0 3.992548158748832e-08
amino O 0 5.703121974676151e-09
acid O 0 2.49722309497713e-09
changes O 0 2.992925074440933e-10
in O 0 1.578398300949857e-09
APC O 0 3.360819391673431e-07
associated O 0 5.059098473481072e-09
with O 0 2.3102356139226288e-10
both O 0 1.4215619792423695e-09
FAP B-Disease 0 5.568516644416377e-05
and O 0 6.635289651057974e-08
non O 1 0.9999074935913086
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.1052958370783017e-07
. O 0 2.248346619992958e-09
. O 0 9.936532485710359e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.008376381359994411
cancer B-Disease 1 0.9999778270721436
risk O 0 1.267111997549364e-07
of O 0 4.690234163717832e-06
the O 0 3.629337470556493e-06
APC O 0 0.03849424794316292
I1307K O 0 0.0001310610241489485
polymorphism O 0 2.5123488285316853e-06
. O 0 7.92974717001016e-08

Germ O 1 0.9990322589874268
- O 0 5.8862260630121455e-05
line O 0 4.5525422365244594e-07
and O 0 3.067292864145088e-09
somatic O 0 2.2481081884961895e-07
truncating O 0 2.3826372341773094e-07
mutations O 0 4.2213303963478666e-09
of O 0 6.084994197408378e-08
the O 0 5.03866637302508e-08
APC B-Disease 0 3.6724966321344255e-06
gene O 0 2.9795130807031e-09
are O 0 2.4264815851049448e-11
thought O 0 2.492929473962846e-10
to O 0 2.83971512970993e-10
initiate O 0 1.3522506378649268e-05
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.1295560598373413
formation O 0 0.008811929263174534
in O 0 5.288982265483355e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.005775078199803829
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.221777097271115e-06
respectively O 0 1.2679910241786274e-06
. O 0 1.356586665224313e-07

Recently O 0 5.980762580293231e-06
, O 0 9.899718378392208e-09
an O 0 2.433399037826689e-09
isoleucine O 0 1.4403409295482561e-05
- O 0 2.3352704374701716e-06
- O 0 7.267659043463937e-07
> O 0 9.599698103102128e-08
lysine O 0 1.9112775362373213e-07
polymorphism O 0 1.8515724065082395e-08
at O 0 1.2950241767839543e-08
codon O 0 4.842108936031764e-08
1307 O 0 1.8893143760578823e-06
( O 0 8.404711371312601e-10
I1307K O 0 1.0790925841774879e-07
) O 0 5.4061043835984535e-11
of O 0 7.949031988196964e-10
the O 0 2.186879344279191e-09
APC B-Disease 0 7.679135478610988e-07
gene O 0 3.17551251960424e-09
has O 0 3.2679664530022023e-11
been O 0 3.826751762692204e-11
identified O 0 1.3827687606049466e-10
in O 0 7.572857618765028e-11
6 O 0 1.9179586807638316e-09
% O 0 5.4947348754330605e-12
- O 0 6.024544196847614e-10
7 O 0 1.6693704196768522e-09
% O 0 3.249387087525535e-12
of O 0 6.72550348745915e-11
the O 0 1.0676386857921827e-10
Ashkenazi O 0 1.90840285796412e-08
Jewish O 0 5.805332214947612e-09
population O 0 7.831942039349116e-11
. O 0 1.9356505287504433e-09

To O 0 1.256349335676532e-08
assess O 0 9.907543585541134e-08
the O 0 9.66987556694221e-09
risk O 0 2.8496238702047094e-09
of O 0 2.128078824270574e-09
this O 0 2.0483515925096007e-11
common O 0 1.0469751732244958e-09
APC B-Disease 0 4.965594939676521e-07
allelic O 0 1.5785396954015596e-06
variant O 0 3.729582886080607e-06
in O 0 9.51881531818799e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999881982803345
, O 0 1.958188100559255e-08
we O 0 3.329621578451736e-10
have O 0 1.4215036266140846e-11
analyzed O 0 1.7639130156510419e-09
a O 0 1.6143740511065374e-10
large O 0 5.560188975906044e-10
cohort O 0 6.875659863680994e-08
of O 0 1.025152140954333e-08
unselected O 0 2.3968517780303955e-05
Ashkenazi O 0 3.1650054665988137e-07
Jewish O 0 5.491131105372915e-08
subjects O 0 4.871772034675814e-07
with O 0 2.5486789567708e-08
adenomatous B-Disease 1 0.9134418964385986
polyps I-Disease 0 6.126884272816824e-06
and O 0 2.2245242092822082e-08
. O 0 1.0436062680696523e-08
or O 1 0.9878997206687927
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.7600755014844935e-09
for O 0 1.3880914195851801e-09
the O 0 2.4145601074110346e-08
APC O 0 2.3095315555110574e-05
I1307K O 0 1.2639244232559577e-05
polymorphism O 0 5.6577812301839e-07
. O 0 1.326243790344961e-07

The O 0 3.853400357911596e-06
APC O 0 1.544296355859842e-05
I1307K O 0 3.765751898754388e-06
allele O 0 5.3677338129887175e-09
was O 0 5.31322807972856e-09
identified O 0 2.27703175759153e-10
in O 0 2.2343023264870254e-10
48 O 0 2.5076714038618775e-09
( O 0 4.388580818193155e-11
10 O 0 7.798272583237065e-10
. O 0 2.838522125681031e-11
1 O 0 4.831890998424626e-10
% O 0 7.30418069777583e-12
) O 0 7.461949461107231e-12
of O 0 9.126708833129271e-10
476 O 0 3.786220759138814e-07
patients O 0 1.8083673580804316e-07
. O 0 8.785352179074835e-08

Compared O 0 1.23579070532287e-07
with O 0 7.977145610738035e-10
the O 0 3.208503185359035e-10
frequency O 0 2.962132483741442e-10
in O 0 9.605156947589677e-12
two O 0 2.321988738437919e-12
separate O 0 1.3788017602656133e-11
population O 0 2.2191577460188572e-13
control O 0 3.860570196856372e-11
groups O 0 8.760553914244351e-12
, O 0 3.77326295208924e-11
the O 0 1.5813181875046212e-09
APC O 0 6.696583909615583e-07
I1307K O 0 7.578575491606898e-07
allele O 0 1.7589810719087495e-09
is O 0 6.1281035801386e-11
associated O 0 1.961681511675195e-10
with O 0 3.3177332409151106e-11
an O 0 1.1543678339609453e-11
estimated O 0 2.083221442572558e-11
relative O 0 5.451418205737468e-10
risk O 0 2.649775954211009e-09
of O 0 2.990440250982829e-08
1 O 0 1.7978796051920654e-07
. O 0 3.447619434382432e-08

5 O 0 1.3836210200679488e-05
- O 0 1.0367128197685815e-05
1 O 0 5.514978056453401e-07
. O 0 3.202838527727181e-08

7 O 0 1.5956329662003554e-05
for O 0 5.785929033663706e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999576807022095
( O 0 8.461304901175026e-08
both O 0 1.2273397409501285e-08
P O 0 1.2974978744750842e-05
= O 0 3.8551384307083936e-08
. O 0 9.47488421054743e-10
01 O 0 1.8848620584321907e-06
) O 0 7.355187015001263e-10
. O 0 3.524081693129233e-09

Furthermore O 0 1.064309344656067e-06
, O 0 8.501111814496198e-09
compared O 0 3.924939040444997e-09
with O 0 6.481861158924573e-10
noncarriers O 0 3.9944436139194295e-05
, O 0 1.468078991706534e-08
APC O 0 5.729985787183978e-06
I1307K O 0 1.3326238104127697e-06
carriers O 0 2.006866228754234e-09
had O 0 3.158759920296461e-10
increased O 0 3.66374153237814e-11
numbers O 0 4.8278259862089e-11
of O 0 1.412858630089886e-08
adenomas B-Disease 0 0.024358225986361504
and O 0 0.0008550015627406538
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999938011169434
per O 0 7.054383388549468e-08
patient O 0 1.4516224382532528e-06
( O 0 1.1083860940175327e-08
P O 0 2.5108489353442565e-05
= O 0 2.164604140375559e-08
. O 0 3.530134518037187e-10
03 O 0 8.235997484007385e-08
) O 0 2.5391699159937886e-11
, O 0 5.396911650218383e-12
as O 0 1.4735499279106e-11
well O 0 2.984418268070499e-11
as O 0 3.964374314935348e-11
a O 0 2.3126295323194768e-10
younger O 0 2.633260276496685e-09
age O 0 3.621240862727859e-09
at O 0 5.684933057636954e-08
diagnosis O 0 2.192694182667765e-06
. O 0 1.995492660000764e-08

We O 0 1.563394675940799e-07
conclude O 0 1.500674216003972e-07
that O 0 1.7401725893595454e-10
the O 0 3.3428522172584962e-09
APC O 0 1.0852947980311e-06
I1307K O 0 1.9649660316645168e-06
variant O 0 2.5415414484086796e-07
leads O 0 8.429439368740077e-09
to O 0 3.336360077099698e-10
increased O 0 9.87388393269839e-09
adenoma B-Disease 1 1.0
formation O 0 0.0012234016321599483
and O 0 1.499334700838517e-08
directly O 0 2.79978884520915e-09
contributes O 0 8.374131943433838e-10
to O 0 1.4110985990800629e-10
3 O 0 1.8711117100167485e-09
% O 0 1.2002267235633468e-11
- O 0 3.5969119349665846e-10
4 O 0 5.759547838657397e-10
% O 0 1.9217091026119126e-12
of O 0 3.2527931737025284e-11
all O 0 7.283718767014946e-11
Ashkenazi O 0 3.891934738931013e-06
Jewish O 1 0.999871015548706
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.3684497680042114e-07

The O 0 1.0787900350806012e-07
estimated O 0 1.6813536118931438e-09
relative O 0 4.238814632628873e-09
risk O 0 2.284092914806024e-09
for O 0 2.6187338408867333e-10
carriers O 0 1.036848162883075e-09
may O 0 2.625080153251247e-10
justify O 0 1.5432027877793075e-09
specific O 0 2.1791711490859456e-10
clinical O 0 6.324579082672699e-09
screening O 0 6.312957379073225e-10
for O 0 3.649576127418008e-11
the O 0 3.1763955354868756e-10
360 O 0 3.4282146010866654e-09
, O 0 6.09112899008224e-11
000 O 0 1.0296566932410656e-09
Americans O 0 2.7563899079874332e-11
expected O 0 6.658962964367632e-11
to O 0 6.39541544722455e-11
harbor O 0 1.2291462780922302e-07
this O 0 1.7449245173772887e-11
allele O 0 6.49728118529147e-11
, O 0 3.212543078778829e-11
and O 0 7.364111404006835e-11
genetic O 0 4.762162886251531e-10
testing O 0 3.876172272043732e-09
in O 0 3.5892414040894494e-11
the O 0 4.378305357155554e-11
setting O 0 3.955964000823542e-09
of O 0 3.3364189189200033e-09
long O 0 7.40066896653957e-10
- O 0 1.204597577242339e-08
term O 0 5.27513899228893e-09
- O 0 1.075781508319551e-08
outcome O 0 1.412941541545365e-09
studies O 0 3.542937332401408e-10
may O 0 3.559958230980875e-11
impact O 0 1.5254595364666557e-09
significantly O 0 5.120461832319734e-09
on O 0 0.006901542656123638
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 2.2100664409663295e-06
in O 0 5.904264577250018e-11
this O 0 1.7365103495772805e-12
population O 0 3.079927805849092e-12
. O 0 5.681827230930026e-10

Localization O 0 1.7949763787328266e-05
of O 0 5.434345098365156e-07
human O 0 4.618090798658159e-08
BRCA1 O 0 1.201170363174242e-07
and O 0 2.8001521101828075e-09
its O 0 3.4968037354587977e-09
loss O 0 9.524139699124134e-08
in O 0 3.39523564818478e-09
high O 0 1.530110353087366e-06
- O 0 4.3643967728712596e-07
grade O 0 1.197993810819753e-06
, O 0 5.92989768399832e-10
non B-Disease 0 2.240142202936113e-05
- I-Disease 1 0.8651811480522156
inherited I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 8.388115020352416e-06

Although O 0 6.452386713817759e-08
the O 0 5.692243121302454e-09
link O 0 6.546635678006396e-09
between O 0 5.767517574639669e-10
the O 0 3.1505542619214566e-09
BRCA1 O 0 8.877336767909583e-07
tumour B-Disease 1 1.0
- O 0 2.4358209884667303e-06
suppressor O 0 1.1629695109149907e-06
gene O 0 2.0091421859547154e-08
and O 0 2.4106626028697065e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.182240747636513e-10
established O 0 5.455352614092135e-09
, O 0 6.947283720526443e-11
the O 0 3.419788341396668e-10
role O 0 5.548059234250502e-10
, O 0 6.004385877389495e-11
if O 0 4.555581606391357e-12
any O 0 8.287909247783887e-11
, O 0 1.709068303545891e-10
of O 0 9.46556788505859e-09
BRCA1 O 0 8.771405646257335e-08
in O 0 8.762621739322185e-09
non B-Disease 0 0.15236088633537292
- I-Disease 1 0.9997591376304626
familial I-Disease 1 0.9999439716339111
cancers I-Disease 1 0.9999991655349731
is O 0 2.7506577016112033e-09
unclear O 0 3.48082167533903e-08
. O 0 4.970171474383278e-08

BRCA1 O 0 9.591234993422404e-05
mutations O 0 1.4379773460859724e-07
are O 0 6.080058123636434e-10
rare O 0 1.8696358239367328e-08
in O 0 1.6433521210501567e-08
sporadic B-Disease 0 0.019016142934560776
cancers I-Disease 1 0.999455988407135
, O 0 2.1685206963439896e-09
but O 0 5.382545520404847e-10
loss O 0 2.7677111802404397e-07
of O 0 3.838780230580596e-06
BRCA1 O 0 4.3860941900675243e-07
resulting O 0 2.1205961431292053e-08
from O 0 5.6942845994001345e-09
reduced O 0 2.7014763759325433e-09
expression O 0 7.273213697978065e-10
or O 0 3.7223407689523924e-10
incorrect O 0 1.7645128025378654e-08
subcellular O 0 4.5735342268926615e-07
localization O 0 4.18393909740189e-07
is O 0 8.880374907649369e-11
postulated O 0 1.0675190731390671e-09
to O 0 2.6049332829680694e-11
be O 0 1.3270483670280164e-11
important O 0 1.4614560950310107e-10
in O 0 4.916423934631098e-10
non B-Disease 0 6.9919583438604604e-06
- I-Disease 0 0.00027741509256884456
familial I-Disease 1 0.999886155128479
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 6.6150414568255655e-06

Epigenetic O 0 0.00031119384220801294
loss O 0 0.03483721986413002
, O 0 1.389901438386687e-08
however O 0 5.070920905403398e-10
, O 0 8.777886056909878e-11
has O 0 1.3363645042993588e-12
not O 0 8.486287302218731e-13
received O 0 2.916903177330177e-11
general O 0 4.5180226226904097e-10
acceptance O 0 3.1194549166002616e-09
due O 0 4.7502455302605995e-09
to O 0 3.8319980522061314e-10
controversy O 0 5.229397359585164e-09
regarding O 0 1.4218276556121623e-09
the O 0 6.641639460625015e-10
subcellular O 0 2.7170576899493426e-08
localization O 0 8.905134052383801e-08
of O 0 1.2611054422961843e-08
BRCA1 O 0 8.005224927387644e-09
proteins O 0 2.4191446068577704e-10
, O 0 1.4580009422004991e-10
reports O 0 1.107626879104373e-09
of O 0 3.051770391948594e-09
which O 0 3.0026380687386833e-11
have O 0 4.205139708668426e-12
ranged O 0 2.4658710628955305e-09
from O 0 3.170367024463161e-10
exclusively O 0 5.301057925954922e-10
nuclear O 0 3.3781386576947625e-08
, O 0 1.170290531149476e-10
to O 0 6.618039449790558e-11
conditionally O 0 9.674916157109692e-08
nuclear O 0 1.1883695378855919e-06
, O 0 4.901536398982387e-10
to O 0 2.2791174503211664e-10
the O 0 1.0336971278945839e-08
ER O 1 0.9161336421966553
/ O 0 8.314043498103274e-07
golgi O 0 4.5000492718827445e-06
, O 0 2.8781483862871937e-09
to O 0 5.154806026475001e-10
cytoplasmic O 0 2.5570395578711214e-08
invaginations O 0 1.0180815479543526e-06
into O 0 7.465748019797047e-09
the O 0 1.0852140519546083e-08
nucleus O 0 8.995438065539929e-07
. O 0 2.8982626076867746e-08

In O 0 1.1531619037441487e-07
an O 0 4.4260833886866635e-10
attempt O 0 5.463204111322284e-09
to O 0 6.55062948329288e-10
resolve O 0 8.771568360543824e-09
this O 0 5.570185632186586e-11
issue O 0 2.898773721060621e-10
, O 0 1.0703504749187687e-10
we O 0 1.3838892705397843e-11
have O 0 1.1431691530894295e-11
comprehensively O 0 1.3786097952106502e-07
characterized O 0 1.6130060842556304e-08
19 O 0 7.91940877320485e-08
anti O 0 1.3132101912560756e-06
- O 0 2.128489541064482e-06
BRCA1 O 0 1.5911721220618347e-06
antibodies O 0 1.93104270351796e-07
. O 0 1.1442054415056191e-07

These O 0 1.0358646562735885e-07
reagents O 0 2.2237154553295113e-06
detect O 0 3.836759788100608e-06
a O 0 1.4888702715154523e-08
220 O 0 1.8712269067577836e-08
- O 0 4.107156215127361e-08
kD O 0 4.273961451417563e-07
protein O 0 7.040880656283832e-10
localized O 0 8.95269636203011e-09
in O 0 1.2677217609002867e-10
discrete O 0 8.169293574944447e-10
nuclear O 0 1.1204640770756669e-07
foci O 0 2.044963167691094e-07
in O 0 6.707751021295394e-10
all O 0 2.077025218483186e-10
epithelial O 0 1.4989399943488024e-08
cell O 0 1.0400061967175134e-07
lines O 0 1.1850808334656904e-08
, O 0 1.5321567625736776e-10
including O 0 2.0271392897619478e-10
those O 0 6.318532502769258e-11
derived O 0 4.170734424491229e-09
from O 0 7.880683483563189e-08
breast B-Disease 0 0.00026673232787288725
malignancies I-Disease 0 0.0023651099763810635
. O 0 1.8793951994666713e-07

Immunohistochemical O 0 0.0002958392142318189
staining O 0 1.6084342860267498e-05
of O 0 3.1699701139586978e-06
human O 0 3.0716569199285004e-07
breast O 0 2.8152233426226303e-05
specimens O 0 5.645864575853921e-07
also O 0 4.18574863658705e-09
revealed O 0 3.598006799165887e-07
BRCA1 O 0 1.866018010332482e-06
nuclear O 0 0.00014822294178884476
foci O 0 8.720320329302922e-05
in O 0 8.766989623154586e-08
benign O 1 0.9999991655349731
breast O 1 0.9999967813491821
, O 0 4.977447929377377e-07
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 6.345397650875384e-06
low B-Disease 1 0.9999959468841553
- I-Disease 1 0.9999836683273315
grade I-Disease 1 0.9999996423721313
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 5.0178250603494234e-06

Conversely O 0 2.7614939881459577e-06
, O 0 2.052738956592748e-08
BRCA1 O 0 1.0866850885804524e-07
expression O 0 5.883518561233814e-09
was O 0 2.1099449298844775e-08
reduced O 0 1.63011804055202e-09
or O 0 2.5589785845880897e-10
undetectable O 0 5.156394422556332e-08
in O 0 4.4977802732271144e-11
the O 0 8.256070133105808e-11
majority O 0 2.8468434207229443e-12
of O 0 1.7862097911880426e-10
high O 0 2.7381807399251556e-07
- O 0 1.380171511300432e-06
grade O 0 2.7210748157813214e-05
, O 0 1.1442420344565107e-08
ductal B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 1.0
, O 0 1.781414127322023e-08
suggesting O 0 5.972615291227612e-09
that O 0 8.536085033261642e-11
absence O 0 3.277547122593205e-08
of O 0 1.8988899910254986e-06
BRCA1 O 0 2.1721994016843382e-06
may O 0 2.108101471165469e-09
contribute O 0 2.5185992180709604e-10
to O 0 2.598498360928403e-10
the O 0 3.651070112908883e-09
pathogenesis O 0 8.118141749946517e-07
of O 0 1.0230034597213944e-08
a O 0 1.795264353843251e-10
significant O 0 9.899557562587091e-11
percentage O 0 1.442324371048187e-09
of O 0 1.2988189190821231e-08
sporadic B-Disease 1 0.7486531734466553
breast I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.999940037727356
. O 0 1.336683297381569e-08
. O 0 5.673559400065642e-08

